{"A": [{"Nom": "ABASAGLAR 100UI/ML (3,64MG/ML) SOL. INJ. EN STYLO PREREMPLI KWIKPEN  B/05 STYLOS PREREMLIS DE 3 ML", "Img": "https://pharmnet-dz.com//img/medics/5866.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5866", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "AUTRICHE", "Nom Commercial": "ABASAGLAR", "Tarif de reference": "- DA", "PPA": " DA", "Code DCI": "14B215", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,64MG/ML)", "Conditionnement": "B/05 STYLOS PREREMLIS DE 3 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ABILIFY 10MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/2288.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2288", "Laboratoire": " OTSUKA PHARMACEUTICAL EUROPE LTD", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ABILIFY", "Tarif de reference": "6552 DA", "PPA": "5452.00 DA", "Num Enregistrement": "414/ 16 D 103 /08", "Code DCI": "16D103", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ABILIFY 15MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/2290.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2290", "Laboratoire": " OTSUKA PHARMACEUTICAL EUROPE LTD", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ABILIFY", "Tarif de reference": "6552 DA", "PPA": "5452.00 DA", "Num Enregistrement": "414/ 16 D 104 /08", "Code DCI": "16D104", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ABILIFY 15MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/4441.png", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "ABILIFY", "Tarif de reference": "7020 DA", "PPA": " DA", "Num Enregistrement": "511/16D104/08/16", "Code DCI": "16D104", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ABILIZOLE 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2285.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ABILIZOLE", "Tarif de reference": "5,842.20 DA", "PPA": "5,630.16 DA", "Num Enregistrement": "352/ 16 D 103 /15", "Code DCI": "16D103", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ABILIZOLE 15MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2291.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ABILIZOLE", "Tarif de reference": "5,842.20 DA", "PPA": "5,842.27 DA", "Num Enregistrement": "352/ 16 D 104 /15", "Code DCI": "16D104", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ABUFENE 400MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3034.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3034", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " MENOPAUSE (PRODUITS NON HORMONAUX)", "C.Therapeutique": " GYNECOLOGIE", "Info": " BETA - ALANINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ABUFENE", "Tarif de reference": "0 DA", "PPA": "328.61 DA", "Num Enregistrement": "269/ 11 F 048 /98", "Code DCI": "11F048", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "ACARLYSE 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/4642.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACARLYSE", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "289/14A136/16", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEBUTOLOL IVAL 200MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACEBUTOLOL IVAL", "Tarif de reference": "314.7 DA", "PPA": "340.00 DA", "Num Enregistrement": "195/ 06 F 067 /10", "Code DCI": "06F067", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEBUTOLOL IVAL 400MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACEBUTOLOL IVAL", "Tarif de reference": "582 DA", "PPA": "580.00 DA", "Num Enregistrement": "235/ 06 F 068 /11", "Code DCI": "06F068", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEBUTOLOL SANDOZ 200MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3227", "Laboratoire": " SANDOZ", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACEBUTOLOL SANDOZ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 06 F 067 /06", "Code DCI": "06F067", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ACEPRAL 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/4112.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "ACEPRAL", "Tarif de reference": "66.8 DA", "PPA": "66.00 DA", "Num Enregistrement": "003/ 03 A 001 /97", "Code DCI": "02D049", "Forme": "COMP. PELLI. LP", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEPRAL L- NOURRISSON 100MG/SACH.-DOSE PDRE. SOL. BUV.  B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACEPRAL L- NOURRISSON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 A 104 /08", "Code DCI": "03A104", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/SACH.-DOSE", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEPRAL-L 1000MG 1G/SACH.-DOSE PDRE. SOL. BUV. B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACEPRAL-L 1000MG", "Tarif de reference": "133.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 A 069 /09", "Code DCI": "03A069", "Forme": "PDRE. SOL. BUV.", "Dosage": "1G/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEPRAL-L 160MG/SACHET-DOSE (288MG/SACHET ACETYLSALICYLATE DE DL LYSINE) PDRE. SOL. BUV. EN SACHET B/30SACHETS-DOSE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACEPRAL-L", "Tarif de reference": "127.2 DA", "PPA": "N/A", "Num Enregistrement": "003/ 12 A 144 /09", "Code DCI": "12A144", "Forme": "PDRE. SOL. BUV.", "Dosage": "160MG/SACHET-DOSE (288MG/SACHET ACETYLSALICYLATE DE DL LYSINE)", "Conditionnement": "B/30SACHETS-DOSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEPRAL-L ADULTES 500MG/SACH.-DOSE PDRE. SOL. BUV. EN SACH.-DOSE B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACEPRAL-L ADULTES", "Tarif de reference": "66.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 A 025 /08", "Code DCI": "03A025", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACEPRAL-L ENFANT 250MG/SACH.-DOSE PDRE. SOL. BUV. EN SACH.-DOSE B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACEPRAL-L ENFANT", "Tarif de reference": "117.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 A 024 /08", "Code DCI": "03A024", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACETADOL 0.03 SOL. BUV. B/1 FL DE 100ML+PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PARACETAMOL ET DERIVES", "C.Pharmacologique": " ANTALGIQUES", "C.Therapeutique": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACETADOL", "Tarif de reference": "72.9 DA", "PPA": "N/A", "Num Enregistrement": "503/03B061/16", "Code DCI": "03B061", "Forme": "SOL. BUV.", "Dosage": "3%", "Conditionnement": "B/1 FL DE 100ML+PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACFUSID 0,02 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "ACFUSID", "Tarif de reference": "144,9 DA", "PPA": "N/A", "Code DCI": "07C016", "Forme": "PDE. DERM.", "Dosage": "2%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACICLOSINA 3% (OU 30MG/G) PDE.OPHT. T/5G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CIPAN", "C.Pharmacologique": " ANTIVIRAUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "ACICLOSINA", "Tarif de reference": "307.75 DA", "PPA": "N/A", "Num Enregistrement": "218/ 17 F 042 /99", "Code DCI": "17F042", "Forme": "PDE. OPHT.", "Dosage": "3% (OU 30MG/G)", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACICLOVIR GL 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " N/D", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACICLOVIR GL", "Tarif de reference": "623.44 DA", "PPA": "623.44 DA", "Num Enregistrement": "065/13P097/15", "Code DCI": "13P097", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACICLOVIR MYLAN 250MG/FL. DE PDRE. PDRE. SOL. INJ. IV B/05 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/420.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=420", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACICLOVIR MYLAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "450/ 13 P 098 /07/15", "Code DCI": "13P098", "Forme": "PDRE. SOL. INJ.", "Dosage": "250MG/FL. DE PDRE.", "Conditionnement": "B/05 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACICLOVIR MYLAN 500MG/FL. DE PDRE. PDRE. SOL. INJ. IV B/05 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3523.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3523", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACICLOVIR MYLAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "450/ 13 P 308 /06 ", "Code DCI": "13P308", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/05 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIDE AMINOCAPROIQUE 2G/10ML SOL INJ IV B/10AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANTIFIBRINOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE AMINOCAPROIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACIDE AMINOCAPROIQUE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 12 C 011 /98", "Code DCI": "12C011", "Forme": "SOL. INJ.", "Dosage": "2G/10ML", "Conditionnement": "B/10AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIDE BIOTIC  SOL. POUR HEMODIALYSE BIDON 10L ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE LIQUIDE", "Pays": "ALGERIE", "Nom Commercial": "ACIDE BIOTIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 25 G 020 /06", "Code DCI": "25G020", "Forme": "SOL. DIALYSE", "Conditionnement": "BIDON 10L ", "Commercialisation": true, "Remboursable": null}, {"Nom": "ACIDE FOLIQUE - API 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1746.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " API", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACIDE FOLIQUE - API", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "348/ 12 E 020 /15", "Code DCI": "12E020", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIDE ZOLEDRONIQUE HIKMA 4MG/FLACON PDRE LYOPHILISEE P/ PERF IV  B/01 FL DE PDRE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " ACIDE ZOLEDRONIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ACIDE ZOLEDRONIQUE HIKMA", "Tarif de reference": "12140 DA", "PPA": "N/A", "Num Enregistrement": "001/ 05 F 123 /14", "Code DCI": "05F123", "Forme": "SOL. PERF.", "Dosage": "4MG/FLACON", "Conditionnement": "B/01 FL DE PDRE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIDERM 0,1G/0,2G/2G/0,1G/0,7G/ 100ML SOL. FL/250 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " OXYQUINOLEINE/ACIDE SALICYLIQUE/ LAURYLSULFATE DE SODIUM/ACIDE TARTRIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACIDERM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 07 P 074 /99", "Code DCI": "07P074", "Forme": "SOL.", "Dosage": "0,1G/0,2G/2G/0,1G/0,7G/ 100ML", "Conditionnement": "FL/250 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ACIDIAL  SOL. POUR HEMODIALYSE BIDON 10L ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE  POUDRE", "Pays": "ALGERIE", "Nom Commercial": "ACIDIAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 25 G 056 /06", "Code DCI": "25G056", "Forme": "SOL. DIALYSE", "Conditionnement": "BIDON 10L ", "Commercialisation": true, "Remboursable": null}, {"Nom": "ACIDRINE 2,50MG/250MG/200MG COMP. A CROQ. B/40 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LAURYL SULFATE DE MYRTECAINE / AMINOACETATE D'ALUMINIUM / SULFATE DE GALACTONE", "Pays": "ALGERIE", "Nom Commercial": "ACIDRINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "031/ 10 B 004 /97", "Code DCI": "10B004", "Forme": "COMP. A CROQ.", "Dosage": "2,50MG/250MG/200MG", "Conditionnement": "B/40 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIFIX 175MG/200MG/5ML SUSP. BUV. FLACON FL./200ML", "Img": "https://pharmnet-dz.com//img/medics/3905.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3905", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "ALGERIE", "Nom Commercial": "ACIFIX", "Tarif de reference": "134 DA", "PPA": "N/A", "Num Enregistrement": "242/ 10 B 105 /06", "Code DCI": "10B105", "Forme": "SUSP. BUV.", "Dosage": "175MG/200MG/5ML", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIFUDAL 0.01 GEL OPHT T/3G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACIDE FUSIDIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACIFUDAL", "Tarif de reference": "162 DA", "PPA": "N/A", "Num Enregistrement": "003/ 17 D 104 /08", "Code DCI": "17D104", "Forme": "GEL. OPHT.", "Dosage": "0.01", "Conditionnement": "T/3G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIFUDAL 0.02 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1676.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1676", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACIFUDAL", "Tarif de reference": "166.65 DA", "PPA": "166,65 DA", "Num Enregistrement": "003/ 07 C 017 /08", "Code DCI": "07C017", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACIFUDAL 0.02 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACIFUDAL", "Tarif de reference": "144.9 DA", "PPA": "N/A", "Num Enregistrement": "003/ 07 C 016 /08", "Code DCI": "07C016", "Forme": "PDE. DERM.", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACLASTA 5MG/100ML SOL INJ P/PERF B/01FL DE 100ML", "Img": "https://pharmnet-dz.com//img/medics/1086.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1086", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " ACIDE ZOLEDRONIQUE MONOHYDRATE (EXPRIME EN ACIDE ZOLEDRONIQUE)", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "ACLASTA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 05 F 165/14", "Code DCI": "05F165", "Forme": "SOL. INJ.", "Dosage": "5MG/100ML", "Conditionnement": "B/01FL DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACNESTOP 0.01 GEL T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLINDAMYCINE PHOSPHATE EXPRIME EN CLINDAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACNESTOP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/07B159/16", "Code DCI": "07B159", "Forme": "GEL", "Dosage": "1.0%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACROBAY 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ACROBAY", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "418/14A136/16", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTEMRA 20MG/ML/FLACON  CONCENTRE POUR SOLUTION A DILUER POUR PERFUSION IV  BOITE DE 1 FLACON DE 4 ML ( 80 mg/4ml), 10ml (200mg/10ml), 20ml( 400 mg/20ml)", "Img": "https://pharmnet-dz.com//img/medics/4235.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4235", "Laboratoire": " ROCHE", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "ACTEMRA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/21J068/15", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG/ML/FLACON ", "Conditionnement": "BOITE DE 1 FLACON DE 4 ML ( 80 mg/4ml), 10ml (200mg/10ml), 20ml( 400 mg/20ml)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTICAL 0.1 SIROP FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM PIDOLATE", "Pays": "ALGERIE", "Nom Commercial": "ACTICAL", "Tarif de reference": "137.5 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 135 /07", "Code DCI": "14G135", "Forme": "SIROP", "Dosage": "0.1", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTICAL 135MG/10ML DE CALCIUM** (1G/10ML OU 10% DE PIDOLATE DE CALCIUM) AMP. BUV. B/20AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM PIDOLATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "ACTICAL", "Tarif de reference": "220 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 328 /09", "Code DCI": "14G328", "Forme": "AMP. BUV.", "Dosage": "135MG/10ML DE CALCIUM** (1G/10ML OU 10% DE PIDOLATE DE CALCIUM)", "Conditionnement": "B/20AMP. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTICARBINE 14MG/70MG COMP. ENRO. B/42", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PAPAVERINE CHLORHYDRATE/CHARBON ACTIVE", "Pays": "ALGERIE", "Nom Commercial": "ACTICARBINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "318/ 10 B 143 /05", "Code DCI": "10B143", "Forme": "COMP. PELLI.", "Dosage": "14MG/70MG", "Conditionnement": "B/42", "Commercialisation": true, "Remboursable": null}, {"Nom": "ACTILYSE 20MG PDRE ET  SOLVT. SOL. INJ. B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1815", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ALTEPLASE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACTILYSE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 12 F 115 /05", "Code DCI": "12F115", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTILYSE 50MG PDRE ET  SOLVT. SOL. INJ. B/1+1", "Img": "https://pharmnet-dz.com//img/medics/1816.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1816", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ALTEPLASE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACTILYSE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 12 F 116 /05", "Code DCI": "12F116", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTIMAG 15% (0,75G/5ML SOIT 61MG/5ML DE MAGNESIUM ELEMENT) SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM ELEMENT  (SOUS FORME DE MAGNESIUM PIDOLATE)", "Pays": "ALGERIE", "Nom Commercial": "ACTIMAG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 14 G 162 /98/14", "Code DCI": "14G162", "Forme": "SOL. BUV.", "Dosage": "15% (0,75G/5ML SOIT 61MG/5ML DE MAGNESIUM ELEMENT)", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ACTOCYL 80MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " VECOPHARM", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ACTOCYL", "Tarif de reference": "43 DA", "PPA": "N/A", "Num Enregistrement": "301/ 12 A 146 /08", "Code DCI": "12A146", "Forme": "COMP. SEC.", "Dosage": "80MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTONEL  5MG COMP PELL B/28", "Img": "https://pharmnet-dz.com//img/medics/1415.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1415", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE SEL MONOSODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACTONEL ", "Tarif de reference": "1899.8 DA", "PPA": "3,656.25 DA", "Num Enregistrement": "230/ 21 D 040 /03", "Code DCI": "21D040", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTONEL 35MG COMP PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1411.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1411", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE SEL MONOSODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACTONEL", "Tarif de reference": "1,899.80 DA", "PPA": "3,656.25 DA", "Num Enregistrement": "230/ 21 C 041 /03", "Code DCI": "21C041", "Forme": "COMP. PELLI.", "Dosage": "35MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTOS 15MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/3716.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " PIOGLITAZONE CHLORHYDRATE EXPRIME EN PIOGLITAZONE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ACTOS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "118 / 14 A 309 /08", "Code DCI": "14A309", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTOS 30MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/3717.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " PIOGLITAZONE CHLORHYDRATE EXPRIME EN PIOGLITAZONE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ACTOS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "118/ 14 A 310 /08", "Code DCI": "14A310", "Forme": "COMP.", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTRAPID HM 100UI/ML SOL INJ FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/3743.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3743", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE MONOCOMPOSEE", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "ACTRAPID HM", "Tarif de reference": "0 DA", "PPA": "797.00 DA", "Num Enregistrement": "069/ 14 B 194 /00", "Code DCI": "14B194", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACTRAPID HM PENFILL 100UI/ML SOL INJ. B/5 CART. de 1,5 ML ET B/5CART  DE 3ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3730", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE RAPIDE", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "ACTRAPID HM PENFILL", "Tarif de reference": "0 DA", "PPA": "2134.00 DA", "Num Enregistrement": "069/ 14 B 153 /98", "Code DCI": "14B153", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART. de 1,5 ML ET B/5CART  DE 3ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACUILIX 20MG/12,5MG COMP .PELLI .SEC B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=184", "Laboratoire": " PFIZER", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACUILIX", "Tarif de reference": "0 DA", "PPA": "1075.00 DA", "Num Enregistrement": "045/ 06 E 131 /97", "Code DCI": "06E131", "Forme": "COMP. PELLI.", "Dosage": "20MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACUITEL 20MG COMP. ENRO. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=183", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACUITEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 06 E 130 /97/15", "Code DCI": "06E130", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACUITEL 5MG COMP. ENRO. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/182.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=182", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACUITEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 06 E 129 /97/15", "Code DCI": "06E129", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ACUPAN 10MG/ML (OU 20MG/2ML) SOL. INJ. IM/IV B/05AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/2695.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2695", "Laboratoire": " BIOCODEX", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " ANTALGIQUES", "Info": " NEFOPAM CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ACUPAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "101/ 03 H 112 /09", "Code DCI": "03H112", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (OU 20MG/2ML)", "Conditionnement": "B/05AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADAPALENE NOVAGENERICS 0.001 GEL P. APPLI. LOCALE T/30G", "Img": "https://pharmnet-dz.com//img/medics/1660.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1660", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ADAPALENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ADAPALENE NOVAGENERICS", "Tarif de reference": "312.77 DA", "PPA": "N/A", "Num Enregistrement": "149/ 07 B 109 /13", "Code DCI": "07B109", "Forme": "SOL. APP. LOCALE", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADCAL 500MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE", "Pays": "JORDANIE", "Nom Commercial": "ADCAL", "Tarif de reference": "465 DA", "PPA": "N/A", "Num Enregistrement": "043/ 14 G 141 /08", "Code DCI": "14G141", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADDNOK 20MG COMP. PELLI. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ADDNOK", "Tarif de reference": "1620 DA", "PPA": "N/A", "Num Enregistrement": "286/16A095/16", "Code DCI": "16A095", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADEPAL 0,15MG/0,03MG(BLANCS)  ET 0,20MG/0,04MG(ROSE ORANGE) COMP. B/3X21(7BLANCS + 14 ROSE ORANGE)", "Img": "https://pharmnet-dz.com//img/medics/3040.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3040", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ADEPAL", "Tarif de reference": "220.86 DA", "PPA": "N/A", "Num Enregistrement": "030/ 11 H 028 /98", "Code DCI": "11H028", "Forme": "COMP.", "Dosage": "0,15MG/0,03MG(BLANCS)  ET 0,20MG/0,04MG(ROSE ORANGE)", "Conditionnement": "B/3X21(7BLANCS + 14 ROSE ORANGE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADEX LP 1,5MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/1485.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " INDAPAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ADEX LP", "Tarif de reference": "690 DA", "PPA": "690.00 DA", "Num Enregistrement": "317/ 06 H 163 /11", "Code DCI": "06H163", "Forme": "COMP. PELLI. LP", "Dosage": "1,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADIPINE 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/61.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NIFEDIPINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ADIPINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 B 017 /97", "Code DCI": "06B017", "Forme": "CAPS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADIPINE 20MG GLES. A \u00b5GRLES.  LP B/30", "Img": "https://pharmnet-dz.com//img/medics/65.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=65", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NIFEDIPINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ADIPINE", "Tarif de reference": "405.89 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 B 018 /98/07", "Code DCI": "06B018", "Forme": "GLES. LP", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADRECAINE-GEO 2% / 1/80000 SOL.INJ. USAGE DENTAIRE B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE CHLORHYDRATE / ADRENALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ADRECAINE-GEO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "304/ 02 C 022 /08", "Code DCI": "02C022", "Forme": "SOL. INJ.", "Dosage": "2% / 1/80000", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ADRENALINE AGUETTANT 0,25MG/ML SOL.INJ. B/100AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=34", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ADRENALINE AGUETTANT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "075/ 06 A 001 /98", "Code DCI": "06A001", "Forme": "SOL. INJ.", "Dosage": "0,25MG/ML", "Conditionnement": "B/100AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADRENALINE AGUETTANT 1MG/ML SOL.INJ. B/10AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/35.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=35", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ADRENALINE AGUETTANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "075/ 06 A 002 /98", "Code DCI": "06A002", "Forme": "SOL. INJ.", "Dosage": "1MG/ML", "Conditionnement": "B/10AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADRENALINE RAZES SANS SULFITE 1MG/ML  SOL INJ  B/50 AMPS 1ML", "Img": "https://pharmnet-dz.com//img/medics/36.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ADRENALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ADRENALINE RAZES SANS SULFITE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 06 A 002 /14", "Code DCI": "06A002", "Forme": "SOL. INJ.", "Dosage": "1MG/ML ", "Conditionnement": "B/50 AMPS 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ADVATE 1000UI/FL DE PDRE  (50UI/ML)  PDRE ET SOLVANT P/SOL INJ IV  B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1842", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " OCTOCOG ALFA  (FACTEUR VIII RECOMBINANT DE COAGULATION ANTI-HEMOPHILIQUE)", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "ADVATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "298/ 12 J 155 /14", "Code DCI": "12J155", "Forme": "PDRE. INJ.", "Dosage": "1000UI/FL DE PDRE  (50UI/ML) ", "Conditionnement": "B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADVATE 250UI/FL DE PDRE (50UI/ML)  PDRE ET SOLVANT P/ SOL INJ IV  B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1840", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " OCTOCOG ALFA  (FACTEUR VIII RECOMBINANT DE COAGULATION ANTI-HEMOPHILIQUE)", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "ADVATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "298/ 12 J 154 /14", "Code DCI": "12J154", "Forme": "PDRE. INJ.", "Dosage": "250UI/FL DE PDRE (50UI/ML) ", "Conditionnement": "B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ADVATE 500UI/FL DE PDRE (50UI/ML)  PDRE ET SOLVANT P/ SOL INJ IV  B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1829", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR HUMAIN VIII  ANTI HEMOPHILIQUE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "ADVATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "298/ 12 J 044 /14", "Code DCI": "12J044", "Forme": "PDRE. INJ.", "Dosage": "500UI/FL DE PDRE (50UI/ML) ", "Conditionnement": "B/01FL DE PDRE+01 SERINGUE A USAGE UNIQUE DE 10ML + 01 FL DE SOLVANT (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "AEROLIN 100\u00b5G/BOUFFEE AERO. FL/400DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EIPICO ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "AEROLIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "109/ 20 A 017 /99", "Code DCI": "20A017", "Forme": "AERO.", "Dosage": "100\u00b5G/BOUFFEE", "Conditionnement": "FL/400DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "AERRANE 100ML/100ML - 250ML/250ML LIQUIDE. P. INHAL. PAR VAPEUR CARTON DE 06 FL. DE 100ML ET CARTON DE 06 FL. DE 250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4050", "Laboratoire": " BAXTER", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ISOFLURANE", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "AERRANE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 02 B 007 /12", "Code DCI": "02B007", "Forme": "LIQUIDE P. INHAL", "Dosage": "100ML/100ML - 250ML/250ML", "Conditionnement": "CARTON DE 06 FL. DE 100ML ET CARTON DE 06 FL. DE 250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "AFUNDAS-L 50MG/FL. DE PDRE. PDRE lyophilis\u00e9e P. SOL. A DILUER P. PERF. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "AFUNDAS-L", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "13R284", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG/FL", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "AFUNDAS-L 70MG/FL. DE PDRE. PDRE lyophilis\u00e9e P. SOL. A DILUER P. PERF. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "AFUNDAS-L", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "13R285", "Forme": "PDRE. SOL. INJ.", "Dosage": "70MG/FL", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "AGRASTAT 0,25MG/ML SOL. A DILUER P. PERF. IV B/01FL. DE 50ML", "Img": "https://pharmnet-dz.com//img/medics/118.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=118", "Laboratoire": " IROKO CARDIO (UK) LIMITED", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TIROFIBAN CHLORHYDRATE MONOHYDRATE EXPRIME EN TIROFIBAN", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AGRASTAT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "473/ 06 C 210 /06/12", "Code DCI": "06C210", "Forme": "SOL. PERF.", "Dosage": "0,25MG/ML", "Conditionnement": "B/01FL. DE 50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AIRDITINE 0,5MG/ML SIROP B/1FL. DE 120ML + BOUCHON DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medics/4030.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4030", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AIRDITINE", "Tarif de reference": "370.8 DA", "PPA": "N/A", "Num Enregistrement": "352/ 01 A 048 /12", "Code DCI": "01A048", "Forme": "SIROP", "Dosage": "0,5MG/ML", "Conditionnement": "B/1FL. DE 120ML + BOUCHON DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "AIRDITINE 5MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/4028.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AIRDITINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/ 01 A 047 /12", "Code DCI": "01A047", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "AKARYD 10MG COMP. PELLI.  B/20", "Img": "https://pharmnet-dz.com//img/medics/3987.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AKARYD", "Tarif de reference": " N/A", "PPA": "239.00 DA", "Num Enregistrement": "268/ 01 A 033 /05/12", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "AKNETT 10MG CAPS. MOLLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AKNETT", "Tarif de reference": "1167.9 DA", "PPA": "N/A", "Num Enregistrement": "321/ 07 L 058 /08", "Code DCI": "07L058", "Forme": "CAPS. MOLLE", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AKNETT 20MG CAPS. MOLLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AKNETT", "Tarif de reference": "2022 DA", "PPA": "N/A", "Num Enregistrement": "321/ 07 L 059 /06", "Code DCI": "07L059", "Forme": "CAPS. MOLLE", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALBUMINE HUMAINE 20% BIOTEST 0.2 SOL. PERF. FL./ 50ML ET FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/1827.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOTEST PHARMA GmBH", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ALBUMINE HUMAINE", "Pays": "ALLEMAGNE", "Nom Commercial": "ALBUMINE HUMAINE 20% BIOTEST", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "370/ 12 J 042 /07", "Code DCI": "12J042", "Forme": "SOL. INJ.", "Dosage": "0.2", "Conditionnement": "FL./ 50ML ET FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALBUREL 20% (20G/100ML) SOL. P. PERF. IV B/1FL. DE 50ML ET B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " CPCM", "C.Pharmacologique": " HEMATOLOGIE ET HEMOSTASE", "C.Therapeutique": " ALBUMINE HUMAINE", "Pays": "ALGERIE", "Nom Commercial": "ALBUREL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 12 K 042 /12", "Code DCI": "12K042", "Forme": "SOL. PERF.", "Dosage": "20% (20G/100ML)", "Conditionnement": "B/1FL. DE 50ML ET B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL CAMPHRE 90\u00b0 SOL. USAGE EXTERNE FL./1000ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE CAMPHRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CAMPHRE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 26 B 036 /00", "Code DCI": "26B036", "Forme": "SOL. EXTERNE", "Dosage": "90\u00b0", "Conditionnement": "FL./1000ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL CHIRURGICAL 70\u00b0 SOL. USAGE EXTERNE FL./1000ML", "Img": "https://pharmnet-dz.com//img/medics/1256.png", "Laboratoire": " RIADH PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "314/ 26 B 038 /15", "Code DCI": "26B038", "Forme": "SOL. EXTERNE", "Dosage": "70\u00b0", "Conditionnement": "FL./1000ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALCOOL CHIRURGICAL 70\u00b0 SOL. USAGE EXTERNE FL./1000ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LABIOCO", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "464/ 26 B 038 /10", "Code DCI": "26B038", "Forme": "SOL. EXTERNE", "Dosage": "70\u00b0", "Conditionnement": "FL./1000ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL CHIRURGICAL 70\u00b0 SOL. USAGE EXTERNE FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RHUMEL PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "234/ 26 B 038 /02", "Code DCI": "26B038", "Forme": "SOL. EXTERNE", "Dosage": "70\u00b0", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL CHIRURGICAL 70\u00b0 SOL. USAGE EXTERNE FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ZH SANTE LABO SARL", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "379/ 26 B 038 /09", "Code DCI": "26B038", "Forme": "SOL. EXTERNE", "Dosage": "70\u00b0", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL CHIRURGICAL 70\u00b0 SOL. USAGE EXTERNE FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 26 B 038 /03", "Code DCI": "26B038", "Forme": "SOL. EXTERNE", "Dosage": "70\u00b0", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL CHIRURGICAL 70\u00b0 SOL. USAGE EXTERNE FL/60ML ET FL/1000ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOLAB", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "349/ 26 B 038 /06", "Code DCI": "26B038", "Forme": "SOL. EXTERNE", "Dosage": "70\u00b0", "Conditionnement": "FL/60ML ET FL/1000ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL CHIRURGICAL 90\u00b0 SOL. USAGE EXTERNE FL./1000ML", "Img": "https://pharmnet-dz.com//img/medics/1264.png", "Laboratoire": " RIADH PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "314/ 26 B 041 /15", "Code DCI": "26B041", "Forme": "SOL. EXTERNE", "Dosage": "90\u00b0", "Conditionnement": "FL./1000ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALCOOL CHIRURGICAL 90\u00b0 SOL. USAGE EXTERNE FL./1000ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL CHIRURGICAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 26 B 041 /99/09", "Code DCI": "26B041", "Forme": "SOL. EXTERNE", "Dosage": "90\u00b0", "Conditionnement": "FL./1000ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL DENATURE 70\u00b0 SOL. ANTISEPTIQUE FL./1000ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL DENATURE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 26 B 038 /08", "Code DCI": "26B038", "Forme": "SOL. EXTERNE", "Dosage": "70\u00b0", "Conditionnement": "FL./1000ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALCOOL DENATURE RPP 90\u00b0 SOL HYDRO ALCOOLIQUE CAMPHRE  FL/1000ML", "Img": "https://pharmnet-dz.com//img/medics/4635.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " RIADH PHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL DENATURE RPP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "314/26B042/16", "Code DCI": "N/D", "Forme": "SOL. EXTERNE", "Dosage": "90\u00b0", "Conditionnement": "FL/1000ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALCOOL IODE 1% RPP 0.01 SOL HYDROALCOOLIQUE EN APP CUTANEE FL./1L", "Img": "https://pharmnet-dz.com//img/medics/4637.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " RIADH PHARM", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " IODE BISUBLIME / ALCOOL ETHYLIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL IODE 1% RPP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "314/07P164/16", "Code DCI": "07P164", "Forme": "SOL. EXTERNE", "Dosage": "1%", "Conditionnement": "FL./1L", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALCOOL IODEE 0.01 SOL. APPLI. LOCALE FL./1L", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " IODE BISUBLIME / ALCOOL ETHYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ALCOOL IODEE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 07 P 164 /09", "Code DCI": "07P164", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "FL./1L", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALDACTAZINE 25MG/15MG COMP.PELLI.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1483.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1483", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SPIRONOLACTONE / ALTIZIDE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ALDACTAZINE", "Tarif de reference": "435.59 DA", "PPA": "N/A", "Num Enregistrement": "045/ 06 H 096 /97/08", "Code DCI": "06H096", "Forme": "COMP. PELLI.", "Dosage": "25MG/15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALDACTONE 75MG COMP.PELLI.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1481.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1481", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SPIRONOLACTONE MICRONISEE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ALDACTONE", "Tarif de reference": "721.29 DA", "PPA": "N/A", "Num Enregistrement": "045/ 06 H 095 /97/08", "Code DCI": "06H095", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALDOMET 250MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/161.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=161", "Laboratoire": " ASPEN EUROPE GMBH", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " METHYLDOPA SESQUIHYDRATEE EXPRIME EN METHYLDOPA ANHYDRE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ALDOMET", "Tarif de reference": "242.5 DA", "PPA": "N/A", "Num Enregistrement": "467/ 06 E 061 /99/11", "Code DCI": "06E061", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALDURAZYME 100U DE LARONIDASE /ML (500U DE LARONIDASE /ML) SOL. A DILUER P. PERF. IV B/01 FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/3481.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3481", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LARONIDASE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ALDURAZYME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 14 N 348 /15", "Code DCI": "14N348", "Forme": "SOL. PERF.", "Dosage": "100U DE LARONIDASE /ML (500U DE LARONIDASE /ML)", "Conditionnement": "B/01 FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALERFEN 1MG/5ML SOL.BUV. FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ALERFEN", "Tarif de reference": "167.5 DA", "PPA": "122.00 DA", "Num Enregistrement": "003/ 20 A 013 /98", "Code DCI": "20A013", "Forme": "SOL. BUV.", "Dosage": "1MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALEXAN 20MG/ML (OU 100MG/5ML) SOL INJ  FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/971.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYTARABINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "ALEXAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 012 /05", "Code DCI": "05A012", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG/ML (OU 100MG/5ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALEXAN 50MG/ML (OU 500MG/10ML -  1000MG/20ML) SOL INJ  1FL/10ML ET 1FL/20ML", "Img": "https://pharmnet-dz.com//img/medics/1014.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYTARABINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "ALEXAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 107 /05", "Code DCI": "05A107", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (OU 500MG/10ML -  1000MG/20ML)", "Conditionnement": "1FL/10ML ET 1FL/20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALFINOR 8MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " BETAHISTINE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "ALFINOR", "Tarif de reference": "560 DA", "PPA": "N/A", "Num Enregistrement": "178/ 18 C 007 /98", "Code DCI": "18C007", "Forme": "COMP.", "Dosage": "8MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALGIFEN 20MG/ML (100MG/5ML) SUSP. BUV. FL./180ML+SERING DE 5ML P. ADMINIST. OR. GRADUEE EN KG DE POIDS CORPOREL , B/01 FL. DE 200ML + PIPETTE GRADUEE EN KG ET ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ALGIFEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 04 B 042 /05/11", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./180ML+SERING DE 5ML P. ADMINIST. OR. GRADUEE EN KG DE POIDS CORPOREL , B/01 FL. DE 200ML + PIPETTE GRADUEE EN KG ET ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALGIMOL 170MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "ALGIMOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "026/ 03 B 096 /01/09", "Code DCI": "03B096", "Forme": "SUPPO.", "Dosage": "170MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALGIMOL ENFANT 200MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "ALGIMOL ENFANT", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "026/ 03 B 042 /06", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALGIMOL ENFANT 300MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "ALGIMOL ENFANT", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "026/ 03 B 043 /06", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALGIMOL-PEDIATRIQUE 0.03 SOL. BUV. FL 90ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "ALGIMOL-PEDIATRIQUE", "Tarif de reference": "72.9 DA", "PPA": "N/A", "Num Enregistrement": "026/ 03 B 061 /05", "Code DCI": "03B061", "Forme": "SOL. BUV.", "Dosage": "0.03", "Conditionnement": "FL 90ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALIMTA 500MG/FL. DE PDRE. PDRE. LYOPH. P. SOL. A DILUER P. PERF. B/01FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/2.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " PEMETREXED DISODIQUE EXPRIME EN PEMETREXED", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ALIMTA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 05 G 102 /06/13", "Code DCI": "05G102", "Forme": "LYOPH. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALKERAN 2MG COMP. PELLI. B/50", "Img": "https://pharmnet-dz.com//img/medics/978.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=978", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " MELPHALAN", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ALKERAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 05 A 024 /99", "Code DCI": "05A024", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALLERTINE 10MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3988.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3988", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ALLERTINE", "Tarif de reference": "120 DA", "PPA": "120 DA", "Num Enregistrement": "003/ 01 A 033 /03/09", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALLERTINE 1MG/ML SIROP FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ALLERTINE", "Tarif de reference": "96.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 01 A 034 /06", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALMIDE 0,1% COLLY. FL. COMPT. GTTES. 5ML", "Img": "https://pharmnet-dz.com//img/medics/2346.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2346", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " LODOXAMIDE", "Pays": "FRANCE", "Nom Commercial": "ALMIDE", "Tarif de reference": "79.5 DA", "PPA": " DA", "Num Enregistrement": "028/ 17 B 121 /06", "Code DCI": "17B121", "Forme": "COLLY. SOL.", "Dosage": "0,1%", "Conditionnement": "FL. COMPT. GTTES. 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALODIPINE 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/84.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ALODIPINE", "Tarif de reference": "663 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 B 243 /10", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALODIPINE 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ALODIPINE", "Tarif de reference": "571.48 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 B 123 /07", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALPHA-TRYPSINE 5400UAE PDE.DERM. T/20G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " CHYMOTRYPSINE", "Pays": "ALGERIE", "Nom Commercial": "ALPHA-TRYPSINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 21 A 002 /97", "Code DCI": "21A002", "Forme": "PDE. DERM.", "Dosage": "5400UAE", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALPROFENE 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2745.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2745", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ALPROFENE", "Tarif de reference": "138.4 DA", "PPA": "200.00 DA", "Num Enregistrement": "231/ 04 B 017 /04", "Code DCI": "04B017", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALUSTAL 0,1IR/ML+1IR/ML+10IR/ML SUSP. INJ. B/03FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " STALLERGENES S.A.", "C.Pharmacologique": " ALLERGENES A USAGE THERAPEUTIQUE", "C.Therapeutique": " ALLERGOLOGIE", "Info": " EXTRAITS ALLERGENIQUES DERMATOPHAGOIDES PTERONYSSINUS", "Pays": "FRANCE", "Nom Commercial": "ALUSTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "130/ 01 D 029 /00/14", "Code DCI": "01D029", "Forme": "SUSP. INJ.", "Dosage": "0,1IR/ML+1IR/ML+10IR/ML", "Conditionnement": "B/03FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALUSTAL 0,1IR/ML+1IR/ML+10IR/ML SUSP. INJ. B/03FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " STALLERGENES S.A.", "C.Pharmacologique": " ALLERGENES A USAGE THERAPEUTIQUE", "C.Therapeutique": " ALLERGOLOGIE", "Info": " EXTRAITS ALLERGENIQUES MELANGE DE 5 GRAMINES", "Pays": "FRANCE", "Nom Commercial": "ALUSTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "130/ 01 D 037 /00/14", "Code DCI": "01D037", "Forme": "SUSP. INJ.", "Dosage": "0,1IR/ML+1IR/ML+10IR/ML", "Conditionnement": "B/03FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALUSTAL 10IR/ML SUSP. INJ. B/01 FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " STALLERGENES S.A.", "C.Pharmacologique": " ALLERGENES A USAGE THERAPEUTIQUE", "C.Therapeutique": " ALLERGOLOGIE", "Info": " EXTRAITS ALLERGENIQUES MELANGE DE 5 GRAMINES", "Pays": "FRANCE", "Nom Commercial": "ALUSTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "130/ 01 D 038 /00/14", "Code DCI": "01D038", "Forme": "SUSP. INJ.", "Dosage": "10IR/ML", "Conditionnement": "B/01 FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALUSTAL 10IR/ML SUSP. INJ. B/01 FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " STALLERGENES S.A.", "C.Pharmacologique": " ALLERGENES A USAGE THERAPEUTIQUE", "C.Therapeutique": " ALLERGOLOGIE", "Info": " EXTRAITS ALLERGENIQUES DERMATOPHAGOIDES PTERONYSSINUS 100%", "Pays": "FRANCE", "Nom Commercial": "ALUSTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "130/ 01 D 030 /00/14", "Code DCI": "01D030", "Forme": "SUSP. INJ.", "Dosage": "10IR/ML", "Conditionnement": "B/01 FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ALVIL 20MG/ML (100MG/5ML) SUSP. BUV. FL./200ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ALVIL", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "026/ 04 B 042 /07", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./200ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ALZOR 2% (20MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2361.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2361", "Laboratoire": " UNIMED", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "ALZOR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 17 C 121 /08/14", "Code DCI": "17C121", "Forme": "COLLY. SOL.", "Dosage": "2% (20MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAPIRIDE HUP 1MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3639.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAPIRIDE HUP", "Tarif de reference": "250.8 DA", "PPA": "250.00 DA", "Num Enregistrement": "380/ 14 A 187 /10", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAPIRIDE HUP 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3650.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAPIRIDE HUP", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "380/ 14 A 188 /10", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAPIRIDE HUP 3MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3663.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAPIRIDE HUP", "Tarif de reference": "720 DA", "PPA": "720.00 DA", "Num Enregistrement": "380/ 14 A 189 /10", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAPIRIDE HUP 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3675.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAPIRIDE HUP", "Tarif de reference": " N/A", "PPA": "750.00 DA", "Num Enregistrement": "380/ 14 A 190 /11", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMAREL 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3640.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3640", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAREL", "Tarif de reference": "250.8 DA", "PPA": "N/A", "Num Enregistrement": "392/ 14 A 187 /00/09", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAREL 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3651.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3651", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAREL", "Tarif de reference": "450 DA", "PPA": "N/A", "Num Enregistrement": "392/ 14 A 188 /00/07", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAREL 3MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3664.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3664", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAREL", "Tarif de reference": "720 DA", "PPA": "N/A", "Num Enregistrement": "392/ 14 A 189 /00/07", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAREL 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3676.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3676", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAREL", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "392/ 14 A 190 /00/07", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMAREL 6MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3720.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3720", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMAREL", "Tarif de reference": "920.1 DA", "PPA": "N/A", "Num Enregistrement": "392/ 14 A 324 /09", "Code DCI": "14A324", "Forme": "COMP. PELLI.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMATRILINE 4% (40MG/ML) SOL.BUV.GTTES. FL./30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMATRILINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "457/ 16 A 003 /09", "Code DCI": "16A003", "Forme": "SOL. BUV. GTTES.", "Dosage": "4% (40MG/ML)", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMBOLAR 0.003 SOL. BUV. FL/150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AMBOLAR", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "055/ 20 D 064 /98", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": "0.003", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMBROBIOTIC 0.003 SIROP FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AMBROBIOTIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 D 064 /05", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": "0.003", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMBROBIOTIC LP 75MG** PELLETS EN GLES. LP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL (CHLORHYDRATE)", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AMBROBIOTIC LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 D 243 /11", "Code DCI": "20D243", "Forme": "PELLETS LP", "Dosage": "75MG**", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMBRODAL 0,003 SOL. BUV. B/01 FL DE 100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AMBRODAL", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": " 0,003", "Conditionnement": "100 ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "AMIKOZ 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medics/3566.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMIKOZ", "Tarif de reference": " N/A", "PPA": "273.00 DA", "Num Enregistrement": "268/ 13 R 258 /06/13", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMIKOZ 50MG GLES. B/03 ET B/07", "Img": "https://pharmnet-dz.com//img/medics/3544.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMIKOZ", "Tarif de reference": " N/A", "PPA": "511.00 DA", "Num Enregistrement": "268/ 13 R 155 /06/13", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03 ET B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMIOCARDONE 200MG  COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/127.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AMIOCARDONE", "Tarif de reference": "420 DA", "PPA": "420 DA", "Num Enregistrement": "003/ 06 D 041 /09", "Code DCI": "06D041", "Forme": "COMP SEC.", "Dosage": "200MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMIOCARDONE 50MG/ML (150MG/3ML) SOL. INJ. IV B/06 AMP. DE 3ML ET B/50 AMP. DE 3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AMIOCARDONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 06 D 040 /07", "Code DCI": "06D040", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (150MG/3ML)", "Conditionnement": "B/06 AMP. DE 3ML ET B/50 AMP. DE 3ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMIODARONE HUP 200MG  COMP SEC  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "AMIODARONE HUP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "380/ 06 D 041 /14", "Code DCI": "06D041", "Forme": "COMP SEC.", "Dosage": "200MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMIODARONE MEDOCHEMIE 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "CHYPRE", "Nom Commercial": "AMIODARONE MEDOCHEMIE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "178/ 06 D 041 /98", "Code DCI": "06D041", "Forme": "COMP SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMIODARONE MYLAN 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=130", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "AMIODARONE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 06 D 041 /07", "Code DCI": "06D041", "Forme": "COMP SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMIRONE 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/133.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "AMIRONE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "329/ 06 D 041 /07", "Code DCI": "06D041", "Forme": "COMP SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMISULPRIDE BEKER 200MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2266.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2266", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMISULPRIDE BEKER", "Tarif de reference": "2061.7 DA", "PPA": "2061.7 DA", "Num Enregistrement": "447/ 16 D 094 /13", "Code DCI": "16D094", "Forme": "COMP. SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMISULPRIDE BEKER 400MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/4471.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4471", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMISULPRIDE BEKER", "Tarif de reference": "3482.4 DA", "PPA": "3482.40  DA", "Num Enregistrement": "447/16D160/16", "Code DCI": "16D160", "Forme": "COMP. SEC.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMISULPRIDE LDM 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMISULPRIDE LDM", "Tarif de reference": "- DA", "PPA": "N/A", "Code DCI": "16D094", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMITRAL 100MG COMP. DISPERS.  B/30", "Img": "https://pharmnet-dz.com//img/medics/2408.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2408", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMITRAL", "Tarif de reference": "2139.9 DA", "PPA": "1943.00 DA", "Num Enregistrement": "352/ 15 A 053 /10", "Code DCI": "15A053", "Forme": "COMP. DISPERS.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMITRAL 25MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medics/2405.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2405", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMITRAL", "Tarif de reference": "854.4 DA", "PPA": "742.00 DA", "Num Enregistrement": "352/ 15 A 052 /10", "Code DCI": "15A052", "Forme": "COMP. DISPERS.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMITRAL 5MG COMP. DISPERS.  B/30", "Img": "https://pharmnet-dz.com//img/medics/2402.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2402", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMITRAL", "Tarif de reference": "479.4 DA", "PPA": "409.00 DA", "Num Enregistrement": "352/ 15 A 051 /10", "Code DCI": "15A051", "Forme": "COMP. DISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMITRIPTYLINE 4% (40MG/ML) SOL. BUV. GTTES. FL./20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMITRIPTYLINE", "Tarif de reference": "0 DA", "PPA": "115.00 DA", "Num Enregistrement": "088/ 16 A 003 /03", "Code DCI": "16A003", "Forme": "SOL. BUV. GTTES.", "Dosage": "4% (40MG/ML)", "Conditionnement": "FL./20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLIBON 10MG COMP. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLIBON", "Tarif de reference": "663 DA", "PPA": "1989.00 DA", "Num Enregistrement": "050/ 06 B 243 /07", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLIBON 5MG COMP. B/30 ET  B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Pays": "ALGERIE", "Nom Commercial": "AMLIBON", "Tarif de reference": " N/A", "PPA": "1718.00 DA", "Num Enregistrement": "050/ 06 B 123 /05/11", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30 ET  B/90", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMLODAL 10MG COMP. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/85.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=85", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODAL", "Tarif de reference": "663.00 DA", "PPA": "649.72 DA", "Num Enregistrement": "318/ 06 B 243 /15", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODAL 5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/4281.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4281", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODAL", "Tarif de reference": "612.30 DA", "PPA": "633.12 DA", "Num Enregistrement": "309/06B123/15", "Code DCI": "06B123", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODEX 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/67.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODEX", "Tarif de reference": "612.3 DA", "PPA": " DA", "Num Enregistrement": "231/ 06 B 123 /10", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPAL  5MG GLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPAL ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "039/06B123/05/16", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMLODIPINE BEKER 10MG GLES B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/86.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=86", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE BEKER", "Tarif de reference": "662.99 DA", "PPA": "663.00 DA", "Num Enregistrement": "447/ 06 B 243 /14", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPINE BEKER 5MG GLES  B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/68.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=68", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE BEKER", "Tarif de reference": "612.3 DA", "PPA": "489.00 DA", "Num Enregistrement": "447/ 06 B 123 /14", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPINE MM 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE MM", "Tarif de reference": "612.3 DA", "PPA": "612.00 DA", "Num Enregistrement": "470/ 06 B 123 /13", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPINE ZENTIVA 10MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE ZENTIVA", "Tarif de reference": "663 DA", "PPA": "1650.00 DA", "Num Enregistrement": "428/ 06 B 243 /12", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPINE ZENTIVA 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE ZENTIVA", "Tarif de reference": "612.3 DA", "PPA": "1500.00 DA", "Num Enregistrement": "428/ 06 B 123 /12", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPINE+VALSARTAN LDM 10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE+VALSARTAN LDM", "Tarif de reference": "1650 DA", "PPA": "1650.00 DA", "Num Enregistrement": "309/ 06 E 259 /14", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPINE+VALSARTAN LDM 5MG/160MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE+VALSARTAN LDM", "Tarif de reference": "1650 DA", "PPA": "1630.00 DA", "Num Enregistrement": "309/ 06 E 258 /14", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLODIPINE+VALSARTAN LDM 5MG/80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLODIPINE+VALSARTAN LDM", "Tarif de reference": "1650 DA", "PPA": "1500.00 DA", "Num Enregistrement": "309/ 06 E 257 /14", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLOMED 5MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOMED", "Tarif de reference": "612.3 DA", "PPA": "N/A", "Num Enregistrement": "426/ 06 B 123 /12", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLOPINE 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOPINE", "Tarif de reference": " N/A", "PPA": "612.00 DA", "Num Enregistrement": "065/ 06 B 123 /06/11", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMLOR 10MG GLES. B/28", "Img": "https://pharmnet-dz.com//img/medics/88.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=88", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOR", "Tarif de reference": "618.8 DA", "PPA": " DA", "Num Enregistrement": "045/ 06 B 243 /11", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLOR 5MG GLES. B/28 ET B/98 ", "Img": "https://pharmnet-dz.com//img/medics/73.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=73", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOR", "Tarif de reference": "0 DA", "PPA": "2000.00 DA", "Num Enregistrement": "045/ 06 B 123 /97/09", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/28 ET B/98 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLORIDAL 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLORIDAL", "Tarif de reference": "663 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 B 243 /09", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLORIDAL 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLORIDAL", "Tarif de reference": "612.3 DA", "PPA": "612.00 DA", "Num Enregistrement": "003/ 06 B 123 /09", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLOVAL  10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOVAL ", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "039/06E259/15", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLOVAL  5MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOVAL ", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "039/06E258/15", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLOVAL  5MG/80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOVAL ", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "039/06E257/15", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMLOVASTE 5MG/10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMLOVASTE", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 290 /11", "Code DCI": "06M290", "Forme": "COMP. PELLI.", "Dosage": "5MG/10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN 1G/200MG PDRE. P. SOL. INJ. IV  B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMOCLAN", "Tarif de reference": " DA", "PPA": "572.00 DA", "Num Enregistrement": "001/ 13 G 182 /05/13", "Code DCI": "13G182", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/200MG", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOCLAN 500MG/100MG /FL. DE PDRE. PDRE. P. SOL. INJ. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/340.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE/ ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMOCLAN", "Tarif de reference": "0 DA", "PPA": "899.00 DA", "Num Enregistrement": "001/ 13 G 280 /05", "Code DCI": "13G280", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/100MG /FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN 8:1 100MG/12,5MG/ML PDRE. P. SUSP. BUV. ENFANT ET NOURRISSON B/1FL.DE 30ML (NOURRISSON) - B/1FL.DE 60ML (ENFANT) DE SUSP. BUV. APRES RECONST. + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/283.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=283", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOCLAN 8:1", "Tarif de reference": "296.7 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 181 /13", "Code DCI": "13G181", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/12,5MG/ML", "Conditionnement": "B/1FL.DE 30ML (NOURRISSON) - B/1FL.DE 60ML (ENFANT) DE SUSP. BUV. APRES RECONST. + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN 8:1 1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/14 ET B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOCLAN 8:1", "Tarif de reference": "785.28 DA", "PPA": "593.00 DA", "Num Enregistrement": "001/ 13 G 269 /13", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG/SACHET", "Conditionnement": "B/14 ET B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN 8:1 500MG/62,5MG PDRE. P. SUSP. BUV. EN SACHET DOSE B/12 ET B/14", "Img": "https://pharmnet-dz.com//img/medics/294.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=294", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOCLAN 8:1", "Tarif de reference": "458.08 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 204 /13", "Code DCI": "13G204", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/12 ET B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN BID 200MG/28,5MG /5ML PDRE. P.  SUSP. BUV. B/1FL/70ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMOCLAN BID", "Tarif de reference": "408.1 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 265 /03", "Code DCI": "13G265", "Forme": "PDRE. SUSP. BUV.", "Dosage": "200MG/28,5MG /5ML", "Conditionnement": "B/1FL/70ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN BID 400MG/57MG/5ML PDRE. P.  SUSP. BUV. B/1FL. DE 35ML ET B/1FL. DE 70ML (DE SUSPENSION BUVABLE APRES RECONSTITUTION) AVEC PIPIETTE GRADUEE EN KG ", "Img": "https://pharmnet-dz.com//img/medics/328.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=328", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMOCLAN BID", "Tarif de reference": "692.3 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 266 /04/13", "Code DCI": "13G266", "Forme": "PDRE. SUSP. BUV.", "Dosage": "400MG/57MG/5ML", "Conditionnement": "B/1FL. DE 35ML ET B/1FL. DE 70ML (DE SUSPENSION BUVABLE APRES RECONSTITUTION) AVEC PIPIETTE GRADUEE EN KG ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN BID 875MG/125MG COMP. PELLI. PILULIER/10", "Img": "https://pharmnet-dz.com//img/medics/331.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=331", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMOCLAN BID", "Tarif de reference": "572.6 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 267 /04/13", "Code DCI": "13G267", "Forme": "COMP. PELLI.", "Dosage": "875MG/125MG", "Conditionnement": "PILULIER/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOCLAN FORTE 250MG/62,5MG/5ML PDRE.P.SUP.BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medics/244.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMOCLAN FORTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 051 /97/09", "Code DCI": "13G051", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/62,5MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOCLAN FORTE 500MG/125MG COMP. B/12", "Img": "https://pharmnet-dz.com//img/medics/234.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMOCLAN FORTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 050 /98/09", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOCLAV ENFANT 100MG/12,5MG/ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP.  BUV. APRES RECONST.+ UNE SERING. P. ADMINIST. ORA. ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOCLAV ENFANT", "Tarif de reference": "593 DA", "PPA": "N/A", "Num Enregistrement": "319/ 13 G 181 /11", "Code DCI": "13G181", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/12,5MG/ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP.  BUV. APRES RECONST.+ UNE SERING. P. ADMINIST. ORA. ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMODEX G\u00e9 500MG/5ML PDRE. SUSP. BUV. FL./60ML +CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMODEX G\u00e9", "Tarif de reference": "205.2 DA", "PPA": "245.00 DA", "Num Enregistrement": "323/ 13 G 220 /08", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "FL./60ML +CUILLERE MESURE", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMODEX-G\u00e9 1G COMP. DISPERS. B/06 ET B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMODEX-G\u00e9", "Tarif de reference": "316.82 DA", "PPA": "375.00 DA", "Num Enregistrement": "323/ 13 G 230 /04", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/06 ET B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMODEX-G\u00e9 250MG/5ML PDRE. P. SUSP. BUV. FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMODEX-G\u00e9", "Tarif de reference": "0 DA", "PPA": "185.00 DA", "Num Enregistrement": "323/ 13 G 047 /04", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMODEX-G\u00e9 500MG GLES B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMODEX-G\u00e9", "Tarif de reference": " N/A", "PPA": "154.00 DA", "Num Enregistrement": "323/ 13 G 045 /04", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOTRIDAL 100MG COMP.DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOTRIDAL", "Tarif de reference": "1997.24 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 053 /08", "Code DCI": "15A053", "Forme": "COMP. DISPERS.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOTRIDAL 25MG COMP.DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOTRIDAL", "Tarif de reference": "797.44 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 052 /08", "Code DCI": "15A052", "Forme": "COMP. DISPERS.", "Dosage": "25MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOTRIDAL 50MG COMP. DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOTRIDAL", "Tarif de reference": "1400 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 089 /09", "Code DCI": "15A089", "Forme": "COMP. DISPERS.", "Dosage": "50MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOTRIDAL 5MG COMP.DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOTRIDAL", "Tarif de reference": "447.44 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 051 /08", "Code DCI": "15A051", "Forme": "COMP. DISPERS.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXAL 125MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+GOBELET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXAL", "Tarif de reference": "132 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 046 /13", "Code DCI": "13G046", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+GOBELET DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXAL 1G COMP. DISPERS. B/12 ET B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 230 /08/15", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/12 ET B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOXAL 250MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES  RECONST.+ GOBELET DOSEUR ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 047 /99/13", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES  RECONST.+ GOBELET DOSEUR ", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOXAL 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 045 /97/14", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOXAL 500MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + GOBELET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXAL", "Tarif de reference": "205.2 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 220 /13", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + GOBELET DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXICILLINE / ACIDE CLAVULANIQUE SANDOZ ADULTE 1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/08 ET B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=336", "Laboratoire": " SANDOZ", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AMOXICILLINE / ACIDE CLAVULANIQUE SANDOZ ADULTE", "Tarif de reference": "523.52 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 G 269 /09", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG/SACHET", "Conditionnement": "B/08 ET B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXICILLINE / ACIDE CLAVULANIQUE SANDOZ ADULTE 500MG / 62,5MG COMP. PELLI. B/16 - B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=318", "Laboratoire": " SANDOZ", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AMOXICILLINE / ACIDE CLAVULANIQUE SANDOZ ADULTE", "Tarif de reference": "523.52 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 G 245 /09", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": "500MG / 62,5MG", "Conditionnement": "B/16 - B/24", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXICILLINE EG 125MG/5ML PDRE. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/891.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=891", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXICILLINE EG", "Tarif de reference": "184.5 DA", "PPA": "N/A", "Num Enregistrement": "380/ 13 G 046 /09/14", "Code DCI": "13G046", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXICILLINE EG 1G COMP. DISPERS. B/14", "Img": "https://pharmnet-dz.com//img/medics/309.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=309", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXICILLINE EG", "Tarif de reference": "399.9 DA", "PPA": "N/A", "Num Enregistrement": "380/ 13 G 230 /03/14", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXICILLINE EG 250MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE-MESURE", "Img": "https://pharmnet-dz.com//img/medics/898.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=898", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXICILLINE EG", "Tarif de reference": "199.99 DA", "PPA": "N/A", "Num Enregistrement": "380/ 13 G 047 /07/13", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE-MESURE", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXICILLINE EG 500MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE-MESURE", "Img": "https://pharmnet-dz.com//img/medics/299.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=299", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXICILLINE EG", "Tarif de reference": "209.9 DA", "PPA": "N/A", "Num Enregistrement": "380/ 13 G 220 /07/13", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE-MESURE", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXIMEX 125MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXIMEX", "Tarif de reference": "132 DA", "PPA": "184.00 DA", "Num Enregistrement": "400/ 13 G 046 /11", "Code DCI": "13G046", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXIMEX 1G COMP. DISPERS. B/06 ET B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXIMEX", "Tarif de reference": " N/A", "PPA": "399.00 DA", "Num Enregistrement": "400/ 13 G 230 /04/11", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/06 ET B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOXIMEX 250MG/5ML PDRE. P. SUSP. BUV. FL/60ML DE SUSP. BUV. APRES RECONST.+UNE  CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXIMEX", "Tarif de reference": " N/A", "PPA": "199.00 DA", "Num Enregistrement": "400/ 13 G 047 /05/11", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML DE SUSP. BUV. APRES RECONST.+UNE  CUILLERE MESURE", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOXIMEX 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/883.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXIMEX", "Tarif de reference": "139.32 DA", "PPA": "163.00 DA", "Num Enregistrement": "400/ 13 G 045 /09", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXIMEX 500MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP.  BUV. APRES RECONST.+UNE CUILLERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXIMEX", "Tarif de reference": "205.2 DA", "PPA": "209.00 DA", "Num Enregistrement": "400/ 13 G 220 /11", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP.  BUV. APRES RECONST.+UNE CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXYPEN 125MG/5ML PDRE. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": "132 DA", "PPA": "132.00 DA", "Num Enregistrement": "003/ 13 G 046 /08", "Code DCI": "13G046", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXYPEN 1G COMP. DISPER. B/06 - B/14 - B/16", "Img": "https://pharmnet-dz.com//img/medics/313.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=313", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": "362.08 DA", "PPA": "362.08 DA", "Num Enregistrement": "003/ 13 G 230 /07", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/06 - B/14 - B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXYPEN 1G/FL. DE PDRE. PDRE. P. SOL. INJ. IM (solvant  LIDOCAINE) ET IM/IV (sans solvant) B/1FL. DE PDRE.+1AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE 3%) (IM) ET BOITE DE 50FL. DE PDRE.SANS SOLV.* (IM/IV) ", "Img": "https://pharmnet-dz.com//img/medics/879.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=879", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": "130 DA", "PPA": "130 DA", "Num Enregistrement": "003/ 13 G 043 /99/11", "Code DCI": "13G043", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.+1AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE 3%) (IM) ET BOITE DE 50FL. DE PDRE.SANS SOLV.* (IM/IV) ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXYPEN 250MG COMP. DISPERS. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 302 /09", "Code DCI": "13G302", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOXYPEN 250MG/5ML PDRE. P. SUSP. BUV. FL/60ML DE SOL. APRES RECONSTIT.", "Img": "https://pharmnet-dz.com//img/medics/900.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 047 /99/10", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML DE SOL. APRES RECONSTIT.", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMOXYPEN 500MG COMP. DISPERS. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": "127.92 DA", "PPA": "139.00 DA", "Num Enregistrement": "003/ 13 G 301 /06", "Code DCI": "13G301", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXYPEN 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/884.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": "139.32 DA", "PPA": "139.00 DA", "Num Enregistrement": "003/ 13 G 045 /98", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXYPEN 500MG/5ML PDRE. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/306.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": "205.2 DA", "PPA": "205.00 DA", "Num Enregistrement": "003/ 13 G 220 /08", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMOXYPEN 500MG/FL. DE PDRE. PDRE. P. SOL. INJ. IM (solvant  LIDOCAINE) ET IM/IV (sans solvant) B/1FL. DE PDRE.+1AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE 3%) (IM) ET BOITE DE 50FL. DE PDRE.SANS SOLV.* (IM/IV) ", "Img": "https://pharmnet-dz.com//img/medics/878.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMOXYPEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 042 /99/11", "Code DCI": "13G042", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.+1AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE 3%) (IM) ET BOITE DE 50FL. DE PDRE.SANS SOLV.* (IM/IV) ", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMPAL 125MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+GOBELET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 055 /13", "Code DCI": "13G055", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+GOBELET DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPAL 250MG/5ML PDRE. P. SUSP. BUV. FL. DE 60ML DE SUSP. BUV. APRES RECONST.+ GOBELET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 056 /13", "Code DCI": "13G056", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL. DE 60ML DE SUSP. BUV. APRES RECONST.+ GOBELET DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPAL 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 058 /97/08", "Code DCI": "13G058", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMPILINE   500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/255.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=255", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPILINE  ", "Tarif de reference": "160 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 058 /98", "Code DCI": "13G058", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPILINE 1G/FL. DE PDRE. PDRE. P. SOL. INJ. B/1FL. DE PDRE. + 1AMP. DE 5ML DESOLV.  (EPPI)   ET   B/50FL. DE PDRE. SANS SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE SODIQUE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPILINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 054 /98/11", "Code DCI": "13G054", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 5ML DESOLV.  (EPPI)   ET   B/50FL. DE PDRE. SANS SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMPILINE 500MG/FL. DE PDRE PDRE. P. SOL. INJ. B/1FL. DE PDRE + 1AMP. DE 5ML DE SOLV.(E.P.P.I)  ET  B/50FL. DE PDRE SANS SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE SODIQUE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPILINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 053 /99/11", "Code DCI": "13G053", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE", "Conditionnement": "B/1FL. DE PDRE + 1AMP. DE 5ML DE SOLV.(E.P.P.I)  ET  B/50FL. DE PDRE SANS SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMPIMEX 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPIMEX", "Tarif de reference": "0 DA", "PPA": "166.00 DA", "Num Enregistrement": "400/ 13 G 058 /09", "Code DCI": "13G058", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPINAX 1G/FL. DE PDRE. PDRE. ET SOLV. P. SOL. INJ. IM/IV B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI) ET B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/250.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=250", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE SODIQUE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPINAX", "Tarif de reference": "101.5 DA", "PPA": "136.00 DA", "Num Enregistrement": "293/ 13 G 054 /10", "Code DCI": "13G054", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI) ET B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPINAX 250MG/5ML PDRE. P. SUSP. BUV. FL./60ML  ET  FL./100ML  (DE SUSP. BUV. APRES RECONSTITUTION)", "Img": "https://pharmnet-dz.com//img/medics/253.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=253", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPINAX", "Tarif de reference": "0 DA", "PPA": "167.00 DA", "Num Enregistrement": "293/ 13 G 056 /11", "Code DCI": "13G056", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL./60ML  ET  FL./100ML  (DE SUSP. BUV. APRES RECONSTITUTION)", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPINAX 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/257.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=257", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPICILLINE TRIHYDRATE EXPRIME EN AMPICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPINAX", "Tarif de reference": "0 DA", "PPA": "169.00 DA", "Num Enregistrement": "293/ 13 G 058 /04/10", "Code DCI": "13G058", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPLID 10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPLID", "Tarif de reference": "1500 DA", "PPA": "N/A", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMPLID 5MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AMPLID", "Tarif de reference": "1500 DA", "PPA": "N/A", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AMURETIC 5MG/50MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3293.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMILORIDE (SOUS FORME DE CHLORHYDRATE)**/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "AMURETIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 06 H 094 /98/12 ", "Code DCI": "06H094", "Forme": "COMP.", "Dosage": "5MG/50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "AMYZOL 25MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LEK", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "SLOVENIE", "Nom Commercial": "AMYZOL", "Tarif de reference": "285 DA", "PPA": "N/A", "Num Enregistrement": "188/ 16 A 001 /99", "Code DCI": "16A001", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANAFRANIL 10MG COMP.ENRO. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2532", "Laboratoire": " DEFIANTE FARMACEUTICA LDA", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "ANAFRANIL", "Tarif de reference": "0 DA", "PPA": "282.00 DA", "Num Enregistrement": "322/ 16 A 005 /97/09", "Code DCI": "16A005", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANAFRANIL 25MG COMP.ENRO. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2535", "Laboratoire": " DEFIANTE FARMACEUTICA LDA", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "ANAFRANIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "322/ 16 A 006 /97/09", "Code DCI": "16A006", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANAFRANIL 25MG/2ML SOL.INJ. B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2531", "Laboratoire": " DEFIANTE FARMACEUTICA LDA", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "ANAFRANIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "322/ 16 A 004 /97", "Code DCI": "16A004", "Forme": "SOL. INJ.", "Dosage": "25MG/2ML", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANAFRANIL 75MG COMP.ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2540", "Laboratoire": " DEFIANTE FARMACEUTICA LDA", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "ANAFRANIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "322/ 16 A 007 /97/09", "Code DCI": "16A007", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANASTRODEX   1MG COMP PELLI B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ANASTROZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ANASTRODEX  ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "323/09B139/16", "Code DCI": "09B139", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANASTROZOLE CINFA 1MG COMP PELLI B/28", "Img": "https://pharmnet-dz.com//img/medics/611.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CINFA", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ANASTROZOLE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "ANASTROZOLE CINFA", "Tarif de reference": "6,512.56 DA", "PPA": "6,512.56 DA", "Num Enregistrement": "157/ 09 B 139 /14", "Code DCI": "09B139", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANDRIOL TESTOCAPS 40MG CAPS. B/30", "Img": "https://pharmnet-dz.com//img/medics/596.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=596", "Laboratoire": " ORGANON", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TESTOSTERONE UNDECANOATE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ANDRIOL TESTOCAPS", "Tarif de reference": "951.62 DA", "PPA": "N/A", "Num Enregistrement": "005/ 09 A 074 /97/08", "Code DCI": "09A074", "Forme": "CAPS.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANDROCUR 50MG COMP.SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/591.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=591", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CYPROTERONE ACETATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ANDROCUR", "Tarif de reference": "1410 DA", "PPA": "N/A", "Num Enregistrement": "070/ 09 A 002 /97", "Code DCI": "09A002", "Forme": "COMP SEC.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANDROTARDYL 250MG/ML SOL.INJ.HUIL. B/1AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=592", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TESTOSTERONE (ENANTHATE)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ANDROTARDYL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "070/ 09 A 003 /97", "Code DCI": "09A003", "Forme": "SOL. INJ.", "Dosage": "250MG/ML", "Conditionnement": "B/1AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANESDERM GE 5% 2,5G/2,5G/100G CREME  T/5G AVEC DEUX PANSEMENTS ADHESIFS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4098", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE / PRILOCAINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ANESDERM GE 5%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "186/ 02 C 046 /09", "Code DCI": "02C046", "Forme": "CR\u00c8ME", "Dosage": "2,5G/2,5G/100G", "Conditionnement": "T/5G AVEC DEUX PANSEMENTS ADHESIFS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANESTANE 100% STABILISE PAR THYMOL 0,01% SOL. P. INHAL. FL/250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " HALOTHANE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ANESTANE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 02 B 056 /05", "Code DCI": "02B056", "Forme": "LIQUIDE P. INHAL", "Dosage": "100% STABILISE PAR THYMOL 0,01%", "Conditionnement": "FL/250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ANESTOCIL 0,4% (4mg/ml) COLLY. EN SOL. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA) ", "C.Pharmacologique": " ANESTHESIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " OXYBUPROCAINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ANESTOCIL", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "17A001", "Forme": "COLLY. SOL.", "Dosage": "0,4% (", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "ANGIOPRIL 20MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PETRA PHARM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ANGIOPRIL", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "258/ 06 E 060 /05", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANGIOPRIL 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PETRA PHARM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ANGIOPRIL", "Tarif de reference": "276 DA", "PPA": "N/A", "Num Enregistrement": "258/ 06 E 059 /05", "Code DCI": "06E059", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANGIOTEC 20MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ANGIOTEC", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "043/ 06 E 060 /98", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANGIOTEC 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ANGIOTEC", "Tarif de reference": "276 DA", "PPA": "N/A", "Num Enregistrement": "043/ 06 E 059 /98", "Code DCI": "06E059", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANGIOZIDE 20MG/12,5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ANGIOZIDE", "Tarif de reference": "709 DA", "PPA": "N/A", "Num Enregistrement": "043/ 06 E 222 /07", "Code DCI": "06E222", "Forme": "COMP.", "Dosage": "20MG/12,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANGIZAR 50MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ANGIZAR", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "418/ 06 E 126 /12", "Code DCI": "06E126", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANGODAL 10MG COMP. SEC. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANGODAL", "Tarif de reference": "105.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 C 024 /08", "Code DCI": "06C024", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANGODAL 20MG GLES.LP B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANGODAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 C 026 /09", "Code DCI": "06C026", "Forme": "COMP. LP", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANTADINE 100MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANTADINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "097/ 04 B 033 /07/15", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ANTAG 20MG GLES. A MICROG. GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medics/3836.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3836", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANTAG", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "293/ 10 A 001 /04/10", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANTALFEN 200MG COMP. PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medics/2836.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANTALFEN", "Tarif de reference": "90 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 040 /09", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANTALFEN 20MG/ML (100MG/5ML) SUSP. BUV. FL./200ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/918.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=918", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ANTALFEN", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 042 /08/15", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./200ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANTALFEN 400MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2727.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2727", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANTALFEN", "Tarif de reference": "157 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 010 /09 ", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANTALFEN 5% ( 5G/100 G ) GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " IBUPROFENE", "Pays": "ALGERIE", "Nom Commercial": "ANTALFEN", "Tarif de reference": "145.00 DA", "PPA": "N/A", "Code DCI": "21A057", "Forme": "GEL DERM.", "Dosage": "5% ( 5G/100 G )", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANTALFEN 600MG  COMP PELL  B/10", "Img": "https://pharmnet-dz.com//img/medics/923.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=923", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANTALFEN", "Tarif de reference": "78.5 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 044 /14", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ANTAPROFENE  100MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ANTAPROFENE ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/04B033/15", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ANTI GRIP 450MG/20MG/20MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SANAMED", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE / ACIDE ASCORBIQUE / CAFEINE", "Pays": "ALGERIE", "Nom Commercial": "ANTI GRIP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "097/ 03 A 105 /08", "Code DCI": "03A105", "Forme": "COMP.", "Dosage": "450MG/20MG/20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ANXIENAD 1MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ANXIENAD", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "468/ 16 B 042 /15", "Code DCI": "16B042", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ANXYPAM 6MG COMP. QUADRISEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ANXYPAM", "Tarif de reference": "204.60 DA", "PPA": "N/A", "Code DCI": "16B098", "Forme": "COMP SEC.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "API E 100MG COMP. A CROQ. B/20", "Img": "https://pharmnet-dz.com//img/medics/3435.png", "Laboratoire": " API", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " TOCOPHEROL", "Pays": "ALGERIE", "Nom Commercial": "API E", "Tarif de reference": "0 DA", "PPA": "114.00 DA", "Num Enregistrement": "348/ 14 H 110 /06", "Code DCI": "14H110", "Forme": "COMP. A CROQ.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "APICARPIN 0.01 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PILOCARPINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "APICARPIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "165/ 17 C 009 /98", "Code DCI": "17C009", "Forme": "COLLY. SOL.", "Dosage": "0.01", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APICARPIN 0.02 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2353.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PILOCARPINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "APICARPIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "165/ 17 C 010 /98", "Code DCI": "17C010", "Forme": "COLLY. SOL.", "Dosage": "0.02", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIDRA 100UI/ML SOL. INJ. EN CARTOUCHE SC B/03 CART.  DE 3ML POUR (OPTICLIK OU POUR OPTIPEN)", "Img": "https://pharmnet-dz.com//img/medics/3314.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3314", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "APIDRA", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "376/ 14 B 312 /08 ", "Code DCI": "14B312", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/03 CART.  DE 3ML POUR (OPTICLIK OU POUR OPTIPEN)", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIDRA 100UI/ML SOL. INJ. EN FLACON SC B/1FL.DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/3315.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3315", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "APIDRA", "Tarif de reference": "3,314.44 DA", "PPA": "3,314.44 DA", "Num Enregistrement": "376/ 14 B 313 /08 ", "Code DCI": "14B313", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1FL.DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIDRA OPTISET 100UI/ML (3,49MG/ML) SOL. INJ. STYLO PREREMPLI SC B/5 STYLO PREREMPLIS DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3320.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3320", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "APIDRA OPTISET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 14 B 332 /09", "Code DCI": "14B332", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,49MG/ML)", "Conditionnement": "B/5 STYLO PREREMPLIS DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIDRA SOLOSTAR 100UI/ML (3,49MG/ML) SOL. INJ. EN STYLO PREREMPLI B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3321.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3321", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "APIDRA SOLOSTAR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 14 B 332 /09", "Code DCI": "14B332", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,49MG/ML)", "Conditionnement": "B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIFEN 200MG COMP.  B/20", "Img": "https://pharmnet-dz.com//img/medics/2837.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " API", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "APIFEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "348/ 04 B 040 /08", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "APIFEN 400MG COMP.  B/20", "Img": "https://pharmnet-dz.com//img/medics/2734.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " API", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "APIFEN", "Tarif de reference": "157 DA", "PPA": " DA", "Num Enregistrement": "348/ 04 B 010 /08", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIFLOX 0,3% (OU 3MG/ML) COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2389.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NORFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "APIFLOX", "Tarif de reference": "229 DA", "PPA": " DA", "Num Enregistrement": "165/ 17 D 029 /98", "Code DCI": "17D029", "Forme": "COLLY. SOL.", "Dosage": "0,3% (OU 3MG/ML)", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIFRIN -10 0.1 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/1996.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PHENYLEPHRINE ", "Pays": "JORDANIE", "Nom Commercial": "APIFRIN -10", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "165/ 17 H 061 /98", "Code DCI": "17H061", "Forme": "COLLY.", "Dosage": "0.1", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APILOR 10MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " API", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "APILOR", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "348/ 01 A 033 /08", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "APIROVIT 250MG/250MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3436.png", "Laboratoire": " API", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE CHLORHYDRATE / PYRIDOXINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "APIROVIT", "Tarif de reference": "135 DA", "PPA": " DA", "Num Enregistrement": "348/ 14 H 112 /06", "Code DCI": "14H112", "Forme": "COMP.", "Dosage": "250MG/250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "APISCORBUT 1G COMP. EFFERV. B/20", "Img": "https://pharmnet-dz.com//img/medics/3458.png", "Laboratoire": " API", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "APISCORBUT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "348/ 14 H 222 /07", "Code DCI": "14H222", "Forme": "COMP. EFFERV.", "Dosage": "1G", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "APISCORBUT 500MG COMP. EFFERV. B/20", "Img": "https://pharmnet-dz.com//img/medics/3447.png", "Laboratoire": " API", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "APISCORBUT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "348/ 14 H 168 /08", "Code DCI": "14H168", "Forme": "COMP. EFFERV.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "APITIDINE 150MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3858.png", "Laboratoire": " API", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "APITIDINE", "Tarif de reference": "103.2 DA", "PPA": "N/A", "Num Enregistrement": "348/ 10 A 003 /06  ", "Code DCI": "10A003", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "APITIDINE 150MG COMP. EFFERV. B/20", "Img": "https://pharmnet-dz.com//img/medics/3879.png", "Laboratoire": " API", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "APITIDINE", "Tarif de reference": "103.2 DA", "PPA": "N/A", "Num Enregistrement": "348/ 10 A 159 /07", "Code DCI": "10A159", "Forme": "COMP. EFFERV.", "Dosage": "150MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "APITIDINE 300MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/3867.png", "Laboratoire": " API", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "APITIDINE", "Tarif de reference": "114.3 DA", "PPA": " DA", "Num Enregistrement": "348/ 10 A 102 /06", "Code DCI": "10A102", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "APITIDINE 300MG COMP. EFFERV. B/10", "Img": "https://pharmnet-dz.com//img/medics/3880.png", "Laboratoire": " API", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "APITIDINE", "Tarif de reference": "114.3 DA", "PPA": "N/A", "Num Enregistrement": "348/ 10 A 160 /07", "Code DCI": "10A160", "Forme": "COMP. EFFERV.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "APITROPIN 0.005 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "APITROPIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "165/ 17 H 057 /98", "Code DCI": "17H057", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APITROPIN 0.01 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/1991.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "APITROPIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "165/ 17 H 058 /98", "Code DCI": "17H058", "Forme": "COLLY.", "Dosage": "0.01", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "APONIL 100MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NIMESULIDE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "APONIL", "Tarif de reference": " N/A", "PPA": "634.00 DA", "Num Enregistrement": "178/ 04 B 067 /09", "Code DCI": "04B067", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "APRIVAL 150MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APRIVAL", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 156 /11", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "APRIVAL 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APRIVAL", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 157 /11", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "APROSART 150MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/208.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APROSART", "Tarif de reference": "1290 DA", "PPA": "1250.00 DA", "Num Enregistrement": "352/ 06 E 156 /10", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "APROSART 300MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/219.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APROSART", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "352/ 06 E 157 /10", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "APROVASC  300MG/10MG COMP.PELLI S\u00e9CABLE B/30", "Img": "https://pharmnet-dz.com//img/medics/4298.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APROVASC ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "392/06E312/15", "Code DCI": "N/D", "Forme": "COMP. SEC.", "Dosage": "300MG/10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "APROVASC 150MG/5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4263.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APROVASC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "392/06E310/15", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "150MG/5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "APROVASC 300MG/5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4264.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APROVASC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "392/06E311/15", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "300MG/5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "APROVEL 150MG COMP PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/209.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=209", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APROVEL", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "392/ 06 E 156 /01/11", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "APROVEL 300MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/220.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=220", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "APROVEL", "Tarif de reference": "0 DA", "PPA": "1204.00 DA", "Num Enregistrement": "392/ 06 E 157 /01/11", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "APTAMIL PEPTI JUNIOR   LAIT EN POUDRE B/400G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " DANONE NUTRICIA A &O", "C.Pharmacologique": " LAITS & FARINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LAIT EN POUDRE SANS PROTEINES DE LAIT DE VACHE", "Pays": "FRANCE", "Nom Commercial": "APTAMIL PEPTI JUNIOR ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "474/ 14 L 131 /03/13", "Code DCI": "14L131", "Forme": "LAIT EN PDRE.", "Conditionnement": "B/400G", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARACYTINE 100MG PDRE ET SOLV. POUR SOL.INJ. B/1FL. DE PDRE.+1AMP.DE 5ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYTARABINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ARACYTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "076/ 05 A 012 /98", "Code DCI": "05A012", "Forme": "PDRE. SOL. INJ.", "Dosage": "100MG", "Conditionnement": "B/1FL. DE PDRE.+1AMP.DE 5ML DE SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARACYTINE 1G LYOPH. P. USAG. PARENT. IV B/101FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYTARABINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ARACYTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "076/ 05 A 057/00 ", "Code DCI": "05A057", "Forme": "LYOPH. P. USAG. PARENT. IV", "Dosage": "1G", "Conditionnement": "B/101FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARACYTINE 500MG PDRE.SOL.INJ. B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYTARABINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ARACYTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "076/ 05 A 056 /99", "Code DCI": "05A056", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARADEX 150 150MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/210.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARADEX 150", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "268/ 06 E 156 /13", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARADEX 300 300MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/221.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARADEX 300", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "268/ 06 E 157 /13", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARANESP 100\u00b5G/ML (30\u00b5G/0,3ML) (50\u00b5G/0,5ML) SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE B/04 SERINGUES PREREMPLIES DE 0,3ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,3ML SANS SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,5ML AVEC SYST. DE", "Img": "https://pharmnet-dz.com//img/medics/1852.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1852", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DARBEPOETINE ALFA", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ARANESP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 12 L 176 /15", "Code DCI": "12L176", "Forme": "SOL. INJ.", "Dosage": "100\u00b5G/ML (30\u00b5G/0,3ML) (50\u00b5G/0,5ML)", "Conditionnement": "B/04 SERINGUES PREREMPLIES DE 0,3ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,3ML SANS SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,5ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,5ML SANS SYST. DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARANESP 200\u00b5G/ML (60\u00b5G/0,3ML) (80\u00b5G/0,4ML) (100\u00b5G/0,5ML) SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE B/04 SERINGUES PREREMPLIES DE 0,3ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,3ML SANS SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1853", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DARBEPOETINE ALFA", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ARANESP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 12 L 177 /15", "Code DCI": "12L177", "Forme": "SOL. INJ.", "Dosage": "200\u00b5G/ML (60\u00b5G/0,3ML) (80\u00b5G/0,4ML) (100\u00b5G/0,5ML)", "Conditionnement": "B/04 SERINGUES PREREMPLIES DE 0,3ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,3ML SANS SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,4ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,4ML SANS SYST. DE SECURITE , B/04 SERING", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARANESP 25\u00b5G/ML (10\u00b5G/0,4ML) SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE B/04 SERINGUES PREREMPLIES DE 0,4ML SANS SYST. DE SECURITE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1851", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DARBEPOETINE ALFA", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ARANESP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 12 L 174 /15", "Code DCI": "12L174", "Forme": "SOL. INJ.", "Dosage": "25\u00b5G/ML (10\u00b5G/0,4ML)", "Conditionnement": "B/04 SERINGUES PREREMPLIES DE 0,4ML SANS SYST. DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARANESP 40\u00b5G/ML (20\u00b5G/0,5ML) SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE B/04 SERINGUES PREREMPLIES DE 0,5ML SANS SYST. DE SECURITE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4271", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " DARBEPOETINE ALFA", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ARANESP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/12L175/15", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "40\u00b5G/ML (20\u00b5G/0,5ML)", "Conditionnement": "B/04 SERINGUES PREREMPLIES DE 0,5ML SANS SYST. DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARANESP 500\u00b5G/ML (150\u00b5G/0,3ML) (300\u00b5G/0,6ML) (500\u00b5G/1,0ML) SOL. INJ. SC./IV. EN SERINGUE PREREMPLIE B/04 SERINGUES PREREMPLIES DE 0,3ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,3ML SANS SYST. DE SECURITE , B/01 SERINGUE PREREMPLIE DE 0,6ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1854", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DARBEPOETINE ALFA", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ARANESP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 12 L 178 /15", "Code DCI": "12L178", "Forme": "SOL. INJ.", "Dosage": "500\u00b5G/ML (150\u00b5G/0,3ML) (300\u00b5G/0,6ML) (500\u00b5G/1,0ML)", "Conditionnement": "B/04 SERINGUES PREREMPLIES DE 0,3ML AVEC SYST. DE SECURITE , B/04 SERINGUES PREREMPLIES DE 0,3ML SANS SYST. DE SECURITE , B/01 SERINGUE PREREMPLIE DE 0,6ML AVEC SYST. DE SECURITE , B/01 SERINGUE PREREMPLIE DE 0,6ML SANS SYST. DE SECURITE , B/01 SERINGUE P", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARASID 100 - ARASID 500 - ARASID 1000 100M/ML (500MG/5ML - 1000MG/10ML) SOL. INJ. P. PERF. IV OU SC B/1FL. DE 1ML - B/1FL. DE 5ML - B/1FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/24.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CPCM", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYTARABINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARASID 100 - ARASID 500 - ARASID 1000", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "286/ 05 G 156 /12", "Code DCI": "05G156", "Forme": "SOL. INJ.", "Dosage": "100M/ML (500MG/5ML - 1000MG/10ML)", "Conditionnement": "B/1FL. DE 1ML - B/1FL. DE 5ML - B/1FL. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARAVA 100MG COMP PELLI B/3", "Img": "https://pharmnet-dz.com//img/medics/1419.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1419", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ARAVA", "Tarif de reference": "3,702.26 DA", "PPA": "3,702.26 DA", "Num Enregistrement": "230/ 21 D 044 /03", "Code DCI": "21D044", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/3", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARAVA 10MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medics/1417.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1417", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ARAVA", "Tarif de reference": "3,990.00 DA", "PPA": "3,990.00 DA", "Num Enregistrement": "230/ 21 D 042 /03", "Code DCI": "21D042", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARAVA 20MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medics/1418.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1418", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ARAVA", "Tarif de reference": "5,895.00 DA", "PPA": "5,895.00 DA", "Num Enregistrement": "230/ 21 D 043 /03", "Code DCI": "21D043", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARAVEL 150MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARAVEL", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "426/ 06 E 156 /13", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARAVEL 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARAVEL", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "426/ 06 E 157 /13", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARBITAN 160MG  COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARBITAN", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 E 166 /14", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARBITAN 80MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARBITAN", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 E 147 /14", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARBOSE 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARBOSE", "Tarif de reference": "410.10 DA", "PPA": "N/A", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARBREX 100MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES", "C.Therapeutique": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARBREX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "510/04B035/17", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARBREX 200MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES", "C.Therapeutique": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARBREX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "510/04B036/17", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARCHIFAR 1G/FL DE PDRE POUDRE POR SOLU, INJECT OU PERF IV B/10 FLACONS DE  POUDRE      ", "Img": "https://pharmnet-dz.com//img/medics/5992.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "ARCHIFAR", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "178/13G470/18", "Code DCI": "13G470", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL  DE PDRE ", "Conditionnement": "B/10 FLACONS  DE PDRE ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AREDIA 15MG/5ML SOL.INJ. B/4+4", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1408", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PAMIDRONATE SODIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AREDIA", "Tarif de reference": "21970.6 DA", "PPA": "N/A", "Num Enregistrement": "068/ 21 C 015 /98", "Code DCI": "21C015", "Forme": "SOL. INJ.", "Dosage": "15MG/5ML", "Conditionnement": "B/4+4", "Commercialisation": true, "Remboursable": true}, {"Nom": "AREDIA 90MG/10ML PDRE.SOL.INJ I.V B/1+1", "Img": "https://pharmnet-dz.com//img/medics/1409.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1409", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PAMIDRONATE SODIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AREDIA", "Tarif de reference": "31678.14 DA", "PPA": " DA", "Num Enregistrement": "068/ 21 C 034 /01", "Code DCI": "21C034", "Forme": "PDRE. SOL.", "Dosage": "90MG/10ML", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "AREPANRIX H1N1 3,7\u00b5G/AMP. DE 0,25ML DE SUSP. (P.A.)+1AMP. D'EMULSION DE 0,25ML(ADJUVANT) CORRESPONDANT A 3,75\u00b5G/0,5ML (OU 3,75\u00b5G/DOSE) APRES MELANGE  SUSP. ET EMULSION POUR EMULSION INJ. B/50AMP. DE SUSP. +2X25AMP. D'EMULSION", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " VACCINS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PURIFIED ANTIGEN FRACTIONS OF INACTIVATED SPLIT VIRIONS A / CALIFORNIA / 7/ 2009 (H1N1)v NYMCX - 179A                        (VACCIN GRIPPAL)", "Pays": "ROYAUME UNI", "Nom Commercial": "AREPANRIX H1N1", "Tarif de reference": " N/A", "PPA": "FRACTIONS OF INACTIVATED SPLIT VIRIONS A / CALIFORNIA / 7/ 2009 (H1N1)v NYMCX - 179A                        (VACCIN GRIPPAL)", "Num Enregistrement": "262/ 13 U 453 /09", "Code DCI": "13U453", "Forme": "SUSP.", "Dosage": "3,7\u00b5G/AMP. DE 0,25ML DE SUSP. (P.A.)+1AMP. D'EMULSION DE 0,25ML(ADJUVANT) CORRESPONDANT A 3,75\u00b5G/0,5ML (OU 3,75\u00b5G/DOSE) APRES MELANGE ", "Conditionnement": "B/50AMP. DE SUSP. +2X25AMP. D'EMULSION", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARICLARE 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARICLARE", "Tarif de reference": "574.00 DA", "PPA": "N/A", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": " B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARIDONE HUP 10MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/2496.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARIDONE HUP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "380/ 15 F 075 /11", "Code DCI": "15F075", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARIDONE HUP 5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/2491.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARIDONE HUP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "380/ 15 F 074 /11", "Code DCI": "15F074", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARIMIDEX 1MG COMP.ENRO. B/28", "Img": "https://pharmnet-dz.com//img/medics/612.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=612", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ANASTROZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ARIMIDEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "036/ 09 B 139 /05", "Code DCI": "09B139", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARINIA 10MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARINIA", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "001/ 16 D 103 /14", "Code DCI": "16D103", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARINIA 15MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARINIA", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "001/ 16 D 104 /14", "Code DCI": "16D104", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARIPIPRAZOLE BEKER  15MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/4694.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARIPIPRAZOLE BEKER ", "Tarif de reference": "5842.20 DA", "PPA": "5842.20 DA", "Num Enregistrement": "447/16D104/17", "Code DCI": "16D104", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARIPIPRAZOLE BEKER  20MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/4695.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARIPIPRAZOLE BEKER ", "Tarif de reference": "6510.00 DA", "PPA": "6510.00 DA", "Num Enregistrement": "447/16D161/17", "Code DCI": "16D161", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARIPIPRAZOLE BEKER COMP 10MG B/30", "Img": "https://pharmnet-dz.com//img/medics/4710.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ARIPIPRAZOLE BEKER", "Tarif de reference": "194,74 DA", "PPA": "5842,20 DA", "Code DCI": "16D103", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": false, "Remboursable": true}, {"Nom": "AROMASINE 25MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/602.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=602", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " EXEMESTANE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AROMASINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 09 A 142 /06", "Code DCI": "09A142", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AROVAN 10MG COMP. PELLI.  B/30", "Img": "https://pharmnet-dz.com//img/medics/1556.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AROVAN", "Tarif de reference": "837.6 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 198 /12", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AROVAN 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AROVAN", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 225 /12", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AROVAN 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1594.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AROVAN", "Tarif de reference": "1980 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 232 /13", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AROVAN 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1609.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AROVAN", "Tarif de reference": "2040 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 233 /13", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARTELAC 3,20MG/ML COLLY. FL./10ML", "Img": "https://pharmnet-dz.com//img/medics/2016.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2016", "Laboratoire": " DR GERHARD MANN CHEM-PHARM FABRIK GMBH", "C.Pharmacologique": " SUPPLEANCE LACRYMALE", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " HYPROMELLOSE", "Pays": "ALLEMAGNE", "Nom Commercial": "ARTELAC", "Tarif de reference": "227.42 DA", "PPA": "N/A", "Num Enregistrement": "445/ 17 N 163 /09", "Code DCI": "17N163", "Forme": "COLLY.", "Dosage": "3,20MG/ML", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARTIZ 10MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/3972.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3972", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ARTIZ", "Tarif de reference": "60 DA", "PPA": "N/A", "Num Enregistrement": "352/ 01 A 003 /06/13", "Code DCI": "01A003", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARTIZ 10MG/ML  SOL BUV EN GTTES  B /FL 30ML +PIPETTE GRADUEE ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4611", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ARTIZ", "Tarif de reference": "240.15 DA", "PPA": " DA", "Num Enregistrement": "352/01A041/16", "Code DCI": "01A041", "Forme": "SOL. BUV.", "Dosage": "10MG/ML ", "Conditionnement": "B /FL 30ML +PIPETTE GRADUEE ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ARTROLIFE 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "ARTROLIFE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 04 B 015 /96", "Code DCI": "04B015", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "ARTROLIFE 50MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "ARTROLIFE", "Tarif de reference": "98.5 DA", "PPA": "N/A", "Num Enregistrement": "010/ 04 B 014 /98", "Code DCI": "04B014", "Forme": "SUPPO.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASCALOL 25G/100G  SOL. APPLI. LOCALE FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTIPARASITAIRES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BENZOATE DE BENZYLE", "Pays": "ALGERIE", "Nom Commercial": "ASCALOL", "Tarif de reference": " N/A", "PPA": "244.00 DA", "Num Enregistrement": "318/ 07 R 179 /14", "Code DCI": "07R179", "Forme": "SOL. APP. LOCALE", "Dosage": "25G/100G ", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASIA  MIGRAINE 1MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " ASIA PHARMACEUTICALS", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " ERGOTAMINE TARTRATE  ASSOCIE", "Pays": "SYRIE", "Nom Commercial": "ASIA  MIGRAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "121/ 15 B 018 /99", "Code DCI": "15B018", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASIAPIRINE 81 81MG COMP. PELLI. GASTRO-RESIST. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASIAPIRINE 81", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "097/ 12 A 111 /04", "Code DCI": "12A111", "Forme": "COMP. PELLI.", "Dosage": "81MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASIATICOSID 0.01 CREME T/10G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " EXTRAIT DE CENTELLA ASIATICA", "Pays": "ITALIE", "Nom Commercial": "ASIATICOSID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 07 A 002 /98", "Code DCI": "07A002", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/10G", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASIATICOSID 0.02 PDRE FL. POUDREUR DE 2G", "Img": "https://pharmnet-dz.com//img/medics/1636.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1636", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " EXTRAIT DE CENTELLA ASIATICA", "Pays": "ITALIE", "Nom Commercial": "ASIATICOSID", "Tarif de reference": "158.63 DA", "PPA": "N/A", "Num Enregistrement": "013/ 07 A 001 /96/10", "Code DCI": "07A001", "Forme": "PDRE", "Dosage": "0.02", "Conditionnement": "FL. POUDREUR DE 2G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASMADIL 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ASMADIL", "Tarif de reference": "165 DA", "PPA": "N/A", "Num Enregistrement": "118/ 20 A 015 /98", "Code DCI": "20A015", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASMALINE 0,5MG/ML SOL INJ SC/IV B/50AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ASMALINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 20 A 020 /05", "Code DCI": "20A020", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML", "Conditionnement": "B/50AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASMANORE 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ASMANORE", "Tarif de reference": "165 DA", "PPA": "N/A", "Num Enregistrement": "043/ 20 A 015 /98", "Code DCI": "20A015", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPALGINE 81MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPALGINE", "Tarif de reference": "43 DA", "PPA": "N/A", "Num Enregistrement": "418/ 12 A 111 /08", "Code DCI": "12A111", "Forme": "COMP. PELLI.", "Dosage": "81MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPEC 100MG COMP. SEC. B/98", "Img": "https://pharmnet-dz.com//img/medics/1703.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1703", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPEC", "Tarif de reference": "259.7 DA", "PPA": "259.70 DA", "Num Enregistrement": "447/ 12 A 131 /09", "Code DCI": "12A131", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/98", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPEGIC 1G SOL.INJ. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4119", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE LYSINE", "Pays": "FRANCE", "Nom Commercial": "ASPEGIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 03 A 023 /98", "Code DCI": "03A023", "Forme": "SOL. INJ.", "Dosage": "1G", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPEGIC 500MG/FL. DE PDRE. PDRE.ET SOLV. P. SOL. INJ. IM/IV B/06 FL. DE PDRE. + 06AMP. DE 5ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medics/4116.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4116", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "FRANCE", "Nom Commercial": "ASPEGIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 03 A 004 /97/09", "Code DCI": "03A004", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/06 FL. DE PDRE. + 06AMP. DE 5ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPEGIC 500MG/SACH.-DOSE PDRE. SOL. BUV. EN SACH.-DOSE B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/4123.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4123", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "FRANCE", "Nom Commercial": "ASPEGIC", "Tarif de reference": "66.8 DA", "PPA": "N/A", "Num Enregistrement": "376/ 03 A 025 /97/08", "Code DCI": "03A025", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPEGIC ADULTE 1G/SACH.-DOSE PDRE. SOL. BUV. EN SACH.-DOSE B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/4126.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4126", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "FRANCE", "Nom Commercial": "ASPEGIC ADULTE", "Tarif de reference": "255.74 DA", "PPA": "N/A", "Num Enregistrement": "376/ 03 A 069 /08", "Code DCI": "03A069", "Forme": "PDRE. SOL. BUV.", "Dosage": "1G/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPEGIC ENFANT 250MG/SACH.-DOSE PDRE. SOL. BUV. EN SACH.-DOSE B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/4121.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4121", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "FRANCE", "Nom Commercial": "ASPEGIC ENFANT", "Tarif de reference": "117.6 DA", "PPA": "N/A", "Num Enregistrement": "376/ 03 A 024 /03", "Code DCI": "03A024", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPEGIC NOURRISSON 100MG/SACH.-DOSE PDRE. SOL. BUV. SACHET B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/4131.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4131", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "FRANCE", "Nom Commercial": "ASPEGIC NOURRISSON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "376/ 03 A 104 /97/09", "Code DCI": "03A104", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASPEVASC 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1704.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1704", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPEVASC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/ 12 A 131 /06", "Code DCI": "12A131", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPICARD 81MG COMP. ENRO. GASTRO-RESIST. B/120", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " TABUK", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "ASPICARD", "Tarif de reference": "258 DA", "PPA": "N/A", "Num Enregistrement": "173/ 12 A 111 /07", "Code DCI": "12A111", "Forme": "COMP. PELLI.", "Dosage": "81MG", "Conditionnement": "B/120", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPIGAL 500MG/FL. DE PDRE. PDRE.ET SOLV. P. SOL. INJ. IM/IV B/01FL. DE PDRE +01AMP. DE 5ML DE SOLV. (EPPI) ET B/50FL. DE PDRE    ", "Img": "https://pharmnet-dz.com//img/medics/4117.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPIGAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 03 A 004 /06/14", "Code DCI": "03A004", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE +01AMP. DE 5ML DE SOLV. (EPPI) ET B/50FL. DE PDRE    ", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASPIRINE BEKER 500MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/4113.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4113", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPIRINE BEKER", "Tarif de reference": "93.52 DA", "PPA": "125.00 DA", "Num Enregistrement": "447/ 03 A 001 /10", "Code DCI": "03A001", "Forme": "COMP. SEC.", "Dosage": "500MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPIRINE BIOTIC 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/4127.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPIRINE BIOTIC", "Tarif de reference": "53 DA", "PPA": "50.00 DA", "Num Enregistrement": "003/ 03 A 084 /06 ", "Code DCI": "03A084", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPIRINE BIOTIC 160MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPIRINE BIOTIC", "Tarif de reference": "60 DA", "PPA": "N/A", "Num Enregistrement": "003/ 12 A 150 /09", "Code DCI": "12A150", "Forme": "COMP. SEC.", "Dosage": "160MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPIRINE CARDIO 100MG COMP. PILULIER/60", "Img": "https://pharmnet-dz.com//img/medics/1705.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPIRINE CARDIO", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "263/ 12 A 131 /07/13", "Code DCI": "12A131", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "PILULIER/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPIRINE UPSA VITAMINE C TAMPONNEE EFFERVESCENTE 330MG/200MG COMP. EFFERV B/20", "Img": "https://pharmnet-dz.com//img/medics/4124.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4124", "Laboratoire": " PROPHARMAL", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE/ ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPIRINE UPSA VITAMINE C TAMPONNEE EFFERVESCENTE", "Tarif de reference": "0 DA", "PPA": "152.00 DA", "Num Enregistrement": "201/ 03 A 033 /00/14", "Code DCI": "03A033", "Forme": "COMP. EFFERV.", "Dosage": "330MG/200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASPRO ACCEL 500MG/50MG COMP. EFFERV. SEC.  B/20", "Img": "https://pharmnet-dz.com//img/medics/4129.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4129", "Laboratoire": " BAYER", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE / CAFEINE", "Pays": "FRANCE", "Nom Commercial": "ASPRO ACCEL", "Tarif de reference": " N/A", "PPA": "208.00 DA", "Num Enregistrement": "395/ 03 A 103 /09", "Code DCI": "03A103", "Forme": "COMP. EFFERV.", "Dosage": "500MG/50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASPRO ACCEL 500MG/50MG COMP. PELLI. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/4128.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4128", "Laboratoire": " BAYER", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE / CAFEINE", "Pays": "FRANCE", "Nom Commercial": "ASPRO ACCEL", "Tarif de reference": " N/A", "PPA": "216.00 DA", "Num Enregistrement": "395/ 03 A 102 /08", "Code DCI": "03A102", "Forme": "COMP. PELLI.", "Dosage": "500MG/50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASPROCARD 81MG COMP. ENRO. GASTRO-RESIST. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ASPROCARD", "Tarif de reference": "64.5 DA", "PPA": "N/A", "Num Enregistrement": "304/ 12 A 111 /07", "Code DCI": "12A111", "Forme": "COMP. PELLI.", "Dosage": "81MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASTENIA 0,4MG/0,005MG/10MG/1,4MG/1,6MG/2MG/18MG/0,2MG/6MG/0,150MG/0,001MG/  60MG/2,4MG COMP. EFFERV. T/20", "Img": "https://pharmnet-dz.com//img/medics/3464.png", "Laboratoire": " API", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " VITAMINE A / VITAMINE D3 / VIATAMINE E / VITAMINE B1 /  VITAMINE B2/ VITAMINE B6 / NICOTINAMIDE /ACIDE FOLIQUE / ACIDE PANTHOTENIQUE / BIOTINE / VITAMINE B12 / VITAMINE C / BETA CAROTENE", "Pays": "ALGERIE", "Nom Commercial": "ASTENIA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "348/ 14 H 334 /09", "Code DCI": "14H334", "Forme": "COMP. EFFERV.", "Dosage": "0,4MG/0,005MG/10MG/1,4MG/1,6MG/2MG/18MG/0,2MG/6MG/0,150MG/0,001MG/  60MG/2,4MG", "Conditionnement": "T/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASTHALIN 100\u00b5G/BOUFFEE SOL.INHAL.BUCCAL. FL/200DOSES", "Img": "https://pharmnet-dz.com//img/medics/2088.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ASTHALIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 017 /99", "Code DCI": "20A017", "Forme": "AERO.", "Dosage": "100\u00b5G/BOUFFEE", "Conditionnement": "FL/200DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "ASTHALIN 2MG** COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/2077.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ASTHALIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 015 /98/09", "Code DCI": "20A015", "Forme": "COMP.", "Dosage": "2MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ASTHALIN 5MG/ML** SOL.INHAL.PAR NEBULISEUR FL/15ML", "Img": "https://pharmnet-dz.com//img/medics/2091.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2091", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ASTHALIN", "Tarif de reference": "163.75 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 018 /99/09", "Code DCI": "20A018", "Forme": "AERO.", "Dosage": "5MG/ML**", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATABEK 16MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3152.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3152", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATABEK", "Tarif de reference": "1289.99 DA", "PPA": "1290.00 DA", "Num Enregistrement": "447/ 06 E 234 /12", "Code DCI": "06E234", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATABEK 8MG COMP. SEC B/30", "Img": "https://pharmnet-dz.com//img/medics/3105.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3105", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATABEK", "Tarif de reference": "1289.99 DA", "PPA": "1290.00 DA", "Num Enregistrement": "447/ 06 E 197 /12", "Code DCI": "06E197", "Forme": "COMP. SEC.", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATACAND 16MG COMP. SEC.  B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Nom Commercial": "ATACAND", "Code DCI": "06E234", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": " B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATACAND 4MG COMP SEC B/28", "Img": "https://pharmnet-dz.com//img/medics/3103.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3103", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATACAND", "Tarif de reference": "652.96 DA", "PPA": " DA", "Num Enregistrement": "256/ 06 E 196 /02", "Code DCI": "06E196", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATACAND 8MG COMP SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Nom Commercial": "ATACAND", "Code DCI": "06E197", "Forme": "COMP. SEC.", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATACURE 10MG/ML (50MG/5ML) SOL. INJ. IV B/05AMP DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/4108.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ATRACURIUM", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ATACURE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 02 D 047 /05/13", "Code DCI": "02D047", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (50MG/5ML)", "Conditionnement": "B/05AMP DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATARAX 100MG COMP.PELLI. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/2610.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2610", "Laboratoire": " UCB PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATARAX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "046/ 16 B 041 /98", "Code DCI": "16B041", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATARAX 25MG COMP.SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/2607.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2607", "Laboratoire": " UCB PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATARAX", "Tarif de reference": "0 DA", "PPA": "1204.00 DA", "Num Enregistrement": "046/ 16 B 040 /98", "Code DCI": "16B040", "Forme": "COMP.", "Dosage": "25MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATARAX 2MG/ML SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medics/2173.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2173", "Laboratoire": " UCB PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATARAX", "Tarif de reference": "0 DA", "PPA": "204.00 DA", "Num Enregistrement": "046/ 16 B 079 /98", "Code DCI": "16B079", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATARAX 50MG/ML SOL.INJ. B/6AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " UCB PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATARAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "046/ 16 B 039 /98", "Code DCI": "16B039", "Forme": "SOL. INJ.", "Dosage": "50MG/ML", "Conditionnement": "B/6AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATENOCLOR 50MG/12,5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATENOLOL / CHLORTHALIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATENOCLOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035/ 06 E 291 /09", "Code DCI": "06E291", "Forme": "COMP. PELLI.", "Dosage": "50MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATENOR 100MG COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3234.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATENOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATENOR", "Tarif de reference": " N/A", "PPA": "317.00 DA", "Num Enregistrement": "035/ 06 F 069 /00/07", "Code DCI": "06F069", "Forme": "COMP SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATEPADENE 30MG GLES.  B/30", "Img": "https://pharmnet-dz.com//img/medics/2676.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2676", "Laboratoire": " MAYOLY SPINDLER", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " ADENOSINE TRIPHOSPHATE", "Pays": "FRANCE", "Nom Commercial": "ATEPADENE", "Tarif de reference": "0 DA", "PPA": "496,21 DA", "Num Enregistrement": "067/ 03 F 082 /06 ", "Code DCI": "03F082", "Forme": "GLES.", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "ATHYMIL 30MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ORGANON", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " MIANSERINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ATHYMIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "005/ 16 A 014 /96", "Code DCI": "16A014", "Forme": "COMP.", "Dosage": "30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATHYROZOL 5MG COMP. SEC. B/50", "Img": "https://pharmnet-dz.com//img/medics/617.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=617", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTI-THYROIDIENS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CARBIMAZOLE", "Pays": "ALGERIE", "Nom Commercial": "ATHYROZOL", "Tarif de reference": "194.92 DA", "PPA": "N/A", "Num Enregistrement": "065/ 09 E 007 /13", "Code DCI": "09E007", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATINAL 100MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3235.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATENOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATINAL", "Tarif de reference": "317.4 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 F 069 /06", "Code DCI": "06F069", "Forme": "COMP SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATINAL 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATENOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATINAL", "Tarif de reference": "245.4 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 F 149 /07", "Code DCI": "06F149", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATOR 10MG COMP. PELLI. SEC. B/28 ", "Img": "https://pharmnet-dz.com//img/medics/1557.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1557", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATOR", "Tarif de reference": "781.76 DA", "PPA": "781.00 DA", "Num Enregistrement": "317/ 06 M 198 /10", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATOR 20MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1581.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1581", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATOR", "Tarif de reference": "1164.24 DA", "PPA": " DA", "Num Enregistrement": "317/ 06 M 225 /11", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATOR 40MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/1595.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1595", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATOR", "Tarif de reference": "1848 DA", "PPA": "1848.00 DA", "Num Enregistrement": "317/ 06 M 232 /11", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATOR 80MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1604.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1604", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATOR", "Tarif de reference": "1904 DA", "PPA": "1904.00 DA", "Num Enregistrement": "317/ 06 M 233 /12", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORIN 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1558.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1558", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORIN", "Tarif de reference": "837.60 DA", "PPA": "837.59 DA", "Num Enregistrement": "447/ 06 M 198 /11", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": " B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORIN 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1582.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1582", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORIN", "Tarif de reference": "1247.39 DA", "PPA": "1247.40 DA", "Num Enregistrement": "447/ 06 M 225 /11", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORIN 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1596.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1596", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORIN", "Tarif de reference": "1980.00 DA", "PPA": "1979.99 DA", "Num Enregistrement": "447/ 06 M 232 /11", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": " B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORIN 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1605.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1605", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORIN", "Tarif de reference": "2040.00 DA", "PPA": "2039.99 DA", "Num Enregistrement": "447/ 06 M 233 /11", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE GEBER 10MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GEBER HEALTH", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE GEBER", "Tarif de reference": "837.6 DA", "PPA": "837.00 DA", "Num Enregistrement": "472/ 06 M 198 /15", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE GEBER 20MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GEBER HEALTH", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE GEBER", "Tarif de reference": "1247.4 DA", "PPA": "1247.00 DA", "Num Enregistrement": "472/ 06 M 225 /15", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE GEBER 40MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GEBER HEALTH", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE GEBER", "Tarif de reference": "1980 DA", "PPA": "1980.00 DA", "Num Enregistrement": "472/ 06 M 232 /15", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE IVAL 10MG COMP.PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE IVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "195/ 06 M 198 /07/12", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATORVASTATINE IVAL 20MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE IVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "195/ 06 M 225 /13", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATORVASTATINE IVAL 40MG  COMP.PELL  B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA-IVAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE IVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "195/ 06 M 232 /14", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATORVASTATINE LDM  10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE LDM ", "Tarif de reference": "837.6 DA", "PPA": "N/A", "Num Enregistrement": "309/06M198/16", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE LDM 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE LDM", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "309/06M225/16", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE LDM 40MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE LDM", "Tarif de reference": "1980 DA", "PPA": "N/A", "Num Enregistrement": "309/06M232/16", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE LDM 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE LDM", "Tarif de reference": "2040.00 DA", "PPA": "N/A", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE MM  10MG  COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE MM", "Tarif de reference": "837.6 DA", "PPA": "837.00 DA", "Num Enregistrement": "470/ 06 M 198 /14", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": " 10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE NOVAGENERICS 10MG COMP. PELLI. PILULIER DE 30", "Img": "https://pharmnet-dz.com//img/medics/1562.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE NOVAGENERICS", "Tarif de reference": "837.6 DA", "PPA": "837.00 DA", "Num Enregistrement": "149/ 06 M 198 /13", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "PILULIER DE 30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE NOVAGENERICS 20MG COMP. PELLI. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/1585.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE NOVAGENERICS", "Tarif de reference": "1247.4 DA", "PPA": "1247.00 DA", "Num Enregistrement": "149/ 06 M 225 /15", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE NOVAGENERICS 40MG  COMP PELL  PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/1599.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE NOVAGENERICS", "Tarif de reference": "1980 DA", "PPA": "1980.00 DA", "Num Enregistrement": "149/ 06 M 232 /14", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG ", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATORVASTATINE NOVAGENERICS 80MG  COMP . PELLI. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/1606.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATORVASTATINE NOVAGENERICS", "Tarif de reference": "2040 DA", "PPA": "2040.00 DA", "Num Enregistrement": "149/ 06 M 233 /14", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG ", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATOVAL 10MG COMP. PELLI. B/10 ET B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATOVAL", "Tarif de reference": "279.2 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 198 /08", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/10 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATOVAL 20MG COMP. PELLI. B/10 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATOVAL", "Tarif de reference": "415.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 225 /08", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/10 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATP NOVAGENERICS  30MG GLES.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " ADENOSINE TRIPHOSPHATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATP NOVAGENERICS ", "Tarif de reference": "-- DA", "PPA": " DA", "Num Enregistrement": "149/03F082/17", "Code DCI": "03F082", "Forme": "GLES.", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "ATROPINE - ALCON 0.003 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1987", "Laboratoire": " ALCON", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATROPINE - ALCON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "028/ 17 H 056 /97", "Code DCI": "17H056", "Forme": "COLLY.", "Dosage": "0.003", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATROPINE - ALCON 0.005 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1989", "Laboratoire": " ALCON", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATROPINE - ALCON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "028/ 17 H 057 /97", "Code DCI": "17H057", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATROPINE - ALCON 0.01 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/1992.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ALCON", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATROPINE - ALCON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "028/ 17 H 058 /97", "Code DCI": "17H058", "Forme": "COLLY.", "Dosage": "0.01", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATROVENT ADUL . 0,50MG/2ML SOL.INHAL.PAR NEBULISEUR B/10 RECIPIENTS UNIDOSES DE  2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2104", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " IPRATROPIUM BROMURE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATROVENT ADUL .", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 20 A 047 /99", "Code DCI": "20A047", "Forme": "SOL. INHAL.", "Dosage": "0,50MG/2ML", "Conditionnement": "B/10 RECIPIENTS UNIDOSES DE  2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATROVENT ENF. 0,25MG/2ML SOL.INHAL.PAR NEBULISEUR B/10 RECIPIENTS UNIDOSES DE  2ML", "Img": "https://pharmnet-dz.com//img/medics/2103.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2103", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " IPRATROPIUM BROMURE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ATROVENT ENF.", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 20 A 046 /99", "Code DCI": "20A046", "Forme": "SOL. INHAL.", "Dosage": "0,25MG/2ML", "Conditionnement": "B/10 RECIPIENTS UNIDOSES DE  2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATRYLINE 25MG COMP. ENRO. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATRYLINE", "Tarif de reference": " N/A", "PPA": "285.00 DA", "Num Enregistrement": "065/ 16 A 001 /04/13", "Code DCI": "16A001", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATRYLINE 4% (40MG/ML) GTTES. BUV. FL. COMPT.GTTES DE  20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATRYLINE", "Tarif de reference": " N/A", "PPA": "120.00 DA", "Num Enregistrement": "065/ 16 A 003 /08/14", "Code DCI": "16A003", "Forme": "SOL. BUV. GTTES.", "Dosage": "4% (40MG/ML)", "Conditionnement": "FL. COMPT.GTTES DE  20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATRYLINE 50MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ATRYLINE", "Tarif de reference": " N/A", "PPA": "315.00 DA", "Num Enregistrement": "065/ 16 A 002 /04/14", "Code DCI": "16A002", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ATUSSINE ADULTES 0,2G/0,2G/100ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/2154.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2154", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE / MEPYRAMINE MALEATE", "Pays": "ALGERIE", "Nom Commercial": "ATUSSINE ADULTES", "Tarif de reference": "0 DA", "PPA": "167.00 DA", "Num Enregistrement": "285/ 20 B 102 /03/08", "Code DCI": "20B102", "Forme": "SIROP", "Dosage": "0,2G/0,2G/100ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ATUSSINE ENFANTS 0,1G/0,1G/0,4G/100ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/2155.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2155", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE /  MEPYRAMINE MALEATE / GUA\u00cfFENESINE", "Pays": "ALGERIE", "Nom Commercial": "ATUSSINE ENFANTS", "Tarif de reference": "0 DA", "PPA": "148.00 DA", "Num Enregistrement": "285/ 20 B 103 /03/08", "Code DCI": "20B103", "Forme": "SIROP", "Dosage": "0,1G/0,1G/0,4G/100ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AUGMENTIMEX ADULTES 500MG/62,5MG COMP. PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AUGMENTIMEX ADULTES", "Tarif de reference": "523.52 DA", "PPA": "N/A", "Num Enregistrement": "400/ 13 G 245 /07", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "AUGMENTIN 1G/200MG PDRE.SOL.INJ B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=289", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AUGMENTIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 13 G 182 /99", "Code DCI": "13G182", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "AUGMENTIN 250MG/62,5MG/5ML PDRE.SOL.BUV. FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SMITHKLINE BEECHAM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AUGMENTIN", "Tarif de reference": "349.8 DA", "PPA": "N/A", "Num Enregistrement": "042/ 13 G 051 /98", "Code DCI": "13G051", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/62,5MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AUGMENTIN 2G/200MG PDRE.SOL.INJ B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=293", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AUGMENTIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 13 G 183 /99", "Code DCI": "13G183", "Forme": "PDRE. SOL. INJ.", "Dosage": "2G/200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "AUGMENTIN 500MG COMP. B/12", "Img": "https://pharmnet-dz.com//img/medics/235.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SMITHKLINE BEECHAM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AUGMENTIN", "Tarif de reference": "392.64 DA", "PPA": "N/A", "Num Enregistrement": "042/ 13 G 050 /98", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AUGMENTIN 500MG/50MG PDRE. P. SOL.INJ. B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=232", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AUGMENTIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 13 G 049 /98", "Code DCI": "13G049", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/50MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": null}, {"Nom": "AUGMENTIN ADULTE 1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/337.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=337", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AUGMENTIN ADULTE", "Tarif de reference": "785.28 DA", "PPA": "N/A", "Num Enregistrement": "305/ 13 G 269 /04/15", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG/SACHET", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AUGMENTIN ADULTES 500MG/62,5MG COMP PELLI B/16 ET B/24", "Img": "https://pharmnet-dz.com//img/medics/319.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=319", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AUGMENTIN ADULTES", "Tarif de reference": "785.28 DA", "PPA": "N/A", "Num Enregistrement": "262/ 13 G 245 /02", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/16 ET B/24", "Commercialisation": true, "Remboursable": true}, {"Nom": "AUGMENTIN ENFANT ET AUGMENTIN NOURRISSON  100MG/12,5MG/ML PDRE. P. SUSP. BUV. B/FL. DE PDRE. DE 30ML DE SUSP. BUV. ET B/1FL. DE PDRE. DE 60ML  DE SUSP. BUV. (APRES RECONSTITUTION) ", "Img": "https://pharmnet-dz.com//img/medics/285.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=285", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AUGMENTIN ENFANT ET AUGMENTIN NOURRISSON ", "Tarif de reference": "593.4 DA", "PPA": "N/A", "Num Enregistrement": "305/ 13 G 181 /99/11", "Code DCI": "13G181", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/12,5MG/ML", "Conditionnement": "B/FL. DE PDRE. DE 30ML DE SUSP. BUV. ET B/1FL. DE PDRE. DE 60ML  DE SUSP. BUV. (APRES RECONSTITUTION) ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AUGMENTIN ENFANTS 500MG/62,5MG PDRE. P. SUSP. BUV. EN SACHET DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/295.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=295", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AUGMENTIN ENFANTS", "Tarif de reference": "392.64 DA", "PPA": "N/A", "Num Enregistrement": "262/ 13 G 204 /04", "Code DCI": "13G204", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVAMYS 27,50\u00b5G/DOSE SUSP. P. PULV. NAS. FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AVAMYS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "262/22E045/15", "Code DCI": "N/D", "Forme": "SUSP.NAS.", "Dosage": "27,50\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": null}, {"Nom": "AVANDIA 4MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3701.png", "Laboratoire": " SMITHKLINE BEECHAM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ROSIGLITASONE MALEATE EXPRIME EN ROSIGLITASONE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AVANDIA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "042/ 14 A 205 /03/09", "Code DCI": "14A205", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVANDIA 8MG COMP. B/14 ET B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SMITHKLINE BEECHAM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ROSIGLITASONE MALEATE EXPRIME EN ROSIGLITASONE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AVANDIA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "042/ 14 A 206 /03", "Code DCI": "14A206", "Forme": "COMP.", "Dosage": "8MG", "Conditionnement": "B/14 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVASTIN 25MG/ML (OU 100MG/4ML - 400MG/16ML) SOL. A DILUER PERF. FL.AMP. DE 4ML ET FL.AMP.DE 16ML", "Img": "https://pharmnet-dz.com//img/medics/1061.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1061", "Laboratoire": " ROCHE", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " BEVACIZUMAB", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "AVASTIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 05 D 134 /09", "Code DCI": "05D134", "Forme": "SOL. PERF.", "Dosage": "25MG/ML (OU 100MG/4ML - 400MG/16ML)", "Conditionnement": "FL.AMP. DE 4ML ET FL.AMP.DE 16ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVELOX 400MG** COMP. PELLI. B/5 - B/7", "Img": "https://pharmnet-dz.com//img/medics/396.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=396", "Laboratoire": " BAYER", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " MOXIFLOXACINE CHLORHYDRATE EXPRIME EN MOXIFLOXACINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "AVELOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 13 K 461 /10", "Code DCI": "13K461", "Forme": "COMP. PELLI.", "Dosage": "400MG**", "Conditionnement": "B/5 - B/7", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVISINE 37,5MG GLES LP  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AVISINE", "Tarif de reference": "870.6 DA", "PPA": "800.00 DA", "Num Enregistrement": "286/ 16 A 125 /14", "Code DCI": "16A125", "Forme": "GLES. LP", "Dosage": "37,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVISINE 75 MG GLES LP  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AVISINE", "Tarif de reference": "1741.2 DA", "PPA": "1700.00 DA", "Num Enregistrement": "286/ 16 A 126 /14", "Code DCI": "16A126", "Forme": "GLES. LP ", "Dosage": "75 MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVLOCARDYL 40MG COMP.SEC. B/50", "Img": "https://pharmnet-dz.com//img/medics/3238.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3238", "Laboratoire": " ZENECA PHARMA", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPRANOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AVLOCARDYL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "171/ 06 F 073 /99", "Code DCI": "06F073", "Forme": "COMP. SEC.", "Dosage": "40MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "AVONEX 30\u00b5G/0,5ML (OU 6MUI/0,5ML) SOL INJ IM  B/04 SERINGUES  PRE REMPLIES DE 0,5ML", "Img": "https://pharmnet-dz.com//img/medics/2503.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2503", "Laboratoire": " BIOGEN IDEC LIMITED", "C.Pharmacologique": " SCLEROSE EN PLAQUE", "C.Therapeutique": " NEUROLOGIE", "Info": " INTERFERON BETA 1A", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AVONEX", "Tarif de reference": "81828 DA", "PPA": "81828.00 DA", "Num Enregistrement": "375/ 15 G 078 /07", "Code DCI": "15G078", "Forme": "SOL. INJ.", "Dosage": "30\u00b5G/0,5ML (OU 6MUI/0,5ML)", "Conditionnement": "B/04 SERINGUES  PRE REMPLIES DE 0,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZANTAC 50MG/2ML SOL.INJ. B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3851", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "AZANTAC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 10 A 002 /99", "Code DCI": "10A002", "Forme": "SOL. INJ.", "Dosage": "50MG/2ML", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZATHIOPRINE MYLAN 50MG COMP. PELLI. SEC. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1018", "Laboratoire": " MYLAN", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " AZATHIOPRINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AZATHIOPRINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 B 043 /06/15", "Code DCI": "05B043", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "AZIMYCINE 250MG GLES. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AZIMYCINE", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 176 /07", "Code DCI": "13E176", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZIMYCINE 40MG/ML (200MG/5ML) PDRE. SUSP. BUV. FL./15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AZIMYCINE", "Tarif de reference": "432 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 177 /07", "Code DCI": "13E177", "Forme": "PDRE. SOL. BUV.", "Dosage": "40MG/ML (200MG/5ML)", "Conditionnement": "FL./15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZITHRAL 500MG COMP. PELLI. SEC. B/03 ", "Img": "https://pharmnet-dz.com//img/medics/833.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AZITHRAL", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 E 299 /12", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZITHROM HUP 500MG COMP. PELLI. SEC. B/03", "Img": "https://pharmnet-dz.com//img/medics/834.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AZITHROM HUP", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "380/ 13 E 299 /12", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZITHROMYCINE BEKER 500MG COMP. PELLI. SEC. B/03", "Img": "https://pharmnet-dz.com//img/medics/835.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=835", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AZITHROMYCINE BEKER", "Tarif de reference": "549.96 DA", "PPA": "549.00 DA", "Num Enregistrement": "447/ 13 E 299 /13", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZITHROMYCINE NS 500MG COMP . PEL. SEC B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "AZITHROMYCINE NS", "Tarif de reference": "549,96 DA", "PPA": "N/A", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZOPT 10MG/ML COLLY. EN SUSP. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2365.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2365", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " BRINZOLAMIDE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "AZOPT", "Tarif de reference": "1315.32 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 C 140 /05/15", "Code DCI": "17C140", "Forme": "COLLY. SOL.", "Dosage": "10MG/ML", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "AZYTER 15MG/G** COLLY. EN SOL. EN RECIPIENT UNIDOSE B/06RECIPIENTS UNIDOSES SOUS SACHET", "Img": "https://pharmnet-dz.com//img/medics/1960.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1960", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "AZYTER", "Tarif de reference": "0 DA", "PPA": "709.00 DA", "Num Enregistrement": "022/ 17 D 164 /09", "Code DCI": "17D164", "Forme": "COLLY.", "Dosage": "15MG/G**", "Conditionnement": "B/06RECIPIENTS UNIDOSES SOUS SACHET", "Commercialisation": true, "Remboursable": true}], "B": [{"Nom": "B.SIX 250MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " PYRIDOXINE", "Pays": "ALGERIE", "Nom Commercial": "B.SIX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 H 102 /97", "Code DCI": "14H102", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "BACICOLINE A LA BACTRACINE 25MUI/1G/50 000UI/ 1G/100ML PDRE. ET SOLV. POUR COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " COLISTIMETHATE SODIQUE / HYDROCORTISONE (ACETATE) / BACITRACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BACICOLINE A LA BACTRACINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "026/ 17 D 018 /99/06", "Code DCI": "17D018", "Forme": "PDRE. SOL. COLLY.", "Dosage": "25MUI/1G/50 000UI/ 1G/100ML", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BACLON 10MG COMP SECABLE B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " MYORELAXANTS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " BACLOFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BACLON", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "418/21E025/16", "Code DCI": "21E025", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "BACRO 10MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1423", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " MYORELAXANTS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " BACLOFENE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "BACRO", "Tarif de reference": "437.5 DA", "PPA": "N/A", "Num Enregistrement": "012/ 21 E 025 /98/09", "Code DCI": "21E025", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "BACTISOL  200MG/40MG/5ML SUSPENSION BUVABLE BOITE DE 01 FLACON DE 100ML + CM DE 5ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SULFAMIDES", "C.Pharmacologique": " INFECTIOLOGIE", "C.Therapeutique": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BACTISOL ", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "503/13M090/16", "Code DCI": "13M090", "Forme": "SUSP. BUV.", "Dosage": "200MG/40MG/5ML", "Conditionnement": "BOITE DE 01 FLACON DE 100ML + CM DE 5ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "BACTIZOL 1G/FL PDRE. ET SOLV.SOL.INJ. IM B/1FL. PDRE. + 1AMP.SOLV. (0,5% LIDOCAINE) DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BACTIZOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 B 013 /01/09", "Code DCI": "13B013", "Forme": "PDRE. INJ.", "Dosage": "1G/FL", "Conditionnement": "B/1FL. PDRE. + 1AMP.SOLV. (0,5% LIDOCAINE) DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BACTIZOL 1G/FL PDRE.SOL.INJ IM/IV B/25FL.DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BACTIZOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 B 012 /97/09", "Code DCI": "13B012", "Forme": "PDRE. INJ.", "Dosage": "1G/FL", "Conditionnement": "B/25FL.DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "BALSOFUMINE  SIMPLE  SOL. P. INHAL. FL/84ML", "Img": "https://pharmnet-dz.com//img/medics/1345.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1345", "Laboratoire": " SANOFI WINTHROP", "C.Pharmacologique": " MEDICAMENTS DES AFFECTIONS RESPIRATOIRES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BALSAMIQUES POUR INHALATION", "Pays": "FRANCE", "Nom Commercial": "BALSOFUMINE  SIMPLE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "052/ 20 E 043 /99", "Code DCI": "20E043", "Forme": "SOL. INHAL.", "Dosage": "1", "Conditionnement": "FL/84ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BALSOFUMINE MENTHOLEE 0.01 SOL. P. INHAL. FL/84ML", "Img": "https://pharmnet-dz.com//img/medics/1347.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1347", "Laboratoire": " SANOFI WINTHROP", "C.Pharmacologique": " MEDICAMENTS DES AFFECTIONS RESPIRATOIRES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BALSAMIQUES POUR INHALATION", "Pays": "FRANCE", "Nom Commercial": "BALSOFUMINE MENTHOLEE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "052/ 20 E 070 /99", "Code DCI": "20E070", "Forme": "SOL. INHAL.", "Dosage": "0.01", "Conditionnement": "FL/84ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BALSOFUMINE MENTHOLEE 0.04 SOL. P. INHAL. FL/84ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANOFI WINTHROP", "C.Pharmacologique": " MEDICAMENTS DES AFFECTIONS RESPIRATOIRES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BALSAMIQUES POUR INHALATION", "Pays": "FRANCE", "Nom Commercial": "BALSOFUMINE MENTHOLEE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "052/ 20 E 071 /99", "Code DCI": "20E071", "Forme": "SOL. INHAL.", "Dosage": "0.04", "Conditionnement": "FL/84ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BANEOCIN 250UI/5000UI/G PDE DERM. T/20G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " BACITRACINE / NEOMYCINE", "Pays": "ALGERIE", "Nom Commercial": "BANEOCIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 07 C 134 /02/07", "Code DCI": "07C134", "Forme": "PDE. DERM.", "Dosage": "250UI/5000UI/G", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": null}, {"Nom": "BANEOCIN 250UI/5000UI/G PDRE. DERM. FL/10G", "Img": "https://pharmnet-dz.com//img/medics/1687.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1687", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " BACITRACINE / NEOMYCINE", "Pays": "AUTRICHE", "Nom Commercial": "BANEOCIN", "Tarif de reference": "160.26 DA", "PPA": " DA", "Num Enregistrement": "080/ 07 C 135 /02", "Code DCI": "07C135", "Forme": "PDRE. DERM.", "Dosage": "250UI/5000UI/G", "Conditionnement": "FL/10G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BARACLUDE 0,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3524.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3524", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ENTECAVIR", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "BARACLUDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 13 P 313 /08", "Code DCI": "13P313", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BARACLUDE 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3525.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3525", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ENTECAVIR", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "BARACLUDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 13 P 314 /08", "Code DCI": "13P314", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BASALOG ONE 100UI/ML (3,64MG/ML) SOL. INJ. EN STYLO PREREMPLI B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/4677.png", "Laboratoire": " BIOCON LIMITED", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "INDE", "Nom Commercial": "BASALOG ONE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "494/14B215/17", "Code DCI": "14B215", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,64MG/ML)", "Conditionnement": "B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BASDENE 25MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medics/620.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=620", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTI-THYROIDIENS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BENZYLTHIOURACILE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BASDENE", "Tarif de reference": "228.92 DA", "PPA": "N/A", "Num Enregistrement": "269/ 09 E 112 /99/15", "Code DCI": "09E112", "Forme": "COMP.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "BC FER 55,14MG** FER FERREUX / 75MG / 1,5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERREUX SOUS FORME DE SULFATE FERREUX ANHYDRE EXPRIME EN FER FERREUX / ACIDE ASCORBIQUE / ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "BC FER", "Tarif de reference": "230.1 DA", "PPA": "N/A", "Num Enregistrement": "003/ 12 E 151 /09", "Code DCI": "12E151", "Forme": "GLES.", "Dosage": "55,14MG** FER FERREUX / 75MG / 1,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "B-CORTOSONE 0,5MG/ML (0,05%) SOL.BUV. GTTES B/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "B-CORTOSONE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "318/09H020/16", "Code DCI": "09H020", "Forme": "SUSP. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BECLATE - NASAL 50\u00b5G/BOUFFEE AERO.NAS. FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BECLOMETASONE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BECLATE - NASAL", "Tarif de reference": "692 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 072 /99", "Code DCI": "20A072", "Forme": "AERO.", "Dosage": "50\u00b5G/BOUFFEE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "BECLATE 250\u00b5G/BOUFFEE SUSP.INHAL. FL/200DOSES", "Img": "https://pharmnet-dz.com//img/medics/2059.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BECLOMETASONE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BECLATE", "Tarif de reference": "408 DA", "PPA": " DA", "Num Enregistrement": "182/ 20 A 003 /99", "Code DCI": "20A003", "Forme": "AERO.", "Dosage": "250\u00b5G/BOUFFEE", "Conditionnement": "FL/200DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "BECLOJET 250\u00b5G/BOUFFEE SUSP.INHAL.BUCCALE FL/200DOSES", "Img": "https://pharmnet-dz.com//img/medics/2060.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2060", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BECLOMETASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BECLOJET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "092/ 20 A 003 /99", "Code DCI": "20A003", "Forme": "AERO.", "Dosage": "250\u00b5G/BOUFFEE", "Conditionnement": "FL/200DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "BECONASE 50\u00b5G/ Dose SUSP.NAS. FL/100DOSES", "Img": "https://pharmnet-dz.com//img/medics/2062.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2062", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BECLOMETASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BECONASE", "Tarif de reference": "346 DA", "PPA": "N/A", "Num Enregistrement": "262/ 20 A 004 /98", "Code DCI": "20A004", "Forme": "SUSP.NAS.", "Dosage": "50\u00b5G/ Dose", "Conditionnement": "FL/100DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "BEDELIX 3G PDRE . ORAL . RECT . B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3903.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3903", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MONTMORILLONITE BEIDELLITIQUE", "Pays": "FRANCE", "Nom Commercial": "BEDELIX", "Tarif de reference": "312.34 DA", "PPA": "N/A", "Num Enregistrement": "020/ 10 B 088 /96", "Code DCI": "10B088", "Forme": "PDRE. ORAL. RECT.", "Dosage": "3G", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "BEKERDIS  80MG COMP. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4418.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4418", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BEKERDIS ", "Tarif de reference": "1290.00 DA", "PPA": "1290.00 DA", "Num Enregistrement": "447/06E264/16", "Code DCI": "06E264", "Forme": "COMP.", "Dosage": "80MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "BEKTAL  100MG COMP.PELLI B/30", "Img": "https://pharmnet-dz.com//img/medics/3176.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3176", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BEKTAL ", "Tarif de reference": "1290 DA", "PPA": "1290 DA", "Num Enregistrement": "447/ 06 E 240 /11", "Code DCI": "06E240", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BEKTAL  50MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/163.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=163", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BEKTAL ", "Tarif de reference": "1290 DA", "PPA": "1290 DA", "Num Enregistrement": "447/ 06 E 126 /11", "Code DCI": "06E126", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BENDAZOLE 100MG COMP. B/6", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " MEBENDAZOLE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "BENDAZOLE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "043/ 19 B 006 /98", "Code DCI": "19B006", "Forme": "COMP. A CROQ.", "Dosage": "100MG", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "BENZATHINE BENZYLPENICILLINE BIOCARE 1 200 000UI/FL. DE PDRE. PDRE. P. SUSP. INJ. IM B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/260.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " BENZATHINE BENZYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BENZATHINE BENZYLPENICILLINE BIOCARE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 G 061 /11", "Code DCI": "13G061", "Forme": "PDRE. SOL. INJ.", "Dosage": "1 200 000UI/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "BEPANTHENE 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1646.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1646", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " DEXPANTHENOL (VIT. B5)", "Pays": "FRANCE", "Nom Commercial": "BEPANTHENE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "395/ 07 B 008 /99/11", "Code DCI": "07B008", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "BEPANTHENE 250MG/ML (500MG/2ML) SOL. INJ. IM B/06AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/1645.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1645", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " DEXPANTHENOL (VIT. B5)", "Pays": "FRANCE", "Nom Commercial": "BEPANTHENE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "395/ 07 B 007 /99/11", "Code DCI": "07B007", "Forme": "SOL. INJ.", "Dosage": "250MG/ML (500MG/2ML)", "Conditionnement": "B/06AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BERLTHYROX  50\u00b5G COMP. SEC B/50 ET B/100", "Img": "https://pharmnet-dz.com//img/medics/4464.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BERLIN CHEMIE AG", "C.Pharmacologique": " HORMONES THYROIDIENNES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LEVOTHYROXINE  SODIQUE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "BERLTHYROX ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "431/09K056/16", "Code DCI": "09K056", "Forme": "COMP. SEC.", "Dosage": "50\u00b5G", "Conditionnement": "B/50 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "BERTOCIL ( 5MG/ML) 0,5% COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA) ", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " BETAXOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "BERTOCIL", "Tarif de reference": "- DA", "PPA": "N/A", "Code DCI": "17C006", "Forme": "COLLY.", "Dosage": "( 5MG/ML) 0,5%", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETABIO 0,5MG/ML (0,05%) SOL.BUV. GTTES B/ FL 30ML+PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETABIO", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "235/09H020/16", "Code DCI": "09H020", "Forme": "SUSP. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/ FL 30ML+PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "BETABIO 2MG COMP. DISPERS. SEC. PILULIER DE 20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETABIO", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/9H133/16", "Code DCI": "09H133", "Forme": "COMP. DISPERS.", "Dosage": "2MG", "Conditionnement": "PILULIER DE 20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETACROVIS 0,5MG/ML (0,05%) SOL.BUV. GTTES FL/40ML", "Img": "https://pharmnet-dz.com//img/medics/633.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=633", "Laboratoire": " GENCOPHARM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETACROVIS", "Tarif de reference": "204.67 DA", "PPA": "N/A", "Num Enregistrement": "455/ 09 H 020 /99/09", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "FL/40ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETACYL 0,05G%/3G% PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/501.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=501", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE / ACIDE SALICYLIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETACYL", "Tarif de reference": "118.95 DA", "PPA": "N/A", "Num Enregistrement": "003/ 07 H 041 /09", "Code DCI": "07H041", "Forme": "PDE. DERM.", "Dosage": "0,05G%/3G%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETADERM 0.1 SOL.DERM. FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA) ", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "BETADERM", "Tarif de reference": "125 DA", "PPA": "N/A", "Num Enregistrement": "185/ 07 P 077 /03", "Code DCI": "07P077", "Forme": "SOL. DERM.", "Dosage": "0.1", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETADERME 0.001 CREME DERM. T/20G", "Img": "https://pharmnet-dz.com//img/medics/489.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " EIPICO ", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "BETADERME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "109/ 07 H 038 /99", "Code DCI": "07H038", "Forme": "CR\u00c8ME", "Dosage": "0.001", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETADERMINE 0.1 SOL.DERM. FL/120ML ET FL/500ML", "Img": "https://pharmnet-dz.com//img/medics/549.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " RIADH PHARM", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "BETADERMINE", "Tarif de reference": "120 DA", "PPA": " DA", "Num Enregistrement": "314/ 07 P 077 /05", "Code DCI": "07P077", "Forme": "SOL. DERM.", "Dosage": "0.1", "Conditionnement": "FL/120ML ET FL/500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETADINE SCRUB 0.04 SOL.DERM. (MOUSSANTE) FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " VIATRIS", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "FRANCE", "Nom Commercial": "BETADINE SCRUB", "Tarif de reference": "126.25 DA", "PPA": "N/A", "Num Enregistrement": "063/ 07 P 076 /97", "Code DCI": "07P076", "Forme": "SOL. DERM.", "Dosage": "0.04", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAFACT 50UI/ML (500UI/10ML)  POUDRE ET SOLVANT POUR SOLUTION INJ  B/01 FLACON DE POUDRE +5ML DE SOLVANT EPPI AVEC SYST\u00c8ME DE TRANSFERT ET UNE AIGUILLE -FILTRE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " FACTEURS SANGUINS", "C.Pharmacologique": " HEMATOLOGIE ET HEMOSTASE", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BETAFACT", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "513/12J104/16", "Code DCI": "12J104", "Forme": "PDRE. SOL. INJ.", "Dosage": "50UI/ML (500UI/10ML) ", "Conditionnement": "B/01 FLACON DE POUDRE +5ML DE SOLVANT EPPI AVEC SYST\u00c8ME DE TRANSFERT ET UNE AIGUILLE -FILTRE", "Commercialisation": true, "Remboursable": null}, {"Nom": "BETAFERON 250\u00b5G/ML (8MUI/ML) DE SOL. RECONSTITUEE PDRE. ET SOLV. P. SOL. INJ. SC B/15PRESENTATIONS UNITAIRES CONTENANT CHACUNE 1FLACON DE PDRE.+1SERING.PREREMPLIE DE 1,2ML DE SOLV.+2TAMPONS IMBIBES D'ALCOOL+1ADAPTEUR POUR FLACON AVEC AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/2506.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2506", "Laboratoire": " BAYER", "C.Pharmacologique": " SCLEROSE EN PLAQUE", "C.Therapeutique": " NEUROLOGIE", "Info": " INTERFERON BETA-1B RECOMBINANT", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "BETAFERON", "Tarif de reference": "76141.95 DA", "PPA": " DA", "Num Enregistrement": "424/ 15 G 096 /12", "Code DCI": "15G096", "Forme": "SOL. INJ.", "Dosage": "250\u00b5G/ML (8MUI/ML) DE SOL. RECONSTITUEE", "Conditionnement": "B/15PRESENTATIONS UNITAIRES CONTENANT CHACUNE 1FLACON DE PDRE.+1SERING.PREREMPLIE DE 1,2ML DE SOLV.+2TAMPONS IMBIBES D'ALCOOL+1ADAPTEUR POUR FLACON AVEC AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAHIST 24MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " BETAHISTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAHIST", "Tarif de reference": "928,20 DA", "PPA": "N/A", "Code DCI": "18C024", "Forme": "COMP.", "Dosage": "24MG", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAHISTINE NOVAGENERICS 24 MG COMP B/60", "Img": "https://pharmnet-dz.com//img/medics/4204.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAHISTINE NOVAGENERICS", "Tarif de reference": "1008 DA", "PPA": " DA", "Num Enregistrement": "149/18C024/15", "Code DCI": "18C024", "Forme": "COMP.", "Dosage": "24 MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAIODINE 0.05 SOL. APPL. LOCALE  FL./70ML EN SPRAY", "Img": "https://pharmnet-dz.com//img/medics/563.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=563", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "BETAIODINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "388/ 07 P 163 /09", "Code DCI": "07P163", "Forme": "SOL. APP. LOCALE", "Dosage": "0.05", "Conditionnement": "FL./70ML EN SPRAY", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAKSIM 500MG/2ML PDRE.SOL.INJ.IV B/1+1", "Img": "https://pharmnet-dz.com//img/medics/1918.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "BETAKSIM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "176/ 13 B 015 /01", "Code DCI": "13B015", "Forme": "PDRE. INJ.", "Dosage": "500MG/2ML", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAMETHASONE NOVAGENERICS 0.0005 CREME T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAMETHASONE NOVAGENERICS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "149/07H038/16", "Code DCI": "07H038", "Forme": "CR\u00c8ME", "Dosage": "0.05%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAMETHASONE NOVAGENERICS 0.0005 PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAMETHASONE NOVAGENERICS", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "149/ 07 H 039 /13", "Code DCI": "07H039", "Forme": "PDE. DERM.", "Dosage": "0.0005", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAMETHASONE NOVAGENERICS 0.001 PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETHAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAMETHASONE NOVAGENERICS", "Tarif de reference": "150 DA", "PPA": "N/A", "Num Enregistrement": "149/ 07 H 165 /13", "Code DCI": "07H165", "Forme": "PDE. DERM.", "Dosage": "0.001", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAMETHASONE PHYSIOPHARM 0,5MG/ML (0,05%) SOL. BUV. GTTES. B/1FL DE 30ML+ PIPETTE GRADUEE EN ML  (2ml)", "Img": "https://pharmnet-dz.com//img/medics/4376.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4376", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAMETHASONE PHYSIOPHARM", "Tarif de reference": "168.16 DA", "PPA": "168.16 DA", "Num Enregistrement": "462/09H020/16", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/1FL DE 30ML+ PIPETTE GRADUEE EN ML  (2ml)", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAMETHASONE-ACIDE SALICYLIQUE NOVAGENERICS 0,05G/3G/100G PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE / ACIDE SALICYLIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAMETHASONE-ACIDE SALICYLIQUE NOVAGENERICS", "Tarif de reference": "118.95 DA", "PPA": "N/A", "Num Enregistrement": "149/ 07 H 041 /13", "Code DCI": "07H041", "Forme": "PDE. DERM.", "Dosage": "0,05G/3G/100G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETAPROSONE 0,5MG/ML (0,05%) SOL. BUV. GTTES. B/1FL. COMPT. GTTES. DE 30ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAPROSONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 09 H 020 /11", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/1FL. COMPT. GTTES. DE 30ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "BETAPROSONE 0.0005 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETAPROSONE", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "088/ 07 H 039 /03", "Code DCI": "07H039", "Forme": "PDE. DERM.", "Dosage": "0.0005", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASERC 24MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medics/2033.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2033", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " BETAHISTINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BETASERC", "Tarif de reference": "1008 DA", "PPA": "N/A", "Num Enregistrement": "031/ 18 C 024 /06", "Code DCI": "18C024", "Forme": "COMP.", "Dosage": "24MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASONE 0,5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASONE", "Tarif de reference": "159.9 DA", "PPA": "N/A", "Num Enregistrement": "003/ 09 H 159 /08", "Code DCI": "09H159", "Forme": "COMP. ORODISPERS.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASONE 0,5MG/ML (0,05%) SOL. BUV. GTTES. FL. COMPTE GTTES.DE 30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 09 H 020 /09", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "FL. COMPTE GTTES.DE 30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASONE 0.0005 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/495.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=495", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASONE", "Tarif de reference": "109.05 DA", "PPA": "120 DA", "Num Enregistrement": "003/ 07 H 039 /99", "Code DCI": "07H039", "Forme": "PDE. DERM.", "Dosage": "0.0005", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASONE 0.001 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/496.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=496", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASONE", "Tarif de reference": "109.05 DA", "PPA": "109.05 DA", "Num Enregistrement": "003/ 07 H 039 /99", "Code DCI": "07H039", "Forme": "PDE. DERM.", "Dosage": "0.001", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASONE 0.001 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASONE", "Tarif de reference": "150 DA", "PPA": "N/A", "Num Enregistrement": "003/07H165/99/16", "Code DCI": "07H165", "Forme": "PDE. DERM.", "Dosage": "0.1%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASONE 1MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASONE", "Tarif de reference": "163.2 DA", "PPA": "N/A", "Num Enregistrement": "003/ 09 H 160 /08", "Code DCI": "09H160", "Forme": "COMP. ORODISPERS.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASONE 2MG COMP. DISPERS. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 09 H 133 /11", "Code DCI": "09H133", "Forme": "COMP. DISPERS.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETASTENE 0,5MG/ML (0,05%) SOL. BUV. GTTES. B/1FL DE 30ML +SERINGUE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASTENE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/09H020/17", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/1FL DE 30ML +SERINGUE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "BETASTENE 0,5MG/ML (0,05%) SOL. BUV. GTTES. B/1FL. COMPTE-GTTES. DE 30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " GLUCOCORTICOIDES", "C.Pharmacologique": " ENDOCRINOLOGIE ET HORMONES", "C.Therapeutique": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETASTENE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "503/09H020/15", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/1FL. COMPTE-GTTES. DE 30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BETIXIM 100MG/5ML** (FORME HYDRATEE 117MG/5ML) PDRE. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "BETIXIM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "226/ 13 B 198 /08", "Code DCI": "13B198", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG/5ML** (FORME HYDRATEE 117MG/5ML)", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETIXIM 200MG GLES. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "BETIXIM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "226/ 13 B 201 /09", "Code DCI": "13B201", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETIXIM 400MG GLES. B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "BETIXIM", "Tarif de reference": "895 DA", "PPA": "N/A", "Num Enregistrement": "226/ 13 B 294 /08", "Code DCI": "13B294", "Forme": "GLES.", "Dosage": "400MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETOPTIC 0.005 COLLY. FL/3ML", "Img": "https://pharmnet-dz.com//img/medics/2349.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2349", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " BETAXOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BETOPTIC", "Tarif de reference": "182.01 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 C 006 /97", "Code DCI": "17C006", "Forme": "COLLY. SOL.", "Dosage": "0.005", "Conditionnement": "FL/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BETSOL 0.0005 LOTION DERM. B/1FL. DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " GENCOPHARM", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BETSOL", "Tarif de reference": " N/A", "PPA": "136.00 DA", "Num Enregistrement": "455/ 07 H 040 /99/12", "Code DCI": "07H040", "Forme": "LOTION", "Dosage": "0.0005", "Conditionnement": "B/1FL. DE 15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BEVACOL 135MG COMP. ENRO. B/48", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "BEVACOL", "Tarif de reference": "347.52 DA", "PPA": "N/A", "Num Enregistrement": "043/ 10 E 184 /08", "Code DCI": "10E184", "Forme": "COMP. ENRO.", "Dosage": "135MG", "Conditionnement": "B/48", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIAFINE 0,670G/100G EMULS.POUR APPLIC. CUTANEE T/93G (100ML)  ET T/186G(200ML)", "Img": "https://pharmnet-dz.com//img/medics/559.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=559", "Laboratoire": " JOHNSON & JOHNSON CONSUMER FRANCE SAS", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " TROLAMINE PURE", "Pays": "FRANCE", "Nom Commercial": "BIAFINE", "Tarif de reference": "517.04 DA", "PPA": "N/A", "Num Enregistrement": "365/ 07 P 136 /02", "Code DCI": "07P136", "Forme": "EMULSION PERF.", "Dosage": "0,670G/100G", "Conditionnement": "T/93G (100ML)  ET T/186G(200ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "BICADEX 50MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BICALUTAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BICADEX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "323/09A137/16", "Code DCI": "09A137", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "BICALUTAMIDE CINFA 50MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CINFA", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BICALUTAMIDE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "BICALUTAMIDE CINFA", "Tarif de reference": "0 DA", "PPA": "5350.00 DA", "Num Enregistrement": "157/ 09 A 137 /14", "Code DCI": "09A137", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIDICLO LP 75mg MICROGRAULES A LIB\u00e9RATION PROLONG\u00e9E EN G\u00e9lule B/30", "Img": "https://pharmnet-dz.com//img/medics/4285.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BIDICLO LP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "149/04B037/15", "Code DCI": "04B037", "Forme": "MICROGRANULES", "Dosage": "75mg", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BILAXTEN 20MG COMP. SEC. B/10 ET B/20", "Img": "https://pharmnet-dz.com//img/medics/4032.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4032", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " BILASTINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BILAXTEN", "Tarif de reference": "0 DA", "PPA": "496,32 DA", "Num Enregistrement": "001/ 01 A 049 /12", "Code DCI": "01A049", "Forme": "COMP SEC.", "Dosage": "20MG", "Conditionnement": "B/10 ET B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "BINOVAX 4MG/1,25MG  COMP  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL TER-BUTYLAMINE / INDAPAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BINOVAX", "Tarif de reference": "1215.9 DA", "PPA": "N/A", "Num Enregistrement": "149/ 06 E 228 /14", "Code DCI": "06E228", "Forme": "COMP. PELLI.", "Dosage": "4MG/1,25MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BINOZYT 250MG GLES. B/06", "Img": "https://pharmnet-dz.com//img/medics/800.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=800", "Laboratoire": " SANDOZ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BINOZYT", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "050/ 13 E 176 /04/10", "Code DCI": "13E176", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "BINOZYT 40MG/ML (200MG/5ML) PDRE. SOL. BUV. FL/15ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANDOZ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BINOZYT", "Tarif de reference": "432 DA", "PPA": "N/A", "Num Enregistrement": "050/ 13 E 177 /09", "Code DCI": "13E177", "Forme": "PDRE. SOL. BUV.", "Dosage": "40MG/ML (200MG/5ML)", "Conditionnement": "FL/15ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "BINOZYT 500MG COMP. ENRO. B/03", "Img": "https://pharmnet-dz.com//img/medics/836.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=836", "Laboratoire": " SANDOZ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BINOZYT", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "050/ 13 E 299 /06", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCALYPTOL A LA PHOLCODINE 131MG/19,75MG/100ML SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medics/2160.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2160", "Laboratoire": " ZAMBON FRANCE", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PHOLCODINE / GAIACOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BIOCALYPTOL A LA PHOLCODINE", "Tarif de reference": "0 DA", "PPA": "202.00 DA", "Num Enregistrement": "093/ 20 B 235 /97/14", "Code DCI": "20B235", "Forme": "SIROP", "Dosage": "131MG/19,75MG/100ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCARB  ENFANT 0.02 SIROP  FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "BIOCARB  ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "235/ 20 D 041 /06/14", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIOCARB ADULTE 0.05 SIROP F/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "BIOCARB ADULTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "235/ 20 D 042 /06/14", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "F/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIOCETAM 1000MG COMP PELLI B/60", "Img": "https://pharmnet-dz.com//img/medics/4363.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCETAM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/15A105/16", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCETAM 250MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2435.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCETAM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 15 A 072 /15", "Code DCI": "15A072", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCETAM 500MG COMP PELLI B/60", "Img": "https://pharmnet-dz.com//img/medics/4362.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCETAM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/15A073/16", "Code DCI": "15A073", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCETAM 750MG COMP. PELL. SEC B/60", "Img": "https://pharmnet-dz.com//img/medics/4366.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCETAM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/15A102/16", "Code DCI": "15A102", "Forme": "COMP. SEC.", "Dosage": "750MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCLAV 100MG/12,5MG/ML PDRE. P. SUSP. BUV. ENFANT  B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + 1SERING. GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medics/286.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=286", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCLAV", "Tarif de reference": "593.4 DA", "PPA": " DA", "Num Enregistrement": "293/ 13 G 181 /13", "Code DCI": "13G181", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/12,5MG/ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. + 1SERING. GRADUEE EN KG", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCLAV 500MG/62,5MG COMP. PELLI. B/16 ET B/24", "Img": "https://pharmnet-dz.com//img/medics/320.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=320", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCLAV", "Tarif de reference": "523.52 DA", "PPA": " DA", "Num Enregistrement": "293/ 13 G 245 /13", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/16 ET B/24", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCLAV 8:1 1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/08 - B/12 - B/14", "Img": "https://pharmnet-dz.com//img/medics/338.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=338", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCLAV 8:1", "Tarif de reference": "916.16 DA", "PPA": "739.00 DA", "Num Enregistrement": "293/ 13 G 269 /13 ", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG/SACHET", "Conditionnement": "B/08 - B/12 - B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOCLAV 8:1 500MG/62,5MG PDRE. P. SUSP. BUV. EN SACHET DOSE B/12 ET B/14", "Img": "https://pharmnet-dz.com//img/medics/296.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOCLAV 8:1", "Tarif de reference": "458.08 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 G 204 /13", "Code DCI": "13G204", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/12 ET B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIODAZOLE 500MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIODAZOLE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/13F199/12", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIODAZOLE 500MG SOL. INJ.  B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " UNIQUE PHARMACETICAL ", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BIODAZOLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "276/ 13 F 038 /05", "Code DCI": "13F038", "Forme": "SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIOFENAC 0.01 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medics/1368.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BIOFENAC", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "263/ 21 A 004 /11", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOFENAC 100MG COMP. PELLI. LP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BIOFENAC", "Tarif de reference": "280 DA", "PPA": "N/A", "Num Enregistrement": "263/04B007/03/16", "Code DCI": "04B007", "Forme": "COMP. PELLI. LP", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOFENAC 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2719.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BIOFENAC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 04 B 009 /05/13", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIOFENAC 50MG COMP. PELLI. GASTRORESIST. B/30", "Img": "https://pharmnet-dz.com//img/medics/2700.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BIOFENAC", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "263/ 04 B 006 /03/15", "Code DCI": "04B006", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOFENAC LP 75MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2832.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BIOFENAC LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 04 B 037 /07/15", "Code DCI": "04B037", "Forme": "GLES. MICROGRLES. LP", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIOHYDRATE 5,5G/0,3G/0,2G/0,1G/0,05G/100ML SOL.DE REHYDRATATION VOIE PARENTERALE POCHE/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE MONOHYDRATE/CHLORURE DE SODIUM/CHLORURE DE POTASSIUM/GLUCONATE DE CALCIUM/CHLORURE DE MAGNESIUM", "Pays": "ALGERIE", "Nom Commercial": "BIOHYDRATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 14 G 317 /08", "Code DCI": "14G317", "Forme": "SOL.", "Dosage": "5,5G/0,3G/0,2G/0,1G/0,05G/100ML", "Conditionnement": "POCHE/500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIOMYCINE 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " CYCLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " DOXYCYCLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOMYCINE", "Tarif de reference": "372 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 C 020 /07", "Code DCI": "13C020", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIONOLYTE G5 0,2G/0,4G/5G/100ML SOL. PERF.IV FL./500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3410", "Laboratoire": " FRESENIUS KABI", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE POTASSIUM / CHLORURE DE SODIUM / GLUCOSE ANHYDRE", "Pays": "FRANCE", "Nom Commercial": "BIONOLYTE G5", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "332/ 14 G 321 /08", "Code DCI": "14G321", "Forme": "SOL. INJ.", "Dosage": "0,2G/0,4G/5G/100ML", "Conditionnement": "FL./500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOPAMOX 1G/FL. DE PDRE. PDRE. P. SOL. INJ. IM B/01 FL. DE PDRE. + 01 AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE+EPPI) ET B/50 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/880.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=880", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOPAMOX", "Tarif de reference": "130 DA", "PPA": "192.00 DA", "Num Enregistrement": "293/ 13 G 043 /10 ", "Code DCI": "13G043", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE. + 01 AMP. DE 5ML DE SOLV. (ALCOOL BENZYLIQUE+EPPI) ET B/50 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOPAMOX 1G/SACHET GRANUL\u00e9s POUR SUSPENSION BUVABLE B/08", "Img": "https://pharmnet-dz.com//img/medics/4331.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4331", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOPAMOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/13G268/16", "Code DCI": "13G268", "Forme": "GRLES. SOL. BUV.", "Dosage": "1G/SACHET", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOPAMOX 250MG/5ML PDRE. P. SUSP. BUV. FL./60ML ET FL./100ML (DE SUSP. BUV. APRES RECONSTITUTION)", "Img": "https://pharmnet-dz.com//img/medics/226.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=226", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOPAMOX", "Tarif de reference": "132 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 G 047 /11", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL./60ML ET FL./100ML (DE SUSP. BUV. APRES RECONSTITUTION)", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOPAMOX 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/885.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=885", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOPAMOX", "Tarif de reference": "139.32 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 G 045 /04/10", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOPAMOX 500MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. +  BOUCHON DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medics/301.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=301", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIOPAMOX", "Tarif de reference": "205.2 DA", "PPA": "205.00 DA", "Num Enregistrement": "293/ 13 G 220 /13", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST. +  BOUCHON DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "BI-OROGYL 1,5MUI/250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/844.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=844", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE / METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BI-OROGYL", "Tarif de reference": "387.5 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 E 307 /07/12", "Code DCI": "13E307", "Forme": "COMP. PELLI.", "Dosage": "1,5MUI/250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOTINE 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ROCHE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " VITAMINE H", "Pays": "FRANCE", "Nom Commercial": "BIOTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "128/ 14 H 113 /99", "Code DCI": "14H113", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "BIOTINE 5MG/ML AMP.INJ. B/6", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ROCHE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " VITAMINE H", "Pays": "FRANCE", "Nom Commercial": "BIOTINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "128/ 14 H 114 /99", "Code DCI": "14H114", "Forme": "SOL. INJ.", "Dosage": "5MG/ML", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIOVEX 500MG/ 200MG/ 25MG GRANULES POUR SOL BUV EN SACHET ADULTE B/08 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/1464.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1464", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / ACIDE ASCORBIQUE / MALEATE DE PHENIRAMINE", "Pays": "ALGERIE", "Nom Commercial": "BIOVEX", "Tarif de reference": "250 DA", "PPA": "N/A", "Num Enregistrement": "293/22 A 033/13", "Code DCI": "22A033", "Forme": "GRLES.", "Dosage": "500MG/ 200MG/ 25MG", "Conditionnement": "B/08 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIPRETERAX ARGININE 5MG/1,25MG COMP. PELLI. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/3223.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3223", "Laboratoire": " SERVIER", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL ARGININE / INDAPAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BIPRETERAX ARGININE", "Tarif de reference": "0 DA", "PPA": "839.00 DA", "Num Enregistrement": "040/ 06 E 301 /13", "Code DCI": "06E301", "Forme": "COMP. PELLI.", "Dosage": "5MG/1,25MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIPROFENID 150MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/937.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "BIPROFENID", "Tarif de reference": "280 DA", "PPA": "N/A", "Num Enregistrement": "376/ 04 B 053 /07", "Code DCI": "04B053", "Forme": "COMP. SEC.", "Dosage": "150MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIPROTENS 10MG  COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/3245.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIPROTENS", "Tarif de reference": "585 DA", "PPA": "585.00 DA", "Num Enregistrement": "352/ 06 F 162 /10", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIPROTENS 5MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/3261.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIPROTENS", "Tarif de reference": "290.1 DA", "PPA": "290.00 DA", "Num Enregistrement": "352/ 06 F 267 /12", "Code DCI": "06F267", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIRLOTIB 100MG COMP. PELLI. PILULIER/10", "Img": "https://pharmnet-dz.com//img/medics/1055.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " BDR PHARMACEUTICALS INTERNATIONAL PVT LTD", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " ERLOTINIB CHLORHYDRATE EXPRIME EN ERLOTINIB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BIRLOTIB", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "488/ 05 C 174 /14", "Code DCI": "05C174", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "PILULIER/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIRLOTIB 150MG COMP. PELLI. PILULIER/10", "Img": "https://pharmnet-dz.com//img/medics/1056.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " BDR PHARMACEUTICALS INTERNATIONAL PVT LTD", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " ERLOTINIB CHLORHYDRATE EXPRIME EN ERLOTINIB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BIRLOTIB", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "488/ 05 C 175 /14", "Code DCI": "05C175", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "PILULIER/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIRODOGYL 1,5MUI/250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/845.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=845", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE / METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BIRODOGYL", "Tarif de reference": "387.5 DA", "PPA": "384.00 DA", "Num Enregistrement": "392/ 13 E 307 /09", "Code DCI": "13E307", "Forme": "COMP. PELLI.", "Dosage": "1,5MUI/250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "BIROVIT HUP 250MG/250MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/3437.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE CHLORHYDRATE / PYRIDOXINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "BIROVIT HUP", "Tarif de reference": " N/A", "PPA": "217.00 DA", "Num Enregistrement": "380/ 14 H 112 /15", "Code DCI": "14H112", "Forme": "COMP.", "Dosage": "250MG/250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "BISOPROLOL BEKER 10MG  COMP PELL SEC  B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/3246.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3246", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BISOPROLOL BEKER", "Tarif de reference": "585 DA", "PPA": "585.00 DA", "Num Enregistrement": "447/ 06 F 162 /14", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "BISOPROLOL BEKER 5MG  COMP PELL  B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/3262.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3262", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BISOPROLOL BEKER", "Tarif de reference": "290.1 DA", "PPA": "290.00 DA", "Num Enregistrement": "447/ 06 F 267 /14", "Code DCI": "06F267", "Forme": "COMP. PELLI.", "Dosage": "5MG ", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "BISOPROLOL HUP 10MG  COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3247.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BISOPROLOL HUP", "Tarif de reference": "585 DA", "PPA": "582.00 DA", "Num Enregistrement": "380/ 06 F 162 /11", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BISOPROLOL MM 10MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BISOPROLOL MM", "Tarif de reference": "585 DA", "PPA": "N/A", "Num Enregistrement": "470/ 06 F 162 /13", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BISOPROLOL MM 5MG COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BISOPROLOL MM", "Tarif de reference": "290.1 DA", "PPA": "N/A", "Num Enregistrement": "470/06F267/16", "Code DCI": "06F267", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BISPIRADENT 1,5MUI/250MG COMP. PELLI. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medics/846.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE / METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BISPIRADENT", "Tarif de reference": "387.5 DA", "PPA": "N/A", "Num Enregistrement": "263/ 13 E 307 /09", "Code DCI": "13E307", "Forme": "COMP. PELLI.", "Dosage": "1,5MUI/250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "BLEOMYCINE 15MG PDRE.SOL.INJ. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=967", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " BLEOMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BLEOMYCINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 05 A 004 /96", "Code DCI": "05A004", "Forme": "PDRE. SOL. INJ.", "Dosage": "15MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "BLEU DE METHYLENE 0.01 SOL. USAGE EXTERNE FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RHUMEL PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " BLEU DE METHYLENE", "Pays": "ALGERIE", "Nom Commercial": "BLEU DE METHYLENE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "234/ 26 B 035 /00", "Code DCI": "26B035", "Forme": "SOL. EXTERNE", "Dosage": "0.01", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BLOPRESS 16 PLUS 16MG / 12,5MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3148.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "BLOPRESS 16 PLUS", "Tarif de reference": "1622.88 DA", "PPA": "1620.00 DA", "Num Enregistrement": "118/ 06 E 231 /09", "Code DCI": "06E231", "Forme": "COMP. SEC.", "Dosage": "16MG / 12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "BLOPRESS 16MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3153.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "BLOPRESS", "Tarif de reference": "1204 DA", "PPA": "1204.00 DA", "Num Enregistrement": "118/ 06 E 234 /07", "Code DCI": "06E234", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "BLOPRESS 8 PLUS 8MG / 12,5MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3144.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "BLOPRESS 8 PLUS", "Tarif de reference": "1521.24 DA", "PPA": "1204.00 DA", "Num Enregistrement": "118/ 06 E 230 /09", "Code DCI": "06E230", "Forme": "COMP. SEC.", "Dosage": "8MG / 12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "BLOPRESS 8MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3106.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "BLOPRESS", "Tarif de reference": "1204 DA", "PPA": "1480.00 DA", "Num Enregistrement": "118/ 06 E 197 /07", "Code DCI": "06E197", "Forme": "COMP. SEC.", "Dosage": "8MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "BONACOR 10MG  COMP. PELLI SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BONACOR", "Tarif de reference": "585 DA", "PPA": "585.00 DA", "Num Enregistrement": "001/ 06 F 162 /12", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BONACOR 5MG COMP. PELLI SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BONACOR", "Tarif de reference": "290.1 DA", "PPA": "290.00 DA", "Num Enregistrement": "001/ 06 F 267 /12", "Code DCI": "06F267", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BONEFOS 800MG COMP. PELLI. B/100", "Img": "https://pharmnet-dz.com//img/medics/1085.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1085", "Laboratoire": " BAYER", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " CLODRONATE DISODIQUE TETRAHYDRATE", "Liste": "Liste I", "Pays": "FINLANDE", "Nom Commercial": "BONEFOS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 05 F 153 /12", "Code DCI": "05F153", "Forme": "COMP. PELLI.", "Dosage": "800MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "BOROCLARINE 0,1G/ 1G / 0,1G COLLY. FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " EUROPHTA", "C.Pharmacologique": " ANTISEPTIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " BORAX / ACIDE BORIQUE / PHENYLEPHRINE CHLORHYDRATE", "Pays": "MONACO", "Nom Commercial": "BOROCLARINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "316/ 17 E 113 /99", "Code DCI": "17E113", "Forme": "COLLY.", "Dosage": "0,1G/ 1G / 0,1G", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BOROSTYROL 0,90G/0,60G/1,34G/100G CREME T/50G", "Img": "https://pharmnet-dz.com//img/medics/561.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=561", "Laboratoire": " MAYOLY SPINDLER", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " THYMOL / LEVOMENTHOL / SALOL", "Pays": "FRANCE", "Nom Commercial": "BOROSTYROL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "067/ 07 P 138 /03", "Code DCI": "07P138", "Forme": "CR\u00c8ME", "Dosage": "0,90G/0,60G/1,34G/100G", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "BOSENTAS 125MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/1633.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1633", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BOSENTAS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "182/ 06 N 306 /15", "Code DCI": "06N306", "Forme": "COMP. PELLI.", "Dosage": "125MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BOSENTAS 62,5MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/1630.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1630", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " N/D", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BOSENTAS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "182/ 06 N 305 /15", "Code DCI": "06N305", "Forme": "COMP. PELLI.", "Dosage": "62,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BREQUAL 100\u00b5G/50\u00b5G CAPSULES CONTENANT PDRE.PR INHAL. B/60 ", "Img": "https://pharmnet-dz.com//img/medics/5914.png", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE (SOUS FORME DE PROPIONATE)** / SALMETEROL**(SOUS FORME DE XINAFOATE)", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "BREQUAL", "Tarif de reference": "1500.00 DA", "PPA": "N/A", "Code DCI": "20A104", "Forme": "PDRE. INHAL.", "Dosage": "100\u00b5G/50\u00b5G", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "BREQUAL 250\u00b5G/50\u00b5G CAPSULES CONTENANT PDRE.PR INHAL. B/60 +INHALATEUR DE QHALER", "Img": "https://pharmnet-dz.com//img/medics/5913.png", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE EXPRIME EN SALMETEROL", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "BREQUAL", "Tarif de reference": "2100.00 DA", "PPA": " DA", "Code DCI": "20A105", "Forme": "PDRE. INHAL.", "Dosage": "250\u00b5G/50\u00b5G", "Conditionnement": "B/60 +INHALATEUR DE QHALER", "Commercialisation": true, "Remboursable": true}, {"Nom": "BREQUAL 500\u00b5G/50\u00b5G CAPSULES CONTENANT PDRE.PR INHAL. B/60 +INHALATEUR DE QHALER", "Img": "https://pharmnet-dz.com//img/medics/5912.png", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE (SOUS FORME DE PROPIONATE)** / SALMETEROL**(SOUS FORME DE XINAFOATE)", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "BREQUAL", "Tarif de reference": "2580.00 DA", "PPA": " DA", "Code DCI": "20A106", "Forme": "PDRE. INHAL.", "Dosage": "500\u00b5G/50\u00b5G", "Conditionnement": "B/60 +INHALATEUR DE QHALER", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRICANYL  5MG/2ML SOL. P. INHAL. BUCC. PAR NEBULISEUR EN RECIPIENT UNIDOSE DE 2ML B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2109", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE SULFATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BRICANYL ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "036/ 20 A 050 /97", "Code DCI": "20A050", "Forme": "SOL. INHAL.", "Dosage": "5MG/2ML", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRICANYL 0,5MG/ML SOL.INJ.S/C B/8", "Img": "https://pharmnet-dz.com//img/medics/2095.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2095", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BRICANYL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "036/ 20 A 020 /97", "Code DCI": "20A020", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRICANYL LP 5MG COMP. LP PILULIER/60", "Img": "https://pharmnet-dz.com//img/medics/2105.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2105", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BRICANYL LP", "Tarif de reference": "576.93 DA", "PPA": "N/A", "Num Enregistrement": "256/ 20 A 048 /97/14", "Code DCI": "20A048", "Forme": "COMP. LP", "Dosage": "5MG", "Conditionnement": "PILULIER/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRICANYL TURBUHALER 0,5MG/ DOSE PDRE. P. INHAL. BUCC. Fl./100DOSES", "Img": "https://pharmnet-dz.com//img/medics/2110.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2110", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE SULFATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BRICANYL TURBUHALER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "036/ 20 A 051 /97/14", "Code DCI": "20A051", "Forme": "PDRE. INHAL.", "Dosage": "0,5MG/ DOSE", "Conditionnement": "Fl./100DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRIDION 100MG/ML (200MG/2ML) (500MG/5ML) SOL. INJ. IV B/10 FL DE 2ML ET B/10 FL DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ORGANON", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " SUGAMMADEX SODIQUE EXPRIME EN SUGAMMADEX", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "BRIDION", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "005/ 02 B 061 /14", "Code DCI": "02B061", "Forme": "SOL. INJ.", "Dosage": "100MG/ML (200MG/2ML) (500MG/5ML)", "Conditionnement": "B/10 FL DE 2ML ET B/10 FL DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BRILIQUE 90MG COMP. PELLI. B/60 ET B/100", "Img": "https://pharmnet-dz.com//img/medics/1712.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1712", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TICAGRELOR", "Liste": "Liste I", "Pays": "SUEDE", "Nom Commercial": "BRILIQUE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 12 A 166 /13", "Code DCI": "12A166", "Forme": "COMP. PELLI.", "Dosage": "90MG", "Conditionnement": "B/60 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRISTOPEN 250MG/5ML PDRE .SOL. BUV FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BRISTOPEN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "017/ 13 G 161 /97", "Code DCI": "13G161", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BROMAZEPAM 6MG COMP. QUADRI SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2179.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2179", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BROMAZEPAM", "Tarif de reference": "0 DA", "PPA": "200.00 DA", "Num Enregistrement": "235/ 16 B 098 /02/07", "Code DCI": "16B098", "Forme": "COMP. SEC.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BROMAZEPAM IVAL 6MG COMP. QUADRISEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BROMAZEPAM IVAL", "Tarif de reference": "204.6 DA", "PPA": "204.00 DA", "Num Enregistrement": "195/ 16 B 098 /07", "Code DCI": "16B098", "Forme": "COMP. SEC.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BROMAZEPAM PHYSIOPHARM 6MG COMP. QUADRISEC. B/30 ET PILULIER DE 30", "Img": "https://pharmnet-dz.com//img/medics/2181.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BROMAZEPAM PHYSIOPHARM", "Tarif de reference": "204.6 DA", "PPA": "N/A", "Num Enregistrement": "462/ 16 B 098 /13", "Code DCI": "16B098", "Forme": "COMP. SEC.", "Dosage": "6MG", "Conditionnement": "B/30 ET PILULIER DE 30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BROMHEXINE 10MG/5ML (OU 0,2%) SOL. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/1340.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BROMHEXINE", "Pays": "ALGERIE", "Nom Commercial": "BROMHEXINE", "Tarif de reference": "0 DA", "PPA": "140 DA", "Num Enregistrement": "003/ 20 D 204 /08", "Code DCI": "20D204", "Forme": "SIROP", "Dosage": "10MG/5ML (OU 0,2%)", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "BRONCHOCALM ADULTES 0,2% SIROP  FL/150ML", "Img": "https://pharmnet-dz.com//img/medics/1295.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1295", "Laboratoire": " ELAIA PHARM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Pays": "FRANCE", "Nom Commercial": "BRONCHOCALM ADULTES", "Tarif de reference": "151.5 DA", "PPA": " DA", "Num Enregistrement": "153/ 20 C 206 /05", "Code DCI": "20C206", "Forme": "SIROP", "Dosage": "0,2%", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRONCHOCALM ENFANTS 0,1% SIROP  FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/1297.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1297", "Laboratoire": " ELAIA PHARM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Pays": "FRANCE", "Nom Commercial": "BRONCHOCALM ENFANTS", "Tarif de reference": "137.5 DA", "PPA": " DA", "Num Enregistrement": "153/ 20 C 207 /05", "Code DCI": "20C207", "Forme": "SIROP", "Dosage": "0,1%", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRONCHOLACTOL ADULTES 0.05 SIROP FL/150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LGPA", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "BRONCHOLACTOL ADULTES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "311/ 20 D 042 /06", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BRONCHOLACTOL ENFANT 0.02 SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LGPA", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "BRONCHOLACTOL ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "311/ 20 D 041 /06", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BRONCOTERIL 12\u00b5G PDRE. POUR INHAL. EN GLES. AVEC INHALATEUR. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FARMANIC-CHEMI PHARMA S.A.", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FORMOTEROL FUMARATE", "Liste": "Liste I", "Pays": "GRECE", "Nom Commercial": "BRONCOTERIL", "Tarif de reference": "2400 DA", "PPA": "N/A", "Num Enregistrement": "444/ 20 A 091 /09", "Code DCI": "20A091", "Forme": "PDRE. INHAL.", "Dosage": "12\u00b5G", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "BRONOVA 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " BROMOCRIPTINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "BRONOVA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 15 D 028 /98", "Code DCI": "15D028", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "BROXOL 0.003 SIROP  FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/1331.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1331", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BROXOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 20 D 064 /07", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": "0.003", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BRUFEN 20MG/ML (100MG/5ML) SUSP. BUV. FL./145ML + UNE CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medics/910.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ABBOTT", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "BRUFEN", "Tarif de reference": "142.1 DA", "PPA": " DA", "Num Enregistrement": "147/ 04 B 042 /10", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./145ML + UNE CUILLERE MESURE", "Commercialisation": true, "Remboursable": true}, {"Nom": "BUDECORT 200\u00b5G/DOSE AEROSOL BUCCAL  FL/200DOSES", "Img": "https://pharmnet-dz.com//img/medics/2102.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "BUDECORT", "Tarif de reference": " N/A", "PPA": "790.00 DA", "Num Enregistrement": "182/ 20 A 044 /00/09", "Code DCI": "20A044", "Forme": "AERO.", "Dosage": "200\u00b5G/DOSE", "Conditionnement": "FL/200DOSES", "Commercialisation": true, "Remboursable": null}, {"Nom": "BUDEK PLUS 400\u00b5G/12\u00b5G/DOSE PDRE. P. INHAL. EN GELULE B/01 FL./60 GELULES + INHALATEUR ORAL", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LABORATORIO DE PRODUCTOS ETICOS C.E.I.S.A", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL", "Pays": "ARGENTINE", "Nom Commercial": "BUDEK PLUS", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "20F230", "Forme": "PDRE. INHAL.", "Dosage": "400\u00b5G/12\u00b5G/DOSE", "Conditionnement": "B/01 FL./60 GELULES + INHALATEUR ORAL", "Commercialisation": true, "Remboursable": true}, {"Nom": "BUDIAIR 200\u00b5G ET BUDIAIR 200\u00b5G JET 200\u00b5G/DOSE SOL. SOUS PRESSION P. INHAL. BUCC. FL./200DOSES ET FL./200DOSES + CHAMBRE P. INHAL.(JET)", "Img": "https://pharmnet-dz.com//img/medics/1350.png", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE DIPROPIONATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "BUDIAIR 200\u00b5G ET BUDIAIR 200\u00b5G JET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "092/ 20 F 044 /10", "Code DCI": "20F044", "Forme": "SOL. INHAL.", "Dosage": "200\u00b5G/DOSE", "Conditionnement": "FL./200DOSES ET FL./200DOSES + CHAMBRE P. INHAL.(JET)", "Commercialisation": true, "Remboursable": true}, {"Nom": "BUFEN 20MG/ML (100MG/5ML) SUSP. BUV. FL./125ML", "Img": "https://pharmnet-dz.com//img/medics/911.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=911", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BUFEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 04 B 042 /05", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BUPIVACAINE AGUETTANT 0.0025 SOL .INJ. B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4097", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " BUPIVACAINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "BUPIVACAINE AGUETTANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "075/ 02 C 044 /01", "Code DCI": "02C044", "Forme": "SOL. INJ.", "Dosage": "0.0025", "Conditionnement": "B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BUPIVACAINE MYLAN 0.005 SOL. INJ. B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4071", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " BUPIVACAINE CHLORHYDRATE ANHYDRE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "BUPIVACAINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 02 C 016 /07", "Code DCI": "02C016", "Forme": "SOL. INJ.", "Dosage": "0.005", "Conditionnement": "B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BUPIVACAINE MYLAN 5MG/ML (20MG/4ML) SOL. INJ. IRACH. B/20AMP. DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4103", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " BUPIVACAINE CHLORHYDRATE ANHYDRE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "BUPIVACAINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 02 C 060 /10", "Code DCI": "02C060", "Forme": "SOL. INJ.", "Dosage": "5MG/ML (20MG/4ML)", "Conditionnement": "B/20AMP. DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "BUPRINAL 0,3MG/ML SOL. INJ. IM/IV/SC/VOIE MEDULLAIRE B/05 AMP. DE 2ML CONTENANT 1ML DE SOLUTION", "Img": "https://pharmnet-dz.com//img/medics/2662.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2662", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " BUPRENORPHINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BUPRINAL", "Tarif de reference": "475 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 F 013 /09/14", "Code DCI": "03F013", "Forme": "SOL. INJ.", "Dosage": "0,3MG/ML", "Conditionnement": "B/05 AMP. DE 2ML CONTENANT 1ML DE SOLUTION", "Commercialisation": true, "Remboursable": true}, {"Nom": "BUSILVEX 6MG/ML (60MG/10ML) SOL. A DILUER P. PERF. IV B/08FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1266", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " BUSULFAN", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "BUSILVEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 27 A 001 /13", "Code DCI": "27A001", "Forme": "SOL. INJ.", "Dosage": "6MG/ML (60MG/10ML)", "Conditionnement": "B/08FL. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "BUTAFEN 200MG GLES. A MICROGRLES.  B/20", "Img": "https://pharmnet-dz.com//img/medics/2838.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2838", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BUTAFEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 04 B 040 /05/12", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BUTAFEN 600MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/924.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=924", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BUTAFEN", "Tarif de reference": "235.5 DA", "PPA": "212.00 DA", "Num Enregistrement": "293/ 04 B 044 /12", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "BUTAFEN LP 400MG MICROGRANULES LP EN GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/936.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=936", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "BUTAFEN LP", "Tarif de reference": "157 DA", "PPA": " DA", "Num Enregistrement": "293/ 04 B 052 /12", "Code DCI": "04B052", "Forme": "GLES. MICROGRLES. LP", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "BYZOLEX 10MG  COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3250.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "BYZOLEX", "Tarif de reference": "585 DA", "PPA": "585.00 DA", "Num Enregistrement": "268/ 06 F 162 /12", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}], "C": [{"Nom": "CABERNEX 0,5MG COMP.  B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-PROLACTINE", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CABERGOLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CABERGOLINE", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "09D168", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIAL 67,5MG/5ML (0,5G/5ML EN CALCIUM PIDOLATE)   SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM PIDOLATE", "Pays": "ALGERIE", "Nom Commercial": "CALCIAL", "Tarif de reference": " N/A", "PPA": "189.00 DA", "Num Enregistrement": "077/ 14 G 135 /97/15", "Code DCI": "14G135", "Forme": "SIROP", "Dosage": "67,5MG/5ML (0,5G/5ML EN CALCIUM PIDOLATE)  ", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCIBRO 2G COMP. EFFERV. T/20", "Img": "https://pharmnet-dz.com//img/medics/3338.png", "Laboratoire": " API", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " BROMO-GALACTOGLUCONATE DE CALCIUM", "Pays": "ALGERIE", "Nom Commercial": "CALCIBRO", "Tarif de reference": "0 DA", "PPA": "260.00 DA", "Num Enregistrement": "348/ 14 G 027 /11", "Code DCI": "14G027", "Forme": "COMP. EFFERV.", "Dosage": "2G", "Conditionnement": "T/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIBRONAT 2G COMP.EFFER. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SPC", "C.Pharmacologique": " PSYCHIATRIE", "C.Therapeutique": " CALCIUM BROMOGALACTOGLUCONATE", "Pays": "FRANCE", "Nom Commercial": "CALCIBRONAT", "Tarif de reference": " N/A", "PPA": "428.00 DA", "Num Enregistrement": "496/ 16 G 163 /97/15", "Code DCI": "16G163", "Forme": "COMP. EFFERV.", "Dosage": "2G", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCIDOSE 500MG/SACHET DOSE (1250MG/SACHET DOSE DE CARBONATE DE CALCIUM ) PDRE. SUSP. BUV.EN SACHET DOSE B/30", "Img": "https://pharmnet-dz.com//img/medics/3343.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3343", "Laboratoire": " MERINAL", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "CALCIDOSE", "Tarif de reference": "232.5 DA", "PPA": "N/A", "Num Enregistrement": "268/ 14 G 029 /07", "Code DCI": "14G029", "Forme": "PDRE. SUSP. BUV.", "Dosage": "500MG/SACHET DOSE (1250MG/SACHET DOSE DE CARBONATE DE CALCIUM )", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIDOSE VITAMINE D 400UI/500MG/SACHET PDRE. ORALE EN SACH.-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3463.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3463", "Laboratoire": " MERINAL", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "CALCIDOSE VITAMINE D", "Tarif de reference": "405 DA", "PPA": "N/A", "Num Enregistrement": "268/ 14 H 325 /09", "Code DCI": "14H325", "Forme": "PDRE.", "Dosage": "400UI/500MG/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIUM API 500MG COMP. EFFER. FL./20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " API", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "CALCIUM API", "Tarif de reference": "155 DA", "PPA": "189.00 DA", "Num Enregistrement": "348/ 14 G 315 /08", "Code DCI": "14G315", "Forme": "COMP. EFFERV.", "Dosage": "500MG", "Conditionnement": "FL./20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIUM CHLORURE 0.1 SOL INJ IV AMP. DE 5ML ET AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/3340.png", "Laboratoire": " UNIMED", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CHLORURE", "Pays": "TUNISIE", "Nom Commercial": "CALCIUM CHLORURE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 14 G 028 /96", "Code DCI": "14G028", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "AMP. DE 5ML ET AMP. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIUM CHLORURE 0.1 SOL.INJ.IV B/100AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CHLORURE", "Pays": "FRANCE", "Nom Commercial": "CALCIUM CHLORURE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 028 /98", "Code DCI": "14G028", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "B/100AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCIUM D3 IVAL 400UI/500MG COMP. A CROQUER B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "CALCIUM D3 IVAL", "Tarif de reference": "810 DA", "PPA": "N/A", "Num Enregistrement": "195/ 14 G 175 /09", "Code DCI": "14G175", "Forme": "COMP. A CROQ.", "Dosage": "400UI/500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIUM D3 NOVAGENERICS 400UI/500MG COMP. A SUCER PILULIER DE 60", "Img": "https://pharmnet-dz.com//img/medics/5869.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "CALCIUM D3 NOVAGENERICS", "Tarif de reference": "810.00 DA", "PPA": " DA", "Code DCI": "14G175", "Forme": "COMP. A SUCER", "Dosage": "400UI/500MG", "Conditionnement": "PILULIER DE 60", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIUM D3 SOPHAL 400UI/500MG COMP. A SUCER OU A CROQUER  B/60 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "CALCIUM D3 SOPHAL", "Tarif de reference": "810.00 DA", "PPA": "N/A", "Code DCI": "14G175", "Forme": "COMP. A SUCER", "Dosage": "400UI/500MG", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIUM FOLINAT EBEWE 15MG** GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FOLINATE DE CALCIUM  (EXPRIME EN ACIDE FOLINIQUE)** ", "Pays": "AUTRICHE", "Nom Commercial": "CALCIUM FOLINAT EBEWE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "141/ 12 E 031 /98/08", "Code DCI": "12E031", "Forme": "GLES.", "Dosage": "15MG**", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCIUM FOLINATE EBEWE 10MG/ML ( 50MG/5ML) SOL. INJ. IM/IV B/5AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " FOLINATE DE CALCIUM EXPRIME EN ACIDE FOLINIQUE", "Pays": "AUTRICHE", "Nom Commercial": "CALCIUM FOLINATE EBEWE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "141/ 05 H 132 /09", "Code DCI": "05H132", "Forme": "SOL. INJ.", "Dosage": "10MG/ML ( 50MG/5ML)", "Conditionnement": "B/5AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCIUM HYSA 500MG DE CALCIUM (1250MG DE CALCIUM CARBONATE) PDRE. P. SUSP. BUV. EN SACH. B/30", "Img": "https://pharmnet-dz.com//img/medics/3341.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3341", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "CALCIUM HYSA", "Tarif de reference": "232.5 DA", "PPA": " DA", "Num Enregistrement": "388/ 14 G 029 /11", "Code DCI": "14G029", "Forme": "PDRE. SUSP. BUV.", "Dosage": "500MG DE CALCIUM (1250MG DE CALCIUM CARBONATE)", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCIUM NOVAGENERICS 500MG COMP A SUCER SEC B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CALCIUM NOVAGENERICS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "149/14G141/17", "Code DCI": "14G141", "Forme": "COMP. A SUCER", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCIUM SANDOZ 3,40G/0,150G/SACHET OU 500MG EN CALCIUM ELEMENT PDRE  EN SACH. POUR SOL.BUV. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3384", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM GLUCONOLACTATE/CARBONATE DE CALCIUM", "Pays": "FRANCE", "Nom Commercial": "CALCIUM SANDOZ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "007/ 14 G 104 /98/14", "Code DCI": "14G104", "Forme": "PDRE. SOL. BUV.", "Dosage": "3,40G/0,150G/SACHET OU 500MG EN CALCIUM ELEMENT", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCIUM SANDOZ 500MG** ( SEL 2,94G / 0,3 G) COMP.EFFERV. B/20", "Img": "https://pharmnet-dz.com//img/medics/3344.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3344", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM  ELEMENT** (SOUS FORME DE CALCIUM GLUCONOLACTATE ET SOUS FORME CARBONATE DE CALCIUM)", "Pays": "FRANCE", "Nom Commercial": "CALCIUM SANDOZ", "Tarif de reference": "135 DA", "PPA": "N/A", "Num Enregistrement": "007/ 14 G 035 /97/08", "Code DCI": "14G035", "Forme": "COMP. EFFERV.", "Dosage": "500MG** ( SEL 2,94G / 0,3 G)", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALCO 100UI/ML SOL. INJ. B/5AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " CALCITONINE SYNTHETIQUE DE SAUMON", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "CALCO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 21 C 012 /96/10", "Code DCI": "21C012", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALCO 50UI/ML SOL.INJ. B/5AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " CALCITONINE SYNTHETIQUE DE SAUMON", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "CALCO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 21 C 011 /96/11", "Code DCI": "21C011", "Forme": "SOL. INJ.", "Dosage": "50UI/ML", "Conditionnement": "B/5AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALMIG 50MG COMP. B/2  ET B/6", "Img": "https://pharmnet-dz.com//img/medics/2471.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2471", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " SUMATRIPTAN SUCCINATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CALMIG", "Tarif de reference": "419.3 DA", "PPA": " DA", "Num Enregistrement": "242/ 15 B 059 /04", "Code DCI": "15B059", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/2  ET B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALMOFEN 100MG/5ML SUSP,BUVABLE FL 125ML+PIPETTE GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CALMOFEN", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/04B042/16", "Code DCI": "04B042", "Forme": "SUSP. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "FL 125ML+PIPETTE GRADUEE EN KG", "Commercialisation": true, "Remboursable": null}, {"Nom": "CALMOFEN 400MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CALMOFEN", "Tarif de reference": "157 DA", "PPA": "N/A", "Num Enregistrement": "317/04B010/16", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CALMOZINC 0,46 PDE T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " OXYDE DE ZINC", "Pays": "ALGERIE", "Nom Commercial": "CALMOZINC", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "07A130", "Forme": "PDE.", "Dosage": "46%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": false}, {"Nom": "CALPEROS 500MG COMP A SUCER SEC B/60", "Img": "https://pharmnet-dz.com//img/medics/3388.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3388", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE", "Pays": "FRANCE", "Nom Commercial": "CALPEROS", "Tarif de reference": "509.67 DA", "PPA": "N/A", "Num Enregistrement": "269/ 14 G 141 /98", "Code DCI": "14G141", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "CAMPHOBIOTIC ADULTE 0,1G/0,06G/0,05G /0,15G/0,07G/0,01G SUPPO. ADULTE B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CAMPHRE / GAIACOL / EUCALYPTOL / GAIACOL GLYCOLATE D'ETHYL / CREOSOTE / AMYLEINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "CAMPHOBIOTIC ADULTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 C 063 /97/11", "Code DCI": "20C063", "Forme": "SUPPO.", "Dosage": "0,1G/0,06G/0,05G /0,15G/0,07G/0,01G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAMPHOBIOTIC ENFANT 0,04G/0,05G/0,02G /0,08G SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CAMPHRE / EUCALYPTOL / GAIACOL / GAIACOL GLYCOLATE D'ETHYL", "Pays": "ALGERIE", "Nom Commercial": "CAMPHOBIOTIC ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 C 062 /97/09", "Code DCI": "20C062", "Forme": "SUPPO.", "Dosage": "0,04G/0,05G/0,02G /0,08G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAMPHOBIOTIC NOURRISSON 0,03G/0,03G SUPPO. NOURR. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " EUCALYPTOL / GAIACOL GLYCOLATE D'ETHYL", "Pays": "ALGERIE", "Nom Commercial": "CAMPHOBIOTIC NOURRISSON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 C 061 /97/09", "Code DCI": "20C061", "Forme": "SUPPO.", "Dosage": "0,03G/0,03G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAMPTO 20MG/ML  (OU 40MG/2ML  ET 100MG/5ML) SOL. A  DILUER  PERF. IV STRICTE B/1FL/ 2ML (40MG/2ML) ET  B/1FL./5ML (100MG/5ML)", "Img": "https://pharmnet-dz.com//img/medics/1002.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1002", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " IRINOTECAN", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CAMPTO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 05 A 076 /97/03", "Code DCI": "05A076", "Forme": "SOL. INJ.", "Dosage": "20MG/ML  (OU 40MG/2ML  ET 100MG/5ML)", "Conditionnement": "B/1FL/ 2ML (40MG/2ML) ET  B/1FL./5ML (100MG/5ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "CANCIDAS 50MG/FL. DE PDRE. PDRE. P. SOL. A DILUER P. PERF. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3578.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3578", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "CANCIDAS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 13 R 284 /06/13", "Code DCI": "13R284", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CANCIDAS 70MG/FL. DE PDRE. PDRE. P. SOL. A DILUER P. PERF. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3579.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3579", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CASPOFUNGINE ACETATE EXPRIME EN CASPOFUNGINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "CANCIDAS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 13 R 285 /06:13", "Code DCI": "13R285", "Forme": "PDRE. SOL. INJ.", "Dosage": "70MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CANDERAX 16MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CANDERAX", "Tarif de reference": " N/A", "PPA": "1290.00 DA", "Num Enregistrement": "035/ 06 E 234 /15", "Code DCI": "06E234", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CANDERAX 8MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CANDERAX", "Tarif de reference": " N/A", "PPA": "1290.00 DA", "Num Enregistrement": "035 / 06 E 197 /15", "Code DCI": "06E197", "Forme": "COMP. SEC.", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CANDERAX PLUS 16MG/12,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CANDERAX PLUS", "Tarif de reference": " N/A", "PPA": "1738.00 DA", "Num Enregistrement": "035/ 06 E 231 /15", "Code DCI": "06E231", "Forme": "COMP. SEC.", "Dosage": "16MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CANDERAX PLUS 8MG/12,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CANDERAX PLUS", "Tarif de reference": " N/A", "PPA": "1290.00 DA", "Num Enregistrement": "035/ 06 E 230 /15", "Code DCI": "06E230", "Forme": "COMP. SEC.", "Dosage": "8MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CANESTEN 1G% CREME.DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1688.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1688", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOTRIMAZOLE", "Pays": "ESPAGNE", "Nom Commercial": "CANESTEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "124/ 07 D 024 /98", "Code DCI": "07D024", "Forme": "CR\u00c8ME", "Dosage": "1G%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CANMAB 150MG/FL. DE PDRE PDRE. ET SOLV. P. SOL. A DILUER P. PERF. IV B/01 FL. DE PDRE. + B/01 FL. DE SOLV. DE 10ML (EAU BACTERIOSTATIQUE POUR INJECTION)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " BIOCON LIMITED", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TRASTUZUMAB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CANMAB", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "494/ 05 D 112 /15", "Code DCI": "05D112", "Forme": "LYOPH. SOL. INJ.", "Dosage": "150MG/FL. DE PDRE", "Conditionnement": "B/01 FL. DE PDRE. + B/01 FL. DE SOLV. DE 10ML (EAU BACTERIOSTATIQUE POUR INJECTION)", "Commercialisation": true, "Remboursable": null}, {"Nom": "CANTAPONE 200MG COMP. PELLI. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/2485.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " ENTACAPONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CANTAPONE", "Tarif de reference": " N/A", "PPA": "2611.00 DA", "Num Enregistrement": "352/ 15 D 077 /15", "Code DCI": "15D077", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPD / DPCA 2 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 2   15G GLUCOSE/LITRE SOL. GLUCOSE B/04 POCHES DE 2L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRESINIUS MEDICAL CARE", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DIALYSE EN POCHE LIQUIDE HYPERTONIQUE", "Pays": "ALLEMAGNE", "Nom Commercial": "CAPD / DPCA 2 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 2  ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "336/ 25 G 054 /05", "Code DCI": "25G054", "Forme": "SOL. GLUCOSE", "Dosage": "15G GLUCOSE/LITRE", "Conditionnement": "B/04 POCHES DE 2L", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPD / DPCA 3 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 3   42,5G DE GLUCOSE / LITRE SOL. GLUCOSE B/4 POCHES DE 2L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRESINIUS MEDICAL CARE", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DIALYSE EN POCHE LIQUIDE HYPERTONIQUE", "Pays": "ALLEMAGNE", "Nom Commercial": "CAPD / DPCA 3 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 3  ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "336/ 25 G 019 /05", "Code DCI": "25G019", "Forme": "SOL. DIALYSE", "Dosage": "42,5G DE GLUCOSE / LITRE", "Conditionnement": "B/4 POCHES DE 2L", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPD / DPCA 4 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 4   22,73G GLUCOSE/LITRE SOL. GLUCOSE B/04 POCHES DE 2L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRESINIUS MEDICAL CARE", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DIALYSE EN POCHE LIQUIDE HYPERTONIQUE", "Pays": "ALLEMAGNE", "Nom Commercial": "CAPD / DPCA 4 - DIALYSE PERITONEALE CONTINUE  AMBULATOIRE STAY SAFE 4  ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "336/ 25 G 055 /05", "Code DCI": "25G055", "Forme": "SOL. GLUCOSE", "Dosage": "22,73G GLUCOSE/LITRE", "Conditionnement": "B/04 POCHES DE 2L", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPD FORMULE 55 15G DE GLUCOSE / LITRE SOL . P. DIALYSE POCHE DE 2L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIEFFE MEDITAL", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DIALYSE EN POCHE ISOTONIQUE", "Pays": "ITALIE", "Nom Commercial": "CAPD FORMULE 55", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "129/ 25 G 018 /99", "Code DCI": "25G018", "Forme": "SOL. DIALYSE", "Dosage": "15G DE GLUCOSE / LITRE", "Conditionnement": "POCHE DE 2L", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPD FORMULE 62 42,5G DE GLUCOSE / LITRE SOL . P. DIALYSE POCHE DE 2L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIEFFE MEDITAL", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DIALYSE EN POCHE LIQUIDE HYPERTONIQUE", "Pays": "ITALIE", "Nom Commercial": "CAPD FORMULE 62", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "129/ 25 G 019 /99", "Code DCI": "25G019", "Forme": "SOL. DIALYSE", "Dosage": "42,5G DE GLUCOSE / LITRE", "Conditionnement": "POCHE DE 2L", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPEGARD 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/8.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CAPECITABINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CAPEGARD", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 108 /09", "Code DCI": "05G108", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPEMAX 500MG COMP. PELLI. B/120", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " INTAS PHARMACEUTICALS LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CAPECITABINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CAPEMAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "478/ 05 G 108 /12", "Code DCI": "05G108", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/120", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPOCARD PLUS 50MG/25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/186.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=186", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CAPOCARD PLUS", "Tarif de reference": "502.2 DA", "PPA": "N/A", "Num Enregistrement": "055/ 06 E 137 /03/10", "Code DCI": "06E137", "Forme": "COMP. SEC.", "Dosage": "50MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CAPTAFER 125MG COMP. DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CAPTAFER", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/24D017/16", "Code DCI": "24D017", "Forme": "COMP. DISPERS.", "Dosage": "125MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPTAFER 250MG COMP. DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CAPTAFER", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "317/24D018/16", "Code DCI": "24D018", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CAPTAFER 500MG COMP. DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CAPTAFER", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/24D019/16", "Code DCI": "24D019", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "CAPTOPRIL LS 25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/139.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=139", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CAPTOPRIL LS", "Tarif de reference": "148.8 DA", "PPA": " DA", "Num Enregistrement": "231/ 06 E 052 /08", "Code DCI": "06E052", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CAPTOPRIL LS 50MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/140.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=140", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CAPTOPRIL LS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/ 06 E 053 /08", "Code DCI": "06E053", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARBATOL 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3498.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "CARBATOL", "Tarif de reference": "261 DA", "PPA": "265.00 DA", "Num Enregistrement": "055/ 15 A 004 /98", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARBAZINE 200MG COMP. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "CARBAZINE", "Tarif de reference": "261 DA", "PPA": "N/A", "Num Enregistrement": "174/ 15 A 004 /98", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARBIMAZOLE GS 5MG COMP. SEC. B/50", "Img": "https://pharmnet-dz.com//img/medics/618.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=618", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-THYROIDIENS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CARBIMAZOLE", "Pays": "ALGERIE", "Nom Commercial": "CARBIMAZOLE GS", "Tarif de reference": "297.5 DA", "PPA": "N/A", "Num Enregistrement": "242/ 09 E 007 /01/11", "Code DCI": "09E007", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARBIMOL 200MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medics/3500.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3500", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CARBIMOL", "Tarif de reference": "261 DA", "PPA": " DA", "Num Enregistrement": "235/ 15 A 004 /14", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARBIMOL LP 400MG COMP. PELLI. SEC. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2397.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2397", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CARBIMOL LP", "Tarif de reference": "363 DA", "PPA": " DA", "Num Enregistrement": "235/ 15 A 036 /10", "Code DCI": "15A036", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARBODAL SANS SUCRE 0.05 SOL. ORA. FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "CARBODAL SANS SUCRE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "318/ 20 D 042 /07", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARBOLAM 0.02 SIROP ENFANTS ET NOURRISSONS FL./125ML + CUILLERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "CARBOLAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 20 D 041 /08", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL./125ML + CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARBOLAM 0.05 SIROP ADULTE FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "CARBOLAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 20 D 042 /08", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARBOMEX 0.02 SIROP  FL /100ML+GOBLET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARBOMEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "400/20D041/16", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "2%", "Conditionnement": "FL /100ML+GOBLET DOSEUR", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARBONAPHTINE PECTINEE  GRLES. B/100G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CHARBON ACTIF COMPOSE", "Pays": "FRANCE", "Nom Commercial": "CARBONAPHTINE PECTINEE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "004/ 10 B 008 /96", "Code DCI": "10B008", "Forme": "GRLES.", "Conditionnement": "B/100G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARBOPHOS 400MG COMP. A CROQ. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " TRADIPHAR", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CHARBON  VEGETAL ", "Pays": "FRANCE", "Nom Commercial": "CARBOPHOS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "425/ 10 B 009 /96/08", "Code DCI": "10B009", "Forme": "COMP. A CROQ.", "Dosage": "400MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARBOPLATINE EBEWE 10MG/ML (OU 50MG/5ML -  150MG/15ML - 450MG/45ML) SOL. PERF. FL/5ML -  FL/15ML - FL/45ML", "Img": "https://pharmnet-dz.com//img/medics/1005.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1005", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CARBOPLATINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "CARBOPLATINE EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 086 /05", "Code DCI": "05A086", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (OU 50MG/5ML -  150MG/15ML - 450MG/45ML)", "Conditionnement": "FL/5ML -  FL/15ML - FL/45ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARBOPLATINE MYLAN 10MG/ML  (OU 50MG/5/ML -  150MG/15ML -  450MG/45ML) SOL. INJ. PERF. B/1FL./5ML - B/1FL./15ML  ET  B/1FL./45ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1118", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CARBOPLATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CARBOPLATINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 G 086 /07", "Code DCI": "05G086", "Forme": "SOL. INJ.", "Dosage": "10MG/ML  (OU 50MG/5/ML -  150MG/15ML -  450MG/45ML)", "Conditionnement": "B/1FL./5ML - B/1FL./15ML  ET  B/1FL./45ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARDAXEL BGL 16MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3155.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3155", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDAXEL BGL", "Tarif de reference": " N/A", "PPA": "1250.00 DA", "Num Enregistrement": "235/ 06 E 234 /15", "Code DCI": "06E234", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARDAXEL BGL 8MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3108.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3108", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDAXEL BGL", "Tarif de reference": " N/A", "PPA": "1240.00 DA", "Num Enregistrement": "235/ 06 E 197 /15", "Code DCI": "06E197", "Forme": "COMP. SEC.", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARDAXEL PLUS  16MG / 12,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4262", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDAXEL PLUS ", "Tarif de reference": "1622.88 DA", "PPA": "N/A", "Num Enregistrement": "235/06E231/15", "Code DCI": "06E231", "Forme": "COMP.", "Dosage": "16MG / 12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDAXEL PLUS 8MG/12,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4213", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDAXEL PLUS", "Tarif de reference": "1521.24 DA", "PPA": "N/A", "Num Enregistrement": "235/06E230/15", "Code DCI": "06E230", "Forme": "COMP.", "Dosage": "8MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDIJECT 250MG/FL. DE PDRE. LYOPH. SOL. INJ. IV B/01 FL.DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOBUTAMINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CARDIJECT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 06 A 253 /08", "Code DCI": "06A253", "Forme": "LYOPH. SOL. INJ.", "Dosage": "250MG/FL. DE PDRE.", "Conditionnement": "B/01 FL.DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARDIOFLUX 75MG/75MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL / ACIDE ACETYLSALICYLIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDIOFLUX", "Tarif de reference": "2059.5 DA", "PPA": "N/A", "Num Enregistrement": "321/ 06 J 251 /08", "Code DCI": "06J251", "Forme": "COMP.", "Dosage": "75MG/75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDIOTENS  150MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDIOTENS ", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "097/06E156/16", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDIOTENS 300 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDIOTENS 300", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "097/06E157/16", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDIPEN LP 50MG MICROGRLES. LP EN GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDIPEN LP", "Tarif de reference": "612 DA", "PPA": "N/A", "Num Enregistrement": "426/ 06 B 015 /13", "Code DCI": "06B015", "Forme": "COMP. LP", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDITAL 200MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDITAL", "Tarif de reference": "209.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 F 067 /01", "Code DCI": "06F067", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDITEL  40MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDITEL ", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "097/06E263/16", "Code DCI": "06E263", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDITEL  80MG COMP, B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDITEL ", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "097/06E264/16", "Code DCI": "06E264", "Forme": "COMP.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDOX 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CARDOX", "Tarif de reference": "405 DA", "PPA": "N/A", "Num Enregistrement": "001/ 25 B 041 /08", "Code DCI": "25B041", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDOX 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDOX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "001/25B042/16", "Code DCI": "25B042", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARDOX 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CARDOX", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "001/ 25 B 043 /07", "Code DCI": "25B043", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDULAR 1MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PFIZER", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CARDULAR", "Tarif de reference": "270 DA", "PPA": "N/A", "Num Enregistrement": "045/ 25 B 041 /99", "Code DCI": "25B041", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDULAR 2MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/1165.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1165", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARDULAR", "Tarif de reference": "550 DA", "PPA": "N/A", "Num Enregistrement": "045/ 25 B 042 /99/12", "Code DCI": "25B042", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARDULAR 4MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PFIZER", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CARDULAR", "Tarif de reference": "1100 DA", "PPA": "N/A", "Num Enregistrement": "045/ 25 B 043 /99", "Code DCI": "25B043", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARTEOL 0.01 COLLY. FL/3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2350", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARTEOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CARTEOL", "Tarif de reference": "0 DA", "PPA": "365.00 DA", "Num Enregistrement": "096/ 17 C 007 /98", "Code DCI": "17C007", "Forme": "COLLY. SOL.", "Dosage": "0.01", "Conditionnement": "FL/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARTEOL 0.02 COLLY. FL/3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2356", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARTEOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CARTEOL", "Tarif de reference": "0 DA", "PPA": "494.00 DA", "Num Enregistrement": "096/ 17 C 101 /99", "Code DCI": "17C101", "Forme": "COLLY. SOL.", "Dosage": "0.02", "Conditionnement": "FL/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARTEOL LP 0.01 COLLY. EN SOL. LP  FL./3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2368", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARTEOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CARTEOL LP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "096/ 17 C 146 /07", "Code DCI": "17C146", "Forme": "COLLY. SOL. LP ", "Dosage": "0.01", "Conditionnement": "FL./3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARTEOL LP 0.02 COLLY. EN SOL. LP  FL./3ML", "Img": "https://pharmnet-dz.com//img/medics/2369.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2369", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARTEOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CARTEOL LP", "Tarif de reference": "491.6 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 C 147 /07", "Code DCI": "17C147", "Forme": "COLLY. SOL. LP ", "Dosage": "0.02", "Conditionnement": "FL./3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CARVEDILOL LDM 25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CARVEDILOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARVEDILOL LDM", "Tarif de reference": " N/A", "PPA": "1204.00 DA", "Num Enregistrement": "309/ 06 F 209 /07/13", "Code DCI": "06F209", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CARVEDILOL LDM 6,25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CARVEDILOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CARVEDILOL LDM", "Tarif de reference": " N/A", "PPA": "694.00 DA", "Num Enregistrement": "309/ 06 F 208 /07/13", "Code DCI": "06F208", "Forme": "COMP. SEC.", "Dosage": "6,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CASODEX 50MG COMP. ENRO. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/601.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=601", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BICALUTAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CASODEX", "Tarif de reference": "0 DA", "PPA": "7593.00 DA", "Num Enregistrement": "256/ 09 A 137 /05/14", "Code DCI": "09A137", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CATACOL 1MG/ML COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2003.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ALCON", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " INOSINE MONOPHOSPHATE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "CATACOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 K 071 /97", "Code DCI": "17K071", "Forme": "COLLY.", "Dosage": "1MG/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CATAFLAM 50MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/951.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=951", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC POTASSIQUE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "CATAFLAM", "Tarif de reference": "300 DA", "PPA": " DA", "Num Enregistrement": "068/ 04 B 063 /11", "Code DCI": "04B063", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CATAPRESSAN 0,15MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/144.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=144", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLONIDINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CATAPRESSAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 06 E 056 /98", "Code DCI": "06E056", "Forme": "COMP.", "Dosage": "0,15MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CATAPRESSAN 0,15MG/ML SOL.INJ. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/143.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=143", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLONIDINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CATAPRESSAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 06 E 055 /98", "Code DCI": "06E055", "Forme": "SOL. INJ.", "Dosage": "0,15MG/ML", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEBEMYXINE 3 400UI/10 000UI COLLY. EN SOL. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2385.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2385", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NEOMYCINE/POLYMYXINE B", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CEBEMYXINE", "Tarif de reference": "0 DA", "PPA": "155.00 DA", "Num Enregistrement": "096/ 17 D 027 /98", "Code DCI": "17D027", "Forme": "COLLY.", "Dosage": "3 400UI/10 000UI", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEBEMYXINE 340 000UI/1 000 000 UI /100G PDE OPHT T/5G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1951", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NEOMYCINE / POLYMYXINE B", "Pays": "FRANCE", "Nom Commercial": "CEBEMYXINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "096/ 17 D 129 /02", "Code DCI": "17D129", "Forme": "PDE. OPHT.", "Dosage": "340 000UI/1 000 000 UI /100G", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEBENICOL 0.004 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CHLORAMPHENICOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CEBENICOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 D 015 /98", "Code DCI": "17D015", "Forme": "COLLY.", "Dosage": "0.004", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEBESINE 0,4% COLLY. EN SOL. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2340.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2340", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANESTHESIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " OXYBUPROCAINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CEBESINE", "Tarif de reference": "131.28 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 A 001 /98", "Code DCI": "17A001", "Forme": "COLLY. SOL.", "Dosage": "0,4%", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEDROX 1G COMP. B/12", "Img": "https://pharmnet-dz.com//img/medics/743.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=743", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFADROXIL MONOHYDRATE EXPRIME EN CEFADROXIL ANHYDRE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEDROX", "Tarif de reference": "680.28 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 298 /07/13", "Code DCI": "13B298", "Forme": "COMP.", "Dosage": "1G", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEDROXAL 1G COMP. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFADROXIL MONOHYDRATE EXPRIME EN CEFADROXIL ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CEDROXAL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "039/13B298/16", "Code DCI": "13B298", "Forme": "COMP.", "Dosage": "1G", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFACET G\u00e9 1G COMP. PELLI. SEC. B/6", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CEFACET G\u00e9", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 13 B 223 /00/09", "Code DCI": "13B223", "Forme": "COMP. PELLI.", "Dosage": "1G", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFACET G\u00e9 250MG** GRLES. SACHET B/12 SACH.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CEFACET G\u00e9", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 13 B 203 /99/09", "Code DCI": "13B203", "Forme": "GRLES.", "Dosage": "250MG**", "Conditionnement": "B/12 SACH.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFACET G\u00e9 500MG** COMP.PELLI.SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CEFACET G\u00e9", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 13 B 010 /98/09", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG**", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFAXONE 100MG/ML (1000MG/10ML) PDRE.ET SOLV. SOL. IV      B/1FL. PDRE. + 1AMP. DE SOLV. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/1924.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1924", "Laboratoire": " UNIMED", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "CEFAXONE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 13 B 019 /08", "Code DCI": "13B019", "Forme": "PDRE. INJ.", "Dosage": "100MG/ML (1000MG/10ML)", "Conditionnement": "B/1FL. PDRE. + 1AMP. DE SOLV. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFAZAL 1G PDRE. SOL. INJ. IM B/01FL. PDRE. + 01AMP. DE SOLVANT. (LIDOCAINE 0,8%) DE 05ML", "Img": "https://pharmnet-dz.com//img/medics/1909.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CEFAZAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 B 013 /07/14", "Code DCI": "13B013", "Forme": "PDRE. INJ.", "Dosage": "1G", "Conditionnement": "B/01FL. PDRE. + 01AMP. DE SOLVANT. (LIDOCAINE 0,8%) DE 05ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFAZAL 1G/FL. DE PDRE. PDRE. SOL. INJ. I.V. B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/1901.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CEFAZAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "039/ 13 B 012 /06/14", "Code DCI": "13B012", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFAZOL 200MG/ML (OU 1G/5ML) PDRE. ET SOLV. SOL. INJ.IM B/1FL. DE PDRE + 1AMP. DE SOLVANT (LIDOCAINE) 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " UNIMED", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "CEFAZOL", "Tarif de reference": "181 DA", "PPA": "N/A", "Num Enregistrement": "023/ 13 B 013 /08", "Code DCI": "13B013", "Forme": "PDRE. INJ.", "Dosage": "200MG/ML (OU 1G/5ML)", "Conditionnement": "B/1FL. DE PDRE + 1AMP. DE SOLVANT (LIDOCAINE) 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFAZOLIN 1G/FL. DE PDRE. PDRE. ET SOLV.SOL.INJ. IM B/1FL. PDRE.+1AMP. DE 3ML DE SOLV. (0,5% LIDOCAINE)", "Img": "https://pharmnet-dz.com//img/medics/1906.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1906", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFAZOLIN", "Tarif de reference": "128.9 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 013 /02/08", "Code DCI": "13B013", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. PDRE.+1AMP. DE 3ML DE SOLV. (0,5% LIDOCAINE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFAZOLIN 1G/FL. DE PDRE. PDRE. SOL. INJ. IV B/01FL. PDRE. ET B/10FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/1902.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFAZOLIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 012 /02/08", "Code DCI": "13B012", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/01FL. PDRE. ET B/10FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFAZOLIN 500MG/FL. DE PDRE. PDRE.  ET SOLV. SOL INJ IM  B/1FL. DE PDRE. +1AMP. DE 2ML DE SOLV. (0,5% LIDOCAINE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE SODIQUE EXPRIME EN CEFAZOLINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFAZOLIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 257 /02/08", "Code DCI": "13B257", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. +1AMP. DE 2ML DE SOLV. (0,5% LIDOCAINE)", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFAZOLINE   1G PDRE.SOL.INJ IM/IV B/1+1 et B/50FL*", "Img": "https://pharmnet-dz.com//img/medics/683.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=683", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "CEFAZOLINE  ", "Tarif de reference": "181 DA", "PPA": " DA", "Num Enregistrement": "080/ 13 B 184 /98", "Code DCI": "13B184", "Forme": "PDRE. INJ.", "Dosage": "1G", "Conditionnement": "B/1+1 et B/50FL*", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFIX  100MG/5ML PDRE. SUSP. BUV. FL./30ML ET FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CEFIX ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 13 B 198 /07", "Code DCI": "13B198", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "FL./30ML ET FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFIZOX 1G/FL. DE PDRE. PDRE. SOL. INJ. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTIZOXIME SODIQUE EXPRIME EN CEFTIZOXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFIZOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 194 /01/10", "Code DCI": "13B194", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFIZOX 1G/FL. DE PDRE.** PDRE. ET SOLV. SOL INJ IM  B/1FL. DE PDRE. + 1AMP. DE 4ML DE SOLV.(0,5%LIDOCAINE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTIZOXIME SODIQUE EXPRIME EN CEFTIZOXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFIZOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 226 /01/10", "Code DCI": "13B226", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.**", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 4ML DE SOLV.(0,5%LIDOCAINE)", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFIZOX 500MG PDRE. P. SOL. INJ. IV B/1", "Img": "https://pharmnet-dz.com//img/medics/720.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTIZOXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFIZOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 214 /00", "Code DCI": "13B214", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFIZOX 500MG SOL.INJ. IM B/1+1", "Img": "https://pharmnet-dz.com//img/medics/701.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTIZOXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFIZOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 205 /00", "Code DCI": "13B205", "Forme": "SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFODEX 1GR/FLACON  POUDRE ET SOLVANT POUR PREPARATION INJECTABLE IM ET IV  B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CEFODEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "323/13B014/16", "Code DCI": "13B014", "Forme": "PDRE. SOL. INJ.", "Dosage": "1GR/FLACON ", "Conditionnement": "B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT ", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFOFIX 1500MG/FL. DE PDRE. PDRE.SOL.INJ IV B/1FL. DE PDRE. + 1FL. DE 6ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME SODIQUE EXPRIME EN CEFUROXIME", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "CEFOFIX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 211 /01", "Code DCI": "13B211", "Forme": "PDRE. SOL. INJ.", "Dosage": "1500MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE 6ML DE SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFOFIX 750MG/ FL. DE PDRE. 3ML(IM)**  et 750MG/6ML(IV)** PDRE. P. SOL. INJ. IM ET IV B/1FL. DE PDRE. + 1FL. DE 3ML DE SOLV (IM) ET  B/1FL. DE PDRE. + 1FL. DE 6ML DE SOLV (IV)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME SODIQUE EXPRIME EN CEFUROXIME", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "CEFOFIX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 210 /01", "Code DCI": "13B210", "Forme": "PDRE. SOL. INJ.", "Dosage": "750MG/ FL. DE PDRE. 3ML(IM)**  et 750MG/6ML(IV)**", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE 3ML DE SOLV (IM) ET  B/1FL. DE PDRE. + 1FL. DE 6ML DE SOLV (IV)", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFOTAL 1G/FL. DE PDRE. PDRE. SOL. INJ. B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CEFOTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 B 014 /06", "Code DCI": "13B014", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFROZINE 250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JERUSALEM PHARMACEUTICALS CO LTD", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME ", "Liste": "Liste I", "Pays": "PALESTINE", "Nom Commercial": "CEFROZINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "369/ 13 B  208 /08/15", "Code DCI": "13B208", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFROZINE 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JERUSALEM PHARMACEUTICALS CO LTD", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME AXETIL", "Liste": "Liste I", "Pays": "PALESTINE", "Nom Commercial": "CEFROZINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "369/ 13 B 296 /08/15", "Code DCI": "13B296", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFTAX 1G PDRE .SOL.INJ.IM/IV B/01Fl", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RANBAXY", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CEFTAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "216/ 13 B 014 /05", "Code DCI": "13B014", "Forme": "PDRE. INJ.", "Dosage": "1G", "Conditionnement": "B/01Fl", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFTAZIM 1G/FL. DE PDRE. (ADULTE) PDRE. P. SOL. INJ. IM/IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/717.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=717", "Laboratoire": " UNIMED", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTAZIDIME", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "CEFTAZIM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 13 B 213 /13", "Code DCI": "13B213", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE. (ADULTE)", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFTAZIM 500MG/FL. DE PDRE. (ENFANT ET NOURRISSON) PDRE. P. SOL. INJ. IM/IV B/1FL. DE PDRE. P. ENFANT ET NOURRISSON", "Img": "https://pharmnet-dz.com//img/medics/715.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=715", "Laboratoire": " UNIMED", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTAZIDIME", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "CEFTAZIM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 13 B 212 /13", "Code DCI": "13B212", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE. (ENFANT ET NOURRISSON)", "Conditionnement": "B/1FL. DE PDRE. P. ENFANT ET NOURRISSON", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFTRIAXONA HIKMA 1000MG/FL. DE PDRE. PDRE.  ET SOLV. SOL INJ IM  B/1FL. DE PDRE. + 1FL. SOLV.(1%LIDOCAINE) DE 3,5ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "CEFTRIAXONA HIKMA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 255 /01", "Code DCI": "13B255", "Forme": "PDRE. SOL. INJ.", "Dosage": "1000MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1FL. SOLV.(1%LIDOCAINE) DE 3,5ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFTRIAXONA HIKMA 1G/FL. DE PDRE. PDRE. ET SOLV. P. SOL. INJ. IV B/1FL. DE PDRE. + 1AMP. DE 10ML DE SOLV.(E.P.P.I.)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "CEFTRIAXONA HIKMA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 019 /02/13", "Code DCI": "13B019", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 10ML DE SOLV.(E.P.P.I.)", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFTRIAXONA HIKMA 500MG/FL. DE PDRE. PDRE.  ET SOLV. P. SOL. INJ. IM  B/1FL.. DE PDRE. + 1FL.  DE 2ML DE SOLV.(1%LIDOCAINE) ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "CEFTRIAXONA HIKMA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 247 /01", "Code DCI": "13B247", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/1FL.. DE PDRE. + 1FL.  DE 2ML DE SOLV.(1%LIDOCAINE) ", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFTRIAXONA HIKMA 500MG/FL. DE PDRE. PDRE. ET SOL. P. SOL. INJ. IV B/1FL. DE PDRE. +1FL. DE 5ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "CEFTRIAXONA HIKMA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 158 /01", "Code DCI": "13B158", "Forme": "PDRE. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. +1FL. DE 5ML DE SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CEFUCARE 250MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME ", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEFUCARE", "Tarif de reference": "396.9 DA", "PPA": "N/A", "Num Enregistrement": "226/ 13 B 208 /09", "Code DCI": "13B208", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEFUTIL 250MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CEFUTIL", "Tarif de reference": "396.9 DA", "PPA": "N/A", "Num Enregistrement": "304/ 13 B 208 /08", "Code DCI": "13B208", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELEBREX 100MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2808.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2808", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELEBREX", "Tarif de reference": "480 DA", "PPA": " DA", "Num Enregistrement": "045/ 04 B 035 /00/12", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELEBREX 200MG GLES. B/10 - B/15 - B/30", "Img": "https://pharmnet-dz.com//img/medics/2820.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2820", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELEBREX", "Tarif de reference": "455.5 DA", "PPA": " DA", "Num Enregistrement": "045/ 04 B 036 /00/12", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10 - B/15 - B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOBREX HUP 100MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2809.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOBREX HUP", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "380/ 04 B 035 /14", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOBREX HUP 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2821.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOBREX HUP", "Tarif de reference": "1366.5 DA", "PPA": "1366.00 DA", "Num Enregistrement": "380/ 04 B 036 /14", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOMEX 100MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2810.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOMEX", "Tarif de reference": "480 DA", "PPA": " DA", "Num Enregistrement": "400/ 04 B 035 /14", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOMEX 200MG GLES B/10", "Img": "https://pharmnet-dz.com//img/medics/2822.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOMEX", "Tarif de reference": "455.5 DA", "PPA": " DA", "Num Enregistrement": "400/ 04 B 036 /14", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOX 100MG GLES. B/10 +B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/04B035/16", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/10 +B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CELECOXIB 200MG GLES. B/10 ET B/30", "Img": "https://pharmnet-dz.com//img/medics/4711.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB", "Tarif de reference": "624 DA", "PPA": " DA", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOXIB BEKER 100MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medics/2811.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2811", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB BEKER", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "447/ 04 B 035 /14", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOXIB BEKER 200MG GLES. B/10 ", "Img": "https://pharmnet-dz.com//img/medics/2823.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2823", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB BEKER", "Tarif de reference": "455.50 DA", "PPA": "455.50 DA", "Num Enregistrement": "447/ 04 B 036 /15", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOXIB LDM 100MG  GLES  B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB LDM", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "309/ 04 B 035 /14", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOXIB LDM 200MG  GLES  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB LDM", "Tarif de reference": "455.5 DA", "PPA": "1366.00 DA", "Num Enregistrement": "309/ 04 B 036 /14", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOXIB NOVAGENERICS 100MG  GLES  B/20", "Img": "https://pharmnet-dz.com//img/medics/2813.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB NOVAGENERICS", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "149/ 04 B 035 /14", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOXIB NOVAGENERICS 200MG  GLES  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB NOVAGENERICS", "Tarif de reference": "455.5 DA", "PPA": "455.00 DA", "Num Enregistrement": "149/ 04 B 036 /14", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELECOXIB ZENTIVA 100MG GLES. B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELECOXIB ZENTIVA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "428/ 04 B 035 /15", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": null}, {"Nom": "CELESTENE 0,5MG/ML (0,05%) SOL.BUV. GTTES FL/30 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=636", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CELESTENE", "Tarif de reference": "0 DA", "PPA": "168.00 DA", "Num Enregistrement": "027/ 09 H 020 /97/08", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "FL/30 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELESTENE 2MG COMP. DISPERS. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/4266.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4266", "Laboratoire": " MSD FRANCE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CELESTENE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/09H133/04/15", "Code DCI": "09H133", "Forme": "COMP. DISPERS.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELESTENE 2MG COMP. DISPERS. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3765.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3765", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CELESTENE", "Tarif de reference": "294.12 DA", "PPA": "N/A", "Num Enregistrement": "027/ 09 H 133 /04", "Code DCI": "09H133", "Forme": "COMP. DISPERS.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELESTENE CHRONODOSE 2,7MG/3MG/AMP. SUSP.INJ. B/1AMP. +1SERINGUE + 2AIGUILLES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=630", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE (ACETATE) / BETAMETHASONE  (PHOSPHATE DISODIQUE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CELESTENE CHRONODOSE", "Tarif de reference": "0 DA", "PPA": "223.00 DA", "Num Enregistrement": "027/ 09 H 018 /97", "Code DCI": "09H018", "Forme": "SUSP. INJ.", "Dosage": "2,7MG/3MG/AMP.", "Conditionnement": "B/1AMP. +1SERINGUE + 2AIGUILLES", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELETASONE 0,5MG/ML (0,05%) SOL.BUV. GTTES B/01 FL 30ML+01 SERINGUE DOSEUSE GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/637.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELETASONE", "Tarif de reference": "0 DA", "PPA": "168.00 DA", "Num Enregistrement": "263/ 09 H 020 /14", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/01 FL 30ML+01 SERINGUE DOSEUSE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELEXAL 200MG GLES B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELEXAL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "039/04B036/16", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CELOPRAM 10MG COMP. PELLI.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELOPRAM", "Tarif de reference": "364.84 DA", "PPA": "N/A", "Num Enregistrement": "317/16A105/16", "Code DCI": "16A105", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELOPRAM 20MG  COMP. PELLI. SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELOPRAM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/16A130/16", "Code DCI": "16A130", "Forme": "COMP. SEC.", "Dosage": "20MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CELOPRAM 20MG/ML  SOLUTION BUVABLE EN GOUTTES B/01 FLACON DE 30ML  AVEC COMPTE GOUTTE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELOPRAM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/16A165/16", "Code DCI": "N/D", "Forme": "SOL. BUV. GTTES.", "Dosage": "20MG/ML ", "Conditionnement": "B/01 FLACON DE 30ML  AVEC COMPTE GOUTTE", "Commercialisation": true, "Remboursable": null}, {"Nom": "CELVEX 100MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELVEX", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "418/ 04 B 035 /14", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CELVEX 200MG GLES. B/10 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CELVEX", "Tarif de reference": "455.5 DA", "PPA": "455.00 DA", "Num Enregistrement": "418/ 04 B 036 /12", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEPHADAR  125MG/5ML PDRE.OR. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/1896.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEPHADAR ", "Tarif de reference": "154 DA", "PPA": "226.00 DA", "Num Enregistrement": "055/ 13 B 011/98", "Code DCI": "13B011", "Forme": "GRLES. SOL. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEPHADAR 250MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEPHADAR", "Tarif de reference": "278 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 B 009 /98", "Code DCI": "13B009", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEPHADAR FORTE 250MG/5ML PDRE.OR. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEPHADAR FORTE", "Tarif de reference": "311 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 B 156 /00", "Code DCI": "13B156", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEPHADAR FORTE 500MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/1888.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CEPHADAR FORTE", "Tarif de reference": "556 DA", "PPA": "528.00 DA", "Num Enregistrement": "055/ 13 B 010 /98", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEPHALEX 250MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/1882.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "CEPHALEX", "Tarif de reference": "278 DA", "PPA": "548.00 DA", "Num Enregistrement": "173/ 13 B 009 /98", "Code DCI": "13B009", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEPHALEX 250MG/5ML PDRE .SOL BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/1926.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "CEPHALEX", "Tarif de reference": "311 DA", "PPA": " DA", "Num Enregistrement": "173/ 13 B 156 /99", "Code DCI": "13B156", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEPHALEX 500MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/1889.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1889", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "CEPHALEX", "Tarif de reference": "521 DA", "PPA": "N/A", "Num Enregistrement": "173/ 13 B 010 /98", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CERAZETTE 0,075MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/3056.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3056", "Laboratoire": " ORGANON", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " DESOGESTREL", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "CERAZETTE", "Tarif de reference": "119.84 DA", "PPA": "N/A", "Num Enregistrement": "005/ 11 H 072 /07/15", "Code DCI": "11H072", "Forme": "COMP.", "Dosage": "0,075MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEREZYME 400 UNITES D'IMIGLUCERASE / FL. DE PDRE. PDRE. A DILUER SOL. PERF. IV B/01FL.  DE PDRE. 400UI", "Img": "https://pharmnet-dz.com//img/medics/3479.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3479", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " IMIGLUCERASE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "CEREZYME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 14 N 316 /06/14", "Code DCI": "14N316", "Forme": "PDRE.", "Dosage": "400 UNITES D'IMIGLUCERASE / FL. DE PDRE.", "Conditionnement": "B/01FL.  DE PDRE. 400UI", "Commercialisation": true, "Remboursable": true}, {"Nom": "CERUBIDINE 20MG PDRE.SOL.INJ. B/10FL.", "Img": "https://pharmnet-dz.com//img/medics/974.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=974", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " DAUNORUBICINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CERUBIDINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 05 A 014 /96", "Code DCI": "05A014", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG", "Conditionnement": "B/10FL.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CERULYSE 5G/100G SOL. AURIC. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2036.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2036", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " OTOLOGIE", "Info": " XYLENE", "Pays": "FRANCE", "Nom Commercial": "CERULYSE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "096/ 18 D 016 /98", "Code DCI": "18D016", "Forme": "SOL. AURIC.", "Dosage": "5G/100G", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETADOL 325MG / 37,5MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CETADOL", "Tarif de reference": " N/A", "PPA": "193.00 DA", "Num Enregistrement": "418/ 03 F 115 /15", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "CETALGINE 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/4154.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "CETALGINE", "Tarif de reference": "85 DA", "PPA": "110.00 DA", "Num Enregistrement": "231/ 03 B 007 /02", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETALGINE 150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/4172.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "CETALGINE", "Tarif de reference": "85 DA", "PPA": "110.00 DA", "Num Enregistrement": "231/ 03 B 041 /07", "Code DCI": "03B041", "Forme": "SUPPO.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETALGINE 200MG SUPP0 B/10", "Img": "https://pharmnet-dz.com//img/medics/4177.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "CETALGINE", "Tarif de reference": "85 DA", "PPA": " DA", "Num Enregistrement": "231/ 03 B 042 /02", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETALGINE 300MG SUPP0. B/10", "Img": "https://pharmnet-dz.com//img/medics/4183.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "CETALGINE", "Tarif de reference": "110 DA", "PPA": "120.00 DA", "Num Enregistrement": "231/ 03 B 043 /02", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETIRIZINE GL 10MG/ML  SOL BUV EN GTTES  B/1 FL DE 15 ML +01 SERINGUE DOSEUSE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CETIRIZINE GL", "Tarif de reference": "240,15 DA", "PPA": " DA", "Code DCI": "01A041", "Forme": "SOL. BUV. GTTES.", "Dosage": "10MG/ML ", "Conditionnement": "B/1 FL DE 15 ML +01 SERINGUE DOSEUSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETIRIZINE MYLAN 10MG COMP. PELLI.SEC. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3973", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CETIRIZINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 01 A 003 /07/13", "Code DCI": "01A003", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": null}, {"Nom": "CETIRIZINE PHYSIOPHARM 10MG COMP. PELLI. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medics/3974.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CETIRIZINE PHYSIOPHARM", "Tarif de reference": "60 DA", "PPA": "N/A", "Num Enregistrement": "462/ 01 A 003 /13", "Code DCI": "01A003", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETIZAL  1G  PDRE P/ SOL INJ IM/IV  B/50 FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTIZOXIME SODIQUE EXPRIME EN CEFTIZOXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CETIZAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 B 463 /14", "Code DCI": "13B463", "Forme": "PDRE. SOL. INJ.", "Dosage": " 1G ", "Conditionnement": "B/50 FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "CETORNAN 5G/SACHET-DOSE PDRE. P. SOL. BUV. OU GASTRO-ENTERALE B/10 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3466.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3466", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " NUTRITION ENTERALE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " OXOGLURATE D'ORNITHINE EXPRIME EN OXOGLURATE DE L(+)ORNITHINE MONOHYDRATE", "Pays": "FRANCE", "Nom Commercial": "CETORNAN", "Tarif de reference": "1312.8 DA", "PPA": "N/A", "Num Enregistrement": "092/ 14 J 173 /00", "Code DCI": "14J173", "Forme": "PDRE. SOL. BUV.", "Dosage": "5G/SACHET-DOSE", "Conditionnement": "B/10 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETROTIDE 0,25MG/FL. DE PDRE PDRE ET SOLV. SOL. INJ. SC B/01FL. PDRE + 01 SERING. PRE REMPL. SOLV. (EPPI) + 01 AIGUILLE 20G + 01 AIGUILLE HYPODERMIQUE 27G + 02 TAMPONS IMBIBES D'ALCOOL", "Img": "https://pharmnet-dz.com//img/medics/3797.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3797", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CETRORELIX ACETATE EXPRIME EN CETRORELIX", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "CETROTIDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "062/ 09 J 148 /06/15", "Code DCI": "09J148", "Forme": "PDRE. SOL. INJ.", "Dosage": "0,25MG/FL. DE PDRE", "Conditionnement": "B/01FL. PDRE + 01 SERING. PRE REMPL. SOLV. (EPPI) + 01 AIGUILLE 20G + 01 AIGUILLE HYPODERMIQUE 27G + 02 TAMPONS IMBIBES D'ALCOOL", "Commercialisation": true, "Remboursable": true}, {"Nom": "CETROTIDE 3,00MG/FL. DE PDRE PDRE ET SOLV. SOL. INJ. SC B/01FL. PDRE + 01 SERING. PRE REMPL. SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SERONO EUROPE LIMITED", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CETRORELIX ACETATE EXPRIME EN CETRORELIX", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "CETROTIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "219/ 09 J 149 /06", "Code DCI": "09J149", "Forme": "PDRE. SOL. INJ.", "Dosage": "3,00MG/FL. DE PDRE", "Conditionnement": "B/01FL. PDRE + 01 SERING. PRE REMPL. SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "CEVLODIL 0,5% CREME T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CETRIMIDE", "Pays": "ALGERIE", "Nom Commercial": "CEVLODIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 07 P 066 /97/09", "Code DCI": "07P066", "Forme": "CR\u00c8ME", "Dosage": "0,5%", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHAMPIX 0,5MG** ET 1MG** COMP. PELLI. B/25 (11COMP. A 0,5MG ET 14COMP. A 1,00MG)", "Img": "https://pharmnet-dz.com//img/medics/2336.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2336", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " N/D", "C.Therapeutique": " PSYCHIATRIE", "Info": " VARENICLINE** (SOUS FORME DE TARTRATE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "CHAMPIX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 16 F 128 /09", "Code DCI": "16F128", "Forme": "COMP. PELLI.", "Dosage": "0,5MG** ET 1MG**", "Conditionnement": "B/25 (11COMP. A 0,5MG ET 14COMP. A 1,00MG)", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHAMPIX 1MG** COMP. PELLI. B/28 ET B/56", "Img": "https://pharmnet-dz.com//img/medics/2337.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2337", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " N/D", "C.Therapeutique": " PSYCHIATRIE", "Info": " VARENICLINE** (SOUS FORME DE TARTRATE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "CHAMPIX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 16 F 129 /08", "Code DCI": "16F129", "Forme": "COMP. PELLI.", "Dosage": "1MG**", "Conditionnement": "B/28 ET B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHARBON ACTIVE IVAL 300MG COMP.  B/40", "Img": "https://pharmnet-dz.com//img/medics/3921.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3921", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CHARBON ACTIVE", "Pays": "ALGERIE", "Nom Commercial": "CHARBON ACTIVE IVAL", "Tarif de reference": "319.8 DA", "PPA": "N/A", "Num Enregistrement": "195/ 10 B 172 /07", "Code DCI": "10B172", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHARBONEL 300MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3922.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CHARBON ACTIVE", "Pays": "ALGERIE", "Nom Commercial": "CHARBONEL", "Tarif de reference": "159.8 DA", "PPA": "N/A", "Num Enregistrement": "289/ 10 B 172 /08", "Code DCI": "10B172", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHIBRO-CADRON 100MG/350000UI/100ML COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/2381.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2381", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CHIBRO-CADRON", "Tarif de reference": "106.25 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 D 024 /99", "Code DCI": "17D024", "Forme": "COLLY.", "Dosage": "100MG/350000UI/100ML", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHIBROXINE 0,3% (OU 3MG/ML) COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/2390.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2390", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NORFLOXACINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CHIBROXINE", "Tarif de reference": "114.5 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 D 029 /99", "Code DCI": "17D029", "Forme": "COLLY. SOL.", "Dosage": "0,3% (OU 3MG/ML)", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHLOROQUINE 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTI-PALUDEENS", "C.Therapeutique": " PARASITOLOGIE", "Info": " CHLOROQUINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CHLOROQUINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "099/ 19 C 014 /99", "Code DCI": "19C014", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHLORPROMAZINE  25MG SOL.INJ. FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE (CHLORHYDRATE) EXPRIME EN CHLORPROMAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CHLORPROMAZINE ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 16 D 053 /98", "Code DCI": "16D053", "Forme": "SOL. INJ.", "Dosage": "25MG", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHLORURE DE POTASSIUM AGUETTANT 0.1 SOL.INJ. B/50AMP. DE  20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3364", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE POTASSIUM", "Pays": "FRANCE", "Nom Commercial": "CHLORURE DE POTASSIUM AGUETTANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "075/ 14 G 059 /00", "Code DCI": "14G059", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "B/50AMP. DE  20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHLORURE DE POTSSIUM 0.1 SOL INJ IV B/100  AMP DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " UNIMED", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE POTASSIUM", "Pays": "TUNISIE", "Nom Commercial": "CHLORURE DE POTSSIUM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "023/ 14 G 058 /96", "Code DCI": "14G058", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "B/100  AMP DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0,9% 0.009 SOL.INJ. PERF. POCHE DE 250 ML AVEC 2 TWIN VALVES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "ALGERIE", "Nom Commercial": "CHLORURE DE SODIUM 0,9%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 077 /97/09", "Code DCI": "14G077", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "POCHE DE 250 ML AVEC 2 TWIN VALVES", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0,9% 0.009 SOL.INJ. PERF. POCHE DE 500 ML AVEC 2 TWIN VALVES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "ALGERIE", "Nom Commercial": "CHLORURE DE SODIUM 0,9%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 078 /97/09", "Code DCI": "14G078", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "POCHE DE 500 ML AVEC 2 TWIN VALVES", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0,9% 0.009 SOLUTE .MASSIF P. PERF. POCHE DE 500ML ET FLACON EN POLYPROPYLENE DE 500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "ALGERIE", "Nom Commercial": "CHLORURE DE SODIUM 0,9%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 14 G 078 /00/07", "Code DCI": "14G078", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "POCHE DE 500ML ET FLACON EN POLYPROPYLENE DE 500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0,9% GIFRER 0.009 SOL.INJ. AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "FRANCE", "Nom Commercial": "CHLORURE DE SODIUM 0,9% GIFRER", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "004/ 14 G 076 /96", "Code DCI": "14G076", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0,9% GIFRER 0.009 SOL.INJ. AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "FRANCE", "Nom Commercial": "CHLORURE DE SODIUM 0,9% GIFRER", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "004/ 14 G 075 /96", "Code DCI": "14G075", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0.009 SOL.INJ. B/100AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "FRANCE", "Nom Commercial": "CHLORURE DE SODIUM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 076 /96", "Code DCI": "14G076", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "B/100AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0.1 SOL.INJ. B/100AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "CHLORURE DE SODIUM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 080 /96", "Code DCI": "14G080", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "B/100AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM 0.1 SOL.INJ. B/50AMP. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "FRANCE", "Nom Commercial": "CHLORURE DE SODIUM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 081 /96", "Code DCI": "14G081", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "B/50AMP. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CHLORURE DE SODIUM BIEFFE 0.009 SOL INJ.  POCHE DE 500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3380", "Laboratoire": " BIEFFE MEDITAL", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "ITALIE", "Nom Commercial": "CHLORURE DE SODIUM BIEFFE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "129/ 14 G 078 /99", "Code DCI": "14G078", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "POCHE DE 500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CHLORURE DE SODIUM HYPERTONIQUE SAIDAL 0.1 SOL INJ A DILUER P/ PERF IV  B/50 AMPS DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "CHLORURE DE SODIUM HYPERTONIQUE SAIDAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 080 /14", "Code DCI": "14G080", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "B/50 AMPS DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CIAFAL 20MG COMP. PELLI.  B/2 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIAFAL", "Tarif de reference": "- DA", "PPA": "N/A", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/02", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIAFAL 20MG COMP. PELLI. B/1 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIAFAL", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIBACALCINE 0,5MG PDRE.SOL.INJ B/5+5", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1407", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " CALCITONINE HUMAINE DE SYNTHESE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CIBACALCINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "068/ 21 C 013 /97", "Code DCI": "21C013", "Forme": "PDRE. SOL. INJ.", "Dosage": "0,5MG", "Conditionnement": "B/5+5", "Commercialisation": true, "Remboursable": true}, {"Nom": "CICLAID 100MG/ML  SOL. BUV.  B/01 FL 50ML +SERINGUE GRADUEE EN ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1266", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CICLAID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 27 A 005 /14", "Code DCI": "27A005", "Forme": "SOL. BUV.", "Dosage": "100MG/ML ", "Conditionnement": "B/01 FL 50ML +SERINGUE GRADUEE EN ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CICOLINA 100MG/ML** (OU 10G/100ML) SOL. BUV. FL./60ML + PIPETTE DOSEUSE", "Img": "https://pharmnet-dz.com//img/medics/2469.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2469", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " CITICOLINE** (SOUS FORME MONOSODIQUE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CICOLINA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "317/ 15 B 045 /09", "Code DCI": "15B045", "Forme": "SOL. BUV.", "Dosage": "100MG/ML** (OU 10G/100ML)", "Conditionnement": "FL./60ML + PIPETTE DOSEUSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIFLODINE 5MG GELULE B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "CIFLODINE", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "12E020", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "CILAGRA 50MG  COMP. ENRO. B/04", "Img": "https://pharmnet-dz.com//img/medics/1218.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CILAGRA", "Tarif de reference": " N/A", "PPA": "530.00 DA", "Num Enregistrement": "352/ 25 N 045 /10", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "CILANEM 500MG**/500MG**/FL. DE PDRE. PDRE. SOL. INJ. B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RANBAXY", "C.Pharmacologique": " INFECTIOLOGIE", "C.Therapeutique": " IMIPENEM**(SOUS FORME MONOHYDRATEE) / CILASTATINE (ACIDE)** (SOUS FORME SODIQUE)", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CILANEM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "216/ 13 W 187 /10", "Code DCI": "13W187", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG**/500MG**/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "CILOXAN 0.003 COLLY. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/1952.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1952", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CIPROFLOXACINE ** (SOUS FORME D' HDROCHLORIDE MONOHYDRATE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CILOXAN", "Tarif de reference": "360.1 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 D 131 /09", "Code DCI": "17D131", "Forme": "COLLY.", "Dosage": "0.003", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CILOXAN 0.003 PDE.OPHT. T/3,5G", "Img": "https://pharmnet-dz.com//img/medics/1956.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1956", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CILOXAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 D 151 /08", "Code DCI": "17D151", "Forme": "PDE. OPHT.", "Dosage": "0.003", "Conditionnement": "T/3,5G", "Commercialisation": true, "Remboursable": false}, {"Nom": "CIMAHER 5MG/ML (50MG/10ML) SOL. INJ. IV B/04FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/1062.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CENTRO IMMUNOLOGIA MOLECULAR (CIM)", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " NIMOTUZUMAB", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "CIMAHER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "443/ 05 D 143 /09", "Code DCI": "05D143", "Forme": "SOL. INJ.", "Dosage": "5MG/ML (50MG/10ML)", "Conditionnement": "B/04FL. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPRO 500 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/377.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=377", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPRO 500", "Tarif de reference": "1125.6 DA", "PPA": "1125.00 DA", "Num Enregistrement": "317/ 13 K 253 /11", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPRO 750 750MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/388.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=388", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPRO 750", "Tarif de reference": "1470 DA", "PPA": "1481.00 DA", "Num Enregistrement": "317/ 13 K 254 /11", "Code DCI": "13K254", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROCINE 250MG/5ML PELLETS P. SUSP. BUV. FL./60ML  DE SUSP. BUV.APRES RECONSTITUTION + BOUCHON DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROCINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 K 462 /11", "Code DCI": "13K462", "Forme": "PELLETS. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL./60ML  DE SUSP. BUV.APRES RECONSTITUTION + BOUCHON DOSEUR GRADUE", "Commercialisation": true, "Remboursable": null}, {"Nom": "CIPRODAR 0,3%** COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CIPROFLOXACINE ** (SOUS FORME D' HDROCHLORIDE MONOHYDRATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPRODAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "272/ 17 D 131 /03/09", "Code DCI": "17D131", "Forme": "COLLY.", "Dosage": "0,3%**", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CIPRODAR 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/378.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CIPRODAR", "Tarif de reference": " N/A", "PPA": "794.00 DA", "Num Enregistrement": "055/ 13 K 253 /02/12", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CIPROFLOXACINE  ZENTIVA 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXACINE  ZENTIVA", "Tarif de reference": "804 DA", "PPA": "1050.00 DA", "Num Enregistrement": "428/ 13 K 253 /13", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROFLOXACINE BEKER  500MG COMP. PELLI. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medics/380.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=380", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXACINE BEKER ", "Tarif de reference": "804 DA", "PPA": "800 DA", "Num Enregistrement": "447/ 13 K 253 /12", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROFLOXACINE BEKER  750MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/389.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=389", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXACINE BEKER ", "Tarif de reference": "1055.00 DA", "PPA": "1050.00 DA", "Num Enregistrement": "447/ 13 K 254 /13", "Code DCI": "13K254", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROFLOXACINE BIOCARE 250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/373.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXACINE BIOCARE", "Tarif de reference": "453.4 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 K 252 /13", "Code DCI": "13K252", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROFLOXACINE BIOCARE 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/381.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXACINE BIOCARE", "Tarif de reference": "804 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 K 253 /13", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROFLOXACINE RAZES 2MG/ML (200MG/100ML) (400MG/200ML)  SOL INJ P/ PERF IV  B/01 DE FL. DE 100ML CAISSE/48 BOITES ,  B/01 DE FL. DE 200ML CAISSE/24 BOITES", "Img": "https://pharmnet-dz.com//img/medics/370.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXACINE RAZES", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "433/ 13 K 251 /14", "Code DCI": "13K251", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (200MG/100ML) (400MG/200ML) ", "Conditionnement": "B/01 DE FL. DE 100ML CAISSE/48 BOITES ,  B/01 DE FL. DE 200ML CAISSE/24 BOITES", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROFLOXAL 250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXAL", "Tarif de reference": "453.4 DA", "PPA": "N/A", "Num Enregistrement": "039/13K252/15", "Code DCI": "13K252", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROFLOXAL 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROFLOXAL", "Tarif de reference": "1125.6 DA", "PPA": "N/A", "Num Enregistrement": "039/13K253/15", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROLON 250MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/374.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=374", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CIPROLON", "Tarif de reference": "453.4 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 K 252 /02/09", "Code DCI": "13K252", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROLON 2MG/ML (200MG/100ML) (400MG/200ML) SOL INJ PERF.IV B/01FL. DE 100ML - B/01POCHE DE 200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CIPROLON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 K 251 /02/09", "Code DCI": "13K251", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (200MG/100ML) (400MG/200ML)", "Conditionnement": "B/01FL. DE 100ML - B/01POCHE DE 200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CIPROLON 500MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/382.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=382", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CIPROLON", "Tarif de reference": "804 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 K 253 /02/09", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIPROLON 750MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CIPROLON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 K 254 /02/09", "Code DCI": "13K254", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CIPROMINE 4MG COMP. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIPROMINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "457/01A055/16", "Code DCI": "N/D", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "CIPTADINE 4MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3332.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3332", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Pays": "JORDANIE", "Nom Commercial": "CIPTADINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 F 025 /03/09", "Code DCI": "14F025", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "CIREXA 100MG  GLES  B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIREXA", "Tarif de reference": "480 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 035 /14", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CIREXA 200MG GLES  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CIREXA", "Tarif de reference": "455.5 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 036 /14", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CISPLATIN EBEWE 0,5MG/ML (25MG/50ML) - (50MG/100ML) CONC.SOL.INJ. PERF. IV B/1FL DE 50 ML  - B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medics/11.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=11", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " CISPLATINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "CISPLATIN EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 G 110 /98/09", "Code DCI": "05G110", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML (25MG/50ML) - (50MG/100ML)", "Conditionnement": "B/1FL DE 50 ML  - B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CISPLATINE MYLAN 1MG/ML (OU 10MG/10ML - 25MG/25ML - 50MG/50ML) SOL. INJ. A DILUER PERF.IV FL./10ML - FL./25ML - FL./50ML", "Img": "https://pharmnet-dz.com//img/medics/12.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=12", "Laboratoire": " MYLAN", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " CISPLATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CISPLATINE MYLAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "450/ 05 G 111 /09", "Code DCI": "05G111", "Forme": "SOL. INJ.", "Dosage": "1MG/ML (OU 10MG/10ML - 25MG/25ML - 50MG/50ML)", "Conditionnement": "FL./10ML - FL./25ML - FL./50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CITAFINE 1G/FL. DE PDRE. PDRE. P. SOL. INJ. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/1116.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CITAFINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "471/ 05 G 085 /13", "Code DCI": "05G085", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CITAL 50MG COMP B/10", "Img": "https://pharmnet-dz.com//img/medics/3809.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3809", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " INDUCTEURS DE L'OVULATION", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CLOMIFENE CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CITAL", "Tarif de reference": "270 DA", "PPA": "N/A", "Num Enregistrement": "242/ 09 L 058 /04", "Code DCI": "09L058", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CITICOLINE GL 100MG/ML SOL. BUV.  B/01 FL DE40 ML  +1SERINGUE GRADUEE ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " N/D", "C.Pharmacologique": " NEUROLOGIE", "C.Therapeutique": " CITICOLINE** (SOUS FORME SODIQUE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CITICOLINE GL", "Tarif de reference": "815 DA", "PPA": "N/A", "Num Enregistrement": "065/15K045/16", "Code DCI": "15K045", "Forme": "SOL. BUV.", "Dosage": "100MG/ML", "Conditionnement": "B/01 FL DE40 ML  +1SERINGUE GRADUEE ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CITICOLINE ISO 100MG/ML** SOL. BUV. GTTES. FL./50ML AVEC PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/2509.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2509", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " NEUROLOGIE", "Info": " CITICOLINE** (SOUS FORME MONOSODIQUE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CITICOLINE ISO", "Tarif de reference": "815 DA", "PPA": " DA", "Num Enregistrement": "073/ 15 K 045 /09", "Code DCI": "15K045", "Forme": "SOL. BUV. GTTES.", "Dosage": "100MG/ML**", "Conditionnement": "FL./50ML AVEC PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "CITICOLINE PHARMAGHREB 100MG/ML** (OU 10G/100ML) SOL. BUV. FL./30ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " NEUROLOGIE", "C.Therapeutique": " CITICOLINE** (SOUS FORME MONOSODIQUE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CITICOLINE PHARMAGHREB", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 15 K 045 /10", "Code DCI": "15K045", "Forme": "SOL. BUV. GTTES.", "Dosage": "100MG/ML** (OU 10G/100ML)", "Conditionnement": "FL./30ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "CITIZEN 300MG COMP LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CITIZEN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "010/ 06 B 010 /02", "Code DCI": "06B010", "Forme": "COMP. LP", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CITRATE DE BETAINE 2G/10ML AMP. BUV. B/20AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CITRATE DE BETAINE", "Pays": "ALGERIE", "Nom Commercial": "CITRATE DE BETAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 R 164 /07", "Code DCI": "10R164", "Forme": "AMP. BUV.", "Dosage": "2G/10ML", "Conditionnement": "B/20AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CITRATE DE BETAINE-BIOTIC 2G PDRE. SOL. BUV. B/20SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CITRATE DE BETAINE", "Pays": "ALGERIE", "Nom Commercial": "CITRATE DE BETAINE-BIOTIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 R 165 /07", "Code DCI": "10R165", "Forme": "PDRE. SOL. BUV.", "Dosage": "2G", "Conditionnement": "B/20SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLAFORAN 1G PDRE.SOL INJ.IV B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ROUSSEL", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CLAFORAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "033/ 13 B 014 /97", "Code DCI": "13B014", "Forme": "PDRE. INJ.", "Dosage": "1G", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLAFORAN 500MG PDRE.SOL.INJ.IV B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ROUSSEL", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CLAFORAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "033/ 13 B 015 /97", "Code DCI": "13B015", "Forme": "PDRE. INJ.", "Dosage": "500MG", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLAFOTAX 1G/FL. DE PDRE. PDRE. ET SOLVT. SOL. INJ. IV B/1FL. DE PDRE. + 1AMP. DE SOLVT. (E.P.P.I.) DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLAFOTAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "118/ 13 B 014 /09", "Code DCI": "13B014", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE SOLVT. (E.P.P.I.) DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLAMOCLAV  1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EURL GENIS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAMOCLAV ", "Tarif de reference": "785.28 DA", "PPA": "N/A", "Num Enregistrement": "480/13G269/16", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG/SACHET", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAMOXYL 1G COMP. DISPERS. B/06 - B/12 ET B/14", "Img": "https://pharmnet-dz.com//img/medics/314.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=314", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAMOXYL", "Tarif de reference": "0 DA", "PPA": "316.00 DA", "Num Enregistrement": "305/ 13 G 230 /00/11", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/06 - B/12 ET B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAMOXYL 250MG/5ML PDRE. P. SUSP.BUV. F/60ML", "Img": "https://pharmnet-dz.com//img/medics/227.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=227", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAMOXYL", "Tarif de reference": "132 DA", "PPA": "N/A", "Num Enregistrement": "305/ 13 G 047 /97", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "F/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAMOXYL 500MG/5ML PDRE. SUSP. BUV.  FL/60ML", "Img": "https://pharmnet-dz.com//img/medics/302.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=302", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAMOXYL", "Tarif de reference": "205.2 DA", "PPA": "N/A", "Num Enregistrement": "305/ 13 G 220 /06", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAMOXYPEN 100MG/12,5MG/ML PDRE. P. SUSP. BUV. ENFANT ET NOURRISSON B/1FLACON DE 30ML  DE SUSP. BUV. APRES RECONST. +SERING. P. ADMINIST. ORALE GRADUEE EN KG (NOURRISSON) ET                                                                                  ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAMOXYPEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 181 /13", "Code DCI": "13G181", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/12,5MG/ML", "Conditionnement": "B/1FLACON DE 30ML  DE SUSP. BUV. APRES RECONST. +SERING. P. ADMINIST. ORALE GRADUEE EN KG (NOURRISSON) ET                                                                                                                                                      ", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLAMOXYPEN 1G/200MG PDRE. SOL. INJ. IV B/20FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAMOXYPEN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 182 /06", "Code DCI": "13G182", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/200MG", "Conditionnement": "B/20FL.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLARADINE 1MG/ML SOL. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/4007.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4007", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLARADINE", "Tarif de reference": "96.6 DA", "PPA": " DA", "Num Enregistrement": "073/ 01 A 034 /07", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLARDINE 1MG/ML SOL. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/4008.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4008", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLARDINE", "Tarif de reference": "96.6 DA", "PPA": "169.00 DA", "Num Enregistrement": "317/ 01 A 034 /07", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLARIDAR 125MG/5ML PDRE. P. SUSP. BUV. EN FLACON B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2,5ML ET A 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLARIDAR", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 E 323 /12", "Code DCI": "13E323", "Forme": "GRLES. SOL. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2,5ML ET A 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLARIDAR 250MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/823.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLARIDAR", "Tarif de reference": " N/A", "PPA": "1656.00 DA", "Num Enregistrement": "055/ 13 E 244 /07/13", "Code DCI": "13E244", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLARIDAR 250MG/5ML PDRE. P. SUSP. BUV. EN FLACON B/1FL. DE 100ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2,5ML ET A 5ML", "Img": "https://pharmnet-dz.com//img/medics/829.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLARIDAR", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 E 297 /12", "Code DCI": "13E297", "Forme": "GRLES. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "B/1FL. DE 100ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2,5ML ET A 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLARIDAR 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/816.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLARIDAR", "Tarif de reference": " N/A", "PPA": "1656.00 DA", "Num Enregistrement": "055/ 13 E 215 /07/13", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLARITAL 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/817.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLARITAL", "Tarif de reference": "574 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 E 215 /11", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLARITHROMYCINE GEO 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLARITHROMYCINE GEO", "Tarif de reference": "574 DA", "PPA": "N/A", "Num Enregistrement": "304/ 13 E 215 /08", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLARITT 250MG/5ML SUSP. ORALE FL./70ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLARITT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 E 297 /06", "Code DCI": "13E297", "Forme": "GRLES. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL./70ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLARITT 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLARITT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 E 215 /06", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLARITYNE 1MG/ML SIROP FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4002", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CLARITYNE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "027/ 01 A 034 /97/03", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVAMOX 500MG/125MG COMP.PELLI. B/12", "Img": "https://pharmnet-dz.com//img/medics/237.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVAMOX", "Tarif de reference": "392.64 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 050 /08", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVAMOX 500MG/62,5MG COMP.PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVAMOX", "Tarif de reference": "523.52 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 245 /08", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODA R 625 500MG/125MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLAVODA R 625", "Tarif de reference": "458.08 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 G 050 /12", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODAR 1G 875MG*/125MG* COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/332.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLAVODAR 1G", "Tarif de reference": "801.64 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 G 267 /12", "Code DCI": "13G267", "Forme": "COMP. PELLI.", "Dosage": "875MG*/125MG*", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODAR 200/28,5 200MG**/28,5MG** PDRE. P. SUSP. BUV. B/1FL. DE 70ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE MESURE DE 2,5ML ET  UNE CUILLERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLAVODAR 200/28,5", "Tarif de reference": "408.1 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 G 265 /12", "Code DCI": "13G265", "Forme": "PDRE. SUSP. BUV.", "Dosage": "200MG**/28,5MG**", "Conditionnement": "B/1FL. DE 70ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE MESURE DE 2,5ML ET  UNE CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODAR FORTE 400/57 400MG** / 57MG** PDRE. P. SUSP. BUV. B/1FL. DE 70ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLAVODAR FORTE 400/57", "Tarif de reference": "692.3 DA", "PPA": "999.00 DA", "Num Enregistrement": "055/ 13 G 266 /12", "Code DCI": "13G266", "Forme": "PDRE. SUSP. BUV.", "Dosage": "400MG** / 57MG**", "Conditionnement": "B/1FL. DE 70ML DE SUSP. BUV. APRES RECONST. + UNE CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX  1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/12SACH", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "768,12 DA", "PPA": " DA", "Num Enregistrement": "323/13G269/17", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG", "Conditionnement": "B/12SACH", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX  1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/14SACH", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX ", "Tarif de reference": "B/14SACH DA", "PPA": " DA", "Num Enregistrement": "323/13G269/17", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG", "Conditionnement": "B/14SACH", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX  250MG/62,5MG/5ML PDRE.P.SUP.BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "323/13G051/16", "Code DCI": "13G051", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/62,5MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLAVODEX  500MG/125MG COMP.PELL B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/12", "Commercialisation": false, "Remboursable": true}, {"Nom": "CLAVODEX 100MG/12,5MG/ML PDRE. P. SUSP. BUV.  FL/30 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "296,7 DA", "PPA": " DA", "Num Enregistrement": "323/13G181/17", "Code DCI": "13G181", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG/12,5MG/ML", "Conditionnement": "FL/30 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX 100MG/12,5MG/ML PDRE. P. SUSP. BUV. FL /60 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "593,4 DA", "PPA": " DA", "Num Enregistrement": "323/13G181/17", "Code DCI": "13G181", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/12,5MG/ML", "Conditionnement": "FL /60 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX 500MG / 62,5MG COMP. PELLI.  B/16 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "523,52 DA", "PPA": " DA", "Num Enregistrement": "323/13G245/17", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX 500MG / 62,5MG COMP. PELLI. B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "785,28 DA", "PPA": " DA", "Num Enregistrement": "323/13G245/17", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": " B/24", "Conditionnement": "500MG / 62,5MG", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX 500MG/62,5MG PDRE. P. SUSP. BUV. EN SACHET DOSE B/12 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "392,64 DA", "PPA": " DA", "Num Enregistrement": "323/13G204/17", "Code DCI": "13G204", "Forme": "PDRE. SUSP. BUV.", "Dosage": " 500MG/62,5MG", "Conditionnement": " B/12 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX 500MG/62,5MG PDRE. P. SUSP. BUV. EN SACHET DOSE B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX", "Tarif de reference": "458,08 DA", "PPA": " DA", "Num Enregistrement": "323/13G204/17", "Code DCI": "13G204", "Forme": "PDRE. SUSP. BUV.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX DUO 400MG/57MG/5ML PDRE. P.  SUSP. BUV. F/70 ML +PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX DUO", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "323/13G266/16", "Code DCI": "13G266", "Forme": "PDRE. SUSP. BUV.", "Dosage": "400MG/57MG/5ML", "Conditionnement": "F/70 ML +PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLAVODEX DUO 875MG/125MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX DUO", "Tarif de reference": "572,6 DA", "PPA": " DA", "Num Enregistrement": "323/13G267/17", "Code DCI": "13G267", "Forme": "COMP. PELLI.", "Dosage": "875MG/125MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVODEX DUO 875MG/125MG COMP. PELLI. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVODEX DUO", "Tarif de reference": "687,12 DA", "PPA": " DA", "Num Enregistrement": "323/13G267/17", "Code DCI": "13G267", "Forme": "COMP. PELLI.", "Dosage": "875MG/125MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVOR 1G/125MG/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/12SACH.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " APU", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVOR", "Tarif de reference": "785.28 DA", "PPA": "N/A", "Num Enregistrement": "287/ 13 G 269 /09", "Code DCI": "13G269", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/125MG/SACHET", "Conditionnement": "B/12SACH.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVOR 500MG/62,5MG COMP. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " APU", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVOR", "Tarif de reference": "523.52 DA", "PPA": "N/A", "Num Enregistrement": "287/ 13 G 245 /09", "Code DCI": "13G245", "Forme": "COMP. PELLI.", "Dosage": "500MG/62,5MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLAVUCILLINE 500MG/125MG COMP.ENRO. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLAVUCILLINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035/ 13 G 050 /01/07", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLENIL 250\u00b5G/BOUFFEE AERO. FL/200DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2061", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BECLOMETASONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CLENIL", "Tarif de reference": "408 DA", "PPA": "N/A", "Num Enregistrement": "092/ 20 A 003 /98", "Code DCI": "20A003", "Forme": "AERO.", "Dosage": "250\u00b5G/BOUFFEE", "Conditionnement": "FL/200DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLIMASTON 1MG/10MG COMP PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3030.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3030", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " OESTROPROGESTATIFS", "C.Therapeutique": " GYNECOLOGIE", "Info": " ESTRADIOL /DYDROGESTERONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CLIMASTON", "Tarif de reference": "695.91 DA", "PPA": "N/A", "Num Enregistrement": "031/ 11 D 065 /03", "Code DCI": "11D065", "Forme": "COMP. PELLI.", "Dosage": "1MG/10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLIMASTON 1MG/5MG COMP PELLI B/28", "Img": "https://pharmnet-dz.com//img/medics/3031.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3031", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " OESTROPROGESTATIFS", "C.Therapeutique": " GYNECOLOGIE", "Info": " ESTRADIOL/DYDROGESTERONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CLIMASTON", "Tarif de reference": "644.89 DA", "PPA": "N/A", "Num Enregistrement": "031/ 11 D 066 /03", "Code DCI": "11D066", "Forme": "COMP. PELLI.", "Dosage": "1MG/5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLIMASTON 2MG/10MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3029.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3029", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " OESTROPROGESTATIFS", "C.Therapeutique": " GYNECOLOGIE", "Info": " ESTRADIOL/DYDROGESTERONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CLIMASTON", "Tarif de reference": "716.14 DA", "PPA": "N/A", "Num Enregistrement": "031/ 11 D 061 /00", "Code DCI": "11D061", "Forme": "COMP. PELLI.", "Dosage": "2MG/10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLIMENE 2MG/1MG COMP.ENRO. B/21", "Img": "https://pharmnet-dz.com//img/medics/3052.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3052", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ESTRADIOL VALERATE / CYPROTERONE ACETATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CLIMENE", "Tarif de reference": "594.62 DA", "PPA": "N/A", "Num Enregistrement": "070/ 11 H 063 /01", "Code DCI": "11H063", "Forme": "COMP. PELLI.", "Dosage": "2MG/1MG", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLINARAM 150MG GLES B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLINDAMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLINARAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 13 D 025 /98/15", "Code DCI": "13D025", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLINDACIN 150MG GLES. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLINDAMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLINDACIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "174/ 13 D 025 /98", "Code DCI": "13D025", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLINDAMYL 150MG GLES. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLINDAMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLINDAMYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "118/ 13 D 025 /98", "Code DCI": "13D025", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLINIMYCIN 150MG GLES. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HAYAT PHARMACEUTICAL INDUSTRIES Co LTD", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLINDAMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLINIMYCIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "098/ 13 D 025 /98", "Code DCI": "13D025", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOBECORT 0,05% CREME DERM. T/156", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " EL KENDI", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOBETASOL PROPIONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOBECORT", "Tarif de reference": "384.3 DA", "PPA": "N/A", "Num Enregistrement": "352/07H174/16", "Code DCI": "07H174", "Forme": "CR\u00c8ME", "Dosage": "0,05%", "Conditionnement": "T/156", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOBECORT 0.0005 PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " EL KENDI", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOBETASOL PROPIONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOBECORT", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/07H176/16", "Code DCI": "07H176", "Forme": "PDE. DERM.", "Dosage": "0.05%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLODIPRAL 75MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLODIPRAL", "Tarif de reference": "1800 DA", "PPA": "366.00 DA", "Num Enregistrement": "039/ 06 J 159 /13", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOFENAL  50MG GLES. A MICROGRANULES GASTRORESIST. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOFENAL ", "Tarif de reference": "180 DA", "PPA": "N/A", "Num Enregistrement": "003/ 04 B 006 /07", "Code DCI": "04B006", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOFENAL 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2720.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2720", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOFENAL", "Tarif de reference": "87.6 DA", "PPA": "87.6 DA", "Num Enregistrement": "003/ 04 B 009 /98/09", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOFENAL 25MG/ML (75MG/3ML) SOL.INJ.IM  B/02AMP. DE 3ML ET B/50AMP. DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/2696.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2696", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOFENAL", "Tarif de reference": "81.6 DA", "PPA": "82,6 DA", "Num Enregistrement": "003/ 04 B 004 /05/13", "Code DCI": "04B004", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (75MG/3ML)", "Conditionnement": "B/02AMP. DE 3ML ET B/50AMP. DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOFENAL ENFANT 25MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2712.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOFENAL ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 04 B 008 /99/09", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLOFENAL LP 100MG GLES.GASTRO. RESIST. L.P. B/20", "Img": "https://pharmnet-dz.com//img/medics/2706.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOFENAL LP", "Tarif de reference": "280 DA", "PPA": "280.00 DA", "Num Enregistrement": "003/ 04 B 007 /07", "Code DCI": "04B007", "Forme": "GLES. LP", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOFENAL LP 75MG GLES.GASTRO. RESIST. L.P. B/30", "Img": "https://pharmnet-dz.com//img/medics/2833.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOFENAL LP", "Tarif de reference": "366.6 DA", "PPA": "366.00 DA", "Num Enregistrement": "003/ 04 B 037 /07", "Code DCI": "04B037", "Forme": "GLES. MICROGRLES. LP", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOFRANIL 25MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CLOFRANIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "330/ 16 A 006 /07", "Code DCI": "16A006", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOGEL 0.01 GEL DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1369.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1369", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOGEL", "Tarif de reference": "87 DA", "PPA": "87 DA", "Num Enregistrement": "003/ 21 A 004 /00/10", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOMID 50MG COMP. B/5 ", "Img": "https://pharmnet-dz.com//img/medics/3810.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3810", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INDUCTEURS DE L'OVULATION", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CLOMIFENE CITRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CLOMID", "Tarif de reference": "46.4 DA", "PPA": " DA", "Num Enregistrement": "230/ 09 L 058 /97", "Code DCI": "09L058", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/5 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOMIDINE 50MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ASIA PHARMACEUTICALS", "C.Pharmacologique": " INDUCTEURS DE L'OVULATION", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CLOMIFENE CITRATE", "Liste": "Liste I", "Pays": "SYRIE", "Nom Commercial": "CLOMIDINE", "Tarif de reference": "270 DA", "PPA": "N/A", "Num Enregistrement": "121/ 09 L 058 /99", "Code DCI": "09L058", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOMIFERT 50MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " INDUCTEURS DE L'OVULATION", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CLOMIFENE CITRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLOMIFERT", "Tarif de reference": "270 DA", "PPA": "N/A", "Num Enregistrement": "055/ 09 L 058 /98", "Code DCI": "09L058", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOMOVAL 50MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " INDUCTEURS DE L'OVULATION", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CLOMIFENE CITRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLOMOVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "174/ 09 L 058 /99", "Code DCI": "09L058", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLOMYCINE 0.01 PDE.OPHT. T/5G", "Img": "https://pharmnet-dz.com//img/medics/2375.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2375", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CHLORTETRACYCLINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOMYCINE", "Tarif de reference": "107.5 DA", "PPA": "110 DA", "Num Enregistrement": "003/ 17 D 017 /97", "Code DCI": "17D017", "Forme": "PDE. OPHT.", "Dosage": "0.01", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOMYCINE 0.03 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1671.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1671", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CHLORTETRACYCLINE", "Pays": "ALGERIE", "Nom Commercial": "CLOMYCINE", "Tarif de reference": "0 DA", "PPA": "95 DA", "Num Enregistrement": "003/ 07 C 015 /99", "Code DCI": "07C015", "Forme": "PDE. DERM.", "Dosage": "0.03", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": false}, {"Nom": "CLONA 2,5MG/ML SOL. BUV. GTTES. FL. COMPTE GTTES. DE 20ML", "Img": "https://pharmnet-dz.com//img/medics/3513.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3513", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CLONAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLONA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "242/ 15 A 009 /10", "Code DCI": "15A009", "Forme": "SOL. BUV. GTTES.", "Dosage": "2,5MG/ML", "Conditionnement": "FL. COMPTE GTTES. DE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLONA 2MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3510.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3510", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CLONAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLONA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/ 15 A 008 /09", "Code DCI": "15A008", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLONAPRIME 10MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2533.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2533", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLONAPRIME", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/ 16 A 005 /09", "Code DCI": "16A005", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLONAPRIME 25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2537.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2537", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLONAPRIME", "Tarif de reference": "0 DA", "PPA": "263.00 DA", "Num Enregistrement": "235/ 16 A 006 /10", "Code DCI": "16A006", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLONAPRIME 75MG COMP. PELLI. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/2541.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2541", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLONAPRIME", "Tarif de reference": "0 DA", "PPA": "441.00 DA", "Num Enregistrement": "235/ 16 A 007 /12", "Code DCI": "16A007", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOPIDOGREL LDM 75MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOPIDOGREL LDM", "Tarif de reference": "1800 DA", "PPA": "1800.00 DA", "Num Enregistrement": "309/ 06 J 159/ 13", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOPIDOGREL NOVAGENERICS 75MG  MICROGRANULES EN GLES  PILULIER/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOPIDOGREL NOVAGENERICS", "Tarif de reference": "1800 DA", "PPA": "N/A", "Num Enregistrement": "149/ 06 J 159 /14", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG ", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOPIDROL 75MG GLES. B/28 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOPIDROL", "Tarif de reference": "1680 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 J 159 /09", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/28 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOPIVAL 75MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOPIVAL", "Tarif de reference": "1680 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 J 159 /09 ", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOPLAV 75MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLOPLAV", "Tarif de reference": "1800 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 J 159 /12", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOPRAMID 0.001 SOL.BUV FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/2861.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2861", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLOPRAMID", "Tarif de reference": "85 DA", "PPA": "85 DA", "Num Enregistrement": "003/ 10 F 044 /99/09", "Code DCI": "10F044", "Forme": "SOL. BUV.", "Dosage": "0.001", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLORACEF FORTE 250MG/5ML GRLES. P. SUSP. BUV. EN FLACON B/1FL. DE 75ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2,5ML ET A 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLORACEF FORTE", "Tarif de reference": "0 DA", "PPA": "605.00 DA", "Num Enregistrement": "055/ 13 B 260 /12", "Code DCI": "13B260", "Forme": "SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "B/1FL. DE 75ML DE SUSP. BUV. APRES RECONST.+UNE CUILLERE MESURE GRADUEE A 2,5ML ET A 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLORACEF FORTE 500MG GLES. B/16", "Img": "https://pharmnet-dz.com//img/medics/734.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=734", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLORACEF FORTE", "Tarif de reference": "1053.6 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 B 262 /09", "Code DCI": "13B262", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLORACEF MR 500MG COMP. PELLI. LM B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLORACEF MR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 13 B 473 /14", "Code DCI": "13B473", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLORACEF MR 750MG COMP. PELLI. LM B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR MONOHYDRATE EXPRIME EN CAFACLOR", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CLORACEF MR", "Tarif de reference": " N/A", "PPA": "942.00 DA", "Num Enregistrement": "055/ 13 B 474 /14", "Code DCI": "13B474", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLORAMID 10MG  COMP. B/40 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLORAMID", "Tarif de reference": "132 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 043 /97", "Code DCI": "10F043", "Forme": "COMP.", "Dosage": "10MG ", "Conditionnement": "B/40 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLORAMID 10MG /2ML SOL. INJ. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CLORAMID", "Tarif de reference": "721 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 042 /03", "Code DCI": "10F042", "Forme": "SOL. INJ.", "Dosage": "10MG /2ML", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLORAXENE 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2596.png", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLORAXENE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/ 16 B 024 /09", "Code DCI": "16B024", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLORAXENE 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2593.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2593", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLORAXENE", "Tarif de reference": "130 DA", "PPA": "N/A", "Num Enregistrement": "231/ 16 B 023 /09", "Code DCI": "16B023", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOTASOL 0,05% CREME DERM. T/45G", "Img": "https://pharmnet-dz.com//img/medics/523.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=523", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOBETASOL PROPIONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOTASOL", "Tarif de reference": "384.3 DA", "PPA": "N/A", "Num Enregistrement": "263/ 07 H 174 /11", "Code DCI": "07H174", "Forme": "CR\u00c8ME", "Dosage": "0,05%", "Conditionnement": "T/45G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOTASOL 0,05% GEL P. APPLI. CAPILLAIRE T/45G", "Img": "https://pharmnet-dz.com//img/medics/524.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=524", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOBETASOL PROPIONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOTASOL", "Tarif de reference": "362.25 DA", "PPA": "N/A", "Num Enregistrement": "263/ 07 H 175 /11", "Code DCI": "07H175", "Forme": "GEL. DERM.", "Dosage": "0,05%", "Conditionnement": "T/45G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOTASOL 0.0005 PDE.DERM. T/45G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOBETASOL PROPIONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOTASOL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/07H176/16", "Code DCI": "07H176", "Forme": "PDE. DERM.", "Dosage": "0.05%", "Conditionnement": "T/45G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLOTERMEX  0.01 CREME DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/4523.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOTRIMAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOTERMEX ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "400/07D024/16", "Code DCI": "07D024", "Forme": "CR\u00c8ME", "Dosage": "1%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOTTAFACT  1,5G/100ML POUDRE ET SOLVANT POUR SOLUTION INJECTABLE I B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT 100ML +SYST\u00c8ME DE TRANSFERT MUNI D'UN event \u00e0 FILTRE STERILISANT", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CLOTTAFACT ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "513/12J182/16", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "1,5G/100ML", "Conditionnement": "B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT 100ML +SYST\u00c8ME DE TRANSFERT MUNI D'UN event \u00e0 FILTRE STERILISANT", "Commercialisation": true, "Remboursable": null}, {"Nom": "CLOVIR 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/417.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=417", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOVIR", "Tarif de reference": "472 DA", "PPA": "N/A", "Num Enregistrement": "190/ 13 P 097 /98/13", "Code DCI": "13P097", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOVIRAX 0.05 CREME DERM. T/2G ET T/10G", "Img": "https://pharmnet-dz.com//img/medics/482.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=482", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIHERPETIQUES & ANTIVIRAUX LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOVIRAX", "Tarif de reference": "63 DA", "PPA": "N/A", "Num Enregistrement": "035/ 07 E 033 /98/13", "Code DCI": "07E033", "Forme": "CR\u00c8ME", "Dosage": "0.05", "Conditionnement": "T/2G ET T/10G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOVIRAX 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOVIRAX", "Tarif de reference": "-- DA", "PPA": " DA", "Num Enregistrement": "035/13P097/17", "Code DCI": "13P097", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CLOXTON 200MG COMP. PELLI. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3229.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3229", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CLOXTON", "Tarif de reference": "209.8 DA", "PPA": "1233.00 DA", "Num Enregistrement": "235/ 06 F 067 /10", "Code DCI": "06F067", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO  AVASART 300MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ANTI-HYPERTENSEURS", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO  AVASART", "Tarif de reference": "2084.1 DA", "PPA": "N/A", "Num Enregistrement": "510/06E256/16", "Code DCI": "06E256", "Forme": "COMP. PELLI.", "Dosage": "300MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO APROSART 150MG/12,5MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/3120.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO APROSART", "Tarif de reference": "1544.4 DA", "PPA": "1233.00 DA", "Num Enregistrement": "352/ 06 E 219 /10", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO APROSART 300MG / 25MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3181.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO APROSART", "Tarif de reference": "2084.1 DA", "PPA": "1718.00 DA", "Num Enregistrement": "352 / 06 E 256 /12", "Code DCI": "06E256", "Forme": "COMP. PELLI.", "Dosage": "300MG / 25MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO APROSART 300MG/12,5MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/3128.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO APROSART", "Tarif de reference": "2084.1 DA", "PPA": "1708.00 DA", "Num Enregistrement": "352/ 06 E 220 /10", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO AVASART 300MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ANTI-HYPERTENSEURS", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO AVASART", "Tarif de reference": "2084.1 DA", "PPA": "N/A", "Num Enregistrement": "510/06E220/16", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO AVSART  150MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ANTI-HYPERTENSEURS", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO AVSART ", "Tarif de reference": "1544.4 DA", "PPA": "N/A", "Num Enregistrement": "510/06E219/16", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO BIPROTENS 10MG/6,25MG COMP. PELLI.  B/30", "Img": "https://pharmnet-dz.com//img/medics/3268.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO BIPROTENS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 06 F 302 /13", "Code DCI": "06F302", "Forme": "COMP. PELLI.", "Dosage": "10MG/6,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CO BIPROTENS 5MG/6,25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3267.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO BIPROTENS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 F 299 /13", "Code DCI": "06F299", "Forme": "COMP. PELLI.", "Dosage": "5MG/6,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO SARCAND 8MG/12,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3146.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Pays": "ALGERIE", "Nom Commercial": "CO SARCAND", "Tarif de reference": "1629.9 DA", "PPA": "1500.00 DA", "Num Enregistrement": "352/ 06 E 230 /14", "Code DCI": "06E230", "Forme": "COMP. SEC.", "Dosage": "8MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO SARTEG 160MG/25MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/3167.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO SARTEG", "Tarif de reference": "2190 DA", "PPA": "2190.00 DA", "Num Enregistrement": "352/ 06 E 238 /11", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO SARTEG 320MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3224.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO SARTEG", "Tarif de reference": " N/A", "PPA": "2190.00 DA", "Num Enregistrement": "352/ 06 E 307 /15", "Code DCI": "06E307", "Forme": "COMP. PELLI.", "Dosage": "320MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CO VALASTAN  160MG/12,5MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3158.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3158", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO VALASTAN", "Tarif de reference": "2190.00 DA", "PPA": "2190.00 DA", "Num Enregistrement": "447/ 06 E 237 /14", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": " 160MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO VALASTAN 160MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3168.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3168", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO VALASTAN", "Tarif de reference": "2190.00 DA", "PPA": "2190.00 DA", "Num Enregistrement": "447/ 06 E 238 /11", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO VALASTAN 80MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3074.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3074", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO VALASTAN", "Tarif de reference": "2190.00 DA", "PPA": "2190.00 DA", "Num Enregistrement": "447/ 06 E 158 /11", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO VALSARTAN IVAL 160MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO VALSARTAN IVAL", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 237 /13", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-APRIVAL 150MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-APRIVAL", "Tarif de reference": "1544.4 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 219 /11", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-APRIVAL 300MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-APRIVAL", "Tarif de reference": "2084.1 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 220 /11", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-APRIVAL 300MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-APRIVAL", "Tarif de reference": "2084.1 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 256 /11", "Code DCI": "06E256", "Forme": "COMP. PELLI.", "Dosage": "300MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COAPROVEL 150MG/12,5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3122.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3122", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COAPROVEL", "Tarif de reference": "1232 DA", "PPA": "N/A", "Num Enregistrement": "392/ 06 E 219 /06/14", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "COAPROVEL 300MG/12,5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3130.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3130", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COAPROVEL", "Tarif de reference": "1604.96 DA", "PPA": "N/A", "Num Enregistrement": "392/ 06 E 220 /06/14", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "COAPROVEL 300MG/25MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3185.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3185", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COAPROVEL", "Tarif de reference": "1,944.50 DA", "PPA": "1604.00 DA", "Num Enregistrement": "392/ 06 E 256 /08", "Code DCI": "06E256", "Forme": "COMP. PELLI.", "Dosage": "300MG/25MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-ARADEX 150MG/12,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3123.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ARADEX", "Tarif de reference": " N/A", "PPA": "1320.00 DA", "Num Enregistrement": "268/ 06 E 219 /15", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CO-ARADEX 300MG/12,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3131.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ARADEX", "Tarif de reference": " N/A", "PPA": "1719.00 DA", "Num Enregistrement": "268/ 06 E 220 /15", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CO-ARADEX 300MG/25MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3183.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ARADEX", "Tarif de reference": " N/A", "PPA": "1719.00 DA", "Num Enregistrement": "268/ 06 E 256 /15", "Code DCI": "06E256", "Forme": "COMP. PELLI.", "Dosage": "300MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "COARAVEL 150MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COARAVEL", "Tarif de reference": "1544.4 DA", "PPA": "N/A", "Num Enregistrement": "426/ 06 E 219 /13", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-ARBITAN 160MG/12,5MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ARBITAN", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 E 237 /14", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-ARBITAN 160MG/25MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ARBITAN", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 E 238 /14", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-ARBITAN 80MG/12,5MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ARBITAN", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 E 158 /14", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-ATABEK 16MG/12,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3150.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3150", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ATABEK", "Tarif de reference": "1738.8 DA", "PPA": "1738.79 DA", "Num Enregistrement": "447/ 06 E 231 /12", "Code DCI": "06E231", "Forme": "COMP. SEC.", "Dosage": "16MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-ATABEK 8MG/12,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3147.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3147", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ATABEK", "Tarif de reference": "1629.9 DA", "PPA": "1629.89 DA", "Num Enregistrement": "447/ 06 E 230 /12", "Code DCI": "06E230", "Forme": "COMP. SEC.", "Dosage": "8MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-ATABEK 8MG/12,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-ATABEK", "Tarif de reference": "1629,9 DA", "PPA": "N/A", "Code DCI": "06E230", "Forme": "COMP SEC.", "Dosage": "8MG/12.5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COBAMINE 1000\u00b5G/ML SOL. INJ. B/5 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " CYANOCOBALAMINE", "Pays": "ALGERIE", "Nom Commercial": "COBAMINE", "Tarif de reference": "0 DA", "PPA": "220.00 DA", "Num Enregistrement": "003/ 12 E 021/98", "Code DCI": "12E021", "Forme": "SOL. INJ.", "Dosage": "1000\u00b5G/ML", "Conditionnement": "B/5 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "COBEKTAL 100MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3174.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3174", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COBEKTAL", "Tarif de reference": "2190.00 DA", "PPA": "2190.00 DA", "Num Enregistrement": "447/ 06 E 239 /11", "Code DCI": "06E239", "Forme": "COMP. PELLI.", "Dosage": "100MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COBEKTAL 50MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3097.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3097", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COBEKTAL", "Tarif de reference": "2190 DA", "PPA": "2190.00 DA", "Num Enregistrement": "447/ 06 E 167 /11", "Code DCI": "06E167", "Forme": "COMP. PELLI.", "Dosage": "50MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CODEINE BIOTIC LP 28,5MG PELLETS LP EN GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CODEINE PHOSPHATE", "Pays": "ALGERIE", "Nom Commercial": "CODEINE BIOTIC LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 B 215 /11", "Code DCI": "20B215", "Forme": "PELLETS LP", "Dosage": "28,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "CODOFEBRIL 500 MG/30 MG CP EFFERVESCENT SECABLE B/ 01 TUBE DE 16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " API", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CODOFEBRIL", "Tarif de reference": "108.64 DA", "PPA": " DA", "Num Enregistrement": "348/03B027/17", "Code DCI": "03B028", "Forme": "COMP. EFFERV.", "Dosage": "500 MG/30 MG", "Conditionnement": "B/ 01 TUBE DE 16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CODOLIPRANE 400MG/20MG COMP.SEC. B/16 ", "Img": "https://pharmnet-dz.com//img/medics/4163.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4163", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Pays": "FRANCE", "Nom Commercial": "CODOLIPRANE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 03 B 026 /99", "Code DCI": "03B026", "Forme": "COMP. SEC.", "Dosage": "400MG/20MG", "Conditionnement": "B/16 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "COEXPANDOL  400MG/20MG COMP B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COEXPANDOL ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/03B026/16", "Code DCI": "03B026", "Forme": "COMP.", "Dosage": "400MG/20MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-HYSARTAN 50MG/12,5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3098", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-HYSARTAN", "Tarif de reference": "2044 DA", "PPA": "1903.00 DA", "Num Enregistrement": "468/ 06 E 167 /13", "Code DCI": "06E167", "Forme": "COMP. PELLI.", "Dosage": "50MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-IRBEK 150MG/12,5MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3124.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3124", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-IRBEK", "Tarif de reference": "1320 DA", "PPA": "1320 DA", "Num Enregistrement": "447/ 06 E 219 /11", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-IRBEK 300MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3132.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3132", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-IRBEK", "Tarif de reference": "1719.60 DA", "PPA": "1719.60 DA", "Num Enregistrement": "447/ 06 E 220 /11", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-IRBEK 300MG/25MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3186.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3186", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-IRBEK", "Tarif de reference": "1719.60 DA", "PPA": "1719.60 DA", "Num Enregistrement": "447/ 06 E 256 /10", "Code DCI": "06E256", "Forme": "COMP. PELLI.", "Dosage": "300MG/25MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-IRBEVEL 150MG / 12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3125.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-IRBEVEL", "Tarif de reference": "1544.4 DA", "PPA": "N/A", "Num Enregistrement": "263/ 06 E 219 /11", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG / 12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-IRBEVEL 300MG / 12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3133.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-IRBEVEL", "Tarif de reference": "2084.1 DA", "PPA": "N/A", "Num Enregistrement": "263/ 06 E 220 /11", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG / 12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-IRBEVEL 300MG / 25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3184.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-IRBEVEL", "Tarif de reference": "2084.1 DA", "PPA": "N/A", "Num Enregistrement": "263/ 06 E 256 /11", "Code DCI": "06E256", "Forme": "COMP. PELLI.", "Dosage": "300MG / 25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLCHICINE OPOCALCIUM 1MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1402.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1402", "Laboratoire": " GALENIQUES VERNIN", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " COLCHICINE CRISTALISEE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "COLCHICINE OPOCALCIUM", "Tarif de reference": "265.62 DA", "PPA": "N/A", "Num Enregistrement": "466/ 21 B 009 /98/11", "Code DCI": "21B009", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLCHIMED 1MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1403.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1403", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " COLCHICINE CRISTALISEE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COLCHIMED", "Tarif de reference": "203.73 DA", "PPA": "N/A", "Num Enregistrement": "317/ 21 B 009 /14", "Code DCI": "21B009", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLCHIMEX 1MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1404.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " COLCHICINE CRISTALISEE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COLCHIMEX", "Tarif de reference": "0 DA", "PPA": "203.00 DA", "Num Enregistrement": "400/ 21 B 009 /15", "Code DCI": "21B009", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLECALCIFEROL 200 000UI/ML SOL.BUV. B/1AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COLECALCIFEROL (OU VIT.D3)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "COLECALCIFEROL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 14 H 094 /99", "Code DCI": "14H094", "Forme": "SOL. BUV.", "Dosage": "200 000UI/ML", "Conditionnement": "B/1AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLESTOR 40MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1551.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1551", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COLESTOR", "Tarif de reference": "897.6 DA", "PPA": "897.6 DA", "Num Enregistrement": "447/ 06 M 151 /13", "Code DCI": "06M151", "Forme": "GLES.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLESTOR LP 80MG COMP. PELLI. LP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1610.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1610", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COLESTOR LP", "Tarif de reference": "1530.00 DA", "PPA": "1530.00 DA", "Num Enregistrement": "447/ 06 M 236 /15", "Code DCI": "06M236", "Forme": "COMP. PELLI. LP", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-LIPIRINAD 80MG / 12,5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-LIPIRINAD", "Tarif de reference": "2044 DA", "PPA": "N/A", "Num Enregistrement": "468/ 06 E 158 /14", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG / 12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLOCLEAN 59G/5,68G/1,68G/1,64G/0,75G/SACHET PDRE. SOL. BUV. B/04 SACH.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 3350 (POLYETHYLENE GLYCOL 3350) / SULFATE SODIUM ANHYDRE / BICARBONATE SODIUM / CHLORURE SODIUM / CHLORURE POTASSIUM ", "Pays": "ALGERIE", "Nom Commercial": "COLOCLEAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 10 L 163 /07", "Code DCI": "10L163", "Forme": "PDRE. SOL. BUV.", "Dosage": "59G/5,68G/1,68G/1,64G/0,75G/SACHET", "Conditionnement": "B/04 SACH.", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLOSTOP 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/2887.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2887", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "COLOSTOP", "Tarif de reference": "182 DA", "PPA": "181.00 DA", "Num Enregistrement": "462/ 10 F 051 /10", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COLOSTOP 200MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5830", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "COLOSTOP", "Tarif de reference": "273.00 DA", "PPA": " DA", "Code DCI": "10F193", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COMBANTRIN 125MG COMP. B/6", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " PYRANTEL", "Pays": "ALGERIE", "Nom Commercial": "COMBANTRIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "045/ 19 B 010 /98", "Code DCI": "19B010", "Forme": "COMP.", "Dosage": "125MG", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "COMBANTRIN 125MG/2,5ML SIROP FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " PYRANTEL", "Pays": "ALGERIE", "Nom Commercial": "COMBANTRIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "045/ 19 B 011 /99", "Code DCI": "19B011", "Forme": "SIROP", "Dosage": "125MG/2,5ML", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "COMTAN 200MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2486.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2486", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " ENTACAPONE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "COMTAN", "Tarif de reference": "0 DA", "PPA": "3507.00 DA", "Num Enregistrement": "068/ 15 D 077 /07", "Code DCI": "15D077", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE  SOL. BIDON/10L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CHLORURE DE SODIUM / CHLORURE DE POTASSIUM / CHLORURE DE CALCIUM / CHLORURE DE MAGNESIUM / ACIDE ACETIQUE ", "Pays": "ALGERIE", "Nom Commercial": "CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 25 G 048 /04", "Code DCI": "25G048", "Forme": "SOL. DIALYSE", "Conditionnement": "BIDON/10L", "Commercialisation": true, "Remboursable": null}, {"Nom": "CO-NORTA 50MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3099.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3099", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-NORTA", "Tarif de reference": "2190 DA", "PPA": "2190.00 DA", "Num Enregistrement": "317/ 06 E 167 /11", "Code DCI": "06E167", "Forme": "COMP. PELLI.", "Dosage": "50MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-NORTA FORT 100MG/25MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3175.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3175", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-NORTA FORT", "Tarif de reference": "2044 DA", "PPA": "2044.00 DA", "Num Enregistrement": "317/ 06 E 239 /11", "Code DCI": "06E239", "Forme": "COMP. PELLI.", "Dosage": "100MG/25MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CONSIUM 100MG/FL. DE PDRE. PDRE. P. SOL. INJ. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/1089.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " CARMUSTINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CONSIUM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "471/ 05 G 006 /13", "Code DCI": "05G006", "Forme": "PDRE. SOL. INJ.", "Dosage": "100MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "CONSTILAX 10G/SACHET PDRE. SOL. BUV. B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 4000 (POLYETHYLENE GLYCOL)", "Pays": "ALGERIE", "Nom Commercial": "CONSTILAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 L 098 /06", "Code DCI": "10L098", "Forme": "PDRE. SOL. BUV.", "Dosage": "10G/SACHET", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "CONTRACIDE 4MG/8MG/2MG/100ML SUSP. BUV. FL/250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / TRISILICATE DE MAGNESIUM / DIMETICONE", "Pays": "FRANCE", "Nom Commercial": "CONTRACIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 10 B 109 /99/09", "Code DCI": "10B109", "Forme": "SUSP. BUV.", "Dosage": "4MG/8MG/2MG/100ML", "Conditionnement": "FL/250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CONTRAPAQUE 300 I =300MG/ML (647MG/ML) SOL. INJ. B/1FL.DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " UNIQUE PHARMACETICAL ", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOHEXOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CONTRAPAQUE 300", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "276/ 08 C 017 /08", "Code DCI": "08C017", "Forme": "SOL. INJ.", "Dosage": "I =300MG/ML (647MG/ML)", "Conditionnement": "B/1FL.DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CONTRAPAQUE 350 755MG/ML (I =350MG/ML) SOL. INJ. B/1FL.DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " UNIQUE PHARMACETICAL ", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOHEXOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CONTRAPAQUE 350", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "276/ 08 C 018 /08", "Code DCI": "08C018", "Forme": "SOL. INJ.", "Dosage": "755MG/ML (I =350MG/ML)", "Conditionnement": "B/1FL.DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CONVEP 200MG/ML SOL.BUV. FL./60ML + SERINGUE DOSEUSE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " ILADJ PHARMACEUTIQUE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "CONVEP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "430/ 15 A 003 /09", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL./60ML + SERINGUE DOSEUSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "COPARALGAN 400MG/20MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/4164.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Pays": "ALGERIE", "Nom Commercial": "COPARALGAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 026 /09", "Code DCI": "03B026", "Forme": "COMP. SEC.", "Dosage": "400MG/20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COPARAMOL 400MG/20MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/4165.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4165", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Pays": "ALGERIE", "Nom Commercial": "COPARAMOL", "Tarif de reference": "150 DA", "PPA": "N/A", "Num Enregistrement": "231/ 03 B 026 /06", "Code DCI": "03B026", "Forme": "COMP. SEC.", "Dosage": "400MG/20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COPARAMOL FORT 500MG/30MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/4556.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4556", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COPARAMOL FORT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/03B028/16", "Code DCI": "03B028", "Forme": "COMP.", "Dosage": "500MG/30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COPEGUS 200MG COMP. PELLI. B/168", "Img": "https://pharmnet-dz.com//img/medics/441.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=441", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " RIBAVIRINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "COPEGUS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 13 P 281 /09", "Code DCI": "13P281", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/168", "Commercialisation": true, "Remboursable": true}, {"Nom": "COPRALGIR 400MG/20MG COMP SEC B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ELAIA PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Pays": "FRANCE", "Nom Commercial": "COPRALGIR", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "153/ 03 B 026 /04", "Code DCI": "03B026", "Forme": "COMP. SEC.", "Dosage": "400MG/20MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORDARONE 200MG COMP.SEC B/30", "Img": "https://pharmnet-dz.com//img/medics/131.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=131", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CORDARONE", "Tarif de reference": "649.72 DA", "PPA": "N/A", "Num Enregistrement": "255/ 06 D 041 /97", "Code DCI": "06D041", "Forme": "COMP SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORDARONE 50MG/ML (150MG/3ML) SOL.INJ.IV. B/06 AMP. DE 3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=125", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CORDARONE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 06 D 040 /97", "Code DCI": "06D040", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (150MG/3ML)", "Conditionnement": "B/06 AMP. DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORECT  50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORECT ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "263/14A136/16", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORED XL 80MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORED XL", "Tarif de reference": "1800 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 M 236 /12", "Code DCI": "06M236", "Forme": "COMP. PELLI. LP", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORENIPRIL 10MG/25MG COMP. SEC. B/40 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORENIPRIL", "Tarif de reference": "1621.2 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 E 278 /09", "Code DCI": "06E278", "Forme": "COMP.", "Dosage": "10MG/25MG", "Conditionnement": "B/40 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORENIPRIL 5MG/12,5MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORENIPRIL", "Tarif de reference": "1372.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 E 277 /09", "Code DCI": "06E277", "Forme": "COMP.", "Dosage": "5MG/12,5MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-RETA 160MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-RETA", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "317/06E238/16", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-RETA 80MG/12,5MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-RETA", "Tarif de reference": "2044 DA", "PPA": "N/A", "Num Enregistrement": "317/06E158/16", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORONOL 0,3% ( 3mg/ml)  COLLY. EN SOL.  FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORONOL", "Tarif de reference": "161,95 DA", "PPA": "N/A", "Code DCI": "17D157", "Forme": "COLLY.", "Dosage": "0,3% ", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORPRILOR 20MG COMP SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " RUBIO", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "CORPRILOR", "Tarif de reference": "480 DA", "PPA": "N/A", "Num Enregistrement": "107/ 06 E 060 /04", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORPRILOR 5MG COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " RUBIO", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "CORPRILOR", "Tarif de reference": "276 DA", "PPA": "N/A", "Num Enregistrement": "107/ 06 E 059 /04", "Code DCI": "06E059", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORRECTOL 1MG/ML COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2004.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ALCON", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " INOSINE MONOPHOSPHATE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "CORRECTOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 K 071 /97", "Code DCI": "17K071", "Forme": "COLLY.", "Dosage": "1MG/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORSALIC 0,1%/ 5% PDE.DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/519.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=519", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " MOMETASONE FUROATE MONOHYDRATE / ACIDE SALICYLIQUE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "CORSALIC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "386/ 07 H 162 /09", "Code DCI": "07H162", "Forme": "PDE. DERM.", "Dosage": "0,1%/ 5%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": false}, {"Nom": "CORTEN 1%** CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/508.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=508", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "PALESTINE", "Nom Commercial": "CORTEN", "Tarif de reference": "167.77 DA", "PPA": "N/A", "Num Enregistrement": "406/ 07 H 048 /09", "Code DCI": "07H048", "Forme": "CR\u00c8ME", "Dosage": "1%**", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORTIDAL 1MG/ML SOLUTION BUVABLE FL 50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORTIDAL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "318/09H174/16", "Code DCI": "N/D", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL 50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CORTIDERM 0.01 CREME DERM. T/10G", "Img": "https://pharmnet-dz.com//img/medics/509.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=509", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "CORTIDERM", "Tarif de reference": "93.62 DA", "PPA": "N/A", "Num Enregistrement": "190/ 07 H 048 /98", "Code DCI": "07H048", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/10G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORTIMOXAL 400MG/80MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/4609.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORTIMOXAL", "Tarif de reference": "115.2 DA", "PPA": " DA", "Num Enregistrement": "039/13M092/99/16", "Code DCI": "13M092", "Forme": "COMP.", "Dosage": "400MG/80MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORTINOVA 10MG COMP. B/25", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CORTINOVA", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "013/ 09 H 028 /99", "Code DCI": "09H028", "Forme": "COMP SEC.", "Dosage": "10MG", "Conditionnement": "B/25", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORTIPRED 20MG COMP. EFFERV. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " API", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORTIPRED", "Tarif de reference": "392 DA", "PPA": "487.00 DA", "Num Enregistrement": "348/ 09 H 035 /11", "Code DCI": "09H035", "Forme": "COMP. EFFERV.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORTISAF 0.001 CREME DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " MOMETASONE (SOUS FORME DE FUROATE)**", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "CORTISAF", "Tarif de reference": " N/A", "PPA": "507.00 DA", "Num Enregistrement": "386/ 07 H 160 /09", "Code DCI": "07H160", "Forme": "CR\u00c8ME", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CORTISAF 0.001 PDE. DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/518.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=518", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " MOMETASONE (SOUS FORME DE FUROATE)**", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "CORTISAF", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "386/ 07 H 161 /09", "Code DCI": "07H161", "Forme": "PDE. DERM.", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": false}, {"Nom": "CORTOP 500MG PDRE. SOL. INJ  B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROCORTISONE HEMISUCCINATE ", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CORTOP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "084/ 09 H 027 /04", "Code DCI": "09H027", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": null}, {"Nom": "CORTORAL 4MG COMP. B/24 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIAMCINOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORTORAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 09 H 040 /97", "Code DCI": "09H040", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/24 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORVASAL 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/93.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORVASAL", "Tarif de reference": "266.5 DA", "PPA": "N/A", "Num Enregistrement": "428/ 06 C 022 /97/11", "Code DCI": "06C022", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORVASAL 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/100.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=100", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CORVASAL", "Tarif de reference": "492.22 DA", "PPA": "N/A", "Num Enregistrement": "428/ 06 C 023 /97/11", "Code DCI": "06C023", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CORZEM 60MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "CORZEM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "174/ 06 B 009 /99", "Code DCI": "06B009", "Forme": "COMP.", "Dosage": "60MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COSARCAND 16MG/12,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3151.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COSARCAND", "Tarif de reference": "1738.8 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 E 231 /14", "Code DCI": "06E231", "Forme": "COMP. SEC.", "Dosage": "16MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COSARTEG 160MG/12,5MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/3161.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COSARTEG", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 E 237 /10", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COSARTEG 80MG/12,5MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/3077.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COSARTEG", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 E 158 /10", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COSMOFER 50MG/ML ** (OU 100MG/2ML) DE FER FERRIQUE SOL. INJ.IM/IV OU PERF. B/5AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " PHARMACOSMOS A/S", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE", "Pays": "DANEMARK", "Nom Commercial": "COSMOFER", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "438/ 12 E 077 /09 ", "Code DCI": "12E077", "Forme": "SOL. INJ.", "Dosage": "50MG/ML ** (OU 100MG/2ML) DE FER FERRIQUE", "Conditionnement": "B/5AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "COSOPT 20MG/5MG/ML COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2366.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2366", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "COSOPT", "Tarif de reference": "919.1 DA", "PPA": "N/A", "Num Enregistrement": "024/ 17 C 141 /06/15", "Code DCI": "17C141", "Forme": "COLLY. SOL.", "Dosage": "20MG/5MG/ML", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "COSOTIMOL 20MG/5MG/ML COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COSOTIMOL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "380/17C141/16", "Code DCI": "17C141", "Forme": "COLLY. SOL.", "Dosage": "20MG/5MG/ML", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "COTAREG 160MG / 12,5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/4380.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4380", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "COTAREG", "Tarif de reference": "2044 DA", "PPA": " DA", "Num Enregistrement": "068/06E237/07", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG / 12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "COTAREG 80MG/12,5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3078", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "COTAREG", "Tarif de reference": " N/A", "PPA": "2095.00 DA", "Num Enregistrement": "068/ 06 E 158 /01/09", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "CO-TENSOPREL 50MG/25MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/187.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-TENSOPREL", "Tarif de reference": "502.2 DA", "PPA": "408.00 DA", "Num Enregistrement": "268/ 06 E 137 /14", "Code DCI": "06E137", "Forme": "COMP. SEC.", "Dosage": "50MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COTRIM 200MG/40MG/5ML SUSP.BUV. F/100ML", "Img": "https://pharmnet-dz.com//img/medics/401.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=401", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COTRIM", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "242/ 13 M 090 /05", "Code DCI": "13M090", "Forme": "SUSP. BUV.", "Dosage": "200MG/40MG/5ML", "Conditionnement": "F/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "COTRIMOXAL FORTE 800MG/160MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COTRIMOXAL FORTE", "Tarif de reference": "115.2 DA", "PPA": "N/A", "Num Enregistrement": "039/ 13 M 169 /12", "Code DCI": "13M169", "Forme": "COMP SEC.", "Dosage": "800MG/160MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COTRIMOXAZOLE 200MG/40MG/5ML SUSP.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COTRIMOXAZOLE", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "088/ 13 M 090 /02", "Code DCI": "13M090", "Forme": "SUSP. BUV.", "Dosage": "200MG/40MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-VALEX 160MG/12,5MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medics/3162.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-VALEX", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "268/ 06 E 237/14", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-VALEX 160MG/25MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medics/3170.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-VALEX", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "268/ 06 E 238/14", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-VALEX 80MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3079.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-VALEX", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "268/ 06 E 158/14", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CO-VALSARTAN IVAL 160MG / 25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CO-VALSARTAN IVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 238 /14", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG / 25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "COVERSYL 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3217.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3217", "Laboratoire": " SERVIER", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL ARGININE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "COVERSYL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "040/ 06 E 284 /09", "Code DCI": "06E284", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COVERSYL 5MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3216.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3216", "Laboratoire": " SERVIER", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL ARGININE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "COVERSYL", "Tarif de reference": "0 DA", "PPA": "812.00 DA", "Num Enregistrement": "040/ 06 E 283 /09", "Code DCI": "06E283", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COVESTAG 160MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COVESTAG", "Tarif de reference": "2190 DA", "PPA": "2106.00 DA", "Num Enregistrement": "470/ 06 E 237 /12", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COVESTAG 80MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COVESTAG", "Tarif de reference": "2190 DA", "PPA": "1850.00 DA", "Num Enregistrement": "470/ 06 E 158 /12", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "COXIBREX 100MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2817.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COXIBREX", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "289/ 04 B 035 /12", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "COXIBREX 200MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medics/2828.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COXIBREX", "Tarif de reference": "455.5 DA", "PPA": "455.00 DA", "Num Enregistrement": "289/ 04 B 036 /12", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "COZAAR 100MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MSD FRANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "COZAAR", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "06E240", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "COZAAR 50MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MSD FRANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "COZAAR", "Tarif de reference": "- DA", "PPA": "N/A", "Code DCI": "06E126", "Forme": "COMP SEC.", "Dosage": "50MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "COZIBRAT 150MG/12,5MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COZIBRAT", "Tarif de reference": "1544.4 DA", "PPA": "1221.00 DA", "Num Enregistrement": "470/ 06 E 219 /12", "Code DCI": "06E219", "Forme": "COMP. PELLI.", "Dosage": "150MG/12,5MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "COZIBRAT 300MG/12,5MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "COZIBRAT", "Tarif de reference": "2084.1 DA", "PPA": "1690.00 DA", "Num Enregistrement": "470/ 06 E 220 /12", "Code DCI": "06E220", "Forme": "COMP. PELLI.", "Dosage": "300MG/12,5MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CREON 12 000 UI GLES. B/60 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " ENZYMES DIGESTIVES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " POUDRE DE PANCREAS", "Pays": "FRANCE", "Nom Commercial": "CREON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "031/ 10 K 060 /98", "Code DCI": "10K060", "Forme": "GLES.", "Dosage": "12 000 UI", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "CRESOVAST 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CRESOVAST", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06M269", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CRESOVAST 20MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medics/1616.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CRESOVAST", "Tarif de reference": " N/A", "PPA": "1247.00 DA", "Num Enregistrement": "352/ 06 M 270 /14", "Code DCI": "06M270", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRESTATINE 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CRESTATINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/06M269/16", "Code DCI": "06M269", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRESTATINE 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CRESTATINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/06M270/16", "Code DCI": "06M270", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRESTOR 10MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1614.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1614", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CRESTOR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 06 M 269 /08", "Code DCI": "06M269", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CRESTOR 20MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1617.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1617", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CRESTOR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 06 M 270 /09", "Code DCI": "06M270", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CRESTOR 5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1625.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1625", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CRESTOR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 06 M 296 /12", "Code DCI": "06M296", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CROFENON 300MG COMP. ENRO.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPAFENONE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROFENON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 06 D 048 /99/10", "Code DCI": "06D048", "Forme": "COMP. ENRO.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROFURIL 344 MG/100 ML SUSP.BUV. FL/250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " NITROFURANES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FURAZOLIDONE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "CROFURIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 13 L 089 /98/07", "Code DCI": "13L089", "Forme": "SUSP. BUV.", "Dosage": "344 MG/100 ML", "Conditionnement": "FL/250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROMETRINE 0,25MG/ML SOL.BUV.GTTES. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROMETRINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 11 C 012 /98", "Code DCI": "11C012", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,25MG/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CROMIVAL 500MG SUPPO. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "CROMIVAL", "Tarif de reference": "156 DA", "PPA": "N/A", "Num Enregistrement": "012/ 04 B 012 /98", "Code DCI": "04B012", "Forme": "SUPPO.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "CROMIZOLE 1G% CREME.DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOTRIMAZOLE", "Pays": "ITALIE", "Nom Commercial": "CROMIZOLE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 07 D 024 /99", "Code DCI": "07D024", "Forme": "CR\u00c8ME", "Dosage": "1G%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CRONIDINE 0,15MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLONIDINE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "CRONIDINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 06 E 056 /98/14", "Code DCI": "06E056", "Forme": "COMP.", "Dosage": "0,15MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRONIL 10MG DRG. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CRONIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 16 A 005 /96/09", "Code DCI": "16A005", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRONIL 25MG DRG. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CRONIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 16 A 006 /96/09", "Code DCI": "16A006", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRONIL 75MG DRG. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CRONIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 16 A 007 /96/09", "Code DCI": "16A007", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRONOLONE 0.001 PDE.OPHT. B/1T. DE 5G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TRIAMCINOLONE ACETONIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CRONOLONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 G 054 /98/13", "Code DCI": "17G054", "Forme": "PDE. OPHT.", "Dosage": "0.001", "Conditionnement": "B/1T. DE 5G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRONOLONE 1MG COMP. B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIAMCINOLONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CRONOLONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 09 H 039 /98/10", "Code DCI": "09H039", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRONOLONE 4MG COMP. B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIAMCINOLONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CRONOLONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 09 H 040 /98/07", "Code DCI": "09H040", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": null}, {"Nom": "CRONOLONE-NEO 0,35 %** / 0,1 %** PDE.OPHT. B/1T. DE 3G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NEOMYCINE (SULFATE)** / TRIAMCINOLONE (ACETONIDE)**", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CRONOLONE-NEO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 D 028 /98/13", "Code DCI": "17D028", "Forme": "PDE. OPHT.", "Dosage": "0,35 %** / 0,1 %**", "Conditionnement": "B/1T. DE 3G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROPHENICOL 0.004 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CHLORAMPHENICOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROPHENICOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 17 D 015 /98", "Code DCI": "17D015", "Forme": "COLLY.", "Dosage": "0.004", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CROPHENICOL 0.01 PDE.OPHT. T/5G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CHLORAMPHENICOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROPHENICOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 D 016 /99/10", "Code DCI": "17D016", "Forme": "PDE. OPHT.", "Dosage": "0.01", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROPINE 0.0025 COLLY. FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROPINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 17 H 055 /98", "Code DCI": "17H055", "Forme": "COLLY.", "Dosage": "0.0025", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CROPINE 0.005 COLLY. FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROPINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 H 057 /99/13", "Code DCI": "17H057", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROPINE 0.01 COLLY. FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ATROPINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROPINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 H 058 /99/13", "Code DCI": "17H058", "Forme": "COLLY.", "Dosage": "0.01", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROSULCAF 10 % / 0,5% COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " SULFACETAMIDE / CHLORAMPHENICOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROSULCAF", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 17 D 035 /99", "Code DCI": "17D035", "Forme": "COLLY.", "Dosage": "10 % / 0,5%", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CROTIAZIDE 5MG**/50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMILORIDE (SOUS FORME DE CHLORHYDRATE)**/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROTIAZIDE", "Tarif de reference": "205.5 DA", "PPA": "N/A", "Num Enregistrement": "012/ 06 H 094 /98", "Code DCI": "06H094", "Forme": "COMP.", "Dosage": "5MG**/50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CROTIROXINE 100\u00b5G COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " HORMONES THYROIDIENNES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LEVOTHYROXINE  SODIQUE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "CROTIROXINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 09 K 057 /98/10", "Code DCI": "09K057", "Forme": "COMP. SEC.", "Dosage": "100\u00b5G", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROTIROXINE 50\u00b5G COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " HORMONES THYROIDIENNES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LEVOTHYROXINE  SODIQUE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "CROTIROXINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 09 K 056 /98/10", "Code DCI": "09K056", "Forme": "COMP. SEC.", "Dosage": "50\u00b5G", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROVIFENE 50MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " INDUCTEURS DE L'OVULATION", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CLOMIFENE CITRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROVIFENE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 09 L 058 /98/14", "Code DCI": "09L058", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROVIMAZOLE 5MG COMP. SEC. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " ANTI-THYROIDIENS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CARBIMAZOLE", "Pays": "ITALIE", "Nom Commercial": "CROVIMAZOLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 09 E 007 /98/13", "Code DCI": "09E007", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROXIZINE 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROXIZINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 16 B 041 /98/09", "Code DCI": "16B041", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CROXIZINE 25MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "CROXIZINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 16 B 040 /98/09", "Code DCI": "16B040", "Forme": "COMP.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CURACNE  5MG  5MG CAPS. MOLLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CURACNE  5MG ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "07L144", "Forme": "CAPS. MOLLE", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CURACNE 10MG CAPS. MOLLES B/30", "Img": "https://pharmnet-dz.com//img/medics/528.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=528", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CURACNE", "Tarif de reference": "1167.9 DA", "PPA": "2477.00 DA", "Num Enregistrement": "186/ 07 L 058 /06", "Code DCI": "07L058", "Forme": "CAPS. MOLLE", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CURACNE 20MG CAPS. MOLLES B/30", "Img": "https://pharmnet-dz.com//img/medics/531.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=531", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CURACNE", "Tarif de reference": "2022 DA", "PPA": " DA", "Num Enregistrement": "186/ 07 L 059 /06", "Code DCI": "07L059", "Forme": "CAPS. MOLLE", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CURACNE 5MG CAPS. MOLLES B/30", "Img": "https://pharmnet-dz.com//img/medics/537.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=537", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CURACNE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "186/ 07 L 144 /06", "Code DCI": "07L144", "Forme": "CAPS. MOLLE", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CURAM 250MG/62,5MG/5ML PDRE.SUSP.BUV FL/60ML", "Img": "https://pharmnet-dz.com//img/medics/246.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "CURAM", "Tarif de reference": "349.8 DA", "PPA": " DA", "Num Enregistrement": "080/ 13 G 051 /99", "Code DCI": "13G051", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/62,5MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "CURAM 500MG/125MG COMP.ENRO. B/12", "Img": "https://pharmnet-dz.com//img/medics/239.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "CURAM", "Tarif de reference": "392.64 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 G 050 /99", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "CUTACNYL 0.025 GEL. DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1663", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CUTACNYL", "Tarif de reference": "0 DA", "PPA": "216.00 DA", "Num Enregistrement": "123/ 07 B 113 /00/14", "Code DCI": "07B113", "Forme": "GEL. DERM.", "Dosage": "0.025", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CUTACNYL 0.05 GEL.DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1648.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1648", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CUTACNYL", "Tarif de reference": "150 DA", "PPA": "N/A", "Num Enregistrement": "123/ 07 B 013 /98/14", "Code DCI": "07B013", "Forme": "GEL. DERM.", "Dosage": "0.05", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CUTACNYL 0.1 GEL. DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1651.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1651", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "CUTACNYL", "Tarif de reference": "162.8 DA", "PPA": "N/A", "Num Enregistrement": "123/ 07 B 014 /98/14", "Code DCI": "07B014", "Forme": "GEL. DERM.", "Dosage": "0.1", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYACETINE 60MG GLES. A MICROGRANULES GASTRO-RESIST. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CYACETINE", "Tarif de reference": "390.9 DA", "PPA": "2573.00 DA", "Num Enregistrement": "035/ 16 A 107 /15", "Code DCI": "16A107", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "60MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYANOCOBAL 500 \u00b5G/ML (OU 1000\u00b5G/2ML) SOL.INJ. B/5AMP.DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " CYANOCOBALAMINE (OU VIT.B12)", "Pays": "ALGERIE", "Nom Commercial": "CYANOCOBAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 12 E 142 /97/08", "Code DCI": "12E142", "Forme": "SOL. INJ.", "Dosage": "500 \u00b5G/ML (OU 1000\u00b5G/2ML)", "Conditionnement": "B/5AMP.DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYCLADOL 20MG  (COMPLEXE PIROXICAM BETA CYCLODEXTRINE 191,2MG) COMP. EFFERV. B/14", "Img": "https://pharmnet-dz.com//img/medics/938.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=938", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM  (SOUS FORME COMPLEXE PIROXICAM BETA CYCLODEXTRINE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "CYCLADOL", "Tarif de reference": "200.2 DA", "PPA": "409.00 DA", "Num Enregistrement": "092/ 04 B 054 /07", "Code DCI": "04B054", "Forme": "COMP. EFFERV.", "Dosage": "20MG  (COMPLEXE PIROXICAM BETA CYCLODEXTRINE 191,2MG)", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYCLADOL 20MG COMP. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMETIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CYCLADOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "360/ 04 B 022 /06/13", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYCLO 3 1,6G/2G/100G CREME T./40G", "Img": "https://pharmnet-dz.com//img/medics/1533.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1533", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " EXTRAIT SEC DE RUSCUS ACULEATUS / EXTRAIT FLUIDE DE MELILOT", "Pays": "FRANCE", "Nom Commercial": "CYCLO 3", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 06 K 281 /09", "Code DCI": "06K281", "Forme": "CR\u00c8ME", "Dosage": "1,6G/2G/100G", "Conditionnement": "T./40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYCLO 3 FORT 150MG/150MG/100MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1524.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1524", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RUSCUS/HESPERIDINE METHYLCHALCONE/ACIDE ASCORBIQUE", "Pays": "FRANCE", "Nom Commercial": "CYCLO 3 FORT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "099/ 06 K 109 /98", "Code DCI": "06K109", "Forme": "GLES.", "Dosage": "150MG/150MG/100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "CYMBALTA 30MG GLES. GASTRO-RESIST. B/28", "Img": "https://pharmnet-dz.com//img/medics/2568.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2568", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "CYMBALTA", "Tarif de reference": "0 DA", "PPA": "2337.00 DA", "Num Enregistrement": "034/ 16 A 106 /07/15", "Code DCI": "16A106", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "30MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYMBALTA 60MG GLES. GASTRO-RESIST. B/28", "Img": "https://pharmnet-dz.com//img/medics/2572.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2572", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "CYMBALTA", "Tarif de reference": "0 DA", "PPA": "3589.00 DA", "Num Enregistrement": "034/ 16 A 107 /07/15", "Code DCI": "16A107", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "60MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYMOXETINE   60MG  MICRO-GRANUL. EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/5941.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " OXYMETAZOLINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CYMOXETINE", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "16A107", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "60MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYMOXETINE  30MG GELULE GASTRO RESISTANTE B/30", "Img": "https://pharmnet-dz.com//img/medics/5940.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "CYMOXETINE ", "Tarif de reference": "-- DA", "PPA": " DA", "Code DCI": "16A106", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYPRODINE 4MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " API", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Pays": "ALGERIE", "Nom Commercial": "CYPRODINE", "Tarif de reference": " N/A", "PPA": "115.00 DA", "Num Enregistrement": "348/ 14 F 025 /07", "Code DCI": "14F025", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYTOCARB 10MG /ML (OU  150MG/15ML  -  450MG/45ML) SOL.INJ PERF B/FL/15ML  ET B/1FL/45ML ", "Img": "https://pharmnet-dz.com//img/medics/1006.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CARBOPLATINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CYTOCARB", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 086 /03", "Code DCI": "05A086", "Forme": "SOL. INJ.", "Dosage": "10MG /ML (OU  150MG/15ML  -  450MG/45ML)", "Conditionnement": "B/FL/15ML  ET B/1FL/45ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYTOCRISTIN 1MG/ML SOL INJ  B/1FL/1ML", "Img": "https://pharmnet-dz.com//img/medics/991.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " VINCRISTINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CYTOCRISTIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 039 /03", "Code DCI": "05A039", "Forme": "SOL. INJ.", "Dosage": "1MG/ML", "Conditionnement": "B/1FL/1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYTOMID 250MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/595.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " FLUTAMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CYTOMID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 09 A 072 /08", "Code DCI": "09A072", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYTOPLATIN-10 0,5MG/ML (OU 10MG/20ML) SOL. INJ. POUR PERF.  B/1FL. 20ML", "Img": "https://pharmnet-dz.com//img/medics/1015.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CISPLATINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CYTOPLATIN-10", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 110 /05", "Code DCI": "05A110", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML (OU 10MG/20ML)", "Conditionnement": "B/1FL. 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYTOPLATIN-50 1MG/ML (OU 50MG/50ML) SOL. INJ. POUR PERF.  B/1FL 50ML", "Img": "https://pharmnet-dz.com//img/medics/1016.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CISPLATINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CYTOPLATIN-50", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 111 /05", "Code DCI": "05A111", "Forme": "SOL. INJ.", "Dosage": "1MG/ML (OU 50MG/50ML)", "Conditionnement": "B/1FL 50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "CYTOTAM 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TAMOXIFENE CITRATE EXPRIME EN TAMOXIFENE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CYTOTAM", "Tarif de reference": "645.6 DA", "PPA": "N/A", "Num Enregistrement": "182 / 05 E 136 /09", "Code DCI": "05E136", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "CYTOTREX 2,5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/990.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "CYTOTREX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 032 /08", "Code DCI": "05A032", "Forme": "COMP.", "Dosage": "2,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}], "D": [{"Nom": "DACRYOSERUM 1,8%/1,2% SOL.LAVAGE OPHT. FL/150 ML ET B/20RECIPIENTS UNIDOSES DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " MC NEIL ", "C.Pharmacologique": " ANTISEPTIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACIDE BORIQUE/BORATE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "DACRYOSERUM", "Tarif de reference": " N/A", "PPA": "237.00 DA", "Num Enregistrement": "179/ 17 E 037 /98/08", "Code DCI": "17E037", "Forme": "COLLY.", "Dosage": "1,8%/1,2%", "Conditionnement": "FL/150 ML ET B/20RECIPIENTS UNIDOSES DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DAD MOUTH WASH 0,1% SOL.BAIN.BOUCHE FL/200 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " HEXETIDINE", "Pays": "JORDANIE", "Nom Commercial": "DAD MOUTH WASH", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 23 B 012 /98", "Code DCI": "23B012", "Forme": "SOL. BAIN BOUCHE", "Dosage": "0,1%", "Conditionnement": "FL/200 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DADCROME 0.02 COLLY. F/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CROMOGLYCATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DADCROME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "272/ 17 B 003 /98/09", "Code DCI": "17B003", "Forme": "COLLY. SOL.", "Dosage": "0.02", "Conditionnement": "F/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DADCROME 0.02 SOL.NAS. F/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " IMMUNOTHERAPIE & ANTI-ALLERGIQUES", "C.Therapeutique": " RHINOLOGIE", "Info": " CROMOGLYCATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DADCROME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "272/ 22 C 006 /98/09", "Code DCI": "22C006", "Forme": "SOL. NAS.", "Dosage": "0.02", "Conditionnement": "F/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DAFALGAN CODEINE 500MG/30MG COMP .PELLI. B/16 ", "Img": "https://pharmnet-dz.com//img/medics/4167.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4167", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Pays": "FRANCE", "Nom Commercial": "DAFALGAN CODEINE", "Tarif de reference": "127.51 DA", "PPA": "N/A", "Num Enregistrement": "017/ 03 B 028 /99", "Code DCI": "03B028", "Forme": "COMP. PELLI.", "Dosage": "500MG/30MG", "Conditionnement": "B/16 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAFLON 300MG (150MG EN DIOSMINE ET 150MG EN HESPERIDINE) COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SERVIER", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "FRANCE", "Nom Commercial": "DAFLON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "040/ 06 K 108 /97", "Code DCI": "06K108", "Forme": "COMP.", "Dosage": "300MG (150MG EN DIOSMINE ET 150MG EN HESPERIDINE)", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DAFLON 500MG (450MG EN DIOSMINE ET 50MG EN FLAVONOIDES EXPRIMES EN HESPERIDINE) COMP. ENRO. B/15  ET  B/30 ", "Img": "https://pharmnet-dz.com//img/medics/1530.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1530", "Laboratoire": " SERVIER", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FRACTION FLAVONOIQUE PURIFIEE MICRONISEE (SOIT EN DIOSMINE ET FLAVONOIDES EXPRIMES EN  HESPERIDINE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DAFLON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "040/ 06 K 199 /04", "Code DCI": "06K199", "Forme": "COMP. ENRO.", "Dosage": "500MG (450MG EN DIOSMINE ET 50MG EN FLAVONOIDES EXPRIMES EN HESPERIDINE)", "Conditionnement": "B/15  ET  B/30 ", "Commercialisation": true, "Remboursable": false}, {"Nom": "DAGHTAN 100 100MG COMP PELL SEC  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " TAPHCO SPA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATENOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DAGHTAN 100", "Tarif de reference": "317,40 DA", "PPA": "N/A", "Code DCI": "06F069", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAGHTAN 50 50MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " TAPHCO SPA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATENOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DAGHTAN 50", "Tarif de reference": "245,4 DA", "PPA": "N/A", "Code DCI": "06F149", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAIVOBET 50\u00b5G/0,5MG/G PDE. T/60G", "Img": "https://pharmnet-dz.com//img/medics/568.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=568", "Laboratoire": " LEO", "C.Pharmacologique": " DERMATOLOGIE", "C.Therapeutique": " CALCIPOTRIOL HYDRATE EXPRIME EN CALCIPOTRIOL / BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "DAIVOBET", "Tarif de reference": "4443.5 DA", "PPA": "N/A", "Num Enregistrement": "083/ 07 S 152 /08/15", "Code DCI": "07S152", "Forme": "PDE. DERM.", "Dosage": "50\u00b5G/0,5MG/G", "Conditionnement": "T/60G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAIVONEX 50\u00b5G/G CREME DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/534.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=534", "Laboratoire": " LEO", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " CALCIPOTRIOL", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DAIVONEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "083/ 07 L 106 /01", "Code DCI": "07L106", "Forme": "CR\u00c8ME", "Dosage": "50\u00b5G/G", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAIVONEX 50\u00b5G/G LOTION FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=535", "Laboratoire": " LEO", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " CALCIPOTRIOL", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DAIVONEX", "Tarif de reference": "0 DA", "PPA": "1306.00 DA", "Num Enregistrement": "083/ 07 L 107 /01", "Code DCI": "07L107", "Forme": "LOTION", "Dosage": "50\u00b5G/G", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAIVONEX 50\u00b5G/G PDE. DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/533.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=533", "Laboratoire": " LEO", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " CALCIPOTRIOL", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DAIVONEX", "Tarif de reference": "1332.11 DA", "PPA": "N/A", "Num Enregistrement": "083/ 07 L 099 /98", "Code DCI": "07L099", "Forme": "PDE. DERM.", "Dosage": "50\u00b5G/G", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAKIN COOPER STABILISE  0,5% DE CHLORE ACTIF SOL. USAGE EXTERNE FL./250ML", "Img": "https://pharmnet-dz.com//img/medics/1240.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1240", "Laboratoire": " COOPER  France", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " HYPOCHLORITE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "DAKIN COOPER STABILISE ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "419/ 26 B 014 /08", "Code DCI": "26B014", "Forme": "SOL. EXTERNE", "Dosage": "0,5% DE CHLORE ACTIF", "Conditionnement": "FL./250ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAKIN RPP 0,5% DE CHLORE ACTIF SOL. USAGE EXTERNE FL/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RIADH PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " HYPOCHLORITE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "DAKIN RPP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "314/ 26 B 014 /04", "Code DCI": "26B014", "Forme": "SOL. EXTERNE", "Dosage": "0,5% DE CHLORE ACTIF", "Conditionnement": "FL/500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DAKTARIN 2G% GEL BUCCAL T/40G", "Img": "https://pharmnet-dz.com//img/medics/1142.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1142", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " N/D", "C.Therapeutique": " STOMATOLOGIE", "Info": " MICONAZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DAKTARIN", "Tarif de reference": "0 DA", "PPA": "468.00 DA", "Num Enregistrement": "095/ 23 D 037 /06", "Code DCI": "23D037", "Forme": "GEL", "Dosage": "2G%", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAKTAZOL 2G% GEL BUCCAL T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " STOMATOLOGIE", "Info": " MICONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DAKTAZOL", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "23D037", "Forme": "GEL", "Dosage": "2G%", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DALVEX 100MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DALVEX", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "14A342", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DANATROL 200MG GLES BT/100", "Img": "https://pharmnet-dz.com//img/medics/613.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=613", "Laboratoire": " SANOFI WINTHROP", "C.Pharmacologique": " ANTI-GONADOTROPES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DANAZOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DANATROL", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "255/ 09 C 005 /98", "Code DCI": "09C005", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "BT/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "DANDREX 0.02 SHAMPOING FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/472.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=472", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "PALESTINE", "Nom Commercial": "DANDREX", "Tarif de reference": "458 DA", "PPA": " DA", "Num Enregistrement": "406/ 07 D 141 /13", "Code DCI": "07D141", "Forme": "SHAMPOING", "Dosage": "0.02", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAONIL 5MG COMP SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3612.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3612", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DAONIL", "Tarif de reference": "37 DA", "PPA": " DA", "Num Enregistrement": "253/ 14 A 003 /98", "Code DCI": "14A003", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAROXIME 125MG COMP. FL./10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME AXETIL EXPRIME EN CEFUROXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "DAROXIME", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 B 207 /08", "Code DCI": "13B207", "Forme": "COMP.", "Dosage": "125MG", "Conditionnement": "FL./10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAROXIME 250MG COMP. PILULIER/14", "Img": "https://pharmnet-dz.com//img/medics/709.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=709", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME ", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "DAROXIME", "Tarif de reference": "555.66 DA", "PPA": "N/A", "Num Enregistrement": "055/ 13 B 208 /08/15", "Code DCI": "13B208", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "PILULIER/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "DARTIX 5MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DARTIX", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DAUNOTEC 20MG/FL. DE LYOPHILISAT LYOPHILISAT ET SOLVANT POUR SOL. INJ. B/01 FL. DE LYOPHILISAT + 01 FL. DE 10ML DE SOLVANT (NACL 0,9%)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DAUNORUBICINE CHLORHYDRATE EXPRIME EN DAUNORUBICINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "DAUNOTEC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 014 /14", "Code DCI": "05G014", "Forme": "LYOPH. SOL. INJ.", "Dosage": "20MG/FL. DE LYOPHILISAT", "Conditionnement": "B/01 FL. DE LYOPHILISAT + 01 FL. DE 10ML DE SOLVANT (NACL 0,9%)", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEBRICALM  100MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DEBRICALM ", "Tarif de reference": "128.4 DA", "PPA": "N/A", "Num Enregistrement": "366/10F095/16", "Code DCI": "10F095", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEBRIDAT 0,7870G POUR 100G  PDRE. SUSP. BUV. (EN FLACON) FL/250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2896", "Laboratoire": " PFIZER", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DEBRIDAT", "Tarif de reference": "301.29 DA", "PPA": "N/A", "Num Enregistrement": "045/ 10 F 052 /97", "Code DCI": "10F052", "Forme": "PDRE. SUSP. BUV.", "Dosage": "0,7870G POUR 100G ", "Conditionnement": "FL/250ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEBRIDAT 100MG COMP.PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2888.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2888", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DEBRIDAT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 10 F 051 /97/09", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEBRIDAT 200MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2910.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2910", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DEBRIDAT", "Tarif de reference": "273 DA", "PPA": " DA", "Num Enregistrement": "045/ 10 F 193 /10", "Code DCI": "10F193", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEBRITINE 0,787G/100G (4,8MG/ML) GRLES. P. SUSP. BUV. (EN FLACON) B/1FL. DE 250ML DE SUSP. BUV. APRES RECONST.", "Img": "https://pharmnet-dz.com//img/medics/2897.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DEBRITINE", "Tarif de reference": "0 DA", "PPA": "328.00 DA", "Num Enregistrement": "380/ 10 F 052 /12", "Code DCI": "10F052", "Forme": "PDRE. SUSP. BUV.", "Dosage": "0,787G/100G (4,8MG/ML)", "Conditionnement": "B/1FL. DE 250ML DE SUSP. BUV. APRES RECONST.", "Commercialisation": true, "Remboursable": true}, {"Nom": "DECA-DURABOLIN 50MG/ML SOL INJ HUILEUSE IM B/1AMP DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/621.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ORGANON", "C.Pharmacologique": " ANABOLISANTS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " NANDROLONE DECANOATE", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "DECA-DURABOLIN", "Tarif de reference": "0 DA", "PPA": "264.00 DA", "Num Enregistrement": "005/ 09 F 082 /03", "Code DCI": "09F082", "Forme": "SOL. INJ.", "Dosage": "50MG/ML", "Conditionnement": "B/1AMP DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DECAPEPTYL  L.P. 11,25MG/FL. DE PDRE. PDRE. ET SOLVT. P.SUSP. INJ. IM LP SUR 03MOIS B/01FL. DE PDRE + 01AMP. DE DE 2ML DE SOLVT. + SERINGUE + 02 AIGUILLES", "Img": "https://pharmnet-dz.com//img/medics/1073.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1073", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " TRIPTORELINE PAMOATE EXPRIME EN TRIPTORELINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DECAPEPTYL  L.P.", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "020/ 05 E 140 /06/15", "Code DCI": "05E140", "Forme": "PDRE. SOL. INJ.", "Dosage": "11,25MG/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE + 01AMP. DE DE 2ML DE SOLVT. + SERINGUE + 02 AIGUILLES", "Commercialisation": true, "Remboursable": true}, {"Nom": "DECAPEPTYL 0,1MG/ML PDRE.ET SOLV. POUR SOL.INJ. SC B/ 7FL. DE LYOPH. + 7AMP. SOLV. 01ML", "Img": "https://pharmnet-dz.com//img/medics/3787.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3787", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIPTORELINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DECAPEPTYL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "020/ 09 J 052 /99/15", "Code DCI": "09J052", "Forme": "PDRE. SOL. INJ.", "Dosage": "0,1MG/ML", "Conditionnement": "B/ 7FL. DE LYOPH. + 7AMP. SOLV. 01ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DECAPEPTYL LP 3,75MG 3,75MG PDRE. ET SOLV. P. SUSP.INJ. IM FORME LP SUR 28JOURS B/01FL. DE PDRE. + 01 AMP. DE SOLV. (MANNITOL) DE 2ML + 02 AIGUILLES + 01 SERINGUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3788", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIPTORELINE ACETATE EXPRIME EN TRIPTORELINE", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "DECAPEPTYL LP 3,75MG", "Tarif de reference": " N/A", "PPA": "13681.00 DA", "Num Enregistrement": "020/ 09 J 053 /97/15", "Code DCI": "09J053", "Forme": "PDRE. SOL. INJ.", "Dosage": "3,75MG", "Conditionnement": "B/01FL. DE PDRE. + 01 AMP. DE SOLV. (MANNITOL) DE 2ML + 02 AIGUILLES + 01 SERINGUE", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEDROGYL 5\u00b5G/GTTE. SOL. BUV GTTES FL./10ML", "Img": "https://pharmnet-dz.com//img/medics/3420.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3420", "Laboratoire": " DESMA PHARMA", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIFEDIOL", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DEDROGYL", "Tarif de reference": "0 DA", "PPA": "665.00 DA", "Num Enregistrement": "351/ 14 H 092 /97", "Code DCI": "14H092", "Forme": "SOL. BUV. GTTES.", "Dosage": "5\u00b5G/GTTE.", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEFEROX 125MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEFEROX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 24 D 017 /15", "Code DCI": "24D017", "Forme": "COMP.", "Dosage": "125MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEFEROX 250MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEFEROX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 24 D 018 /15", "Code DCI": "24D018", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEFEROX 500MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEFEROX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 24 D 019 /15", "Code DCI": "24D019", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEFLAMAC 0.01 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DEFLAMAC", "Tarif de reference": "145 DA", "PPA": "155.00 DA", "Num Enregistrement": "418/ 21 A 004 /14", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEFLAMBETA 0,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DEFLAMBETA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "010/ 09 H 019 /98", "Code DCI": "09H019", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEKTAGEL 0,02 GEL BUCCAL  T/40G ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " STOMATOLOGIE", "Info": " MICONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEKTAGEL", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "23D037", "Forme": "GEL", "Dosage": "0,02", "Conditionnement": "T/40G ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DELAKET 30MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DELAPRIL", "Pays": "ITALIE", "Nom Commercial": "DELAKET", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "092/ 06 E 268 /08", "Code DCI": "06E268", "Forme": "COMP.", "Dosage": "30MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEMENTILE 10MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4469.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " TABUK", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEMENTILE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "173/15F075/16", "Code DCI": "15F075", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DENACINE 1% (10MG/ML) SOL. P. APPL. LOCALE FL./30ML", "Img": "https://pharmnet-dz.com//img/medics/1667.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1667", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLINDAMYCINE", "Liste": "Liste I", "Pays": "PALESTINE", "Nom Commercial": "DENACINE", "Tarif de reference": "476.74 DA", "PPA": "N/A", "Num Enregistrement": "406/ 07 B 147 /08", "Code DCI": "07B147", "Forme": "SOL. APP. LOCALE", "Dosage": "1% (10MG/ML)", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DENACINE EMULGEL 0.01 GEL DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1670.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1670", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLINDAMYCINE PHOSPHATE EXPRIME EN CLINDAMYCINE", "Liste": "Liste I", "Pays": "PALESTINE", "Nom Commercial": "DENACINE EMULGEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "406/ 07 B 159 /09", "Code DCI": "07B159", "Forme": "GEL. DERM.", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DENORAL ADULTES 0,006G/0,0225G/0,090G/100ML SIROP. F/125ML", "Img": "https://pharmnet-dz.com//img/medics/2163.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2163", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUZEPIDE/CLOCINIZINE/PHOLCODINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DENORAL ADULTES", "Tarif de reference": "0 DA", "PPA": "160 DA", "Num Enregistrement": "003/ 20 C 033 /05", "Code DCI": "20C033", "Forme": "SIROP", "Dosage": "0,006G/0,0225G/0,090G/100ML", "Conditionnement": "F/125ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "DENORAL ENFANTS 0,004G/0,015G/0,040G/100ML SIROP. F/125ML", "Img": "https://pharmnet-dz.com//img/medics/2162.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2162", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUZEPIDE/CLOCINIZINE/PHOLCODINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DENORAL ENFANTS", "Tarif de reference": "0 DA", "PPA": "150 DA", "Num Enregistrement": "003/ 20 C 032 /05", "Code DCI": "20C032", "Forme": "SIROP", "Dosage": "0,004G/0,015G/0,040G/100ML", "Conditionnement": "F/125ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "DEPADIUM 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3100.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LERCANIDIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEPADIUM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 E 168 /14", "Code DCI": "06E168", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPAKINE 200MG COMP. GASTRORESIST. B/40", "Img": "https://pharmnet-dz.com//img/medics/3485.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3485", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DEPAKINE", "Tarif de reference": "323.95 DA", "PPA": "N/A", "Num Enregistrement": "255/ 15 A 001 /97", "Code DCI": "15A001", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPAKINE 200MG/ML SOL.BUV. B/1FL DE 40ML + SERING. P. ADMINIST. ORALE GRADUEE EN MG", "Img": "https://pharmnet-dz.com//img/medics/3492.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3492", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DEPAKINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "392/ 15 A 003 /98/13", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "B/1FL DE 40ML + SERING. P. ADMINIST. ORALE GRADUEE EN MG", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPAKINE 500MG COMP GASTR RESIST. B/40 ", "Img": "https://pharmnet-dz.com//img/medics/3488.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3488", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DEPAKINE", "Tarif de reference": "888.72 DA", "PPA": "N/A", "Num Enregistrement": "255/ 15 A 002 /97", "Code DCI": "15A002", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/40 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPAKINE CHRONO 500MG COMP.PELLI. SEC. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2400.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2400", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DEPAKINE CHRONO", "Tarif de reference": "1003.96 DA", "PPA": "N/A", "Num Enregistrement": "255/ 15 A 043 /99", "Code DCI": "15A043", "Forme": "COMP. SEC.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPO-MEDROL 40MG/ML SUSP.INJ. B/1SERING. PREREMPL. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE ACETATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DEPO-MEDROL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "076/ 09 H 090 /99", "Code DCI": "09H090", "Forme": "SUSP. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/1SERING. PREREMPL. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPONIT NT 10MG/24H PATCH B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRINITRINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "DEPONIT NT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 038 /03", "Code DCI": "06C038", "Forme": "PATCH", "Dosage": "10MG/24H", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPONIT NT 5MG/24H PATCH B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRINITRINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "DEPONIT NT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 200 /03", "Code DCI": "06C200", "Forme": "PATCH", "Dosage": "5MG/24H", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPRESS 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEPRESS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "321/ 16 A 130 /09", "Code DCI": "16A130", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEPRESTAT LP 25MG MICRGLES. LP EN GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEPRESTAT LP", "Tarif de reference": "285 DA", "PPA": "N/A", "Num Enregistrement": "418/ 16 A 158 /13", "Code DCI": "16A158", "Forme": "MICROGRANULES LP. GLES.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPRETINE 10MG** COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/2587.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2587", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE** (SOUS FORME DE CHLORHYDRATE HEMIHYDRATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEPRETINE", "Tarif de reference": "887.4 DA", "PPA": "N/A", "Num Enregistrement": "352/ 16 A 154 /12", "Code DCI": "16A154", "Forme": "COMP. PELLI.", "Dosage": "10MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPRETINE 20MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/2554.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2554", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEPRETINE", "Tarif de reference": "1741.2 DA", "PPA": "N/A", "Num Enregistrement": "352/ 16 A 095 /10", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPRISOLE  20MG  COMP ORODISPERSIBLE B/20", "Img": "https://pharmnet-dz.com//img/medics/3772.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEPRISOLE", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "235/ 09 H 144 /14", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": " 20MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEPRISOLE 5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medics/3768.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEPRISOLE", "Tarif de reference": "257.4 DA", "PPA": "N/A", "Num Enregistrement": "235/ 09 H 143 /12", "Code DCI": "09H143", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMADINE 0.1 SOL. P. APPL. LOCALE FL/50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " LABIOCO", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "DERMADINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "464/ 07 P 077 /10", "Code DCI": "07P077", "Forme": "SOL. DERM.", "Dosage": "0.1", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DERMAFINE 0.01 CREME DERM. B/01 TUBE DE 15G", "Img": "https://pharmnet-dz.com//img/medics/461.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " LGPA", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DERMAFINE", "Tarif de reference": "0 DA", "PPA": "202.00 DA", "Num Enregistrement": "311/ 07 D 094 /15", "Code DCI": "07D094", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "B/01 TUBE DE 15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMASONE 0.0005 LOTION DERM. FL./15G", "Img": "https://pharmnet-dz.com//img/medics/499.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DERMASONE", "Tarif de reference": "0 DA", "PPA": "135.00 DA", "Num Enregistrement": "235/ 07 H 040 /13", "Code DCI": "07H040", "Forme": "LOTION", "Dosage": "0.0005", "Conditionnement": "FL./15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMA-T 0.01 SOL. APPLI. LOCALE FL/30ML", "Img": "https://pharmnet-dz.com//img/medics/1668.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1668", "Laboratoire": " TABUK ", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLINDAMYCINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "DERMA-T", "Tarif de reference": "681.62 DA", "PPA": "N/A", "Num Enregistrement": "173/ 07 B 147 /06", "Code DCI": "07B147", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMESTRIL 25\u00b5G/24H PATCH B/8", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SANOFI WINTHROP", "C.Pharmacologique": " OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ESTRADIOL ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DERMESTRIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "052/ 09 G 010 /98", "Code DCI": "09G010", "Forme": "PATCH", "Dosage": "25\u00b5G/24H", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMOBACTER 0,2G/0,5G/100ML SOL. P. APPL. CUTANEE FL./300ML", "Img": "https://pharmnet-dz.com//img/medics/562.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=562", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CHLORHEXIDINE DIGLUCONATE/ BENZALKONIUM CHLORURE ", "Pays": "FRANCE", "Nom Commercial": "DERMOBACTER", "Tarif de reference": "345 DA", "PPA": "341.00 DA", "Num Enregistrement": "087/ 07 P 153 /07", "Code DCI": "07P153", "Forme": "SOL. APP. LOCALE", "Dosage": "0,2G/0,5G/100ML", "Conditionnement": "FL./300ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMOCUIVRE 0,2% / 10% PDE DERM T/25 G ET T/100G", "Img": "https://pharmnet-dz.com//img/medics/558.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=558", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " SULFATE DE CUIVRE / OXYDE DE ZINC", "Pays": "FRANCE", "Nom Commercial": "DERMOCUIVRE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "096/ 07 P 101 /00", "Code DCI": "07P101", "Forme": "PDE. DERM.", "Dosage": "0,2% / 10%", "Conditionnement": "T/25 G ET T/100G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMOFIX 0.02 CREME  T/20G", "Img": "https://pharmnet-dz.com//img/medics/466.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=466", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " SERTACONAZOLE NITRATE", "Pays": "ESPAGNE", "Nom Commercial": "DERMOFIX", "Tarif de reference": "254.04 DA", "PPA": "N/A", "Num Enregistrement": "207/ 07 D 108 /00", "Code DCI": "07D108", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMOFIX 0.02 GEL T/100G", "Img": "https://pharmnet-dz.com//img/medics/470.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=470", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " SERTACONAZOLE NITRATE", "Pays": "ESPAGNE", "Nom Commercial": "DERMOFIX", "Tarif de reference": "458 DA", "PPA": "N/A", "Num Enregistrement": "207/ 07 D 139 /03", "Code DCI": "07D139", "Forme": "GEL", "Dosage": "0.02", "Conditionnement": "T/100G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DERMOFIX 0.02 SOLUTION DERMIQUE EN SPRAY F/30ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " SERTACONAZOLE NITRATE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "DERMOFIX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "207/07D181/15", "Code DCI": "N/D", "Forme": "SOL. DERM.", "Dosage": "2%", "Conditionnement": "F/30ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEROXAT 20MG COMP. PELLI. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medics/2555.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2555", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEROXAT", "Tarif de reference": "766 DA", "PPA": "N/A", "Num Enregistrement": "305/ 16 A 095 /00/10", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "DESACROVIS 0,050G/100G (OU 0,05%) PDE. DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " DEXAMETHASONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DESACROVIS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 07 H 043 /98/14", "Code DCI": "07H043", "Forme": "PDE. DERM.", "Dosage": "0,050G/100G (OU 0,05%)", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": null}, {"Nom": "DESACROVIS 0,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DEXAMETHASONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DESACROVIS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 09 H 023 /98/14", "Code DCI": "09H023", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DESFERAL 500MG/7,5ML PDRE. ET SOLV. P. SOL. INJ. B/1+1", "Img": "https://pharmnet-dz.com//img/medics/1145.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1145", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFEROXAMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DESFERAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 24 D 004 /98", "Code DCI": "24D004", "Forme": "SOL. INJ.", "Dosage": "500MG/7,5ML", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "DESIRETT 0,075MG COMP. PELL B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " EXELTIS GERMANY GMBH ", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " DESOGESTREL", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "DESIRETT", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "11H072", "Forme": "COMP. PELLI.", "Dosage": "0,075 MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "DESLOR 0,5MG/ML SIROP B/1FL. DE 150ML + UNE SERING. MESURE GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/4031.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4031", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DESLOR", "Tarif de reference": "463.5 DA", "PPA": "N/A", "Num Enregistrement": "317/ 01 A 048 /11", "Code DCI": "01A048", "Forme": "SIROP", "Dosage": "0,5MG/ML", "Conditionnement": "B/1FL. DE 150ML + UNE SERING. MESURE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "DESLOR 5MG COMP. PELLI. B/15 ET B/30", "Img": "https://pharmnet-dz.com//img/medics/4029.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4029", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DESLOR", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "317/ 01 A 047 /11", "Code DCI": "01A047", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/15 ET B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "DESLORAL 5MG COMP. PELLI.  B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DESLORAL", "Tarif de reference": "90  DA", "PPA": " DA", "Code DCI": "01A047", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": " B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "DESLORAL 5MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DESLORAL", "Tarif de reference": "180 DA", "PPA": "N/A", "Code DCI": "01A047", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DESOMEDINE 0,1%** COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/1967.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1967", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTISEPTIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " HEXAMIDINE (SOUS FORME DE DI-ISETHIONATE)**", "Pays": "FRANCE", "Nom Commercial": "DESOMEDINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 E 158 /08", "Code DCI": "17E158", "Forme": "COLLY.", "Dosage": "0,1%**", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "DESPAVINE 100MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3951.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DESPAVINE", "Tarif de reference": "217.2 DA", "PPA": "N/A", "Num Enregistrement": "235/ 10 E 035 /09", "Code DCI": "10E035", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DETENPRESS 10MG  COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DETENPRESS", "Tarif de reference": "585 DA", "PPA": "N/A", "Num Enregistrement": "426/ 06 F 162 /13", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DETICENE 100MG PDRE.SOL.INJ. B/10FL.", "Img": "https://pharmnet-dz.com//img/medics/973.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=973", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " DACARBAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DETICENE", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "230/ 05 A 013 /99", "Code DCI": "05A013", "Forme": "PDRE. SOL. INJ.", "Dosage": "100MG", "Conditionnement": "B/10FL.", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXAFLOX 1MG/3MG/ML COLLY. EN SUSP. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/1984.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1984", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / OFLOXACINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "DEXAFLOX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "386/ 17 G 168 /12 ", "Code DCI": "17G168", "Forme": "COLLY.", "Dosage": "1MG/3MG/ML", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "DEXAFREE  1MG/ML  COLLYRE B/30", "Img": "https://pharmnet-dz.com//img/medics/1985.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1985", "Laboratoire": " THEA", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE PHOSPHATE SODIQUE EXPRIME EN DEXAMETHASONE PHOSPHATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DEXAFREE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "022/ 17 G 173 /14", "Code DCI": "17G173", "Forme": "COLLY.", "Dosage": " 1MG/ML ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXAL 0,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/645.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DEXAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEXAL", "Tarif de reference": "159 DA", "PPA": "N/A", "Num Enregistrement": "242/ 09 H 023 /04", "Code DCI": "09H023", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXALEK 0,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " LEK", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DEXAMETHASONE", "Liste": "Liste I", "Pays": "SLOVENIE", "Nom Commercial": "DEXALEK", "Tarif de reference": "159 DA", "PPA": "N/A", "Num Enregistrement": "188/ 09 H 023 /99", "Code DCI": "09H023", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXAMETHASONE 20MG SOL.INJ. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DEXAMETHASONE (PHOSPHATE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DEXAMETHASONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 09 H 022 /98", "Code DCI": "09H022", "Forme": "SOL. INJ.", "Dosage": "20MG", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXAMETYD 4MG/ML SOL,INJ IM/IV OU LOCAL EN AMP B/5AMP  5ML ET B/50 AMP 1ML", "Img": "https://pharmnet-dz.com//img/medics/4575.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DEXAMETHASONE PHOSPHATE SODIQUE EXPRIME EN DEXAMETHASONE PHOSPHATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEXAMETYD", "Tarif de reference": "215.55 DA", "PPA": " DA", "Num Enregistrement": "433/09H021/16", "Code DCI": "09H021", "Forme": "SOL. INJ.", "Dosage": "4MG/ML", "Conditionnement": "B/5AMP  5ML ET B/50 AMP 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXAMEX 100MG/350000UI/100ML COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2382.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2382", "Laboratoire": " UNIMED", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "DEXAMEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 17 D 024 /99/15", "Code DCI": "17D024", "Forme": "COLLY.", "Dosage": "100MG/350000UI/100ML", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXASONE 4MG/ML SOL. INJ. B/5AMP./1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DEXAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEXASONE", "Tarif de reference": "215.55 DA", "PPA": "215.00 DA", "Num Enregistrement": "003/ 09 H 021 /08", "Code DCI": "09H021", "Forme": "SOL. INJ.", "Dosage": "4MG/ML", "Conditionnement": "B/5AMP./1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXCHLORPHENIRAMINE AFRO 0,5MG/5ML SOL BUVABLE F/125 ML+CUILLERE DE MESURE  DE 5ML GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ANTIHISTAMINIQUES", "C.Pharmacologique": " ALLERGOLOGIE", "C.Therapeutique": " DEXCHLORPHENIRAMINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DEXCHLORPHENIRAMINE AFRO", "Tarif de reference": "125 DA", "PPA": "N/A", "Num Enregistrement": "503/01A007/16", "Code DCI": "01A007", "Forme": "SOL. BUV.", "Dosage": "0,5MG/5ML", "Conditionnement": "F/125 ML+CUILLERE DE MESURE  DE 5ML GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXERYL 15G/8G/2G/100G CREME DERM. T/250G", "Img": "https://pharmnet-dz.com//img/medics/569.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=569", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " N/D", "C.Therapeutique": " DERMATOLOGIE", "Info": " GLYCEROL / VASELINE / PARAFFINE LIQUIDE", "Pays": "FRANCE", "Nom Commercial": "DEXERYL", "Tarif de reference": "0 DA", "PPA": "445.00 DA", "Num Enregistrement": "099/ 07 T 177 /13", "Code DCI": "07T177", "Forme": "CR\u00c8ME", "Dosage": "15G/8G/2G/100G", "Conditionnement": "T/250G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXNEPOLY 0,1%/0,35%/600000UI/100ML COLLY. FL/3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE / POLYMYXINE B", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DEXNEPOLY", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 G 048 /99/07", "Code DCI": "17G048", "Forme": "COLLY.", "Dosage": "0,1%/0,35%/600000UI/100ML", "Conditionnement": "FL/3ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEXOREN 0,25MG COMP.SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3270.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3270", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DEXOREN", "Tarif de reference": "104.4 DA", "PPA": "152.00 DA", "Num Enregistrement": "242/ 06 G 079 /05", "Code DCI": "06G079", "Forme": "COMP. SEC.", "Dosage": "0,25MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DEXSTOP 0,2% SIROP FL./125ML", "Img": "https://pharmnet-dz.com//img/medics/1296.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1296", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "DEXSTOP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 20 C 206 /06", "Code DCI": "20C206", "Forme": "SIROP", "Dosage": "0,2%", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DEXSTOP ENFANTS O,1% SIROP  FL/ 125ML", "Img": "https://pharmnet-dz.com//img/medics/1298.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1298", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "DEXSTOP ENFANTS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 20 C 207/05", "Code DCI": "20C207", "Forme": "SIROP", "Dosage": "O,1%", "Conditionnement": "FL/ 125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIABAMINE BGL 1000MG COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABAMINE BGL", "Tarif de reference": "173.4 DA", "PPA": "172.00 DA", "Num Enregistrement": "235/ 14 A 224 /14", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIABAMINE BGL 500MG  COMP PELL B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABAMINE BGL", "Tarif de reference": "182 DA", "PPA": "184.00 DA", "Num Enregistrement": "235/ 14 A 006 /14", "Code DCI": "14A006", "Forme": "COMP. PELLI.", "Dosage": "500MG ", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIABAMINE BGL 850MG COMP. PELLI. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABAMINE BGL", "Tarif de reference": "492 DA", "PPA": "490.00 DA", "Num Enregistrement": "235/ 14 A 007 /10", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIABENIL 2,5MG COMP. SEC. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABENIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 A 002 /03/09", "Code DCI": "14A002", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIABENIL 5MG COMP. SEC. B/60 - B/100", "Img": "https://pharmnet-dz.com//img/medics/3613.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3613", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABENIL", "Tarif de reference": "111 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 A 003 /01/09", "Code DCI": "14A003", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/60 - B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIABENORM 0,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3690.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABENORM", "Tarif de reference": "0 DA", "PPA": "355.00 DA", "Num Enregistrement": "003/ 14 A 200 /08", "Code DCI": "14A200", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIABENORM 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3694.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABENORM", "Tarif de reference": "0 DA", "PPA": "440.00 DA", "Num Enregistrement": "003/ 14 A 201 /07", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIABENORM 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3700.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIABENORM", "Tarif de reference": "0 DA", "PPA": "560.00 DA", "Num Enregistrement": "003/ 14 A 202 /07", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIACENE 50 50MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " SANAMED", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIACENE 50", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "097/04B045/17", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIAFEX 220MG/5ML (OU 4%) SUSP. BUV. FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/3931.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3931", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DIAFEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 10 C 018 /09", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "220MG/5ML (OU 4%)", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIAGLINIDE 0,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3687.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3687", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIAGLINIDE", "Tarif de reference": "366 DA", "PPA": "N/A", "Num Enregistrement": "293/ 14 A 200 /14", "Code DCI": "14A200", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIAGLINIDE 1MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3691.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3691", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIAGLINIDE", "Tarif de reference": "0 DA", "PPA": "370.00 DA", "Num Enregistrement": "293/ 14 A 201 /14", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIAGLINIDE 2MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3695.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3695", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIAGLINIDE", "Tarif de reference": "390 DA", "PPA": "N/A", "Num Enregistrement": "293/ 14 A 202 /14", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIAGUANID 1000MG  COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3704.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIAGUANID", "Tarif de reference": " N/A", "PPA": "165.00 DA", "Num Enregistrement": "003/ 14 A 224 /14", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIAGUANID 850MG COMP. PELLI. B/30 ET B/120", "Img": "https://pharmnet-dz.com//img/medics/3624.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIAGUANID", "Tarif de reference": "147.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 A 007 /05", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30 ET B/120", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIALAMOL 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DIALAMOL", "Tarif de reference": "30 DA", "PPA": "N/A", "Num Enregistrement": "457/ 03 B 040 /11", "Code DCI": "03B040", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIALOMINE 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIALOMINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "457/ 06 C 022 /13", "Code DCI": "06C022", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIAMICRON 30MG COMP. LM  B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3711.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3711", "Laboratoire": " SERVIER", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLICLAZIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIAMICRON", "Tarif de reference": "552.71 DA", "PPA": "N/A", "Num Enregistrement": "040/ 14 A 303 /06/13", "Code DCI": "14A303", "Forme": "COMP. PELLI. LP", "Dosage": "30MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIANE 35 2MG /35\u00b5G COMP.ENRO. B/21 ", "Img": "https://pharmnet-dz.com//img/medics/3825.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3825", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CYPROTERONE /  ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIANE 35", "Tarif de reference": "570 DA", "PPA": "N/A", "Num Enregistrement": "070/ 09 P 069 /97", "Code DCI": "09P069", "Forme": "COMP. PELLI.", "Dosage": "2MG /35\u00b5G", "Conditionnement": "B/21 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIANEAL PDA 1,36% 13,6G/L (1,36%) DE GLUCOSE ANHYDRE , 15G/L DE GLUCOSE MONONHYDRATE/ (5,38G / 0,184/G / 0,051G / 4,480G)/L                                              SOIT 132mmole de sodium / 1,25mmole de calcium / 0,25mmole de magn\u00e9sium  / 95,00 mole ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1208", "Laboratoire": " BAXTER", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " GLUCOSE ANHYDRE (SOUS FORME MONOHYDRATEE) / SODIUM CHLORURE / CALCIUM CHLORURE DIHYDRATE / MAGNESIUM CHLORURE HEXAHYDRATE / SODIUM LACTATE", "Pays": "ROYAUME UNI", "Nom Commercial": "DIANEAL PDA 1,36%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 25 G 063 /12", "Code DCI": "25G063", "Forme": "SOL. DIALYSE", "Dosage": "13,6G/L (1,36%) DE GLUCOSE ANHYDRE , 15G/L DE GLUCOSE MONONHYDRATE/ (5,38G / 0,184/G / 0,051G / 4,480G)/L                                              SOIT 132mmole de sodium / 1,25mmole de calcium / 0,25mmole de magn\u00e9sium  / 95,00 mole de chlorure / 40mm", "Conditionnement": "POCHE FLEXIBLE (SYST\u00c8ME II CONNEXION A VIS LUER) VIAFLEX PVC DE FORMULE PL 146-3                                    CARTON  DE 05 POCHES SIMPLES DE 2000ML,CARTON DE 02 POCHES SIMPLE DE 5000ML - CARTON DE 05 POCHES DOUBLES DE 2000ML ,                      ", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIANEAL PDA 22,70G/L (2,27%) DE GLUCOSE ANHYDRE , 25G/L SOUS FORME  MONONHYDRATE/ (5,38G/4,48G/0,184G/0,051G)/L SOIT 132mmole de sodium / 1,25mmole de calcium / 0,25mmole de magn\u00e9sium  / 95,00 mole de chlorure / 40mmole de lactate )/L  SOL. P. DIALYSE PER", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1209", "Laboratoire": " BAXTER", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " GLUCOSE ANHYDRE (SOUS FORME MONOHYDRATEE) / SODIUM CHLORURE / SODIUM LACTATE / CALCIUM CHLORURE DIHYDRATE / MAGNESIUM CHLORURE HEXAHYDRATE", "Pays": "ROYAUME UNI", "Nom Commercial": "DIANEAL PDA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 25 G 064 /12", "Code DCI": "25G064", "Forme": "SOL. DIALYSE", "Dosage": "22,70G/L (2,27%) DE GLUCOSE ANHYDRE , 25G/L SOUS FORME  MONONHYDRATE/ (5,38G/4,48G/0,184G/0,051G)/L SOIT 132mmole de sodium / 1,25mmole de calcium / 0,25mmole de magn\u00e9sium  / 95,00 mole de chlorure / 40mmole de lactate )/L ", "Conditionnement": "POCHE POCHE FLEXIBLE (SYST\u00c8ME II CONNEXION A VIS LUER                                                                                             CARTON  DE 02 POCHES SIMPLES DE 2000ML, CARTON DE 05 POCHES SIMPLES DE 2000ML ,                              ", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIANEAL PDA 38,6G/L (3,86%) DE GLUCOSE ANHYDRE , 42,5G/L DE GLUCOSE MONONHYDRATE/ (5,38G / 0,184/G / 0,051G / 4,480G)/L                                              SOIT 132mmole de sodium / 1,25mmole de calcium / 0,25mmole de magn\u00e9sium  / 95,00 mole de c", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1210", "Laboratoire": " BAXTER", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " GLUCOSE ANHYDRE (SOUS FORME MONOHYDRATEE) / SODIUM CHLORURE / CALCIUM CHLORURE DIHYDRATE / MAGNESIUM CHLORURE HEXAHYDRATE / SODIUM LACTATE", "Pays": "ROYAUME UNI", "Nom Commercial": "DIANEAL PDA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 25 G 065 /12", "Code DCI": "25G065", "Forme": "SOL. DIALYSE", "Dosage": "38,6G/L (3,86%) DE GLUCOSE ANHYDRE , 42,5G/L DE GLUCOSE MONONHYDRATE/ (5,38G / 0,184/G / 0,051G / 4,480G)/L                                              SOIT 132mmole de sodium / 1,25mmole de calcium / 0,25mmole de magn\u00e9sium  / 95,00 mole de chlorure / 40", "Conditionnement": "POCHE FLEXIBLE (SYST\u00c8ME II CONNEXION A VIS LUER) VIAFLEX PVC DE FORMULE PL 146-3                                    CARTON  DE 05 POCHES SIMPLES DE 2000ML, CARTON DE 05 POCHES DOUBLES DE 2000ML ,                                 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIAPHAG 80MG COMP B/60", "Img": "https://pharmnet-dz.com//img/medics/3616.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3616", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLICLAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIAPHAG", "Tarif de reference": "298.8 DA", "PPA": "298.8 DA", "Num Enregistrement": "003/ 14 A 004 /97", "Code DCI": "14A004", "Forme": "COMP.", "Dosage": "80MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIARYL 2MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DIARYL", "Tarif de reference": "128.2 DA", "PPA": "140.00 DA", "Num Enregistrement": "418/ 10 H 056 /08", "Code DCI": "10H056", "Forme": "GLES.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIATAG  100MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIATAG ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "14A342", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIAZEPAM 0.01 SOL .BUV .GTTES FL/20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " DIAZEPAM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIAZEPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 16 B 029 /00", "Code DCI": "16B029", "Forme": "SOL. BUV. GTTES.", "Dosage": "0.01", "Conditionnement": "FL/20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIAZEPAM 10MG/2ML SOL.INJ. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " DIAZEPAM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIAZEPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 16 B 025 /00", "Code DCI": "16B025", "Forme": "SOL. INJ.", "Dosage": "10MG/2ML", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICEF 250MG/5ML PDRE. P. SUSP. BUV. B/1FL DE 75MLDE SUSP. BUV. APRES RECONST.+UNE CUILLERE-MESURE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JAZEERA PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "DICEF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "225/ 13 B 260 /06/13", "Code DCI": "13B260", "Forme": "SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "B/1FL DE 75MLDE SUSP. BUV. APRES RECONST.+UNE CUILLERE-MESURE", "Commercialisation": true, "Remboursable": null}, {"Nom": "DICEF 500MG GLES B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JAZEERA PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "DICEF", "Tarif de reference": "0 DA", "PPA": "958.00 DA", "Num Enregistrement": "225/ 13 B 262 /03", "Code DCI": "13B262", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICETEL 100MG COMP.PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/3963.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3963", "Laboratoire": " ABBOTT", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " PINAVERIUM BROMURE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DICETEL", "Tarif de reference": "203.60 DA", "PPA": "377.69 DA", "Num Enregistrement": "147/ 10 E 104 /99/15", "Code DCI": "10E104", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICETEL 50MG COMP.PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/3956.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3956", "Laboratoire": " ABBOTT", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " PINAVERIUM BROMURE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DICETEL", "Tarif de reference": "203.60 DA", "PPA": "247.75 DA", "Num Enregistrement": "147/ 10 E 036 /97/13", "Code DCI": "10E036", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLAMID 25MG/ML (75MG/3ML) SOL. INJ. IM B/02AMP. DE 3ML ET B/50AMP. DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/2697.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2697", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLAMID", "Tarif de reference": "81.6 DA", "PPA": " DA", "Num Enregistrement": "433/ 04 B 004 /12", "Code DCI": "04B004", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (75MG/3ML)", "Conditionnement": "B/02AMP. DE 3ML ET B/50AMP. DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFAL 50MG CP PELLICULE GASTRO RESISTANT  B/30", "Img": "https://pharmnet-dz.com//img/medics/4688.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "039/04B006/98/17", "Code DCI": "04B006", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFAL 50MG CP PELLICULE GASTRO RESISTANT  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFAL", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "04B006", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFAL LP 75MG COMP. PELLI. LP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFAL LP", "Tarif de reference": "244,4 DA", "PPA": "N/A", "Code DCI": "04B037", "Forme": "COMP. PELLI. LP", "Dosage": "75MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFAR 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFAR", "Tarif de reference": "87.6 DA", "PPA": "N/A", "Num Enregistrement": "366/ 04 B 009 /09", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFAR 25MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFAR", "Tarif de reference": "56.8 DA", "PPA": "N/A", "Num Enregistrement": "366/04B008/15", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFAR 50MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFAR", "Tarif de reference": "88.5 DA", "PPA": "N/A", "Num Enregistrement": "366/04B046/15", "Code DCI": "04B046", "Forme": "SUPPO.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFENAC NOVA GENERICS 0.01 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFENAC NOVA GENERICS", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "149/ 21 A 004 /11", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFENAC NOVAGENERICS LP 100MG GLES. LP  B/20", "Img": "https://pharmnet-dz.com//img/medics/2707.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFENAC NOVAGENERICS LP", "Tarif de reference": "280 DA", "PPA": "280.00 DA", "Num Enregistrement": "149/ 04 B 007 /13", "Code DCI": "04B007", "Forme": "GLES. LP", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFENIL 0.01 GEL DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFENIL", "Tarif de reference": "87 DA", "PPA": "N/A", "Num Enregistrement": "026/ 21 A 004 /09", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOFENIL 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFENIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "026/ 04 B 009 /01/09", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "DICLOFENIL-ENFANT 25MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOFENIL-ENFANT", "Tarif de reference": "56.8 DA", "PPA": "N/A", "Num Enregistrement": "026/ 04 B 008 /05", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICLOGESIC 0.001 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " PRODUITS POUR CRISTALLIN", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DICLOGESIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "272/ 17 J 118 /02/09", "Code DCI": "17J118", "Forme": "COLLY.", "Dosage": "0.001", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DICLOGESIC RETARD 100MG COMP. PELLI. LP B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "DICLOGESIC RETARD", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "04B007", "Forme": "COMP. PELLI. LP", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICYNONE 250MG COMP. B/20 ", "Img": "https://pharmnet-dz.com//img/medics/1824.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1824", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " HEMOSTATIQUES GENERAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ETAMSYLATE", "Pays": "FRANCE", "Nom Commercial": "DICYNONE", "Tarif de reference": "233.65 DA", "PPA": "N/A", "Num Enregistrement": "255/ 12 H 040 /98", "Code DCI": "12H040", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DICYNONE 250MG SOL.INJ. B/6AMP. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1822", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " HEMOSTATIQUES GENERAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ETAMSYLATE", "Pays": "FRANCE", "Nom Commercial": "DICYNONE", "Tarif de reference": "0 DA", "PPA": "235.00 DA", "Num Enregistrement": "255/ 12 H 039 /98", "Code DCI": "12H039", "Forme": "SOL. INJ.", "Dosage": "250MG", "Conditionnement": "B/6AMP. DE 2ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIDERAL 40MG COMP B/50", "Img": "https://pharmnet-dz.com//img/medics/3239.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANOFI DOGU", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPRANOLOL", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "DIDERAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "250/ 06 F 073 / 01", "Code DCI": "06F073", "Forme": "COMP. SEC.", "Dosage": "40MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "DI-DOLEX 325MG / 37,5MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2683.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " MERINAL", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DI-DOLEX", "Tarif de reference": "193.6 DA", "PPA": "N/A", "Num Enregistrement": "268/ 03 F 115 /11", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIFFERINE 0.001 CREME P. APPLI. CUTANEE T/30G", "Img": "https://pharmnet-dz.com//img/medics/1669.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1669", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ADAPALENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIFFERINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "123/ 07 B 157 /08/15", "Code DCI": "07B157", "Forme": "SOL. APP. LOCALE", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": false}, {"Nom": "DIFFERINE 0.001 GEL. APPLI. LOCALE T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1659", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ADAPALENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIFFERINE", "Tarif de reference": "0 DA", "PPA": "473.00 DA", "Num Enregistrement": "123/ 07 B 109 /00", "Code DCI": "07B109", "Forme": "SOL. APP. LOCALE", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIFFUMAX 200MG COMP.SEC.LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MENARINI", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " THEOPHYLLINE", "Pays": "ITALIE", "Nom Commercial": "DIFFUMAX", "Tarif de reference": "146.4 DA", "PPA": "168.00 DA", "Num Enregistrement": "203/ 20 A 024 /00", "Code DCI": "20A024", "Forme": "COMP. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIFLUCARE 50MG GLES. B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIFLUCARE", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIFLU-G\u00e9 50MG GLES B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIFLU-G\u00e9", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 13 R 155 /04/14", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIGESTAT 100MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medics/2904.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2904", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DIGESTAT", "Tarif de reference": "128.4 DA", "PPA": " DA", "Num Enregistrement": "231/ 10 F 095 /03", "Code DCI": "10F095", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIGESTAT 200MG  COMP  B/30", "Img": "https://pharmnet-dz.com//img/medics/2911.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2911", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DIGESTAT", "Tarif de reference": "273 DA", "PPA": " DA", "Num Enregistrement": "231/ 10 F 193 /14", "Code DCI": "10F193", "Forme": "COMP. PELLI.", "Dosage": "200MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIGOXINE 0,5MG/2ML SOL.INJ.IV B/05 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DIGOXINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 06 G 081 /98", "Code DCI": "06G081", "Forme": "SOL. INJ.", "Dosage": "0,5MG/2ML", "Conditionnement": "B/05 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIGOXINE CPCM 0,25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " CPCM", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIGOXINE CPCM", "Tarif de reference": "156.6 DA", "PPA": "156.00 DA", "Num Enregistrement": "286/ 06 G 079 /08", "Code DCI": "06G079", "Forme": "COMP. SEC.", "Dosage": "0,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIGOXINE NATIVELLE 0,25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PROCTER & GAMBLE PHARMACEUTICALS France", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIGOXINE NATIVELLE", "Tarif de reference": "156.6 DA", "PPA": "N/A", "Num Enregistrement": "151/ 06 G 079 /99", "Code DCI": "06G079", "Forme": "COMP. SEC.", "Dosage": "0,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIGOXINE STREULI 0,125MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3278", "Laboratoire": " STREULI PHARMA AG", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "DIGOXINE STREULI", "Tarif de reference": "78.3 DA", "PPA": " DA", "Num Enregistrement": "401/ 06 G 249 /07", "Code DCI": "06G249", "Forme": "COMP.", "Dosage": "0,125MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIGOXINE STREULI 0,25MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3272", "Laboratoire": " STREULI PHARMA AG", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "DIGOXINE STREULI", "Tarif de reference": "156.6 DA", "PPA": " DA", "Num Enregistrement": "401/ 06 G 079 /07", "Code DCI": "06G079", "Forme": "COMP. SEC.", "Dosage": "0,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIGROMIN 2MG/ML SOL.BUV FL/50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " DIHYDROERGOTAMINE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "DIGROMIN", "Tarif de reference": "222 DA", "PPA": "N/A", "Num Enregistrement": "012/ 15 B 021 /99", "Code DCI": "15B021", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DI-HYDAN 100MG COMP.SEC. B/60 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " GENOPHARM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PHENYTOINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DI-HYDAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "257/ 15 A 016 /97", "Code DCI": "15A016", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "DILACARD 12,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3259.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3259", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CARVEDILOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DILACARD", "Tarif de reference": "873.34 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 F 250 /11", "Code DCI": "06F250", "Forme": "COMP.", "Dosage": "12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DILACARD 25MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3257.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3257", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CARVEDILOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DILACARD", "Tarif de reference": "1209.9 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 F 209 /10", "Code DCI": "06F209", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DILACARD 3,125MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3260.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3260", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CARVEDILOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DILACARD", "Tarif de reference": "348.9 DA", "PPA": "430.00 DA", "Num Enregistrement": "352/ 06 F 252 /11", "Code DCI": "06F252", "Forme": "COMP.", "Dosage": "3,125MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DILACARD 6,25MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3255.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3255", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CARVEDILOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DILACARD", "Tarif de reference": "697.8 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 F 208 /10", "Code DCI": "06F208", "Forme": "COMP. SEC.", "Dosage": "6,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DILTIAL 60MG COMP. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EIPICO ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "DILTIAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "109/ 06 B 009 /99", "Code DCI": "06B009", "Forme": "COMP.", "Dosage": "60MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DILTIAZEM - BAYER LP 120MG GLES.LP B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DILTIAZEM - BAYER LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "236/ 06 B 141 /00", "Code DCI": "06B141", "Forme": "GLES. LP", "Dosage": "120MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "DILTIAZEM - BAYER LP 90MG GLES LP B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DILTIAZEM - BAYER LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "236/ 06 B 140 /00", "Code DCI": "06B140", "Forme": "GLES. LP", "Dosage": "90MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIMEPRA 2MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2921.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DIMEPRA", "Tarif de reference": "128.2 DA", "PPA": "128.00 DA", "Num Enregistrement": "035/ 10 H 056 /07", "Code DCI": "10H056", "Forme": "GLES.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIOSMECTA 3G/SACHET PDRE. P. SUSP. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIOSMECTITE", "Pays": "ALGERIE", "Nom Commercial": "DIOSMECTA", "Tarif de reference": "319,80 DA", "PPA": "N/A", "Code DCI": "10B015", "Forme": "PDRE. SUSP. BUV.", "Dosage": "3G/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIOSMINE GGAM 600MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "ALGERIE", "Nom Commercial": "DIOSMINE GGAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "318/ 06 K 160 /06", "Code DCI": "06K160", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIOSMINE MYLAN 600MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1526", "Laboratoire": " MYLAN", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "FRANCE", "Nom Commercial": "DIOSMINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 06 K 160 /07/12", "Code DCI": "06K160", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIOSMINE UPC 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "ALGERIE", "Nom Commercial": "DIOSMINE UPC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "285/ 06 K 108 /06", "Code DCI": "06K108", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIOVEINE 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1522.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1522", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "ALGERIE", "Nom Commercial": "DIOVEINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/ 06 K 108 /09", "Code DCI": "06K108", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "DIOVEINE 600MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1527.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1527", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "ALGERIE", "Nom Commercial": "DIOVEINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/ 06 K 160 /09", "Code DCI": "06K160", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "DIOVENOR 600MG 600MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1528.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1528", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "FRANCE", "Nom Commercial": "DIOVENOR 600MG", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "087/ 06 K 160 /00/09", "Code DCI": "06K160", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPRIM 200MG/40MG/5ML SUSP. BUV. B/1FL. DE 100ML+UN BOUCHON DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIPRIM", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "318/ 13 M 090 /09", "Code DCI": "13M090", "Forme": "SUSP. BUV.", "Dosage": "200MG/40MG/5ML", "Conditionnement": "B/1FL. DE 100ML+UN BOUCHON DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPRIVAN  10MG/ML EMULSION INJECTABLE EN SURINGUE Pr\u00e9-remplie B/1 DE 50 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4283", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " PROPOFOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIPRIVAN ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/02B64/15", "Code DCI": "N/D", "Forme": "EMULSION PERF.", "Dosage": "10MG/ML", "Conditionnement": "B/1 DE 50 ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPRIVAN  \u00b2 EMULSION INJECTABLE EN SURINGUE Pr\u00e9-remplie B/1 DE 50 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " PROPOFOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIPRIVAN ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "256/02B065/15", "Code DCI": "N/D", "Forme": "EMULSION PERF.", "Dosage": "\u00b2", "Conditionnement": "B/1 DE 50 ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "DIPROLOL 10MG COMP PELL SEC  B/30", "Img": "https://pharmnet-dz.com//img/medics/4252.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4252", "Laboratoire": " SANAMED", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIPROLOL", "Tarif de reference": "585 DA", "PPA": " DA", "Num Enregistrement": "097/06F162/09/15", "Code DCI": "06F162", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPROLOL 5MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANAMED", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIPROLOL", "Tarif de reference": "290.1 DA", "PPA": "N/A", "Num Enregistrement": "097/06F267/15", "Code DCI": "06F267", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPROSALIC 0,05%/3% PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=503", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE / ACIDE SALICYLIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIPROSALIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "027/ 07 H 041 /97/09", "Code DCI": "07H041", "Forme": "PDE. DERM.", "Dosage": "0,05%/3%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPROSONE 0.0005 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/491.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=491", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIPROSONE", "Tarif de reference": "125.6 DA", "PPA": "N/A", "Num Enregistrement": "027/ 07 H 038 /97/08", "Code DCI": "07H038", "Forme": "CR\u00c8ME", "Dosage": "0.0005", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPROSONE 0.0005 LOTION B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medics/500.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=500", "Laboratoire": " MSD FRANCE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIPROSONE", "Tarif de reference": "0 DA", "PPA": "128.00 DA", "Num Enregistrement": "024/ 07 H 040 /98/13", "Code DCI": "07H040", "Forme": "LOTION", "Dosage": "0.0005", "Conditionnement": "B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPROSONE 0.0005 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=497", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIPROSONE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "027/ 07 H 039 /97/09", "Code DCI": "07H039", "Forme": "PDE. DERM.", "Dosage": "0.0005", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIPROSTENE 5MG/2MG/SERINGUE SUSP.INJ. 1SERINGUE  PRE REMPLE  + 2 AIGUILLES", "Img": "https://pharmnet-dz.com//img/medics/628.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=628", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETASONE / BETAMETHASONE PHOSPHATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DIPROSTENE", "Tarif de reference": "307.26 DA", "PPA": "N/A", "Num Enregistrement": "027/ 09 H 017 /97", "Code DCI": "09H017", "Forme": "SUSP. INJ.", "Dosage": "5MG/2MG/SERINGUE", "Conditionnement": "1SERINGUE  PRE REMPLE  + 2 AIGUILLES", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIRIL 5MG**/50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PETRA PHARM ", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMILORIDE (SOUS FORME DE CHLORHYDRATE)**/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIRIL", "Tarif de reference": "205.5 DA", "PPA": "N/A", "Num Enregistrement": "258/ 06 H 094 /05", "Code DCI": "06H094", "Forme": "COMP.", "Dosage": "5MG**/50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DISTENSOL 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DISTENSOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "010/ 16 D 087 /99", "Code DCI": "16D087", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DITAMIN 2MG/ML SOL.BUV. FL/50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " LEK", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " DIHYDROERGOTAMINE", "Liste": "Liste II", "Pays": "SLOVENIE", "Nom Commercial": "DITAMIN", "Tarif de reference": "222 DA", "PPA": "N/A", "Num Enregistrement": "188/ 15 B 021 /99", "Code DCI": "15B021", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DITROPAN 5MG COMP.SEC B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1185", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-ENURETIQUES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " OXYBUTYNINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DITROPAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 25 D 008 /98", "Code DCI": "25D008", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIURAZOL 250MG COMP. B/24  ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACETAZOLAMIDE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "DIURAZOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "010/ 06 H 084 /98", "Code DCI": "06H084", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/24  ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIUSEMIDE 20MG/2ML SOL.INJ. B/5AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "DIUSEMIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "118/ 06 H 087 /98", "Code DCI": "06H087", "Forme": "SOL. INJ.", "Dosage": "20MG/2ML", "Conditionnement": "B/5AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIVALAN 160MG  COMP PELL B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ANTI-HYPERTENSEURS", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIVALAN", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "518/06E166/16", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIVALAN 80MG  COMP PELL  B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ANTI-HYPERTENSEURS", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIVALAN", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "518/06E147/16", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIVALAN PLUS 160MG / 12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ANTI-HYPERTENSEURS", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DIVALAN PLUS", "Tarif de reference": "2044 DA", "PPA": "N/A", "Num Enregistrement": "518/06E237/16", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG / 12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DIVIDO 75MG GLES. DOUBLE LIBERATION B/20", "Img": "https://pharmnet-dz.com//img/medics/950.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=950", "Laboratoire": " TABUK ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "DIVIDO", "Tarif de reference": "244.4 DA", "PPA": " DA", "Num Enregistrement": "173/ 04 B 062 /06/14", "Code DCI": "04B062", "Forme": "GLES. DL", "Dosage": "75MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOBUJECT 250MG/20ML SOL.INJ.PERF. B/5AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHERING OY", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOBUTAMINE", "Liste": "Liste I", "Pays": "FINLANDE", "Nom Commercial": "DOBUJECT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "189/ 06 A 003 /99", "Code DCI": "06A003", "Forme": "SOL. INJ. PERF.", "Dosage": "250MG/20ML", "Conditionnement": "B/5AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOBUTAMINE 250MG/FL. DE PDRE. LYOPH. SOL. PERF. IV B/20 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LIORAD", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOBUTAMINE", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "DOBUTAMINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "436/ 06 A 253 /09", "Code DCI": "06A253", "Forme": "LYOPH. SOL. INJ.", "Dosage": "250MG/FL. DE PDRE.", "Conditionnement": "B/20 FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOBUTAMINE MYLAN 12,5MG/ML (250MG/20ML) SOL. INJ. A DILUER  PERF. B/10AMP. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=38", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOBUTAMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DOBUTAMINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 06 A 003 /08", "Code DCI": "06A003", "Forme": "SOL. INJ. PERF.", "Dosage": "12,5MG/ML (250MG/20ML)", "Conditionnement": "B/10AMP. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOBUTAMINE PANPHARMA 12,5MG/ML (OU 250MG/20ML) SOL. A DILUER PERF. B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PANPHARMA", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOBUTAMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DOBUTAMINE PANPHARMA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "108/ 06 A 003 /08", "Code DCI": "06A003", "Forme": "SOL. INJ. PERF.", "Dosage": "12,5MG/ML (OU 250MG/20ML)", "Conditionnement": "B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOCATRIL 30MG/SACH. PDRE. ORALE EN SACHET DOSE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE MALEATE EXPRIME EN DOMPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOCATRIL", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10H178", "Forme": "PDRE. SOL. BUV.", "Dosage": "30MG/SACH", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOCATRIL 30MG/SACH. PDRE. ORALE EN SACHET DOSE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE MALEATE EXPRIME EN DOMPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOCATRIL", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10H178", "Forme": "PDRE. SOL. BUV.", "Dosage": "30MG/SACH", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOCEFREZ 20MG/FL. DE LYOPH. LYOPH. ET SOLV. P. PERF. IV B/1FL. DE LYOPH.+1FL. DE 1ML DE SOLV. (POLYSORBATE-ETHANOL)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DOCETAXEL ANHYDRE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "DOCEFREZ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 05 G 071 /12", "Code DCI": "05G071", "Forme": "LYOPH. SOL. INJ.", "Dosage": "20MG/FL. DE LYOPH.", "Conditionnement": "B/1FL. DE LYOPH.+1FL. DE 1ML DE SOLV. (POLYSORBATE-ETHANOL)", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOCEFREZ 80MG/FL. DE LYOPH. LYOPH. ET SOLV. P. PERF. IV B/1FL. DE LYOPH.+1FL. DE 4ML DE SOLV. (POLYSORBATE-ETHANOL)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DOCETAXEL ANHYDRE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "DOCEFREZ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 05 G 072 /12", "Code DCI": "05G072", "Forme": "LYOPH. SOL. INJ.", "Dosage": "80MG/FL. DE LYOPH.", "Conditionnement": "B/1FL. DE LYOPH.+1FL. DE 4ML DE SOLV. (POLYSORBATE-ETHANOL)", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOCETAX 120MG/FL. DE CONC. CONC. SOL.INJ. B/1FL. DE CONC. DE 3ML+ 1FL. DE SOLVT. DE 9ML", "Img": "https://pharmnet-dz.com//img/medics/22.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DOCETAXEL ANHYDRE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "DOCETAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 142 /08", "Code DCI": "05G142", "Forme": "SOL. INJ.", "Dosage": "120MG/FL. DE CONC.", "Conditionnement": "B/1FL. DE CONC. DE 3ML+ 1FL. DE SOLVT. DE 9ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOCETAX 20MG/FL. DE CONC. CONC. SOL.INJ. B/1FL. DE CONC. DE 0,5ML+ 1FL. DE SOLVT. DE 1,5ML", "Img": "https://pharmnet-dz.com//img/medics/1106.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DOCETAXEL ANHYDRE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "DOCETAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 071 /08", "Code DCI": "05G071", "Forme": "LYOPH. SOL. INJ.", "Dosage": "20MG/FL. DE CONC.", "Conditionnement": "B/1FL. DE CONC. DE 0,5ML+ 1FL. DE SOLVT. DE 1,5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOCETAX 80MG/FL. DE CONC. SOL. CONC. INJ. B/1FL./2ML DE CONC. + 1FL. DE 6ML DE SOLVT.", "Img": "https://pharmnet-dz.com//img/medics/1109.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DOCETAXEL ANHYDRE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "DOCETAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 072 /08", "Code DCI": "05G072", "Forme": "LYOPH. SOL. INJ.", "Dosage": "80MG/FL. DE CONC.", "Conditionnement": "B/1FL./2ML DE CONC. + 1FL. DE 6ML DE SOLVT.", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOFEBRIL 1G COMP. EFFERV. B/10", "Img": "https://pharmnet-dz.com//img/medics/2628.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " API", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOFEBRIL", "Tarif de reference": "50 DA", "PPA": "117.00 DA", "Num Enregistrement": "348/ 03 B 080 /08", "Code DCI": "03B080", "Forme": "COMP. EFFERV.", "Dosage": "1G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOFEBRIL 500MG COMP. EFFERV. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " API", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOFEBRIL", "Tarif de reference": "50 DA", "PPA": "117.00 DA", "Num Enregistrement": "348/ 03 B 010 /08", "Code DCI": "03B010", "Forme": "COMP. EFFERV.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOFEBRIL 500MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " API", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOFEBRIL", "Tarif de reference": "50 DA", "PPA": "117.00 DA", "Num Enregistrement": "348/ 03 B 005 /06", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOFEBRIL C 330MG/200MG COMP. EFFERV. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " API", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "DOFEBRIL C", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "348/ 03 B 034 /08", "Code DCI": "03B034", "Forme": "COMP. EFFERV.", "Dosage": "330MG/200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOGMATIL 50MG GLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INSTITUT MEDICAL ALGERIEN", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOGMATIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "049/ 16 D 066 /97", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOGMATIL SANS SUCRE 25MG/5ML OU 0,5% SOL. BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/4652.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4652", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOGMATIL SANS SUCRE", "Tarif de reference": "118.00 DA", "PPA": "167.00 DA", "Num Enregistrement": "392/16D067/97/16", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML OU 0,5%", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLEX 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2673.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " MERINAL", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLEX", "Tarif de reference": "289.2 DA", "PPA": "322.00 DA", "Num Enregistrement": "268/ 03 F 047 /12", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLI RHUME 500MG/30MG COMP SEC. B/16", "Img": "https://pharmnet-dz.com//img/medics/4196.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4196", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL /  PSEUDOEPHEDRINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "DOLI RHUME", "Tarif de reference": "230 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 057 /01/09", "Code DCI": "03B057", "Forme": "COMP. SEC.", "Dosage": "500MG/30MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLI-BIEN 1G COMP B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLI-BIEN", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "318/03B081/16", "Code DCI": "03B081", "Forme": "COMP.", "Dosage": "1G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLI-BIEN 500MG COMP B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLI-BIEN", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "318/03B005/16", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLICRANE 1G COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/2629.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLICRANE", "Tarif de reference": "50 DA", "PPA": "70.00 DA", "Num Enregistrement": "400/ 03 B 081 /11", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLICRANE 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLICRANE", "Tarif de reference": "50 DA", "PPA": "54.00 DA", "Num Enregistrement": "400/ 03 B 005 /11", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 100MG PDRE. P. SOL. BUV. EN SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4602.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4602", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "102.24 DA", "PPA": "110 DA", "Num Enregistrement": "392/03B006/00/16", "Code DCI": "03B006", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 100MG SUPPO SEC B/10", "Img": "https://pharmnet-dz.com//img/medics/4155.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4155", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "46 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 007 /00/07", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 150MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4612.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4612", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "102.24 DA", "PPA": "105 DA", "Num Enregistrement": "392/03B044/00/16", "Code DCI": "03B044", "Forme": "PDRE. SUSP. BUV.", "Dosage": "150MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 150MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medics/4173.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4173", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 041 /00/07", "Code DCI": "03B041", "Forme": "SUPPO.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 1G COMP. B/08", "Img": "https://pharmnet-dz.com//img/medics/2630.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2630", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "40 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 081 /09", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 2,4% 120MG/5ML  SUSP. BUV. SANS SUCRE EDULCOREE A LA SACCHARINE SODIQUE ET AU SORBITOL AROME FRAISE B/01FL. DE 125ML + UNE CUILLERE MESURE GRADUEE A 5ML", "Img": "https://pharmnet-dz.com//img/medics/2654.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2654", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE 2,4%", "Tarif de reference": "96.25 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 117 /13", "Code DCI": "03B117", "Forme": "SOL. BUV.", "Dosage": "120MG/5ML ", "Conditionnement": "B/01FL. DE 125ML + UNE CUILLERE MESURE GRADUEE A 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 200MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4613.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4613", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "110.28 DA", "PPA": " DA", "Num Enregistrement": "392/03B045/00/16", "Code DCI": "03B045", "Forme": "PDRE. SUSP. BUV.", "Dosage": "200MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 200MG SUPPO.  B/10", "Img": "https://pharmnet-dz.com//img/medics/4178.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4178", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 042 /00/07", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 300MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4603.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4603", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "120 DA", "PPA": " DA", "Num Enregistrement": "392/03B046/00/16", "Code DCI": "03B046", "Forme": "PDRE. SUSP. BUV.", "Dosage": "300MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 300MG SUPPO  B/10", "Img": "https://pharmnet-dz.com//img/medics/4184.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4184", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 043 /00/07", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLIPRANE 500MG COMP. B/16", "Img": "https://pharmnet-dz.com//img/medics/4134.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4134", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLIPRANE", "Tarif de reference": "40 DA", "PPA": "N/A", "Num Enregistrement": "392/ 03 B 005 /98/09", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLISED 200MG/400MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOLISED", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "321/04B059/08/16", "Code DCI": "N/D", "Forme": "COMP. SEC.", "Dosage": "200MG/400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOLMATOL 325MG / 37,5MG COMP. PELLI. B/10 ET B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLMATOL", "Tarif de reference": "96.8 DA", "PPA": "N/A", "Num Enregistrement": "035/ 03 F 115 /14", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/10 ET B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLODENT 0,75G/100G SOLUTION  GINGIVALE FL/36G", "Img": "https://pharmnet-dz.com//img/medics/1132.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1132", "Laboratoire": " GILBERT", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " AMYLEINE CHLORAL", "Pays": "FRANCE", "Nom Commercial": "DOLODENT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "133/ 23 B 018 /98", "Code DCI": "23B018", "Forme": "SOL. GINGIVALE", "Dosage": "0,75G/100G", "Conditionnement": "FL/36G", "Commercialisation": true, "Remboursable": false}, {"Nom": "DOLOKIL 325MG / 37,5MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BAC PHARMA SPA", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLOKIL", "Tarif de reference": "193.6 DA", "PPA": "N/A", "Num Enregistrement": "479/ 03 F 115 /13", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLOMOL 250MG SUPPO. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "JORDANIE", "Nom Commercial": "DOLOMOL", "Tarif de reference": "60 DA", "PPA": "N/A", "Num Enregistrement": "001/ 03 B 071 /07", "Code DCI": "03B071", "Forme": "SUPPO.", "Dosage": "250MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLOMOL 250MG/5ML SUSP. BUV. B/1FL. DE 120ML + GOBLET DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLOMOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 03 B 070 /06/12", "Code DCI": "03B070", "Forme": "SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "B/1FL. DE 120ML + GOBLET DE 15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOLPRIV 0.03 SOL. BUV. FL/100ML +BOUCHON DOSEUR", "Img": "https://pharmnet-dz.com//img/medics/2616.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLPRIV", "Tarif de reference": "81 DA", "PPA": "N/A", "Num Enregistrement": "035/ 03 B 061 /08", "Code DCI": "03B061", "Forme": "SOL. BUV.", "Dosage": "0.03", "Conditionnement": "FL/100ML +BOUCHON DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLPRIV 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/4156.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLPRIV", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "035/ 03 B 007 /09", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLPRIV 150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/4174.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLPRIV", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "035/ 03 B 041 /09", "Code DCI": "03B041", "Forme": "SUPPO.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLPRIV 200MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/4179.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLPRIV", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035/ 03 B 042 /09", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOLPRIV 300MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/4185.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLPRIV", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "035/ 03 B 043 /09", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLTRAM 100MG COMP. ENRO. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLTRAM", "Tarif de reference": "639.9 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 F 107 /09", "Code DCI": "03F107", "Forme": "COMP. ENRO. LP", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLTRAM 150MG COMP. ENRO. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLTRAM", "Tarif de reference": "690 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 F 108 /09", "Code DCI": "03F108", "Forme": "COMP. ENRO. LP", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLTRAM 200MG COMP. ENRO. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLTRAM", "Tarif de reference": "739.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 F 109 /09", "Code DCI": "03F109", "Forme": "COMP. ENRO. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLTRAM 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2665.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLTRAM", "Tarif de reference": "289.2 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 F 047 /09", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLYC 1G COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/2631.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2631", "Laboratoire": " MERINAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLYC", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "268/ 03 B 081 /12", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLYC 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/4148.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4148", "Laboratoire": " MERINAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "DOLYC", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "268/ 03 B 005 /06", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLYMEX  300MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLYMEX ", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "400/03B043/16", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLYMEX 100MG SUPPO, B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLYMEX", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "400/03B007/16", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOLYMEX 200MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medics/4497.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOLYMEX", "Tarif de reference": "85 DA", "PPA": " DA", "Num Enregistrement": "400/03B042/16", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERIDE 1MG/ML SUSP.BUV. FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERIDE", "Tarif de reference": "168 DA", "PPA": "N/A", "Num Enregistrement": "055/ 10 F 047 /98", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERIDONE 1MG/ML SOL. BUV. FL/180ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERIDONE", "Tarif de reference": "201.6 DA", "PPA": "N/A", "Num Enregistrement": "065/ 10 F 047 /03", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL/180ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERIDONE BEKER 10MG COMP. PELLI. B/40", "Img": "https://pharmnet-dz.com//img/medics/4712.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERIDONE BEKER", "Tarif de reference": "260,40 DA", "PPA": " DA", "Code DCI": "10F046", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERIDONE BGL 1MG/ML SUSP. BUV. B/1FL. DE 200ML + 1SERING. P. ADMINIST. OR. GRADUE EN KG", "Img": "https://pharmnet-dz.com//img/medics/2873.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2873", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERIDONE BGL", "Tarif de reference": "226 DA", "PPA": "N/A", "Num Enregistrement": "235/ 10 F 047 /12", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "B/1FL. DE 200ML + 1SERING. P. ADMINIST. OR. GRADUE EN KG", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERIDONE LPA 1MG/ML SUSP. BUV. FL./200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERIDONE LPA", "Tarif de reference": "224 DA", "PPA": "226.00 DA", "Num Enregistrement": "026/ 10 F 047 /08", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERIMEX 1MG/ML SUSP. BUV. FL./200ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERIMEX", "Tarif de reference": "224.00 DA", "PPA": "N/A", "Code DCI": "10F047", "Forme": "SUSP. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERONE 10MG COMP. PELLI. B/40", "Img": "https://pharmnet-dz.com//img/medics/2866.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERONE", "Tarif de reference": "260.4 DA", "PPA": "260.00 DA", "Num Enregistrement": "035/ 10 F 046 /07", "Code DCI": "10F046", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMPERONE 1MG/ML SUSP.BUV. FL/200ML + PIPETTE GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMPERONE", "Tarif de reference": "168 DA", "PPA": "N/A", "Num Enregistrement": "035/10F047/16", "Code DCI": "10F047", "Forme": "SUSP. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL/200ML + PIPETTE GRADUEE EN KG", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOMSTAL 6,25MG/5ML SIROP FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/3981.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3981", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DOXYLAMINE SUCCINATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOMSTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 01 A 008 /09", "Code DCI": "01A008", "Forme": "SIROP", "Dosage": "6,25MG/5ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DONCEPT 10MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DONCEPT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/ 15 F 075 /14", "Code DCI": "15F075", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DONCEPT 5MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DONCEPT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/ 15 F 074 /14", "Code DCI": "15F074", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DONEPEZIL BEKER 10MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/2498.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2498", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DONEPEZIL BEKER", "Tarif de reference": "4060.00 DA", "PPA": "4060.00 DA", "Num Enregistrement": "447/ 15 F 075 /13", "Code DCI": "15F075", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "DONEPEZIL BEKER 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2493.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2493", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DONEPEZIL BEKER", "Tarif de reference": "4050.00 DA", "PPA": "4050.00 DA", "Num Enregistrement": "447/ 15 F 074 /13", "Code DCI": "15F074", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOPAMINE 200 PIERRE FABRE 200MG/5ML SOL. INJ.PERF. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=41", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOPAMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DOPAMINE 200 PIERRE FABRE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 06 A 005 /99", "Code DCI": "06A005", "Forme": "SOL. INJ. PERF.", "Dosage": "200MG/5ML", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOPAMINE 50MG/10ML SOL.INJ.PERF. B/50 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=40", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOPAMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DOPAMINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 06 A 004 /98", "Code DCI": "06A004", "Forme": "SOL. INJ. PERF.", "Dosage": "50MG/10ML", "Conditionnement": "B/50 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOPAMINE-200 40MG/ML (200MG/5ML) SOL. INJ. PERF. B/50 AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EMPRESSA LABORATORIOS AICA", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DOPAMINE", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "DOPAMINE-200", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "435/ 06 A 005 /09", "Code DCI": "06A005", "Forme": "SOL. INJ. PERF.", "Dosage": "40MG/ML (200MG/5ML)", "Conditionnement": "B/50 AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOPEZIL  5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2494.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOPEZIL ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "317/ 15 F 074 /11", "Code DCI": "15F074", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOPEZIL 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2499.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOPEZIL", "Tarif de reference": "0 DA", "PPA": "5485.00 DA", "Num Enregistrement": "317/ 15 F 075 /11", "Code DCI": "15F075", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOPRIN 1MG/ML SUSP. BUV. FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/2875.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2875", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DOPRIN", "Tarif de reference": "112 DA", "PPA": "N/A", "Num Enregistrement": "242/ 10 F 047 /09", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORAMINE 0,5MG/5ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DEXCHLORPHENIRAMINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DORAMINE", "Tarif de reference": "125 DA", "PPA": "N/A", "Num Enregistrement": "088/ 01 A 007 /02", "Code DCI": "01A007", "Forme": "SIROP", "Dosage": "0,5MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORICEPT 10 MG COMP ORODISPERSIBLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DORICEPT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/15F104/15", "Code DCI": "15F075", "Forme": "COMP. DISPERS.", "Dosage": "10 MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORICEPT 5 MG COMP ORODISPERSIBLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DORICEPT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/15F103/15", "Code DCI": "15F074", "Forme": "COMP. DISPERS.", "Dosage": "5 MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORMAZINE 0.04 SUSP.BUV. GTTES FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENCOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DORMAZINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "455/16D055/99", "Code DCI": "16D055", "Forme": "SUSP. BUV.", "Dosage": "4%", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORMAZINE 0.04 SUSP.BUV. GTTES FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DORMAZINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 16 D 055 /99", "Code DCI": "16D055", "Forme": "SUSP. BUV. GTTES.", "Dosage": "0.04", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORMAZINE 100MG DRG. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "DORMAZINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 16 D 054 /98/13", "Code DCI": "16D054", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DORZAMED  2% (20MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ANTI-GLAUCOMATEUX", "C.Pharmacologique": " OPHTALMOLOGIE", "C.Therapeutique": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "DORZAMED ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "521/17C121/16", "Code DCI": "17C121", "Forme": "COLLY.", "Dosage": "2% (20MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORZAMIDE 2% (20MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2358.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " OUBARI PHARMA ", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE", "Liste": "Liste I", "Pays": "SYRIE", "Nom Commercial": "DORZAMIDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "071/ 17 C 121/ 13", "Code DCI": "17C121", "Forme": "COLLY. SOL.", "Dosage": "2% (20MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DORZASOPT 20MG/5MG/ML COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ANTI-GLAUCOMATEUX", "C.Pharmacologique": " OPHTALMOLOGIE", "C.Therapeutique": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "DORZASOPT", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "521/17C141/16", "Code DCI": "17C141", "Forme": "COLLY.", "Dosage": "20MG/5MG/ML", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOSTINEX 0,5MG COMP.  PILULIER/08", "Img": "https://pharmnet-dz.com//img/medics/616.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=616", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTI-PROLACTINE", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CABERGOLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DOSTINEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 09 D 168 /13", "Code DCI": "09D168", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "PILULIER/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOTAREM 0,5MMOL/ML SOL.INJ.IV FL/10 ML - 15ML - 20ML", "Img": "https://pharmnet-dz.com//img/medics/571.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=571", "Laboratoire": " GUERBET", "C.Pharmacologique": " I.R.M.", "C.Therapeutique": " DIAGNOSTIC", "Info": " GADOTERATE DE MEGLUMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DOTAREM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "168/ 08 A 002 /99", "Code DCI": "08A002", "Forme": "SOL. INJ.", "Dosage": "0,5MMOL/ML", "Conditionnement": "FL/10 ML - 15ML - 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOTUR 100MG COMP. SEC.  B/10", "Img": "https://pharmnet-dz.com//img/medics/760.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=760", "Laboratoire": " SANDOZ", "C.Pharmacologique": " CYCLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " DOXYCYCLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOTUR", "Tarif de reference": "186 DA", "PPA": "N/A", "Num Enregistrement": "050/ 13 C 020 /98/10", "Code DCI": "13C020", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOUCE + 27G/20G PDE. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1640.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1640", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " OXYDE DE ZINC / HUILE DE FOIE DE MORUE", "Pays": "ALGERIE", "Nom Commercial": "DOUCE +", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "088/ 07 A 006 /99", "Code DCI": "07A006", "Forme": "PDE.", "Dosage": "27G/20G", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": false}, {"Nom": "DOXAMEX LP 4MG COMP. LP. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOXAMEX LP", "Tarif de reference": "1100 DA", "PPA": "N/A", "Num Enregistrement": "400/ 25 B 061 /09", "Code DCI": "25B061", "Forme": "COMP. LP", "Dosage": "4MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOXAZOSINE BEKER 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1167.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1167", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOXAZOSINE BEKER", "Tarif de reference": "825 DA", "PPA": "662.00 DA", "Num Enregistrement": "447/ 25 B 042 /13", "Code DCI": "25B042", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOXAZOSINE BEKER 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/4236.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOXAZOSINE BEKER", "Tarif de reference": "1493.40 DA", "PPA": "1493.40 DA", "Num Enregistrement": "447/25B043/15", "Code DCI": "25B043", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": false, "Remboursable": true}, {"Nom": "DOXURUBICIN \"EBEWE\" 2MG/ML (10MG/5ML -  50MG/25ML) CONCENTRE SOL. INJ. PERF.  B/1FL/5ML ET B/1FL./25ML", "Img": "https://pharmnet-dz.com//img/medics/1096.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " DAUNORUBICINE CHLORHYDRATE EXPRIME EN DAUNORUBICINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "DOXURUBICIN \"EBEWE\"", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 G 015 /98/08", "Code DCI": "05G015", "Forme": "LYOPH. SOL. INJ.", "Dosage": "2MG/ML (10MG/5ML -  50MG/25ML)", "Conditionnement": "B/1FL/5ML ET B/1FL./25ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOXYLINE 100MG GLES. B/06", "Img": "https://pharmnet-dz.com//img/medics/761.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=761", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " CYCLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " DOXYCYCLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOXYLINE", "Tarif de reference": "111.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 C 020 /98", "Code DCI": "13C020", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "DOXYNUP 100MG COMP. DISPERS. B/06", "Img": "https://pharmnet-dz.com//img/medics/765.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " CYCLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " DOXYCYCLINE MONOHYDRATE EXPRIME EN DOXYCYCLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOXYNUP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "380/ 13 C 444 /15", "Code DCI": "13C444", "Forme": "COMP. DISPERS.", "Dosage": "100MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": null}, {"Nom": "DOZAX 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DOZAX", "Tarif de reference": "1620.00 DA", "PPA": " DA", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DPCA FORMULE 91 5,670G/0,257G/ 0,152G/ 6,537G (3,922g/l de lactate de sodium pur)/ 25G  (correspondant \u00e0 22,7g/l ou 2,27% de glucose anhydre) / 1000mL SOIT : 132mmol/l en SODIUM, 1,75mmol/l en CALCIUM, 0,75mmol/l en MAGNESIUM, 35mmol/l en LACTATE , 102mmo", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BAXTER", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CHLORURE DE SODIUM / CHLORURE DE CALCIUM DIHYDRATE / CHLORURE DE MAGNESIUM HEXAHYDRATE / SOLUTION DE LACTATE DE SODIUM A 60% / GLUCOSE MONOHYDRATE ", "Pays": "ITALIE", "Nom Commercial": "DPCA FORMULE 91", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 25 G 062 /12 ", "Code DCI": "25G062", "Forme": "SOL. DIALYSE", "Dosage": "5,670G/0,257G/ 0,152G/ 6,537G (3,922g/l de lactate de sodium pur)/ 25G  (correspondant \u00e0 22,7g/l ou 2,27% de glucose anhydre) / 1000mL SOIT : 132mmol/l en SODIUM, 1,75mmol/l en CALCIUM, 0,75mmol/l en MAGNESIUM, 35mmol/l en LACTATE , 102mmol/l en chlorure,", "Conditionnement": "POCHE DOUBLE DE 2000ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "DRIPTANE 5MG COMP.SEC. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FOURNIER", "C.Pharmacologique": " ANTI-ENURETIQUES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " OXYBUTYNINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "DRIPTANE", "Tarif de reference": " N/A", "PPA": "489.00 DA", "Num Enregistrement": "019/ 25 D 008 /97", "Code DCI": "25D008", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "DROMAX 70MG COMP. B/04", "Img": "https://pharmnet-dz.com//img/medics/1430.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DROMAX", "Tarif de reference": " N/A", "PPA": "1760.00 DA", "Num Enregistrement": "263/ 21 G 050 /15", "Code DCI": "21G050", "Forme": "COMP.", "Dosage": "70MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "DUDREX 5MG/50MG COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3296.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3296", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMILORIDE (SOUS FORME DE CHLORHYDRATE)**/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DUDREX", "Tarif de reference": "205.5 DA", "PPA": "N/A", "Num Enregistrement": "065/ 06 H 094 /03/11", "Code DCI": "06H094", "Forme": "COMP.", "Dosage": "5MG/50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DULOX 30MG MICRO-GRANUL. EN GLES. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DULOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 16 A 106 /15", "Code DCI": "16A106", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "30MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DULOX 60MG MICRO-GRANUL. EN GLES. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DULOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 16 A 107 /15", "Code DCI": "16A107", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "60MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DUOFEM 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2666.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DUOFEM", "Tarif de reference": "289.2 DA", "PPA": "289.00 DA", "Num Enregistrement": "035/ 03 F 047 /10", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUOFILM 16,7G/16,7G/100G SOL. FL/15ML", "Img": "https://pharmnet-dz.com//img/medics/536.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=536", "Laboratoire": " STIEFEL LIMITED", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE SALICYLIQUE / ACIDE LACTIQUE", "Pays": "IRELAND", "Nom Commercial": "DUOFILM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "125/ 07 L 120 /01", "Code DCI": "07L120", "Forme": "SOL.", "Dosage": "16,7G/16,7G/100G", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUOVIR 150MG/300MG COMP. PELL. B/60", "Img": "https://pharmnet-dz.com//img/medics/432.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LAMIVUDINE/ZIDOVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "DUOVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 277 /05", "Code DCI": "13P227", "Forme": "COMP. PELLI.", "Dosage": "150MG/300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "DUPHALAC 10G/15ML SOL.BUV.SACHET B/20 ", "Img": "https://pharmnet-dz.com//img/medics/2937.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2937", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "FRANCE", "Nom Commercial": "DUPHALAC", "Tarif de reference": "258 DA", "PPA": "N/A", "Num Enregistrement": "031/ 10 L 097 /98", "Code DCI": "10L097", "Forme": "SOL. BUV. SACHET", "Dosage": "10G/15ML", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUPHASTON 10MG COMP .PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/3816.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3816", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DYDROGESTERONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DUPHASTON", "Tarif de reference": "332.84 DA", "PPA": "N/A", "Num Enregistrement": "031/ 09 N 060 /98/04", "Code DCI": "09N060", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUROGESIC 100\u00b5G/HEURE DISPOSITIF TRANSDERMIQUE B/05", "Img": "https://pharmnet-dz.com//img/medics/2693.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2693", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES MAJEURS (STUPEFIANTS)", "C.Therapeutique": " ANTALGIQUES", "Info": " FENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "DUROGESIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 03 G 079 /07", "Code DCI": "03G079", "Forme": "DISPOSITIF", "Dosage": "100\u00b5G/HEURE", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUROGESIC 12\u00b5G/HEURE  DISPOSITIF TRANSDERMIQUE B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2694", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES MAJEURS (STUPEFIANTS)", "C.Therapeutique": " ANTALGIQUES", "Info": " FENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "DUROGESIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 03 G 106 /08", "Code DCI": "03G106", "Forme": "DISPOSITIF", "Dosage": "12\u00b5G/HEURE ", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": null}, {"Nom": "DUROGESIC 25\u00b5G/HEURE  DISPOSITIF TRANSDERMIQUE B/05", "Img": "https://pharmnet-dz.com//img/medics/2690.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2690", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES MAJEURS (STUPEFIANTS)", "C.Therapeutique": " ANTALGIQUES", "Info": " FENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "DUROGESIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 03 G 076 /07", "Code DCI": "03G076", "Forme": "DISPOSITIF", "Dosage": "25\u00b5G/HEURE ", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUROGESIC 50\u00b5G/HEURE  DISPOSITIF TRANSDERMIQUE B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2691", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES MAJEURS (STUPEFIANTS)", "C.Therapeutique": " ANTALGIQUES", "Info": " FENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "DUROGESIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 03 G 077 /07", "Code DCI": "03G077", "Forme": "DISPOSITIF", "Dosage": "50\u00b5G/HEURE ", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": null}, {"Nom": "DUROGESIC 75\u00b5G/HEURE  DISPOSITIF TRANSDERMIQUE B/05", "Img": "https://pharmnet-dz.com//img/medics/2692.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2692", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES MAJEURS (STUPEFIANTS)", "C.Therapeutique": " ANTALGIQUES", "Info": " FENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "DUROGESIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 03 G 078 /07", "Code DCI": "03G078", "Forme": "DISPOSITIF", "Dosage": "75\u00b5G/HEURE ", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "DURRAX 2MG/ML SIROP FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/2174.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2174", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "DURRAX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "242/ 16 B 079 /09", "Code DCI": "16B079", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUSPAVERINE 100MG MICROGLES. EN GLES.  B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3952.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DUSPAVERINE", "Tarif de reference": "217.2 DA", "PPA": "217.00 DA", "Num Enregistrement": "289/ 10 E 035 /12 ", "Code DCI": "10E035", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "DUSPAVERINE 200MG MICROGLES. LP EN GLES.  B/30", "Img": "https://pharmnet-dz.com//img/medics/2849.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DUSPAVERINE", "Tarif de reference": "217.2 DA", "PPA": "308.00 DA", "Num Enregistrement": "289/ 10 E 116 /13", "Code DCI": "10E116", "Forme": "GLES. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "DYAREX 2MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DYAREX", "Tarif de reference": "128.2 DA", "PPA": "N/A", "Num Enregistrement": "268/ 10 H 056 /05", "Code DCI": "10H056", "Forme": "GLES.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "DYNASTAT 40MG / FLACON  POUDRE POUR SOL INJ IM/IV  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4259", "Laboratoire": " PFIZER", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "DYNASTAT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/04B071/15", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG / FLACON ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "DYSENTYL 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/3927.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "DYSENTYL", "Tarif de reference": " N/A", "PPA": "197.00 DA", "Num Enregistrement": "268/ 10 C 017 /06/14", "Code DCI": "10C017", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "DYSPORT 500UNITES SPEYWOOD 500UI SPEYWOOD (Une Unit\u00e9 Speywood correspond \u00e0 DL 50 chez la souris par voie intra p\u00e9riton\u00e9ale) PDRE. SOL. INJ. B/01", "Img": "https://pharmnet-dz.com//img/medics/2507.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2507", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " NEUROLOGIE", "Info": " TOXINE BOTULINIQUE TYPE  A : COMPLEXE TOXINE - HEMAGLUTININE Bo TX-A", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "DYSPORT 500UNITES SPEYWOOD", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "020/ 15 H 079 /07", "Code DCI": "15H079", "Forme": "PDRE. SOL. BUV.", "Dosage": "500UI SPEYWOOD (Une Unit\u00e9 Speywood correspond \u00e0 DL 50 chez la souris par voie intra p\u00e9riton\u00e9ale)", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}], "E": [{"Nom": "EASYLACT 66,5% ( 66,5 g/100ml) SOL BUV FL/200ML+GOBLET DOSEUR DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " N/D", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "EASYLACT", "Tarif de reference": "172.00 DA", "PPA": "N/A", "Code DCI": "10L062", "Forme": "SOL. BUV.", "Dosage": "66,5%", "Conditionnement": "200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EAU OXYGENE 30V 30V SOL. USAGE EXTERNE FL./1000ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " PEROXYDE D' HYDROGENE", "Pays": "ALGERIE", "Nom Commercial": "EAU OXYGENE 30V", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 26 B 040 /04", "Code DCI": "26B040", "Forme": "SOL. EXTERNE", "Dosage": "30V", "Conditionnement": "FL./1000ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU OXYGENEE 10 VOLUMES SOL. USAGE EXTERNE FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RHUMEL PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EAU OXYGENEE", "Pays": "ALGERIE", "Nom Commercial": "EAU OXYGENEE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "234/ 26 B 015 /02", "Code DCI": "26B015", "Forme": "SOL. APP. LOCALE", "Dosage": "10 VOLUMES", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EAU OXYGENEE 10V 10 VOLUMES SOL. USAGE EXTERNE FL./1L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LABIOCO", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EAU OXYGENEE", "Pays": "ALGERIE", "Nom Commercial": "EAU OXYGENEE 10V", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "464/ 26 B 015 /10", "Code DCI": "26B015", "Forme": "SOL. APP. LOCALE", "Dosage": "10 VOLUMES", "Conditionnement": "FL./1L", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU OXYGENEE 10VOLUMES SOL. USAGE EXTERNE F/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EAU OXYGENEE", "Pays": "ALGERIE", "Nom Commercial": "EAU OXYGENEE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "319/ 26 B 015 /06", "Code DCI": "26B015", "Forme": "SOL. APP. LOCALE", "Dosage": "10VOLUMES", "Conditionnement": "F/60ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU OXYGENEE GIFRER 10 VOLUMES SOL. APPLI. LOCALE ", "Img": "https://pharmnet-dz.com//img/medics/1245.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1245", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EAU OXYGENEE", "Pays": "FRANCE", "Nom Commercial": "EAU OXYGENEE GIFRER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "004/ 26 B 015 /96", "Code DCI": "26B015", "Forme": "SOL. APP. LOCALE", "Dosage": "10 VOLUMES", "Conditionnement": "250", "Commercialisation": true, "Remboursable": true}, {"Nom": "EAU OXYGENEE OFFICINALE 10 VOLUMES SOL. USAGE EXTERNE FL/1L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EAU OXYGENEE", "Pays": "ALGERIE", "Nom Commercial": "EAU OXYGENEE OFFICINALE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 26 B 015 /99/09", "Code DCI": "26B015", "Forme": "SOL. APP. LOCALE", "Dosage": "10 VOLUMES", "Conditionnement": "FL/1L", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU POUR PREPARATION INJECTABLE AMP. DE 3ML --- B/50 AMP. de 3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE", "Pays": "ALGERIE", "Nom Commercial": "EAU POUR PREPARATION INJECTABLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 184 /00", "Code DCI": "14G184", "Forme": "\u2026", "Dosage": "AMP. DE 3ML", "Conditionnement": "B/50 AMP. de 3ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU POUR PREPARATION INJECTABLE AMP. DE 5ML --- B/50 AMP. de 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE", "Pays": "ALGERIE", "Nom Commercial": "EAU POUR PREPARATION INJECTABLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 185 /00", "Code DCI": "14G185", "Forme": "\u2026", "Dosage": "AMP. DE 5ML", "Conditionnement": "B/50 AMP. de 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU POUR PREPARATION INJECTABLE RAZES AMP. DE 10ML --- B/50AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE IM/IV", "Pays": "ALGERIE", "Nom Commercial": "EAU POUR PREPARATION INJECTABLE RAZES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 14 G 186 /13", "Code DCI": "14G186", "Forme": "\u2026", "Dosage": "AMP. DE 10ML", "Conditionnement": "B/50AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU POUR PREPARATIONS INJECTABLES --- --- FL/500 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE IM/IV", "Pays": "ALGERIE", "Nom Commercial": "EAU POUR PREPARATIONS INJECTABLES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 042 /97", "Code DCI": "14G042", "Forme": "\u2026", "Dosage": "---", "Conditionnement": "FL/500 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU POUR PREPARATIONS INJECTABLES RAZES --- --- FL/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE IM/IV", "Pays": "ALGERIE", "Nom Commercial": "EAU POUR PREPARATIONS INJECTABLES RAZES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 14 G 042 /15", "Code DCI": "14G042", "Forme": "\u2026", "Dosage": "---", "Conditionnement": "FL/500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU POUR PREPARATIONS INJECTABLES RAZES AMP. DE 2ML --- B/50 AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE IM/IV", "Pays": "ALGERIE", "Nom Commercial": "EAU POUR PREPARATIONS INJECTABLES RAZES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 14 G 183 /15", "Code DCI": "14G183", "Forme": "\u2026", "Dosage": "AMP. DE 2ML", "Conditionnement": "B/50 AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU POUR PREPARATIONS INJECTABLES RAZES AMP. DE 5ML --- B/50 AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE", "Pays": "ALGERIE", "Nom Commercial": "EAU POUR PREPARATIONS INJECTABLES RAZES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 14 G 185 /15", "Code DCI": "14G185", "Forme": "\u2026", "Dosage": "AMP. DE 5ML", "Conditionnement": "B/50 AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU. P. PREPARAT. INJ. STERILE APYROGENE  SOL.INJ. B/100 AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU DISTILLEE STERILE", "Pays": "FRANCE", "Nom Commercial": "EAU. P. PREPARAT. INJ. STERILE APYROGENE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 039 /96", "Code DCI": "14G039", "Forme": "SOL. INJ.", "Conditionnement": "B/100 AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EAU. P. PREPARAT. INJ. STERILE APYROGENE  SOL.INJ. B/50AMP. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU DISTILLEE STERILE", "Pays": "FRANCE", "Nom Commercial": "EAU. P. PREPARAT. INJ. STERILE APYROGENE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 040 /96", "Code DCI": "14G040", "Forme": "SOL. INJ.", "Conditionnement": "B/50AMP. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ECAZIDE 50MG/25MG COMP .SEC. B/28 ET B/30", "Img": "https://pharmnet-dz.com//img/medics/4527.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ECAZIDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/06E137/99/16", "Code DCI": "06E137", "Forme": "COMP. SEC.", "Dosage": "50MG/25MG", "Conditionnement": "B/28 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ECLARAN 0.05 GEL.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1649.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1649", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ECLARAN", "Tarif de reference": "168.75 DA", "PPA": "N/A", "Num Enregistrement": "099/ 07 B 013 /98", "Code DCI": "07B013", "Forme": "GEL. DERM.", "Dosage": "0.05", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ECLARAN 0.1 GEL. DERM. T/45G", "Img": "https://pharmnet-dz.com//img/medics/1652.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1652", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ECLARAN", "Tarif de reference": "183.15 DA", "PPA": " DA", "Num Enregistrement": "099/ 07 B 014 /98", "Code DCI": "07B014", "Forme": "GEL. DERM.", "Dosage": "0.1", "Conditionnement": "T/45G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ECOMI 1G% LAIT DERMIQUE FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " GEYMONAT S.P.A", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ECONAZOLE", "Pays": "ITALIE", "Nom Commercial": "ECOMI", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "220/ 07 D 026 /99/07", "Code DCI": "07D026", "Forme": "LAIT DERMIQUE", "Dosage": "1G%", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ECONAZOLE NOVAGENERICS 0.01 LAIT DERMIQUE FL./30ML", "Img": "https://pharmnet-dz.com//img/medics/1696.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ECONAZOLE", "Pays": "ALGERIE", "Nom Commercial": "ECONAZOLE NOVAGENERICS", "Tarif de reference": "0 DA", "PPA": "240.00 DA", "Num Enregistrement": "149/ 07 D 026 /15", "Code DCI": "07D026", "Forme": "LAIT DERMIQUE", "Dosage": "0.01", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ECONAZYL 0.01 CREME.DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1692.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1692", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ECONAZOLE (NITRATE)", "Pays": "ALGERIE", "Nom Commercial": "ECONAZYL", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "088/ 07 D 025 /05", "Code DCI": "07D025", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ECOVAR 150MG OVULES GYNECO. B/03", "Img": "https://pharmnet-dz.com//img/medics/3001.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3001", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ECONAZOLE (NITRATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ECOVAR", "Tarif de reference": "169.8 DA", "PPA": "N/A", "Num Enregistrement": "231/ 11 A 001 /06", "Code DCI": "11A001", "Forme": "OVULE ", "Dosage": "150MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "ECOVAR LP 150MG OVULE  GYNECO. LP. B/01", "Img": "https://pharmnet-dz.com//img/medics/3011.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3011", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ECONAZOLE (NITRATE)", "Pays": "ALGERIE", "Nom Commercial": "ECOVAR LP", "Tarif de reference": "360 DA", "PPA": "N/A", "Num Enregistrement": "231/ 11 A 071 /10", "Code DCI": "11A071", "Forme": "OVULE LP", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "EDEX 10\u00b5G/ML PDRE ET  SOLVT. SOL. INJ. B/2 CARTOUCHE BI-COMPARTIMENT DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " ALPROSTADIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EDEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "273/ 25 N 034 /05", "Code DCI": "25N034", "Forme": "PDRE. INJ.", "Dosage": "10\u00b5G/ML", "Conditionnement": "B/2 CARTOUCHE BI-COMPARTIMENT DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EDEX 20\u00b5G/ML PDRE ET  SOLVT. SOL. INJ. B/2 CARTOUCHE BI-COMPARTIMENT DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " ALPROSTADIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EDEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "273/ 25 N 035 /05", "Code DCI": "25N035", "Forme": "PDRE. INJ.", "Dosage": "20\u00b5G/ML", "Conditionnement": "B/2 CARTOUCHE BI-COMPARTIMENT DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EFAVIR 200MG GLES. B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " EFAVIRENZ", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "EFAVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 286 /09", "Code DCI": "13P286", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": null}, {"Nom": "EFAVIR 600MG COMP. PELLI. PILULIER DE 30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " EFAVIRENZ", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "EFAVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 287 /13", "Code DCI": "13P287", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "PILULIER DE 30", "Commercialisation": true, "Remboursable": null}, {"Nom": "EFFERALGAN 500MG COMP. SEC B/16", "Img": "https://pharmnet-dz.com//img/medics/4135.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4135", "Laboratoire": " PROPHARMAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EFFERALGAN", "Tarif de reference": "40 DA", "PPA": "N/A", "Num Enregistrement": "201/ 03 B 005 /96/14", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "EFFERALGAN PEDIATRIQUE 0.03 SOL. BUV. FL/90ML", "Img": "https://pharmnet-dz.com//img/medics/2617.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2617", "Laboratoire": " PROPHARMAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EFFERALGAN PEDIATRIQUE", "Tarif de reference": "72.9 DA", "PPA": "N/A", "Num Enregistrement": "201/ 03 B 061 /96/11                                       ", "Code DCI": "03B061", "Forme": "SOL. BUV.", "Dosage": "0.03", "Conditionnement": "FL/90ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EFFERALGAN VITAMINE C 330MG/200MG COMP .EFFER. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " UPSA", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / ACIDE ASCORBIQUE", "Pays": "FRANCE", "Nom Commercial": "EFFERALGAN VITAMINE C", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "008/ 03 B 034 /00", "Code DCI": "03B034", "Forme": "COMP. EFFERV.", "Dosage": "330MG/200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "EFFERALGAN VITAMINE C 500MG/200MG COMP EFFERV B/16", "Img": "https://pharmnet-dz.com//img/medics/2657.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2657", "Laboratoire": " PROPHARMAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "EFFERALGAN VITAMINE C", "Tarif de reference": "0 DA", "PPA": "70.00 DA", "Num Enregistrement": "201/ 03 B 118 /14", "Code DCI": "03B118", "Forme": "COMP. EFFERV.", "Dosage": "500MG/200MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "EFFEXOR LP 37,5MG GLES. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2575", "Laboratoire": " WYETH PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EFFEXOR LP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "030/ 16 A 125 /08", "Code DCI": "16A125", "Forme": "GLES. LP", "Dosage": "37,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EFFICORT HYDROPHILE 0.00127 CREME HYDROPHILE T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE ACEPONATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EFFICORT HYDROPHILE", "Tarif de reference": " N/A", "PPA": "240.00 DA", "Num Enregistrement": "123/ 07 H 118 /01/15", "Code DCI": "07H118", "Forme": "CR\u00c8ME", "Dosage": "0.00127", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": null}, {"Nom": "EFFICORT LIPOPHILE 0.00127 CREME LIPOPHILE T/30G", "Img": "https://pharmnet-dz.com//img/medics/511.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=511", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE ACEPONATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EFFICORT LIPOPHILE", "Tarif de reference": "231.14 DA", "PPA": "N/A", "Num Enregistrement": "123/ 07 H 117 /01", "Code DCI": "07H117", "Forme": "CR\u00c8ME", "Dosage": "0.00127", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "EFFUCINE 0.02 PDE. DERM T./15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " LGPA", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EFFUCINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "311/07C016/15", "Code DCI": "07C016", "Forme": "PDE. DERM.", "Dosage": "2%", "Conditionnement": "T./15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "EGORIE 250MG COMP. PELLI. B/64", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EGORIE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "468/ 15 A 072 /15", "Code DCI": "15A072", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/64", "Commercialisation": true, "Remboursable": null}, {"Nom": "ELAPRASE 2MG/ML  SOLUT, A DILUER POUR PERF IV  1 FL 3 ML (6MG/3ML)", "Img": "https://pharmnet-dz.com//img/medics/4365.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4365", "Laboratoire": " SHIRE HUMAN GENETIC THERAPIES INC (SHIRE HGT)", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "ELAPRASE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "493/14N353/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "2MG/ML ", "Conditionnement": "1 FL 3 ML (6MG/3ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELIGARD 22,5MG PDRE. ET SOLV. P. SOL. INJ. SC DIFFUSION LENTE SUR 3 MOIS B/01KIT DE 2 PLATEAUX THERMOFORMES CONTENANT : (01 SERING. PREREMP. D. SOLV. (SERING. A) + 01 PISTON A TIGE LONGUE) + (01 SERING. PREREMP. D. PDRE. (SERING. B) + 01 AIGUILLE STERILE ", "Img": "https://pharmnet-dz.com//img/medics/1076.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1076", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " LEUPRORELINE ACETATE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ELIGARD", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "374/ 05 E 171 /14", "Code DCI": "05E171", "Forme": "PDRE. SOL. INJ.", "Dosage": "22,5MG", "Conditionnement": "B/01KIT DE 2 PLATEAUX THERMOFORMES CONTENANT : (01 SERING. PREREMP. D. SOLV. (SERING. A) + 01 PISTON A TIGE LONGUE) + (01 SERING. PREREMP. D. PDRE. (SERING. B) + 01 AIGUILLE STERILE 20G)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELIGARD 45MG PDRE. ET SOLV. P. SOL. INJ. SC DIFFUSION LENTE SUR 6 MOIS B/01KIT DE 2 PLATEAUX THERMOFORMES CONTENANT : (01 SERING. PREREMP. D. SOLV. (SERING. A) + 01 PISTON A TIGE LONGUE) + (01 SERING. PREREMP. D. PDRE. (SERING. B) + 01 AIGUILLE STERILE 18", "Img": "https://pharmnet-dz.com//img/medics/1077.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1077", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " LEUPRORELINE ACETATE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ELIGARD", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "374/ 05 E 172 /14", "Code DCI": "05E172", "Forme": "PDRE. SOL. INJ.", "Dosage": "45MG", "Conditionnement": "B/01KIT DE 2 PLATEAUX THERMOFORMES CONTENANT : (01 SERING. PREREMP. D. SOLV. (SERING. A) + 01 PISTON A TIGE LONGUE) + (01 SERING. PREREMP. D. PDRE. (SERING. B) + 01 AIGUILLE STERILE 18G)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELIQUIS 2,5 MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PFIZER", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE EMBONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ELIQUIS", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": " 2,5 MG ", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELISOR 20MG COMP.SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PAROXETINE CHLORHYDRATE HEMIHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ELISOR", "Tarif de reference": "----- DA", "PPA": "N/A", "Code DCI": "06M134", "Forme": "COMP SEC.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELOXATINE 100MG/FL. DE LYOPH. ET 100MG/FL. DE SOL. A DILUER  (OU 5MG/ML)  LYOPH. PERF. ET SOL. A DILUER PERF. B/1FL. DE LYOPH. ET B/1FL. DE SOL. A DILUER DE 20ML", "Img": "https://pharmnet-dz.com//img/medics/1122.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1122", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " OXALIPLATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ELOXATINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 05 G 090 /00/09", "Code DCI": "05G090", "Forme": "LYOPH. SOL. INJ.", "Dosage": "100MG/FL. DE LYOPH. ET 100MG/FL. DE SOL. A DILUER  (OU 5MG/ML) ", "Conditionnement": "B/1FL. DE LYOPH. ET B/1FL. DE SOL. A DILUER DE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELOXATINE 50MG/ FL. DE LYOPH. ET 50MG/FL. DE SOL. A DILUER (OU 5MG/ML) LYOPH. PERF. ET SOL. A DILUER PERF. B/1FL. DE LYOPH. ET B/1FL. DE SOL. A DILUER DE 10ML ", "Img": "https://pharmnet-dz.com//img/medics/1119.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1119", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " OXALIPLATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ELOXATINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 05 G 089 /00/09", "Code DCI": "05G089", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG/ FL. DE LYOPH. ET 50MG/FL. DE SOL. A DILUER (OU 5MG/ML)", "Conditionnement": "B/1FL. DE LYOPH. ET B/1FL. DE SOL. A DILUER DE 10ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELUDRIL 0,5ML/0,5G/100ML BAIN DE BOUCHE FL/90 ML", "Img": "https://pharmnet-dz.com//img/medics/1136.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1136", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " CHLORHEXIDINE DIGLUCONATE /CHLOROBUTANOL HEMIHYDRATE", "Pays": "FRANCE", "Nom Commercial": "ELUDRIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 23 B 026 /99", "Code DCI": "23B026", "Forme": "SOL. BAIN BOUCHE", "Dosage": "0,5ML/0,5G/100ML", "Conditionnement": "FL/90 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ELUDRIL 50MG/15MG pour 100ML COLLU. FL/55 ML", "Img": "https://pharmnet-dz.com//img/medics/1126.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1126", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " CHLORHEXIDINE/TETRACAINE", "Pays": "FRANCE", "Nom Commercial": "ELUDRIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 23 B 007 /98", "Code DCI": "23B007", "Forme": "COLLU.", "Dosage": "50MG/15MG pour 100ML", "Conditionnement": "FL/55 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EMESET 2MG/ML (OU 4MG/2ML ET 8MG/4ML) SOL. INJ. B/5AMP 2ML ET 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "EMESET", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 10 F 048 /03", "Code DCI": "10F048", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (OU 4MG/2ML ET 8MG/4ML)", "Conditionnement": "B/5AMP 2ML ET 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EMETIKAN 10 10MG CP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " TAPHCO SPA", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "EMETIKAN 10", "Tarif de reference": "195,3 DA", "PPA": "N/A", "Code DCI": "10F046", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EMIDIUM HUP 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2867.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "EMIDIUM HUP", "Tarif de reference": "195.3 DA", "PPA": "199.00 DA", "Num Enregistrement": "380/ 10 F 046 /14", "Code DCI": "10F046", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENALAPRIL / HYDROCHLOROTHIAZIDE MYLAN 20MG** /12,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3135", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ENALAPRIL / HYDROCHLOROTHIAZIDE MYLAN", "Tarif de reference": "1063.5 DA", "PPA": "N/A", "Num Enregistrement": "450/ 06 E 222 /06", "Code DCI": "06E222", "Forme": "COMP.", "Dosage": "20MG** /12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENALAPRIL 20MG COMP.SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ASIA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "SYRIE", "Nom Commercial": "ENALAPRIL", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "121/ 06 E 060 /03", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENALAPRIL MYLAN 20MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=156", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ENALAPRIL MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 06 E 060 /06/12", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "ENALAPRIL MYLAN 5MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=149", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ENALAPRIL MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 06 E 059 /06/12", "Code DCI": "06E059", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "ENALAPRIL WINTHROP 20MG COMP SEC B/28", "Img": "https://pharmnet-dz.com//img/medics/157.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ENALAPRIL WINTHROP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 06 E 060 /09", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENANTONE LP 11,25MG  5,625MG/ML (OU 11,25MG/2ML) MICROSPHERES ET SOL. POUR USAGE PARENT.S.C./I.M.  LP B/1FL. DE PDRE. + 1AMP./2ML SOLV. + 1SERIN.", "Img": "https://pharmnet-dz.com//img/medics/1068.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1068", "Laboratoire": " TAKEDA", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " LEUPRORELINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ENANTONE LP 11,25MG ", "Tarif de reference": "0 DA", "PPA": "39232.00 DA", "Num Enregistrement": "411/ 05 E 122 /08", "Code DCI": "05E122", "Forme": "MICROSPHERES", "Dosage": "5,625MG/ML (OU 11,25MG/2ML)", "Conditionnement": "B/1FL. DE PDRE. + 1AMP./2ML SOLV. + 1SERIN.", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENANTONE LP 3,75MG 1,875 MG/ML (OU 3,75MG/2ML) PDRE. ET SOLV. POUR SUSP. INJ. S.C./I.M.  L.P. B/1FL. DE PDRE. + 1AMP./2ML SOLV. + 1SERIN.", "Img": "https://pharmnet-dz.com//img/medics/1067.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1067", "Laboratoire": " TAKEDA", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " LEUPRORELINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ENANTONE LP 3,75MG", "Tarif de reference": "0 DA", "PPA": "15286.00 DA", "Num Enregistrement": "411/ 05 E 121 /08", "Code DCI": "05E121", "Forme": "PDRE. SOL. INJ.", "Dosage": "1,875 MG/ML (OU 3,75MG/2ML)", "Conditionnement": "B/1FL. DE PDRE. + 1AMP./2ML SOLV. + 1SERIN.", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENANTUM 25 MG COMP. PELLI.  B/20", "Img": "https://pharmnet-dz.com//img/medics/4256.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4256", "Laboratoire": " MENARINI", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste II", "Pays": "ESPAGNE", "Nom Commercial": "ENANTYUM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "203/03H124/15", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "25 MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENBREL 25MG/SERING SOL. INJ. SC EN SERING. PREREMPL COFFRET 04 SERING. PREREMPL. DE 1ML + 04 TAMPONS ALCOOLISES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4433", "Laboratoire": " PFIZER", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " ETANERCEPT", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ENBREL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/21J063/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "25MG/SERING", "Conditionnement": "COFFRET 04 SERING. PREREMPL. DE 1ML + 04 TAMPONS ALCOOLISES", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENBREL 50MG/SERING. SOL. INJ. SC EN SERING. PREREMPL. COFFRET 04 SERING. PREREMPL. DE 1ML + 04 TAMPONS ALCOOLISES", "Img": "https://pharmnet-dz.com//img/medics/1452.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1452", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " N/D", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ETANERCEPT", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ENBREL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 21 J 062 /14", "Code DCI": "21J062", "Forme": "SOL. INJ.", "Dosage": "50MG/SERING.", "Conditionnement": "COFFRET 04 SERING. PREREMPL. DE 1ML + 04 TAMPONS ALCOOLISES", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENCIFER 20MG/ML (100MG/5ML) SOL. INJ. P. PERF. IV OU EN INJ. DANS LE DIALYSEUR B/01FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/1799.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE", "Pays": "INDE", "Nom Commercial": "ENCIFER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "471/ 12 E 135 /13", "Code DCI": "12E135", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "B/01FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENCOFLUIDE ADULTE 0,25G/0,01G/2G/0,2G/1G/0,048G/100ML SOL.BUV. FL/180 ML", "Img": "https://pharmnet-dz.com//img/medics/2148.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2148", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERPINE / EUCALYPTOL / BENZOATE DE SODIUM /GUAIFENESINE (DCI) / TEINTURE D'IPECA / CODEINE BASE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ENCOFLUIDE ADULTE", "Tarif de reference": "183 DA", "PPA": "N/A", "Num Enregistrement": "003/ 20 B 030 /97/09", "Code DCI": "20B030", "Forme": "SOL. BUV.", "Dosage": "0,25G/0,01G/2G/0,2G/1G/0,048G/100ML", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENCORATE  200MG COMP. B/100 ET B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "INDE", "Nom Commercial": "ENCORATE ", "Tarif de reference": "0 DA", "PPA": "685.00 DA", "Num Enregistrement": "330/ 15 A 001 /05", "Code DCI": "15A001", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/100 ET B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENCORATE 500MG COMP. B/100 ET B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "INDE", "Nom Commercial": "ENCORATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "330/ 15 A 002 /05", "Code DCI": "15A002", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/100 ET B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENDOLET 30MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/4647.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " TABUK", "C.Pharmacologique": " N/D", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ENDOLET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "173/09S171/16", "Code DCI": "09S171", "Forme": "COMP. PELLI.", "Dosage": "30MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENDOLET 60MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/4648.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " TABUK", "C.Pharmacologique": " N/D", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ENDOLET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "173/09S172/16", "Code DCI": "09S172", "Forme": "COMP. PELLI.", "Dosage": "60MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENDOLET 90MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/4676.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " TABUK", "C.Pharmacologique": " N/D", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ENDOLET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "173/09S173/17", "Code DCI": "09S173", "Forme": "COMP. PELLI.", "Dosage": "90MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENDOXAN 1G/FL. DE PDRE PDRE. P. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE 75ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=6", "Laboratoire": " BAXTER", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CYCLOPHOSPHAMIDE MONOHYDRATEE EXPRIME EN CYCLOPHOSPHAMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ENDOXAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 05 G 104 /09", "Code DCI": "05G104", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE", "Conditionnement": "B/01FL. DE PDRE. DE CONTENANCE 75ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ENDOXAN 200MG/FL. DE PDRE. PDRE. P. SOL. INJ. IV B/1FL. DE PDRE. DE CONTENANCE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " BAXTER", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CYCLOPHOSPHAMIDE ANHYDRE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ENDOXAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 05 G 009 /09", "Code DCI": "05G009", "Forme": "PDRE. SOL. INJ.", "Dosage": "200MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. DE CONTENANCE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ENDOXAN 500MG/FL. DE PDRE. PDRE. P. SOL. INJ. IV B/1FL. DE PDRE. DE CONTENANCE 50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1092", "Laboratoire": " BAXTER", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CYCLOPHOSPHAMIDE ANHYDRE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ENDOXAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 05 G 010 /09", "Code DCI": "05G010", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. DE CONTENANCE 50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ENDOXAN 50MG COMP. ENRO. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1094", "Laboratoire": " BAXTER", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CYCLOPHOSPHAMIDE MONOHYDRATEE EXPRIME EN CYCLOPHOSPHAMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ENDOXAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 05 G 011 /12", "Code DCI": "05G011", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "ENDRONAX 70MG COMP. B/04", "Img": "https://pharmnet-dz.com//img/medics/1431.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ENDRONAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035/ 21 G 050 /09/15", "Code DCI": "21G050", "Forme": "COMP.", "Dosage": "70MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "ENERMAG 1,5G/10ML SOL. BUV. B/20AMP.AUTOCASSABLES", "Img": "https://pharmnet-dz.com//img/medics/3359.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM PIDOLATE", "Pays": "ALGERIE", "Nom Commercial": "ENERMAG", "Tarif de reference": "320 DA", "PPA": "320.00 DA", "Num Enregistrement": "003/ 14 G 054 /07", "Code DCI": "14G054", "Forme": "SOL. BUV.", "Dosage": "1,5G/10ML", "Conditionnement": "B/20AMP.AUTOCASSABLES", "Commercialisation": true, "Remboursable": true}, {"Nom": "ENERMAG 15% (1,5G/10ML) SIROP. FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM ELEMENT  (SOUS FORME DE MAGNESIUM PIDOLATE)", "Pays": "ALGERIE", "Nom Commercial": "ENERMAG", "Tarif de reference": "172.5 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 162 /08", "Code DCI": "14G162", "Forme": "SOL. BUV.", "Dosage": "15% (1,5G/10ML)", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EOSINE AQUEUSE - GIFRER & BARBEZAT 0.02 SOL. APPL. LOCALE FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/1249.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1249", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EOSINE AQUEUSE", "Pays": "FRANCE", "Nom Commercial": "EOSINE AQUEUSE - GIFRER & BARBEZAT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "004/ 26 B 017 /96", "Code DCI": "26B017", "Forme": "SOL. EXTERNE", "Dosage": "0.02", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EOSINE AQUEUSE 0.02 SOL. USAGE EXTERNE FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RHUMEL PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EOSINE AQUEUSE", "Pays": "ALGERIE", "Nom Commercial": "EOSINE AQUEUSE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "234/ 26 B 017 /00", "Code DCI": "26B017", "Forme": "SOL. EXTERNE", "Dosage": "0.02", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EOSINE AQUEUSE 0.02 SOL. USAGE EXTERNE FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " EOSINE AQUEUSE", "Pays": "ALGERIE", "Nom Commercial": "EOSINE AQUEUSE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 26 B 017 /03", "Code DCI": "26B017", "Forme": "SOL. EXTERNE", "Dosage": "0.02", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EPIGENT 40 40MG SOL.INJ. B/5 ", "Img": "https://pharmnet-dz.com//img/medics/1859.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EIPICO ", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "EPIGENT 40", "Tarif de reference": "223.35 DA", "PPA": " DA", "Num Enregistrement": "109/ 13 A 004 /99", "Code DCI": "13A004", "Forme": "SOL. INJ.", "Dosage": "40MG", "Conditionnement": "B/5 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPIGENT 80 80MG/2ML SOL.INJ. IM / IV B/1", "Img": "https://pharmnet-dz.com//img/medics/1865.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1865", "Laboratoire": " EIPICO ", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "EPIGENT 80", "Tarif de reference": "61 DA", "PPA": " DA", "Num Enregistrement": "109/ 13 A 005 /99", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "80MG/2ML", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPILAT 10 10MG GLES B/30", "Img": "https://pharmnet-dz.com//img/medics/62.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EIPICO ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NIFEDIPINE ", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "EPILAT 10", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "109/ 06 B 017 /99", "Code DCI": "06B017", "Forme": "CAPS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPILEPTAM 250MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EPILEPTAM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/15A072/16", "Code DCI": "15A072", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "EPILEPTAM 500MG COMP,PELLI, B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EPILEPTAM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/15A073/16", "Code DCI": "15A073", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "EPINTAS 2MG/ML (10MG/5ML  ET 50MG/25ML) SOL. INJ. P. PERF. IV B/01FL. DE 5ML ET B/01FL. DE 25ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " INTAS PHARMACEUTICALS LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " EPIRUBICINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "EPINTAS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "478/ 05 G 103 /13", "Code DCI": "05G103", "Forme": "SOL. PERF.", "Dosage": "2MG/ML (10MG/5ML  ET 50MG/25ML)", "Conditionnement": "B/01FL. DE 5ML ET B/01FL. DE 25ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EPIRUBICIN EBEWE 2MG/ML (10MG/5ML -  50MG/25ML  -  100MG/50ML). SOL.  PERF. FL./5ML  ET  FL./25ML  ET  FL./50ML.", "Img": "https://pharmnet-dz.com//img/medics/1010.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1010", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " EPIRUBICINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "EPIRUBICIN EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 103 /05", "Code DCI": "05A103", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (10MG/5ML -  50MG/25ML  -  100MG/50ML).", "Conditionnement": "FL./5ML  ET  FL./25ML  ET  FL./50ML.", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPIRUDEX 2MG/ML (10MG/5ML - 50MG/25ML ) SOL. P. PERF. IV B/01FL. DE 5ML - B/01FL. DE 25ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " EPIRUBICINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EPIRUDEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "323/05G103/16", "Code DCI": "05G103", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (10MG/5ML - 50MG/25ML )", "Conditionnement": "B/01FL. DE 5ML - B/01FL. DE 25ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "EPITOMAX 15MG GLES. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2444", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPITOMAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "095/ 15 A 080 /07", "Code DCI": "15A080", "Forme": "GLES.", "Dosage": "15MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPITOMAX 200MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2448", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPITOMAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "095/ 15 A 084 /07", "Code DCI": "15A084", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPIVAL 200MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "EPIVAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 15 A 001 /07", "Code DCI": "15A001", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPIVAL 500MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "EPIVAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 15 A 002 /07", "Code DCI": "15A002", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPIVIR 10MG/ML SOL.BUV. FL/240ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=435", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LAMIVUDINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "EPIVIR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "112/ 13 P 237 /01", "Code DCI": "13P237", "Forme": "SOL. BUV.", "Dosage": "10MG/ML", "Conditionnement": "FL/240ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPIVIR 150MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/433.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=433", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LAMIVUDINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "EPIVIR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "112/ 13 P 236 /01", "Code DCI": "13P236", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPIZOLONE-DEPOT 40MG/ML SUSPENSION AQUEUSE INJECTABLE  B/ 01 FL DE 40MG/ML ET B/ 01 FL DE 80 MG/2ML ", "Img": "https://pharmnet-dz.com//img/medics/5939.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " EIPICO ", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE ACETATE", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "EPIZOLONE-DEPOT", "Tarif de reference": "- DA", "PPA": " DA", "Code DCI": "09H090", "Forme": "SUSP. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/ 01 FL DE 40MG/ML ET B/ 01 FL DE 80 MG/2ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPOTIN 2000UI/ML (SOIT 16,8\u00b5G//FL DE 1ML) SOL. INJ. IV/SC B/10FL. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/1788.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "EPOTIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "329/ 12 E 112 /06/13", "Code DCI": "12E112", "Forme": "SOL. INJ.", "Dosage": "2000UI/ML (SOIT 16,8\u00b5G//FL DE 1ML)", "Conditionnement": "B/10FL. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPREX 10 000UI/ML SOL.INJ. B/6SERINGUES PRE REMPLIES", "Img": "https://pharmnet-dz.com//img/medics/1767.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1767", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPREX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 12 E 063 /99", "Code DCI": "12E063", "Forme": "LYOPH. SOL. INJ.", "Dosage": "10 000UI/ML", "Conditionnement": "B/6SERINGUES PRE REMPLIES", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPREX 2000UI /0,5ML SOL.INJ. B/6SERINGUES PRE REMPLIES", "Img": "https://pharmnet-dz.com//img/medics/1763.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1763", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPREX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 12 E 061 /99", "Code DCI": "12E061", "Forme": "SOL. INJ.", "Dosage": "2000UI /0,5ML", "Conditionnement": "B/6SERINGUES PRE REMPLIES", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPREX 2000UI/ML (OU 1000U/0,5/ML) SOL.INJ. B/6SERINGUES PRE REMPLIES ", "Img": "https://pharmnet-dz.com//img/medics/1761.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1761", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPREX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 12 E 060 /99", "Code DCI": "12E060", "Forme": "LYOPH. SOL. INJ.", "Dosage": "2000UI/ML (OU 1000U/0,5/ML)", "Conditionnement": "B/6SERINGUES PRE REMPLIES ", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPREX 3000UI /0,3ML SOL INJ B/6 SERINGUES PRE REMPLIES", "Img": "https://pharmnet-dz.com//img/medics/1787.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPREX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 12 E 110 /03", "Code DCI": "12E110", "Forme": "SOL. INJ.", "Dosage": "3000UI /0,3ML", "Conditionnement": "B/6 SERINGUES PRE REMPLIES", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPREX 40 000UI/ML  ( OU 20 000UI/0,5ML) SOL. INJ. B/01SERING. PRE REMPLIE 0,5ML ET B/01SERING. PRE REMPLIE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1794", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPREX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 12 E 130 /07", "Code DCI": "12E130", "Forme": "SOL. INJ.", "Dosage": "40 000UI/ML  ( OU 20 000UI/0,5ML)", "Conditionnement": "B/01SERING. PRE REMPLIE 0,5ML ET B/01SERING. PRE REMPLIE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EPREX 4000UI/0,4ML SOL.INJ. B/6SERINGUES PRE REMPLIES", "Img": "https://pharmnet-dz.com//img/medics/1765.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1765", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EPREX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 12 E 062 /99", "Code DCI": "12E062", "Forme": "SOL. INJ.", "Dosage": "4000UI/0,4ML", "Conditionnement": "B/6SERINGUES PRE REMPLIES", "Commercialisation": true, "Remboursable": true}, {"Nom": "EPTOL 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "EPTOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 15 A 004 /09", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "EQUORAL  100MG/ML SOL. BUV. FL./50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " IVAX PHARMACEUTICALS", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "TCHEQUIE", "Nom Commercial": "EQUORAL ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "397/ 05 B 047 /07", "Code DCI": "05B047", "Forme": "SOL. INJ.", "Dosage": "100MG/ML", "Conditionnement": "FL./50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERACID 250MG COMP B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ERACID", "Tarif de reference": "280 DA", "PPA": "N/A", "Num Enregistrement": "043/ 13 E 244 /03", "Code DCI": "13E244", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERACID 500MG COMP. ENRO. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ERACID", "Tarif de reference": "574 DA", "PPA": "N/A", "Num Enregistrement": "043/ 13 E 215 /07", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERBITUX 2MG/ML (OU 100MG/50ML) SOL. INJ. PERF. FL/50ML", "Img": "https://pharmnet-dz.com//img/medics/1060.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " MERCK KG aA", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " CETUXIMAB", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ERBITUX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "062/ 05 D 117 /08", "Code DCI": "05D117", "Forme": "SOL. PERF.", "Dosage": "2MG/ML (OU 100MG/50ML)", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERBITUX 5MG/ML (100MG/20ML - 500MG/100ML) SOL. INJ. P. PERF. B/1FL. DE 20ML ET B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medics/1063.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1063", "Laboratoire": " MERCK KG aA", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " CETUXIMAB", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ERBITUX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "062/ 05 D 157 /12", "Code DCI": "05D157", "Forme": "SOL. PERF.", "Dosage": "5MG/ML (100MG/20ML - 500MG/100ML)", "Conditionnement": "B/1FL. DE 20ML ET B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERECTA 100MG  COMP PELL  B/4", "Img": "https://pharmnet-dz.com//img/medics/1233.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ERECTA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "149/25 N 060 /14", "Code DCI": "25N060", "Forme": "COMP. PELLI.", "Dosage": "100MG ", "Conditionnement": "B/4", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERECTA 50MG  COMP PELL  B/02 ET B/08", "Img": "https://pharmnet-dz.com//img/medics/1219.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ERECTA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "149/ 25 N 045 /14", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/02 ET B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "EREMCINE 10MG/ML (25MG/2,5ML) SOL. INJ. IM OU IV LENTE B/1FL. DE 2,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EREMPHARMA", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TOBRAMYCINE SULFATE EXPRIME EN TOBRAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EREMCINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "389/ 13 A 465 /12", "Code DCI": "13A465", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (25MG/2,5ML)", "Conditionnement": "B/1FL. DE 2,5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EREMCINE 50MG/ML (75MG/1,5ML) SOL. INJ. IM OU IV LENTE B/1FL. DE 1,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EREMPHARMA", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TOBRAMYCINE SULFATE EXPRIME EN TOBRAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "EREMCINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "389/ 13 A 466 /12", "Code DCI": "13A466", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (75MG/1,5ML)", "Conditionnement": "B/1FL. DE 1,5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERIXIUM 20MG COMP. PELLI. B/04", "Img": "https://pharmnet-dz.com//img/medics/1228.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ERIXIUM", "Tarif de reference": " N/A", "PPA": "998.00 DA", "Num Enregistrement": "352/ 25 N 052 /13", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERODAL 200MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML  DE SUSP. BUV. APRES RECONST. +GOBELET DOSEUR GRADUE ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ERODAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 028 /11", "Code DCI": "13E028", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "B/1FL. DE 60ML  DE SUSP. BUV. APRES RECONST. +GOBELET DOSEUR GRADUE ", "Commercialisation": true, "Remboursable": true}, {"Nom": "EROMYCIN 200MG/5ML GRLES. SUSP. BUV. FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "EROMYCIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "329/ 13 E 028 /07", "Code DCI": "13E028", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERTICAN 20MG/ML (40MG/2ML - 100MG/5ML) SOL. INJ. P. PERF. IV B/1FL. DE 2ML ET B/1FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " IRINOTECAN CHLORHYDRATE TRIHYDRATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ERTICAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 076 /12", "Code DCI": "05G076", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (40MG/2ML - 100MG/5ML)", "Conditionnement": "B/1FL. DE 2ML ET B/1FL. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERTIVIX  0,5 MG  COMP,SECA B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RANBAXY", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ENTECAVIR", "Liste": "Liste I", "Nom Commercial": "ERTIVIX ", "Code DCI": "13P313", "Forme": "COMP. SEC.", "Dosage": "0,5 MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERTIVIX  1MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RANBAXY", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ENTECAVIR", "Liste": "Liste I", "Nom Commercial": "ERTIVIX ", "Code DCI": "13P314", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERY 500MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/783.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=783", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ERY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "269/ 13 E 029 /98", "Code DCI": "13E029", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERYBESAN 200MG/5ML GRLES.SUSP.BUV. FL/60 ML", "Img": "https://pharmnet-dz.com//img/medics/777.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=777", "Laboratoire": " SANDOZ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ERYBESAN", "Tarif de reference": "266.5 DA", "PPA": "N/A", "Num Enregistrement": "050/ 13 E 028 /98", "Code DCI": "13E028", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "FL/60 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERYBESAN 500MG COMP.ENRO. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANDOZ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ERYBESAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 13 E 029 /98/10", "Code DCI": "13E029", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERYTHRODAR 200MG/5ML SUSP.BUV. FL/100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ERYTHRODAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 13 E 028 /99/14", "Code DCI": "13E028", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "FL/100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ERYTHROMIL 200MG/5ML SUSP.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/779.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ERYTHROMIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "118/ 13 E 028 /98", "Code DCI": "13E028", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ERYTHROMIL 500MG COMP. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ERYTHROMIL", "Tarif de reference": "241.5 DA", "PPA": "N/A", "Num Enregistrement": "118/ 13 E 029 /99", "Code DCI": "13E029", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "ESCITALOPRAM BEKER 10MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/2565.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2565", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ESCITALOPRAM BEKER", "Tarif de reference": "364.84 DA", "PPA": "364.84 DA", "Num Enregistrement": "447/ 16 A 105 /12", "Code DCI": "16A105", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ESCITOL 10MG/ML SOL. BUV. GTTES. FL./15ML AVEC COMPTE GOUTTES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "ESCITOL", "Tarif de reference": " N/A", "PPA": "744.00 DA", "Num Enregistrement": "177/ 16 A 131 /09/15", "Code DCI": "16A131", "Forme": "SOL. BUV. GTTES.", "Dosage": "10MG/ML", "Conditionnement": "FL./15ML AVEC COMPTE GOUTTES", "Commercialisation": true, "Remboursable": null}, {"Nom": "ESCITOL 20MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "ESCITOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "177/ 16 A 130 /09", "Code DCI": "16A130", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "ESMERON 50MG/5ML SOL.INJ. B/12FL. DE 5ML ", "Img": "https://pharmnet-dz.com//img/medics/4111.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ORGANON", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ROCURONIUM BROMURE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ESMERON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "005/ 02 D 049 /99", "Code DCI": "02D049", "Forme": "SOL. INJ.", "Dosage": "50MG/5ML", "Conditionnement": "B/12FL. DE 5ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "ESORAL 20MG MICROGLES. GASTRORESIST. EN GLES. B/16 ET B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE MAGNESIUM TRIHYDRATE EXPRIME EN ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ESORAL", "Tarif de reference": "224 DA", "PPA": "1351.00 DA", "Num Enregistrement": "317/ 10 A 180 /13", "Code DCI": "10A180", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/16 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ESORAL 40MG MICROGLES. GASTRORESIST. EN GLES. B/16 ET B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ESORAL", "Tarif de reference": "224 DA", "PPA": "951.00 DA", "Num Enregistrement": "317/ 10 A 181 /13", "Code DCI": "10A181", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/16 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ESTROGEL 1,212G/SACHET DOSE (8,08G/SACHET DOSE DE SEL BOEHMITE) SUSP. BUV. B/24 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3898.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3898", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OXYDE D'ALUMINIUM HYDRATE EXPRIME EN OXYDE D'ALUMINIUM", "Pays": "ALGERIE", "Nom Commercial": "ESTROGEL", "Tarif de reference": "241.2 DA", "PPA": "275.00 DA", "Num Enregistrement": "388/ 10 B 013 /08", "Code DCI": "10B013", "Forme": "SUSP. BUV.", "Dosage": "1,212G/SACHET DOSE (8,08G/SACHET DOSE DE SEL BOEHMITE)", "Conditionnement": "B/24 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ETACID 50\u00b5G/DOSE SPRAY NASAL FL./140DOSES ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " WORLD MEDECINE ILAC ", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " MOMETASONE (SOUS FORME DE FUROATE)**", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "ETACID", "Tarif de reference": "-- DA", "PPA": " DA", "Code DCI": "22E036", "Forme": "SPRAY NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL./140DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "ETAMSYLATE 250MG/2ML SOL INJ B/10AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " HEMOSTATIQUES GENERAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ETAMSYLATE", "Pays": "ITALIE", "Nom Commercial": "ETAMSYLATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 12 H 039 /00", "Code DCI": "12H039", "Forme": "SOL. INJ.", "Dosage": "250MG/2ML", "Conditionnement": "B/10AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ETHER GIFRER  SOL. APPLI. LOCALE FL/200ML-FL/400ML- FL/800ML", "Img": "https://pharmnet-dz.com//img/medics/1239.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1239", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " ETHER DIETHYLIQUE", "Pays": "FRANCE", "Nom Commercial": "ETHER GIFRER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "004/ 26 B 013 /96", "Code DCI": "26B013", "Forme": "SOL. APP. LOCALE", "Dosage": "0", "Conditionnement": "FL/200ML-FL/400ML- FL/800ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ETOPOSID EBEWE 100MG 20MG/ML (OU 100MG/5ML) CONCENTRE PERF. IV  B/1FL/5 ML", "Img": "https://pharmnet-dz.com//img/medics/975.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=975", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " ETOPOSIDE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "ETOPOSID EBEWE 100MG", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 019 /98/08", "Code DCI": "05A019", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (OU 100MG/5ML)", "Conditionnement": "B/1FL/5 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ETOPOSIDE MYLAN 20MG/ML (100MG/5ML) SOL. A DILUER P. PERF. IV B/10FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1099", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " ETOPOSIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ETOPOSIDE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 G 019 /12", "Code DCI": "05G019", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "B/10FL. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ETOSID 20MG/ML (OU 100MG/5ML) SOL. INJ. B/01FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/976.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " ETOPOSIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ETOSID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 019 /07", "Code DCI": "05A019", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (OU 100MG/5ML)", "Conditionnement": "B/01FL. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "EUCARBON 180MG / 25MG /105MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/2945.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2945", "Laboratoire": " TRENKA CHM PHARMA FABRIK GES M.B.H.", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CHARBON  VEGETAL / EXTRAIT DE RHUBARBE / FEUILLES DE SENE", "Pays": "AUTRICHE", "Nom Commercial": "EUCARBON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "078/ 10 L 138 /97", "Code DCI": "10L138", "Forme": "COMP.", "Dosage": "180MG / 25MG /105MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "EUFOR 80MG COMP. ORODISPERS. B/10 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " N/D", "Info": " PHLOROGLUCINOL DIHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EUFOR", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/10E108/16", "Code DCI": "10E108", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/10 ET B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "EUPNEX 10 MG/5ML SIROP FL/180 ML", "Img": "https://pharmnet-dz.com//img/medics/2164.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2164", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " OXELADINE", "Pays": "ALGERIE", "Nom Commercial": "EUPNEX", "Tarif de reference": "181.8 DA", "PPA": "181.8 DA", "Num Enregistrement": "003/ 20 C 034 /98", "Code DCI": "20C034", "Forme": "SIROP", "Dosage": "10 MG/5ML", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EURAXYL 0.1 CREME T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTIPRURIGINEUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CROTAMITON", "Pays": "ALGERIE", "Nom Commercial": "EURAXYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "366/ 07 G 036 /10", "Code DCI": "07G036", "Forme": "CR\u00c8ME", "Dosage": "0.1", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": null}, {"Nom": "EVAL 0,15MG/0,03MG(BLANCS)  ET  0,20MG/0,04MG(ROSE ORANGE) COMP. B/3X21(7BLANCS + 14 ROSE ORANGE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " FAMY CARE ", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "EVAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "291/ 11 H 028 /04", "Code DCI": "11H028", "Forme": "COMP.", "Dosage": "0,15MG/0,03MG(BLANCS)  ET  0,20MG/0,04MG(ROSE ORANGE)", "Conditionnement": "B/3X21(7BLANCS + 14 ROSE ORANGE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "EVAPAUSE 100MG CAPS. MOLLE ORA.ET VAG. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PROGESTERONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EVAPAUSE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "195/ 09 N 109 /09", "Code DCI": "09N109", "Forme": "CAPS. MOLLE", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EVIFEN 60MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1435.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " EL KENDI", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " RALOXIFENE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EVIFEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 21 G 054 /15", "Code DCI": "21G054", "Forme": "COMP. PELLI.", "Dosage": "60MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "EVISTA 60MG COMP.PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1436.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1436", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " RALOXIFENE CHLORHYDRATE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "EVISTA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 21 G 054 /00/08", "Code DCI": "21G054", "Forme": "COMP. PELLI.", "Dosage": "60MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXBITAN 10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXBITAN", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "001/06E259/17", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXBITAN 10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXBITAN", "Tarif de reference": "1500 DA", "PPA": "N/A", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXBITAN 5MG/160MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXBITAN", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "001/06E258/16", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXBITAN 5MG/80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXBITAN", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "001/06E257/16", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXFORGE 10MG/160MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3198.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3198", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "EXFORGE", "Tarif de reference": "1540 DA", "PPA": " DA", "Num Enregistrement": "068/ 06 E 259 /08", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXFORGE 5MG/160MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3194.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3194", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "EXFORGE", "Tarif de reference": "1540 DA", "PPA": "1718.00 DA", "Num Enregistrement": "068/ 06 E 258 /08", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXFORGE 5MG/80MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3190.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3190", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "EXFORGE", "Tarif de reference": "1540 DA", "PPA": " DA", "Num Enregistrement": "068/ 06 E 257 /08", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXFORMEDIC 10MG/160MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXFORMEDIC", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "418/06E259/16", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXFORMEDIC 5MG/160MG  COMP PELL  B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXFORMEDIC", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "418/06E258/16", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXFORMEDIC 5MG/80MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXFORMEDIC", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "418/06E257/16", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXIRB 5MG/150 MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXIRB", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "5MG/150 MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXJADE 125MG COMP. DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medics/1147.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1147", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "EXJADE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 24 D 017 /08", "Code DCI": "24D017", "Forme": "COMP.", "Dosage": "125MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXJADE 250MG COMP. DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medics/1149.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1149", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "EXJADE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 24 D 018 /08", "Code DCI": "24D018", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXJADE 500MG COMP. DISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medics/1151.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1151", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "EXJADE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 24 D 019 /09", "Code DCI": "24D019", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXODERIL 0.01 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " NAFTIFINE CHLORHYDRATE", "Pays": "AUTRICHE", "Nom Commercial": "EXODERIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "080/ 07 D 132 /01", "Code DCI": "07D132", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXODERIL 0.01 SOL. DERM. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/468.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=468", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " NAFTIFINE CHLORHYDRATE", "Pays": "AUTRICHE", "Nom Commercial": "EXODERIL", "Tarif de reference": "307.13 DA", "PPA": "N/A", "Num Enregistrement": "080/ 07 D 131 /01", "Code DCI": "07D131", "Forme": "SOL. DERM.", "Dosage": "0.01", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXPANDOL 100MG PDRE. P. SOL. BUV. EN SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4150.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4150", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL", "Tarif de reference": "102.24 DA", "PPA": "100.00 DA", "Num Enregistrement": "235/ 03 B 006 /11", "Code DCI": "03B006", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXPANDOL 150MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4188.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4188", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL", "Tarif de reference": "102.24 DA", "PPA": "102.00 DA", "Num Enregistrement": "235/ 03 B 044 /11", "Code DCI": "03B044", "Forme": "PDRE. SOL. BUV.", "Dosage": "150MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXPANDOL 1G COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/2638.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2638", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL", "Tarif de reference": "44 DA", "PPA": "N/A", "Num Enregistrement": "235/ 03 B 081 /08/14", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXPANDOL 200MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4190.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4190", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL", "Tarif de reference": "110.28 DA", "PPA": "107.00 DA", "Num Enregistrement": "235/ 03 B 045 /11", "Code DCI": "03B045", "Forme": "PDRE. SOL. BUV.", "Dosage": "200MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXPANDOL 300MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4193.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4193", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "235/ 03 B 046 /11", "Code DCI": "03B046", "Forme": "PDRE. SOL. BUV.", "Dosage": "300MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXPANDOL 500MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/4136.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4136", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "235/ 03 B 005 /00/13", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "EXPANDOL 500MG POUDRE POUR SOLUT BUVABLE EN SACHET  B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL", "Tarif de reference": "30 DA", "PPA": "N/A", "Num Enregistrement": "235/03B066/16", "Code DCI": "03B066", "Forme": "PDRE. SUSP. BUV.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXPANDOL PLUS 500MG/65MG COMP. B/16", "Img": "https://pharmnet-dz.com//img/medics/2641.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2641", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CAFEINE", "Pays": "ALGERIE", "Nom Commercial": "EXPANDOL PLUS", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "235/ 03 B 088 /14", "Code DCI": "03B088", "Forme": "COMP. SEC.", "Dosage": "500MG/65MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXSART 10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXSART", "Tarif de reference": " N/A", "PPA": "1650.00 DA", "Num Enregistrement": "035/ 06 E 259 /15", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "EXSART 5MG/160MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXSART", "Tarif de reference": "1500 DA", "PPA": "N/A", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": " 5MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXSART 5MG/80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXSART", "Tarif de reference": " N/A", "PPA": "1650.00 DA", "Num Enregistrement": "035/ 06 E 257 /15", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "EXTENCINE 600 000UI/FL. DE PDRE. PDRE. P. SUSP. INJ. IM B/01 FL. DE PDRE. + 01 AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/258.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=258", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " BENZATHINE BENZYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXTENCINE", "Tarif de reference": "120.47 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 G 060 /11", "Code DCI": "13G060", "Forme": "PDRE. SOL. INJ.", "Dosage": "600 000UI/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE. + 01 AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXTRADOL  500MG/65MG COMP. B/16 ET B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CAFEINE", "Pays": "ALGERIE", "Nom Commercial": "EXTRADOL ", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "03B088", "Forme": "COMP.", "Dosage": "500MG/65MG", "Conditionnement": "B/16 & B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXTRAMADOL 325MG / 37,5MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXTRAMADOL", "Tarif de reference": "193.6 DA", "PPA": "270.00 DA", "Num Enregistrement": "470/ 03 F 115 /13", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXTRANEAL 7,5% 75G/L (7,5%) D'ICODEXTRINE (5,4G/4,5G/0,257G/0,051G)/L                                                  SOIT PAR LITRE 133MMOL DE SODIUM, 1,75MMOL DE CALCIUM, 0,25MMOL DE MAGNESIUM, 96MMOL DE CHLORURE , 40MMOL DE LACTATE SOL. P. DIALYSE PER", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1211", "Laboratoire": " BAXTER", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " ICODEXTRINE (DCI)/SODIUM CHLORURE/SODIUM LACTATE / CALCIUM CHLORURE / MAGNESIUM CHLORURE ", "Pays": "ROYAUME UNI", "Nom Commercial": "EXTRANEAL 7,5%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 25 G 066 /12", "Code DCI": "25G066", "Forme": "SOL. DIALYSE", "Dosage": "75G/L (7,5%) D'ICODEXTRINE (5,4G/4,5G/0,257G/0,051G)/L                                                  SOIT PAR LITRE 133MMOL DE SODIUM, 1,75MMOL DE CALCIUM, 0,25MMOL DE MAGNESIUM, 96MMOL DE CHLORURE , 40MMOL DE LACTATE", "Conditionnement": "B/05POCHES SIMPLES DE 2L ET B/05POCHES DOUBLES DE 2L ( POCHES FLEXIBLES -SYST\u00c8ME II CONNEXION A VIS LUER - VIAFLEX EN PVC DE FORMULE PL146-3)", "Commercialisation": true, "Remboursable": null}, {"Nom": "EXVAL 10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3197.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXVAL", "Tarif de reference": "1650 DA", "PPA": "1650.00 DA", "Num Enregistrement": "352/ 06 E 259 /11", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXVAL 5MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3192.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXVAL", "Tarif de reference": "1650 DA", "PPA": "1649.00 DA", "Num Enregistrement": "352/ 06 E 258 /11", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EXVAL 5MG/80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3189.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "EXVAL", "Tarif de reference": "1650 DA", "PPA": "1649.00 DA", "Num Enregistrement": "352/ 06 E 257 /11", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EZETROL 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1627.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1627", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " EZETIMIBE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "EZETROL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 06 M 298 /13", "Code DCI": "06M298", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "EZILAX 0.6666 SIROP B/1FLDE 200 ML+BOUCHON DOSEUR  ET  B/1FLDE 300ML+BOUCHON DOSEUR ", "Img": "https://pharmnet-dz.com//img/medics/2930.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2930", "Laboratoire": " EL KENDI", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "EZILAX", "Tarif de reference": "258 DA", "PPA": "N/A", "Num Enregistrement": "352/ 10 L 062 /99/09", "Code DCI": "10L062", "Forme": "SOL. BUV.", "Dosage": "0.6666", "Conditionnement": "B/1FLDE 200 ML+BOUCHON DOSEUR  ET  B/1FLDE 300ML+BOUCHON DOSEUR ", "Commercialisation": true, "Remboursable": true}], "F": [{"Nom": "FABRAZYME 35MG/FL. DE PDRE. PDRE. P/SOL. A DILUER P/PERFUSION IV B/01 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3482.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3482", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " AGALSIDASE BETA", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "FABRAZYME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 14 N 349 /15", "Code DCI": "14N349", "Forme": "PDRE. SOL. INJ.", "Dosage": "35MG/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "FACTIVE 320MG COMP. B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GEMIFLOXACINE MESYLATE EXPRIME EN GEMIFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "FACTIVE", "Tarif de reference": " N/A", "PPA": "2518.00 DA", "Num Enregistrement": "001/ 13 K 334 /09", "Code DCI": "13K334", "Forme": "COMP. PELLI.", "Dosage": "320MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": null}, {"Nom": "FAGYX 500MG COMP. PELLI. B/4", "Img": "https://pharmnet-dz.com//img/medics/2056.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2056", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " AUTRES ANTI-PARASITAIRES", "C.Therapeutique": " PARASITOLOGIE", "Info": " TINIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAGYX", "Tarif de reference": "0 DA", "PPA": "200.00 DA", "Num Enregistrement": "293/ 19 D 026 /07", "Code DCI": "19D026", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/4", "Commercialisation": true, "Remboursable": true}, {"Nom": "FAMISAS 200MG/FL. DE PDRE. PDRE. P. SOL. INJ. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CYCLOPHOSPHAMIDE ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAMISAS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 05 G 009 /06", "Code DCI": "05G009", "Forme": "PDRE. SOL. INJ.", "Dosage": "200MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "FAMISAS 500MG/FL. DE PDRE. PDRE. P. SOL. INJ. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CYCLOPHOSPHAMIDE ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAMISAS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 05 G 010 /06", "Code DCI": "05G010", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "FAMISAS 50MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYCLOPHOSPHAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAMISAS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 05 A 011 /06", "Code DCI": "05A011", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "FAMOXYL  125MG/5ML PDRE. P. SUSP. BUV. FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " THERACIA PRODUCTION", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAMOXYL ", "Tarif de reference": "132 DA", "PPA": "N/A", "Num Enregistrement": "326/ 13 G 046 /05", "Code DCI": "13G046", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FAMOXYL  250MG/5ML PDRE. P. SUSP. BUV. FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " THERACIA PRODUCTION", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAMOXYL ", "Tarif de reference": "132 DA", "PPA": "N/A", "Num Enregistrement": "326/ 13 G 047 /05", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FAMOXYL  500MG GLES B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " THERACIA PRODUCTION", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAMOXYL ", "Tarif de reference": "139.32 DA", "PPA": "N/A", "Num Enregistrement": "326/ 13 G 045 /05", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "FAMOXYL  500MG/5ML PDRE SUSP. BUV. FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " THERACIA PRODUCTION", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FAMOXYL ", "Tarif de reference": "205.2 DA", "PPA": "N/A", "Num Enregistrement": "326/ 13 G 220 /05", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FAMYNON 0,25MG/0,05MG COMP B/3X21", "Img": "https://pharmnet-dz.com//img/medics/3046.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " FAMY CARE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FAMYNON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "291/ 11 H 041 /04", "Code DCI": "11H041", "Forme": "COMP.", "Dosage": "0,25MG/0,05MG", "Conditionnement": "B/3X21", "Commercialisation": true, "Remboursable": true}, {"Nom": "FARMIDOX 850MG COMP. PELLI.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FARMIDOX", "Tarif de reference": "492 DA", "PPA": "N/A", "Num Enregistrement": "077/14A007/16", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FASIGYNE 500MG COMP.ENRO. B/4", "Img": "https://pharmnet-dz.com//img/medics/2057.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2057", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " AUTRES ANTI-PARASITAIRES", "C.Therapeutique": " PARASITOLOGIE", "Info": " TINIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FASIGYNE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 19 D 026 /98/06", "Code DCI": "19D026", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/4", "Commercialisation": true, "Remboursable": true}, {"Nom": "FASLODEX 20MG/SERING. DE 5ML SOL. INJ. IM EN SERING. PREREMPL. B/2SERING. PREREMPL. DE 5ML AVEC 02AIGUILLES PROTEGEES (BD SAFETYGLIDE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " FULVESTRANT", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "FASLODEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "256/ 05 E 164 /13", "Code DCI": "05E164", "Forme": "SOL. INJ.", "Dosage": "20MG/SERING. DE 5ML", "Conditionnement": "B/2SERING. PREREMPL. DE 5ML AVEC 02AIGUILLES PROTEGEES (BD SAFETYGLIDE)", "Commercialisation": true, "Remboursable": null}, {"Nom": "FEBRECTOL ADULTES 600MG/40MG SUPPO. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1282", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PARACETAMOL/HUILE ESSENTIELLE DE PIN DE SYLVESTRE", "Pays": "FRANCE", "Nom Commercial": "FEBRECTOL ADULTES", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 20 C 116 /05", "Code DCI": "20C116", "Forme": "SUPPO.", "Dosage": "600MG/40MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEBRECTOL ENFANTS 300MG/30MG SUPPO. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1281", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PARACETAMOL/HUILE ESSENTIELLE DE PIN DE SYLVESTRE", "Pays": "FRANCE", "Nom Commercial": "FEBRECTOL ENFANTS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 20 C 115 /05", "Code DCI": "20C115", "Forme": "SUPPO.", "Dosage": "300MG/30MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEBRECTOL NOURRISSONS 150MG/20MG SUPPO. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1280", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PARACETAMOL/HUILE ESSENTIELLE DE PIN DE SYLVESTRE", "Pays": "FRANCE", "Nom Commercial": "FEBRECTOL NOURRISSONS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 20 C 114 /05", "Code DCI": "20C114", "Forme": "SUPPO.", "Dosage": "150MG/20MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEDICARD 40MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPRANOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FEDICARD", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/ 06 F 073 /13", "Code DCI": "06F073", "Forme": "COMP. SEC.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEIBA 500U\u00b0/FL. DE PDRE. (500U\u00b0/20ML)      U\u00b0=UNITE FEIBA PDRE. ET SOLVT. SOL. INJ. IV B/1FL. DE PDRE. + 1FL. DE SOLVT.(EPPI) DE 20ML+1AIGUILLE A USAGE UNIQUE A AILETTE AVEC PINCE + 1SERINGUE A USAGE UNIQUE + 1BAXJECT II HI-FLOW POUR LA RECONSTITUTION OU ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1839", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEURS DE COAGULATION AYANT UNE ACTIVITE COURT-CIRCUITANT L'INHIBITEUR DE FACTEUR VIII (facteurs antih\u00e9mophiliques)", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "FEIBA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "298/ 12 J 147 /09", "Code DCI": "12J147", "Forme": "PDRE. INJ.", "Dosage": "500U\u00b0/FL. DE PDRE. (500U\u00b0/20ML)      U\u00b0=UNITE FEIBA", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE SOLVT.(EPPI) DE 20ML+1AIGUILLE A USAGE UNIQUE A AILETTE AVEC PINCE + 1SERINGUE A USAGE UNIQUE + 1BAXJECT II HI-FLOW POUR LA RECONSTITUTION OU B/1FL. DE PDRE. + 1FL. DE SOLVT.(EPPI) DE 20ML+1AIGUILLE DE PERFUSION + UNE AIGUILLE D'", "Commercialisation": true, "Remboursable": true}, {"Nom": "FELCAM 0,005 GEL  T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHINOLOGIE", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FELCAM", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "21A005", "Forme": "GEL DERM.", "Dosage": " 0,005", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FELCAM 20MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medics/2766.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FELCAM", "Tarif de reference": " N/A", "PPA": "143.00 DA", "Num Enregistrement": "035/ 04 B 022 /00/07", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "FELDENE 20MG COMP.DISPER.SEC. B/10", "Img": "https://pharmnet-dz.com//img/medics/2767.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2767", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FELDENE", "Tarif de reference": "143 DA", "PPA": " DA", "Num Enregistrement": "045/ 04 B 022 /99", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FELDENE 20MG/ML SOL. INJ. IM B/02 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2781", "Laboratoire": " PFIZER", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FELDENE", "Tarif de reference": "127.6 DA", "PPA": "143.00 DA", "Num Enregistrement": "045/ 04 B 024 /98", "Code DCI": "04B024", "Forme": "SOL. INJ.", "Dosage": "20MG/ML", "Conditionnement": "B/02 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEMARA 2,5MG COMP PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/597.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=597", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LETROZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FEMARA", "Tarif de reference": "6946.98 DA", "PPA": "N/A", "Num Enregistrement": "068/ 09 A 120 /00", "Code DCI": "09A120", "Forme": "COMP. PELLI.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEMAZOL 2,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LETROZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FEMAZOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "321/ 09 A 120 /08", "Code DCI": "09A120", "Forme": "COMP. PELLI.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEMPRESS PLUS 15MG**/25MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOEXIPRIL CHLORHYDRATE / HYDROCHLOROTHIAZIDE", "Pays": "ALLEMAGNE", "Nom Commercial": "FEMPRESS PLUS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "273/ 06 E 271 /09", "Code DCI": "06E271", "Forme": "COMP. PELLI.", "Dosage": "15MG**/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "FENAQUENE 100MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medics/2723.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2723", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FENAQUENE", "Tarif de reference": "87.6 DA", "PPA": " DA", "Num Enregistrement": "231/ 04 B 009 /00", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENAQUENE 25MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2714.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2714", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FENAQUENE", "Tarif de reference": "56.8 DA", "PPA": "110.00 DA", "Num Enregistrement": "231/ 04 B 008 /04", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENAQUENE 50MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/931.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=931", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FENAQUENE", "Tarif de reference": "88.5 DA", "PPA": " DA", "Num Enregistrement": "231/ 04 B 046 /07", "Code DCI": "04B046", "Forme": "SUPPO.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENATE 160MG MICROGRANULES EN GLES  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HYPOLIPIDEMIANTS", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FENATE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "320/06M214/16", "Code DCI": "06M214", "Forme": "MICROGRANULES", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "FENDOL 50MG/5ML SUSP. BUV. B/1FL. DE 120ML+GOBLET DE 15 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE MEFENAMIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FENDOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 048 /06/12", "Code DCI": "04B048", "Forme": "SUSP. BUV.", "Dosage": "50MG/5ML", "Conditionnement": "B/1FL. DE 120ML+GOBLET DE 15 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FENIRAMINE  0,5 MG/5ML (0,01%) SIROP FL de 125 ml +cuill\u00e8re de mesure de 5 ml", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DEXCHLORPHENIRAMINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "feniramine", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "01A007", "Forme": "SIROP", "Dosage": "0,5MG/5ML(0,01 %)", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENOFIBRATE HUP 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1534.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FENOFIBRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FENOFIBRATE HUP", "Tarif de reference": "903.9 DA", "PPA": "N/A", "Num Enregistrement": "380/ 06 M 120 /12", "Code DCI": "06M120", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENOFIBRATE IVAL 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FENOFIBRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FENOFIBRATE IVAL", "Tarif de reference": "903.9 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 M 120 /06 ", "Code DCI": "06M120", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENOFIBRATE MM 160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1579.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1579", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FENOFIBRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FENOFIBRATE MM", "Tarif de reference": "903.9 DA", "PPA": "N/A", "Num Enregistrement": "470/ 06 M 214 /13", "Code DCI": "06M214", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENOTYL LP 160MG GLES. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPRANOLOL CHLORHYDRATE MONOHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FENOTYL LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 F 074 /10", "Code DCI": "06F074", "Forme": "GLES. LP", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENOTYL LP 80MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPRANOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FENOTYL LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 F 293 /11", "Code DCI": "06F293", "Forme": "GLES.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENOXAM 0.005 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medics/1377.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FENOXAM", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "263/ 21 A 005 /12", "Code DCI": "21A005", "Forme": "GEL DERM.", "Dosage": "0.005", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENOXAM 20MG COMP. DISPERS. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FENOXAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FENTANYL JANSSEN 0,05MG/ML (0,5MG/10ML) SOL.INJ. B/10AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4044", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES POUR ANESTHESIE", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " FENTANYL CITRATE EXPRIME EN FENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "FENTANYL JANSSEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 02 A 002 /08", "Code DCI": "02A002", "Forme": "SOL. INJ.", "Dosage": "0,05MG/ML (0,5MG/10ML)", "Conditionnement": "B/10AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FENTANYL JANSSEN 0,1MG/AMP. SOL.INJ. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4045", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES POUR ANESTHESIE", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " FENTANYL CITRATE EXPRIME EN FENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "FENTANYL JANSSEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 02 A 002 /98", "Code DCI": "02A002", "Forme": "SOL. INJ.", "Dosage": "0,1MG/AMP.", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": null}, {"Nom": "FER RAZES 100MG/5ML SOL. INJ. P. PERF. IV. B/05 AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/1800.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FER RAZES", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "433/ 12 E 135 /15", "Code DCI": "12E135", "Forme": "SOL. INJ.", "Dosage": "100MG/5ML", "Conditionnement": "B/05 AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERACUR 4,75G/100ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FEREDETATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "FERACUR", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "003/ 12 E 025 /00", "Code DCI": "12E025", "Forme": "SIROP", "Dosage": "4,75G/100ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEROFER 10MG/ML** (OU 50MG/5ML)** EN  FER  ELEMENTAIRE SIROP FL/150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LGPA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERRIQUE** (SOUS FORME DE COMPLEXE D'HYDROXYDE FERRIQUE POLYMALTOSE)", "Pays": "ALGERIE", "Nom Commercial": "FEROFER", "Tarif de reference": "240 DA", "PPA": "N/A", "Num Enregistrement": "311/ 12 E 109 /09", "Code DCI": "12E109", "Forme": "SIROP", "Dosage": "10MG/ML** (OU 50MG/5ML)** EN  FER  ELEMENTAIRE", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEROLAM 4,75 G/100ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FEREDETATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "FEROLAM", "Tarif de reference": "140 DA", "PPA": "189.00 DA", "Num Enregistrement": "077/ 12 E 025 /98", "Code DCI": "12E025", "Forme": "SIROP", "Dosage": "4,75 G/100ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEROMAX 20MG/ML (100MG/5ML) SOL. INJ. P. PERF. IV OU EN INJ. DANS LE DIALYSEUR B/05AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "FEROMAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "329/ 12 E 135 /13", "Code DCI": "12E135", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "B/05AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FERRO SANOL 30MG/ML FER II (170MG/ML COMPLEXE GLYCINE SULFATE FERREUX) SOL. BUV. GTTES. FL./30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERREUX (II)  (SOUS FORME DE COMPLEXE GLYCINE SULFATE FERREUX)", "Pays": "ALLEMAGNE", "Nom Commercial": "FERRO SANOL", "Tarif de reference": "144 DA", "PPA": "280.00 DA", "Num Enregistrement": "273/ 12 E 126 /07", "Code DCI": "12E126", "Forme": "SOL. BUV. GTTES.", "Dosage": "30MG/ML FER II (170MG/ML COMPLEXE GLYCINE SULFATE FERREUX)", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERRO SANOL DUODENAL 567,7MG \u00e9quivalent en Fer (2+) 100MG CAPS \u00e0 gran.gastro-r\u00e9sist B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE DE FER II - GLYCINE SULFATE", "Pays": "ALLEMAGNE", "Nom Commercial": "FERRO SANOL DUODENAL", "Tarif de reference": "123.5 DA", "PPA": "786.00 DA", "Num Enregistrement": "273/ 12 E 107 /03", "Code DCI": "12E107", "Forme": "CAPS.", "Dosage": "567,7MG \u00e9quivalent en Fer (2+) 100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERRO SANOL GYN 454,13MG \u00e9quivalent en Fer (2+) 80MG/1MG GLES \u00e0 gran .gastro-r\u00e9sist B/30 ET B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE DE FER II - GLYCINE SULFATE / ACIDE FOLIQUE", "Pays": "ALLEMAGNE", "Nom Commercial": "FERRO SANOL GYN", "Tarif de reference": "297 DA", "PPA": "N/A", "Num Enregistrement": "273/ 12 E 108 /03", "Code DCI": "12E108", "Forme": "GLES.", "Dosage": "454,13MG \u00e9quivalent en Fer (2+) 80MG/1MG", "Conditionnement": "B/30 ET B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERRO SANOL GYN 454,13MG \u00e9quivalent en Fer (2+) 80MG/1MG GLES \u00e0 gran .gastro-r\u00e9sist B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE DE FER II - GLYCINE SULFATE / ACIDE FOLIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FERRO SANOL GYN", "Tarif de reference": "297 DA", "PPA": "N/A", "Num Enregistrement": "268/12E108/03/16", "Code DCI": "12E108", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "454,13MG \u00e9quivalent en Fer (2+) 80MG/1MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERROCURE 20MG/ML (100MG/5ML) SOL. BUV. EN AMP. B/20AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " GENIS EURL", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE", "Pays": "ALGERIE", "Nom Commercial": "FERROCURE", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "480/ 12 E 106 /13", "Code DCI": "12E106", "Forme": "SOL. BUV. AMP.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "B/20AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERROSTRANE 4,75G/100ML SIROP FL/125 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FEREDETATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "FERROSTRANE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "045/ 12 E 025 /96", "Code DCI": "12E025", "Forme": "SIROP", "Dosage": "4,75G/100ML", "Conditionnement": "FL/125 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FERRUM HAUSMANN 10MG/ML (50MG/5ML) SIROP FL150ML+ cuill\u00e8re mesure de 5ml", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERRIQUE** (SOUS FORME DE COMPLEXE D'HYDROXYDE FERRIQUE POLYMALTOSE)", "Pays": "TURQUIE", "Nom Commercial": "FERRUM HAUSMANN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "177/ 12 E 109 /05/14", "Code DCI": "12E109", "Forme": "SIROP", "Dosage": "10MG/ML (50MG/5ML)", "Conditionnement": "FL150ML+ cuill\u00e8re mesure de 5ml", "Commercialisation": true, "Remboursable": null}, {"Nom": "FERRUM HAUSMANN GOUTTES 50MG/ML (200MG/ML) SOL. BUV. GTTES. B/01FL.COMPT. GTTES DE 30ML", "Img": "https://pharmnet-dz.com//img/medics/1798.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE", "Pays": "TURQUIE", "Nom Commercial": "FERRUM HAUSMANN GOUTTES", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "177/ 12 E 134 /07/14", "Code DCI": "12E134", "Forme": "SOL. BUV. GTTES.", "Dosage": "50MG/ML (200MG/ML)", "Conditionnement": "B/01FL.COMPT. GTTES DE 30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERSUCAL 20MG/ML (OU 100MG/5ML) DE FER FERRIQUE SOL. INJ. IV B/05AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE", "Pays": "ALGERIE", "Nom Commercial": "FERSUCAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 12 E 135 /09", "Code DCI": "12E135", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (OU 100MG/5ML) DE FER FERRIQUE", "Conditionnement": "B/05AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FERVEX 0,5G/0,2G/0,025G/SACH.DE 13,1G GRLES. EN SACH.DE 13,1G B/08", "Img": "https://pharmnet-dz.com//img/medics/1466.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1466", "Laboratoire": " UPSA CONSEIL", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / ACIDE ASCORBIQUE / MALEATE DE PHENIRAMINE", "Pays": "FRANCE", "Nom Commercial": "FERVEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "008 / 22 A 033 /08", "Code DCI": "22A033", "Forme": "GRLES.", "Dosage": "0,5G/0,2G/0,025G/SACH.DE 13,1G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "FERVEX ADULTE SANS SUCRE 500MG/200MG/25MG**/SACH. GRLES. P. SUSP. BUV. EN SACH. B/8", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / ACIDE ASCORBIQUE / MALEATE DE PHENIRAMINE", "Pays": "FRANCE", "Nom Commercial": "FERVEX ADULTE SANS SUCRE", "Tarif de reference": " N/A", "PPA": "325.00 DA", "Num Enregistrement": "017/ 22 A 033 /13", "Code DCI": "22A033", "Forme": "GRLES.", "Dosage": "500MG/200MG/25MG**/SACH.", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": null}, {"Nom": "FERVEX ENFANT 0,28G/0,1G/0,01G/SACH.DE 3G GRLES. EN SACH.DE 3G B/08", "Img": "https://pharmnet-dz.com//img/medics/1463.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1463", "Laboratoire": " UPSA CONSEIL", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / ACIDE ASCORBIQUE / MALEATE DE PHENIRAMINE", "Pays": "FRANCE", "Nom Commercial": "FERVEX ENFANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "008/ 22 A  032 /08", "Code DCI": "22A032", "Forme": "GRLES.", "Dosage": "0,28G/0,1G/0,01G/SACH.DE 3G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXODINE 120MG  COMP. PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medics/4010.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4010", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXODINE", "Tarif de reference": "0 DA", "PPA": "228.00 DA", "Num Enregistrement": "352/ 01 A 039 /07/14", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120MG ", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXODINE 180MG COMP. PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medics/4017.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4017", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXODINE", "Tarif de reference": "268.95 DA", "PPA": "N/A", "Num Enregistrement": "352/ 01 A 040 /07/14", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXOFEN 120 120MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFEN 120", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "492/ 01 A 039 /15", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "FEXOFEN 180 180MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFEN 180", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "492/ 01 A 040 /15", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "FEXOFENADINE BEKER 120MG COMP. PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medics/5711.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFENADINE BEKER ", "Tarif de reference": "228 DA", "PPA": " DA", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120 MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXOFENADINE BEKER 180MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/5712.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFENADINE BEKER", "Tarif de reference": "268.95 DA", "PPA": " DA", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXOFENADINE IVAL 120MG  COMP.PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFENADINE IVAL", "Tarif de reference": " N/A", "PPA": "228.00 DA", "Num Enregistrement": "195/ 01 A 039 /07/12", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120MG ", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": null}, {"Nom": "FEXOFENADINE IVAL 180MG COMP. PELLI. SEC. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFENADINE IVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "195/ 01 A 040 /07/14", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": null}, {"Nom": "FEXOFENADINE NOVAGENERICS  180MG COMP. PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFENADINE NOVAGENERICS ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "149/01A040/15", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": null}, {"Nom": "FEXOFENADINE NOVAGENERICS  30MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFENADINE NOVAGENERICS ", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "01A050", "Forme": "COMP. PELLI.", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXOFENADINE NOVAGENERICS 120MG  COMP PELL  B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXOFENADINE NOVAGENERICS", "Tarif de reference": "228 DA", "PPA": "N/A", "Num Enregistrement": "149/ 01 A 039 /14", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120MG ", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXONIDAL 120MG  COMP. PELLI. SEC. B/15", "Img": "https://pharmnet-dz.com//img/medics/4014.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXONIDAL", "Tarif de reference": "228 DA", "PPA": "N/A", "Num Enregistrement": "039/ 01 A 039 /11", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120MG ", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "FEXONIDAL 180MG COMP. PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medics/4019.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FEXONIDAL", "Tarif de reference": "268.95 DA", "PPA": "N/A", "Num Enregistrement": "039/ 01 A 040 /11", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "FINCAR 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " FINASTERIDE", "Pays": "INDE", "Nom Commercial": "FINCAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 25 B 023 /04", "Code DCI": "25B023", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "FIRMACIN 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " MENARINI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "FIRMACIN", "Tarif de reference": "124.1 DA", "PPA": "N/A", "Num Enregistrement": "203/ 04 B 015 /99", "Code DCI": "04B015", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FIRMACIN 50MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " MENARINI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "FIRMACIN", "Tarif de reference": "98.5 DA", "PPA": "N/A", "Num Enregistrement": "203/ 04 B 014 /99", "Code DCI": "04B014", "Forme": "SUPPO.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FIXECAL 400UI/500MG COMP. A SUCER B/28", "Img": "https://pharmnet-dz.com//img/medics/3400.png", "Laboratoire": " API", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COLECALCIFEROL / CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "FIXECAL", "Tarif de reference": "378 DA", "PPA": "286.00 DA", "Num Enregistrement": "348/ 14 G 175 /08", "Code DCI": "14G175", "Forme": "COMP. A CROQ.", "Dosage": "400UI/500MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLAGYL  125MG/5ML SUSP.BUV. FL/120 ML + CUILLERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/864.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLAGYL ", "Tarif de reference": " N/A", "PPA": "183.00 DA", "Num Enregistrement": "263/ 13 F 040 /96/09", "Code DCI": "13F040", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/120 ML + CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLAGYL  250MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLAGYL ", "Tarif de reference": "107 DA", "PPA": "N/A", "Num Enregistrement": "263/13F039/96/16", "Code DCI": "13F039", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLAGYL 500MG OVULE VAGI. B/10", "Img": "https://pharmnet-dz.com//img/medics/3003.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3003", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLAGYL", "Tarif de reference": "181.48 DA", "PPA": "N/A", "Num Enregistrement": "263/ 11 A 002 /96/13", "Code DCI": "11A002", "Forme": "OVULE ", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLAMAZOLE 0.01 CREME DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " SULFADIAZINE ARGENTIQUE", "Pays": "ALGERIE", "Nom Commercial": "FLAMAZOLE", "Tarif de reference": "0 DA", "PPA": "350.00 DA", "Num Enregistrement": "366/ 07 P 079 /10", "Code DCI": "07P079", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLANIZOL 0.0075 GEL DERM. T/25G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "FLANIZOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "174/ 07 C 018 /99", "Code DCI": "07C018", "Forme": "GEL. DERM.", "Dosage": "0.0075", "Conditionnement": "T/25G", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLAXYNE 37,5MG GLES.LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2576.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2576", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLAXYNE", "Tarif de reference": "870.6 DA", "PPA": " DA", "Num Enregistrement": "035/ 16 A 125 /09", "Code DCI": "16A125", "Forme": "GLES. LP", "Dosage": "37,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLAXYNE 75MG  GLES. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2579.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2579", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLAXYNE", "Tarif de reference": "1741.2 DA", "PPA": "N/A", "Num Enregistrement": "035/ 16 A 126 /09", "Code DCI": "16A126", "Forme": "GLES. LP ", "Dosage": "75MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLAZOL 125MG/5ML SUSP. BUV. FL/120ML + BOUCHON DOSEUR", "Img": "https://pharmnet-dz.com//img/medics/865.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLAZOL", "Tarif de reference": "138 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 F 040 /06", "Code DCI": "13F040", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/120ML + BOUCHON DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLAZOL 500MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/869.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=869", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLAZOL", "Tarif de reference": "180 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 F 199 /00/09", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLEXEN 100MG/FL. DE PDRE. PDRE. ET SOLV. P. SOL. INJ. B/06FL. DE PDRE + 06AMP. DE 2,5ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "FLEXEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 04 B 057/97/14", "Code DCI": "04B057", "Forme": "PDRE. SOL. INJ.", "Dosage": "100MG/FL. DE PDRE.", "Conditionnement": "B/06FL. DE PDRE + 06AMP. DE 2,5ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLIXASONE 50\u00b5G/DOSE SPRAY NASAL FL./120DOSES (FL./20ML)", "Img": "https://pharmnet-dz.com//img/medics/1937.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1937", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLIXASONE", "Tarif de reference": "829.2 DA", "PPA": "N/A", "Num Enregistrement": "035/ 22 E 027 /08", "Code DCI": "22E027", "Forme": "SPRAY NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL./120DOSES (FL./20ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLIXONASE 50\u00b5G/DOSE SPRAY.NAS. FL/120DOSE", "Img": "https://pharmnet-dz.com//img/medics/1938.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1938", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "FLIXONASE", "Tarif de reference": "829.2 DA", "PPA": "N/A", "Num Enregistrement": "112/ 22 E 027 /00", "Code DCI": "22E027", "Forme": "SPRAY NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL/120DOSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLIXOTIDE 125\u00b5G/DOSE SUSP.INHAL.BUCCALE FL/120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2115", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FLIXOTIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 20 A 078 /00", "Code DCI": "20A078", "Forme": "SUSP. INHAL.", "Dosage": "125\u00b5G/DOSE", "Conditionnement": "FL/120DOSES", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLIXOTIDE 250\u00b5G/DOSE SUSP.INHAL.BUCCALE FL/60DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2117", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FLIXOTIDE", "Tarif de reference": "1745.37 DA", "PPA": "N/A", "Num Enregistrement": "262/ 20 A 079 /00", "Code DCI": "20A079", "Forme": "SUSP. INHAL.", "Dosage": "250\u00b5G/DOSE", "Conditionnement": "FL/60DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLIXOTIDE 50\u00b5G/DOSE SUSP.INHAL.BUCCALE FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2113", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FLIXOTIDE", "Tarif de reference": "999.3 DA", "PPA": "N/A", "Num Enregistrement": "262/ 20 A 077 /00", "Code DCI": "20A077", "Forme": "SUSP. INHAL.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOCINE 500MG COMP. PELLI.SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MERINAL", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLOCINE", "Tarif de reference": "804.00 DA", "PPA": " DA", "Num Enregistrement": "268/13K253/07/17", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOHALE HFA 125\u00b5G/DOSE SUSP. INHAL.BUCCALE EN SPYAY FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medics/2116.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FLOHALE HFA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 078 /09", "Code DCI": "20A078", "Forme": "SUSP. INHAL.", "Dosage": "125\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOHALE HFA 250\u00b5G/DOSE SUSP. INHAL.BUCCALE EN SPYAY FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FLOHALE HFA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 079 /09", "Code DCI": "20A079", "Forme": "SUSP. INHAL.", "Dosage": "250\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOHALE HFA 50\u00b5G/DOSE SUSP. INHAL.BUCCALE EN SPYAY FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FLOHALE HFA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 077 /09", "Code DCI": "20A077", "Forme": "SUSP. INHAL.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOMIST 50\u00b5G/DOSE SPRAY NASAL FL./100DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FLOMIST", "Tarif de reference": "691 DA", "PPA": "673.00 DA", "Num Enregistrement": "182/ 22 E 027 /08", "Code DCI": "22E027", "Forme": "SPRAY NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL./100DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOSAS 150MG/150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "FLOSAS", "Tarif de reference": "147.5 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 E 039 /08", "Code DCI": "10E039", "Forme": "SUPPO.", "Dosage": "150MG/150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOVENAC  50MG GLES. A \u00b5GRLES. GASTRORESIST. B/20", "Img": "https://pharmnet-dz.com//img/medics/2702.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2702", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLOVENAC ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 04 B 006 /05/11", "Code DCI": "04B006", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOVENAC LP 100MG MICROGRANULES LP en GLES B/10", "Img": "https://pharmnet-dz.com//img/medics/2708.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2708", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLOVENAC LP", "Tarif de reference": "0 DA", "PPA": "139.00 DA", "Num Enregistrement": "293/ 04 B 007 /05/14", "Code DCI": "04B007", "Forme": "GLES. LP", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOVENAC LP 75MG GLES. A MICROGRANULES GASTRORESIST. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2834.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2834", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLOVENAC LP", "Tarif de reference": "366.6 DA", "PPA": " DA", "Num Enregistrement": "293/ 04 B 037 /10", "Code DCI": "04B037", "Forme": "GLES. MICROGRLES. LP", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLOXAMED 0,3% (3MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2391.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2391", "Laboratoire": " UNIMED", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NORFLOXACINE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "FLOXAMED", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 17 D 029 /08", "Code DCI": "17D029", "Forme": "COLLY. SOL.", "Dosage": "0,3% (3MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUBENE 100MG COMP. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " FLUBENDAZOLE", "Pays": "ALGERIE", "Nom Commercial": "FLUBENE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 19 B 004 /09", "Code DCI": "19B004", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUBIFENE 100MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLUBIFENE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "304/ 04 B 033 /06/15", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCAND 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "FLUCAND", "Tarif de reference": " N/A", "PPA": "259.00 DA", "Num Enregistrement": "001/ 13 R 258 /03/09", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCAND 2MG/ML (OU 200MG/100ML) SOL.INJ.IV. FL/100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "FLUCAND", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 R 107 /97/09", "Code DCI": "13R107", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (OU 200MG/100ML)", "Conditionnement": "FL/100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCAND 50MG GLES. B/03 ET B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "FLUCAND", "Tarif de reference": " N/A", "PPA": "219.00 DA", "Num Enregistrement": "001/ 13 R 155 /98/09", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03 ET B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCASONE 50\u00b5G/DOSE SUSP NASAL EN SPRAY FL/120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " FLUTICASONE PROPIONATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCASONE", "Tarif de reference": "892.2 DA", "PPA": "N/A", "Num Enregistrement": "235/22E027/16", "Code DCI": "22E027", "Forme": "SUSP.NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL/120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCAZOL  50MG GLES. B/7", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCAZOL ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "318/13R155/15", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/7", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCIDAL 0.03 PDE. DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE NIFLUMIQUE", "Pays": "ALGERIE", "Nom Commercial": "FLUCIDAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 21 A 001 /98/09", "Code DCI": "21A001", "Forme": "PDE. DERM.", "Dosage": "0.03", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCIDAL 250MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2786.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE NIFLUMIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLUCIDAL", "Tarif de reference": "118.5 DA", "PPA": "N/A", "Num Enregistrement": "003/ 04 B 029 /11", "Code DCI": "04B029", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCON 0.001 COLLY. FL/3ML", "Img": "https://pharmnet-dz.com//img/medics/1978.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1978", "Laboratoire": " ALCON", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " FLUOROMETHOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FLUCON", "Tarif de reference": "148 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 G 134 /03", "Code DCI": "17G134", "Forme": "COLLY.", "Dosage": "0.001", "Conditionnement": "FL/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONALE 150MG  GLES B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONALE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "418/ 13 R 258 /14", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG ", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONALE 50MG GLES. B/03 ET B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONALE", "Tarif de reference": "511 DA", "PPA": "530.00 DA", "Num Enregistrement": "418/ 13 R 155 /13", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03 ET B/07", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONAZOLE BIOCARE 150MG  GLES  B/01", "Img": "https://pharmnet-dz.com//img/medics/3569.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE BIOCARE", "Tarif de reference": "0 DA", "PPA": "273.00 DA", "Num Enregistrement": "293/ 13 R 258 /14", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG ", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONAZOLE BIOCARE 50MG GLES. B/03", "Img": "https://pharmnet-dz.com//img/medics/3548.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE BIOCARE", "Tarif de reference": "219 DA", "PPA": "249.00 DA", "Num Enregistrement": "293/ 13 R 155 /09", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONAZOLE HUP 150MG  GLES  B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE HUP", "Tarif de reference": "0 DA", "PPA": "273.00 DA", "Num Enregistrement": "380/ 13 R 258 /14", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG ", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONAZOLE IVAL 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE IVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "195/ 13 R 258 /13", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCONAZOLE IVAL 50MG GLES B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE IVAL", "Tarif de reference": " N/A", "PPA": "219.00 DA", "Num Enregistrement": "195/ 13 R 155/ 13", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCONAZOLE IVAL 50MG GLES B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE IVAL", "Tarif de reference": " N/A", "PPA": "249.00 DA", "Num Enregistrement": "195/ 13 R 155/ 13", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCONAZOLE LDM 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE LDM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "309/ 13 R 258 /07/14", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUCONAZOLE LDM 50MG GELULE B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE LDM", "Tarif de reference": "219 DA", "PPA": "N/A", "Num Enregistrement": "309/ 13 R 155 /14", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONAZOLE PFIZER 50MG GLES. B/03", "Img": "https://pharmnet-dz.com//img/medics/3552.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3552", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE PFIZER", "Tarif de reference": "219 DA", "PPA": "N/A", "Num Enregistrement": "045/ 13 R 155 /98/15", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUCONAZOLE SANDOZ 50MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medics/3553.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3553", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUCONAZOLE SANDOZ", "Tarif de reference": "730 DA", "PPA": "N/A", "Num Enregistrement": "050/ 13 R 155 /09", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUDARA 10MG COMP. PELLI. FL./20", "Img": "https://pharmnet-dz.com//img/medics/21.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=21", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " FLUDARABINE PHOSPHATE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "FLUDARA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 05 G 141 /09", "Code DCI": "05G141", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "FL./20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUDARA 50MG/FL. DE PDRE LYOPH. P. SOL. INJ. P. PERF. IV B/5FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1111", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " FLUDARABINE PHOSPHATE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "FLUDARA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 05 G 075 /05/13", "Code DCI": "05G075", "Forme": "LYOPH. SOL. INJ.", "Dosage": "50MG/FL. DE PDRE", "Conditionnement": "B/5FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUDARABINE EBEWE 25MG/ML (50MG/2ML) CONC. SOL.INJ.PERF. IV B/01FL. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/1112.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1112", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " FLUDARABINE PHOSPHATE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "FLUDARABINE EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 G 075 /09", "Code DCI": "05G075", "Forme": "LYOPH. SOL. INJ.", "Dosage": "25MG/ML (50MG/2ML)", "Conditionnement": "B/01FL. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUDEX LP 1,5MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/1486.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1486", "Laboratoire": " SERVIER", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " INDAPAMIDE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "FLUDEX LP", "Tarif de reference": "0 DA", "PPA": "606.00 DA", "Num Enregistrement": "040/ 06 H 163 /03/15", "Code DCI": "06H163", "Forme": "COMP. PELLI. LP", "Dosage": "1,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUDIS 100MG COMP. PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLUDIS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/04B033/16", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUIDABAK 0.015 COLLYRE EN SOL.  FL./10ML", "Img": "https://pharmnet-dz.com//img/medics/2017.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2017", "Laboratoire": " THEA", "C.Pharmacologique": " SUPPLEANCE LACRYMALE", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " POVIDONE", "Pays": "FRANCE", "Nom Commercial": "FLUIDABAK", "Tarif de reference": "364.81 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 N 169 /13", "Code DCI": "17N169", "Forme": "COLLY.", "Dosage": "0.015", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUIMEX 200MG COMP. EFFER. B/20", "Img": "https://pharmnet-dz.com//img/medics/1342.png", "Laboratoire": " API", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " ACETYLCYSTEINE OU N ACETYLCYSTEINE", "Pays": "ALGERIE", "Nom Commercial": "FLUIMEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "348/ 20 D 231 /08", "Code DCI": "20D231", "Forme": "COMP. EFFERV.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUIMUCIL 200MG/SACHET-DOSE GRANULES .SOL .BUV EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/1333.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1333", "Laboratoire": " ZAMBON FRANCE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " N-ACETYLCYSTEINE", "Pays": "FRANCE", "Nom Commercial": "FLUIMUCIL", "Tarif de reference": "0 DA", "PPA": "314.00 DA", "Num Enregistrement": "093/ 20 D 083 /01/14", "Code DCI": "20D083", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/SACHET-DOSE", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUISEDAL SANS PROMETHAZINE 130MG/15MG/5ML SIROP B/1FL. DE 125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MAGPHARM LABORATOIRES SARL", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MEGLUMINE (BENZOATE  ANHYDRE) / POLYSORBATE 20", "Pays": "ALGERIE", "Nom Commercial": "FLUISEDAL SANS PROMETHAZINE", "Tarif de reference": " N/A", "PPA": "198.00 DA", "Num Enregistrement": "476/ 20 D 232 /08/13", "Code DCI": "20D232", "Forme": "SIROP", "Dosage": "130MG/15MG/5ML", "Conditionnement": "B/1FL. DE 125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUKAS 150MG GLES. B/01 ET B/04", "Img": "https://pharmnet-dz.com//img/medics/3572.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUKAS", "Tarif de reference": "0 DA", "PPA": "952.00 DA", "Num Enregistrement": "317/ 13 R 258 /12", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01 ET B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUKAS 50MG  GLES B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUKAS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/13R155/16", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUMIDE 1,5MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " INDAPAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLUMIDE", "Tarif de reference": "690 DA", "PPA": "690.00 DA", "Num Enregistrement": "352/ 06 H 163 /09", "Code DCI": "06H163", "Forme": "COMP. PELLI. LP", "Dosage": "1,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUORESCEINE SODIQUE FAURE 0.1 SOL.INJ.IV B/1AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " NOVARTIS OPHTALMICS", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " FLUORESCEINE", "Pays": "FRANCE", "Nom Commercial": "FLUORESCEINE SODIQUE FAURE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "271/ 17 K 068 /98", "Code DCI": "17K068", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "B/1AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUOXETINE MERINAL 20MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2549.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " FLUOXETINE CHLORHYDRATE EXPRIME EN FLUOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUOXETINE MERINAL", "Tarif de reference": " N/A", "PPA": "380.00 DA", "Num Enregistrement": "268/ 16 A 078 /05/11", "Code DCI": "16A078", "Forme": "GLES.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUOXETINE UPC 20MG/5ML SOL. BUV. F/70ML AVEC  PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " FLUOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUOXETINE UPC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "285/ 16 A 088 /06", "Code DCI": "16A088", "Forme": "SOL. BUV.", "Dosage": "20MG/5ML", "Conditionnement": "F/70ML AVEC  PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUPEX 30MG/300MG/37,5MG/1,5MG/15ML SIROP FL./200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " GUAIFENESINE (DCI) / BENZOATE DE SODIUM / TERPINE / EUCALYPTOL ", "Pays": "ALGERIE", "Nom Commercial": "FLUPEX", "Tarif de reference": " N/A", "PPA": "199.00 DA", "Num Enregistrement": "077/ 20 C 214 /08", "Code DCI": "20C214", "Forme": "SIROP", "Dosage": "30MG/300MG/37,5MG/1,5MG/15ML", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLURBINAD 100MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLURBINAD", "Tarif de reference": "179.2 DA", "PPA": "N/A", "Num Enregistrement": "468/ 04 B 033 /14", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLURBIPROFAL 100MG COMP. PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medics/2803.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLURBIPROFAL", "Tarif de reference": "143.36 DA", "PPA": "N/A", "Num Enregistrement": "039/ 04 B 033 /13", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLURIDENT 1MG COMP. A CROQUER B/120", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " FLUOR", "Pays": "ALGERIE", "Nom Commercial": "FLURIDENT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 14 G 142 /07", "Code DCI": "14G142", "Forme": "COMP. A CROQ.", "Dosage": "1MG", "Conditionnement": "B/120", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUSAL 0,02% / 3% PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " FLUMETHASONE PIVALATE MICRONISE / ACIDE SALICYLIQUE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "FLUSAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 07 H 044 /98/10", "Code DCI": "07H044", "Forme": "PDE. DERM.", "Dosage": "0,02% / 3%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "FLUTERAX 2MG/0,625MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUTERAX", "Tarif de reference": "1029.6 DA", "PPA": "N/A", "Num Enregistrement": "352/06E227/15", "Code DCI": "06E227", "Forme": "COMP. SEC.", "Dosage": "2MG/0,625MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUTERAX 4MG/1,25MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medics/3142.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL TER-BUTYLAMINE / INDAPAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUTERAX", "Tarif de reference": "1215.9 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 E 228 /14", "Code DCI": "06E228", "Forme": "COMP. PELLI.", "Dosage": "4MG/1,25MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUVACOL LP 80MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/1612.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1612", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUVACOL LP", "Tarif de reference": "1800 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 236 /14", "Code DCI": "06M236", "Forme": "COMP. PELLI. LP", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUVASTAN 80MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANAMED", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUVASTAN", "Tarif de reference": "1530 DA", "PPA": "N/A", "Code DCI": "06M236", "Forme": "COMP. PELLI. LP", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUVASTATINE LDM 40MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FLUVASTATINE LDM", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "309/ 06 M 151 /14", "Code DCI": "06M151", "Forme": "GLES.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUVERBIEN 100MG COMP. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " FLUBENDAZOLE", "Pays": "ALGERIE", "Nom Commercial": "FLUVERBIEN", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "19B004", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUVERMAL 100MG COMP. B/6", "Img": "https://pharmnet-dz.com//img/medics/2039.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2039", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " FLUBENDAZOLE", "Pays": "FRANCE", "Nom Commercial": "FLUVERMAL", "Tarif de reference": "300.95 DA", "PPA": "N/A", "Num Enregistrement": "095/ 19 B 004 /98", "Code DCI": "19B004", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUVERMAL 100MG/5ML SUSP.BUV. FL/30ML", "Img": "https://pharmnet-dz.com//img/medics/2040.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2040", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " FLUBENDAZOLE", "Pays": "FRANCE", "Nom Commercial": "FLUVERMAL", "Tarif de reference": "328.31 DA", "PPA": "N/A", "Num Enregistrement": "095/ 19 B 005 /98", "Code DCI": "19B005", "Forme": "SUSP. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FLUXOL 0.003 SOL BUV FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FLUXOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 20 D 064 /04", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": "0.003", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FOLACID 5MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "FOLACID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "418/ 12 E 020 /14", "Code DCI": "12E020", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOLENAT 70MG COMP. PILULIER/04", "Img": "https://pharmnet-dz.com//img/medics/1432.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1432", "Laboratoire": " EL KENDI", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FOLENAT", "Tarif de reference": "1900 DA", "PPA": "N/A", "Num Enregistrement": "352/ 21 G 050 /11", "Code DCI": "21G050", "Forme": "COMP.", "Dosage": "70MG", "Conditionnement": "PILULIER/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOLIDEN 5MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medics/1748.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1748", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "FOLIDEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 12 E 020 /04/11", "Code DCI": "12E020", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "FONGENAL 125MG COMP. B/32", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GRISEOFULVINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FONGENAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 R 109 /96/10", "Code DCI": "13R109", "Forme": "COMP.", "Dosage": "125MG", "Conditionnement": "B/32", "Commercialisation": true, "Remboursable": null}, {"Nom": "FONGENAL 250MG COMP. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3540.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GRISEOFULVINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FONGENAL", "Tarif de reference": "135 DA", "PPA": "135 DA", "Num Enregistrement": "003/ 13 R 110 /96/13", "Code DCI": "13R110", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "FONGENAL 500MG  COMP.SEC. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GRISEOFULVINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FONGENAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 R 111/96", "Code DCI": "13R111", "Forme": "COMP. SEC.", "Dosage": "500MG ", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "FONGYNE 500MG OVULES GYNECO. B/10", "Img": "https://pharmnet-dz.com//img/medics/3004.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3004", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FONGYNE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/ 11A 002 /06", "Code DCI": "11A002", "Forme": "OVULE ", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FONITRA 5MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "FONITRA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "470/ 12 E 020 /13", "Code DCI": "12E020", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORACORT HFA 100\u00b5G/6\u00b5G/DOSE SPRAY BUCCAL FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE DIHYDRATE)**", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FORACORT HFA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 F 236 /09", "Code DCI": "20F236", "Forme": "SPRAY. INHAL.", "Dosage": "100\u00b5G/6\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORACORT HFA 200\u00b5G/6\u00b5G/DOSE SPRAY BUCCAL FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE DIHYDRATE)**", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FORACORT HFA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 F 237 /09", "Code DCI": "20F237", "Forme": "SPRAY. INHAL.", "Dosage": "200\u00b5G/6\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORADIL 12\u00b5G PDRE POUR INHAL. EN GLES. AVEC INHALATEUR. B/30 ET B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2125", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FORMOTEROL FUMARATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FORADIL", "Tarif de reference": "2400 DA", "PPA": "N/A", "Num Enregistrement": "068/ 20 A 091 /02", "Code DCI": "20A091", "Forme": "PDRE. INHAL.", "Dosage": "12\u00b5G", "Conditionnement": "B/30 ET B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORATEC HFA 12\u00b5G/DOSE SPRAY INHAL. BUCCALE FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FORMOTEROL FUMARATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FORATEC HFA", "Tarif de reference": "822 DA", "PPA": "N/A", "Num Enregistrement": "182/ 20 A 239 /09", "Code DCI": "20A239", "Forme": "SPRAY. INHAL.", "Dosage": "12\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORCE MEN 50MG COMP PELL  B/01, B/04", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FORCE MEN", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "304/25N045/06/15", "Code DCI": "25N045", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/01, B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "FORENE 100ML/100ML LIQUIDE. P. INHAL. PAR VAPEUR B/01FL. DE 100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ANESTHESIQUES GENERAUX & GAZ", "C.Pharmacologique": " ANESTHESIOLOGIE", "C.Therapeutique": " ISOFLURANE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FORENE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "498/02B007/99/16", "Code DCI": "02B007", "Forme": "LIQUIDE P. INHAL", "Dosage": "100ML/100ML", "Conditionnement": "B/01FL. DE 100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FORENE 100ML/100ML LIQUIDE. P. INHAL. PAR VAPEUR B/01FL. DE 100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ABBOTT", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ISOFLURANE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FORENE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "147/ 02 B 007 /99/13", "Code DCI": "02B007", "Forme": "LIQUIDE P. INHAL", "Dosage": "100ML/100ML", "Conditionnement": "B/01FL. DE 100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FORLAX 10G/SACHET** PRDE SOL BUV B/20 SACHETS DOSE ", "Img": "https://pharmnet-dz.com//img/medics/2942.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2942", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 4000 (POLYETHYLENE GLYCOL)", "Pays": "FRANCE", "Nom Commercial": "FORLAX", "Tarif de reference": "382.01 DA", "PPA": "N/A", "Num Enregistrement": "020/ 10 L 098 /98", "Code DCI": "10L098", "Forme": "PDRE. SOL. BUV.", "Dosage": "10G/SACHET**", "Conditionnement": "B/20 SACHETS DOSE ", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORLAX 4G/SACH. PDRE. SOL. BUV. EN SACH.-DOSE B/20SACH-DOSE", "Img": "https://pharmnet-dz.com//img/medics/2952.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2952", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 4000 (OU PEG=POLYETHYLENE GLYCOL 4000)", "Pays": "FRANCE", "Nom Commercial": "FORLAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "020/ 10 L 189 /09", "Code DCI": "10L189", "Forme": "PDRE. SOL. BUV.", "Dosage": "4G/SACH.", "Conditionnement": "B/20SACH-DOSE", "Commercialisation": true, "Remboursable": false}, {"Nom": "FORMENTIN  1000MG COMP. PELLI. SEC. B/30-B/100", "Img": "https://pharmnet-dz.com//img/medics/4491.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4491", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FORMENTIN ", "Tarif de reference": "173.4 DA", "PPA": " DA", "Num Enregistrement": "293/14A224/16", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/30-B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORMENTIN  500MG COMP. PELLI. B/30ETB/50ETB/100", "Img": "https://pharmnet-dz.com//img/medics/4466.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4466", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FORMENTIN ", "Tarif de reference": "182 DA", "PPA": " DA", "Num Enregistrement": "293/14A006/16", "Code DCI": "14A006", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/30ETB/50ETB/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORMENTIN  850MG COMP. PELLI. B/30 ET B/100", "Img": "https://pharmnet-dz.com//img/medics/4319.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4319", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FORMENTIN ", "Tarif de reference": "492 DA", "PPA": " DA", "Num Enregistrement": "293/14A007/07/16", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORMONIDE 100\u00b5G/6\u00b5G/DOSE** SUSP. INHAL.BUCCALE FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CADILA HEALTHCARE LIMITED", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE DIHYDRATE)**", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FORMONIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "358/ 20 F 236 /09", "Code DCI": "20F236", "Forme": "SPRAY. INHAL.", "Dosage": "100\u00b5G/6\u00b5G/DOSE**", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORMONIDE 200\u00b5G/6\u00b5G/DOSE** SUSP. INHAL.BUCCALE FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CADILA HEALTHCARE LIMITED", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL (SOUS FORME DE FUMARATE DIHYDRATE)**", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FORMONIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "358/ 20 F 237 /09", "Code DCI": "20F237", "Forme": "SPRAY. INHAL.", "Dosage": "200\u00b5G/6\u00b5G/DOSE**", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORMOTEROL ZENTIVA 12\u00b5G PDRE. P. INHAL. EN GLES. + INHALATEUR. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " WINTHROP ARZNEIMITTEL GMBH", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FORMOTEROL FUMARATE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "FORMOTEROL ZENTIVA", "Tarif de reference": "2400 DA", "PPA": "N/A", "Num Enregistrement": "394/ 20 A 091 /12", "Code DCI": "20A091", "Forme": "PDRE. INHAL.", "Dosage": "12\u00b5G", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORTEO 250\u00b5G/ML (600\u00b5G/2,4ML) OU 20\u00b5G/DOSE SOL. INJ. SC. EN STYLO PREREMPLI B/01 STYLO PREREMPLI DE 2,4ML", "Img": "https://pharmnet-dz.com//img/medics/1437.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1437", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " TERIPARATIDE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "FORTEO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 21 G 055 /08/15", "Code DCI": "21G055", "Forme": "SOL. INJ.", "Dosage": "250\u00b5G/ML (600\u00b5G/2,4ML) OU 20\u00b5G/DOSE", "Conditionnement": "B/01 STYLO PREREMPLI DE 2,4ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORTRANS 64G/5,7G/1,68G/1,46G/0,75G/SACHET PDRE. P. SOL. BUV. EN SACHET-DOSE B/04 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2936", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 4000 / SULFATE DE SODIUM ANHYDRE / BICARBONATE DE SODIUM ANHYDRE    / CHLORURE DE SODIUM ANHYDRE / CHLORURE DE POTASSIUM", "Pays": "FRANCE", "Nom Commercial": "FORTRANS", "Tarif de reference": "787.81 DA", "PPA": "N/A", "Num Enregistrement": "020/ 10 L 086 /96/15", "Code DCI": "10R086", "Forme": "PDRE. SOL. BUV.", "Dosage": "64G/5,7G/1,68G/1,46G/0,75G/SACHET", "Conditionnement": "B/04 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORTUM 1G PDRE .SOL.INJ.IM/IV B/1FL", "Img": "https://pharmnet-dz.com//img/medics/718.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=718", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTAZIDIME", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FORTUM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 13 B 213 /00", "Code DCI": "13B213", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": true}, {"Nom": "FORTUM ENF ET NOURR 500MG PDRE .SOL.INJ. IM/IV B/1FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=716", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTAZIDIME", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FORTUM ENF ET NOURR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 13 B 212 /00", "Code DCI": "13B212", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "FORTZAAR 100MG/25MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MSD FRANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FORTZAAR", "Tarif de reference": "- DA", "PPA": "N/A", "Code DCI": "06E239", "Forme": "COMP. PELLI.", "Dosage": "100MG/25MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOSAVANCE 70MG/2800UI COMP. B/04", "Img": "https://pharmnet-dz.com//img/medics/1438.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1438", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALENDRONATE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE / COLECALCIFEROL", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "FOSAVANCE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 21 G 064 /14", "Code DCI": "21G064", "Forme": "COMP.", "Dosage": "70MG/2800UI", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOSEAL 800MG COMP. PELLI. B/180", "Img": "https://pharmnet-dz.com//img/medics/1215.png", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SEVELAMER", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "FOSEAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "471/ 25 M 059 /13", "Code DCI": "25M059", "Forme": "COMP. PELLI.", "Dosage": "800MG", "Conditionnement": "B/180", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOSFOCINE 1G PREP.INJ.PERF. B/1AMP ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=410", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " AUTRES ANTIBIOTIQUES & ANTIBACTERIENS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FOSFOMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FOSFOCINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 13 N 093 /98", "Code DCI": "13N093", "Forme": "SOL. INJ.", "Dosage": "1G", "Conditionnement": "B/1AMP ", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOSFOCINE 4G PREP.INJ.PERF. B/1AMP ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=411", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " AUTRES ANTIBIOTIQUES & ANTIBACTERIENS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FOSFOMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FOSFOCINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 13 N 094 /98", "Code DCI": "13N094", "Forme": "SOL. INJ.", "Dosage": "4G", "Conditionnement": "B/1AMP ", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOSTER  100\u00b5G/6\u00b5G  SOL P/ INHALATION FL/120 DOSES", "Img": "https://pharmnet-dz.com//img/medics/1362.png", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BECLOMETASONE DIPROPIONATE/ FORMOTEROL FUMARATE DIHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "FOSTER", "Tarif de reference": "0 DA", "PPA": "2881.00 DA", "Num Enregistrement": "092/ 20 F 244 /14", "Code DCI": "20F244", "Forme": "SOL. INHAL.", "Dosage": " 100\u00b5G/6\u00b5G ", "Conditionnement": "FL/120 DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "FOXIME 1G/FL. DE PDRE. PDRE. ET SOLV. SOL. INJ. IV B/1FL. DE PDRE + 1AMP. DE 5ML DE SOLV. (E.P.P.I.)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FOXIME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 014 /02/09", "Code DCI": "13B014", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE + 1AMP. DE 5ML DE SOLV. (E.P.P.I.)", "Commercialisation": true, "Remboursable": null}, {"Nom": "FOXIME 1G/FL. DE PDRE.** PDRE.  ET SOLV. SOL INJ IM  B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLVT. (LIDOCAINE 1%)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FOXIME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 256 /02/09", "Code DCI": "13B256", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.**", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLVT. (LIDOCAINE 1%)", "Commercialisation": true, "Remboursable": null}, {"Nom": "FOXIME USP 500MG  SOL INJ IM/IV B./1AMP. + 5ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medics/1920.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "FOXIME USP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "173/ 13 B 015 /04", "Code DCI": "13B015", "Forme": "PDRE. INJ.", "Dosage": "500MG ", "Conditionnement": "B./1AMP. + 5ML DE SOLV.", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRADENE 20MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2775.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FRADENE", "Tarif de reference": "286 DA", "PPA": "N/A", "Num Enregistrement": "289/ 04 B 022 /08", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRADENE 20MG/ML SOL. INJ. IM B/02 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " RAZES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FRADENE", "Tarif de reference": "127.6 DA", "PPA": "127.00 DA", "Num Enregistrement": "433/ 04 B 024 /09", "Code DCI": "04B024", "Forme": "SOL. INJ.", "Dosage": "20MG/ML", "Conditionnement": "B/02 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAGMINE 10 000UI ANTI-XA/1ML  SOL INJ EN SERINGUE PRE-REMPLIE  B/02 SERINGUES PRE-REMPLIES 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1742", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DALTEPARINE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAGMINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 12 B 169 /14", "Code DCI": "12B169", "Forme": "SOL. INJ.", "Dosage": "10 000UI ANTI-XA/1ML ", "Conditionnement": "B/02 SERINGUES PRE-REMPLIES 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAGMINE 2 500UI ANTI-XA/0,2ML SOL. INJ. EN SERING. PREREMPL.  B/02SERING. PREREMPL. DE 0,2ML AVEC SYST\u00c8ME DE SECURITE DE L'AIGUILLE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1739", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DALTEPARINE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAGMINE", "Tarif de reference": "0 DA", "PPA": "453.00 DA", "Num Enregistrement": "045/ 12 B 163 /13", "Code DCI": "12B163", "Forme": "SOL. INJ.", "Dosage": "2 500UI ANTI-XA/0,2ML", "Conditionnement": "B/02SERING. PREREMPL. DE 0,2ML AVEC SYST\u00c8ME DE SECURITE DE L'AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAGMINE 5 000UI ANTI-XA/0,2ML SOL. INJ. EN SERING. PREREMPL.  B/02SERING. PREREMPL. DE 0,2ML AVEC SYST\u00c8ME DE SECURITE DE L'AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/1740.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1740", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DALTEPARINE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAGMINE", "Tarif de reference": "0 DA", "PPA": "721.00 DA", "Num Enregistrement": "045/ 12 B 164 /13", "Code DCI": "12B164", "Forme": "SOL. INJ.", "Dosage": "5 000UI ANTI-XA/0,2ML", "Conditionnement": "B/02SERING. PREREMPL. DE 0,2ML AVEC SYST\u00c8ME DE SECURITE DE L'AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAGMINE 7 500 UI ANTI-XA/0,75ml SOL. INJ. EN SERING. PREREMPL.  B/02SERING. PREREMPL. DE 0,75ML AVEC SYST\u00c8ME DE SECURITE DE L'AIGUILLE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1741", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DALTEPARINE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAGMINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 12 B 165 /13", "Code DCI": "12B165", "Forme": "SOL. INJ.", "Dosage": "7 500 UI ANTI-XA/0,75ml", "Conditionnement": "B/02SERING. PREREMPL. DE 0,75ML AVEC SYST\u00c8ME DE SECURITE DE L'AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAKIDEX 315 000 UI/0,1G/100G  PDE.OPHT. T/5G", "Img": "https://pharmnet-dz.com//img/medics/1950.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1950", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " FRAMYCETINE / DEXAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAKIDEX", "Tarif de reference": "156.61 DA", "PPA": " DA", "Num Enregistrement": "096/ 17 D 125 /01", "Code DCI": "17D125", "Forme": "PDE. OPHT.", "Dosage": "315 000 UI/0,1G/100G ", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAKIDEX 630.000UI/100MG/100ML COLLY. EN SOL. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/1947.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1947", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " FRAMYCETINE / DEXAMETHASONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAKIDEX", "Tarif de reference": "181.67 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 D 108 /99", "Code DCI": "17D108", "Forme": "COLLY. SOL.", "Dosage": "630.000UI/100MG/100ML", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAXIPARINE 2 850UI ANTI XA/0,3ML SOL INJ SC EN SER PRE REMPL. B/2 ET 10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1728", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " NADROPARINE CALCIQUE (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAXIPARINE", "Tarif de reference": "0 DA", "PPA": "536.00 DA", "Num Enregistrement": "262/ 12 B 087 /97", "Code DCI": "12B087", "Forme": "SOL. INJ.", "Dosage": "2 850UI ANTI XA/0,3ML", "Conditionnement": "B/2 ET 10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAXIPARINE 3 800UI AXa/0.4ML SOL.INJ.SC EN SERING. PREREMPL. B/2 ET B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1729", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " NADROPARINE CALCIQUE (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAXIPARINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 12 B 088 /02", "Code DCI": "12B088", "Forme": "SOL. INJ.", "Dosage": "3 800UI AXa/0.4ML", "Conditionnement": "B/2 ET B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAXIPARINE 5 700U I ANTI XA/0,6ML  SOL.INJ.SC EN SERING. PREREMPL. B/2 ET B/10", "Img": "https://pharmnet-dz.com//img/medics/1730.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1730", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " NADROPARINE CALCIQUE (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAXIPARINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 12 B 089 /97", "Code DCI": "12B089", "Forme": "SOL. INJ.", "Dosage": "5 700U I ANTI XA/0,6ML ", "Conditionnement": "B/2 ET B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRAXIPARINE 7 600UI ANTI XA/0,8ML SOL.INJ.SC EN SERING. PREREMPL. B/2 ET B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1731", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " NADROPARINE CALCIQUE (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FRAXIPARINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 12 B 090 /97", "Code DCI": "12B090", "Forme": "SOL. INJ.", "Dosage": "7 600UI ANTI XA/0,8ML", "Conditionnement": "B/2 ET B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FREEGAS 80MG COMP. A CROQUER SANS SUCRE A LA MENTHE B/24", "Img": "https://pharmnet-dz.com//img/medics/3926.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3926", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " SIMETICONE", "Pays": "ALGERIE", "Nom Commercial": "FREEGAS", "Tarif de reference": "0 DA", "PPA": "199.99 DA", "Num Enregistrement": "447/ 10 B 194 /12", "Code DCI": "10B194", "Forme": "COMP. A CROQ.", "Dosage": "80MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": false}, {"Nom": "FRUBIAL FAIBLE 1500UI/125,5MG/20,45MG/5ML SOL. BUV. B/20AMP. DE 5ML ", "Img": "https://pharmnet-dz.com//img/medics/3465.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ERGOCALCIFEROL (OU VIT D2) / GLUCONATE DE CALCIUM / PHOSPHATE BICALCIQUE", "Pays": "ALGERIE", "Nom Commercial": "FRUBIAL FAIBLE", "Tarif de reference": "0 DA", "PPA": "260.00 DA", "Num Enregistrement": "003/ 14 H 340 /97/10", "Code DCI": "14H340", "Forme": "SOL. BUV.", "Dosage": "1500UI/125,5MG/20,45MG/5ML", "Conditionnement": "B/20AMP. DE 5ML ", "Commercialisation": true, "Remboursable": false}, {"Nom": "FRUBIOSE VIT D 1000UI/129MG/36,8 MG/5 ML SUSP.BUV. B/20AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3426", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ERGOCALCIFEROL / GLUCONATE DE CALCIUM / LACTATE DE CALCIUM", "Pays": "FRANCE", "Nom Commercial": "FRUBIOSE VIT D", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 14 H 098 /99", "Code DCI": "14H098", "Forme": "SOL. BUV.", "Dosage": "1000UI/129MG/36,8 MG/5 ML", "Conditionnement": "B/20AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "FRUBIOSE VIT D 5000UI/500MG/350MG/5ML SUSP.BUV. B/20AMP", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ERGOCALCIFEROL / GLUCONATE DE CALCIUM / LACTATE DE CALCIUM", "Pays": "FRANCE", "Nom Commercial": "FRUBIOSE VIT D", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "152/ 14 H 099 /99", "Code DCI": "14H099", "Forme": "SOL. BUV.", "Dosage": "5000UI/500MG/350MG/5ML", "Conditionnement": "B/20AMP", "Commercialisation": true, "Remboursable": null}, {"Nom": "FUCIDANE 0.02 PDE. DERM T./15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FUCIDANE", "Tarif de reference": "144.9 DA", "PPA": "192.00 DA", "Num Enregistrement": "366/ 07 C 016 /08", "Code DCI": "07C016", "Forme": "PDE. DERM.", "Dosage": "0.02", "Conditionnement": "T./15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUCIDINE 0.02 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "FUCIDINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 07 C 016 /98/12", "Code DCI": "07C016", "Forme": "PDE. DERM.", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "FUCIDINE 0.02 PDE.DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4500", "Laboratoire": " LEO", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "FUCIDINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "083/07C016/98/12", "Code DCI": "07C016", "Forme": "PDE. DERM.", "Dosage": "2%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUCIDINE 250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/415.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=415", "Laboratoire": " LEO", "C.Pharmacologique": " AUTRES ANTIBIOTIQUES & ANTIBACTERIENS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACIDE FUSIDIQUE OU FUSIDATE DE SODIUM SEL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FUCIDINE", "Tarif de reference": "1107.63 DA", "PPA": "N/A", "Num Enregistrement": "083/ 13 N 179 /99", "Code DCI": "13N179", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUCIDINE 250MG/5ML SUSP.BUV FL/90ML", "Img": "https://pharmnet-dz.com//img/medics/416.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=416", "Laboratoire": " LEO", "C.Pharmacologique": " AUTRES ANTIBIOTIQUES & ANTIBACTERIENS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACIDE FUSIDIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FUCIDINE", "Tarif de reference": "1652.7 DA", "PPA": "N/A", "Num Enregistrement": "083/ 13 N 180 /00", "Code DCI": "13N180", "Forme": "SUSP.BUV", "Dosage": "250MG/5ML", "Conditionnement": "FL/90ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUCIDINE 500MG/10 ML PDRE.SOL.INJ. B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=414", "Laboratoire": " LEO", "C.Pharmacologique": " AUTRES ANTIBIOTIQUES & ANTIBACTERIENS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACIDE FUSIDIQUE OU FUSIDATE DE SODIUM SEL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FUCIDINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "083/ 13 N 178 /99", "Code DCI": "13N178", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/10 ML", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUCITHALMIC 0.01 GEL OPHT T/3G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2395", "Laboratoire": " LEO", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACIDE FUSIDIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FUCITHALMIC", "Tarif de reference": "162 DA", "PPA": "273.00 DA", "Num Enregistrement": "083/ 17 D 104 /97", "Code DCI": "17D104", "Forme": "GEL. OPHT.", "Dosage": "0.01", "Conditionnement": "T/3G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUCITHALMIC 0.01 GEL OPHT T/3G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ANTI-INFECTIEUX LOCAUX", "C.Pharmacologique": " OPHTALMOLOGIE", "C.Therapeutique": " ACIDE FUSIDIQUE", "Liste": "Liste I", "Pays": "IRELAND", "Nom Commercial": "FUCITHALMIC", "Tarif de reference": "162 DA", "PPA": "N/A", "Num Enregistrement": "501/17D104/97/15", "Code DCI": "17D104", "Forme": "GEL OPHT.", "Dosage": "1%", "Conditionnement": "T/3G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUMAFER 100MG/G PDRE.OR. B/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1757", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FUMARATE FERREUX", "Pays": "FRANCE", "Nom Commercial": "FUMAFER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 12 E 027 /97", "Code DCI": "12E027", "Forme": "PDRE.", "Dosage": "100MG/G", "Conditionnement": "B/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUNGIZONE 10% (10G/100ML) SUSP.BUV. FL/40ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPHOTERICINE B", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FUNGIZONE", "Tarif de reference": " N/A", "PPA": "394.00 DA", "Num Enregistrement": "017/ 13 R 106 /96/15", "Code DCI": "13R106", "Forme": "SUSP. BUV.", "Dosage": "10% (10G/100ML)", "Conditionnement": "FL/40ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "FUNGIZONE 50MG PDRE.SOL.INJ.IV B/01 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMPHOTERICINE B", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "FUNGIZONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 13 R 105 /99", "Code DCI": "13R105", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG", "Conditionnement": "B/01 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "FUROSAN 500MG COMP.SEC B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FARMACEUTICI CROVIS PHILCOM SRL", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "FUROSAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 06 H 091 /99/13", "Code DCI": "06H091", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "FUROSEMIDE 20MG SOL. INJ. B/5AMP ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "FUROSEMIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 06 H 087 /96", "Code DCI": "06H087", "Forme": "SOL. INJ.", "Dosage": "20MG", "Conditionnement": "B/5AMP ", "Commercialisation": true, "Remboursable": null}, {"Nom": "FUROSEMIDE 20MG/2ML SOL INJ B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "FUROSEMIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 06 H 087 /00", "Code DCI": "06H087", "Forme": "SOL. INJ.", "Dosage": "20MG/2ML", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUROSEMIDE ARROW 20MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3287", "Laboratoire": " ARROW GENERIQUES", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "FUROSEMIDE ARROW", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "364/ 06 H 089 /07", "Code DCI": "06H089", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUROSEMIDE HUP 40MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3289.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FUROSEMIDE HUP", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "380/ 06 H 090 /12", "Code DCI": "06H090", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUROSEMIDE IVAL 40MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FUROSEMIDE IVAL", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 H 090 /11", "Code DCI": "06H090", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUROZAL 20MG/2ML SOL INJ B/50", "Img": "https://pharmnet-dz.com//img/medics/3284.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FUROZAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 H 087 /04", "Code DCI": "06H087", "Forme": "SOL. INJ.", "Dosage": "20MG/2ML", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUROZAL 40MG COMP.SEC B/20", "Img": "https://pharmnet-dz.com//img/medics/3291.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FUROZAL", "Tarif de reference": "140 DA", "PPA": "80 DA", "Num Enregistrement": "003/ 06 H 090 /96", "Code DCI": "06H090", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "FUROZAL FAIBLE 20MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "FUROZAL FAIBLE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 H 089 /06  ", "Code DCI": "06H089", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}], "G": [{"Nom": "GAALOX 400MG/400MG COMP. A CROQUER B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "ALGERIE", "Nom Commercial": "GAALOX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 10 B 137 /04", "Code DCI": "10B137", "Forme": "COMP. A CROQ.", "Dosage": "400MG/400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GAALOX PLUS  200MG/200MG/25MG COMP. A CROQUER B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM/HYDROXYDE DE MAGNESIUM/SIMETICONE", "Pays": "ALGERIE", "Nom Commercial": "GAALOX PLUS ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 10 B 142 /05", "Code DCI": "10B142", "Forme": "COMP. A CROQ.", "Dosage": "200MG/200MG/25MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "GABATREX 300MG GLES. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " GABAPENTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GABATREX", "Tarif de reference": "0 DA", "PPA": "1312.00 DA", "Num Enregistrement": "001/ 15 A 086 /08", "Code DCI": "15A086", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "GABATREX 400MG GLES. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " GABAPENTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GABATREX", "Tarif de reference": "0 DA", "PPA": "1607.00 DA", "Num Enregistrement": "001/ 15 A 087 /08", "Code DCI": "15A087", "Forme": "GLES.", "Dosage": "400MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "GADOVIST  604,72MG/ML (SOIT 157,25MG/ML EN GADOLINIUM) SOL. INJ. IV FL./7,5ML - FL./15ML ", "Img": "https://pharmnet-dz.com//img/medics/573.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=573", "Laboratoire": " BAYER", "C.Pharmacologique": " I.R.M.", "C.Therapeutique": " DIAGNOSTIC", "Info": " GADOBUTROL", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "GADOVIST ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 08 A 069 /10", "Code DCI": "08A069", "Forme": "SOL. INJ.", "Dosage": "604,72MG/ML (SOIT 157,25MG/ML EN GADOLINIUM)", "Conditionnement": "FL./7,5ML - FL./15ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GALVUS 50MG COMP B/28", "Img": "https://pharmnet-dz.com//img/medics/3728.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3728", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " VILDAGLIPTINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "GALVUS", "Tarif de reference": "0 DA", "PPA": "2747.00 DA", "Num Enregistrement": "068/ 14 A 345 /13", "Code DCI": "14A345", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "GARDENAL 40MG/FL. DE LYOPH.** LYOPH. ET SOLV.POUR .SOL.INJ B/1FL. DE LYOPH. + 1AMP. DE 2ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3514", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PHENOBARBITAL  (SOUS FORME SODIQUE)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "GARDENAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 15 A 012 /96/09", "Code DCI": "15A012", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG/FL. DE LYOPH.**", "Conditionnement": "B/1FL. DE LYOPH. + 1AMP. DE 2ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "GASEC 20MG GLES. A MICROG. GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GASEC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 10 A 001 /03/09", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "GASTRIUM  50MG/26,7MG/ML SUSP. BUV. B/1 FlaCON DE 200 ML ", "Img": "https://pharmnet-dz.com//img/medics/4451.png", "Laboratoire": " LGPA", "C.Pharmacologique": " ANTI-REFLUX GASTRO-OESOPHAGIEN", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ALGINATE DE SODIUM / BICARBONATE DE SODIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GASTRIUM ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "311/10G054/16", "Code DCI": "10G054", "Forme": "SUSP. BUV.", "Dosage": "50MG/26,7MG/ML", "Conditionnement": "B/1 FlaCON DE 200 ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GASTROGRAFINE I =370MG/ML (10G/66G/100ML) SOL.BUV. OU REC. (APPLIC. GASTRO-INTESTINALE) B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=574", "Laboratoire": " BAYER", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " AMIDOTRIZOATE DE SODIUM / AMIDOTRIZOATE DE MEGLUMINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "GASTROGRAFINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 08 C 008 /97/13", "Code DCI": "08C008", "Forme": "SOL. BUV.", "Dosage": "I =370MG/ML (10G/66G/100ML)", "Conditionnement": "B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GAVISCON  SUSP.BUV. FL/250 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SMITHKLINE BEECHAM", "C.Pharmacologique": " ANTI-REFLUX GASTRO-OESOPHAGIEN", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ALGINATE DE SODIUM / BICARBONATE DE SODIUM", "Pays": "ROYAUME UNI", "Nom Commercial": "GAVISCON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "042/ 10 G 054 /99", "Code DCI": "10G054", "Forme": "SUSP. BUV.", "Conditionnement": "FL/250 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEASPERIQUE 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "GEASPERIQUE", "Tarif de reference": "53 DA", "PPA": "N/A", "Num Enregistrement": "319/ 12 A 131 /07 ", "Code DCI": "12A131", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEASPIRIQUE 500MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "GEASPIRIQUE", "Tarif de reference": "66.8 DA", "PPA": "N/A", "Num Enregistrement": "319/ 03 A 001 /06", "Code DCI": "03A001", "Forme": "COMP. SEC.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GECTAPEN 1 000 000UI/FL. DE PDRE. PDRE. ET SOLV. P. SOL. INJ. IM/IV  ET  PDRE. P. SOL.INJ. IM/IV     B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/263.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=263", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " BENZYLPENICILLINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GECTAPEN", "Tarif de reference": "107 DA", "PPA": "107 DA", "Num Enregistrement": "003/ 13 G 063 /98/10", "Code DCI": "13G063", "Forme": "PDRE. SOL. INJ.", "Dosage": "1 000 000UI/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "GECTAPEN 500 000UI/FL. DE PDRE. PDRE. ET SOLV. P. SOL. INJ. IM/IV  ET  PDRE. P. SOL.INJ. IM/IV     B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " BENZYLPENICILLINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GECTAPEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 062 /98/10", "Code DCI": "13G062", "Forme": "PDRE. SOL. INJ.", "Dosage": "500 000UI/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "GEFENE 20MG/ML (100MG/5ML) SUSP. BUV. FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GEFENE", "Tarif de reference": "122.5 DA", "PPA": "N/A", "Num Enregistrement": "319/ 04 B 042 /08", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEFRANE 0.02 SOL. NAS. FL./15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-INFECTIEUX SANS CORTICOIDES", "C.Therapeutique": " RHINOLOGIE", "Info": " THIOPHENE (SOUS FORME DE CARBOXYLATE DE SODIUM)", "Pays": "ALGERIE", "Nom Commercial": "GEFRANE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "319/ 22 B 004 /07", "Code DCI": "22B004", "Forme": "SOL. NAS.", "Dosage": "0.02", "Conditionnement": "FL./15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GELARTINE 10MG COMP.  B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GELARTINE", "Tarif de reference": "90 DA", "PPA": "N/A", "Num Enregistrement": "319/ 01 A 033 /08", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GELARTINE 1MG/ML SIROP FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GELARTINE", "Tarif de reference": "161 DA", "PPA": "N/A", "Num Enregistrement": "319/ 01 A 034 /08", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GELOFUSINE 4% DE  GELATINE SOL INJ POUR PERF.  B/10FL/500ML", "Img": "https://pharmnet-dz.com//img/medics/1838.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1838", "Laboratoire": " B.BRAUN MEDICAL  S.A", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " GELATINE FLUIDE MODIFIEE", "Pays": "FRANCE", "Nom Commercial": "GELOFUSINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "264/ 12 J 105 /02", "Code DCI": "12J105", "Forme": "PDRE. INJ.", "Dosage": "4% DE  GELATINE", "Conditionnement": "B/10FL/500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GELTIM LP 1MG/G GEL OPHTALMIQUE EN RECIPIENT UNIDOSE B/30RECIPIENTS UNIDOSE EN SACHET DE 10", "Img": "https://pharmnet-dz.com//img/medics/2371.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2371", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GELTIM LP", "Tarif de reference": "964.92 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 C 170 /13", "Code DCI": "17C170", "Forme": "GEL OPHT.", "Dosage": "1MG/G", "Conditionnement": "B/30RECIPIENTS UNIDOSE EN SACHET DE 10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMAL 100MG SUPPO.  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "GEMAL", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "319/ 03 B 007 /06", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMAL 1G COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "GEMAL", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "319/ 03 B 081 /07", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMAL 200MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "GEMAL", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "319/ 03 B 042 /06", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMAL 300MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "GEMAL", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "319/ 03 B 043 /06", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMAL 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "GEMAL", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "319/ 03 B 005 /05", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMAL 500MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "GEMAL", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "319/ 03 B 040 /06", "Code DCI": "03B040", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMATE 400MG SUPPO.  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GEMATE", "Tarif de reference": "135.5 DA", "PPA": "N/A", "Num Enregistrement": "319/ 04 B 031 /06", "Code DCI": "04B031", "Forme": "SUPPO.", "Dosage": "400MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMATE GEL 0.025 GEL DERM. T/60G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE NIFLUMIQUE", "Pays": "ALGERIE", "Nom Commercial": "GEMATE GEL", "Tarif de reference": "174 DA", "PPA": "N/A", "Num Enregistrement": "319/ 21 A 031 /08", "Code DCI": "21A031", "Forme": "GEL DERM.", "Dosage": "0.025", "Conditionnement": "T/60G", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMCITABIN EBEWE 10MG/ML (1000MG/100ML) CONC. P. SOL.INJ. P. PERF.IV FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "GEMCITABIN EBEWE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "141/ 05 G 085 /09", "Code DCI": "05G085", "Forme": "PDRE. SOL. INJ.", "Dosage": "10MG/ML (1000MG/100ML)", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GEMCITABIN EBEWE 10MG/ML (200MG/20ML) CONC. P. SOL.INJ. P. PERF.IV FL./20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "GEMCITABIN EBEWE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "141/ 05 G 094 /09", "Code DCI": "05G094", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (200MG/20ML)", "Conditionnement": "FL./20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GEMCITABIN EBEWE 10MG/ML (500MG/50ML) CONC. P. SOL.INJ. P. PERF.IV FL./50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " GEMCITABINE CHLORHYDRATE EXPRIME EN GEMCITABINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "GEMCITABIN EBEWE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "141/ 05 G 139 /09", "Code DCI": "05G139", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (500MG/50ML)", "Conditionnement": "FL./50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GEMIXINE 320MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/395.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GEMIFLOXACINE MESYLATE EXPRIME EN GEMIFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GEMIXINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352 / 13 K 334 /15", "Code DCI": "13K334", "Forme": "COMP. PELLI.", "Dosage": "320MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "GEMZAR 1G/50ML LYOPHILISAT SOL INJ IV B/1FL", "Img": "https://pharmnet-dz.com//img/medics/1003.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1003", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " GEMCITABINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "GEMZAR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 05 A 085 /00", "Code DCI": "05A085", "Forme": "SOL. INJ.", "Dosage": "1G/50ML", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEMZAR 200MG PDRE. SOL. PERF. IV B/1FL ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " LILLY", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " GEMCITABINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GEMZAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "034/ 05 A 094 /07", "Code DCI": "05A094", "Forme": "PDRE. SOL. INJ.", "Dosage": "200MG", "Conditionnement": "B/1FL ", "Commercialisation": true, "Remboursable": null}, {"Nom": "GENARITYNE 0,5MG/5ML(0,01 %) SIROP FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DEXCHLORPHENIRAMINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GENARITYNE", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "01A007", "Forme": "SIROP", "Dosage": "0,5MG/5ML(0,01 %)", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTADAR 3MG/ML** COLLY. FL./10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " GENTAMICINE (SOUS FORME DE SULFATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTADAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "272/ 17 D 020 /98/09", "Code DCI": "17D020", "Forme": "COLLY.", "Dosage": "3MG/ML**", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GENTAL 40MG/ML  (OU 80MG/2ML) SOL.INJ. B/1FL/2ML", "Img": "https://pharmnet-dz.com//img/medics/1866.jpg", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 A 005 /97/08", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "40MG/ML  (OU 80MG/2ML)", "Conditionnement": "B/1FL/2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GENTALEK 80MG/2ML SOL.INJ. B/1AMP.", "Img": "https://pharmnet-dz.com//img/medics/1867.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LEK", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "SLOVENIE", "Nom Commercial": "GENTALEK", "Tarif de reference": "61 DA", "PPA": " DA", "Num Enregistrement": "188/ 13 A 005 /99", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "80MG/2ML", "Conditionnement": "B/1AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTALLINE 10MG/ML SOL.INJ. B/1 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GENTALLINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "027/ 13 A 003 /97", "Code DCI": "13A003", "Forme": "SOL. INJ.", "Dosage": "10MG/ML", "Conditionnement": "B/1 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTALLINE 40MG/ML SOL.INJ. B/1 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GENTALLINE", "Tarif de reference": "44.67 DA", "PPA": "N/A", "Num Enregistrement": "027/ 13 A 004 /97", "Code DCI": "13A004", "Forme": "SOL. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/1 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTALLINE 80MG/2ML SOL.INJ. B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GENTALLINE", "Tarif de reference": "61 DA", "PPA": "N/A", "Num Enregistrement": "027/ 13 A 005 /97", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "80MG/2ML", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTAMICINE 80MG/2ML SOL.INJ. B/5 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "GENTAMICINE", "Tarif de reference": "305 DA", "PPA": "N/A", "Num Enregistrement": "161/ 13 A 005 /99", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "80MG/2ML", "Conditionnement": "B/5 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTAMICINE BIOCHEMIE 40MG/ML SOL.INJ. B/5 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "GENTAMICINE BIOCHEMIE", "Tarif de reference": "223.35 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 A 004 /98", "Code DCI": "13A004", "Forme": "SOL. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/5 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTAMICINE BIOCHEMIE 80MG/2ML SOL.INJ. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "GENTAMICINE BIOCHEMIE", "Tarif de reference": "244 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 A 005 /98", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "80MG/2ML", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTAMICINE CHAUVIN 0.003 PDE.OPHT. T/5G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2378", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " GENTAMICINE (SOUS FORME DE SULFATE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GENTAMICINE CHAUVIN", "Tarif de reference": "137.25 DA", "PPA": " DA", "Num Enregistrement": "096/ 17 D 021 /98", "Code DCI": "17D021", "Forme": "PDE. OPHT.", "Dosage": "0.003", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTAMINE 40MG/ML (80MG/2ML) SOL. INJ. IM/IV B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " UNILAB", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTAMINE", "Tarif de reference": "61 DA", "PPA": "N/A", "Num Enregistrement": "282/ 13 A 005 /03", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "40MG/ML (80MG/2ML)", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTAMYCINE GEO 40MG/ML (OU 80MG/2ML) SOL. INJ. B/3FL. DE 2ML -  B/1FL.DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTAMYCINE GEO", "Tarif de reference": "61 DA", "PPA": "N/A", "Num Enregistrement": "304/ 13 A 005 /08", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "40MG/ML (OU 80MG/2ML)", "Conditionnement": "B/3FL. DE 2ML -  B/1FL.DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTATIC 20MG/ML** (OU 40MG/2ML) SOL.INJ. IM/IV B/10FL.DE 2ML*   -   B/20FL. DE 2ML*", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTATIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 A 004 /06", "Code DCI": "13A004", "Forme": "SOL. INJ.", "Dosage": "20MG/ML** (OU 40MG/2ML)", "Conditionnement": "B/10FL.DE 2ML*   -   B/20FL. DE 2ML*", "Commercialisation": true, "Remboursable": null}, {"Nom": "GENTAXYN 20MG/ML (40MG/2ML) SOL. INJ. IM/IV B/5AMP. DE 2ML ET B/50AMP. DE 2ML*", "Img": "https://pharmnet-dz.com//img/medics/1863.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTAXYN", "Tarif de reference": "223.35 DA", "PPA": " DA", "Num Enregistrement": "433/ 13 A 004 /13", "Code DCI": "13A004", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (40MG/2ML)", "Conditionnement": "B/5AMP. DE 2ML ET B/50AMP. DE 2ML*", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTAXYN 40MG/ML (80MG/2ML) SOL. INJ. IM/IV B/03AMP. DE 2ML ET B/50AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/1872.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTAXYN", "Tarif de reference": "183 DA", "PPA": " DA", "Num Enregistrement": "433/ 13 A 005 /13", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "40MG/ML (80MG/2ML)", "Conditionnement": "B/03AMP. DE 2ML ET B/50AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTIX 20MG COMP. PELLI. B/02 - B/08", "Img": "https://pharmnet-dz.com//img/medics/1229.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTIX", "Tarif de reference": "490.00 DA", "PPA": "490.00 DA", "Num Enregistrement": "003/ 25 N 052 /09", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/02 - B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTOCIL 3MG/ML (0,3%) COLLY. FL /5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA) ", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " GENTAMICINE (SOUS FORME DE SULFATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GENTOCIL", "Tarif de reference": "65.05 DA", "PPA": "N/A", "Code DCI": "17D020", "Forme": "COLLY.", "Dosage": "3MG/ML (0,3%) ", "Conditionnement": "FL /5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTOMIL 40MG/ML SOL.INJ IM - IV B/5AMP. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "GENTOMIL", "Tarif de reference": "223.35 DA", "PPA": "N/A", "Num Enregistrement": "084/ 13 A 004 /99", "Code DCI": "13A004", "Forme": "SOL. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/5AMP. DE 2ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GENTOMIL 80MG/2ML SOL.INJ B/5AMP. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "GENTOMIL", "Tarif de reference": "305 DA", "PPA": "N/A", "Num Enregistrement": "084/ 13 A 005 /99", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "80MG/2ML", "Conditionnement": "B/5AMP. DE 2ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEOFENAC 50MG CP. PELL. GASTRORESIST. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GEOFENAC", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "04B006", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "BT/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEOFER 20MG/ML (100MG/5ML) SOL. BUV. EN FLACONS B/10 FLACONS DE 5ML       ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GEOFER", "Tarif de reference": "160 DA", "PPA": "N/A", "Num Enregistrement": "304/12E106/16", "Code DCI": "12E106", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "B/10 FLACONS DE 5ML       ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEOLAX 13,125G/0,1785G/0,3507G/0,0466G/SACH. PDRE. SOL.BUV. B/10 SACH. ET B/20 SACH.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 3350 (POLYETHYLENE GLYCOL 3350) / BICARBONATE SODIUM / CHLORURE SODIUM / CHLORURE POTASSIUM ", "Pays": "ALGERIE", "Nom Commercial": "GEOLAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 10 L 129 /07", "Code DCI": "10L129", "Forme": "PDRE. SOL. BUV.", "Dosage": "13,125G/0,1785G/0,3507G/0,0466G/SACH.", "Conditionnement": "B/10 SACH. ET B/20 SACH.", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEPLASTINE 27G/20G/100G PDE. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " OXYDE DE ZINC / HUILE DE FOIE DE MORUE", "Pays": "ALGERIE", "Nom Commercial": "GEPLASTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "319/ 07 A 006 /06", "Code DCI": "07A006", "Forme": "PDE.", "Dosage": "27G/20G/100G", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": null}, {"Nom": "GEPROFEN 0.025 GEL DERM. T/60G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GEPROFEN", "Tarif de reference": "174 DA", "PPA": "N/A", "Num Enregistrement": "319/ 21 A 032 /08", "Code DCI": "21A032", "Forme": "GEL DERM.", "Dosage": "0.025", "Conditionnement": "T/60G", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEPROFENE 100MG SUPPO. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GEPROFENE", "Tarif de reference": "166.08 DA", "PPA": "N/A", "Num Enregistrement": "319/ 04 B 017 /09", "Code DCI": "04B017", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "GERDOL 1MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ANTI-OESTROGENES", "C.Pharmacologique": " ENDOCRINOLOGIE ET HORMONES", "C.Therapeutique": " ANASTROZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GERDOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "502/09B139/15", "Code DCI": "09B139", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GEROXYL 4% (40MG/ML) SOL. BUV. GTTES FL./20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GEROXYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "319/ 16 A 003 /06", "Code DCI": "16A003", "Forme": "SOL. BUV. GTTES.", "Dosage": "4% (40MG/ML)", "Conditionnement": "FL./20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GESPASON  150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "GESPASON ", "Tarif de reference": "147.5 DA", "PPA": "N/A", "Num Enregistrement": "319/ 10 E 039 /06", "Code DCI": "10E039", "Forme": "SUPPO.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GETADINE 0.1 SOL. APPL. LOCALE FL./50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "GETADINE", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "319/ 07 P 077 /08", "Code DCI": "07P077", "Forme": "SOL. DERM.", "Dosage": "0.1", "Conditionnement": "FL./50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "GETRAT 2G/5ML AMP. BUV. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CITRATE DE BETAINE", "Pays": "ALGERIE", "Nom Commercial": "GETRAT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "319/ 10 R 130 /06", "Code DCI": "10R130", "Forme": "AMP. BUV.", "Dosage": "2G/5ML", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "GETRIM 400MG/80MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GETRIM", "Tarif de reference": "115.2 DA", "PPA": "N/A", "Num Enregistrement": "319/ 13 M 092 /08", "Code DCI": "13M092", "Forme": "COMP.", "Dosage": "400MG/80MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GETRIM FORT 800MG/160MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GETRIM FORT", "Tarif de reference": "115.2 DA", "PPA": "N/A", "Num Enregistrement": "319/ 13 M 169 /11", "Code DCI": "13M169", "Forme": "COMP SEC.", "Dosage": "800MG/160MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GINKOR FORT 0,014G/0,3G**/0,3G GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1532.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1532", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " GINKGO BILOBA,EXTRAIT STANDARTISE TITRE A 24% D'HETEROSIDES DE GINKGO ET DE 6% DE GINKGOLIDES-BILOBALIDE / HEPTAMINOL (SOUS FORME DE CHLORHYDRATE)** / TROXERUTINE", "Pays": "FRANCE", "Nom Commercial": "GINKOR FORT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "020/ 06 K 255 /97/09", "Code DCI": "06K255", "Forme": "GLES.", "Dosage": "0,014G/0,3G**/0,3G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "GIVALEX 0,1G/0,5G/0,25G**/100ML COLLU. FL/50 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " HEXETIDINE / SALICYLATE DE CHOLINE / CHLORBUTANOL HEMIHYDRATEE", "Pays": "FRANCE", "Nom Commercial": "GIVALEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 23 B 025 /99/09 ", "Code DCI": "23B025", "Forme": "COLLU.", "Dosage": "0,1G/0,5G/0,25G**/100ML", "Conditionnement": "FL/50 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GIVALEX 0,1G/0,5G/0,25G**/100ML SOL.BAIN.BOUCHE FL/125 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " HEXETIDINE / SALICYLATE DE CHOLINE / CHLORBUTANOL HEMIHYDRATEE", "Pays": "FRANCE", "Nom Commercial": "GIVALEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 23 B 023 /99/09", "Code DCI": "23B023", "Forme": "SOL. BAIN BOUCHE", "Dosage": "0,1G/0,5G/0,25G**/100ML", "Conditionnement": "FL/125 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLATIX 30MG COMP. LM  B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLICLAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLATIX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/14A303/16", "Code DCI": "14A303", "Forme": "COMP. LP", "Dosage": "30MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLAVIP  50MG COMP B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " VILDAGLIPTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLAVIP ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/14A345/16", "Code DCI": "14A345", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLAZIDAL LP 30MG MICRGLES. LP EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLICLAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLAZIDAL LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "039/ 14 A 303 /13", "Code DCI": "14A303", "Forme": "COMP. PELLI. LP", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIBENCROVIS 2,5MG COMP.SEC. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "GLIBENCROVIS", "Tarif de reference": "110.4 DA", "PPA": "N/A", "Num Enregistrement": "012/ 14 A 002 /98", "Code DCI": "14A002", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIBIL 5MG COMP. B/30 ET B/100", "Img": "https://pharmnet-dz.com//img/medics/3614.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3614", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "GLIBIL", "Tarif de reference": "185 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 003 /99/06", "Code DCI": "14A003", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLICLAZIDE BGL 30MG COMP.PELLI. LM. B/30", "Img": "https://pharmnet-dz.com//img/medics/3713.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3713", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLICLAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLICLAZIDE BGL", "Tarif de reference": "451.3 DA", "PPA": "N/A", "Num Enregistrement": "325/ 14 A 303 /14", "Code DCI": "14A303", "Forme": "COMP. PELLI. LP", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLICRON 30MG COMP. PELLI. LM B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLICLAZIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GLICRON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "437/ 14 A 303 /13", "Code DCI": "14A303", "Forme": "COMP. PELLI. LP", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE BEKER 1MG COMP. SEC. B/30 et B/90", "Img": "https://pharmnet-dz.com//img/medics/4392.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4392", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE BEKER", "Tarif de reference": "250.8 DA", "PPA": "250.8 DA", "Num Enregistrement": "447/14A187/16", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE BEKER 2MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/3652.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3652", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE BEKER", "Tarif de reference": "480 DA", "PPA": "479.99 DA", "Num Enregistrement": "447/ 14 A 188 /13", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE BEKER 3MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/3665.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3665", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE BEKER", "Tarif de reference": "720 DA", "PPA": "720.00 DA", "Num Enregistrement": "447/ 14 A 189 /13", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE BEKER 4MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/3677.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3677", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE BEKER", "Tarif de reference": "750 DA", "PPA": "750.00 DA", "Num Enregistrement": "447/ 14 A 190 /13", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE IVAL 1MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE IVAL", "Tarif de reference": "250.8 DA", "PPA": "250.00 DA", "Num Enregistrement": "195/ 14 A 187 /09", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE IVAL 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE IVAL", "Tarif de reference": "480 DA", "PPA": "478.00 DA", "Num Enregistrement": "195/ 14 A 188 /09", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE IVAL 3MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE IVAL", "Tarif de reference": "720 DA", "PPA": "720.00 DA", "Num Enregistrement": "195/ 14 A 189 /09", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE IVAL 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE IVAL", "Tarif de reference": "750 DA", "PPA": "750.00 DA", "Num Enregistrement": "195/ 14 A 190 /09", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE LDM 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE LDM", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "309/ 14 A 188 /13", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE LDM 3MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE LDM", "Tarif de reference": "720 DA", "PPA": "N/A", "Num Enregistrement": "309/14A189/17", "Code DCI": "14A189", "Forme": "COMP.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE PHYSIOPHARM 2MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/4424.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE PHYSIOPHARM", "Tarif de reference": "480 DA", "PPA": " DA", "Num Enregistrement": "462/14A188/16", "Code DCI": "14A188", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE PHYSIOPHARM 4MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/4425.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE PHYSIOPHARM", "Tarif de reference": "750 DA", "PPA": "750 DA", "Num Enregistrement": "462/14A190/16", "Code DCI": "14A190", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE WINTHROP 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE WINTHROP", "Tarif de reference": "250.8 DA", "PPA": "N/A", "Num Enregistrement": "428/ 14 A 187 /09 ", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE WINTHROP 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE WINTHROP", "Tarif de reference": "480 DA", "PPA": "N/A", "Num Enregistrement": "428/ 14 A 188 /09", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMEPIRIDE WINTHROP 3MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE WINTHROP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "428/ 14 A 189 /08", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLIMEPIRIDE WINTHROP 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMEPIRIDE WINTHROP", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "428/ 14 A 190 /08", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMICARE  1MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3648.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3648", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMICARE ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 14 A 187 /07/12", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMICARE  2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3656.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3656", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMICARE ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 14 A 188 /07/13", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMICARE  3MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3672.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3672", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMICARE ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 14 A 189 /07/13", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMICARE  4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3685.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3685", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMICARE ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 14 A 190 /07/12", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIMICARE  6MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3721.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3721", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLIMICARE ", "Tarif de reference": "920.1 DA", "PPA": " DA", "Num Enregistrement": "293/ 14 A 324 /13", "Code DCI": "14A324", "Forme": "COMP. PELLI.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLINIX 0,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLINIX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 200 /14", "Code DCI": "14A200", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLINIX 1MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLINIX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 201 /14", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLINIX 2MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLINIX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 202 /14", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLIVEC 100MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " NOVARTIS S.A.S", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " IMATINIB", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GLIVEC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 A 105 /05", "Code DCI": "05A105", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLODEC  1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLODEC ", "Tarif de reference": "250.8 DA", "PPA": "N/A", "Num Enregistrement": "492/14A187/16", "Code DCI": "14A187", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLODEC 2 2MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLODEC 2", "Tarif de reference": "480.00 DA", "PPA": "N/A", "Code DCI": "14A188", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLODEC 3 3MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLODEC 3", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "14A189", "Forme": "COMP.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLODEC 4MG COM B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLODEC", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "14A190", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLORION 1MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "GLORION", "Tarif de reference": "250.8 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 187 /07", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLORION 2MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "GLORION", "Tarif de reference": "480 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 188 /07", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLORION 3MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "GLORION", "Tarif de reference": "720 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 189 /07", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLORION 4MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "GLORION", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 190 /07", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLORION 6MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "GLORION", "Tarif de reference": "920.1 DA", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 324 /11", "Code DCI": "14A324", "Forme": "COMP. PELLI.", "Dosage": "6MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCAGEN  1MG/ML LYOPH. ET +SOLV, P. USAG. PARENTER. SC/IM/IV B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3325", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " HYPERGLYCEMIANTS", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCAGON", "Pays": "DANEMARK", "Nom Commercial": "GLUCAGEN ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 C 021 /97", "Code DCI": "14C021", "Forme": "LYOPH. SOL. INJ.", "Dosage": "1MG/ML", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCAGEN HYPOKIT 1MG SERINGUE  PRETE B/1FL. DE GLUCAGON + 1SERING. DE 1ML DE SOLV. ", "Img": "https://pharmnet-dz.com//img/medics/3326.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3326", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " HYPERGLYCEMIANTS", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCAGON", "Pays": "DANEMARK", "Nom Commercial": "GLUCAGEN HYPOKIT", "Tarif de reference": "0 DA", "PPA": "2046.00 DA", "Num Enregistrement": "069/ 14 C 139 /98", "Code DCI": "14C139", "Forme": "SERINGUE", "Dosage": "1MG", "Conditionnement": "B/1FL. DE GLUCAGON + 1SERING. DE 1ML DE SOLV. ", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCANTIME 1,5G /5ML SOL. INJ IM OU INJ LOCALE B/5", "Img": "https://pharmnet-dz.com//img/medics/2055.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2055", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " AUTRES ANTI-PARASITAIRES", "C.Therapeutique": " PARASITOLOGIE", "Info": " ANTIMONIATE DE MEGLUMINE", "Pays": "FRANCE", "Nom Commercial": "GLUCANTIME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 19 D 024 /96", "Code DCI": "19D024", "Forme": "SOL. INJ.", "Dosage": "1,5G /5ML", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCAR 100MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/4543.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4543", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCAR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/14A341/16", "Code DCI": "14A341", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOBAY 100MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3725.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3725", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "GLUCOBAY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 14 A 341 /12", "Code DCI": "14A341", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOBAY 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3636.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3636", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "GLUCOBAY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "124/ 14 A 136 /99", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOFORMINE 1000MG COMP. PELLI. SEC. B/30 ET B/100", "Img": "https://pharmnet-dz.com//img/medics/3705.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCOFORMINE", "Tarif de reference": "173.4 DA", "PPA": "N/A", "Num Enregistrement": "380/ 14 A 224/14", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/30 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOFORMINE 500MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3619.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCOFORMINE", "Tarif de reference": "109.2 DA", "PPA": "121.00 DA", "Num Enregistrement": "380/ 14 A 006 /14", "Code DCI": "14A006", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOFORMINE 850MG COMP. PELLI. B/30 ET B/100", "Img": "https://pharmnet-dz.com//img/medics/3625.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCOFORMINE", "Tarif de reference": "147.6 DA", "PPA": "483.00 DA", "Num Enregistrement": "380/ 14 A 007 /13", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOMEX  1000MG COMP PELL B/90", "Img": "https://pharmnet-dz.com//img/medics/4643.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCOMEX ", "Tarif de reference": "173.4 DA", "PPA": " DA", "Num Enregistrement": "400/14A224/16", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOMEX 500MG  COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medics/4626.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCOMEX", "Tarif de reference": "182 DA", "PPA": " DA", "Num Enregistrement": "400/14A006/16", "Code DCI": "14A006", "Forme": "COMP. PELLI.", "Dosage": "500MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOMEX 850MG COMP. PELLI. B/30ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4627.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCOMEX", "Tarif de reference": "492 DA", "PPA": " DA", "Num Enregistrement": "400/14A007/16", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCONAD 850MG COMP. PELLI. B/30 - B/60 - B/90 - B/120", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCONAD", "Tarif de reference": "147.6 DA", "PPA": "147.00 DA", "Num Enregistrement": "468/ 14 A 007 /15", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30 - B/60 - B/90 - B/120", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCONIL 5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "GLUCONIL", "Tarif de reference": "55.5 DA", "PPA": "N/A", "Num Enregistrement": "166/ 14 A 003 /99", "Code DCI": "14A003", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCONOVA 100MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCONOVA", "Tarif de reference": "534.00 DA", "PPA": "N/A", "Code DCI": "14A341", "Forme": "COMP SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCONOVA 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3637.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3637", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCONOVA", "Tarif de reference": "411.27 DA", "PPA": "N/A", "Num Enregistrement": "149/ 14 A 136 /14", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOPACK 0.1 SO. INJ. P. PERF. IV FL. EN POLYPROYLENE DE 500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE", "Pays": "ALGERIE", "Nom Commercial": "GLUCOPACK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 14 G 046 /12", "Code DCI": "14G046", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "FL. EN POLYPROYLENE DE 500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOPACK 0.15 SOL. INJ. P. PERF. IV FL. EN POLYPROYLENE DE 500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE", "Pays": "ALGERIE", "Nom Commercial": "GLUCOPACK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 14 G 048 /13", "Code DCI": "14G048", "Forme": "SOL. INJ.", "Dosage": "0.15", "Conditionnement": "FL. EN POLYPROYLENE DE 500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOPACK 3G/100ML SOL.INJ.P. PERF  POCHE/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE MONOHYDRATE EXPRIME EN GLUCOSE ANHYDRE", "Pays": "ALGERIE", "Nom Commercial": "GLUCOPACK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 14 G 347/14", "Code DCI": "14G347", "Forme": "SOL. INJ.", "Dosage": "3G/100ML", "Conditionnement": "POCHE/500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOPHAGE  1000MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5861", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GLUCOPHAGE ", "Tarif de reference": "173,4 DA", "PPA": "0 DA", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOPHAGE 850MG COMP. PELLI. B/100", "Img": "https://pharmnet-dz.com//img/medics/3627.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3627", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GLUCOPHAGE", "Tarif de reference": "0 DA", "PPA": "492.00 DA", "Num Enregistrement": "062/ 14 A 007 /97/13", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOSE 10% 10% FL. 500ML SOL.INJ. PERF. POCHE DE  500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE", "Pays": "ALGERIE", "Nom Commercial": "GLUCOSE 10%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 046 /97/09", "Code DCI": "14G046", "Forme": "SOL. INJ.", "Dosage": "10% FL. 500ML", "Conditionnement": "POCHE DE  500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOSE 15% FL. 500ML SOL.INJ. FL. DE 500 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE", "Pays": "ALGERIE", "Nom Commercial": "GLUCOSE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 048 /97", "Code DCI": "14G048", "Forme": "SOL. INJ.", "Dosage": "15% FL. 500ML", "Conditionnement": "FL. DE 500 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOSE 5% 0.05 SOLUTE MASSIF P. PERF. POCHE DE 500ML ET  FLACON EN POLYPROPYLENE DE 500ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE", "Pays": "ALGERIE", "Nom Commercial": "GLUCOSE 5%", "Tarif de reference": " N/A", "PPA": "110.00 DA", "Num Enregistrement": "280/ 14 G 044 /01/07", "Code DCI": "14G044", "Forme": "SOL. INJ.", "Dosage": "0.05", "Conditionnement": "POCHE DE 500ML ET  FLACON EN POLYPROPYLENE DE 500ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOSE 5% 5% FL. 500ML SOL.INJ. PERF. POCHE DE 500ML AVEC 2TWIN VALVES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLUCOSE", "Pays": "ALGERIE", "Nom Commercial": "GLUCOSE 5%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 044 /97/05", "Code DCI": "14G044", "Forme": "SOL. INJ.", "Dosage": "5% FL. 500ML", "Conditionnement": "POCHE DE 500ML AVEC 2TWIN VALVES", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOTAC 850MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA SPHERE SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUCOTAC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "490/ 14 A 007 /15", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLUCOVANCE 500MG/2,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3718.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3718", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE / GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GLUCOVANCE", "Tarif de reference": "164.4 DA", "PPA": " DA", "Num Enregistrement": "062/ 14 A 318 /08", "Code DCI": "14A318", "Forme": "COMP. PELLI.", "Dosage": "500MG/2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUCOVANCE 500MG/5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3719.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3719", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE / GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GLUCOVANCE", "Tarif de reference": "164.7 DA", "PPA": " DA", "Num Enregistrement": "062/ 14 A 319 /08", "Code DCI": "14A319", "Forme": "COMP. PELLI.", "Dosage": "500MG/5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUDOSIN 1MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUDOSIN", "Tarif de reference": "250.8 DA", "PPA": "N/A", "Num Enregistrement": "050/ 14 A 187 /11", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUDOSIN 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUDOSIN", "Tarif de reference": "480 DA", "PPA": "477.00 DA", "Num Enregistrement": "050/ 14 A 188 /11", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUDOSIN 3MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUDOSIN", "Tarif de reference": "720 DA", "PPA": "703.00 DA", "Num Enregistrement": "050/ 14 A 189 /11", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLUDOSIN 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLUDOSIN", "Tarif de reference": "750 DA", "PPA": "728.00 DA", "Num Enregistrement": "050/ 14 A 190 /11", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLURENOR 30MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medics/3715.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3715", "Laboratoire": " GUIDOTTI SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIQUIDONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "GLURENOR", "Tarif de reference": "170.94 DA", "PPA": "N/A", "Num Enregistrement": "367/ 14 A 305 /07/15", "Code DCI": "14A305", "Forme": "COMP. SEC.", "Dosage": "30MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYACARB 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLYACARB", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 14 A 136 /14", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYBEK 100MG COMP. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4582.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4582", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLYBEK", "Tarif de reference": "0 DA", "PPA": "624.22 DA", "Num Enregistrement": "447/14A341/16", "Code DCI": "14A341", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYCENORM 0,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLYCENORM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "317/14A200/15", "Code DCI": "14A200", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYCENORM 1MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLYCENORM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "317/14A201/15", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYCENORM 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLYCENORM", "Tarif de reference": " N/A", "PPA": "390.00 DA", "Num Enregistrement": "317/ 14 A 202 /15", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLYCERIN 2,5G SUPPO.ADULTE B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ITALIE", "Nom Commercial": "GLYCERIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 10 M 070 /98", "Code DCI": "10M070", "Forme": "SUPPO.", "Dosage": "2,5G", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLYCERIN 750MG SUPPO.ENFANT B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ITALIE", "Nom Commercial": "GLYCERIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 10 M 069 /98", "Code DCI": "10M069", "Forme": "SUPPO.", "Dosage": "750MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLYCERINE 0,72G SUPPO.BEBE B/10", "Img": "https://pharmnet-dz.com//img/medics/2970.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE", "Tarif de reference": "0 DA", "PPA": "150.00 DA", "Num Enregistrement": "003/ 10 M 124 /01", "Code DCI": "10M124", "Forme": "SUPPO.", "Dosage": "0,72G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYCERINE 1,2G SUPPO.ENFANT B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 M 069 /99", "Code DCI": "10M069", "Forme": "SUPPO.", "Dosage": "1,2G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLYCERINE ADULTE 2,04G SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE ADULTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "366/ 10 M 201 /15", "Code DCI": "10M201", "Forme": "SUPPO.", "Dosage": "2,04G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLYCERINE ADULTES 1,8G SUPPO.ADULTE B/10", "Img": "https://pharmnet-dz.com//img/medics/2965.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE ADULTES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 M 070 /97", "Code DCI": "10M070", "Forme": "SUPPO.", "Dosage": "1,8G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLYCERINE BEBES 0,642G SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE BEBES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "366/ 10 M 199 /15", "Code DCI": "10M199", "Forme": "SUPPO.", "Dosage": "0,642G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "GLYCERINE ENFANTS 1,23G SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2973.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2973", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE ENFANTS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "366/ 10 M 200 /15", "Code DCI": "10M200", "Forme": "SUPPO.", "Dosage": "1,23G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": false}, {"Nom": "GLYCERINE LS ADULTE 1,8G  SUPPOS ADULTE  B/10", "Img": "https://pharmnet-dz.com//img/medics/2966.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2966", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE LS ADULTE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "231/ 10 M 070 /14", "Code DCI": "10M070", "Forme": "SUPPO.", "Dosage": "1,8G ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": false}, {"Nom": "GLYCERINE LS BEBE 0,72G  SUPPO.BEBE B/10", "Img": "https://pharmnet-dz.com//img/medics/2971.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2971", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE LS BEBE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/ 10 M 124 /14", "Code DCI": "10M124", "Forme": "SUPPO.", "Dosage": "0,72G ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYCERINE LS ENFANT 1,20G  SUPPOS  B/10", "Img": "https://pharmnet-dz.com//img/medics/2963.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2963", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GLYCEROL", "Pays": "ALGERIE", "Nom Commercial": "GLYCERINE LS ENFANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/10 M 069 /14", "Code DCI": "10M069", "Forme": "SUPPO.", "Dosage": "1,20G ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GLYSAVIA 100MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GLYSAVIA", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "001/14A342/15", "Code DCI": "14A342", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "GONADOTROPHINE CHORIONIQUE\" ENDO \" 5000UI LYOPH. ET SOLV. P. USAG. PARENTER. B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ORGANON", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " GONADOTROPHINE CHORIONIQUE HUMAINE", "Pays": "FRANCE", "Nom Commercial": "GONADOTROPHINE CHORIONIQUE\" ENDO \"", "Tarif de reference": "0 DA", "PPA": "624.00 DA", "Num Enregistrement": "005/ 09 J 045 /98", "Code DCI": "09J045", "Forme": "PDRE. SOL. INJ.", "Dosage": "5000UI", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "GONAL-F 300UI/0,5ML (22\u00b5G/0,5ML) SOL. INJ SC  EN MULTIDOSE B/1STYLO PREREMPLI DE 0,5ML + 05AIGUILLES POUR STYLO", "Img": "https://pharmnet-dz.com//img/medics/3799.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3799", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "GONAL-F", "Tarif de reference": "0 DA", "PPA": "12155.00 DA", "Num Enregistrement": "062/ 09 J 152 /09", "Code DCI": "09J152", "Forme": "PDRE. SOL. INJ.", "Dosage": "300UI/0,5ML (22\u00b5G/0,5ML)", "Conditionnement": "B/1STYLO PREREMPLI DE 0,5ML + 05AIGUILLES POUR STYLO", "Commercialisation": true, "Remboursable": true}, {"Nom": "GONAL-F 450UI/0,75ML (33\u00b5G/0,75ML) SOL. INJ SC  EN MULTIDOSE B/1STYLO PREREMPLI DE 0,75ML + 07AIGUILLES POUR STYLO", "Img": "https://pharmnet-dz.com//img/medics/3800.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3800", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "GONAL-F", "Tarif de reference": "0 DA", "PPA": "17367.00 DA", "Num Enregistrement": "062/ 09 J 153 /09", "Code DCI": "09J153", "Forme": "PDRE. SOL. INJ.", "Dosage": "450UI/0,75ML (33\u00b5G/0,75ML)", "Conditionnement": "B/1STYLO PREREMPLI DE 0,75ML + 07AIGUILLES POUR STYLO", "Commercialisation": true, "Remboursable": true}, {"Nom": "GONAL-F 75UI/ML (5,5\u03bcG/ML) PDRE ET SOLVANT  SOL. INJ. SC B/1FL DE PDRE + UNE SERINGUE PRE REMPLIE  DE 1ML SOLVANT (EAU PREPARATION INJECTABLE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3792", "Laboratoire": " SERONO EUROPE LIMITED", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "GONAL-F", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "219/ 09 J 129 /02/09", "Code DCI": "09J129", "Forme": "PDRE. SOL. INJ.", "Dosage": "75UI/ML (5,5\u03bcG/ML)", "Conditionnement": "B/1FL DE PDRE + UNE SERINGUE PRE REMPLIE  DE 1ML SOLVANT (EAU PREPARATION INJECTABLE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "GONAL-F 900UI/1,5ML (66\u00b5G/1,5ML) SOL. INJ SC  EN MULTIDOSE B/1STYLO PREREMPLI DE 1,5ML + 14AIGUILLES POUR STYLO", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3801", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "GONAL-F", "Tarif de reference": "0 DA", "PPA": "35177.00 DA", "Num Enregistrement": "062/ 09 J 154 /09", "Code DCI": "09J154", "Forme": "PDRE. SOL. INJ.", "Dosage": "900UI/1,5ML (66\u00b5G/1,5ML)", "Conditionnement": "B/1STYLO PREREMPLI DE 1,5ML + 14AIGUILLES POUR STYLO", "Commercialisation": true, "Remboursable": true}, {"Nom": "GRACIAL 30\u00b5G/125\u00b5G ( COMP. BLANCS) ET 40\u00b5G/25\u00b5G (COMP. BLEUS) COMP. B/22 (15BLANCS +07BLEUS)", "Img": "https://pharmnet-dz.com//img/medics/3057.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " ORGANON", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL / DESOGESTREL", "Pays": "PAYS BAS", "Nom Commercial": "GRACIAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "005/ 11 H 073 /08", "Code DCI": "11H073", "Forme": "COMP.", "Dosage": "30\u00b5G/125\u00b5G ( COMP. BLANCS) ET 40\u00b5G/25\u00b5G (COMP. BLEUS)", "Conditionnement": "B/22 (15BLANCS +07BLEUS)", "Commercialisation": true, "Remboursable": false}, {"Nom": "GRANOCYTE 34 33,6MUI/FL. DE PDRE. (OU 263\u00b5G/FL. DE PDRE.) PDRE. ET SOLV. POUR  SOL. INJ. SC OU POUR PERF. IV B/5FL. DE PDRE. + 5AMP. DE 1ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medics/1770.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1770", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " LENOGRASTIM rHu G-CSF", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "GRANOCYTE 34", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 12 E 064 /97/09", "Code DCI": "12E064", "Forme": "LYOPH. SOL. INJ.", "Dosage": "33,6MUI/FL. DE PDRE. (OU 263\u00b5G/FL. DE PDRE.)", "Conditionnement": "B/5FL. DE PDRE. + 5AMP. DE 1ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "GRINAZOLE 0.1 PATE  T/4,5G", "Img": "https://pharmnet-dz.com//img/medics/1137.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1137", "Laboratoire": " SEPTODENT", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "GRINAZOLE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "044/ 23 B 027 /99", "Code DCI": "23B027", "Forme": "PATE ", "Dosage": "0.1", "Conditionnement": "T/4,5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "GRIPEX 50MG/4MG GLES. A MICROGRAN. B/10", "Img": "https://pharmnet-dz.com//img/medics/1461.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1461", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PHENYLPROPANOLAMINE CHLORHYDRATE/CHLORPHENIRAMINE MALEATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GRIPEX", "Tarif de reference": "157.9 DA", "PPA": "N/A", "Num Enregistrement": "035/ 22 A 026 /99/08", "Code DCI": "22A026", "Forme": "GLES.", "Dosage": "50MG/4MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "GRIPEX ALLERGIE 10MG COMP. PELLI.SEC. B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "GRIPEX", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "01A003", "Forme": "COMP SEC.", "Dosage": "10 MG", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": true}, {"Nom": "GRIPEX PLUS  200MG/30MG COMP. PELLI B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " IBUPROFENE / PSEUDOEPHEDRINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GRIPEX PLUS ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/22A043/16", "Code DCI": "22A043", "Forme": "COMP. PELLI.", "Dosage": "200MG/30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "GRIPEX TOUX GRASSE 0,05 SOL BUV FL./200ML+UNE CUILLERE GRADUE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "GRIPEX TOUX GRASSE", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "20D108", "Forme": "SIROP", "Dosage": "5%", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "G-SULPIRIDE 25MG/5ML (OU 0,5G/100ML) SOL. BUV. FL./200ML", "Img": "https://pharmnet-dz.com//img/medics/2219.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2219", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "G-SULPIRIDE", "Tarif de reference": "118 DA", "PPA": "N/A", "Num Enregistrement": "235/ 16 D 067 /09", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML (OU 0,5G/100ML)", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "G-SULPIRIDE 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2218.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2218", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "G-SULPIRIDE", "Tarif de reference": "140.1 DA", "PPA": " DA", "Num Enregistrement": "235/ 16 D 066 /08", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "GYLAXA 5MG COMP. GASTRO. RESIST. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " BISACODYL", "Pays": "ALGERIE", "Nom Commercial": "GYLAXA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 10 L 162 /08", "Code DCI": "10L162", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "GYNODERMOFIX 300MG OVULE  B/01", "Img": "https://pharmnet-dz.com//img/medics/3017.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3017", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " SERTACONAZOLE NITRATE", "Pays": "ALGERIE", "Nom Commercial": "GYNODERMOFIX", "Tarif de reference": "300 DA", "PPA": "N/A", "Num Enregistrement": "263/ 11 A 085 /11", "Code DCI": "11A085", "Forme": "OVULE ", "Dosage": "300MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "GYNOVASOL 150MG OVULES B/03", "Img": "https://pharmnet-dz.com//img/medics/3002.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3002", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ECONAZOLE (NITRATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "GYNOVASOL", "Tarif de reference": "169.8 DA", "PPA": "N/A", "Num Enregistrement": "366/ 11 A 001 /07", "Code DCI": "11A001", "Forme": "OVULE ", "Dosage": "150MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "GYNOVASOL LP 150MG OVULE LP. B/01", "Img": "https://pharmnet-dz.com//img/medics/3012.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3012", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ECONAZOLE (NITRATE)", "Pays": "ALGERIE", "Nom Commercial": "GYNOVASOL LP", "Tarif de reference": "300 DA", "PPA": "400.00 DA", "Num Enregistrement": "366/ 11 A 071 /10", "Code DCI": "11A071", "Forme": "OVULE LP", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}], "H": [{"Nom": "HADOL 2MG/ML SOL. BUV. GTTES. FL./20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HADOL", "Tarif de reference": "120.4 DA", "PPA": "N/A", "Num Enregistrement": "319/ 16 D 085 /07", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML", "Conditionnement": "FL./20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HAEMOCTIN SDH 500UI PDRE. +  SOLV. INJ. B/1+ 1FL./ 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOTEST PHARMA GmBH", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR HUMAIN VIII  ANTI HEMOPHILIQUE", "Pays": "ALLEMAGNE", "Nom Commercial": "HAEMOCTIN SDH", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "370/ 12 J 044 /07", "Code DCI": "12J044", "Forme": "PDRE. INJ.", "Dosage": "500UI", "Conditionnement": "B/1+ 1FL./ 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HALDOL 5MG/ML SOL.INJ. B/5 AMP de 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2228", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HALDOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "095/ 16 D 084 /98", "Code DCI": "16D084", "Forme": "SOL. INJ.", "Dosage": "5MG/ML", "Conditionnement": "B/5 AMP de 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HALDOL DECANOAS 50MG/ML** SOL.INJ. IM B/5AMP DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/2303.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2303", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL** (SOUS FORME DE DECANOATE )", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HALDOL DECANOAS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 16 D 127 /08", "Code DCI": "16D127", "Forme": "SOL. INJ.", "Dosage": "50MG/ML**", "Conditionnement": "B/5AMP DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HALDOMEX 2MG/ML SOL. BUV. GTTES. FL/20 ML", "Img": "https://pharmnet-dz.com//img/medics/4653.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HALDOMEX", "Tarif de reference": "120.4 DA", "PPA": " DA", "Num Enregistrement": "400/16D085/16", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML", "Conditionnement": "FL/20 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HALLUDOL 2MG/ML SOL. BUV. GTTES. FL./15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HALLUDOL", "Tarif de reference": "90.3 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 D 085 /09", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML", "Conditionnement": "FL./15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HALLUDOL 5MG/ML SOL INJ B/50AMP", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HALLUDOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 16 D 084 /04", "Code DCI": "16D084", "Forme": "SOL. INJ.", "Dosage": "5MG/ML", "Conditionnement": "B/50AMP", "Commercialisation": true, "Remboursable": null}, {"Nom": "HALOPERIDOL 2MG/ML OU 0,2% SOL.BUV.GTTES. FL/20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HALOPERIDOL", "Tarif de reference": "120.4 DA", "PPA": "N/A", "Num Enregistrement": "088/ 16 D 085 /03", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML OU 0,2%", "Conditionnement": "FL/20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HALOPERIDOL BGL 2MG/ML  SOL BUV EN GTTES  B/01 FL COMPTE GTTES/15ML", "Img": "https://pharmnet-dz.com//img/medics/2235.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2235", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HALOPERIDOL BGL", "Tarif de reference": "90.3 DA", "PPA": "90.00 DA", "Num Enregistrement": "235/ 16 D 085 /14", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML ", "Conditionnement": "B/01 FL COMPTE GTTES/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HALOPERIDOL GENERICLAB 2MG/ML (OU 0,2%) SOL. BUV.GTTES. FL. COMPT.GTTES DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HALOPERIDOL GENERICLAB", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 16 D 085 /08/14", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML (OU 0,2%)", "Conditionnement": "FL. COMPT.GTTES DE 15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HARUFEN 30MG PATCH B/7", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SINIL PHARMACEUTICAL CO LTD", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Pays": "COREE", "Nom Commercial": "HARUFEN", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "04B049", "Forme": "PATCH", "Dosage": "30MG", "Conditionnement": "B/7", "Commercialisation": true, "Remboursable": true}, {"Nom": "HASSALYSE 1MG/5ML SOL. BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HASSALYSE", "Tarif de reference": " N/A", "PPA": "137.00 DA", "Num Enregistrement": "073/ 20 A 013 /97/11", "Code DCI": "20A013", "Forme": "SOL. BUV.", "Dosage": "1MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEAMONINE 500UI/FL. DE PDRE. PDRE. ET SOLV. P. SOL. INJ. IV B/01 FL. DE PDRE. + 01 FL. DE SOLV. (5ML) + SERING. JETABLE (5ML) + SYST. D. TRANSFERT A DOUBLE FILTRE", "Img": "https://pharmnet-dz.com//img/medics/1847.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOTEST PHARMA GmBH", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR IX DE COAGULATION HUMAINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "HEAMONINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "370/ 12 J 170 /14", "Code DCI": "12J170", "Forme": "PDRE. INJ.", "Dosage": "500UI/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE. + 01 FL. DE SOLV. (5ML) + SERING. JETABLE (5ML) + SYST. D. TRANSFERT A DOUBLE FILTRE", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEBERBIOVAC HB PEDIATRIQUE 10\u00b5G/0,5ML SOL INJ  B/25FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HEBER BIOTEC", "C.Pharmacologique": " VACCINS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VACCIN ANTI-HEPATITE B = ANTIGENE DE SURFACE RECOMBINANT DE  L' l'HEPATITE B (Ag Hbs)", "Pays": "CUBA", "Nom Commercial": "HEBERBIOVAC HB PEDIATRIQUE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "163/ 13 U 136 /02", "Code DCI": "13U136", "Forme": "SOL. INJ.", "Dosage": "10\u00b5G/0,5ML", "Conditionnement": "B/25FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEBERKINASE 750 000UI LYOPHILISAT  SOL INJ B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " HEBER BIOTEC", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " STREPTOKINASE RECOMBINANT", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "HEBERKINASE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "163/ 12 F 033 /99", "Code DCI": "12F033", "Forme": "LYOPH. SOL. INJ.", "Dosage": "750 000UI", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEBERON ALFA R 10MUI  PDRE.SOL.INJ B/25", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HEBER BIOTEC", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "HEBERON ALFA R", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "163/ 13 P 099 /99", "Code DCI": "13P099", "Forme": "PDRE. SOL. INJ.", "Dosage": "10MUI ", "Conditionnement": "B/25", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEBERON ALFA R 3MUI  PDRE.SOL.INJ B/25", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HEBER BIOTEC", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "HEBERON ALFA R", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "163/ 13 P 101 /99", "Code DCI": "13P101", "Forme": "PDRE. SOL. INJ.", "Dosage": "3MUI ", "Conditionnement": "B/25", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEBERON ALFA R 5MUI PDRE.SOL.INJ B/25", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HEBER BIOTEC", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "HEBERON ALFA R", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "163/ 13 P 100 /99", "Code DCI": "13P100", "Forme": "PDRE. SOL. INJ.", "Dosage": "5MUI", "Conditionnement": "B/25", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEET 0,5MG/ML (0,05%) SOL. BUV. GTTES. FL./30ML", "Img": "https://pharmnet-dz.com//img/medics/638.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=638", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HEET", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/ 09 H 020 /06", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HELESTENE CHRONODOSE 2,7MG/3MG/ML SUSP. INJ IM/LOCALE B/01 AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE (ACETATE) / BETAMETHASONE  (PHOSPHATE DISODIQUE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HELESTENE CHRONODOSE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "380/ 09 H 018 /14", "Code DCI": "09H018", "Forme": "SUSP. INJ.", "Dosage": "2,7MG/3MG/ML", "Conditionnement": "B/01 AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "HELIKIT 75MG PDRE. SOL. BUV. B/1FL. PDRE. (13C UREE) + 1SACH. PDRE.(AC. CITRIQUE ANHYD.) + 02PAILLES + 1KIT DE CONTR\u00d4LE (4T. DE PRELEV)", "Img": "https://pharmnet-dz.com//img/medics/2998.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2998", "Laboratoire": " MAYOLY SPINDLER", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " UREE 13C", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HELIKIT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "067/ 10 S 160 /07/14", "Code DCI": "10S160", "Forme": "PDRE. SOL. BUV.", "Dosage": "75MG", "Conditionnement": "B/1FL. PDRE. (13C UREE) + 1SACH. PDRE.(AC. CITRIQUE ANHYD.) + 02PAILLES + 1KIT DE CONTR\u00d4LE (4T. DE PRELEV)", "Commercialisation": true, "Remboursable": true}, {"Nom": "HELMINTOX 125MG COMP.PELLI.SEC. B/6", "Img": "https://pharmnet-dz.com//img/medics/2048.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2048", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " PYRANTEL", "Pays": "FRANCE", "Nom Commercial": "HELMINTOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "087/ 19 B 010 /98", "Code DCI": "19B010", "Forme": "COMP.", "Dosage": "125MG", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "HELMINTOX 125MG/2,5ML SIROP FL/15ML", "Img": "https://pharmnet-dz.com//img/medics/2050.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2050", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " PYRANTEL", "Pays": "FRANCE", "Nom Commercial": "HELMINTOX", "Tarif de reference": "174.34 DA", "PPA": "N/A", "Num Enregistrement": "087/ 19 B 011 /98", "Code DCI": "19B011", "Forme": "SIROP", "Dosage": "125MG/2,5ML", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HELMINTOX 250MG COMP PELLI.SEC. B/3", "Img": "https://pharmnet-dz.com//img/medics/2051.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2051", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " PYRANTEL", "Pays": "FRANCE", "Nom Commercial": "HELMINTOX", "Tarif de reference": "163.48 DA", "PPA": "N/A", "Num Enregistrement": "087/ 19 B 028 /00", "Code DCI": "19B028", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/3", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEMAX 10 000UI/ML LYOPH. ET SOLV. SOL. INJ. IV/SC B/1FL. DE PDRE + 1SERIING. PRE REMPLIE  DE 1ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIO SIDUS", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "HEMAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "357/ 12 E 063 /08", "Code DCI": "12E063", "Forme": "LYOPH. SOL. INJ.", "Dosage": "10 000UI/ML", "Conditionnement": "B/1FL. DE PDRE + 1SERIING. PRE REMPLIE  DE 1ML DE SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEMAX 1000UI/FL. DE PDRE. (OU 1000UI/ML) PDRE. LYOPHI. ET SOLV.  SOL. INJ. IV ET SC B/1FL.DE PDRE. + UNE AMP. DE 1ML DE SOLV. (E.P.P.I) +1SERING. +2AIGUI. A USAGE UNIQUE +TAMPON IMBIBE D'ALCOOL ISOPROPYLIQUE", "Img": "https://pharmnet-dz.com//img/medics/1813.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOSIDUS S.A", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "HEMAX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "357/ 12 E 157 /08", "Code DCI": "12E157", "Forme": "LYOPH. SOL. INJ.", "Dosage": "1000UI/FL. DE PDRE. (OU 1000UI/ML)", "Conditionnement": "B/1FL.DE PDRE. + UNE AMP. DE 1ML DE SOLV. (E.P.P.I) +1SERING. +2AIGUI. A USAGE UNIQUE +TAMPON IMBIBE D'ALCOOL ISOPROPYLIQUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEMAX 2000UI/FL. DE PDRE. (OU 2000UI/2ML) PDRE. LYOPHI. ET SOLV.  SOL. INJ. IV ET SC B/1FL.DE PDRE.+1SERING. PREREMPLIE DE SOLVT. DE 2ML +2AIGUI. A USAGE UNIQUE +TAMPON IMBIBE D'ALCOOL ISOPROPYLIQUE       -       B/25 FL. DE PDRE. + 25AMP. DE SOLVT. DE 2M", "Img": "https://pharmnet-dz.com//img/medics/1790.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOSIDUS S.A", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "HEMAX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "357/ 12 E 123 /06", "Code DCI": "12E123", "Forme": "LYOPH. SOL. INJ.", "Dosage": "2000UI/FL. DE PDRE. (OU 2000UI/2ML)", "Conditionnement": "B/1FL.DE PDRE.+1SERING. PREREMPLIE DE SOLVT. DE 2ML +2AIGUI. A USAGE UNIQUE +TAMPON IMBIBE D'ALCOOL ISOPROPYLIQUE       -       B/25 FL. DE PDRE. + 25AMP. DE SOLVT. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEMAX 2000UI/ML (4000UI/2ML) LYOPH. ET SOLV. SOL. INJ. IV/SC B/1FL. DE PDRE + 1SERIING. PRE REMPLIE  DE 2ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIO SIDUS", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "HEMAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "357/ 12 E 060 /08 ", "Code DCI": "12E060", "Forme": "LYOPH. SOL. INJ.", "Dosage": "2000UI/ML (4000UI/2ML)", "Conditionnement": "B/1FL. DE PDRE + 1SERIING. PRE REMPLIE  DE 2ML DE SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEMAX 3000UI/FL. DE PDRE. LYOPH. ET SOLV. SOL. INJ. IV/SC B/1FL. DE PDRE. + 1SERING. PREREMPL. DE 2ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIO SIDUS", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "HEMAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "357/ 12 E 145 /09 ", "Code DCI": "12E145", "Forme": "LYOPH. SOL. INJ.", "Dosage": "3000UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1SERING. PREREMPL. DE 2ML DE SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEMAX 3000UI/FL. DE PDRE. LYOPH. ET SOLV. SOL. INJ. IV/SC B/1FL. DE PDRE. + 1SERING. PREREMPL. DE 2ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BIO SIDUS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "HEMAX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "357/12L145/09/15", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "3000UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1SERING. PREREMPL. DE 2ML DE SOLV.", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEMI-DAONIL 2,5MG COMP. SEC. B/60", "Img": "https://pharmnet-dz.com//img/medics/3610.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3610", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HEMI-DAONIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 14 A 002 /98", "Code DCI": "14A002", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEMOLOG 120MG/10MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2986.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2986", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE / RUSCOGENINES", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HEMOLOG", "Tarif de reference": "0 DA", "PPA": "200.00 DA", "Num Enregistrement": "366/ 10 P 084 /09", "Code DCI": "10P084", "Forme": "SUPPO.", "Dosage": "120MG/10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEMOLOG 5,8% / 0,5% CREME RECT. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE / RUSCOGENINES", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HEMOLOG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "366/ 10 P 083 /10", "Code DCI": "10P083", "Forme": "CR\u00c8ME", "Dosage": "5,8% / 0,5%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEMOPRES 5MG**/50MG COMP. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMILORIDE (SOUS FORME DE CHLORHYDRATE)**/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "HEMOPRES", "Tarif de reference": "274 DA", "PPA": "N/A", "Num Enregistrement": "161/ 06 H 094 /99", "Code DCI": "06H094", "Forme": "COMP.", "Dosage": "5MG**/50MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEMORECT 120MG/10MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2987.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2987", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE / RUSCOGENINES", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HEMORECT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 P 084 /03/09", "Code DCI": "10P084", "Forme": "SUPPO.", "Dosage": "120MG/10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": false}, {"Nom": "HEMORECT 5,8% / 0,5% CR\u00c8ME RECT. T/20G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE / RUSCOGENINES", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HEMORECT", "Tarif de reference": " N/A", "PPA": "153.00 DA", "Num Enregistrement": "003/ 10 P 083 /04/10", "Code DCI": "10P083", "Forme": "CR\u00c8ME", "Dosage": "5,8% / 0,5%", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEMOREL-A 500UI/FL. DE LYOPH. LYOPH. ET SOLV. P. PREPARATION INJ. IV B/1FL. DE PDRE. + 1FL. DE 10ML DE SOLV. (EPPI)+ DISPOSITIF D'INJECTION", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " CPCM", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR HUMAIN VIII  ANTI HEMOPHILIQUE", "Pays": "ALGERIE", "Nom Commercial": "HEMOREL-A", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 12 J 044 /12", "Code DCI": "12J044", "Forme": "PDRE. INJ.", "Dosage": "500UI/FL. DE LYOPH.", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE 10ML DE SOLV. (EPPI)+ DISPOSITIF D'INJECTION", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEMOSYLAT 250MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1825.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LGPA", "C.Pharmacologique": " HEMOSTATIQUES GENERAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ETAMSYLATE", "Pays": "ALGERIE", "Nom Commercial": "HEMOSYLAT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "311/ 12 H 040 /11", "Code DCI": "12H040", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEPARINE 25 000UI/ML (125 000UI/5ML) SOL. INJ. IV/SC B/10FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HEPARINE SODIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "HEPARINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 12 B 156 /09", "Code DCI": "12B156", "Forme": "SOL. INJ.", "Dosage": "25 000UI/ML (125 000UI/5ML)", "Conditionnement": "B/10FL. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEPARINE CALCIQUE 5000UI/0,2ML 25 000 UI/ML (OU 5000UI/0,2ML) SOL.INJ.SC.  B/50 SERINGUES DE 0,2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HEPARINATE DE CALCIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HEPARINE CALCIQUE 5000UI/0,2ML", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "083/ 12 B 004 /98", "Code DCI": "12B004", "Forme": "SOL. INJ.", "Dosage": "25 000 UI/ML (OU 5000UI/0,2ML)", "Conditionnement": "B/50 SERINGUES DE 0,2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEPARINE CALCIQUE 7500UI/0,3ML 25 000UI/ML  (OU 7500UI/0,3ML) SOL.INJ.SC. B/50SERINGUES DE 0,3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HEPARINATE DE CALCIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HEPARINE CALCIQUE 7500UI/0,3ML", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "083/ 12 B 005 /98", "Code DCI": "12B005", "Forme": "SOL. INJ.", "Dosage": "25 000UI/ML  (OU 7500UI/0,3ML)", "Conditionnement": "B/50SERINGUES DE 0,3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEPARINE SODIQUE 25 000 UI/5ML SOL.INJ.IV B/50 FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HEPARINE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HEPARINE SODIQUE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "083/ 12 B 007 /98", "Code DCI": "12B007", "Forme": "SOL. INJ.", "Dosage": "25 000 UI/5ML", "Conditionnement": "B/50 FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEPTAGYL 2MG/5ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/3328.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HEPTAGYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 F 024 /96/10", "Code DCI": "14F024", "Forme": "SIROP", "Dosage": "2MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEPTAL 2MG/5ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HEPTAL", "Tarif de reference": " N/A", "PPA": "129.00 DA", "Num Enregistrement": "077/ 14 F 024 /03/14", "Code DCI": "14F024", "Forme": "SIROP", "Dosage": "2MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HERCEPTIN 150MG/FL. DE LYOPH. LYOPH. SOL. INJ. B/01FL. DE LYOPH.", "Img": "https://pharmnet-dz.com//img/medics/1059.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1059", "Laboratoire": " ROCHE", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " TRASTUZUMAB", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "HERCEPTIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 05 D 112 /06/14", "Code DCI": "05D112", "Forme": "LYOPH. SOL. INJ.", "Dosage": "150MG/FL. DE LYOPH.", "Conditionnement": "B/01FL. DE LYOPH.", "Commercialisation": true, "Remboursable": true}, {"Nom": "HERTRAZ 440 440MG/FL. DE PDRE. PDRE. ET SOLV. P. SOL. A DILUER P. PERF. IV B/01 FL. DE PDRE. + B/02 FL. DE SOLV. DE 10ML (EAU BACTERIOSTATIQUE POUR INJECTION)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TRASTUZUMAB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "HERTRAZ 440", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 D 178 /15", "Code DCI": "05D178", "Forme": "SOL. PERF.", "Dosage": "440MG/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE. + B/02 FL. DE SOLV. DE 10ML (EAU BACTERIOSTATIQUE POUR INJECTION)", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEXABRIX 320 I=320MG/ML SOL INJ INTRA-VASC. - INTRA-UTERINE -INTRA-ARTICULAIRE FL 20ML- 50ML -100ML", "Img": "https://pharmnet-dz.com//img/medics/588.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=588", "Laboratoire": " GUERBET", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOXAGLATE DE SODIUM ET DE MEGLUMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HEXABRIX 320", "Tarif de reference": "0 DA", "PPA": "808.00 DA", "Num Enregistrement": "168/ 08 C 065 / 01", "Code DCI": "08C065", "Forme": "SOL. INJ.", "Dosage": "I=320MG/ML", "Conditionnement": "FL 20ML- 50ML -100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEXADERM 0,1% SOL.DERM. FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HEXAMIDINE", "Pays": "ALGERIE", "Nom Commercial": "HEXADERM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 07 P 071 /01/09", "Code DCI": "07P071", "Forme": "SOL. DERM.", "Dosage": "0,1%", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEXADERM 0.001 PDE. DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HEXAMIDINE DI-ISETHIONATE", "Pays": "ALGERIE", "Nom Commercial": "HEXADERM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 07 P 069 /97/09", "Code DCI": "07P069", "Forme": "PDE. DERM.", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": null}, {"Nom": "HEXALYSE 5MG/5MG/5MG COMP A SUCER B/30", "Img": "https://pharmnet-dz.com//img/medics/1936.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1936", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " BICLOTYMOL/LYSOZYME/ENOXOLONE", "Pays": "FRANCE", "Nom Commercial": "HEXALYSE", "Tarif de reference": "0 DA", "PPA": "158.00 DA", "Num Enregistrement": "269/ 22 E 024 /99", "Code DCI": "22E024", "Forme": "COMP. A SUCER", "Dosage": "5MG/5MG/5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEXASPRAY 0,75MG/30G COLLU. FL. PRESSURISE DE 30G", "Img": "https://pharmnet-dz.com//img/medics/1133.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1133", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " BICLOTYMOL", "Pays": "FRANCE", "Nom Commercial": "HEXASPRAY", "Tarif de reference": "259.00 DA", "PPA": "259.00 DA", "Num Enregistrement": "269/ 23 B 020 /99", "Code DCI": "23B020", "Forme": "COLLU.", "Dosage": "0,75MG/30G", "Conditionnement": "FL. PRESSURISE DE 30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEXOMEDINE 0,1% SOL.DERM. FL/45ML", "Img": "https://pharmnet-dz.com//img/medics/541.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=541", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HEXAMIDINE", "Pays": "FRANCE", "Nom Commercial": "HEXOMEDINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 07 P 071 /96", "Code DCI": "07P071", "Forme": "SOL. DERM.", "Dosage": "0,1%", "Conditionnement": "FL/45ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEXOMEDINE 0,15% SOL.DERM. FL/45ML", "Img": "https://pharmnet-dz.com//img/medics/543.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=543", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HEXAMIDINE", "Pays": "FRANCE", "Nom Commercial": "HEXOMEDINE", "Tarif de reference": "67.5 DA", "PPA": " DA", "Num Enregistrement": "016/ 07 P 072 /96", "Code DCI": "07P072", "Forme": "SOL. DERM.", "Dosage": "0,15%", "Conditionnement": "FL/45ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HEXOR 50MG  COMP. ENRO. B/02", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HEXOR", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/25N045/16", "Code DCI": "25N045", "Forme": "COMP. ENRO.", "Dosage": "50MG ", "Conditionnement": "B/02", "Commercialisation": true, "Remboursable": null}, {"Nom": "HFM 27G/20G/100G PDE.DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1642.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1642", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " OXYDE DE ZINC / HUILE DE FOIE DE MORUE", "Pays": "ALGERIE", "Nom Commercial": "HFM", "Tarif de reference": "0 DA", "PPA": "120 DA", "Num Enregistrement": "003/ 07 A 006 /97/09", "Code DCI": "07A006", "Forme": "PDE.", "Dosage": "27G/20G/100G", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": false}, {"Nom": "HIBOR 2500 12 500 UI ANTI Xa/ML (OU 2 500UI ANTI Xa/0,2ML) SOL. INJ. SC B/02 SERING. PRE REMPLIES UNIDOSES DE 0,2ML (2 500UI ANTI Xa/0,2ML)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " BEMIPARINE SODIQUE", "Pays": "JORDANIE", "Nom Commercial": "HIBOR 2500", "Tarif de reference": "0 DA", "PPA": "599.00 DA", "Num Enregistrement": "001/ 12 B 139 /08", "Code DCI": "12B139", "Forme": "SOL. INJ.", "Dosage": "12 500 UI ANTI Xa/ML (OU 2 500UI ANTI Xa/0,2ML)", "Conditionnement": "B/02 SERING. PRE REMPLIES UNIDOSES DE 0,2ML (2 500UI ANTI Xa/0,2ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "HIBOR 3500 17 500UI ANTI Xa/ML SOL. INJ. SC B/02 SERING. PRE REMPLIES UNIDOSES DE 0,2ML ", "Img": "https://pharmnet-dz.com//img/medics/1737.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1737", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " BEMIPARINE SODIQUE", "Pays": "JORDANIE", "Nom Commercial": "HIBOR 3500", "Tarif de reference": "1001.85 DA", "PPA": "N/A", "Num Enregistrement": "001/ 12 B 140 /08", "Code DCI": "12B140", "Forme": "SOL. INJ.", "Dosage": "17 500UI ANTI Xa/ML", "Conditionnement": "B/02 SERING. PRE REMPLIES UNIDOSES DE 0,2ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "HIBOR 5000                                                                                                                       HIBOR 7500                                                                                                                    ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " BEMIPARINE SODIQUE", "Pays": "JORDANIE", "Nom Commercial": "HIBOR 5000                                                                                                                       HIBOR 7500                                                                                                                    ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/ 12 B 138 /08", "Code DCI": "12B138", "Forme": "SOL. INJ.", "Dosage": "25 000UI ANTI Xa/ML  (5 000UI ANTI Xa/0,2ML)                                                            (OU 7 500UIANTI Xa/0,3ML)                                                                                                  (OU 10 000UIANTI Xa/0,4ML)", "Conditionnement": "B/02 SERING. PRE REMPLIES UNIDOSES DE 0,2ML (5 000UI ANTI Xa/0,2ML)                                                                                                                                                                                            ", "Commercialisation": true, "Remboursable": true}, {"Nom": "HIMOXYL 1G/SACHET PDRE P. SUSP. BUV. EN SACHET-DOSE B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EURL GENIS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE E EXPRIME EN AMOXICILLINE ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HIMOXYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "480/ 13 G 268 /14", "Code DCI": "13G268", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1G/SACHET", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "HISTAC 50MG/2ML SOL INJ  B/10 AMP. 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RANBAXY", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "INDE", "Nom Commercial": "HISTAC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "216/ 10 A 002 /05", "Code DCI": "10A002", "Forme": "SOL. INJ.", "Dosage": "50MG/2ML", "Conditionnement": "B/10 AMP. 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HISTAGAN 0,5MG/5ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DEXCHLORPHENIRAMINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HISTAGAN", "Tarif de reference": " N/A", "PPA": "140.00 DA", "Num Enregistrement": "003/ 01 A 007 /97/09", "Code DCI": "01A007", "Forme": "SIROP", "Dosage": "0,5MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HISTAGAN 2MG COMP. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3977.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3977", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DEXCHLORPHENIRAMINE MALEATE", "Pays": "ALGERIE", "Nom Commercial": "HISTAGAN", "Tarif de reference": "120 DA", "PPA": "120 DA", "Num Enregistrement": "003/ 01 A 005 /97/10", "Code DCI": "01A005", "Forme": "COMP SEC.", "Dosage": "2MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "HISTARIZINE 10MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HISTARIZINE", "Tarif de reference": "60 DA", "PPA": "N/A", "Num Enregistrement": "304/ 01 A 003 /04", "Code DCI": "01A003", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "HISTONE 0,5MG/5ML SIROP FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/3980.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3980", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DEXCHLORPHENIRAMINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HISTONE", "Tarif de reference": "100 DA", "PPA": "N/A", "Num Enregistrement": "242/ 01 A 007 /08", "Code DCI": "01A007", "Forme": "SIROP", "Dosage": "0,5MG/5ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HOCINOR 1MG/ML SIROP F/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HOCINOR", "Tarif de reference": "201.25 DA", "PPA": "185.00 DA", "Num Enregistrement": "077/ 01 A 034 /05", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "F/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HOLIT FORT 2MG/ML SOL.BUV.GTTES. FL/15ML", "Img": "https://pharmnet-dz.com//img/medics/2236.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2236", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HOLIT FORT", "Tarif de reference": "90.3 DA", "PPA": "N/A", "Num Enregistrement": "242/ 16 D 085 /06", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HOLOXAN 1G/FL. DE PDRE. PDRE. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE DE 30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=7", "Laboratoire": " BAXTER", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " IFOSFAMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "HOLOXAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 05 G 106 /09", "Code DCI": "05G106", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. DE CONTENANCE DE 30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HOLOXAN 2G/FL. DE PDRE. PDRE. SOL. INJ. IV B/01FL. DE PDRE. DE CONTENANCE DE 50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=19", "Laboratoire": " BAXTER", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " IFOSFAMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "HOLOXAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 05 G 138 /09", "Code DCI": "05G138", "Forme": "PDRE. SOL. INJ.", "Dosage": "2G/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. DE CONTENANCE DE 50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HUBIFEN  400MG  COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HUBIFEN ", "Tarif de reference": "157 DA", "PPA": "N/A", "Num Enregistrement": "380/04B010/16", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUBIFEN  600MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HUBIFEN ", "Tarif de reference": "78.5 DA", "PPA": "N/A", "Num Enregistrement": "380/04B044/16", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUDU 50MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/4027.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4027", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DIPHENHYDRAMINE CHLORHYDRATE", "Pays": "PALESTINE", "Nom Commercial": "HUDU", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "406/ 01 A 044 /08", "Code DCI": "01A044", "Forme": "COMP SEC.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUILE DE PARAFFINE  BIOTIC 0.997 HUILE BUV. FL./200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HUILE DE PARAFFINE LIQUIDE", "Pays": "ALGERIE", "Nom Commercial": "HUILE DE PARAFFINE  BIOTIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 M 066 /08", "Code DCI": "10M066", "Forme": "SOL. BUV.", "Dosage": "0.997", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HUMALOG 100UI/ML (3,5MG/ML) SOL. INJ. SC/IV EN CARTOUCHE POUR STYLO B/05 CARTOUCHES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3744.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3744", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG", "Tarif de reference": "0 DA", "PPA": "5538.00 DA", "Num Enregistrement": "034/ 14 B 195 /09", "Code DCI": "14B195", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/05 CARTOUCHES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMALOG 100UI/ML (3,5MG/ML) SOL.INJ. EN FL. B/01FL.DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/3318.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3318", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 14 B 329 /09", "Code DCI": "14B329", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/01FL.DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMALOG KIWIKPEN 100UI/ML (3,5MG/ML) SOL. INJ. SC EN STYLO PREREMPLI B/05 STYLOS PREREMPLIS DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3322.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3322", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG KIWIKPEN", "Tarif de reference": "0 DA", "PPA": "4925.00 DA", "Num Enregistrement": "034/ 14 B 337 /12", "Code DCI": "14B337", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/05 STYLOS PREREMPLIS DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMALOG MIX 25 100UI/ML (3,5MG/ML) SUSP. INJ. EN FLACON B/01FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3319", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO 25% / INSULINE LISPRO PROTAMINE 75%", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG MIX 25", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 14 B 330 /09", "Code DCI": "14B330", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/01FL. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMALOG MIX 25 100UI/ML (3,5MG/ML) SUSP. INJ. SC EN CARTOUCHE POUR STYLO B/05 CARTOUCHES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3316.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3316", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO 25% / INSULINE LISPRO PROTAMINE 75%", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG MIX 25", "Tarif de reference": "0 DA", "PPA": "5023.00 DA", "Num Enregistrement": "034/ 14 B 326 /09", "Code DCI": "14B326", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/05 CARTOUCHES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMALOG MIX 25 KIWIKPEN 100UI/ML (3,5MG/ML) SUSP. INJ. SC EN STYLO PREREMPLI B/05 STYLOS PREREMPLIS DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3323.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3323", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO 25% / INSULINE LISPRO PROTAMINE 75%", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG MIX 25 KIWIKPEN", "Tarif de reference": "0 DA", "PPA": "5592.00 DA", "Num Enregistrement": "034/ 14 B 338 /12", "Code DCI": "14B338", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/05 STYLOS PREREMPLIS DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMALOG MIX 50 100UI/ML (3,5MG/ML) SUSP. INJ. SC EN CARTOUCHE POUR STYLO B/05 CARTOUCHES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3317.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3317", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO 50% / INSULINE LISPRO PROTAMINE 50%", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG MIX 50", "Tarif de reference": "0 DA", "PPA": "5012.00 DA", "Num Enregistrement": "034/ 14 B 327 /09", "Code DCI": "14B327", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/05 CARTOUCHES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMALOG MIX 50 KIWIKPEN 100UI/ML (3,5MG/ML) SUSP. INJ. SC EN STYLO PREREMPLI B/05 STYLOS PREREMPLIS DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3324.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3324", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE LISPRO 50% / INSULINE LISPRO PROTAMINE 50%", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "HUMALOG MIX 50 KIWIKPEN", "Tarif de reference": "0 DA", "PPA": "5390.00 DA", "Num Enregistrement": "034/ 14 B 339 /12", "Code DCI": "14B339", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/05 STYLOS PREREMPLIS DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMAN ALBUMIN BAXTER BIOSCIENCE 20% (OU 0,2G/ML) SOL. INJ. FL./50ML ET FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ALBUMINE HUMAINE", "Pays": "AUTRICHE", "Nom Commercial": "HUMAN ALBUMIN BAXTER BIOSCIENCE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 12 J 042 /08", "Code DCI": "12J042", "Forme": "SOL. INJ.", "Dosage": "20% (OU 0,2G/ML)", "Conditionnement": "FL./50ML ET FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HUMEX EXPECTORANT ADULTE 0.05 SIROP B/1FL. DE 125ML AVEC GOBELET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " URGO", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "FRANCE", "Nom Commercial": "HUMEX EXPECTORANT ADULTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "296/ 20 D 042 /07/13", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "B/1FL. DE 125ML AVEC GOBELET DOSEUR", "Commercialisation": true, "Remboursable": null}, {"Nom": "HUMEX EXPECTORANT ENFANT  2% (100MG/5ML) SIROP B/1FL. DE 125ML AVEC GOBELET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " URGO", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "FRANCE", "Nom Commercial": "HUMEX EXPECTORANT ENFANT ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "296/ 20 D 041 /07/13", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "2% (100MG/5ML)", "Conditionnement": "B/1FL. DE 125ML AVEC GOBELET DOSEUR", "Commercialisation": true, "Remboursable": null}, {"Nom": "HUMEX MAL DE GORGE 0,030G/0,300G/100ML COLLUTOIRE  B/1FL. PRESSURISE DE 35ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " URGO", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " BENZALKONIUM CHLORURE/LIDOCAINE CHLORHYDRATE", "Pays": "FRANCE", "Nom Commercial": "HUMEX MAL DE GORGE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "296/ 23 B 038 /08", "Code DCI": "23B038", "Forme": "COLLU.", "Dosage": "0,030G/0,300G/100ML", "Conditionnement": "B/1FL. PRESSURISE DE 35ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HUMEX RHUME 500MG/60MG** (COMP.)  ET 500MG/04MG** (GLES.) COMP. (JOUR)  ET   GLES. (NUIT) B/12 COMP. + 04 GLES.", "Img": "https://pharmnet-dz.com//img/medics/1462.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1462", "Laboratoire": " URGO", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL/PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** ET PARACETAMOL/CHLORPHENIRAMINE(SOUS FORME DE MALEATE)**", "Pays": "FRANCE", "Nom Commercial": "HUMEX RHUME", "Tarif de reference": "298 DA", "PPA": "N/A", "Num Enregistrement": "296/ 22 A 029 /04/12", "Code DCI": "22A029", "Forme": "COMP.", "Dosage": "500MG/60MG** (COMP.)  ET 500MG/04MG** (GLES.)", "Conditionnement": "B/12 COMP. + 04 GLES.", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMEX TOUX SECHE ADULTE 0,133G/100ML (OU 20MG/15ML ) SIROP FL./125ML + GOBELET DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " URGO", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Pays": "FRANCE", "Nom Commercial": "HUMEX TOUX SECHE ADULTE", "Tarif de reference": "126.25 DA", "PPA": "N/A", "Num Enregistrement": "296/ 20 B 240 /09", "Code DCI": "20B240", "Forme": "SIROP", "Dosage": "0,133G/100ML (OU 20MG/15ML )", "Conditionnement": "FL./125ML + GOBELET DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMEX TOUX SECHE ENFANT 0,1G/100ML (OU 5MG/5ML) SIROP FL./125ML + GOBELET DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " URGO", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Pays": "FRANCE", "Nom Commercial": "HUMEX TOUX SECHE ENFANT", "Tarif de reference": "137.5 DA", "PPA": "N/A", "Num Enregistrement": "296/ 20 B 207 /09", "Code DCI": "20B207", "Forme": "SIROP", "Dosage": "0,1G/100ML (OU 5MG/5ML)", "Conditionnement": "FL./125ML + GOBELET DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUMIRA 40MG/0,8ML SOL. INJ. SC EN SERING. PREREMPL. B/02 SERING. UNIDOSES PREREMPL. DE 0,8ML+ 02TAMPONS D'ALCOOL", "Img": "https://pharmnet-dz.com//img/medics/1450.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1450", "Laboratoire": " ABBOTT", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ADALIMUMAB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "HUMIRA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "147/ 21 J 058 /09", "Code DCI": "21J058", "Forme": "SOL. INJ.", "Dosage": "40MG/0,8ML", "Conditionnement": "B/02 SERING. UNIDOSES PREREMPL. DE 0,8ML+ 02TAMPONS D'ALCOOL", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUNTERASE 2MG/ML  SOLUT, A DILUER POUR PERF IV  1 FL 3 ML (6MG/3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "COREE", "Nom Commercial": "HUNTERASE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "507/14N353/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "2MG/ML ", "Conditionnement": "1 FL 3 ML (6MG/3ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HUPFOLIQ 5MG  COMP  B/60", "Img": "https://pharmnet-dz.com//img/medics/1750.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "HUPFOLIQ", "Tarif de reference": "0 DA", "PPA": "249.00 DA", "Num Enregistrement": "380/ 12 E 020 /14", "Code DCI": "12E020", "Forme": "COMP.", "Dosage": "5MG ", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUPPACORT RETARD 40MG/ML SUSP. INJ. IM OU LOCALE B/01 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIAMCINOLONE ACETONIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HUPPACORT RETARD", "Tarif de reference": "0 DA", "PPA": "PPACORT RETARD", "Num Enregistrement": "380/ 09 H 091 /15", "Code DCI": "09H091", "Forme": "SUSP. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/01 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUPPOMEDROL 16MG COMP.  SEC B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HUPPOMEDROL", "Tarif de reference": "283.4 DA", "PPA": "N/A", "Num Enregistrement": "380/09H092/16", "Code DCI": "09H092", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUPPOMEDROL 4MG COMP.SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HUPPOMEDROL", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "09H033", "Forme": "COMP SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUPPROSTENE 5MG/2MG/1ML SUSP. INJ. B/01 AMP DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETAMETASONE / BETAMETHASONE PHOSPHATE EXPRIME EN BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HUPPROSTENE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "380/ 09 H 017 /15", "Code DCI": "09H017", "Forme": "SUSP. INJ.", "Dosage": "5MG/2MG/1ML", "Conditionnement": "B/01 AMP DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HUPTADYS 100MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2804.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HUPTADYS", "Tarif de reference": " N/A", "PPA": "248.00 DA", "Num Enregistrement": "380/ 04 B 033 /15", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "HYAN 0,03MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " FAMY CARE ", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "HYAN", "Tarif de reference": "119.84 DA", "PPA": "N/A", "Num Enregistrement": "291/ 11 H 027 /04", "Code DCI": "11H027", "Forme": "COMP.", "Dosage": "0,03MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYCOSONE 10MG COMP SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYCOSONE", "Tarif de reference": "168 DA", "PPA": "N/A", "Num Enregistrement": "304/ 09 H 028 /04", "Code DCI": "09H028", "Forme": "COMP SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYDRACORT 0.005 CREME T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=510", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HYDRACORT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "123/ 07 H 116 /01", "Code DCI": "07H116", "Forme": "CR\u00c8ME", "Dosage": "0.005", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYDREA 500MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " HYDROXYCARBAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HYDREA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 05 A 021 /99/15", "Code DCI": "05A021", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "HYDREX 25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1490.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1490", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " HYDROCHLOROTHIAZIDE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "HYDREX", "Tarif de reference": "200 DA", "PPA": "N/A", "Num Enregistrement": "231/ 06 H 279 /09", "Code DCI": "06H279", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYDROCORT 0.01 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "HYDROCORT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "165/ 17 G 051 /98", "Code DCI": "17G051", "Forme": "COLLY.", "Dosage": "0.01", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYDROCORTAL 100MG/FL. DE LYOPH. LYOPH. P. SOL. INJ. IM/IV B/50FL. DE LYOPH.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROCORTISONE SUCCINATE SODIQUE EXPRIME EN HYDROCORTISONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYDROCORTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 09 H 026 /06/12", "Code DCI": "09H026", "Forme": "SOL. INJ.", "Dosage": "100MG/FL. DE LYOPH.", "Conditionnement": "B/50FL. DE LYOPH.", "Commercialisation": true, "Remboursable": null}, {"Nom": "HYDROCORTISONE IVAL 10MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYDROCORTISONE IVAL", "Tarif de reference": "112 DA", "PPA": "N/A", "Num Enregistrement": "195/ 09 H 028 /11", "Code DCI": "09H028", "Forme": "COMP SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYDROCORTISONE ROUSSEL 10MG COMP. B/25 ", "Img": "https://pharmnet-dz.com//img/medics/653.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=653", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROCORTISONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HYDROCORTISONE ROUSSEL", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "376/ 09 H 028 /99/09", "Code DCI": "09H028", "Forme": "COMP SEC.", "Dosage": "10MG", "Conditionnement": "B/25 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYDROXIL 25MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYDROXIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "077/ 16 B 040 /08", "Code DCI": "16B040", "Forme": "COMP.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYDROXIL 2MG/ML SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYDROXIL", "Tarif de reference": " N/A", "PPA": "194.00 DA", "Num Enregistrement": "077/ 16 B 079 /97/15", "Code DCI": "16B079", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "HYDROXYZINE - AGD 2MG/ML SOL. BUV. FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYDROXYZINE - AGD", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "320/ 16 B 079 /06", "Code DCI": "16B079", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYFRESH 0,2% (OU 2MG/ML) COLLY. EN SOL. FL./10ML", "Img": "https://pharmnet-dz.com//img/medics/2015.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2015", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " SUPPLEANCE LACRYMALE", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " HYALURONATE DE SODIUM", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "HYFRESH", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "386/ 17 N 160 /09", "Code DCI": "17N160", "Forme": "COLLY.", "Dosage": "0,2% (OU 2MG/ML)", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "HYPNOMIDATE 2MG/ML SOL. INJ. IV B/05 AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/4069.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4069", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ETOMIDATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HYPNOMIDATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 02 B 058 /08/15", "Code DCI": "02B058", "Forme": "SOL. INJ.", "Dosage": "2MG/ML", "Conditionnement": "B/05 AMP. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYSACRYL LAURYLEE 0.01 SOL. MOUSSANTE POUR APPLI. CUTANEE FL./500ML", "Img": "https://pharmnet-dz.com//img/medics/3062.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3062", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " GYNECOLOGIE", "Info": " IODE", "Pays": "ALGERIE", "Nom Commercial": "HYSACRYL LAURYLEE", "Tarif de reference": "0 DA", "PPA": "316.00 DA", "Num Enregistrement": "388/ 11 M 076 /08", "Code DCI": "11M076", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "FL./500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYSADRIL 0.002 BAIN DE BOUCHE FL./190ML", "Img": "https://pharmnet-dz.com//img/medics/1140.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1140", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " CHLORHEXIDINE** (SOUS FORME DE DIGLUCONATE)", "Pays": "ALGERIE", "Nom Commercial": "HYSADRIL", "Tarif de reference": "0 DA", "PPA": "197.00 DA", "Num Enregistrement": "388/ 23 B 039 /09", "Code DCI": "23B039", "Forme": "SOL. BAIN BOUCHE", "Dosage": "0.002", "Conditionnement": "FL./190ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYSADRIL ALCOOLIQUE 0.005 SOL. APPLI. LOCALE FL./430ML", "Img": "https://pharmnet-dz.com//img/medics/565.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=565", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CHLORHEXIDINE DIGLUCONATE EXPRIME EN CHLORHEXIDINE", "Pays": "ALGERIE", "Nom Commercial": "HYSADRIL ALCOOLIQUE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "388/ 07 P 171 /09", "Code DCI": "07P171", "Forme": "SOL. APP. LOCALE", "Dosage": "0.005", "Conditionnement": "FL./430ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYSALOX 525MG/600MG/SACHET SUSP. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3906.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3906", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "ALGERIE", "Nom Commercial": "HYSALOX", "Tarif de reference": "0 DA", "PPA": "301.00 DA", "Num Enregistrement": "388/ 10 B 105 /15", "Code DCI": "10B105", "Forme": "SUSP. BUV.", "Dosage": "525MG/600MG/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYSARTAN 100MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYSARTAN", "Tarif de reference": "1204 DA", "PPA": "1204.00 DA", "Num Enregistrement": "468/ 06 E 240 /12", "Code DCI": "06E240", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYSARTAN 50MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYSARTAN", "Tarif de reference": "1204 DA", "PPA": "1204.00 DA", "Num Enregistrement": "468/ 06 E 126 /12", "Code DCI": "06E126", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYTACAND 16MG**/12,5MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/4447.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4447", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HYTACAND", "Tarif de reference": "1622.88 DA", "PPA": " DA", "Num Enregistrement": "256/06E231/06/16", "Code DCI": "06E231", "Forme": "COMP.", "Dosage": "16MG**/12,5MG", "Conditionnement": " B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYTACAND 8MG**/ 12,5MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/4446.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4446", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HYTACAND", "Tarif de reference": "1521.24 DA", "PPA": " DA", "Num Enregistrement": "256/06E230/06/16", "Code DCI": "06E230", "Forme": "COMP.", "Dosage": "8MG**/ 12,5MG", "Conditionnement": " B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYXYAH 2MG/ML SOL. BUV. FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HYDROXYZINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "HYXYAH", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "16B079", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "HYZAAR 50MG/12,5MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MSD FRANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "HYZAAR", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E167", "Forme": "COMP.", "Dosage": "50MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}], "I": [{"Nom": "IBUGESIC 20MG/ML (100MG/5ML) SUSP. BUV. FL./150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "IBUGESIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 04 B 042 /08", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./150ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "IBUMAL 0.05 GEL DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " IBUPROFENE", "Pays": "ALGERIE", "Nom Commercial": "IBUMAL", "Tarif de reference": "116 DA", "PPA": "N/A", "Num Enregistrement": "003/ 21 A 057 /09", "Code DCI": "21A057", "Forme": "GEL DERM.", "Dosage": "0.05", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUMAL 200MG GLES. B/32", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUMAL", "Tarif de reference": "192 DA", "PPA": "115.00 DA", "Num Enregistrement": "003/ 04 B 040 /11", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/32", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPRANE 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPRANE", "Tarif de reference": "192 DA", "PPA": "N/A", "Num Enregistrement": "392/04B040/16", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPRANE 400MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPRANE", "Tarif de reference": "157 DA", "PPA": "N/A", "Num Enregistrement": "392/04B010/16", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPROFAL 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPROFAL", "Tarif de reference": "120 DA", "PPA": "119.00 DA", "Num Enregistrement": "039/ 04 B 040 /13", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPROFAL 400MG COMP. PELLI SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPROFAL", "Tarif de reference": "157 DA", "PPA": "158.00 DA", "Num Enregistrement": "039/ 04 B 010 /13", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPROFAL 600MG COMP. PELLI. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPROFAL", "Tarif de reference": "157 DA", "PPA": "N/A", "Num Enregistrement": "039/ 04 B 044 /13", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPROFENE BEKER 400MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/4222.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4222", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPROFENE BEKER", "Tarif de reference": "157 DA", "PPA": "158.51 DA", "Num Enregistrement": "447/04B010/15", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPROFENE BEKER 600MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/925.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=925", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPROFENE BEKER", "Tarif de reference": "157.00 DA", "PPA": "157.00 DA", "Num Enregistrement": "447/ 04 B 044 /15", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPROFENE IVAL 200MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPROFENE IVAL", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "195/ 04 B 040 /09", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUPROFNE BEKER 200MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/904.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=904", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IBUPROFNE BEKER", "Tarif de reference": "180.00 DA", "PPA": "180.00 DA", "Num Enregistrement": "447/ 04 B 040 /15", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IBUTHOL 5G/3G POUR 100G GEL TUBE DE 50G", "Img": "https://pharmnet-dz.com//img/medics/4565.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IBUTHOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "149/21A069/16", "Code DCI": "N/D", "Forme": "GEL", "Dosage": "5G/3G POUR 100G", "Conditionnement": "TUBE DE 50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "IDEOS 400UI/500MG COMP. A CROQUER B DE 2 TUBES DE 15 CP", "Img": "https://pharmnet-dz.com//img/medics/4651.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4651", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "IDEOS", "Tarif de reference": "810 DA", "PPA": " DA", "Num Enregistrement": "087/14G175/99/16", "Code DCI": "14G175", "Forme": "COMP. A CROQ.", "Dosage": "400UI/500MG", "Conditionnement": "B DE 2 TUBES DE 15 CP", "Commercialisation": true, "Remboursable": true}, {"Nom": "IFFUROXAZIDE 220MG/5ML SUSP.BUV. B/01 FL DE 90ML + GOBLET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IFFUROXAZIDE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/10C018/16", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "220MG/5ML", "Conditionnement": "B/01 FL DE 90ML + GOBLET DOSEUR", "Commercialisation": true, "Remboursable": null}, {"Nom": "IFOXAN 1G/FL. DE PDRE. PDRE. SOL. INJ. IV B/1FL ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " N/D", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " IFOSFAMIDE", "Liste": "Liste I", "Pays": "COREE", "Nom Commercial": "IFOXAN", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "516/05G106/16", "Code DCI": "05G106", "Forme": "SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL ", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMALEK 100MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " IMATINIB MESYLATE EXPRIME EN IMATINIB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMALEK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 05 C 105 /12", "Code DCI": "05C105", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMALEK 400MG COMP. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " IMATINIB MESYLATE EXPRIME EN IMATINIB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMALEK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 05 C 113 /12", "Code DCI": "05C113", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMATIB  100MG GLES. B/120", "Img": "https://pharmnet-dz.com//img/medics/1013.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1013", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " IMATINIB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMATIB ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 105 /06", "Code DCI": "05A105", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/120", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMATIB 400MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1042.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1042", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " IMATINIB MESYLATE EXPRIME EN IMATINIB", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMATIB", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 C 113 /09", "Code DCI": "05C113", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMECISTAL 500MG**!/500MG**/FL. DE PDRE. PDRE. PERF. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " INFECTIOLOGIE", "C.Therapeutique": " IMIPENEM**(SOUS FORME MONOHYDRATEE) / CILASTATINE (ACIDE)** (SOUS FORME SODIQUE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IMECISTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 W 187 /09", "Code DCI": "13W187", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG**!/500MG**/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMINOPRIL 10MG COMP. SEC. B/14 ET B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IMIDAPRIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "IMINOPRIL", "Tarif de reference": " N/A", "PPA": "901.00 DA", "Num Enregistrement": "001/ 06 E 213 /06/12", "Code DCI": "06E213", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/14 ET B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMINOPRIL 20MG COMP. SEC. B/14 - B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IMIDAPRIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "IMINOPRIL", "Tarif de reference": "507.5 DA", "PPA": "1015.00 DA", "Num Enregistrement": "001/ 06 E 285 /09", "Code DCI": "06E285", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/14 - B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "IMINOPRIL 5MG COMP. SEC. B/14 ET B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IMIDAPRIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "IMINOPRIL", "Tarif de reference": " N/A", "PPA": "615.00 DA", "Num Enregistrement": "001/ 06 E 212 /06/12", "Code DCI": "06E212", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/14 ET B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMMUNATE 500UI/FL. DE PDRE. PDRE. LYOPH. ET SOLV. P. SOL. INJ. B/1FL. DE PDRE. LYOPH.+1FL. DE 5ML DE SOLV. (E.P.P.I)+1DISPOSITIF DE TRANSFERT AVEC FILTRE+1SERINGUE A USAGE UNIQUE+1AIGUILLE STERILE+1SYSTEME DE PERFUSION A AILETTES ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR HUMAIN VIII  ANTI HEMOPHILIQUE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "IMMUNATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 12 J 044 /04/13", "Code DCI": "12J044", "Forme": "PDRE. INJ.", "Dosage": "500UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. LYOPH.+1FL. DE 5ML DE SOLV. (E.P.P.I)+1DISPOSITIF DE TRANSFERT AVEC FILTRE+1SERINGUE A USAGE UNIQUE+1AIGUILLE STERILE+1SYSTEME DE PERFUSION A AILETTES ", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMMUNINE 600UI/FL. DE PDRE. PDRE. LYOPH. ET SOLV. P. SOL. INJ. OU P. PERF. B/1FL. DE PDRE. LYOPH.+1FL. DE 5ML DE SOLV. (E.P.P.I)+1AIGUILLE DE TRANSFERET+1AIGUIILE D'AERATION+1AIGUILLE FILTRE+1AIGUILLE JETABLE+1SERINGUE JETABLE (5ML)+1DISPOSITIF DE PERFUSI", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR IX DE COAGULATION HUMAINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "IMMUNINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 12 J 104 /04/13", "Code DCI": "12J104", "Forme": "PDRE. INJ.", "Dosage": "600UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. LYOPH.+1FL. DE 5ML DE SOLV. (E.P.P.I)+1AIGUILLE DE TRANSFERET+1AIGUIILE D'AERATION+1AIGUILLE FILTRE+1AIGUILLE JETABLE+1SERINGUE JETABLE (5ML)+1DISPOSITIF DE PERFUSION ", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMMUNOGLOBULINE HUMAINE ANTI-D (Rho) 250\u00b5G/ML SOL. INJ. B/1AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " FARMACUBA", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " IMMUNOGLOBULINE HUMAINE  (ANTI D)", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "IMMUNOGLOBULINE HUMAINE ANTI-D (Rho)", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "362/ 12 J 049 /06", "Code DCI": "12J049", "Forme": "SOL. INJ.", "Dosage": "250\u00b5G/ML", "Conditionnement": "B/1AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMPLANON NXT 68MG/IMPLANT IMPLANT P. USAGE SOUS CUTANE B/1APPLICATEUR CONTENANT UN IMPLANT", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " ORGANON", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETONOGESTREL", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "IMPLANON NXT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "005/ 11 H 074 /13", "Code DCI": "11H074", "Forme": "IMPLANT", "Dosage": "68MG/IMPLANT", "Conditionnement": "B/1APPLICATEUR CONTENANT UN IMPLANT", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMUREL 50MG COMP. PELLI. B/100", "Img": "https://pharmnet-dz.com//img/medics/1019.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1019", "Laboratoire": " ASPEN PHARMA TRADING LIMITED", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " AZATHIOPRINE", "Liste": "Liste I", "Pays": "IRELAND", "Nom Commercial": "IMUREL", "Tarif de reference": "3091.25 DA", "PPA": "N/A", "Num Enregistrement": "467/ 05 B 043 /99/12", "Code DCI": "05B043", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "IMUSPORIN 100MG CAPS. MOLLES B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMUSPORIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 B 049 /08", "Code DCI": "05B049", "Forme": "CAPS.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMUSPORIN 100MG/ML SOL. BUV. FL./50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMUSPORIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 B 047 /08", "Code DCI": "05B047", "Forme": "SOL. INJ.", "Dosage": "100MG/ML", "Conditionnement": "FL./50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMUSPORIN 25MG CAPS. MOLLES B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMUSPORIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 B 048 /08", "Code DCI": "05B048", "Forme": "CAPS.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMUSPORIN 50MG CAPS. MOLLES B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "IMUSPORIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 B 082 /08", "Code DCI": "05B082", "Forme": "CAPS.", "Dosage": "50MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "IMUZOLE 250MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/858.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IMUZOLE", "Tarif de reference": "107 DA", "PPA": "146.00 DA", "Num Enregistrement": "035/ 13 F 039 /09", "Code DCI": "13F039", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IMUZOLE 500MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IMUZOLE", "Tarif de reference": "160 DA", "PPA": "160.00 DA", "Num Enregistrement": "035/ 13 F 199 /11", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "IMUZOLE 500MG OVULE VAGI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IMUZOLE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/11A002/16", "Code DCI": "11A002", "Forme": "OVULE ", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "INAGRA 50MG  COMP. PELLI.  B/02 ET B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INAGRA", "Tarif de reference": " N/A", "PPA": "1074.00 DA", "Num Enregistrement": "426/ 25 N 045 /12", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/02 ET B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "INCIVO 375MG  COMP PELL  B/01 FL DE 42 COMP", "Img": "https://pharmnet-dz.com//img/medics/3533.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3533", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TELAPREVIR", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "INCIVO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 13 P 469 /14", "Code DCI": "13P469", "Forme": "COMP. PELLI.", "Dosage": "375MG ", "Conditionnement": "B/01 FL DE 42 COMP", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDAPAMIDE BEKER 1,5MG  COMP. PELLI. LP B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/1488.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1488", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " INDAPAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "INDAPAMIDE BEKER LP", "Tarif de reference": "600.00 DA", "PPA": "600.00 DA", "Num Enregistrement": "447/ 06 H 163 /14", "Code DCI": "06H163", "Forme": "COMP. PELLI. LP", "Dosage": "1,5MG ", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDICARDIN 40MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPRANOLOL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "INDICARDIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "118/ 06 F 073 /98", "Code DCI": "06F073", "Forme": "COMP. SEC.", "Dosage": "40MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDOBIOTIC 5MG/15 000UI/5ML COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1954", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " INDOMETACINE/GENTAMICINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INDOBIOTIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "096/ 17 D 138 /04", "Code DCI": "17D138", "Forme": "COLLY.", "Dosage": "5MG/15 000UI/5ML", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDOCOLLYRE 0.001 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/2000.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2000", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " PRODUITS POUR CRISTALLIN", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INDOCOLLYRE", "Tarif de reference": "299.26 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 J 066 /98", "Code DCI": "17J066", "Forme": "COLLY.", "Dosage": "0.001", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDOGESIC 100MG SUPPO. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "INDOGESIC", "Tarif de reference": "62.05 DA", "PPA": "N/A", "Num Enregistrement": "055/ 04 B 015 /99", "Code DCI": "04B015", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDOGESIC 50MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "INDOGESIC", "Tarif de reference": "98.5 DA", "PPA": "N/A", "Num Enregistrement": "055/ 04 B 014 /99", "Code DCI": "04B014", "Forme": "SUPPO.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDOMET 25MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2736.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2736", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INDOMET", "Tarif de reference": "180 DA", "PPA": "180 DA", "Num Enregistrement": "003/ 04 B 013 /96/11", "Code DCI": "04B013", "Forme": "GLES.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDOMIN 100MG SUPPO. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "INDOMIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 015 /97/06", "Code DCI": "04B015", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "INDOMIN 50MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " INDOMETACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "INDOMIN", "Tarif de reference": "98.5 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 014 /97", "Code DCI": "04B014", "Forme": "SUPPO.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "INDPRO 2MG/ML (200MG/100ML) SOL. INJ. P. PERF. IV B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CPCM", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INDPRO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 13 K 251 /12", "Code DCI": "13K251", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (200MG/100ML)", "Conditionnement": "B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "INDRANOL 40MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PROPRANOLOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "INDRANOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "010/ 06 F 073 /99", "Code DCI": "06F073", "Forme": "COMP. SEC.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "INEGY 10MG/20MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/1628.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1628", "Laboratoire": " MSD SP LIMITED ", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " EZETIMIBE / SIMVASTATINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "INEGY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 06 M 303 /13", "Code DCI": "06M303", "Forme": "COMP.", "Dosage": "10MG/20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "INEGY 10MG/40MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1629.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1629", "Laboratoire": " MSD SP LIMITED ", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " EZETIMIBE / SIMVASTATINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "INEGY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 06 M 304 /13", "Code DCI": "06M304", "Forme": "COMP.", "Dosage": "10MG/40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "INEXIUM 40MG COMP. GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medics/3888.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3888", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "INEXIUM", "Tarif de reference": "196 DA", "PPA": " DA", "Num Enregistrement": "256/ 10 A 181 /08", "Code DCI": "10A181", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "INEXIUM 40MG/FL. DE PDRE. PDRE. P. SOL. INJ. IV OU PERF. B/10FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3890.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3890", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE SODIQUE EXPRIME EN ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "INEXIUM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 10 A 197 /12", "Code DCI": "10A197", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG/FL. DE PDRE.", "Conditionnement": "B/10FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "INFANTRIL 50MG COMP.SEC. B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " INDUCTEURS DE L'OVULATION", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CLOMIFENE CITRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "INFANTRIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 09 L 058 /98/09", "Code DCI": "09L058", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "INFLAMINE 250MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE NIFLUMIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "INFLAMINE", "Tarif de reference": "118.5 DA", "PPA": "N/A", "Num Enregistrement": "457/ 04 B 029 /12", "Code DCI": "04B029", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "INICOX 100MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2819.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INICOX", "Tarif de reference": "720 DA", "PPA": "720.00 DA", "Num Enregistrement": "268/ 04 B 035 /13", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "INICOX 200MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2829.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INICOX", "Tarif de reference": "911 DA", "PPA": "911.00 DA", "Num Enregistrement": "268/ 04 B 036 /13", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "INNOHEP 10 000UI ANTI-XA/0,5ML SOL.INJ.SC EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,5ML ET B/10 SERING. PREREMPL. DE 0,5ML(AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE)", "Img": "https://pharmnet-dz.com//img/medics/1716.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1716", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TINZAPARINE SODIQUE  (HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INNOHEP", "Tarif de reference": "2189.76 DA", "PPA": "N/A", "Num Enregistrement": "083/ 12 B 078 /99/13", "Code DCI": "12B078", "Forme": "SOL. INJ.", "Dosage": "10 000UI ANTI-XA/0,5ML", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,5ML ET B/10 SERING. PREREMPL. DE 0,5ML(AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "INNOHEP 14 000UI ANTI-XA/0,7ML SOL.INJ.SC EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,7ML ET B/10 SERING. PREREMPL. DE 0,7ML(AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1717", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TINZAPARINE SODIQUE  (HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INNOHEP", "Tarif de reference": "0 DA", "PPA": "11923.00 DA", "Num Enregistrement": "083/ 12 B 079 /99/13", "Code DCI": "12B079", "Forme": "SOL. INJ.", "Dosage": "14 000UI ANTI-XA/0,7ML", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,7ML ET B/10 SERING. PREREMPL. DE 0,7ML(AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "INNOHEP 18 000UI ANTI-XA/0,9ML SOL.INJ.SC EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,9ML ET B/10 SERING. PREREMPL. DE 0,9ML(AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE)", "Img": "https://pharmnet-dz.com//img/medics/1718.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1718", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TINZAPARINE SODIQUE  (HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INNOHEP", "Tarif de reference": "0 DA", "PPA": "3388.00 DA", "Num Enregistrement": "083/ 12 B 080 /99/13", "Code DCI": "12B080", "Forme": "SOL. INJ.", "Dosage": "18 000UI ANTI-XA/0,9ML", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,9ML ET B/10 SERING. PREREMPL. DE 0,9ML(AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "INNOHEP 2 500UI ANTI XA/0,25ML SOL.INJ.SC EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,25ML AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/1732.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1732", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TINZAPARINE SODIQUE  (HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INNOHEP", "Tarif de reference": "0 DA", "PPA": "497.00 DA", "Num Enregistrement": "083/ 12 B 097 /03/13", "Code DCI": "12B097", "Forme": "SOL. INJ.", "Dosage": "2 500UI ANTI XA/0,25ML", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,25ML AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "INNOHEP 3 500UI ANTI-XA/0,35ML SOL.INJ.SC EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,35ML AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/1733.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1733", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TINZAPARINE SODIQUE  (HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INNOHEP", "Tarif de reference": "749.7 DA", "PPA": "N/A", "Num Enregistrement": "083/ 12 B 098 /03/13", "Code DCI": "12B098", "Forme": "SOL. INJ.", "Dosage": "3 500UI ANTI-XA/0,35ML", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,35ML AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "INNOHEP 4 500UI ANTI-XA/0.45ML SOL.INJ.SC EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,45ML AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/1734.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1734", "Laboratoire": " LEO", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TINZAPARINE SODIQUE  (HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INNOHEP", "Tarif de reference": "0 DA", "PPA": "1019.00 DA", "Num Enregistrement": "083/ 12 B 099 /03/13", "Code DCI": "12B099", "Forme": "SOL. INJ.", "Dosage": "4 500UI ANTI-XA/0.45ML", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,45ML AVEC SYST\u00c8ME DE SECURITE D'AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "INOFER 32,48MG FER FERREUX / 100MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " LISA PHARMA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERREUX / ACIDE SUCCINIQUE  (SOUS FORME DE SUCCINATE FERREUX / ACIDE SUCCINIQUE)", "Pays": "FRANCE", "Nom Commercial": "INOFER", "Tarif de reference": "23.1 DA", "PPA": "N/A", "Num Enregistrement": "385/ 12 E 132 /07", "Code DCI": "12E132", "Forme": "COMP. PELLI.", "Dosage": "32,48MG FER FERREUX / 100MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "INPHADIUM 0,2MG/ML SIROP FL/125ML+PIPETTE DOSEUSE GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medics/2924.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2924", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "INPHADIUM", "Tarif de reference": "217.5 DA", "PPA": " DA", "Num Enregistrement": "317/ 10 H 144 /05/12", "Code DCI": "10H144", "Forme": "SIROP", "Dosage": "0,2MG/ML", "Conditionnement": "FL/125ML+PIPETTE DOSEUSE GRADUEE EN KG", "Commercialisation": true, "Remboursable": true}, {"Nom": "INPHALAC 0.606 SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medics/2931.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2931", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "INPHALAC", "Tarif de reference": "172 DA", "PPA": " DA", "Num Enregistrement": "317/ 10 L 062 /05", "Code DCI": "10L062", "Forme": "SOL. BUV.", "Dosage": "0.606", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INPREDNI 40MG/FL. DE PDRE. PDRE. P. SOL. INJ. IM/IV B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CPCM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INPREDNI", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 09 H 030 /12", "Code DCI": "09H030", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG/FL. DE PDRE.", "Conditionnement": "B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "INSUDAL BASAL 100UI/ML SUSP. INJ.  B/1FL. 5ML  -  B/1FL.10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) ISOPHANE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "INSUDAL BASAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 B 193 /07", "Code DCI": "14B193", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1FL. 5ML  -  B/1FL.10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSUDAL COMB 25 100UI/ML SUSP. INJ.  B/ 1FL. DE 5ML  - B/1FL DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE 25% / INSULINE HUMAINE ISOPHANE 75% ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "INSUDAL COMB 25", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 B 203 /08", "Code DCI": "14B203", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/ 1FL. DE 5ML  - B/1FL DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSUDAL RAPID 100UI/ML SOL. INJ. B/1FL. 5ML -  B/1FL.10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) RAPIDE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "INSUDAL RAPID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 B 197 /06", "Code DCI": "14B197", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1FL. 5ML -  B/1FL.10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSULATARD HM 100UI/ML SUSP INJ  FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3739", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) ISOPHANE ", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "INSULATARD HM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 B 193 /00", "Code DCI": "14B193", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSULATARD HM PENFILL 100UI/ML SUSP INJ  B/5 CART. DE 1,5 ML ET B/5CART DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3733.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3733", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE INTERMEDIAIRE MONOPHASIQUE", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "INSULATARD HM PENFILL", "Tarif de reference": "0 DA", "PPA": "2397.00 DA", "Num Enregistrement": "069/ 14 B 155 /98", "Code DCI": "14B155", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART. DE 1,5 ML ET B/5CART DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSUMAN BASAL 100UI/ML (3,5MG/ML) SUSP .INJ. SC EN FL. B/1FL DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/3740.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3740", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) ISOPHANE ", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "INSUMAN BASAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 14 B 193 /02/09", "Code DCI": "14B193", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/1FL DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSUMAN BASAL 100UI/ML SUSP INJ B/5 CART 3ML (POUR OPTIPEN )", "Img": "https://pharmnet-dz.com//img/medics/3303.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3303", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE ISOPHANE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "INSUMAN BASAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 14 B 211 /03", "Code DCI": "14B211", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART 3ML (POUR OPTIPEN )", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSUMAN COMB 25 100UI/ML (3,5MG/ML) SUSP. INJ. SC EN FL. B/1FL DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE 25% / INSULINE HUMAINE ISOPHANE 75% ", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "INSUMAN COMB 25", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "376/ 14 B 203 /02/09", "Code DCI": "14B203", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML (3,5MG/ML)", "Conditionnement": "B/1FL DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "INSUMAN COMB 25 100UI/ML SUSP INJ B/5 CART 3ML  (POUR OPTIPEN )", "Img": "https://pharmnet-dz.com//img/medics/3302.png", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE 25% / INSULINE HUMAINE ISOPHANE 75% ", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "INSUMAN COMB 25", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "230/ 14 B 210 /03", "Code DCI": "14B210", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART 3ML  (POUR OPTIPEN )", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSUMAN RAPID 100UI/ML SOL INJ B/1FL DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3297", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) RAPIDE ", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "INSUMAN RAPID", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 14 B 197 /02", "Code DCI": "14B197", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1FL DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INSUMAN RAPID 100UI/ML SOL INJ B/5 CART 3ML  ( POUR OPTIPEN )", "Img": "https://pharmnet-dz.com//img/medics/3731.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3731", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE RAPIDE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "INSUMAN RAPID", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 14 B 153 /03", "Code DCI": "14B153", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART 3ML  ( POUR OPTIPEN )", "Commercialisation": true, "Remboursable": true}, {"Nom": "INTETRIX 50MG/200MG GLES . B/20", "Img": "https://pharmnet-dz.com//img/medics/3936.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3936", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TILIQUINOL/TILBROQUINOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INTETRIX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "020/ 10 C 020 /97", "Code DCI": "10C020", "Forme": "GLES.", "Dosage": "50MG/200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "INTETRIX P 3,28G/100G GRLES. B/125G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TILBROQUINOL", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "INTETRIX P", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "020/ 10 C 021 /96", "Code DCI": "10C021", "Forme": "GRLES.", "Dosage": "3,28G/100G", "Conditionnement": "B/125G", "Commercialisation": true, "Remboursable": null}, {"Nom": "INTRALIPIDE 20% 20G/100ML EMULSION PERF.IV POCHE DE 500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3468", "Laboratoire": " FRESENIUS KABI", "C.Pharmacologique": " ALIMENTATION PARENTERALE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " HUILE DE SOJA PURIFIEE", "Pays": "FRANCE", "Nom Commercial": "INTRALIPIDE 20%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "332/ 14 K 124 /08", "Code DCI": "14K124", "Forme": "EMULSION PERF.", "Dosage": "20G/100ML", "Conditionnement": "POCHE DE 500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INTRATECT 50MG/ML (2,5G/50ML OU 5G/100ML OU 10G/200ML) SOL. P. PERF. IV B/01 FL. MUNI D'UN BOUCHON ET D'UNE CAPSULE", "Img": "https://pharmnet-dz.com//img/medics/3599.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3599", "Laboratoire": " BIOTEST PHARMA GmBH", "C.Pharmacologique": " SERUMS & GAMMA GLOBULINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " IMMUNOGLOBULINE HUMAINE NORMALE POLYVALENTE (Ig IV)", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "INTRATECT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "370/ 13 V 471 /14", "Code DCI": "13V471", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (2,5G/50ML OU 5G/100ML OU 10G/200ML)", "Conditionnement": "B/01 FL. MUNI D'UN BOUCHON ET D'UNE CAPSULE", "Commercialisation": true, "Remboursable": true}, {"Nom": "INTRONA 10UI/ML PDRE.SOL.INJ. B/1+1+1seringue +2aiguilles", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INTRONA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 099 /97", "Code DCI": "13P099", "Forme": "PDRE. SOL. INJ.", "Dosage": "10UI/ML", "Conditionnement": "B/1+1+1seringue +2aiguilles", "Commercialisation": true, "Remboursable": null}, {"Nom": "INTRONA 3MUI/ML PDRE.SOL.INJ.IM,SC B/1+1+1seringue +2aiguilles", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INTRONA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 101 /97", "Code DCI": "13P101", "Forme": "PDRE. SOL. INJ.", "Dosage": "3MUI/ML", "Conditionnement": "B/1+1+1seringue +2aiguilles", "Commercialisation": true, "Remboursable": null}, {"Nom": "INTRONA 5MUI PDRE.SOL.INJ.IM,SC B/1+1+1seringue +2aiguilles", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "INTRONA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 100 /97", "Code DCI": "13P100", "Forme": "PDRE. SOL. INJ.", "Dosage": "5MUI", "Conditionnement": "B/1+1+1seringue +2aiguilles", "Commercialisation": true, "Remboursable": null}, {"Nom": "INVANZ 1G/FL. DE PDRE** PDRE. P. SOL. A DILUER  P. PERF.  B/1FL. DE PDRE. DE CONTENANCE 20ML", "Img": "https://pharmnet-dz.com//img/medics/3603.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3603", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERTAPANEM** (SOUS FORME SODIQUE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "INVANZ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 13 W 336 /09 ", "Code DCI": "13W336", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE**", "Conditionnement": "B/1FL. DE PDRE. DE CONTENANCE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "INVERTER 2MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medics/94.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=94", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INVERTER", "Tarif de reference": "315 DA", "PPA": "315 DA", "Num Enregistrement": "003/ 06 C 022 /06", "Code DCI": "06C022", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "INVERTER 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/101.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "INVERTER", "Tarif de reference": "460 DA", "PPA": "460 DA", "Num Enregistrement": "003/ 06 C 023 /06", "Code DCI": "06C023", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IODACRYL 0.04 SOL. MOUSSANTE F/125ML  ET  F/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " GROUPEMENT PHARMACEUTIQUE ALGERIEN (GPA) ", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "IODACRYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "185/ 07 P 076 /06", "Code DCI": "07P076", "Forme": "SOL. DERM.", "Dosage": "0.04", "Conditionnement": "F/125ML  ET  F/500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "IOR LEUKOCIM 300\u00b5G/ML (3MUI/ML) SOL. INJ. SC ET IV B/10FL. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/1771.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " CENTRO IMMUNOLOGIA MOLECULAR (CIM)", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FILGRASTIM", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "IOR LEUKOCIM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "443/ 12 E 065 /09", "Code DCI": "12E065", "Forme": "SOL. INJ.", "Dosage": "300\u00b5G/ML (3MUI/ML)", "Conditionnement": "B/10FL. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "IPAKINE 200MG/ML SOL. BUV. FL 40ML+PIPETTE GRADu\u00e9e", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "IPAKINE", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL 40 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "IPICARE 10MG COMP. PELLI.B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "837,6 DA", "PPA": "N/A", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IPNODIS 5MG/ML SOL INJ B/10AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/2187.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2187", "Laboratoire": " MEDIS (LABORATOIRES DES MEDICAMENTS STERILES)", "C.Pharmacologique": " HYPNOTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " MIDAZOLAM", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "IPNODIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "331/ 16 C 051 /05", "Code DCI": "16C051", "Forme": "SOL. INJ.", "Dosage": "5MG/ML", "Conditionnement": "B/10AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "IPPROTON  40MG LYOPH. SOL. INJ.  B/10FL.", "Img": "https://pharmnet-dz.com//img/medics/3863.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3863", "Laboratoire": " MEDIS (LABORATOIRES DES MEDICAMENTS STERILES)", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE SODIQUE EXPRIME EN OMEPRAZOLE", "Liste": "Liste II", "Pays": "TUNISIE", "Nom Commercial": "IPPROTON ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "331/ 10 A 087 /05", "Code DCI": "10A087", "Forme": "LYOPH. SOL. INJ.", "Dosage": "40MG", "Conditionnement": "B/10FL.", "Commercialisation": true, "Remboursable": true}, {"Nom": "IPRALIN 200\u00b5G/40\u00b5G PDRE. INHAL. EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL SULFATE / BROMURE D'IPRATROPIUM ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IPRALIN", "Tarif de reference": "198 DA", "PPA": "N/A", "Num Enregistrement": "263/ 20 A 241 /09", "Code DCI": "20A241", "Forme": "PDRE. INHAL.", "Dosage": "200\u00b5G/40\u00b5G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBAC 150MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BAC PHARMA SPA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRBAC", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "468/ 06 E 156 /13", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBAC 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BAC PHARMA SPA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRBAC", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "479/ 06 E 157 /13", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBE 150 150MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " TAPHCO SPA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "IRBE 150", "Tarif de reference": "1290.00 DA", "PPA": " DA", "Code DCI": "06E156", "Forme": "COMP.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBEK 150MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/217.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=217", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRBEK", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "447/ 06 E 156 /10", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBEK 300MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3073.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3073", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRBEK", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "447/ 06 E 157 /10", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBEVEL 150MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/213.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRBEVEL", "Tarif de reference": "1290 DA", "PPA": "1100.00 DA", "Num Enregistrement": "263/ 06 E 156 /10", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBEVEL 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/223.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRBEVEL", "Tarif de reference": "1290 DA", "PPA": "1100.00 DA", "Num Enregistrement": "263/ 06 E 157 /10", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRBISART 150MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRBISART", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRESSA 250MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1052.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1052", "Laboratoire": " ASTRAZENECA AB", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " GEFITINIB", "Liste": "Liste I", "Pays": "SUEDE", "Nom Commercial": "IRESSA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 05 C 163 /13", "Code DCI": "05C163", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRINOTECAN MYLAN 20MG/ML (100MG/5ML) (40MG/2ML) SOL A DILUER P. PERF IV B/01FL DE 5ML ET B/01FL DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1114", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " IRINOTECAN CHLORHYDRATE TRIHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "IRINOTECAN MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 G 076 /14", "Code DCI": "05G076", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (100MG/5ML) (40MG/2ML)", "Conditionnement": "B/01FL DE 5ML ET B/01FL DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "IRIS 0,1IR/ML+1IR/ML+10IR/ML SUSP.INJ. COFF./3FL . DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ALLERBIO S.A.", "C.Pharmacologique": " ALLERGENES A USAGE THERAPEUTIQUE", "C.Therapeutique": " ALLERGOLOGIE", "Info": " EXTRAITS ALLERGENIQUES DERMATOPHAGOIDES PTERONYSSINUS", "Pays": "FRANCE", "Nom Commercial": "IRIS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "245/ 01 D 029 /01", "Code DCI": "01D029", "Forme": "SUSP. INJ.", "Dosage": "0,1IR/ML+1IR/ML+10IR/ML", "Conditionnement": "COFF./3FL . DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRIS 10IR/ML SUSP.INJ. COFF/1FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ALLERBIO S.A.", "C.Pharmacologique": " ALLERGENES A USAGE THERAPEUTIQUE", "C.Therapeutique": " ALLERGOLOGIE", "Info": " EXTRAITS ALLERGENIQUES DERMATOPHAGOIDES PTERONYSSINUS 100%", "Pays": "FRANCE", "Nom Commercial": "IRIS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "245/ 01 D 030 /01", "Code DCI": "01D030", "Forme": "SUSP. INJ.", "Dosage": "10IR/ML", "Conditionnement": "COFF/1FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "IROVEL 150MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IROVEL", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "418/ 06 E 156 /14", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IROVEL 300MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IROVEL", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "418/ 06 E 157 /14", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRYS 1MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3645.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3645", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRYS", "Tarif de reference": "250.8 DA", "PPA": "252.00 DA", "Num Enregistrement": "317/ 14 A 187 /10", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRYS 2MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3659.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3659", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRYS", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "317/ 14 A 188 /10", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRYS 3MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3670.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3670", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRYS", "Tarif de reference": "720 DA", "PPA": "720.00 DA", "Num Enregistrement": "317/ 14 A 189 /10", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRYS 4MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3681.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3681", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRYS", "Tarif de reference": "750 DA", "PPA": "750.00 DA", "Num Enregistrement": "317/ 14 A 190 /10", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "IRYS 6MG COMP. PELLI. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3724.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3724", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "IRYS", "Tarif de reference": "920.1 DA", "PPA": "920.00 DA", "Num Enregistrement": "317/ 14 A 324 /12", "Code DCI": "14A324", "Forme": "COMP. PELLI.", "Dosage": "6MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISIOCEF 200MG COMP. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ISIOCEF", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "321/ 13 B 201 /06", "Code DCI": "13B201", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISIOCEF 50MG/5ML PDRE. SUSP. BUV. FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ISIOCEF", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "321/ 13 B 309 /06", "Code DCI": "13B309", "Forme": "PDRE. SUSP. BUV.", "Dosage": "50MG/5ML", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOBUTALINE 0,3MG/ML SOL.BUV. SANS SUCRE FL./150ML", "Img": "https://pharmnet-dz.com//img/medics/2107.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2107", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ISOBUTALINE", "Tarif de reference": "0 DA", "PPA": "195.00 DA", "Num Enregistrement": "073/ 20 A 049 /10", "Code DCI": "20A049", "Forme": "SIROP", "Dosage": "0,3MG/ML", "Conditionnement": "FL./150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOCTINE 2MG/5ML SOL.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ISOCTINE", "Tarif de reference": "109 DA", "PPA": "109.00 DA", "Num Enregistrement": "073/ 14 F 024 /98/14", "Code DCI": "14F024", "Forme": "SIROP", "Dosage": "2MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOFFINE 88,70G/100ML SOL. BUV. FL/150 ML", "Img": "https://pharmnet-dz.com//img/medics/2957.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2957", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HUILE DE PARAFFINE LIQUIDE", "Pays": "ALGERIE", "Nom Commercial": "ISOFFINE", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "073/ 10 M 066 /98/09", "Code DCI": "10M066", "Forme": "SOL. BUV.", "Dosage": "88,70G/100ML", "Conditionnement": "FL/150 ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "ISOFRA 0.0125 SOL . PULV . NAS. FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " FRAMYCETINE", "Pays": "FRANCE", "Nom Commercial": "ISOFRA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "269/ 22 E 014 /98", "Code DCI": "22E014", "Forme": "SOL. NAS.", "Dosage": "0.0125", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ISOKET 0,1% 10MG/10MG  OU (1MG/1ML) SOL. P. PERF. IV B/10AMP. DE  10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ISOKET 0,1%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 211 /06", "Code DCI": "06C211", "Forme": "SOL. PERF.", "Dosage": "10MG/10MG  OU (1MG/1ML)", "Conditionnement": "B/10AMP. DE  10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ISOKET 10MG COMP B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "ISOKET", "Tarif de reference": "176 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 024 /03", "Code DCI": "06C024", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOKET 20MG COMP B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "ISOKET", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 025 /03", "Code DCI": "06C025", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOKET SPRAY 1,25MG/DOSE SOL. PULV. BUCC. FL./15ML (300 PULV.)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "ISOKET SPRAY", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 221 /06", "Code DCI": "06C221", "Forme": "SOL. PERF.", "Dosage": "1,25MG/DOSE", "Conditionnement": "FL./15ML (300 PULV.)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOLACT 0.665 SOL. BUV. SANS SUCRE FL/150ML", "Img": "https://pharmnet-dz.com//img/medics/2932.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2932", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "ISOLACT", "Tarif de reference": "204 DA", "PPA": "204.00 DA", "Num Enregistrement": "073/ 10 L 062 /01/09", "Code DCI": "10L062", "Forme": "SOL. BUV.", "Dosage": "0.665", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOLEP 200MG/ML SOL.BUV. FL/50ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ISOLEP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "073/15A003/16", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL/50ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOLVON 10MG/5ML SIROP F/60ML", "Img": "https://pharmnet-dz.com//img/medics/1339.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1339", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BROMHEXINE", "Pays": "ALGERIE", "Nom Commercial": "ISOLVON", "Tarif de reference": "127 DA", "PPA": "127.00 DA", "Num Enregistrement": "073/ 20 D 204 /05", "Code DCI": "20D204", "Forme": "SIROP", "Dosage": "10MG/5ML", "Conditionnement": "F/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOMAG 0.15 SOL.BUV. FL/150ML", "Img": "https://pharmnet-dz.com//img/medics/3395.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3395", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM ELEMENT  (SOUS FORME DE MAGNESIUM PIDOLATE)", "Pays": "ALGERIE", "Nom Commercial": "ISOMAG", "Tarif de reference": "207 DA", "PPA": " DA", "Num Enregistrement": "073/ 14 G 162 /98/09", "Code DCI": "14G162", "Forme": "SOL. BUV.", "Dosage": "0.15", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOMEDINE 0.001 SOL.DERM. FL/50ML", "Img": "https://pharmnet-dz.com//img/medics/542.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=542", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HEXAMIDINE", "Pays": "ALGERIE", "Nom Commercial": "ISOMEDINE", "Tarif de reference": "109.65 DA", "PPA": " DA", "Num Enregistrement": "073/ 07 P 071 /99/09", "Code DCI": "07P071", "Forme": "SOL. DERM.", "Dosage": "0.001", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOMOL 100MG/5ML SOL.  BUV. F/100ML", "Img": "https://pharmnet-dz.com//img/medics/4151.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4151", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "ISOMOL", "Tarif de reference": "77 DA", "PPA": "119.00 DA", "Num Enregistrement": "073/ 03 B 006 /03", "Code DCI": "03B006", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "F/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISONIAZID 100MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LUPIN LIMITED", "C.Pharmacologique": " ANTITUBERCULEUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ISONIAZIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ISONIAZID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "454/ 13 T 122 /09", "Code DCI": "13T122", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "ISONIAZID 300MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LUPIN LIMITED", "C.Pharmacologique": " ANTITUBERCULEUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ISONIAZIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ISONIAZID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "454/ 13 T 123 /10", "Code DCI": "13T123", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "ISONIAZIDE 100MG COMP. B/1000", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GRUPPO LEPETIT", "C.Pharmacologique": " ANTITUBERCULEUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ISONIAZIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "ISONIAZIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "059/ 13 T 122 /00", "Code DCI": "13T122", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/1000", "Commercialisation": true, "Remboursable": null}, {"Nom": "ISOPERIDOL 2MG/ML SOL.BUV.GTTES. FL/20 ML  -  FL/50ML", "Img": "https://pharmnet-dz.com//img/medics/2237.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2237", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ISOPERIDOL", "Tarif de reference": "0 DA", "PPA": "114.00 DA", "Num Enregistrement": "073/ 16 D 085 /99/09", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML", "Conditionnement": "FL/20 ML  -  FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOPRENALINE CHLORHYDRATE 0,2MG/ML SOL.INJ. B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOPRENALINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ISOPRENALINE CHLORHYDRATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 06 G 082 /98", "Code DCI": "06G082", "Forme": "SOL. INJ.", "Dosage": "0,2MG/ML", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOPTYL 4% (40MG/ML) SOL. BUV. GTTES. FL./20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ISOPTYL", "Tarif de reference": " N/A", "PPA": "99.00 DA", "Num Enregistrement": "073/ 16 A 003 /98/09", "Code DCI": "16A003", "Forme": "SOL. BUV. GTTES.", "Dosage": "4% (40MG/ML)", "Conditionnement": "FL./20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ISORTAT   10MG COMP B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EIPICO ", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste II", "Pays": "EGYPTE", "Nom Commercial": "ISORTAT  ", "Tarif de reference": "105.6 DA", "PPA": "N/A", "Num Enregistrement": "109/ 06 C 024 /00", "Code DCI": "06C024", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISORYTHM LP 250MG GLES LP B/20", "Img": "https://pharmnet-dz.com//img/medics/134.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=134", "Laboratoire": " MERCK LIPHA SANTE ", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DISOPYRAMIDE LP", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ISORYTHM LP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "062/ 06 D 044 /99", "Code DCI": "06D044", "Forme": "COMP. ENRO. LP", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOSPALGINE 10MG/5ML SIROP FL/150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ISOSPALGINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "073/ 10 D 032 /00/09", "Code DCI": "10D032", "Forme": "SOL. BUV.", "Dosage": "10MG/5ML", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ISOTAMINE 2MG/ML GTTE BUV FL/50ML", "Img": "https://pharmnet-dz.com//img/medics/2462.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2462", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " DIHYDROERGOTAMINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ISOTAMINE", "Tarif de reference": "222 DA", "PPA": " DA", "Num Enregistrement": "073/ 15 B 021 /04", "Code DCI": "15B021", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ISOTREX 0.0005 GEL.DERM T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " STIEFEL UK Ltd", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ISOTREX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "125/ 07 B 090 /99", "Code DCI": "07B090", "Forme": "GEL. DERM.", "Dosage": "0.0005", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ITRANOX 100MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ITRACONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ITRANOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "293/ 13 R 464 /12", "Code DCI": "13R464", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ITRASPOR 100MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/3585.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ITRACONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ITRASPOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 R 464 /14", "Code DCI": "13R464", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}], "J": [{"Nom": "JACE 10MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LISINOPRIL DIHYDRATEE EXPRIME EN LISINOPRIL", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "JACE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "386/ 06 E 275 /09", "Code DCI": "06E275", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "JACE 20MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LISINOPRIL DIHYDRATEE EXPRIME EN LISINOPRIL", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "JACE", "Tarif de reference": "285 DA", "PPA": "N/A", "Num Enregistrement": "386/ 06 E 276 /09", "Code DCI": "06E276", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "JACE 5MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LISINOPRIL DIHYDRATEE EXPRIME EN LISINOPRIL", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "JACE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "386/ 06 E 274 /09", "Code DCI": "06E274", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "JANUVIA  100MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3727.png", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "JANUVIA ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 14 A 342 /12", "Code DCI": "14A342", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "JASMINE 3MG / 30\u00b5G COMP. PELLI. B/21", "Img": "https://pharmnet-dz.com//img/medics/3059.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3059", "Laboratoire": " BAYER", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " DROSPIRENONE / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "JASMINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "424/ 11 H 078 /09", "Code DCI": "11H078", "Forme": "COMP. PELLI.", "Dosage": "3MG / 30\u00b5G", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": false}, {"Nom": "JEVTANA 40MG/ML (60MG/1,5ML) SOL. A DILUER ET SOLVANT P./SOL. P./PERF. IV B/01 FL. DE 1,5ML DE SOL. A DILUER + 01 FL. DE 4,5ML DE SOLVANT (ETHANOL 96\u00b0, EPPI)", "Img": "https://pharmnet-dz.com//img/medics/29.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=29", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " CABAZITAXEL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "JEVTANA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 05 G 177 /15", "Code DCI": "05G177", "Forme": "SOL. PERF.", "Dosage": "40MG/ML (60MG/1,5ML)", "Conditionnement": "B/01 FL. DE 1,5ML DE SOL. A DILUER + 01 FL. DE 4,5ML DE SOLVANT (ETHANOL 96\u00b0, EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "JOSACINE 125MG/5 ML GRLES.SUSP.BUV B/01 FL. DE 15G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE", "Img": "https://pharmnet-dz.com//img/medics/810.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=810", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " JOSAMYCINE PROPIONATE EXPRIME EN JOSAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "JOSACINE", "Tarif de reference": "350.91 DA", "PPA": "N/A", "Num Enregistrement": "374/ 13 E 188 /99/15", "Code DCI": "13E188", "Forme": "GRLES. SOL. BUV.", "Dosage": "125MG/5 ML", "Conditionnement": "B/01 FL. DE 15G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE", "Commercialisation": true, "Remboursable": true}, {"Nom": "JOSACINE 250MG PDRE ORALE SACHET B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " JOSAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "JOSACINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "016/ 13 E 191 /99", "Code DCI": "13E191", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "JOSACINE 250MG/5ML GRLES.SUSP.BUV B/01 FL. DE 15G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE", "Img": "https://pharmnet-dz.com//img/medics/811.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=811", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " JOSAMYCINE PROPIONATE EXPRIME EN JOSAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "JOSACINE", "Tarif de reference": "639.04 DA", "PPA": "N/A", "Num Enregistrement": "374/ 13 E 189 /99/15", "Code DCI": "13E189", "Forme": "GRLES. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "B/01 FL. DE 15G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE", "Commercialisation": true, "Remboursable": true}, {"Nom": "JOSACINE 500MG /5ML GRLES.SUSP.BUV B/01 FL. DE 20G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE", "Img": "https://pharmnet-dz.com//img/medics/812.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=812", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " JOSAMYCINE PROPIONATE EXPRIME EN JOSAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "JOSACINE", "Tarif de reference": "916.94 DA", "PPA": "N/A", "Num Enregistrement": "374/ 13 E 190 /99/15", "Code DCI": "13E190", "Forme": "GRLES. SOL. BUV.", "Dosage": "500MG /5ML", "Conditionnement": "B/01 FL. DE 20G CORRESPONDANT A 60ML DE SUSP. RECONSTITUEE AVEC SERINGUE P. ADMINISTRATION ORALE", "Commercialisation": true, "Remboursable": true}, {"Nom": "JOSACINE 500MG COMP.PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/815.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=815", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " JOSAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "JOSACINE", "Tarif de reference": "1043.06 DA", "PPA": "N/A", "Num Enregistrement": "374/ 13 E 202 /99/15", "Code DCI": "13E202", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "JOSACINE 500MG PDRE ORALE SACHET B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " JOSAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "JOSACINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "016/ 13 E 192 /99", "Code DCI": "13E192", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "JUSLINE 30/70 100UI/ML SUSP. INJ. EN FLACON B/01FL./10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) 30% / INSULINE HUMAINE ISOPHANE 70%", "Liste": "Liste II", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "JUSLINE 30/70", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "329/ 14 B 192 /09", "Code DCI": "14B192", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/01FL./10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "JUSLINE N 100UI/ML SUSP. INJ. SC B/1L. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) ISOPHANE ", "Liste": "Liste II", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "JUSLINE N", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "329/ 14 B 193 /09", "Code DCI": "14B193", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1L. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "JUSLINE R 100UI/ML SOL. INJ. SC B/1L. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) RAPIDE ", "Liste": "Liste II", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "JUSLINE R", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "329/ 14 B 197 /09", "Code DCI": "14B197", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1L. DE 10ML", "Commercialisation": true, "Remboursable": true}], "K": [{"Nom": "KALIGON 0.15 SIROP FL/120ML", "Img": "https://pharmnet-dz.com//img/medics/3366.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " POTASSIUM GLUCONATE", "Pays": "ALGERIE", "Nom Commercial": "KALIGON", "Tarif de reference": "196 DA", "PPA": "196 DA", "Num Enregistrement": "003/ 14 G 061 /97/10", "Code DCI": "14G061", "Forme": "SIROP", "Dosage": "0.15", "Conditionnement": "FL/120ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KALIPACK 10% ( 0,1G/ML)  SOL.INJ.A DILUER 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE POTASSIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KALIPACK", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "14G059", "Forme": "SOL. INJ.", "Dosage": "0.1", "Conditionnement": "10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KANISAR 50MG GLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANDOZ", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KANISAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 16 D 066 /99", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "KAPTIRON 125MG COMP. DISPERS.  B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KAPTIRON", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "24D017", "Forme": "COMP. DISPERS.", "Dosage": "125MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAPTIRON 125MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KAPTIRON", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "24D017", "Forme": "COMP. DISPERS.", "Dosage": "125MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAPTIRON 250MG COMP. DISPERS. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KAPTIRON", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "24D018", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAPTIRON 250MG COMP. DISPERS. B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KAPTIRON", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "24D018", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAPTIRON 500MG COMP. DISPERS.  B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "KAPTIRON ", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "447/24D019/17", "Code DCI": "24D019", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAPTIRON 500MG COMP. DISPERS. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KAPTIRON", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "447/24D019/17", "Code DCI": "24D019", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAPTOFER 125MG COMP. DISPERS. ", "Img": "https://pharmnet-dz.com//img/medics/5716.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KAPTOFER", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "24D017", "Forme": "COMP. DISPERS.", "Dosage": "125 MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAPTOFER 250MG COMP. DISPERS. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4696.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KAPTOFER", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "447/24D018/17", "Code DCI": "24D018", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "KARDEGIC 160MG/SACHET** (288MG/SACHET ACETYLSALICYLATE DE DL LYSINE) PDRE. SOL. BUV. B/30 SACHETS DOSE", "Img": "https://pharmnet-dz.com//img/medics/1709.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1709", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE", "Pays": "FRANCE", "Nom Commercial": "KARDEGIC", "Tarif de reference": "127.2 DA", "PPA": "N/A", "Num Enregistrement": "376/ 12 A 144 /08", "Code DCI": "12A144", "Forme": "PDRE. SOL. BUV.", "Dosage": "160MG/SACHET** (288MG/SACHET ACETYLSALICYLATE DE DL LYSINE)", "Conditionnement": "B/30 SACHETS DOSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "KARDEGIC 75MG/SACHET** (135MG/SACH. ACETYLSALICYLATE DE DL LYSINE) PDRE. SOL. BUV. EN SACH. B/30", "Img": "https://pharmnet-dz.com//img/medics/1707.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1707", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE ACETYLSALICYLIQUE** (SOUS FORME D'ACETYLSALICYLIQUE DE DL-LYSINE)", "Pays": "FRANCE", "Nom Commercial": "KARDEGIC", "Tarif de reference": "59.4 DA", "PPA": "N/A", "Num Enregistrement": "376/ 12 A 143 /08", "Code DCI": "12A143", "Forme": "PDRE. SOL. BUV.", "Dosage": "75MG/SACHET** (135MG/SACH. ACETYLSALICYLATE DE DL LYSINE)", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "KAYEXALATE 15G/MESURETTE PDRE.SUSP.OR. et REC. B/454G", "Img": "https://pharmnet-dz.com//img/medics/3327.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3327", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-HYPERKALIEMIANTS", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " POLYSTIRENE SULFONATE DE SODIUM", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "KAYEXALATE", "Tarif de reference": "0 DA", "PPA": "2391.00 DA", "Num Enregistrement": "255/ 14 D 022 /98", "Code DCI": "14D022", "Forme": "PDRE. SUSP. ORALE et REC", "Dosage": "15G/MESURETTE", "Conditionnement": "B/454G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEFENTECH 30MG PATCH SACHET DE 07", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " JEIL PHARMACEUTICAL Co LTD", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Pays": "COREE", "Nom Commercial": "KEFENTECH", "Tarif de reference": "166.18 DA", "PPA": "205.00 DA", "Num Enregistrement": "359/ 04 B 049 /06", "Code DCI": "04B049", "Forme": "PATCH", "Dosage": "30MG", "Conditionnement": "SACHET DE 07", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEFORAL 125MG/5ML PDRE.SUSP.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "KEFORAL", "Tarif de reference": "154 DA", "PPA": "N/A", "Num Enregistrement": "034/ 13 B 011 /97", "Code DCI": "13B011", "Forme": "GRLES. SOL. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEFORAL 250MG/5ML PDRE. SUSP BUV FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "KEFORAL", "Tarif de reference": "186.6 DA", "PPA": "383.00 DA", "Num Enregistrement": "034/ 13 B 156 /98", "Code DCI": "13B156", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEFORAL 500MG** COMP. PELLI. B/12", "Img": "https://pharmnet-dz.com//img/medics/1890.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1890", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KEFORAL", "Tarif de reference": "476.57 DA", "PPA": "N/A", "Num Enregistrement": "263/ 13 B 010 /97/09", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG**", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "KELFER-250 250MG GLES. B/50", "Img": "https://pharmnet-dz.com//img/medics/1152.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERIPRONE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "KELFER-250", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 24 D 022 /06", "Code DCI": "24D022", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "KELFER-500 500MG COMP. ENRO. B/50", "Img": "https://pharmnet-dz.com//img/medics/1153.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERIPRONE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "KELFER-500", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 24 D 023 /06", "Code DCI": "24D023", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "KELOSIROX 250MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KELOSIROX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/24D018/16", "Code DCI": "24D018", "Forme": "COMP. DISPERS.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "KENACORT RETARD 40MG SUSP.INJ. B/1AMP. DE 1ML + 1SERING. DE 5ML ", "Img": "https://pharmnet-dz.com//img/medics/3758.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3758", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIAMCINOLONE ACETONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "KENACORT RETARD", "Tarif de reference": "247 DA", "PPA": "N/A", "Num Enregistrement": "017/ 09 H 091 /97", "Code DCI": "09H091", "Forme": "SUSP. INJ.", "Dosage": "40MG", "Conditionnement": "B/1AMP. DE 1ML + 1SERING. DE 5ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "KENZOPRAZOL 20MG MICRGLES. GASTRORESIST. EN GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/3882.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE MAGNESIUM TRIHYDRATE EXPRIME EN ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KENZOPRAZOL", "Tarif de reference": "280 DA", "PPA": "N/A", "Num Enregistrement": "352/ 10 A 180 /13", "Code DCI": "10A180", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEPAM 100MG/ML SIROP FL./125ML - FL./200ML - FL./300ML (+BOUCHON DE SECURITE ENFANT+PIPETTE GRADUEE DE 2ML,5ML,ET 10ML)", "Img": "https://pharmnet-dz.com//img/medics/2454.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KEPAM", "Tarif de reference": " N/A", "PPA": "3900.00 DA", "Num Enregistrement": "352/ 15 A 100 /13", "Code DCI": "15A100", "Forme": "SIROP", "Dosage": "100MG/ML", "Conditionnement": "FL./125ML - FL./200ML - FL./300ML (+BOUCHON DE SECURITE ENFANT+PIPETTE GRADUEE DE 2ML,5ML,ET 10ML)", "Commercialisation": true, "Remboursable": null}, {"Nom": "KEPAM 250MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2437.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KEPAM", "Tarif de reference": "0 DA", "PPA": "1771.00 DA", "Num Enregistrement": "352/ 15 A 072 /13", "Code DCI": "15A072", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEPAM 500MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2441.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KEPAM", "Tarif de reference": " N/A", "PPA": "3300.00 DA", "Num Enregistrement": "352/ 15 A 073 /13", "Code DCI": "15A073", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "KEPNIROL 0,25MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/2489.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2489", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " ROPINIROLE CHLORHYDRATE EXPRIME EN ROPINIROLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KEPNIROL", "Tarif de reference": "398.5 DA", "PPA": "N/A", "Num Enregistrement": "352/ 15 D 097 /11", "Code DCI": "15D097", "Forme": "COMP. PELLI.", "Dosage": "0,25MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEPNIROL 1MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/2490.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " ROPINIROLE CHLORHYDRATE EXPRIME EN ROPINIROLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KEPNIROL", "Tarif de reference": "0 DA", "PPA": "815.00 DA", "Num Enregistrement": "352/ 15 D 098 /11", "Code DCI": "15D098", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "KEPPRA 250MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2438.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2438", "Laboratoire": " UCB S.A", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "KEPPRA", "Tarif de reference": "1171.8 DA", "PPA": "N/A", "Num Enregistrement": "046/ 15 A 072 /07", "Code DCI": "15A072", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "KERATYL 0.01 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NANDROLONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "KERATYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 K 075 /98", "Code DCI": "17K075", "Forme": "COLLY.", "Dosage": "0.01", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETAMILE 50MG/ML SOL. INJ. B/01FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " KETAMINE CHLORHYDRATE EXPRIME EN KETAMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KETAMILE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 02 B 009 /09", "Code DCI": "02B009", "Forme": "SOL. INJ.", "Dosage": "50MG/ML", "Conditionnement": "B/01FL. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "KETAMINE 10MG/ML SOL. INJ. B/20FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " LIORAD", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " KETAMINE CHLORHYDRATE EXPRIME EN KETAMINE", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "KETAMINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "436/ 02 B 008 /09", "Code DCI": "02B008", "Forme": "SOL. INJ.", "Dosage": "10MG/ML", "Conditionnement": "B/20FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "KETAMINE 50MG/ML SOL. INJ. B/20FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " LIORAD", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " KETAMINE CHLORHYDRATE EXPRIME EN KETAMINE", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "KETAMINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "436/ 02 B 009 /09", "Code DCI": "02B009", "Forme": "SOL. INJ.", "Dosage": "50MG/ML", "Conditionnement": "B/20FL. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "KETEK 400MG COMP PELLI. B/10 ET B/14", "Img": "https://pharmnet-dz.com//img/medics/828.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=828", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TELITHROMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "KETEK", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 13 E 263 /03", "Code DCI": "13E263", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/10 ET B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOCONAZOLE NOVAGENERICS 0,02 SHAMPOING FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KETOCONAZOLE NOVAGENERICS", "Tarif de reference": "458.00 DA", "PPA": " DA", "Num Enregistrement": "149/07D141/18", "Code DCI": "07D141", "Forme": "SHAMPOING", "Dosage": "0,02", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOCONAZOLE NOVAGENERICS 0.02 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KETOCONAZOLE NOVAGENERICS", "Tarif de reference": "198.9 DA", "PPA": "198.00 DA", "Num Enregistrement": "149/ 07 D 028 /13", "Code DCI": "07D028", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOCONAZOLE NOVAGENERICS 0.02 GEL MOUSSANT EN RECIPIENT UNIDOSE  T/20G", "Img": "https://pharmnet-dz.com//img/medics/454.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KETOCONAZOLE NOVAGENERICS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "149/ 07 D 029 /13", "Code DCI": "07D029", "Forme": "GEL MOUSSANT", "Dosage": "0.02", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOCONAZOLE PHARMAGHREB 0.02 CREME  DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KETOCONAZOLE PHARMAGHREB", "Tarif de reference": "198.9 DA", "PPA": "N/A", "Num Enregistrement": "088/ 07 D 028 /10", "Code DCI": "07D028", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETODERM 0.02 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1701.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1701", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "KETODERM", "Tarif de reference": "198.9 DA", "PPA": "N/A", "Num Enregistrement": "095/ 07 D 028 /98/14", "Code DCI": "07D028", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETODERM 0.02 GEL MOUSSANT EN SACHET- DOSE VOIE CUTANEE B/08 SACHET- DOSE DE 6G", "Img": "https://pharmnet-dz.com//img/medics/460.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=460", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Pays": "FRANCE", "Nom Commercial": "KETODERM", "Tarif de reference": "1018.94 DA", "PPA": "N/A", "Num Enregistrement": "095/ 07 D 092 /98", "Code DCI": "07D092", "Forme": "GEL MOUSSANT", "Dosage": "0.02", "Conditionnement": "B/08 SACHET- DOSE DE 6G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETODERM TUBE MONODOSE  0.02 GEL MOUSSANT EN RECIPIENT UNIDOSE VOIE CUTANEE T/20G", "Img": "https://pharmnet-dz.com//img/medics/455.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=455", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "KETODERM TUBE MONODOSE ", "Tarif de reference": "0 DA", "PPA": "1037.00 DA", "Num Enregistrement": "095/ 07 D 029 /98", "Code DCI": "07D029", "Forme": "GEL MOUSSANT", "Dosage": "0.02", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOF 1MG/5ML SOL. BUV. FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/2068.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2068", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KETOF", "Tarif de reference": "134 DA", "PPA": "N/A", "Num Enregistrement": "242/ 20 A 013 /09", "Code DCI": "20A013", "Forme": "SOL. BUV.", "Dosage": "1MG/5ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOFEN 0.025 GEL DERM. T./40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KETOFEN", "Tarif de reference": "116 DA", "PPA": "N/A", "Num Enregistrement": "366/ 21 A 032 /08", "Code DCI": "21A032", "Forme": "GEL DERM.", "Dosage": "0.025", "Conditionnement": "T./40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOFEN 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KETOFEN", "Tarif de reference": "138.4 DA", "PPA": "169.00 DA", "Num Enregistrement": "366/ 04 B 017 /08", "Code DCI": "04B017", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOFEN LP 200MG GLES. LP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KETOFEN LP", "Tarif de reference": "325.6 DA", "PPA": "325.00 DA", "Num Enregistrement": "418/ 04 B 032 /09", "Code DCI": "04B032", "Forme": "COMP. ENRO. LP", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETONAL 50MG/ML (100MG/2ML) SOL.INJ.IM B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LEK", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "SLOVENIE", "Nom Commercial": "KETONAL", "Tarif de reference": "638 DA", "PPA": "N/A", "Num Enregistrement": "188/ 04 B 018 /99", "Code DCI": "04B018", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (100MG/2ML)", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETONEED 50MG/ML (100MG/2ML) SOL.INJ.IM B/05 AMP. DE 2ML ET B/50 AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/2752.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KETONEED", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 04 B 018 /15", "Code DCI": "04B018", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (100MG/2ML)", "Conditionnement": "B/05 AMP. DE 2ML ET B/50 AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "KETOPROFENE LDM 0.025 GEL DERM. T/60G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "KETOPROFENE LDM", "Tarif de reference": "174 DA", "PPA": "N/A", "Num Enregistrement": "309/21A032/16", "Code DCI": "21A032", "Forme": "GEL DERM.", "Dosage": "2.5%", "Conditionnement": "T/60G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOPROFENE LPA 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KETOPROFENE LPA", "Tarif de reference": "138.4 DA", "PPA": "N/A", "Num Enregistrement": "026/ 04 B 017 /09", "Code DCI": "04B017", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETOSKIN 0.02 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1702.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1702", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KETOSKIN", "Tarif de reference": "198.9 DA", "PPA": "198.9 DA", "Num Enregistrement": "003/ 07 D 028 /06", "Code DCI": "07D028", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KETUM 0.025 GEL DERM. T/60G", "Img": "https://pharmnet-dz.com//img/medics/1388.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1388", "Laboratoire": " MENARINI FRANCE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "KETUM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "203/ 21 A 032 /05/14", "Code DCI": "21A032", "Forme": "GEL DERM.", "Dosage": "0.025", "Conditionnement": "T/60G", "Commercialisation": true, "Remboursable": false}, {"Nom": "KIDOCAINE 0.02 SOL. INJ. B/06AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "KIDOCAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 02 C 019 /01/09", "Code DCI": "02C019", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/06AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "KIDROLASE 10.000 UI/FL. DE PDRE. PDRE.SOL.INJ. IV/ IM / PERF./ INTR-RACHIDIENNE B/10FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EUSA PHARMA", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " L-ASPARAGINASE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "KIDROLASE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "390/ 05 G 003 /96/09", "Code DCI": "05G003", "Forme": "PDRE. SOL. INJ.", "Dosage": "10.000 UI/FL. DE PDRE.", "Conditionnement": "B/10FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "KIETYL 6MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2182.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2182", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KIETYL", "Tarif de reference": "204.5 DA", "PPA": "N/A", "Num Enregistrement": "268/ 16 B 098 /05", "Code DCI": "16B098", "Forme": "COMP. SEC.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "KILOSIROX 125MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5716", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " CHELATEURS", "C.Therapeutique": " TOXICOLOGIE", "Info": " DEFERASIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KILOSIROX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/24D017/16", "Code DCI": "24D017", "Forme": "COMP. DISPERS.", "Dosage": "125MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "KINADYN CALCIUM 500MG/SACHET PDRE. P. SUSP. BUV. EN SACHET DOSE B/30SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3342.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE EXPRIME EN CALCIUM ELEMENT", "Pays": "ALGERIE", "Nom Commercial": "KINADYN CALCIUM", "Tarif de reference": " N/A", "PPA": "400.00 DA", "Num Enregistrement": "263/ 14 G 029 /15", "Code DCI": "14G029", "Forme": "PDRE. SUSP. BUV.", "Dosage": "500MG/SACHET", "Conditionnement": "B/30SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "KINADYN MG 3MG/SACHET  POUDRE POR SOLUTION BUVABLE B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KINADYN MG", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/14G356/16", "Code DCI": "N/D", "Forme": "PDRE. SUSP. BUV.", "Dosage": "3MG/SACHET ", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "KIOVIG 100MG/ML (2,5G/25ML- 5G/50ML - 10G/100ML) SOL. P. PERF. IV FL/25ML - FL/50ML - FL/100ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3598", "Laboratoire": " BAXTER", "C.Pharmacologique": " SERUMS & GAMMA GLOBULINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " IMMUNOGLOBULINE HUMAINE NORMALE 1G IV", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "KIOVIG", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "298/ 13 V 451 /12", "Code DCI": "13V451", "Forme": "SOL. INJ.", "Dosage": "100MG/ML (2,5G/25ML- 5G/50ML - 10G/100ML)", "Conditionnement": "FL/25ML - FL/50ML - FL/100ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "KLAVOX 125MG/31,25MG/5ML PDRE.SUSP.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/273.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=273", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "KLAVOX", "Tarif de reference": "436 DA", "PPA": " DA", "Num Enregistrement": "190/ 13 G 159 /01", "Code DCI": "13G159", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/31,25MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KLAVOX 200MG/28MG/5ML PDRE. SUSP. BUV. FL./70ML", "Img": "https://pharmnet-dz.com//img/medics/327.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "KLAVOX", "Tarif de reference": "408.1 DA", "PPA": " DA", "Num Enregistrement": "190/ 13 G 265 /08", "Code DCI": "13G265", "Forme": "PDRE. SUSP. BUV.", "Dosage": "200MG/28MG/5ML", "Conditionnement": "FL./70ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KLAVOX 250MG/62,5MG/5ML PDRE.SUSP.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/247.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=247", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "KLAVOX", "Tarif de reference": "583 DA", "PPA": " DA", "Num Enregistrement": "190/ 13 G 051 /00", "Code DCI": "13G051", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/62,5MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KLAVOX 400MG/57MG/5ML PDRE. SUSP. BUV. F./70ML", "Img": "https://pharmnet-dz.com//img/medics/330.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE / ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "KLAVOX", "Tarif de reference": "692.3 DA", "PPA": " DA", "Num Enregistrement": "190/ 13 G 266 /07", "Code DCI": "13G266", "Forme": "PDRE. SUSP. BUV.", "Dosage": "400MG/57MG/5ML", "Conditionnement": "F./70ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KLAVOX 500MG/125MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/240.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=240", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "KLAVOX", "Tarif de reference": "654.4 DA", "PPA": "N/A", "Num Enregistrement": "190/ 13 G 050 /00/15", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "KLAVOX 875MG/125MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/333.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "KLAVOX", "Tarif de reference": "801.64 DA", "PPA": " DA", "Num Enregistrement": "190/ 13 G 267 /07", "Code DCI": "13G267", "Forme": "COMP. PELLI.", "Dosage": "875MG/125MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "KLAXIN 250MG COMP. ENRO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "KLAXIN", "Tarif de reference": "200 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 E 244 /07", "Code DCI": "13E244", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "KOGENATE 1000UI/FL. DE PDRE. LYOPH. ET SOLVT. SOL. INJ. IV B/1FL. DE PDRE. + 1SERING. PREREMPL. DE SOLVT. (E.P.P.I.) DE 2,5ML", "Img": "https://pharmnet-dz.com//img/medics/1843.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1843", "Laboratoire": " BAYER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " OCTOCOG ALFA  (FACTEUR VIII RECOMBINANT DE COAGULATION ANTI-HEMOPHILIQUE)", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "KOGENATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 12 J 155 /09", "Code DCI": "12J155", "Forme": "PDRE. INJ.", "Dosage": "1000UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1SERING. PREREMPL. DE SOLVT. (E.P.P.I.) DE 2,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KOGENATE 250UI/FL. DE PDRE. LYOPH. ET SOLV. SOL. INJ. IV B/1FL. DE PDRE. + 1SERING. PREREMPL. DE SOLV. (E.P.P.I.) DE 2,5ML", "Img": "https://pharmnet-dz.com//img/medics/1841.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1841", "Laboratoire": " BAYER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " OCTOCOG ALFA  (FACTEUR VIII RECOMBINANT DE COAGULATION ANTI-HEMOPHILIQUE)", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "KOGENATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 12 J 154 /09", "Code DCI": "12J154", "Forme": "PDRE. INJ.", "Dosage": "250UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1SERING. PREREMPL. DE SOLV. (E.P.P.I.) DE 2,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KOGENATE 500UI/FL. DE PDRE. LYOPH. ET SOLV. SOL. INJ. IV B/1FL. DE PDRE. + 1SERING. PREREMPL. DE SOLV. (E.P.P.I.) DE 2,5ML", "Img": "https://pharmnet-dz.com//img/medics/1833.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1833", "Laboratoire": " BAYER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR HUMAIN VIII  ANTI HEMOPHILIQUE", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "KOGENATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 12 J 044 /09", "Code DCI": "12J044", "Forme": "PDRE. INJ.", "Dosage": "500UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1SERING. PREREMPL. DE SOLV. (E.P.P.I.) DE 2,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KOLESTINE 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1540.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KOLESTINE", "Tarif de reference": " N/A", "PPA": "1247.00 DA", "Num Enregistrement": "268/ 06 M 136 /07/13", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "KOLESTINE 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1571.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KOLESTINE", "Tarif de reference": "2190 DA", "PPA": "1980.00 DA", "Num Enregistrement": "268/ 06 M 203 /13", "Code DCI": "06M203", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "KONAKION  MM  10MG/ML SOL.INJ. IV B/05AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1744", "Laboratoire": " HOFFMAN LAROCHE", "C.Pharmacologique": " VITAMINES K", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " PHYTOMENADIONE", "Pays": "SUISSE", "Nom Commercial": "KONAKION  MM ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 12 D 015 /99", "Code DCI": "12D015", "Forme": "SOL. INJ.", "Dosage": "10MG/ML", "Conditionnement": "B/05AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "KONAZOL 0.01 CREME DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ECONAZOLE (NITRATE)", "Pays": "ALGERIE", "Nom Commercial": "KONAZOL", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "026/ 07 D 025 /08", "Code DCI": "07D025", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KOXMA 2MG/5ML SIROP GO\u00dbT ANANAS FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/2081.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2081", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KOXMA", "Tarif de reference": " N/A", "PPA": "187.00 DA", "Num Enregistrement": "242/ 20 A 016 /04/12", "Code DCI": "20A016", "Forme": "SOL. BUV.", "Dosage": "2MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "K-PROFEN 0.025 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LGPA", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "K-PROFEN", "Tarif de reference": "174 DA", "PPA": "N/A", "Num Enregistrement": "311/21A032/15", "Code DCI": "21A032", "Forme": "GEL DERM.", "Dosage": "2.5%", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KUTERID 0.0005 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " LEK", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "SLOVENIE", "Nom Commercial": "KUTERID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "188/ 07 H 038 /99", "Code DCI": "07H038", "Forme": "CR\u00c8ME", "Dosage": "0.0005", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "KYNCEPT 10 MG COMP ORODISPERSIBLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KYNCEPT", "Tarif de reference": "4350.00 DA", "PPA": " DA", "Code DCI": "15F075", "Forme": "COMP. ORODISPERS.", "Dosage": "110MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "KYNCEPT 5 MG COMP ORODISPERSIBLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5881", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "KYNCEPT", "Tarif de reference": "4050.00 DA", "PPA": " DA", "Code DCI": "15F074", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}], "L": [{"Nom": "LABROXIN 5UI/0,5ML SOL.INJ. IM / IV B/06 AMP. DE 0,5 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " OCYTOCIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " OXYTOCINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "LABROXIN", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "11E019", "Forme": "SOL. INJ.", "Dosage": "5UI/0,5ML", "Conditionnement": "B/06 AMP. DE 0,5 ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "LACRIFLUID 0.0013 COLLY. EN SOL.   FL. COMPTE GTTES. DE 10G", "Img": "https://pharmnet-dz.com//img/medics/2014.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2014", "Laboratoire": " EUROPHTA", "C.Pharmacologique": " SUPPLEANCE LACRYMALE", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARBOMERE 980", "Pays": "MONACO", "Nom Commercial": "LACRIFLUID", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "316/ 17 N 156 /07", "Code DCI": "17N156", "Forme": "COLLY.", "Dosage": "0.0013", "Conditionnement": "FL. COMPTE GTTES. DE 10G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LACRINORM 0.002 GEL.OPHT T/10G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2008", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARBOMERE 980", "Pays": "FRANCE", "Nom Commercial": "LACRINORM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "096/ 17 K 133 /01", "Code DCI": "17K133", "Forme": "GEL. OPHT.", "Dosage": "0.002", "Conditionnement": "T/10G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LACRYMASEPTINE 0,180G/0,120G COLLY. B/8DOSES (FL.10ML)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ANTISEPTIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACIDE BORIQUE/BORATE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "LACRYMASEPTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "004/ 17 E 037 /96", "Code DCI": "17E037", "Forme": "COLLY.", "Dosage": "0,180G/0,120G", "Conditionnement": "B/8DOSES (FL.10ML)", "Commercialisation": true, "Remboursable": null}, {"Nom": "LACTAFLEX 0,6G  / 0,04G / 0,027G /0,320G /100ML                                                                     (131,23mmol Sodium / 5,37mmol Potassium / 1,83mmol de Calcium / 111,69mmol de Chlorures / 28,56mmol de Lactates /L)  SOL. P. PERF. POCHE DE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE / POTASSIUM CHLORURE / CALCIUM CHLORURE DIHYDRATE / SODIUM LACTATE", "Pays": "ALGERIE", "Nom Commercial": "LACTAFLEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 14 G 066 /11", "Code DCI": "14G066", "Forme": "SOL. INJ.", "Dosage": "0,6G  / 0,04G / 0,027G /0,320G /100ML                                                                     (131,23mmol Sodium / 5,37mmol Potassium / 1,83mmol de Calcium / 111,69mmol de Chlorures / 28,56mmol de Lactates /L) ", "Conditionnement": "POCHE DE 500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LACTULOSE AGD 66,7% SIROP FL/200ML+GODET GRADUE EN ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "LACTULOSE AGD", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "320/ 10 L 062 /06/12", "Code DCI": "10L062", "Forme": "SOL. BUV.", "Dosage": "66,7%", "Conditionnement": "FL/200ML+GODET GRADUE EN ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LACTULOSE LPA 0.667 SOL. BUV. FL./200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "LACTULOSE LPA", "Tarif de reference": "172 DA", "PPA": "N/A", "Num Enregistrement": "026/ 10 L 062 /09", "Code DCI": "10L062", "Forme": "SOL. BUV.", "Dosage": "0.667", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LACTULOSE MYLAN 10G/15ML SOL. BUV. SACHET-DOSE B/20SACHETS DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2938", "Laboratoire": " MYLAN", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "FRANCE", "Nom Commercial": "LACTULOSE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 10 L 097 /03/10", "Code DCI": "10L097", "Forme": "SOL. BUV. SACHET", "Dosage": "10G/15ML", "Conditionnement": "B/20SACHETS DE 15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LACTUNAD 10G/15ML SOL. BUV. EN SACHET-DOSE B/20 SACHETS-DOSE DE 15 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "LACTUNAD", "Tarif de reference": "258 DA", "PPA": "397.00 DA", "Num Enregistrement": "468/ 10 L 097 /14", "Code DCI": "10L097", "Forme": "SOL. BUV. SACHET", "Dosage": "10G/15ML", "Conditionnement": "B/20 SACHETS-DOSE DE 15 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMIDAZ 0.01 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/462.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=462", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LAMIDAZ", "Tarif de reference": "210 DA", "PPA": "210 DA", "Num Enregistrement": "003/ 07 D 094 /06", "Code DCI": "07D094", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMIDAZ 250MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3559.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LAMIDAZ", "Tarif de reference": "1500 DA", "PPA": "1500 DA", "Num Enregistrement": "003/ 13 R 172 /07", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMIFENE 20MG/ML (100MG/5ML) SOL. BUV. FL./125ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMIFENE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 04 B 042 /08/15", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./125ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "LAMINOX 0.01 SOL. PULV. CUTANEE (EN SPRAY) FL./30ML", "Img": "https://pharmnet-dz.com//img/medics/477.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=477", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "TURQUIE", "Nom Commercial": "LAMINOX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "177/ 07 D 156 /09", "Code DCI": "07D156", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "LAMINOX 250MG COMP. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "TURQUIE", "Nom Commercial": "LAMINOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "177/ 13 R 172 /07/12", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "LAMISIL 0.01 SOL. PULV. CUTANEE FL./15ML", "Img": "https://pharmnet-dz.com//img/medics/478.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=478", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LAMISIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "267/ 07 D 156 /08", "Code DCI": "07D156", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "FL./15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMISIL DERMGEL 0.01 GEL T/15G", "Img": "https://pharmnet-dz.com//img/medics/480.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=480", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LAMISIL DERMGEL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "267/ 07 D 158 /08", "Code DCI": "07D158", "Forme": "GEL", "Dosage": "0.01", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": false}, {"Nom": "LAMISILATE MONODOSE 0.01 SOL. P. APPL. CUTANEE T/4G", "Img": "https://pharmnet-dz.com//img/medics/481.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=481", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LAMISILATE MONODOSE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "267/ 07 D 178 /13", "Code DCI": "07D178", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "T/4G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMITOR 5MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medics/2403.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2403", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMITOR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "242/ 15 A 051 /10", "Code DCI": "15A051", "Forme": "COMP. DISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMIVIR 10MG/ML SOL. BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LAMIVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LAMIVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 237 /03", "Code DCI": "13P237", "Forme": "SOL. BUV.", "Dosage": "10MG/ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LAMIVIR 150MG COMP B/60", "Img": "https://pharmnet-dz.com//img/medics/434.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LAMIVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LAMIVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 236 /03", "Code DCI": "13P236", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "LAMIVUDINE MYLAN 150MG COMP PELL B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LAMIVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LAMIVUDINE MYLAN", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "13P236", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOGINE 100MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LAMOGINE", "Tarif de reference": "1702.5 DA", "PPA": "1702.00 DA", "Num Enregistrement": "001/ 15 A 090 /09 ", "Code DCI": "15A090", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOGINE 25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2411.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2411", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LAMOGINE", "Tarif de reference": "679.67 DA", "PPA": "N/A", "Num Enregistrement": "001/15 A 063 /09", "Code DCI": "15A063", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOGINE 50MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LAMOGINE", "Tarif de reference": "1105.2 DA", "PPA": "1105.00 DA", "Num Enregistrement": "001/15 A 064 /09", "Code DCI": "15A064", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOTRIGINE BEKER 100MG COMP. DISPERS. B/56", "Img": "https://pharmnet-dz.com//img/medics/2409.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2409", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMOTRIGINE BEKER", "Tarif de reference": "3994.48 DA", "PPA": "3175.66 DA", "Num Enregistrement": "447/ 15 A 053 /13", "Code DCI": "15A053", "Forme": "COMP. DISPERS.", "Dosage": "100MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOTRIGINE BEKER 25MG COMP. DISPERS. B/56", "Img": "https://pharmnet-dz.com//img/medics/2406.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2406", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMOTRIGINE BEKER", "Tarif de reference": "1594.88 DA", "PPA": "1383.70 DA", "Num Enregistrement": "447/ 15 A 052 /13", "Code DCI": "15A052", "Forme": "COMP. DISPERS.", "Dosage": "25MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOTRIGINE BEKER 5MG COMP. DISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medics/4426.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4426", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LAMOTRIGINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMOTRIGINE BEKER", "Tarif de reference": "479.4 DA", "PPA": "479.4 DA", "Num Enregistrement": "447/15A051/16", "Code DCI": "15A051", "Forme": "COMP. DISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOVEN 300MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "ALGERIE", "Nom Commercial": "LAMOVEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 06 K 108 /07", "Code DCI": "06K108", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LAMOXYL 1G COMP. DISPER. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMOXYL", "Tarif de reference": "316.82 DA", "PPA": "N/A", "Num Enregistrement": "319/ 13 G 230 /07", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOXYL 250MG/5ML PDRE. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMOXYL", "Tarif de reference": "132 DA", "PPA": "N/A", "Num Enregistrement": "319/ 13 G 047 /07", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOXYL 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMOXYL", "Tarif de reference": "139.32 DA", "PPA": "N/A", "Num Enregistrement": "319/ 13 G 045 /07", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMOXYL 500MG/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. APRES RECONST.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAMOXYL", "Tarif de reference": "205.2 DA", "PPA": "N/A", "Num Enregistrement": "319/ 13 G 220 /11", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. APRES RECONST.", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAMYLASE 20 000 U CEIP/100ML SIROP FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ENZYMES A VISEE ANTI-INFLAMMAT.& ANTI-OEDEMATEUSE", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ALPHA-AMYLASE", "Pays": "ALGERIE", "Nom Commercial": "LAMYLASE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 04 C 027 /15", "Code DCI": "04C027", "Forme": "SIROP", "Dosage": "20 000 U CEIP/100ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LANTUS 100UI/ML SOL. INJ. SC EN CART. B/5CART. DE 3ML  (POUR OPTIPEN )", "Img": "https://pharmnet-dz.com//img/medics/3304.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3304", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "LANTUS", "Tarif de reference": "0 DA", "PPA": "7103.00 DA", "Num Enregistrement": "376/ 14 B 213 /03/09", "Code DCI": "14B213", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5CART. DE 3ML  (POUR OPTIPEN )", "Commercialisation": true, "Remboursable": true}, {"Nom": "LANTUS 100UI/ML SOL. INJ. SC EN FL. B/1FL DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/3305.png", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "LANTUS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "376/ 14 B 214 /03/09", "Code DCI": "14B214", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1FL DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LANTUS OPTISET 100UI/ML (3,64MG/ML) SOL.INJ. SC EN STYLO PREREMPL. B/05 STYLOS PREREMPLIS OPTISET DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3306.png", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "LANTUS OPTISET", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "376/ 14 B 215 /03/09", "Code DCI": "14B215", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,64MG/ML)", "Conditionnement": "B/05 STYLOS PREREMPLIS OPTISET DE 3ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LANTUS SOLOSTAR 100UI/ML (3,64MG/ML) SOL. INJ. EN STYLO PREREMPLI B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3307.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3307", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE GLARGINE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "LANTUS SOLOSTAR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 14 B 215 /09", "Code DCI": "14B215", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (3,64MG/ML)", "Conditionnement": "B/05 STYLOS PREREMPLIS SOLOSTAR DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LANZAPREX 10MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medics/2280.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LANZAPREX", "Tarif de reference": "7020 DA", "PPA": "6102.00 DA", "Num Enregistrement": "352/ 16 D 101 /10", "Code DCI": "16D101", "Forme": "COMP. ORODISPERS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LANZAPREX 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2272.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LANZAPREX", "Tarif de reference": "7020 DA", "PPA": "6000.00 DA", "Num Enregistrement": "352/ 16 D 100 /12", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LANZAPREX 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2269.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LANZAPREX", "Tarif de reference": "3510 DA", "PPA": "3000.00 DA", "Num Enregistrement": "352/ 16 D 099 /12", "Code DCI": "16D099", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LANZOCID 15MG GLES. MICROGRANULES GASTRORESIST. B/14 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LANSOPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LANZOCID", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 A 188 /09", "Code DCI": "10A188", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "15MG", "Conditionnement": "B/14 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAPETI 2MG/5ML SIROP FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/3331.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3331", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LAPETI", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/ 14 F 024 /07", "Code DCI": "14F024", "Forme": "SIROP", "Dosage": "2MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "LAPETI 4MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3334.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3334", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Pays": "ALGERIE", "Nom Commercial": "LAPETI", "Tarif de reference": "200 DA", "PPA": "N/A", "Num Enregistrement": "242/ 14 F 025 /10", "Code DCI": "14F025", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LARGACTIL 0.04 SOL.BUV.GTTES. FL/30ML", "Img": "https://pharmnet-dz.com//img/medics/2200.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LARGACTIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 16 D 055 /96/09", "Code DCI": "16D055", "Forme": "SUSP. BUV. GTTES.", "Dosage": "0.04", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LARGACTIL 100MG  COMP.PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2196.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2196", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LARGACTIL", "Tarif de reference": "259.8 DA", "PPA": " DA", "Num Enregistrement": "016/ 16 D 054 /96", "Code DCI": "16D054", "Forme": "COMP. PELLI.", "Dosage": "100MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LARGAMED 100MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2197", "Laboratoire": " SANAMED", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LARGAMED", "Tarif de reference": "259.8 DA", "PPA": " DA", "Num Enregistrement": "097/ 16 D 054 /09", "Code DCI": "16D054", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LARIMEL 50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACARBOSE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LARIMEL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/14A136/16", "Code DCI": "14A136", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LARMES ARTFICIELLES MARTINET 0.014 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " LARMES ARTIFICIELLES ", "Pays": "FRANCE", "Nom Commercial": "LARMES ARTFICIELLES MARTINET", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 17 K 074 /98", "Code DCI": "17K074", "Forme": "COLLY.", "Dosage": "0.014", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LAROSCORBINE 1G COMP. EFFERV. B/10", "Img": "https://pharmnet-dz.com//img/medics/3459.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3459", "Laboratoire": " BAYER", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "FRANCE", "Nom Commercial": "LAROSCORBINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "395/ 14 H 222 /08", "Code DCI": "14H222", "Forme": "COMP. EFFERV.", "Dosage": "1G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAROXYL 25MG COMP.PELLI B/60 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2516", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LAROXYL", "Tarif de reference": "285 DA", "PPA": " DA", "Num Enregistrement": "128/ 16 A 001 /99", "Code DCI": "16A001", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAROXYL 50MG COMP. PELLI. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LAROXYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "128/ 16 A 002 /99", "Code DCI": "16A002", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAROXYLINE 25MG COMP PELL B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAROXYLINE", "Tarif de reference": "285 DA", "PPA": "N/A", "Num Enregistrement": "380/16A001/16", "Code DCI": "16A001", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAROXYLINE 50MG COMP PELL B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAROXYLINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "380/6A002/16", "Code DCI": "16A002", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "LASILIX 20MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3288.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3288", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LASILIX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 06 H 089 /99", "Code DCI": "06H089", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LASYTEQ 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LASYTEQ", "Tarif de reference": "480 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 E 060 /09", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LATANEKS 50\u00b5G/ML COLLY. FL./2,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " DIAMOND PHARMA", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " LATANOPROST", "Liste": "Liste I", "Pays": "SYRIE", "Nom Commercial": "LATANEKS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "423/ 17 C 127 /08", "Code DCI": "17C127", "Forme": "COLLY. SOL.", "Dosage": "50\u00b5G/ML", "Conditionnement": "FL./2,5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LATASOPT 50\u00b5G/ML COLLY. FL./2,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ANTI-GLAUCOMATEUX", "C.Pharmacologique": " OPHTALMOLOGIE", "C.Therapeutique": " LATANOPROST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LATASOPT", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "521/17C127/16", "Code DCI": "17C127", "Forme": "COLLY.", "Dosage": "50\u00b5G/ML", "Conditionnement": "FL./2,5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LATAZ 50\u00b5G/ML (0,005%) COLLY. F/2,5ML COLLY. F/2,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " RAFARM S.A", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " LATANOPROST", "Liste": "Liste I", "Pays": "GRECE", "Nom Commercial": "LATAZ", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "17C127", "Forme": "COLLY.", "Dosage": " 50\u00b5G/ML  0,005%", "Conditionnement": "F/2,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LATENDRA 0.04 CREME DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1428.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1428", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " CAMPHRE", "Pays": "ALGERIE", "Nom Commercial": "LATENDRA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 21 F 056 /09", "Code DCI": "21F056", "Forme": "CR\u00c8ME", "Dosage": "0.04", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": false}, {"Nom": "LATENSIA 150MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LATENSIA", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 E 156 /09", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LATIDINE 150MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LATIDINE", "Tarif de reference": "154.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 A 003 /08", "Code DCI": "10A003", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LATIDINE 300MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LATIDINE", "Tarif de reference": "342.9 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 A 102 /08", "Code DCI": "10A102", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAVIDA 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAVIDA", "Tarif de reference": "250.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 A 187 /05", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAVIDA 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3660.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAVIDA", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "003/ 14 A 188 /05", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAVIDA 3MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3671.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAVIDA", "Tarif de reference": "720 DA", "PPA": "720.00 DA", "Num Enregistrement": "003/ 14 A 189 /05", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAVIDA 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3682.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAVIDA", "Tarif de reference": "750 DA", "PPA": "750.00 DA", "Num Enregistrement": "003/ 14 A 190 /05", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAVIDA 6MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAVIDA", "Tarif de reference": "920.1 DA", "PPA": "N/A", "Num Enregistrement": "003/ 14 A 324 /09", "Code DCI": "14A324", "Forme": "COMP. PELLI.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAXADYL 10MG SUPPO. B/06", "Img": "https://pharmnet-dz.com//img/medics/2947.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2947", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " BISACODYL", "Pays": "ALGERIE", "Nom Commercial": "LAXADYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "231/ 10 L 153 /06", "Code DCI": "10L153", "Forme": "SUPPO.", "Dosage": "10MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": false}, {"Nom": "LAXADYL 5MG SUPPO. B/06", "Img": "https://pharmnet-dz.com//img/medics/2950.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2950", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " BISACODYL", "Pays": "ALGERIE", "Nom Commercial": "LAXADYL", "Tarif de reference": "0 DA", "PPA": "110.00 DA", "Num Enregistrement": "231/ 10 L 185 /09", "Code DCI": "10L185", "Forme": "SUPPO.", "Dosage": "5MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAXAFINE 100ML/100ML (100%) HUILE BUVABLE B/1FL. DE 125ML ET B/1FL. DE 250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HUILE DE PARAFFINE LIQUIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LAXAFINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "318/ 10 M 066 /13", "Code DCI": "10M066", "Forme": "SOL. BUV.", "Dosage": "100ML/100ML (100%)", "Conditionnement": "B/1FL. DE 125ML ET B/1FL. DE 250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LAXATOL 10G/15ML SOL. BUV. SACH. DOSE B/20SACH-DOSE DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "LAXATOL", "Tarif de reference": "258 DA", "PPA": "N/A", "Num Enregistrement": "289/ 10 L 097 /10", "Code DCI": "10L097", "Forme": "SOL. BUV. SACHET", "Dosage": "10G/15ML", "Conditionnement": "B/20SACH-DOSE DE 15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LAXEL 4,970G/5G PDRE. ORALE EN SACH. B/14SACH. DE 5G", "Img": "https://pharmnet-dz.com//img/medics/2951.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2951", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MAGNESIUM HYDROXYDE", "Pays": "ALGERIE", "Nom Commercial": "LAXEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "388/ 10 L 186 /09", "Code DCI": "10L186", "Forme": "PDRE. SOL. BUV.", "Dosage": "4,970G/5G", "Conditionnement": "B/14SACH. DE 5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LECTIL 16MG COMP. SEC. ADULTE B/45", "Img": "https://pharmnet-dz.com//img/medics/2034.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2034", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " BETAHISTINE (SOUS FORME DE DICHLORHYDRATE)**", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LECTIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "269/ 18 C 025 /08", "Code DCI": "18C025", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/45", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEDERFOLINE 50MG/5ML PDRE.SOL.INJ. B/1 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FOLINATE DE CALCIUM", "Pays": "FRANCE", "Nom Commercial": "LEDERFOLINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 12 E 030 /98", "Code DCI": "12E030", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG/5ML", "Conditionnement": "B/1 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEDERFOLINE 5MG/2ML SOL.INJ. B/1 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FOLINATE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "LEDERFOLINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 12 E 029 /98", "Code DCI": "12E029", "Forme": "SOL. INJ.", "Dosage": "5MG/2ML", "Conditionnement": "B/1 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEDERTREXATE 1G LYOPHILISAT FL/1000MG", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LEDERTREXATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 05 A 030 /98", "Code DCI": "05A030", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G", "Conditionnement": "FL/1000MG", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEDERTREXATE 25MG/ML (50MG/2ML) SOL.INJ. B/1FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LEDERTREXATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 05 A 028 /98", "Code DCI": "05A028", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (50MG/2ML)", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEDERTREXATE 500MG PDRE.SOL.INJ. FL/500MG", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LEDERTREXATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 05 A 029 /99", "Code DCI": "05A029", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG", "Conditionnement": "FL/500MG", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEDERTREXATE 5G/200 ML SOL.INJ. FL/200 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LEDERTREXATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 05 A 031 /98", "Code DCI": "05A031", "Forme": "SOL. INJ.", "Dosage": "5G/200 ML", "Conditionnement": "FL/200 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEFLUBIC ALEMBIC MAMI 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " ALEMBIC MAMI SPA", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEFLUBIC ALEMBIC MAMI", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "21J042", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEFUMIDE 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1445.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LEFUMIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 21 J 042 /10", "Code DCI": "21J042", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEFUMIDE 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1446.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LEFUMIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "182/ 21 J 043 /10", "Code DCI": "21J043", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEKOVIT VIT.C 9MG / VITB1 0,2MG / VIT B2 0,24MG  VITB6 0,28MG /VIT PP 2,60MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LEK", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COMPLEXE VITAMINIQUE", "Pays": "SLOVENIE", "Nom Commercial": "LEKOVIT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "188/ 14 H 096 /99", "Code DCI": "14H096", "Forme": "COMP.", "Dosage": "VIT.C 9MG / VITB1 0,2MG / VIT B2 0,24MG  VITB6 0,28MG /VIT PP 2,60MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEMOD 16MG COMP. EFFER. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "LEMOD", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "161/ 09 H 132 /05", "Code DCI": "09H132", "Forme": "COMP. EFFERV.", "Dosage": "16MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEMOD-DEPO 40MG/ML PDRE. P. USAGE PARENTERAL  B/1FL. DE LYOPH. + 1AMP. DE  DE SOLV.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE ACETATE", "Liste": "Liste I", "Pays": "SERBIE", "Nom Commercial": "LEMOD-DEPO", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "161/ 09 H 090 /99", "Code DCI": "09H090", "Forme": "SUSP. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/1FL. DE LYOPH. + 1AMP. DE  DE SOLV.", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEMOD-SOLU 20MG LYOPH. ET SOLV. P. SOL. INJ. IM/IV  B/1FL. DE LYOPH. + 1AMP. DE 1ML DE SOLV. (EPPI AVEC 0,9% D'ALCOOL BENZYLIQUE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "SERBIE", "Nom Commercial": "LEMOD-SOLU", "Tarif de reference": " N/A", "PPA": "116.00 DA", "Num Enregistrement": "161/ 09 H 029 /99/13", "Code DCI": "09H029", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG", "Conditionnement": "B/1FL. DE LYOPH. + 1AMP. DE 1ML DE SOLV. (EPPI AVEC 0,9% D'ALCOOL BENZYLIQUE)", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEMOD-SOLU 40MG/FL. DE LYOPH.  LYOPHI. P. SOL. INJ. IM/IV B/1FL. DE LYOPH. + 1AMP. DE 1ML DE SOLV. (EPPI AVEC 0,9% D'ALCOOL BENZYLIQUE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "SERBIE", "Nom Commercial": "LEMOD-SOLU", "Tarif de reference": " N/A", "PPA": "173.00 DA", "Num Enregistrement": "161/ 09 H 030 /99/13", "Code DCI": "09H030", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG/FL. DE LYOPH. ", "Conditionnement": "B/1FL. DE LYOPH. + 1AMP. DE 1ML DE SOLV. (EPPI AVEC 0,9% D'ALCOOL BENZYLIQUE)", "Commercialisation": true, "Remboursable": null}, {"Nom": "LENITRAL 15MG/10ML SOL.INJ. B/50AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRINITRINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LENITRAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "169/ 06 C 037 /99", "Code DCI": "06C037", "Forme": "SOL. INJ.", "Dosage": "15MG/10ML", "Conditionnement": "B/50AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LENITRAL 2,5MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRINITRINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LENITRAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "169/ 06 C 032 /99", "Code DCI": "06C032", "Forme": "GLES.", "Dosage": "2,5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LENITRAL 3MG/2ML SOL.INJ. B/50AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRINITRINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LENITRAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "169/ 06 C 036 /99", "Code DCI": "06C036", "Forme": "SOL. INJ.", "Dosage": "3MG/2ML", "Conditionnement": "B/50AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LENTICLEAN 0.009 SOL. DE RIN\u00c7AGE DES LENTILLES SOUPLES B/10 Flacons       ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " UNIMED", "C.Pharmacologique": " AUTRES MEDICAMENTS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " SODIUM CHLORURE +TAMPON PH 7,4", "Pays": "TUNISIE", "Nom Commercial": "LENTICLEAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "023/ 17 M 096 /96", "Code DCI": "17M096", "Forme": "SOL. DE RIN\u00c7AGE", "Dosage": "0.009", "Conditionnement": "B/10 Flacons       ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEPONEX 100MG COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2559.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2559", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOZAPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LEPONEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 16 A 097 /00", "Code DCI": "16A097", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEPONEX 25MG COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2558.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2558", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOZAPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LEPONEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 16 A 096 /00", "Code DCI": "16A096", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEPTICA 150MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Pharmacologique": " NEUROLOGIE", "C.Therapeutique": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEPTICA", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "510/15A068/16", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEPTICA 300MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Pharmacologique": " NEUROLOGIE", "C.Therapeutique": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEPTICA", "Tarif de reference": "7952 DA", "PPA": "N/A", "Num Enregistrement": "510/15A069/16", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEPTICA 50MG GLES  B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Pharmacologique": " NEUROLOGIE", "C.Therapeutique": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEPTICA", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "510/15A066/16", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "LERCA 10MG COMP. PELLI. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LERCANIDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LERCA", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "06E168", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LERCANIDIPINE BEKER 10MG COMP. PELLI. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/3101.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3101", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LERCANIDIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LERCANIDIPINE BEKER", "Tarif de reference": "0 DA", "PPA": "829.27 DA", "Num Enregistrement": "447/ 06 E 168 /15", "Code DCI": "06E168", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "LESCOL 40MG GLES. B/28", "Img": "https://pharmnet-dz.com//img/medics/1553.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1553", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "LESCOL", "Tarif de reference": "837.76 DA", "PPA": "N/A", "Num Enregistrement": "068/ 06 M 151 /00/13", "Code DCI": "06M151", "Forme": "GLES.", "Dosage": "40MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LESCOL XL 80MG COMP. PELLI. LP B/28", "Img": "https://pharmnet-dz.com//img/medics/1613.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1613", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FLUVASTATINE SODIQUE EXPRIME EN FLUVASTATINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "LESCOL XL", "Tarif de reference": "1680 DA", "PPA": "1394.00 DA", "Num Enregistrement": "068/ 06 M 236 /07", "Code DCI": "06M236", "Forme": "COMP. PELLI. LP", "Dosage": "80MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LESLA 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3251.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LESLA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 06 F 162 /15", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LESTONE 0,5MG/ML (0,05%) SOL. BUV. GTTES. B/1FL. COMPTE-GTTES. DE 30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LESTONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "457/ 09 H 020 /13", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "B/1FL. COMPTE-GTTES. DE 30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LETRODEX 2,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LETROZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LETRODEX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "323/09A120/16", "Code DCI": "09A120", "Forme": "COMP. PELLI.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LETROZOLE CINFA 2,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/598.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CINFA", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LETROZOLE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "LETROZOLE CINFA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "157 / 09 A 120 /15", "Code DCI": "09A120", "Forme": "COMP. PELLI.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEUCODININE B 0.1 PDE. T/30G", "Img": "https://pharmnet-dz.com//img/medics/526.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=526", "Laboratoire": " CLS PHARMA", "C.Pharmacologique": " MEDICAMENTS DE LA PIGMENTATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " MEQUINOL", "Pays": "FRANCE", "Nom Commercial": "LEUCODININE B", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "432/ 07 J 097 /98/09", "Code DCI": "07J097", "Forme": "PDE. DERM.", "Dosage": "0.1", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVEMIR FLEXPEN 100U/ML (OU 100UI/ML) SOL. INJ. S/C B/05 STYLOS PRE REMPLIS MULTIDOSE JETABLES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3312.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3312", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE DETEMIR", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "LEVEMIR FLEXPEN", "Tarif de reference": "0 DA", "PPA": "7957.00 DA", "Num Enregistrement": "069/ 14 B 227 /07", "Code DCI": "14B227", "Forme": "SOL. INJ.", "Dosage": "100U/ML (OU 100UI/ML)", "Conditionnement": "B/05 STYLOS PRE REMPLIS MULTIDOSE JETABLES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVEMIR PENFILL 100U/ML (OU 100UI/ML) SOL. INJ. S/C B/05CART. DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3313.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3313", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE DETEMIR", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "LEVEMIR PENFILL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 B 228 /07", "Code DCI": "14B228", "Forme": "SOL. INJ.", "Dosage": "100U/ML (OU 100UI/ML)", "Conditionnement": "B/05CART. DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVETIRACETAM BEKER 250MG COMP PELL SECABLE B/60", "Img": "https://pharmnet-dz.com//img/medics/4664.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVETIRACETAM BEKER", "Tarif de reference": "1771.80 DA", "PPA": "1771.80 DA", "Num Enregistrement": "447/15A072/16", "Code DCI": "15A072", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVETIRACETAM BEKER 500MG COMP PELL SECABLE B/60", "Img": "https://pharmnet-dz.com//img/medics/4628.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVETIRACETAM BEKER", "Tarif de reference": "3550.20 DA", "PPA": "3550.20 DA", "Num Enregistrement": "447/15A073/16", "Code DCI": "15A073", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVETIRACETAM LDM 250MG  COMP PELL B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVETIRACETAM LDM", "Tarif de reference": "0 DA", "PPA": "1771.00 DA", "Num Enregistrement": "309/ 15 A 072 /14", "Code DCI": "15A072", "Forme": "COMP. PELLI.", "Dosage": "250MG ", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVETIRACETAM LDM 500MG COMP PELL SECABLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVETIRACETAM LDM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "309/15A073/17", "Code DCI": "15A073", "Forme": "COMP. SEC.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEVOCARB 250MG/25MG** COMP. SEC. B/100", "Img": "https://pharmnet-dz.com//img/medics/2479.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2479", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVODOPA / CARBIDOPA", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVOCARB", "Tarif de reference": "1360 DA", "PPA": " DA", "Num Enregistrement": "235/ 15 D 032 /11", "Code DCI": "15D032", "Forme": "COMP. SEC.", "Dosage": "250MG/25MG**", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOFLOX 500MG COMP. PELLI. SEC. B/05 ET B/10", "Img": "https://pharmnet-dz.com//img/medics/365.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVOFLOX", "Tarif de reference": "900 DA", "PPA": "900.00 DA", "Num Enregistrement": "317/ 13 K 228 /12", "Code DCI": "13K228", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/05 ET B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOFLOXACINE RAZES 5MG/ML  SOL. P. PERF.  FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/369.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVOFLOXACINE RAZES", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "433/ 13 K 231 /13", "Code DCI": "13K231", "Forme": "SOL. INJ.", "Dosage": "5MG/ML ", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOMED 100MG/10MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medics/2478.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2478", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVODOPA / CARBIDOPA", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "LEVOMED", "Tarif de reference": "836.06 DA", "PPA": "N/A", "Num Enregistrement": "178/ 15 D 031 /98", "Code DCI": "15D031", "Forme": "COMP.", "Dosage": "100MG/10MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOMED 250MG/25MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medics/2480.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2480", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVODOPA / CARBIDOPA", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "LEVOMED", "Tarif de reference": "1018.98 DA", "PPA": "N/A", "Num Enregistrement": "178/ 15 D 032 /99", "Code DCI": "15D032", "Forme": "COMP. SEC.", "Dosage": "250MG/25MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOPHTA 0.0005 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/2344.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2344", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " LEVOCABASTINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LEVOPHTA", "Tarif de reference": "79.5 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 B 109 /99", "Code DCI": "17B109", "Forme": "COLLY. SOL.", "Dosage": "0.0005", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOSPASME 80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "LEVOSPASME", "Tarif de reference": "101.8 DA", "PPA": "N/A", "Num Enregistrement": "468/ 10 E 108 /14", "Code DCI": "10E108", "Forme": "COMP. DISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOTHYROX 100\u00b5G COMP. SEC B/30", "Img": "https://pharmnet-dz.com//img/medics/3806.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3806", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " HORMONES THYROIDIENNES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LEVOTHYROXINE  SODIQUE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LEVOTHYROX", "Tarif de reference": "123.39 DA", "PPA": "N/A", "Num Enregistrement": "062/ 09 K 057 /99/14", "Code DCI": "09K057", "Forme": "COMP. SEC.", "Dosage": "100\u00b5G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOTHYROX 25\u00b5G COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3807.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3807", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " HORMONES THYROIDIENNES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LEVOTHYROXINE  SODIQUE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LEVOTHYROX", "Tarif de reference": "85.71 DA", "PPA": "N/A", "Num Enregistrement": "062/ 09 K 150 /07/14", "Code DCI": "09K150", "Forme": "COMP. SEC.", "Dosage": "25\u00b5G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOTHYROX 50\u00b5G COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3804.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3804", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " HORMONES THYROIDIENNES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LEVOTHYROXINE  SODIQUE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LEVOTHYROX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "062/ 09 K 056 /99/14", "Code DCI": "09K056", "Forme": "COMP. SEC.", "Dosage": "50\u00b5G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEVOTHYROX 75\u00b5G COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3808.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3808", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " HORMONES THYROIDIENNES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LEVOTHYROXINE  SODIQUE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LEVOTHYROX", "Tarif de reference": "129.97 DA", "PPA": "N/A", "Num Enregistrement": "062/ 09 K 151 /07/14", "Code DCI": "09K151", "Forme": "COMP. SEC.", "Dosage": "75\u00b5G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOTYNE 10% (10G/100ML) SOL. BUV. B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LEVOCARNITINE", "Pays": "ALGERIE", "Nom Commercial": "LEVOTYNE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/ 14 G 038 /08 ", "Code DCI": "14G038", "Forme": "SOL. BUV.", "Dosage": "10% (10G/100ML)", "Conditionnement": "B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEVOZAN 0.04 SOL. BUV. GTTES. B/1FL. DE 30ML + 1COMPT. GTTES.", "Img": "https://pharmnet-dz.com//img/medics/2207.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2207", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LEVOMEPROMAZINE CHLORHYDRATE EXPRIME EN LEVOMEPROMAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEVOZAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/ 16 D 059 /11", "Code DCI": "16D059", "Forme": "SOL. BUV. GTTES.", "Dosage": "0.04", "Conditionnement": "B/1FL. DE 30ML + 1COMPT. GTTES.", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEXIN 1G COMP. B/12", "Img": "https://pharmnet-dz.com//img/medics/721.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=721", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LEXIN", "Tarif de reference": "580.31 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 223 /06", "Code DCI": "13B223", "Forme": "COMP. PELLI.", "Dosage": "1G", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEXIN 250MG/5ML SUSP. BUV. FL.100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LEXIN", "Tarif de reference": "311 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 156 /06", "Code DCI": "13B156", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL.100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEXIN 500MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/1891.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1891", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LEXIN", "Tarif de reference": "521 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 010 /06", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEXINAL 1G COMP. PELLI. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEXINAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "039/13B223/15", "Code DCI": "13B223", "Forme": "COMP. PELLI.", "Dosage": "1G", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "LEXINAL 500MG COMP.PELLI. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEXINAL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "039/13B010/15", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEXINAL 500MG GELULE B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE MONOHYDRATEE EXPRIME EN CEFALEXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEXINAL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "039/13B010/17", "Code DCI": "13B010", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "LEXOPAM 6MG COMP QUADRISEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2183.png", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LEXOPAM", "Tarif de reference": "0 DA", "PPA": "205.00 DA", "Num Enregistrement": "285/ 16 B 098 /05/14", "Code DCI": "16B098", "Forme": "COMP. SEC.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIBRAX 5MG/2,5MG COMP. DRAGEIFIES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " STERIPHARMA", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " CHLORDIAZEPOXIDE / BROMURE DE CLIDINIUM", "Liste": "Liste I", "Pays": "MAROC", "Nom Commercial": "LIBRAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "387/ 10 T 173 /07", "Code DCI": "10T173", "Forme": "COMP.", "Dosage": "5MG/2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIDOCAINE  AGUETTANT 0.01 SOL.INJ. B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4072", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LIDOCAINE  AGUETTANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "075/ 02 C 018 /00", "Code DCI": "02C018", "Forme": "SOL. INJ.", "Dosage": "0.01", "Conditionnement": "B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIDOCAINE 1% ADRENALINE AGUETTANT 0.01 SOL.INJ. B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4081", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE CHLORHYDRATE / ADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LIDOCAINE 1% ADRENALINE AGUETTANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "075/ 02 C 021 /98", "Code DCI": "02C021", "Forme": "SOL. INJ.", "Dosage": "0.01", "Conditionnement": "B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIDOCAINE 2% ADRENALINE AGUETTANT 0.02 SOL.INJ. B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE CHLORHYDRATE / ADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LIDOCAINE 2% ADRENALINE AGUETTANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "075/ 02 C 022 /98", "Code DCI": "02C022", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIDOCAINE 2% AGUETTANT 0.02 SOL.INJ. B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LIDOCAINE 2% AGUETTANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "075/ 02 C 019 /98", "Code DCI": "02C019", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIDOCAINE 2%, GEL B/100T. DE 30G ET B/1T. DE 100G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " PHARMADRUG PRODUCTION Gmbh", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE VISQUEUSE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "LIDOCAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "180/ 02 C 027 /01", "Code DCI": "02C027", "Forme": "GEL", "Dosage": "2%,", "Conditionnement": "B/100T. DE 30G ET B/1T. DE 100G", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIDOCAINE-GEO 0.02 SOL. INJ. B/1FL DE  25ML ET B/2FL DE 25ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LIDOCAINE-GEO", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "304/ 02 C 019 /06", "Code DCI": "02C019", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/1FL DE  25ML ET B/2FL DE 25ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIFENYSTIN 100 000UI COMP. VAG. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " NYSTATINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LIFENYSTIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 11 A 004 /99/07", "Code DCI": "11A004", "Forme": "COMP. VAG.", "Dosage": "100 000UI", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIFENYSTIN 500 000UI COMP. ENRO. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " NYSTATINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LIFENYSTIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 13 R 114 /98", "Code DCI": "13R114", "Forme": "COMP. ENRO.", "Dosage": "500 000UI", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIKACIN 125MG/ML (250MG/2ML) SOL.INJ. IM/IV B/1FL. DE 2ML  ET B/50FL. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMIKACINE SULFATE EXPRIME EN AMIKACINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LIKACIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 13 A 454 /98/10", "Code DCI": "13A454", "Forme": "SOL. INJ.", "Dosage": "125MG/ML (250MG/2ML)", "Conditionnement": "B/1FL. DE 2ML  ET B/50FL. DE 2ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIKACIN 250MG/ML (500MG/2ML) SOL. INJ. IM/IV B/1FL. DE 2ML  ET B/50FL. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMIKACINE SULFATE EXPRIME EN AMIKACINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LIKACIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 13 A 001 /00/10", "Code DCI": "13A001", "Forme": "SOL. INJ.", "Dosage": "250MG/ML (500MG/2ML)", "Conditionnement": "B/1FL. DE 2ML  ET B/50FL. DE 2ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LINAPEX 10MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LINAPEX", "Tarif de reference": "390.9 DA", "PPA": "N/A", "Num Enregistrement": "001/ 16 A 105 /11", "Code DCI": "16A105", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LINAPEX 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LINAPEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 16 A 130 /11", "Code DCI": "16A130", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LINAPEX 5MG** COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM** (SOUS FORME D'OXALATE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LINAPEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 16 A 133 /12", "Code DCI": "16A133", "Forme": "COMP. PELLI.", "Dosage": "5MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LINCOCINE 600MG/2ML SOL.INJ. B/1AMP. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LINCOMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LINCOCINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "076/ 13 D 026 /98", "Code DCI": "13D026", "Forme": "SOL. INJ.", "Dosage": "600MG/2ML", "Conditionnement": "B/1AMP. DE 2ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LINCOHEM 600MG/2ML SOL.INJ. B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LINCOMYCINE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "LINCOHEM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "161/ 13 D 026 /98", "Code DCI": "13D026", "Forme": "SOL. INJ.", "Dosage": "600MG/2ML", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": null}, {"Nom": "LINCOSIDE  300MG/ML (600MG/2ML) SOL. INJ. B/1FL. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LINCOMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LINCOSIDE ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "304/ 13 D 026 /09", "Code DCI": "13D026", "Forme": "SOL. INJ.", "Dosage": "300MG/ML (600MG/2ML)", "Conditionnement": "B/1FL. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIORESAL 10MG COMP.SEC. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1424", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " MYORELAXANTS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " BACLOFENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LIORESAL", "Tarif de reference": "437.5 DA", "PPA": "N/A", "Num Enregistrement": "068/ 21 E 025 /98", "Code DCI": "21E025", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPANOR 100MG GLES B/30", "Img": "https://pharmnet-dz.com//img/medics/1538.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1538", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CIPROFIBRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LIPANOR", "Tarif de reference": "458.93 DA", "PPA": "N/A", "Num Enregistrement": "255/ 06 M 133 /98", "Code DCI": "06M133", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPANTHYL 160MG COMP. PELLI.  LM B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FOURNIER", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FENOFIBRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "LIPANTHYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "019/ 06 M 214 /07/15", "Code DCI": "06M214", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIPICARE 10MG COMP. PELLI. B/28 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "781,76 DA", "PPA": "N/A", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 10MG COMP. PELLI. B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "2512,8 DA", "PPA": "N/A", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 20MG COMP. PELLI.  B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "3742,2 DA", "PPA": "N/A", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 20MG COMP. PELLI. B/28 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "1164,24 DA", "PPA": "N/A", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 20MG COMP. PELLI.B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "1247,4 DA", "PPA": "N/A", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 40MG COMP. PELLI.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "1980.00 DA", "PPA": "N/A", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 40MG COMP. PELLI.  B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "5940.00 DA", "PPA": "N/A", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 40MG COMP. PELLI. B/28 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "1848.00 DA", "PPA": "N/A", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 80MG COMP. PELLI.  B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "2040.00 DA", "PPA": " DA", "Num Enregistrement": "293/06M233/17", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 80MG COMP. PELLI. B/28 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "1904.00 DA", "PPA": " DA", "Num Enregistrement": "293/06M233/17", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG ", "Conditionnement": "B/28 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPICARE 80MG COMP. PELLI. B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPICARE", "Tarif de reference": "6120.00 DA", "PPA": " DA", "Num Enregistrement": "293/06M233/17", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOCARD  200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FENOFIBRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LIPOCARD ", "Tarif de reference": "903.9 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 120 /09", "Code DCI": "06M120", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOCARD 140MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FENOFIBRATE (MICRONISE)", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LIPOCARD", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 292 /10", "Code DCI": "06M292", "Forme": "GLES.", "Dosage": "140MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIPODAR 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LIPODAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 06 M 198 /08/13", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIPODAR 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "LIPODAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 06 M 225 /08/13", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LIPOFIBRATE 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1537.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FENOFIBRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LIPOFIBRATE", "Tarif de reference": "903.9 DA", "PPA": "N/A", "Num Enregistrement": "289/ 06 M 120 /07", "Code DCI": "06M120", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPONIL 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPONIL", "Tarif de reference": "--- DA", "PPA": "N/A", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPONIL 20 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPONIL 20", "Tarif de reference": "1247,4 DA", "PPA": "N/A", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPONIL 40 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPRODIM SPA", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "LIPONIL 40", "Tarif de reference": "1980.00 DA", "PPA": "N/A", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPONORM 20MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPONORM", "Tarif de reference": "1164.24 DA", "PPA": "N/A", "Num Enregistrement": "418/ 06 M 136 /09", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOSIC 0,2% (OU 2MG/G) GEL OPHT. T/10G", "Img": "https://pharmnet-dz.com//img/medics/2012.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2012", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " SUPPLEANCE LACRYMALE", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARBOMERE 980", "Pays": "FRANCE", "Nom Commercial": "LIPOSIC", "Tarif de reference": "242.66 DA", "PPA": " DA", "Num Enregistrement": "096/ 17 N 133 /08", "Code DCI": "17N133", "Forme": "GEL. OPHT.", "Dosage": "0,2% (OU 2MG/G)", "Conditionnement": "T/10G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOSTATINE 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPOSTATINE", "Tarif de reference": "837.6 DA", "PPA": "N/A", "Num Enregistrement": "468/ 06 M 198 /14", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOSTATINE 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPOSTATINE", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "468/ 06 M 225 /15", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOVAST  40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "LIPOVAST ", "Tarif de reference": "1980.00 DA", "PPA": "N/A", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOVAST 10 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LIPOVAST 10", "Tarif de reference": "837,60 DA", "PPA": "N/A", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIPOVAST 20 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "LIPOVAST 20", "Tarif de reference": "1247,4 DA", "PPA": " DA", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LISACLIN 600MG SOL.INJ. B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLINDAMYCINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISACLIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 13 D 024 /96", "Code DCI": "13D024", "Forme": "SOL. INJ.", "Dosage": "600MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": null}, {"Nom": "LISAMETACE 40MG/ML SUSP.INJ. B/1AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE ACETATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISAMETACE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 09 H 090 /99/13", "Code DCI": "09H090", "Forme": "SUSP. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/1AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LISAMETHYLE 120MG/FL. DE PDRE.** PDRE. ET SOLV. P. SOL. INJ. IM/IV B/1FL. DE PDRE + 1AMP. DE 2ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE. +50AMP. DE 2ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISAMETHYLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 09 H 031 /98/10", "Code DCI": "09H031", "Forme": "PDRE. SOL. INJ.", "Dosage": "120MG/FL. DE PDRE.**", "Conditionnement": "B/1FL. DE PDRE + 1AMP. DE 2ML DE SOLV. (EPPI)  ET B/50FL. DE PDRE. +50AMP. DE 2ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "LISAMETHYLE 20MG/FL. DE LYOPH.** LYOPH. ET SOLV. P. SOL. INJ. IM/IV B/1FL. DE LYOPH. + 1AMP. DE 2ML DE SOLV. (EPPI)  ET  *B/50FL. DE LYOPH. + 50AMP. DE 2ML DE SOLV. (EPPI) ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISAMETHYLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 09 H 029 /99/10", "Code DCI": "09H029", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG/FL. DE LYOPH.**", "Conditionnement": "B/1FL. DE LYOPH. + 1AMP. DE 2ML DE SOLV. (EPPI)  ET  *B/50FL. DE LYOPH. + 50AMP. DE 2ML DE SOLV. (EPPI) ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LISAMETHYLE 40MG/FL. DE PDRE PDRE. ET SOLV. P. SOL. INJ. IM/IV B/01FL. DE PDRE + 1AMP. DE 2ML DE SOLV. (EPPI)  ET  B/50FL. DE PDRE. + 50AMP. DE 2ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISAMETHYLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 09 H 030 /96/15", "Code DCI": "09H030", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG/FL. DE PDRE", "Conditionnement": "B/01FL. DE PDRE + 1AMP. DE 2ML DE SOLV. (EPPI)  ET  B/50FL. DE PDRE. + 50AMP. DE 2ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "LISAPAN 2MG/ML (4MG/2ML) SOL. INJ. IV B/50AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PANCURONIUM BROMURE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISAPAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 02 D 036 /98/10", "Code DCI": "02D036", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (4MG/2ML)", "Conditionnement": "B/50AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LISATRIAM 40MG/ML SUSP.INJ. B/01AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/3759.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIAMCINOLONE ACETONIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISATRIAM", "Tarif de reference": "168.05 DA", "PPA": "N/A", "Num Enregistrement": "011/ 09 H 091 /98/13", "Code DCI": "09H091", "Forme": "SUSP. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/01AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LISAVIR 200MG COMP. B/25", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "LISAVIR", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "011/ 13 P 097 /99", "Code DCI": "13P097", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/25", "Commercialisation": true, "Remboursable": true}, {"Nom": "LISINOX 20MG COMP. PELLI. GASTRORESIST. B/07 - B/14 - B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE MAGNESIUM TRIHYDRATE EXPRIME EN ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LISINOX", "Tarif de reference": "98 DA", "PPA": "600.00 DA", "Num Enregistrement": "035/ 10 A 180 /14", "Code DCI": "10A180", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/07 - B/14 - B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LISINOX 40MG COMP. PELLI. GASTRORESIST. B/07 - B/14 - B/28", "Img": "https://pharmnet-dz.com//img/medics/3887.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3887", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LISINOX", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "035/ 10 A 181 /14", "Code DCI": "10A181", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/07 - B/14 - B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LIVIAL 2,5MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/610.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=610", "Laboratoire": " ORGANON", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TIBOLONE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "LIVIAL", "Tarif de reference": "2297.81 DA", "PPA": "N/A", "Num Enregistrement": "005/ 09 B 128 /02", "Code DCI": "09B128", "Forme": "COMP.", "Dosage": "2,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LMISARTE + 40MG/12,5MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "TELMISARTE +", "Tarif de reference": "1544,40 DA", "PPA": "N/A", "Code DCI": "06E265", "Forme": "COMP.", "Dosage": "40MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCACID 0.0005 CREME DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1655.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1655", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE TRETINOIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCACID", "Tarif de reference": "219.8 DA", "PPA": "N/A", "Num Enregistrement": "099/ 07 B 087 /99", "Code DCI": "07B087", "Forme": "CR\u00c8ME", "Dosage": "0.0005", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCACID 0.001 LOTION FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1654", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE TRETINOIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCACID", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 07 B 086 /99", "Code DCI": "07B086", "Forme": "LOTION", "Dosage": "0.001", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCAPRED 100MG/100G CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/504.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=504", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " DESONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCAPRED", "Tarif de reference": "245.68 DA", "PPA": "N/A", "Num Enregistrement": "099/ 07 H 042 /98", "Code DCI": "07H042", "Forme": "CR\u00c8ME", "Dosage": "100MG/100G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCATOP 0.001 CREME DERM. T./30G", "Img": "https://pharmnet-dz.com//img/medics/505.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=505", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " DESONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCATOP", "Tarif de reference": "220.66 DA", "PPA": "N/A", "Num Enregistrement": "186/ 07 H 042 /08", "Code DCI": "07H042", "Forme": "CR\u00c8ME", "Dosage": "0.001", "Conditionnement": "T./30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCERYL 0.05 VERNIS A ONGLES MEDICAMENTEUX B/01FL de 2,5ML + 10 SPATULES", "Img": "https://pharmnet-dz.com//img/medics/467.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=467", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " AMOROLFINE CHLORHYDRATE EXPRIME EN AMOROLFINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCERYL", "Tarif de reference": "1824 DA", "PPA": " DA", "Num Enregistrement": "123/ 07 D 110 /00/15", "Code DCI": "07D110", "Forme": "VERNIS", "Dosage": "0.05", "Conditionnement": "B/01FL de 2,5ML + 10 SPATULES", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCOID 0.001 CR\u00c8ME EPAISSE T/30G", "Img": "https://pharmnet-dz.com//img/medics/514.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=514", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)**", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCOID", "Tarif de reference": "272.2 DA", "PPA": "N/A", "Num Enregistrement": "374/ 07 H 127 /02/09", "Code DCI": "07H127", "Forme": "CR\u00c8ME", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCOID 0.001 CR\u00c8ME T/30G", "Img": "https://pharmnet-dz.com//img/medics/513.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=513", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)**", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCOID", "Tarif de reference": "0 DA", "PPA": "275.00 DA", "Num Enregistrement": "374/ 07 H 126 /03/09", "Code DCI": "07H126", "Forme": "CR\u00c8ME", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCOID 0.001 LOTION FL/30ML", "Img": "https://pharmnet-dz.com//img/medics/515.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=515", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)**", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCOID", "Tarif de reference": "0 DA", "PPA": "292.00 DA", "Num Enregistrement": "374/ 07 H 128 /03/09", "Code DCI": "07H128", "Forme": "LOTION", "Dosage": "0.001", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOCOID 0.001 PDE. T/30G", "Img": "https://pharmnet-dz.com//img/medics/516.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=516", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " HYDROCORTISONE (SOUS FORME D'HYDROCORTISONE 17-BUTYRATE)**", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOCOID", "Tarif de reference": "250.88 DA", "PPA": " DA", "Num Enregistrement": "374/ 07 H 129 /03/09", "Code DCI": "07H129", "Forme": "PDE. DERM.", "Dosage": "0.001", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOGYNON 30\u00b5G/0,05MG/6JRS - 40\u00b5G/0,075MG/5JRS - 30\u00b5G/0,125MG/10JRS COMP. ENRO. B/21", "Img": "https://pharmnet-dz.com//img/medics/3048.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL / LEVONORGESTREL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOGYNON", "Tarif de reference": "131.19 DA", "PPA": "N/A", "Num Enregistrement": "070/ 11 H 050 /98", "Code DCI": "11H050", "Forme": "COMP. PELLI.", "Dosage": "30\u00b5G/0,05MG/6JRS - 40\u00b5G/0,075MG/5JRS - 30\u00b5G/0,125MG/10JRS", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOMAC 20MG GLES. A MICROG. GASTRORESIST. PILULIER DE 15", "Img": "https://pharmnet-dz.com//img/medics/3838.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LOMAC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 10 A 001 /99/09", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "PILULIER DE 15", "Commercialisation": true, "Remboursable": null}, {"Nom": "LOMAC 40MG LYOPH. ET SOLV. SOL. INJ.IV B/05FL. DE PDRE. + 05FL. DE SOLV. DE 10ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE SODIQUE EXPRIME EN OMEPRAZOLE", "Liste": "Liste II", "Pays": "INDE", "Nom Commercial": "LOMAC", "Tarif de reference": " N/A", "PPA": "1765.00 DA", "Num Enregistrement": "182/ 10 A 087 /07", "Code DCI": "10A087", "Forme": "LYOPH. SOL. INJ.", "Dosage": "40MG", "Conditionnement": "B/05FL. DE PDRE. + 05FL. DE SOLV. DE 10ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LOMOH-20 2000UI ANTI-Xa/0,2ML (CORRESPONDANT A 20MG/0,2ML) SOL. INJ. SC/IV ET INTRAVASCULAIRE B/1SERING. PREREMPL. DE 0,2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LOMOH-20", "Tarif de reference": "0 DA", "PPA": "269.00 DA", "Num Enregistrement": "471/ 12 B 081 /13", "Code DCI": "12B081", "Forme": "SOL. INJ.", "Dosage": "2000UI ANTI-Xa/0,2ML (CORRESPONDANT A 20MG/0,2ML)", "Conditionnement": "B/1SERING. PREREMPL. DE 0,2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOMOH-40 4000UI ANTI-Xa/0,4ML (CORRESPONDANT A 40MG/0,4ML) SOL. INJ. SC/IV ET INTRAVASCULAIRE B/1SERING. PREREMPL. DE 0,4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LOMOH-40", "Tarif de reference": "0 DA", "PPA": "405.00 DA", "Num Enregistrement": "471/ 12 B 082 /13", "Code DCI": "12B082", "Forme": "SOL. INJ.", "Dosage": "4000UI ANTI-Xa/0,4ML (CORRESPONDANT A 40MG/0,4ML)", "Conditionnement": "B/1SERING. PREREMPL. DE 0,4ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOMOH-60 6000UI ANTI-Xa/0,6ML (CORRESPODANT A 60MG/0,6ML) SOL. INJ. SC/IV ET INTRAVASCULAIRE B/1SERING. PREREMPL. DE 0,6ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LOMOH-60", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "471/ 12 B 083 /13", "Code DCI": "12B083", "Forme": "SOL. INJ.", "Dosage": "6000UI ANTI-Xa/0,6ML (CORRESPODANT A 60MG/0,6ML)", "Conditionnement": "B/1SERING. PREREMPL. DE 0,6ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOMOH-80 8000UI ANTI-Xa/0,8ML (CORRESPONDANT A 80MG/0,8ML) SOL. INJ. SC/IV ET INTRAVASCULAIRE B/1SERING. PREREMPL. DE 0,8ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "LOMOH-80", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "471/ 12 B 084 /13", "Code DCI": "12B084", "Forme": "SOL. INJ.", "Dosage": "8000UI ANTI-Xa/0,8ML (CORRESPONDANT A 80MG/0,8ML)", "Conditionnement": "B/1SERING. PREREMPL. DE 0,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOMZOLE BGL 20MG GLES. MICROGRANULES GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medics/3839.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3839", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LOMZOLE BGL", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "235/ 10 A 001 /10", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPERAMIDE NS 2MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LOPERAMIDE NS", "Tarif de reference": "128.20 DA", "PPA": "N/A", "Code DCI": "10H056", "Forme": "GLES.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPEREX 2MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LOPEREX", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10H056", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPERIDAL 2MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/4293.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LOPERIDAL", "Tarif de reference": "128.2 DA", "PPA": " DA", "Num Enregistrement": "039/10H056/00/15", "Code DCI": "10H056", "Forme": "GLES.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPESTIN 0,2MG/ML SOL. BUV. P. ENF. B/1FL. DE 90ML + MESURETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LOPESTIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 H 144 /10", "Code DCI": "10H144", "Forme": "SIROP", "Dosage": "0,2MG/ML", "Conditionnement": "B/1FL. DE 90ML + MESURETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPESTIN 2MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LOPERAMIDE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LOPESTIN", "Tarif de reference": "128.2 DA", "PPA": "128.00 DA", "Num Enregistrement": "003/ 10 H 056 /06", "Code DCI": "10H056", "Forme": "GLES.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPRA 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CITALOPRAM HYDROBROMURE EXPRIME EN CITALOPRAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOPRA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 16 A 136 /09", "Code DCI": "16A136", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LOPRESS 100MG COMP.PELLI. QUADRISECABLE B/30", "Img": "https://pharmnet-dz.com//img/medics/3254.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3254", "Laboratoire": " SANAMED", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " METOPROLOL TARTRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOPRESS", "Tarif de reference": "0 DA", "PPA": "402.00 DA", "Num Enregistrement": "097/ 06 F 204 /05/14", "Code DCI": "06F204", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPRESSOR  LP 200MG COMP.SEC. L.P. B/30", "Img": "https://pharmnet-dz.com//img/medics/3236.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3236", "Laboratoire": " DAIICHI SANKYO FRANCE SAS", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " METOPROLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOPRESSOR  LP", "Tarif de reference": "0 DA", "PPA": "695.00 DA", "Num Enregistrement": "307/ 06 F 071 /97/04", "Code DCI": "06F071", "Forme": "COMP. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPRIL  25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/4334.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOPRIL ", "Tarif de reference": "148.8 DA", "PPA": " DA", "Num Enregistrement": "285/06E052/97/16", "Code DCI": "06E052", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOPRIL  50MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/4301.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOPRIL ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "285/06E053/97/16", "Code DCI": "06E053", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORADESS   0,5ML/ML SIROP B/1FL DE 120 ML + PIPETTE GRADU\u00e9E EN ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LORADESS  ", "Tarif de reference": "370.8 DA", "PPA": "N/A", "Num Enregistrement": "035/01A048/15", "Code DCI": "01A048", "Forme": "SIROP", "Dosage": "0,5ML/ML", "Conditionnement": "B/1FL DE 120 ML + PIPETTE GRADU\u00e9E EN ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORADESS 5MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LORADESS", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "01A047", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORADINE 10MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3990.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3990", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LORADINE", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "035/ 01 A 033 /98/13", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORATADINE 1MG/ML SIROP FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/4009.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LORATADINE", "Tarif de reference": "161 DA", "PPA": "N/A", "Num Enregistrement": "035/ 01 A 034 /08", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORATADINE BEKER 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3991.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3991", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LORATADINE BEKER", "Tarif de reference": "180 DA", "PPA": "180.00 DA", "Num Enregistrement": "447/ 01 A 033 /14", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORATADINE NOVAGENERICS 10MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LORATADINE NOVAGENERICS", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "149/ 01 A 033 /13", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORATAL  10MG COMP B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LORATAL ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "039/01A033/16", "Code DCI": "01A033", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "LORATAN 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "LORATAN", "Tarif de reference": " N/A", "PPA": "180.00 DA", "Num Enregistrement": "055/ 01 A 033 /01/11", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LORAZEPAM 1MG COMP. QUADRISEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LORAZEPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "320/ 16 B 042 /06", "Code DCI": "16B042", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LORAZEPAM 2,5MG COMP. QUADRISEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LORAZEPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "320/ 16 B 043 /06", "Code DCI": "16B043", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOSARTAN LDM 50MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOSARTAN LDM", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "309/ 06 E 126 /12", "Code DCI": "06E126", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOTENSE 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/91.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOTENSE", "Tarif de reference": "663 DA", "PPA": "662.00 DA", "Num Enregistrement": "352/ 06 B 243 /08", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOTENSE 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/75.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOTENSE", "Tarif de reference": " N/A", "PPA": "557.00 DA", "Num Enregistrement": "352/ 06 B 123 /06", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LOTIBIOL 0.1 SOL. APPLI. LOCALE FL/180 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIPARASITAIRES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BENZOATE DE BENZYLE", "Pays": "ALGERIE", "Nom Commercial": "LOTIBIOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 07 R 080 /97", "Code DCI": "07R080", "Forme": "SOL. APP. LOCALE", "Dosage": "0.1", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LOVENOX 10 000UI ANTI-XA/ML   (CORRESPONDANT A 100MG/ML) SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 1ML AVEC SYST\u00c8ME DE SECURITE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1727", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOVENOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 12 B 085 /96/09", "Code DCI": "12B085", "Forme": "SOL. INJ.", "Dosage": "10 000UI ANTI-XA/ML   (CORRESPONDANT A 100MG/ML)", "Conditionnement": "B/02 SERING. PREREMPL. DE 1ML AVEC SYST\u00c8ME DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOVENOX 2 000UI ANTI-XA/0,2ML (CORRESPONDANT A 20MG/0,2ML) SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,2ML AVEC SYST\u00c8ME DE SECURITE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1719", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOVENOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 12 B 081 /96/09", "Code DCI": "12B081", "Forme": "SOL. INJ.", "Dosage": "2 000UI ANTI-XA/0,2ML (CORRESPONDANT A 20MG/0,2ML)", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,2ML AVEC SYST\u00c8ME DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOVENOX 4 000UI ANTI-XA/0,4ML (CORRESPONDANT A 40MG/0,4ML) SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,4ML AVEC SYST\u00c8ME DE SECURITE", "Img": "https://pharmnet-dz.com//img/medics/1722.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1722", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOVENOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 12 B 082 /96/09 ", "Code DCI": "12B082", "Forme": "SOL. INJ.", "Dosage": "4 000UI ANTI-XA/0,4ML (CORRESPONDANT A 40MG/0,4ML)", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,4ML AVEC SYST\u00c8ME DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOVENOX 6 000UI ANTI-X/0,6ML    (CORRESPONDANT A 60MG/0,6ML) SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,6ML AVEC SYST\u00c8ME DE SECURITE", "Img": "https://pharmnet-dz.com//img/medics/1724.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1724", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOVENOX", "Tarif de reference": "1189.85 DA", "PPA": "N/A", "Num Enregistrement": "376/ 12 B 083 /96/09 ", "Code DCI": "12B083", "Forme": "SOL. INJ.", "Dosage": "6 000UI ANTI-X/0,6ML    (CORRESPONDANT A 60MG/0,6ML)", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,6ML AVEC SYST\u00c8ME DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOVENOX 8 000UI ANTI-XA/0,8ML (CORRESPONDANT A 80MG/0,8ML) SOL.INJ.SC. ET INTRAVASCULAIRE EN SERING. PREREMPL. B/02 SERING. PREREMPL. DE 0,8ML AVEC SYST\u00c8ME DE SECURITE", "Img": "https://pharmnet-dz.com//img/medics/1726.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1726", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTICOAGULANTS INJECTABLES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ENOXAPARINE SODIQUE  (HEPARINE A BAS POIDS MOLECULAIRE HBPM)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOVENOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 12 B 084 /96/09", "Code DCI": "12B084", "Forme": "SOL. INJ.", "Dosage": "8 000UI ANTI-XA/0,8ML (CORRESPONDANT A 80MG/0,8ML)", "Conditionnement": "B/02 SERING. PREREMPL. DE 0,8ML AVEC SYST\u00c8ME DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOWVASC 5MG GLES. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOWVASC", "Tarif de reference": "571.48 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 B 123 /12", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXANAD 250MG  COMP PELL B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOXANAD", "Tarif de reference": "453.4 DA", "PPA": "N/A", "Num Enregistrement": "468/ 13 K 252 /14", "Code DCI": "13K252", "Forme": "COMP. PELLI.", "Dosage": "250MG ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXANAD 500 MG COMP PELL  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOXANAD", "Tarif de reference": "804 DA", "PPA": "N/A", "Num Enregistrement": "468/ 13 K 253 /14", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500 MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXAPAC 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LOXAPINE SUCCINATE EXPRIME EN LOXAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOXAPAC", "Tarif de reference": "1806 DA", "PPA": "N/A", "Num Enregistrement": "285/ 16 D 132 /09", "Code DCI": "16D132", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXAPAC 25MG** COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LOXAPINE SUCCINATE EXPRIME EN LOXAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOXAPAC", "Tarif de reference": "567.9 DA", "PPA": "N/A", "Num Enregistrement": "285/ 16 D 146 /09", "Code DCI": "16D146", "Forme": "COMP. PELLI.", "Dosage": "25MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXAPAC 25MG/ML  SOL. BUV. B/1FL. DE 30ML AVEC PIPETTE", "Img": "https://pharmnet-dz.com//img/medics/2305.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2305", "Laboratoire": " EISAI SAS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LOXAPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOXAPAC", "Tarif de reference": "466.5 DA", "PPA": " DA", "Num Enregistrement": "446/ 16 D 134 /09", "Code DCI": "16D134", "Forme": "SOL. BUV.", "Dosage": "25MG/ML ", "Conditionnement": "B/1FL. DE 30ML AVEC PIPETTE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXAPAC 25MG/ML (OU 50MG/2ML) SOL. INJ.IM B/10AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2318", "Laboratoire": " EISAI SAS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LOXAPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOXAPAC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "446/ 16 D 147 /09", "Code DCI": "16D147", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (OU 50MG/2ML)", "Conditionnement": "B/10AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXEN 1MG/ML (10MG/10ML) SOL.INJ. IV B/5 AMP DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=59", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOXEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 06 B 016 /96/14", "Code DCI": "06B016", "Forme": "SOL. INJ.", "Dosage": "1MG/ML (10MG/10ML)", "Conditionnement": "B/5 AMP DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "LOXEN 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=53", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOXEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 06 B 014 /96", "Code DCI": "06B014", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "LOXEN LP 50MG MICROGRLES. LP EN GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/4379.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4379", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LOXEN LP", "Tarif de reference": "612 DA", "PPA": " DA", "Num Enregistrement": "068/06B015/96/16", "Code DCI": "06B015", "Forme": "MICROGRANULES", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOXIDIPINE LP 50MG MICRGLES. LP EN GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOXIDIPINE LP", "Tarif de reference": "612 DA", "PPA": "N/A", "Num Enregistrement": "470/ 06 B 015 /13", "Code DCI": "06B015", "Forme": "COMP. LP", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOZARTAN GEO 25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOZARTAN GEO", "Tarif de reference": "699.6 DA", "PPA": "N/A", "Num Enregistrement": "304/ 06 E 229 /08", "Code DCI": "06E229", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LOZARTAN GEO 50MG COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LOZARTAN GEO", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "304/06E126/06/16", "Code DCI": "06E126", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LUBENTYL  GELEE POT/250G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2960", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HUILE DE PARAFFINE  EN GELEE", "Pays": "FRANCE", "Nom Commercial": "LUBENTYL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 10 M 067 /98", "Code DCI": "10M067", "Forme": "GELEE", "Dosage": "100MG", "Conditionnement": "POT/250G", "Commercialisation": true, "Remboursable": true}, {"Nom": "LUCENTIS 10MG/ML (2,3MG/0,23ML) SOL. INJ. INTRAVITREENNE B/01FL./0,23ML + 01SERING. GRADUEE +01AIGUI. POUR INJ. + 01AIGUI. POUR FILTRE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2018", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " N/D", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " RANIBIZUMAB", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "LUCENTIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 17 P 161 /09", "Code DCI": "17P161", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (2,3MG/0,23ML)", "Conditionnement": "B/01FL./0,23ML + 01SERING. GRADUEE +01AIGUI. POUR INJ. + 01AIGUI. POUR FILTRE", "Commercialisation": true, "Remboursable": true}, {"Nom": "LUDIOMIL 25MG COMP.PELLI.SEC B/50", "Img": "https://pharmnet-dz.com//img/medics/2543.png", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " MAPROTILINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LUDIOMIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 16 A 010 /97", "Code DCI": "16A010", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "LUDIOMIL 75MG COMP.PELLI.SEC B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2544", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " MAPROTILINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LUDIOMIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 16 A 011 /97", "Code DCI": "16A011", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "LUTEDINE 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/3994.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3994", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LUTEDINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/ 01 A 033 /04/12", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYNOX 250MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/3280.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3280", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACETAZOLAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "LYNOX", "Tarif de reference": "200 DA", "PPA": "N/A", "Num Enregistrement": "242/ 06 H 084 /02", "Code DCI": "06H084", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYRICA 25MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medics/2413.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2413", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "LYRICA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 15 A 065 /06", "Code DCI": "15A065", "Forme": "GLES.", "Dosage": "25MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYRICA 300MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medics/2429.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2429", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "LYRICA", "Tarif de reference": "7952 DA", "PPA": " DA", "Num Enregistrement": "045/ 15 A 069 /06", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYRICA 50MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4468", "Laboratoire": " PFIZER", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LYRICA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/15A066/06/16", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYRIZIN  50MG GLES  B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LYRIZIN ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYRIZIN  75MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LYRIZIN ", "Tarif de reference": "1999,80 DA", "PPA": "N/A", "Code DCI": "15A101", "Forme": "GLES.", "Dosage": "75MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYRIZIN 150MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LYRIZIN", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYRIZIN 300MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "LYRIZIN", "Tarif de reference": "8520.00 DA", "PPA": "N/A", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYSANXIA 10MG COMP. B/40", "Img": "https://pharmnet-dz.com//img/medics/2846.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2846", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " PRAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "LYSANXIA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 16 B 078 /98/09", "Code DCI": "16B078", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYSANXIA 15MG/ML SOL .BUV .GTTES. FL/20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2177", "Laboratoire": " PFIZER", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " PRAZEPAM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "LYSANXIA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 16 B 080 /98", "Code DCI": "16B080", "Forme": "SOL. BUV. GTTES.", "Dosage": "15MG/ML", "Conditionnement": "FL/20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYSOGIC 100MG/SACH.-DOSE PDRE. SOL. BUV. EN SACH.-DOSE B/20 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "LYSOGIC", "Tarif de reference": "117.6 DA", "PPA": "N/A", "Num Enregistrement": "263/ 03 A 002 /06", "Code DCI": "03A002", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG/SACH.-DOSE", "Conditionnement": "B/20 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "LYSOPAINE SANS SUCRE 1,5MG / 20MG COMP. A SUCER EDULCORE AU SORBITOL ET A LA SACCHARINE B/1T. DE 18  ET  B/2T. DE 18 (36)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1141", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " CETYLPYRIDINIUM CHLORURE / LYSOSYME CHLORHYDRATE", "Pays": "FRANCE", "Nom Commercial": "LYSOPAINE SANS SUCRE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 23 B 040 /13", "Code DCI": "23B040", "Forme": "COMP. A SUCER", "Dosage": "1,5MG / 20MG", "Conditionnement": "B/1T. DE 18  ET  B/2T. DE 18 (36)", "Commercialisation": true, "Remboursable": true}], "M": [{"Nom": "MAALOX 525MG/600MG/15ML SUSP.BUV.SACHET B/30 SACHETS DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " THERAPLIX", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "FRANCE", "Nom Commercial": "MAALOX", "Tarif de reference": "301.5 DA", "PPA": "N/A", "Num Enregistrement": "016/ 10 B 105 /99", "Code DCI": "10B105", "Forme": "SUSP. BUV.", "Dosage": "525MG/600MG/15ML", "Conditionnement": "B/30 SACHETS DE 15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAALOX MAUX D'ESTOMAC 3,5G/4G/100ML SUSP.BUV. GO\u00dbT MENTHE B/1FL/250ML", "Img": "https://pharmnet-dz.com//img/medics/3895.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3895", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "ALGERIE", "Nom Commercial": "MAALOX MAUX D'ESTOMAC", "Tarif de reference": "167.5 DA", "PPA": "N/A", "Num Enregistrement": "392/ 10 B 010 /96/09", "Code DCI": "10B010", "Forme": "SUSP. BUV.", "Dosage": "3,5G/4G/100ML", "Conditionnement": "B/1FL/250ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAALUS-ASIA 132MG/275MG COMP. A CROQUER B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ASIA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "SYRIE", "Nom Commercial": "MAALUS-ASIA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "121/ 10 B 137 /04", "Code DCI": "10B137", "Forme": "COMP. A CROQ.", "Dosage": "132MG/275MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "MABTHERA 10MG/ML (100MG/10ML ET 500MG/50ML) SOL. CONC. A DILUER P. PERF.  B/2FL. DE 10ML  ET  B/1FL. DE 50ML ", "Img": "https://pharmnet-dz.com//img/medics/1057.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1057", "Laboratoire": " ROCHE", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " RITUXIMAB", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "MABTHERA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 05 D 109 /06", "Code DCI": "05D109", "Forme": "SOL. PERF.", "Dosage": "10MG/ML (100MG/10ML ET 500MG/50ML)", "Conditionnement": "B/2FL. DE 10ML  ET  B/1FL. DE 50ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MACROLID 200MG/5ML PDRE SUSP. BUV FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "MACROLID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "010/ 13 E 028 /99", "Code DCI": "13E028", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MADECASSOL 0.01 CREME T/10G", "Img": "https://pharmnet-dz.com//img/medics/1639.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1639", "Laboratoire": " ROCHE", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " EXTRAIT DE CENTELLA ASIATICA", "Pays": "FRANCE", "Nom Commercial": "MADECASSOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "058/ 07 A 002 /97", "Code DCI": "07A002", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/10G", "Commercialisation": true, "Remboursable": false}, {"Nom": "MADECASSOL 0.02 PDRE FL/2G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " ROCHE", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " EXTRAIT DE CENTELLA ASIATICA", "Pays": "FRANCE", "Nom Commercial": "MADECASSOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "058/ 07 A 001 /97", "Code DCI": "07A001", "Forme": "PDRE", "Dosage": "0.02", "Conditionnement": "FL/2G", "Commercialisation": true, "Remboursable": null}, {"Nom": "MADOPAR 250 200MG/50MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2477", "Laboratoire": " HOFFMAN LAROCHE", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVODOPA/BENSERAZIDE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "MADOPAR 250", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 15 D 030 /99", "Code DCI": "15D030", "Forme": "COMP.", "Dosage": "200MG/50MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAFEPAIN 500MG  COMP ENRO SEC  B/20", "Img": "https://pharmnet-dz.com//img/medics/961.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=961", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE MEFENAMIQUE", "Liste": "Liste II", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "MAFEPAIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "190/ 04 B 070 /14", "Code DCI": "04B070", "Forme": "COMP. ENRO.", "Dosage": "500MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "MAGNE 15% ( OU 0,75G/5ML) SIROP FL./125ML", "Img": "https://pharmnet-dz.com//img/medics/3396.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3396", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM ELEMENT  (SOUS FORME DE MAGNESIUM PIDOLATE)", "Pays": "ALGERIE", "Nom Commercial": "MAGNE", "Tarif de reference": "172.5 DA", "PPA": "N/A", "Num Enregistrement": "242/ 14 G 162 /06", "Code DCI": "14G162", "Forme": "SOL. BUV.", "Dosage": "15% ( OU 0,75G/5ML)", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAGNESIUM SULFATE 0.15 SOL INJ B/100AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM SULFATE", "Pays": "FRANCE", "Nom Commercial": "MAGNESIUM SULFATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 055 /98", "Code DCI": "14G055", "Forme": "SOL. INJ.", "Dosage": "0.15", "Conditionnement": "B/100AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MAGNEVIST 469,01MG/ML** (0,5MMOL/ML)** SOL. INJ. IV 1FL. DE 10ML - 1FL. DE 15ML -1FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " BAYER", "C.Pharmacologique": " I.R.M.", "C.Therapeutique": " DIAGNOSTIC", "Info": " GADOPENTATE DE DIMEGLUMINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "MAGNEVIST", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "424/ 08 A 001 /00/12", "Code DCI": "08A001", "Forme": "SOL. INJ.", "Dosage": "469,01MG/ML** (0,5MMOL/ML)**", "Conditionnement": "1FL. DE 10ML - 1FL. DE 15ML -1FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MAGNO SANOL 250MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " OXYDE DE MAGNESIUM", "Pays": "ALLEMAGNE", "Nom Commercial": "MAGNO SANOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "273/ 14 G 229 /06", "Code DCI": "14G229", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "MAPEZ 1MG COMP. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MAPEZ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "16B042", "Forme": "COMP SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAPEZ 2,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MAPEZ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "16B043", "Forme": "COMP SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAROCID 500MG COMP. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "MAROCID", "Tarif de reference": "193.2 DA", "PPA": "N/A", "Num Enregistrement": "010/ 13 E 029 /98", "Code DCI": "13E029", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "MARVELON 0,03MG/0,15MG COMP B/3X21 ET B/100X21", "Img": "https://pharmnet-dz.com//img/medics/3037.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3037", "Laboratoire": " ORGANON", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL/DESOGESTREL", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "MARVELON", "Tarif de reference": "306.62 DA", "PPA": "N/A", "Num Enregistrement": "005/ 11 H 026 /96", "Code DCI": "11H026", "Forme": "COMP.", "Dosage": "0,03MG/0,15MG", "Conditionnement": "B/3X21 ET B/100X21", "Commercialisation": true, "Remboursable": true}, {"Nom": "MATADOR 250MG COMP. PELLI. B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MATADOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 13 K 227 /13", "Code DCI": "13K227", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "MATADOR 500MG COMP. PELLI. B/07", "Img": "https://pharmnet-dz.com//img/medics/366.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MATADOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 13 K 228 /15", "Code DCI": "13K228", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "MATADOR 750MG COMP. PELLI. B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MATADOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "055/ 13 K 468 /12", "Code DCI": "13K468", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": null}, {"Nom": "MAXIDROL 0,1G/350000UI/600000UI/100G PDE.OPHT. T/3,5G", "Img": "https://pharmnet-dz.com//img/medics/1977.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1977", "Laboratoire": " ALCON", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE SULFATE / POLYMYXINE B SULFATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MAXIDROL", "Tarif de reference": "160.81 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 G 110 /00/15", "Code DCI": "17G110", "Forme": "PDE. OPHT.", "Dosage": "0,1G/350000UI/600000UI/100G", "Conditionnement": "T/3,5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAXIDROL 100MG/350 000UI/60 0000UI  COLLY. FL/3ML", "Img": "https://pharmnet-dz.com//img/medics/1972.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1972", "Laboratoire": " ALCON", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE / POLYMYXINE B", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MAXIDROL", "Tarif de reference": "116.79 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 G 048 /97", "Code DCI": "17G048", "Forme": "COLLY.", "Dosage": "100MG/350 000UI/60 0000UI ", "Conditionnement": "FL/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MAXILASE 20 000 U CEIP/100ML SIROP ENF. ET AD. FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/965.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=965", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ENZYMES A VISEE ANTI-INFLAMMAT.& ANTI-OEDEMATEUSE", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ALPHA-AMYLASE", "Pays": "ALGERIE", "Nom Commercial": "MAXILASE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "392/ 04 C 027 /96/09", "Code DCI": "04C027", "Forme": "SIROP", "Dosage": "20 000 U CEIP/100ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "MEBEVERINE SAIDAL 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEBEVERINE SAIDAL", "Tarif de reference": "217.2 DA", "PPA": "240.00 DA", "Num Enregistrement": "003/ 10 E 035 /09", "Code DCI": "10E035", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEBEVIS 20MG/ML SUSP.BUV. FL/80ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " MEBENDAZOLE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "MEBEVIS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 19 B 007 /99", "Code DCI": "19B007", "Forme": "SUSP. BUV.", "Dosage": "20MG/ML", "Conditionnement": "FL/80ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MECITABINE 1000MG PDRE. LYOP. P. SOL. P. PERF. IV. B/01 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " GEMCITABINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MECITABINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 05 A 085 /14", "Code DCI": "05A085", "Forme": "SOL. INJ.", "Dosage": "1000MG", "Conditionnement": "B/01 FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "MECITABINE 200MG/FL. DE PDRE PDRE LYOPHILISEE P/INJ. EN PERF. IV B/01 FL. DE PDRE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " GEMCITABINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MECITABINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 05 A 094 /15", "Code DCI": "05A094", "Forme": "PDRE. SOL. INJ.", "Dosage": "200MG/FL. DE PDRE", "Conditionnement": "B/01 FL. DE PDRE", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEDICAINE 2% AVEC ADRENALINE 1/100 000 2% / 1/100 000  (OU 2G / 0,001G / 100ML) SOL. INJ. EN CARPULES B/50 CARPULES DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4089.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4089", "Laboratoire": " MEDIS (LABORATOIRES DES MEDICAMENTS STERILES)", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " MEPIVACAINE  (CHLORHYDRATE) / ADRENALINE (TARTRATE) ", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "MEDICAINE 2% AVEC ADRENALINE 1/100 000", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "331/ 02 C 028 /06", "Code DCI": "02C028", "Forme": "SOL. INJ.", "Dosage": "2% / 1/100 000  (OU 2G / 0,001G / 100ML)", "Conditionnement": "B/50 CARPULES DE 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEDICAINE 3% 0.03 SOL INJ  B/50CARPULES 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4092.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4092", "Laboratoire": " MEDIS (LABORATOIRES DES MEDICAMENTS STERILES)", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " MEPIVACAINE", "Pays": "TUNISIE", "Nom Commercial": "MEDICAINE 3%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "331/ 02 C 030 /05", "Code DCI": "02C030", "Forme": "SOL. INJ.", "Dosage": "0.03", "Conditionnement": "B/50CARPULES 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEDILIUM 1MG/ML SUSP.BUV. FL/200ML + PIPETTE GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEDILIUM", "Tarif de reference": "168 DA", "PPA": "N/A", "Num Enregistrement": "317/10F047/15", "Code DCI": "10F047", "Forme": "SUSP. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL/200ML + PIPETTE GRADUEE EN KG", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEDOCEF 1G PDRE. SOL. INJ. B/01 - B/10 - B/100*", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOPERAZONE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "MEDOCEF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "178/ 13 B 320 /07", "Code DCI": "13B320", "Forme": "PDRE. SOL.", "Dosage": "1G", "Conditionnement": "B/01 - B/10 - B/100*", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEDOCEF 2,00G PDRE. SOL. INJ. B/01-  B/10 - B/100*", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOPERAZONE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "MEDOCEF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "178/ 13 B 321 /07", "Code DCI": "13B321", "Forme": "PDRE. SOL.", "Dosage": "2,00G", "Conditionnement": "B/01-  B/10 - B/100*", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEDOCRIPTINE 2,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTI-PROLACTINE", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BROMOCRIPTINE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "MEDOCRIPTINE", "Tarif de reference": "684.9 DA", "PPA": "N/A", "Num Enregistrement": "178/ 09 D 006 /99", "Code DCI": "09D006", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEDOGLYCIN 600MG/2ML SOL. INJ. B/1 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LINCOMYCINE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "MEDOGLYCIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "178/ 13 D 026 /99", "Code DCI": "13D026", "Forme": "SOL. INJ.", "Dosage": "600MG/2ML", "Conditionnement": "B/1 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEDROL 16MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3761.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3761", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MEDROL", "Tarif de reference": "283.4 DA", "PPA": "N/A", "Num Enregistrement": "076/ 09 H 092 /99", "Code DCI": "09H092", "Forme": "COMP.", "Dosage": "16MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEDROL 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MEDROL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "076/ 09 H 033 /98", "Code DCI": "09H033", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEFESTAN 125MG SUPPO. NOURRISON ET ENFANT  B/06", "Img": "https://pharmnet-dz.com//img/medics/956.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=956", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE MEFENAMIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEFESTAN", "Tarif de reference": "40.62 DA", "PPA": " DA", "Num Enregistrement": "231/ 04 B 065 /09", "Code DCI": "04B065", "Forme": "SUPPO.", "Dosage": "125MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEFESTAN 250MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/960.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=960", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE MEFENAMIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEFESTAN", "Tarif de reference": "0 DA", "PPA": "200.00 DA", "Num Enregistrement": "231/ 04 B 069 /13", "Code DCI": "04B069", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEFESTAN 500MG SUPPO. ENFANT ET ADULTE  B/06", "Img": "https://pharmnet-dz.com//img/medics/957.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=957", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE MEFENAMIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEFESTAN", "Tarif de reference": "150 DA", "PPA": " DA", "Num Enregistrement": "231/ 04 B 066 /09", "Code DCI": "04B066", "Forme": "SUPPO.", "Dosage": "500MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEFLONIL 200\u00b5G PDRE. INHAL.EN GLES. + INHALATEUR B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2122", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "MEFLONIL", "Tarif de reference": "178.8 DA", "PPA": " DA", "Num Enregistrement": "068/ 20 A 089 /09", "Code DCI": "20A089", "Forme": "PDRE. INHAL.", "Dosage": "200\u00b5G", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEFLONIL 400\u00b5G PDRE. INHAL.EN GLES. + INHALATEUR B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2142", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "MEFLONIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 20 A 238 /09", "Code DCI": "20A238", "Forme": "PDRE. INHAL.", "Dosage": "400\u00b5G", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEFLOX 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MEFLOX", "Tarif de reference": "804 DA", "PPA": "N/A", "Num Enregistrement": "457/ 13 K 253 /11", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEGADYN  COMP PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3451.png", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COMPLEXE VITAMINIQUE + OLIGOELEMENTS", "Pays": "TURQUIE", "Nom Commercial": "MEGADYN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "177/ 14 H 177/98/08", "Code DCI": "14H177", "Forme": "COMP. PELLI.", "Dosage": "0", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEGAMAG 400MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/3392.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3392", "Laboratoire": " MAYOLY SPINDLER", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ASPARTATE DE MAGNESIUM DIHYDRATE", "Pays": "FRANCE", "Nom Commercial": "MEGAMAG", "Tarif de reference": "94.5 DA", "PPA": " DA", "Num Enregistrement": "067/ 14 G 161 /06", "Code DCI": "14G161", "Forme": "GLES.", "Dosage": "400MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEGAMOX 500MG/125MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JAZEERA PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "MEGAMOX", "Tarif de reference": "654.4 DA", "PPA": "N/A", "Num Enregistrement": "225/ 13 G 050 /03", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG/125MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEGAMYLASE 3000 U CEIP COMP. ENRO. B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=963", "Laboratoire": " TOP PHARM", "C.Pharmacologique": " ENZYMES A VISEE ANTI-INFLAMMAT.& ANTI-OEDEMATEUSE", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ALPHA-AMYLASE", "Pays": "FRANCE", "Nom Commercial": "MEGAMYLASE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "104/ 04 C 026 /00/15", "Code DCI": "04C026", "Forme": "COMP. ENRO.", "Dosage": "3000 U CEIP", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": false}, {"Nom": "MELAZA 500MG GELULE. LP B/90 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MELAZA", "Tarif de reference": "3156,3 DA", "PPA": " DA", "Code DCI": "10N075", "Forme": "GLES. LP", "Dosage": "500MG", "Conditionnement": "B/90 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MELIANE 20\u00b5G/75\u00b5G COMP. ENRO. B/21", "Img": "https://pharmnet-dz.com//img/medics/3051.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3051", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL/GESTODENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MELIANE", "Tarif de reference": "568.98 DA", "PPA": "N/A", "Num Enregistrement": "070/ 11 H 062 /01", "Code DCI": "11H062", "Forme": "COMP. PELLI.", "Dosage": "20\u00b5G/75\u00b5G", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": true}, {"Nom": "MELIANE 20\u00b5G/75\u00b5G COMP. ENRO. B/21", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " BAYER", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL/GESTODENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MELIANE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "424/11H062/01/16", "Code DCI": "11H062", "Forme": "COMP. ENRO.", "Dosage": "20\u00b5G/75\u00b5G", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": true}, {"Nom": "MELOX 15MG COMP. B/10 ET B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=942", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MELOXICAM", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "MELOX", "Tarif de reference": "312.34 DA", "PPA": "N/A", "Num Enregistrement": "178/ 04 B 058 /09", "Code DCI": "04B058", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/10 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "MELOX 7,5MG COMP. B/10 - B/100*", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=946", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MELOXICAM", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "MELOX", "Tarif de reference": "70 DA", "PPA": " DA", "Num Enregistrement": "178/ 04 B 060 /09", "Code DCI": "04B060", "Forme": "COMP.", "Dosage": "7,5MG", "Conditionnement": "B/10 - B/100*", "Commercialisation": true, "Remboursable": true}, {"Nom": "MENEFLOKS 200MG COMP B/10", "Img": "https://pharmnet-dz.com//img/medics/352.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "MENEFLOKS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "176/ 13 K 086 /01", "Code DCI": "13K086", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "MENODIS 100MG COMP. PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MENODIS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "235/04B033/16", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "MENOPUR 75UI FSH / 75UI LH PDRE. ET SOLV.  B/05FL. DE PDRE. + 05 AMP. DE SOLVT. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/3786.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3786", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " MENOTROPINE OU HORMONE GONADOTROPHINE POST MENOPAUSIQUE HUMAINE HMG EXPRIME EN HORMONE FOLLICULOSTIMULANTE FSH / HORMONE LUTEINISANTE LH", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MENOPUR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/ 09 J 046 /07/14", "Code DCI": "09J046", "Forme": "PDRE. SOL. INJ.", "Dosage": "75UI FSH / 75UI LH", "Conditionnement": "B/05FL. DE PDRE. + 05 AMP. DE SOLVT. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MENTEX 12,5MG/15MG/30MG/125MG/57MG/1MG/5ML SIROP FL./125ML + BOUCHON DOSEUR  ", "Img": "https://pharmnet-dz.com//img/medics/1468.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1468", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " DIPHENHYDRAMINE HYDROCHLORIDE / DEXTROMETHORPHANE HYDROBROMIDE / PSEUDOEPHEDRINE HYDROCHLORIDE / AMMONIUM CHLORIDE / SODIUM CITRATE / MENTHOL ", "Pays": "ALGERIE", "Nom Commercial": "MENTEX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 22 A 035 /08", "Code DCI": "22A035", "Forme": "SIROP", "Dosage": "12,5MG/15MG/30MG/125MG/57MG/1MG/5ML", "Conditionnement": "FL./125ML + BOUCHON DOSEUR  ", "Commercialisation": true, "Remboursable": false}, {"Nom": "MEPACYL 0,1G/25G/25G/100G SOL. P. USAGE DENTAIRE FL/14ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " PRODUITS DENTAIRES PIERRE ROLLAND", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " DEXAMETHASONE ACETATE/METACRESYL ACETATE/PARACHLOROPHENOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MEPACYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "246/ 23 B 036 /02", "Code DCI": "23B036", "Forme": "SOL. DENTAIRE", "Dosage": "0,1G/25G/25G/100G", "Conditionnement": "FL/14ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEPRA 1G/FL DE PDRE POUDRE POR SOLU, INJECT OU PERF IV B/10 FLACONS DE 20ML       ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "MEPRA", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "001/13G470/16", "Code DCI": "13G470", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL DE PDRE", "Conditionnement": "B/10 FLACONS DE 20ML       ", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEPRA 500MG/FLACON  POUDRE POR SOLU, INJECT OU PERF IV B/10FLACONS DE 20 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE", "Liste": "Liste I", "Pays": "PORTUGAL", "Nom Commercial": "MEPRA", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "001/13G477/16", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FLACON ", "Conditionnement": "B/10FLACONS DE 20 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEPRAMIDE 10MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2907.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEPRAMIDE", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "263/ 10 F 152 /06", "Code DCI": "10F152", "Forme": "SUPPO.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEPRENAL 20MG PDRE.SOL.INJ. B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MEPRENAL", "Tarif de reference": "116.82 DA", "PPA": "N/A", "Num Enregistrement": "039/ 09 H 029 /05", "Code DCI": "09H029", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEPRENAL 40MG PDRE.SOL.INJ. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MEPRENAL", "Tarif de reference": "129 DA", "PPA": "N/A", "Num Enregistrement": "039/ 09 H 030 /05", "Code DCI": "09H030", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "MERCILON 0,02MG/0,15MG COMP B/21", "Img": "https://pharmnet-dz.com//img/medics/3047.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " ORGANON", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL/DESOGESTREL", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "MERCILON", "Tarif de reference": "312.64 DA", "PPA": "N/A", "Num Enregistrement": "005/ 11 H  049 /98", "Code DCI": "11H049", "Forme": "COMP.", "Dosage": "0,02MG/0,15MG", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": true}, {"Nom": "MERCUROCHROME 0.02 SOL. USAGE EXTERNE FL/100L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " MERCUROCHROME", "Pays": "ALGERIE", "Nom Commercial": "MERCUROCHROME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 26 B 020 /03", "Code DCI": "26B020", "Forme": "SOL. EXTERNE", "Dosage": "0.02", "Conditionnement": "FL/100L", "Commercialisation": true, "Remboursable": null}, {"Nom": "MERCUROCHROME 0.02 SOL. USAGE EXTERNE FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RHUMEL PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " MERCUROCHROME", "Pays": "ALGERIE", "Nom Commercial": "MERCUROCHROME", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "234/ 26 B 020 /00", "Code DCI": "26B020", "Forme": "SOL. EXTERNE", "Dosage": "0.02", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MERCUROCHROME AQUEUX 2% 0.02 SOL. USAGE EXTERNE FL/1L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " MERCUROCHROME", "Pays": "ALGERIE", "Nom Commercial": "MERCUROCHROME AQUEUX 2%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 26 B 020 /99/09", "Code DCI": "26B020", "Forme": "SOL. EXTERNE", "Dosage": "0.02", "Conditionnement": "FL/1L", "Commercialisation": true, "Remboursable": null}, {"Nom": "MERCUROSCEINE  AQUEUSE- GIFRER 0.02 SOL. APPLI. LOCALE FL/45ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GIFRER BARBEZAT", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " MERCUROCHROME", "Pays": "FRANCE", "Nom Commercial": "MERCUROSCEINE  AQUEUSE- GIFRER", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "004/ 26 B 020 /96", "Code DCI": "26B020", "Forme": "SOL. EXTERNE", "Dosage": "0.02", "Conditionnement": "FL/45ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MERIDONE 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MERIDONE", "Tarif de reference": "195.3 DA", "PPA": "N/A", "Num Enregistrement": "457/ 10 F 046 /13", "Code DCI": "10F046", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MERONEM 1G/FL DE PDRE PDRE P. SOL INJ IV B/10 FL DE POUDRE", "Img": "https://pharmnet-dz.com//img/medics/349.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=349", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " MEROPENEME TRIHYDRATE EXPRIME EN MEROPENEME ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MERONEM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 13 G 470 /14", "Code DCI": "13G470", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL DE PDRE", "Conditionnement": "B/10 FL DE POUDRE", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEROXAZIDE 0.04 SUSP. BUV. B/01 FL. DE 90ML + GOBLET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEROXAZIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "457/ 10 C 018 /14", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "0.04", "Conditionnement": "B/01 FL. DE 90ML + GOBLET DOSEUR", "Commercialisation": true, "Remboursable": null}, {"Nom": "MESOPRAL 20MG GLES. A MICROGRANULES GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE MAGNESIUM TRIHYDRATE EXPRIME EN ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MESOPRAL", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 A 180 /09", "Code DCI": "10A180", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "MESTINON 60MG DRG. B/20 ET B/150", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " MEDA PHARMACEUTICALS SWITZERLAND GMBH ", "C.Pharmacologique": " ANTIMYASTHENIQUES", "C.Therapeutique": " NEUROLOGIE", "Info": " PYRIDOSTIGMINE BROMURE", "Pays": "SUISSE", "Nom Commercial": "MESTINON", "Tarif de reference": " N/A", "PPA": "3477.00 DA", "Num Enregistrement": "465/ 15 C 026 /05", "Code DCI": "15C026", "Forme": "DRG.", "Dosage": "60MG", "Conditionnement": "B/20 ET B/150", "Commercialisation": true, "Remboursable": null}, {"Nom": "METAGYL  125MG/5ML SUSPENSION BUVABLE FL/125ML + GOBLET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE BENZOATE EXPRIME EN METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METAGYL ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/13F040/16", "Code DCI": "13F040", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/125ML + GOBLET DOSEUR", "Commercialisation": true, "Remboursable": null}, {"Nom": "METALYSE 1000 U/ML OU 5MG/ML (10 000U/10ML OU 50MG/10ML) PDRE. ET SOLV. INJ. IV B/1FL. DE PDRE + 1 SERING. PRE REMPLIE DE SOLV. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " TENECTEPLASE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "METALYSE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "152/ 12 F 129 /08", "Code DCI": "12F129", "Forme": "PDRE. SOL. INJ.", "Dosage": "1000 U/ML OU 5MG/ML (10 000U/10ML OU 50MG/10ML)", "Conditionnement": "B/1FL. DE PDRE + 1 SERING. PRE REMPLIE DE SOLV. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METAZID 10MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " EZETIMIBE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METAZID", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "263/06M298/17", "Code DCI": "06M298", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "METEOSPASMYL 60MG/300MG CAPS. B/20", "Img": "https://pharmnet-dz.com//img/medics/2852.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2852", "Laboratoire": " MAYOLY SPINDLER", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " ALVERINE/SIMETICONE", "Pays": "FRANCE", "Nom Commercial": "METEOSPASMYL", "Tarif de reference": "203.6 DA", "PPA": " DA", "Num Enregistrement": "067/ 10 E 128 /03", "Code DCI": "10E128", "Forme": "CAPS.", "Dosage": "60MG/300MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "METEOXANE 125MG/80MG GLES B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IPRAD", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " SIMETICONE / PHLOROGLUCINOL", "Pays": "FRANCE", "Nom Commercial": "METEOXANE", "Tarif de reference": "339.6 DA", "PPA": "N/A", "Num Enregistrement": "240/ 10 B 119 /04", "Code DCI": "10B119", "Forme": "GLES.", "Dosage": "125MG/80MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "METEOXANE 125MG/80MG GLES B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " SIMETICONE / PHLOROGLUCINOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METEOXANE", "Tarif de reference": "339.6 DA", "PPA": "N/A", "Num Enregistrement": "015/10B119/04/15", "Code DCI": "10B119", "Forme": "GLES.", "Dosage": "125MG/80MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "METFOR 850MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/3629.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METFOR", "Tarif de reference": "295.2 DA", "PPA": "N/A", "Num Enregistrement": "352/ 14 A 007 /05", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "METFORAL 1000MG COMP. PELLI. SEC. B/30 ET B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GUIDOTTI SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "METFORAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "367/ 14 A 224 /15", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/30 ET B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "METFORAL 850MG COMP. PELLI. SEC. B/30 - B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GUIDOTTI SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "METFORAL", "Tarif de reference": " N/A", "PPA": "442.00 DA", "Num Enregistrement": "367/ 14 A 007 /99/15", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30 - B/90", "Commercialisation": true, "Remboursable": null}, {"Nom": "METFORMINE ZENTIVA 1000MG COMP. PELLI. B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METFORMINE ZENTIVA", "Tarif de reference": "520.2 DA", "PPA": "520.00 DA", "Num Enregistrement": "428/ 14 A 224 /09", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "METFORMINE ZENTIVA 850MG COMP. PELLI. B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METFORMINE ZENTIVA", "Tarif de reference": " N/A", "PPA": "442.00 DA", "Num Enregistrement": "428/ 14 A 007 /09/14", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHERGIN 0,25MG/ML SOL.BUV.GTTES. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3026", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHERGIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "068/ 11 C 012 /99", "Code DCI": "11C012", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,25MG/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHERGIN 0,2MG/ML SOL.INJ. B/3AMP DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/3020.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3020", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHERGIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 11 C 011 /97", "Code DCI": "11C011", "Forme": "SOL. INJ.", "Dosage": "0,2MG/ML", "Conditionnement": "B/3AMP DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXAT \"EBEWE\" 1000MG PDRE.SOL.INJ. B/1FL (1000 MG/10ML)", "Img": "https://pharmnet-dz.com//img/medics/986.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=986", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "METHOTREXAT \"EBEWE\"", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 030 /98", "Code DCI": "05A030", "Forme": "PDRE. SOL. INJ.", "Dosage": "1000MG", "Conditionnement": "B/1FL (1000 MG/10ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXAT EBEWE 100MG/ML (OU 500MG/5ML ET 1000MG/10ML) CONCENTRE SOL.INJ.PERF. FL/5ML -  FL/10ML ", "Img": "https://pharmnet-dz.com//img/medics/1017.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1017", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "METHOTREXAT EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 126 /98/08", "Code DCI": "05A126", "Forme": "SOL. INJ.", "Dosage": "100MG/ML (OU 500MG/5ML ET 1000MG/10ML)", "Conditionnement": "FL/5ML -  FL/10ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXAT EBEWE 10MG/ML (OU 50MG/5ML) SOL.INJ. B/1FL/5 ML", "Img": "https://pharmnet-dz.com//img/medics/15.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "METHOTREXAT EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 G 124 /98/09", "Code DCI": "05G124", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (OU 50MG/5ML)", "Conditionnement": "B/1FL/5 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXAT EBEWE 2,5MG COMP B/50", "Img": "https://pharmnet-dz.com//img/medics/988.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "METHOTREXAT EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 032 /03/08", "Code DCI": "05A032", "Forme": "COMP.", "Dosage": "2,5MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXATE BELLON 2,5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/989.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=989", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHOTREXATE BELLON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 05 A 032 /96", "Code DCI": "05A032", "Forme": "COMP.", "Dosage": "2,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXATE BELLON 500MG/FL. DE PDRE. LYOPH. P. SOL.INJ. B/10 FL (500 MG/20ML)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=984", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHOTREXATE BELLON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 05 A 029 /96", "Code DCI": "05A029", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/10 FL (500 MG/20ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXATE BELLON 5MG/2ML SOL.INJ. B/1FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=980", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHOTREXATE BELLON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 05 A 026 /96", "Code DCI": "05A026", "Forme": "SOL. INJ.", "Dosage": "5MG/2ML", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHOTREXATE EBEWE 10MG/ML**  (OU 7,5MG/0,75ML - 10MG/ML - 15MG/1,5ML - 20MG/2ML) SOL. INJ. EN SERING. PREREMPL. SC/IM/IV B/1SERING. PREREMPLIE DE 0,75ML - B/1SERING. PREREMPLIE DE 1ML - B/1SERING. PREREMPLIE DE 1,5ML -  B/1SERING. PREREMPLIE DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " METHOTREXATE DISODIQUE EXPRIME EN METHOTREXATE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "METHOTREXATE EBEWE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "141/ 21 J 059 /10", "Code DCI": "21J059", "Forme": "SOL. INJ.", "Dosage": "10MG/ML**  (OU 7,5MG/0,75ML - 10MG/ML - 15MG/1,5ML - 20MG/2ML)", "Conditionnement": "B/1SERING. PREREMPLIE DE 0,75ML - B/1SERING. PREREMPLIE DE 1ML - B/1SERING. PREREMPLIE DE 1,5ML -  B/1SERING. PREREMPLIE DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHOTREXATE MYLAN 100MG/ML (1G/10ML - 5G/50ML) SOL. INJ.  B/10FL. DE 10ML ET B/10FL DE /50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=16", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHOTREXATE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 G 126 /08", "Code DCI": "05G126", "Forme": "SOL. INJ.", "Dosage": "100MG/ML (1G/10ML - 5G/50ML)", "Conditionnement": "B/10FL. DE 10ML ET B/10FL DE /50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHOTREXATE MYLAN 2,5MG/ML (OU 5MG/2ML) SOL. INJ. B/10FL. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1101", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHOTREXATE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 G 026 /08", "Code DCI": "05G026", "Forme": "SOL. INJ.", "Dosage": "2,5MG/ML (OU 5MG/2ML)", "Conditionnement": "B/10FL. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHOTREXATE MYLAN 25MG/ML (OU 50MG/2ML - 500MG/20ML) SOL. INJ. B/10FL DE 2ML ET B/10FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1102", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHOTREXATE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 G 028 /08", "Code DCI": "05G028", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (OU 50MG/2ML - 500MG/20ML)", "Conditionnement": "B/10FL DE 2ML ET B/10FL. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHOTREXATE.BELLON 50MG SOL.INJ. B/10FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=982", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " METHOTREXATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHOTREXATE.BELLON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 05 A 028 /96", "Code DCI": "05A028", "Forme": "SOL. INJ.", "Dosage": "50MG", "Conditionnement": "B/10FL", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHYLERGOBREVIN 0,25MG/ML SOL.BUV.GTTES FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "METHYLERGOBREVIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "161/ 11 C 012 /99", "Code DCI": "11C012", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,25MG/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHYLERGOBREVIN 0,2MG/ML SOL.INJ. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "METHYLERGOBREVIN", "Tarif de reference": "0 DA", "PPA": "173.00 DA", "Num Enregistrement": "161/ 11 C 011 /99", "Code DCI": "11C011", "Forme": "SOL. INJ.", "Dosage": "0,2MG/ML", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHYLERGOMETRINE 0,25MG/ML SOL. BUV.GTTES. FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHYLERGOMETRINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 11 C 012 /99", "Code DCI": "11C012", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,25MG/ML", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHYLERGOMETRINE 0,2MG/ML SOL.INJ. B/100AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHYLERGOMETRINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 11 C 011 /98", "Code DCI": "11C011", "Forme": "SOL. INJ.", "Dosage": "0,2MG/ML", "Conditionnement": "B/100AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METHYLERGOMETRINE ROTEXMEDICA 0,2MG/ML SOL. INJ. IM/IV B/10AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " ROTEXMEDICA GmbH", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "METHYLERGOMETRINE ROTEXMEDICA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "415/ 11 C 011 /08", "Code DCI": "11C011", "Forme": "SOL. INJ.", "Dosage": "0,2MG/ML", "Conditionnement": "B/10AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHYLPREDNISOLONE MYLAN 1G/FL. DE PDRE. PDRE. P. SOL INJ I.V. B/10FL.DE PDRE.*", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3767", "Laboratoire": " MYLAN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE HEMISUCCINATE EXPRIME EN METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHYLPREDNISOLONE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 09 H 135 /06/13", "Code DCI": "09H135", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/10FL.DE PDRE.*", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHYLPREDNISOLONE MYLAN 20MG/FL. DE PDRE. PDRE. P. SOL. INJ. IM/ IV B/20FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=659", "Laboratoire": " MYLAN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHYLPREDNISOLONE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 09 H 029 /07/13", "Code DCI": "09H029", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG/FL. DE PDRE.", "Conditionnement": "B/20FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHYLPREDNISOLONE MYLAN 40MG/FL. DE PDRE. PDRE. P. SOL. INJ. IM/IV B/20FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=664", "Laboratoire": " MYLAN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHYLPREDNISOLONE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 09 H 030 /03/13", "Code DCI": "09H030", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG/FL. DE PDRE.", "Conditionnement": "B/20FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "METHYLPREDNISONE MYLAN 120MG/FL. DE PDRE. PDRE. P. SOL. INJ. IM/IV B/20FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=668", "Laboratoire": " MYLAN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METHYLPREDNISONE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 09 H 031 /01/13", "Code DCI": "09H031", "Forme": "PDRE. SOL. INJ.", "Dosage": "120MG/FL. DE PDRE.", "Conditionnement": "B/20FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "METOCLAM 0.001 SOL. BUV. F/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "METOCLAM", "Tarif de reference": "136 DA", "PPA": "161.00 DA", "Num Enregistrement": "077/ 10 F 044 /03", "Code DCI": "10F044", "Forme": "SOL. BUV.", "Dosage": "0.001", "Conditionnement": "F/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METOCLOPRAMIDE 10MG SOL. INJ. B/10AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "METOCLOPRAMIDE", "Tarif de reference": "144.2 DA", "PPA": "N/A", "Num Enregistrement": "002/ 10 F 042 /98", "Code DCI": "10F042", "Forme": "SOL. INJ.", "Dosage": "10MG", "Conditionnement": "B/10AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "METOCROVIS 200MG COMP. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " METOPROLOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "METOCROVIS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 06 F 071 /99/14", "Code DCI": "06F071", "Forme": "COMP. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "METOPHAGE 850MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/4440.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METOPHAGE", "Tarif de reference": "492 DA", "PPA": " DA", "Num Enregistrement": "289/14A007/07/16", "Code DCI": "14A007", "Forme": "COMP.", "Dosage": "850MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "METOPRAM 10MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "METOPRAM", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "366/10F152/16", "Code DCI": "10F152", "Forme": "SUPPO.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "METOPRESS 100MG GLES. LP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3269.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " METOPROLOL SUCCINATE EXPRIME EN METOPROLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METOPRESS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "289/ 06 F 309 /15", "Code DCI": "06F309", "Forme": "GLES. LP", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "METOPRESS 200MG microgranul\u00e9s a LP EN g\u00e9lules B/30", "Img": "https://pharmnet-dz.com//img/medics/4198.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " METOPROLOL SUCCINATE EXPRIME EN METOPROLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METOPRESS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "289/06F071/15", "Code DCI": "06F071", "Forme": "MICROGRANULES", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "METOPRIN 0.001 SOL. BUV.  FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "METOPRIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "026/ 10 F 044 /02/09", "Code DCI": "10F044", "Forme": "SOL. BUV.", "Dosage": "0.001", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METRIS 500MG SOL. INJ. B/1FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METRIS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 F 038 /06", "Code DCI": "13F038", "Forme": "SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/1FL. DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METROFAGYL 500MG OVULES B/10", "Img": "https://pharmnet-dz.com//img/medics/3005.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3005", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METROFAGYL", "Tarif de reference": "160 DA", "PPA": "160.00 DA", "Num Enregistrement": "366/ 11 A 002 /07/13", "Code DCI": "11A002", "Forme": "OVULE ", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "METROGYL 125MG/5ML SUSP. BUV. FL./120ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METROGYL", "Tarif de reference": "138 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 F 040 /09", "Code DCI": "13F040", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL./120ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METROGYL 250MG COMP.SEC B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METROGYL", "Tarif de reference": " N/A", "PPA": "142.00 DA", "Num Enregistrement": "003/ 13 F 039 /01/09", "Code DCI": "13F039", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "METROGYL 500MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METROGYL", "Tarif de reference": " N/A", "PPA": "185.00 DA", "Num Enregistrement": "003/ 13 F 199 /05/10", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "METROMYCINE 1,5MUI/250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE / METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METROMYCINE", "Tarif de reference": " N/A", "PPA": "386.00 DA", "Num Enregistrement": "457/ 13 E 307 /11", "Code DCI": "13E307", "Forme": "COMP. PELLI.", "Dosage": "1,5MUI/250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "METRONIDAZOLE BEKER 250MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/861.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=861", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METRONIDAZOLE BEKER", "Tarif de reference": "148.50 DA", "PPA": "160.5 DA", "Num Enregistrement": "447/ 13 F 039 /15", "Code DCI": "13F039", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "METRONIDAZOLE BEKER 500MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/872.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=872", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METRONIDAZOLE BEKER", "Tarif de reference": "198.00 DA", "PPA": "160.00 DA", "Num Enregistrement": "447/ 13 F 199 /15", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "METRONIDAZOLE BIEFFE MEDITAL 500MG/100ML ( 0,5%) SOL.INJ POCHES DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIEFFE MEDITAL", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "METRONIDAZOLE BIEFFE MEDITAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "129/ 13 F 038 /01/14", "Code DCI": "13F038", "Forme": "SOL. INJ.", "Dosage": "500MG/100ML ( 0,5%)", "Conditionnement": "POCHES DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "METRONIDAZOLE BIOSEDRA 500MG/100ML ( OU 0,5%) SOL. INJ. PERF.IV FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=857", "Laboratoire": " FRESENIUS KABI", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "METRONIDAZOLE BIOSEDRA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "332/ 13 F 038 /08", "Code DCI": "13F038", "Forme": "SOL. INJ.", "Dosage": "500MG/100ML ( OU 0,5%)", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METRONIDAZOLE HUP 500MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/873.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METRONIDAZOLE HUP", "Tarif de reference": "160 DA", "PPA": "160.00 DA", "Num Enregistrement": "380/ 13 F 199 /14", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "METRONIDAZOLE MM 500MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METRONIDAZOLE MM", "Tarif de reference": "160 DA", "PPA": "201.00 DA", "Num Enregistrement": "470/ 13 F 199 /13", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "METRONIDAZOLE RAZES 0,5% 5MG/ML (500MG/100ML) SOL. INJ. P. PERF. FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/855.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METRONIDAZOLE RAZES 0,5%", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "433/ 13 F 038 /13", "Code DCI": "13F038", "Forme": "SOL. INJ.", "Dosage": "5MG/ML (500MG/100ML)", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "METZOL 125MG/5ML SIROP FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/867.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=867", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "METZOL", "Tarif de reference": "115 DA", "PPA": "N/A", "Num Enregistrement": "242/ 13 F 040 /04", "Code DCI": "13F040", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEVAKINE 200MG/ML SOL. BUV. FL./100ML + PIPETTE GRAD.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MEVAKINE", "Tarif de reference": "0 DA", "PPA": "419.00 DA", "Num Enregistrement": "077/ 15 A 003 /08", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL./100ML + PIPETTE GRAD.", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEVERC 16MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " BETAHISTINE (SOUS FORME DE DICHLORHYDRATE)**", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MEVERC", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "077/18C025/16", "Code DCI": "18C025", "Forme": "COMP.", "Dosage": "16MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "MEVERC 8MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2029.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2029", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " BETAHISTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MEVERC", "Tarif de reference": "130.8 DA", "PPA": "N/A", "Num Enregistrement": "077/ 18 C 007 /07", "Code DCI": "18C007", "Forme": "COMP.", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MEVIROX  250MG LYOPH. SOL. INJ.  B/1FL ", "Img": "https://pharmnet-dz.com//img/medics/421.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=421", "Laboratoire": " MEDIS (LABORATOIRES DES MEDICAMENTS STERILES)", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "MEVIROX ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "331/ 13 P 098 /05", "Code DCI": "13P098", "Forme": "PDRE. SOL. INJ.", "Dosage": "250MG", "Conditionnement": "B/1FL ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIACIN 250MG/ML (500MG/2ML) SOL.INJ. B/6AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMIKACINE SULFATE EXPRIME EN AMIKACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MIACIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 A 001 /98/09", "Code DCI": "13A001", "Forme": "SOL. INJ.", "Dosage": "250MG/ML (500MG/2ML)", "Conditionnement": "B/6AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MIACIN 50MG/ML (100MG/2ML) SOL.INJ B/6 AMP. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMIKACINE SULFATE EXPRIME EN AMIKACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MIACIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 A 234 /00/09", "Code DCI": "13A234", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (100MG/2ML)", "Conditionnement": "B/6 AMP. DE 2ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "MICARDIS 40MG COMP.  B/28", "Img": "https://pharmnet-dz.com//img/medics/3202.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3202", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "MICARDIS", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "152/ 06 E 263 /08", "Code DCI": "06E263", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICARDIS 80MG COMP.  B/28", "Img": "https://pharmnet-dz.com//img/medics/3204.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3204", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "MICARDIS", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "152/ 06 E 264 /08", "Code DCI": "06E264", "Forme": "COMP.", "Dosage": "80MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICARDIS PLUS 40MG/12,5MG COMP.  B/28", "Img": "https://pharmnet-dz.com//img/medics/3205.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "MICARDIS PLUS", "Tarif de reference": "1441.44 DA", "PPA": "N/A", "Num Enregistrement": "152/ 06 E 265 /08", "Code DCI": "06E265", "Forme": "COMP.", "Dosage": "40MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICARDIS PLUS 80MG/12,5MG COMP.  B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "MICARDIS PLUS", "Tarif de reference": "2044 DA", "PPA": "1466.00 DA", "Num Enregistrement": "152/ 06 E 266 /08", "Code DCI": "06E266", "Forme": "COMP.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICODAL 0.02 GEL.DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " MICONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MICODAL", "Tarif de reference": "157.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 07 D 031 /01", "Code DCI": "07D031", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICOGEL 2G% GEL.DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " MICONAZOLE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "MICOGEL", "Tarif de reference": "118.2 DA", "PPA": "N/A", "Num Enregistrement": "182/ 07 D 031 /98", "Code DCI": "07D031", "Forme": "CR\u00c8ME", "Dosage": "2G%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICOHEAL 2G% CREME DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " MICONAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MICOHEAL", "Tarif de reference": "118.2 DA", "PPA": "N/A", "Num Enregistrement": "055/ 07D 031 /97", "Code DCI": "07D031", "Forme": "CR\u00c8ME", "Dosage": "2G%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICONAZOLE NOVAGENERICS 0.02 GEL BUCCAL T/50G + CUILLIERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/1143.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " N/D", "C.Therapeutique": " STOMATOLOGIE", "Info": " MICONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MICONAZOLE NOVAGENERICS", "Tarif de reference": "0 DA", "PPA": "392.00 DA", "Num Enregistrement": "149/ 23 D 037 /15", "Code DCI": "23D037", "Forme": "GEL", "Dosage": "0.02", "Conditionnement": "T/50G + CUILLIERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICOTYDE 10MUI/100MG/250MG/100G PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " NYSTATINE / TRIAMCINOLONE / NEOMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MICOTYDE", "Tarif de reference": "120 DA", "PPA": "155.00 DA", "Num Enregistrement": "366/ 07 C 020 /09", "Code DCI": "07C020", "Forme": "PDE. DERM.", "Dosage": "10MUI/100MG/250MG/100G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICROGYNON 0,15MG/0,03MG COMP.ENRO. B/ 63 ", "Img": "https://pharmnet-dz.com//img/medics/3043.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3043", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MICROGYNON", "Tarif de reference": "209.4 DA", "PPA": "N/A", "Num Enregistrement": "070/ 11 H 040 /98", "Code DCI": "11H040", "Forme": "COMP.", "Dosage": "0,15MG/0,03MG", "Conditionnement": "B/ 63 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MICROLAX 6,25G GEL.RECT.UNIDOSE B/6", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANOFI WINTHROP", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " SORBITOL CITRATE ET LAURYL SULFOACETATE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "MICROLAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "052/ 10 M 071 /98", "Code DCI": "10M071", "Forme": "GEL RECTAL", "Dosage": "6,25G", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": null}, {"Nom": "MICROVAL 0,03MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MICROVAL", "Tarif de reference": "119.84 DA", "PPA": "157.00 DA", "Num Enregistrement": "030/ 11 H 027 /98", "Code DCI": "11H027", "Forme": "COMP.", "Dosage": "0,03MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIDAFLEX 250MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MIDAFLEX", "Tarif de reference": "278 DA", "PPA": "N/A", "Num Enregistrement": "226/ 13 B 009 /99", "Code DCI": "13B009", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIDAFLEX 250MG/5ML** PDRE .SUSP .BUV.  FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MIDAFLEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "226/ 13 B 156 /00/09", "Code DCI": "13B156", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML**", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MIDAFLEX 500MG** GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MIDAFLEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "226/ 13 B 010 /99/09", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG**", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "MIDAZOLAM 5MG/ML (15MG/3ML)  SOL. INJ. IM/IV B/05AMP DE 3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPNOTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " MIDAZOLAM", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MIDAZOLAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 16 C 051 /08/15", "Code DCI": "16C051", "Forme": "SOL. INJ.", "Dosage": "5MG/ML (15MG/3ML) ", "Conditionnement": "B/05AMP DE 3ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MIDAZOLAM MYLAN 1MG/ML (OU 5MG/5ML) SOL. INJ. IM IV ET RECTALE B/10 AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/2193.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2193", "Laboratoire": " MYLAN", "C.Pharmacologique": " HYPNOTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " MIDAZOLAM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MIDAZOLAM MYLAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "450/ 16 C 152 /08", "Code DCI": "16C152", "Forme": "SOL. INJ.", "Dosage": "1MG/ML (OU 5MG/5ML)", "Conditionnement": "B/10 AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIDAZOLAM MYLAN 5MG/ML (50MG/10ML) SOL. INJ. IM/IV ET RECTALE B/10AMP. DE 1ML -  B/10AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2188", "Laboratoire": " MYLAN", "C.Pharmacologique": " HYPNOTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " MIDAZOLAM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MIDAZOLAM MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 16 C 051 /08", "Code DCI": "16C051", "Forme": "SOL. INJ.", "Dosage": "5MG/ML (50MG/10ML)", "Conditionnement": "B/10AMP. DE 1ML -  B/10AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MIGLUCAN 2,5MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIBENCLAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MIGLUCAN", "Tarif de reference": "110.4 DA", "PPA": "N/A", "Num Enregistrement": "105/ 14 A 002 /98", "Code DCI": "14A002", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIGRAZEN 0,5MG DE PIZOTIFENE (0,73MG DE MALATE) COMP. PELLI. B/50", "Img": "https://pharmnet-dz.com//img/medics/2464.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " PIZOTIFENE (SOUS FORME DE MALATE)", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MIGRAZEN", "Tarif de reference": "0 DA", "PPA": "245.00 DA", "Num Enregistrement": "035/ 15 B 022 /07", "Code DCI": "15B022", "Forme": "COMP. PELLI.", "Dosage": "0,5MG DE PIZOTIFENE (0,73MG DE MALATE)", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIGREX 50MG COMP PELLI B/06", "Img": "https://pharmnet-dz.com//img/medics/4571.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " SUMATRIPTAN SUCCINATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MIGREX", "Tarif de reference": "1257.90 DA", "PPA": "1257.90 DA", "Num Enregistrement": "447/15B059/16", "Code DCI": "15B059", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIMPARA 30MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3833.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3833", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "MIMPARA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 09 S 171 /13", "Code DCI": "09S171", "Forme": "COMP. PELLI.", "Dosage": "30MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIMPARA 60MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3834.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3834", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "MIMPARA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 09 S 172 /13", "Code DCI": "09S172", "Forme": "COMP. PELLI.", "Dosage": "60MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIMPARA 90MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3835.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3835", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CINACALCET CHLORHYDRATE EXPRIME EN CINACALCET", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "MIMPARA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 09 S 173 /13", "Code DCI": "09S173", "Forme": "COMP. PELLI.", "Dosage": "90MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MINESSE 15\u00b5G/60\u00b5G COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3055.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYL ESTRADIOL /  GESTODENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MINESSE", "Tarif de reference": "620.44 DA", "PPA": "N/A", "Num Enregistrement": "030/ 11 H 069 /04", "Code DCI": "11H069", "Forme": "COMP. PELLI.", "Dosage": "15\u00b5G/60\u00b5G", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "MINIDRIL 0,15MG/0,03MG COMP. B/21 ", "Img": "https://pharmnet-dz.com//img/medics/3044.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3044", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MINIDRIL", "Tarif de reference": "232.13 DA", "PPA": "N/A", "Num Enregistrement": "030/ 11 H 040 /98", "Code DCI": "11H040", "Forme": "COMP.", "Dosage": "0,15MG/0,03MG", "Conditionnement": "B/21 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MINIDRIL 0,15MG/0,03MG COMP. B/21 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4270", "Laboratoire": " PFIZER", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MINIDRIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/11H040/98/15", "Code DCI": "11H040", "Forme": "COMP.", "Dosage": "0,15MG/0,03MG", "Conditionnement": "B/21 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MINIRIN 4\u00b5G/ML SOL.INJ. B/10AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/1821.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1821", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " HEMOSTATIQUES GENERAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DESMOPRESSINE (ACETATE)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "MINIRIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/ 12 H 038 /04", "Code DCI": "12H038", "Forme": "SOL. INJ.", "Dosage": "4\u00b5G/ML", "Conditionnement": "B/10AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MINIRIN SPRAY 0,1MG/ML (10\u00b5G/DOSE) SOL. ENDONASALE EN FLACON PULVERISATEUR FL./2,5ML (25DOSES)", "Img": "https://pharmnet-dz.com//img/medics/3784.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3784", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DESMOPRESSINE ACETATE TRIHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "MINIRIN SPRAY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/ 09 J 042 /03/15", "Code DCI": "09J042", "Forme": "SOL. ENDONASALE EN FLACON PULVERISATEUR", "Dosage": "0,1MG/ML (10\u00b5G/DOSE)", "Conditionnement": "FL./2,5ML (25DOSES)", "Commercialisation": true, "Remboursable": true}, {"Nom": "MINIRINMELT 60\u00b5G/LYOPH. LYOPH. ORAL SUBLINGUAL B/30 ", "Img": "https://pharmnet-dz.com//img/medics/3802.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3802", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " DESMOPRESSINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "MINIRINMELT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/ 09 J 170 /12", "Code DCI": "09J170", "Forme": "LYOPH. ORAL SUBLINGUAL", "Dosage": "60\u00b5G/LYOPH.", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MINOXIDIL NS 0.02 SOL. P. APPL. CUTANEE B/1FL DE 120ML AVEC PULVERISATEUR ET PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " MINOXIDIL", "Pays": "ALGERIE", "Nom Commercial": "MINOXIDIL NS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "318/ 07 B 146 /13", "Code DCI": "07B146", "Forme": "SOL. APP. LOCALE", "Dosage": "0.02", "Conditionnement": "B/1FL DE 120ML AVEC PULVERISATEUR ET PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "MINOXIDIL NS 0.05 SOL. P. APPL. LOCALE B/1FL. DE 120ML AVEC PULVERISATEUR ET PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " MINOXIDIL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MINOXIDIL NS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "318/ 07 B 091 /13", "Code DCI": "07B091", "Forme": "SOL. APP. LOCALE", "Dosage": "0.05", "Conditionnement": "B/1FL. DE 120ML AVEC PULVERISATEUR ET PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "MIRENA 20\u00b5G/24H 52MG/DISPOSITIF   DISPOSITIF INTRA-UTERIN STERILE B/01DISPOSITIF MUNI D'INSERTEUR (EVO-INSERTEUR)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " BAYER", "C.Pharmacologique": " DISPOSITIFS INTRA-UTERINS", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL", "Liste": "Liste I", "Pays": "FINLANDE", "Nom Commercial": "MIRENA 20\u00b5G/24H", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "424/ 11 J 077 /08", "Code DCI": "11J077", "Forme": "DISPOSITIF", "Dosage": "52MG/DISPOSITIF  ", "Conditionnement": "B/01DISPOSITIF MUNI D'INSERTEUR (EVO-INSERTEUR)", "Commercialisation": true, "Remboursable": null}, {"Nom": "MISULAR 200 MG CP SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MISULAR", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "16D094", "Forme": "COMP SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MITOXANTRON EBEWE 2MG/ML (20MG/10ML) CONC. SOL.INJ.PERF. IV B/01FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1104", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " MITOXANTRONE CHLORHYDRATE EXPRIME EN MITOXANTRONE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "MITOXANTRON EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 G 065 /09", "Code DCI": "05G065", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (20MG/10ML)", "Conditionnement": "B/01FL. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MITRIL  50MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MITRIL ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "16A002", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "MITRIL 25MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medics/2517.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2517", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MITRIL", "Tarif de reference": "285 DA", "PPA": " DA", "Num Enregistrement": "242/ 16 A 001 /03", "Code DCI": "16A001", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "MITRIL 4% (40MG/ML) SOL. BUV. EN GTTES FL./30ML", "Img": "https://pharmnet-dz.com//img/medics/2528.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2528", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MITRIL", "Tarif de reference": "0 DA", "PPA": "125.00 DA", "Num Enregistrement": "242/ 16 A 003 /06", "Code DCI": "16A003", "Forme": "SOL. BUV. GTTES.", "Dosage": "4% (40MG/ML)", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MITRIL 50 50MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/2521.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2521", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MITRIL 50", "Tarif de reference": "0 DA", "PPA": "350.00 DA", "Num Enregistrement": "242/ 16 A 002 /05", "Code DCI": "16A002", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIVACRON 10MG/5ML SOL.INJ.IV B/10 ", "Img": "https://pharmnet-dz.com//img/medics/4110.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4110", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " MIVACURIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MIVACRON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 02 D 048 /99", "Code DCI": "02D048", "Forme": "SOL. INJ.", "Dosage": "10MG/5ML", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIXTARD 30 HM PENFILL 100UI/ML SUSP INJ  B/5 CART. DE 1,5 ML ET B/5CART DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3734.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3734", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE INTERMEDIAIRE BIPHASIQUE", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "MIXTARD 30 HM PENFILL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 B 157 /98", "Code DCI": "14B157", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART. DE 1,5 ML ET B/5CART DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MIXTARD 30HM 100UI/ML SUSP INJ  FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/3736.png", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) 30% / INSULINE HUMAINE ISOPHANE 70%", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "MIXTARD 30HM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 B 192 /00", "Code DCI": "14B192", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MMF 250MG COMP. PELLI. B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1266", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " MYCOPHENOLATE MOFETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MMF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 27 A 003 /13", "Code DCI": "27A003", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": null}, {"Nom": "MMF 500MG COMP. PELLI. B/56", "Img": "https://pharmnet-dz.com//img/medics/1267.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1267", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " MYCOPHENOLATE MOFETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MMF", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "317/ 27 A 002 /10", "Code DCI": "27A002", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "MODENUM 10MG/2ML SOL. INJ. IM/IV B/10 ET B/50", "Img": "https://pharmnet-dz.com//img/medics/2858.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MODENUM", "Tarif de reference": " N/A", "PPA": "265.00 DA", "Num Enregistrement": "433/ 10 F 042 /15", "Code DCI": "10F042", "Forme": "SOL. INJ.", "Dosage": "10MG/2ML", "Conditionnement": "B/10 ET B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "MODESTAMINE 4MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3335.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3335", "Laboratoire": " SANAMED", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Pays": "ALGERIE", "Nom Commercial": "MODESTAMINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "097/ 14 F 025 /09/14", "Code DCI": "14F025", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "MODURETIC 5MG**/50MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1479.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1479", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMILORIDE (SOUS FORME DE CHLORHYDRATE)**/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MODURETIC", "Tarif de reference": "205.5 DA", "PPA": " DA", "Num Enregistrement": "024/ 06 H 094 /98", "Code DCI": "06H094", "Forme": "COMP.", "Dosage": "5MG**/50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOLSIDOMINE BEKER 2MG  COMP SEC B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/95.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=95", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOLSIDOMINE BEKER", "Tarif de reference": "0 DA", "PPA": "266.49 DA", "Num Enregistrement": "447/ 06 C 022 /14", "Code DCI": "06C022", "Forme": "COMP. SEC.", "Dosage": "2MG ", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOLSIDOMINE BEKER 4MG COMP. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/102.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=102", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOLSIDOMINE BEKER", "Tarif de reference": "0 DA", "PPA": "449.99 DA", "Num Enregistrement": "447/ 06 C 023 /14", "Code DCI": "06C023", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOLSIDOMINE IVAL 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOLSIDOMINE IVAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 C 022 /07", "Code DCI": "06C022", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOLSIDOMINE IVAL 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOLSIDOMINE IVAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 C 023 /07", "Code DCI": "06C023", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOLSIKET RETARD 8MG COMP. L.P. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "MOLSIKET RETARD", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 244 /07", "Code DCI": "06C244", "Forme": "COMP. LP", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOLSINE 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOLSINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "263/ 06 C 022 /08", "Code DCI": "06C022", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOLSINE 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOLSINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "263/ 06 C 023 /08", "Code DCI": "06C023", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONO-TILDIEM LP 300MG MICROGLES. LP EN GLES. B/28 ", "Img": "https://pharmnet-dz.com//img/medics/51.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=51", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MONO-TILDIEM LP", "Tarif de reference": "698.48 DA", "PPA": "N/A", "Num Enregistrement": "392/ 06 B 010 /97/15", "Code DCI": "06B010", "Forme": "COMP. LP", "Dosage": "300MG", "Conditionnement": "B/28 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONTELAIR 10MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/2130.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2130", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MONTELAIR", "Tarif de reference": "2400 DA", "PPA": "2400.00 DA", "Num Enregistrement": "352/ 20 A 211 /12", "Code DCI": "20A211", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONTELAIR 4MG COMP. A CROQUER  B/30", "Img": "https://pharmnet-dz.com//img/medics/2133.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2133", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MONTELAIR", "Tarif de reference": "2700 DA", "PPA": "N/A", "Num Enregistrement": "352/ 20 A 225 /13", "Code DCI": "20A225", "Forme": "COMP. A CROQ.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONTELAIR 5MG COMP. A CROQUER B/30", "Img": "https://pharmnet-dz.com//img/medics/2137.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2137", "Laboratoire": " EL KENDI", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MONTELAIR", "Tarif de reference": "2400 DA", "PPA": "2311.00 DA", "Num Enregistrement": "352/ 20 A 226 /13", "Code DCI": "20A226", "Forme": "COMP. A CROQ.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONTELUKAST BEKER  5MG COMP. A CROQUER B/30", "Img": "https://pharmnet-dz.com//img/medics/2138.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2138", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MONTELUKAST BEKER", "Tarif de reference": "2400 DA", "PPA": "2311.97 DA", "Num Enregistrement": "447/ 20 A 226 /15", "Code DCI": "20A226", "Forme": "COMP. A CROQ.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONTELUKAST BEKER 10MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medics/4205.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MONTELUKAST BEKER", "Tarif de reference": "2400 DA", "PPA": "2400 DA", "Num Enregistrement": "477/20A211/15", "Code DCI": "20A211", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONTELUKAST BEKER 4MG COMP. A CROQUER B/30", "Img": "https://pharmnet-dz.com//img/medics/2134.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2134", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MONTELUKAST BEKER ", "Tarif de reference": "2400 DA", "PPA": "2311.00 DA", "Num Enregistrement": "447/ 20 A 225 /15", "Code DCI": "20A225", "Forme": "COMP. A CROQ.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MONURIL ADULTE 3G/SACHET GRLES. SUSP. BUV. B/01SACHET", "Img": "https://pharmnet-dz.com//img/medics/1192.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1192", "Laboratoire": " ZAMBON", "C.Pharmacologique": " ANTI-INFECTIEUX URINAIRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " FOSFOMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MONURIL ADULTE", "Tarif de reference": "0 DA", "PPA": "815.00 DA", "Num Enregistrement": "093/ 25 E 058 /07", "Code DCI": "25E058", "Forme": "GRLES. SOL. BUV.", "Dosage": "3G/SACHET", "Conditionnement": "B/01SACHET", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTIDONE 10MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MOTIDONE", "Tarif de reference": "260.4 DA", "PPA": "N/A", "Num Enregistrement": "077/10F046/16", "Code DCI": "10F046", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTIDONE 1MG/ML SUSP. BUV. FL./200ML+ PIPETTE GRADUEE EN KG/ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2876", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MOTIDONE", "Tarif de reference": "224 DA", "PPA": "N/A", "Num Enregistrement": "077/ 10 F 047 /09/14", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL./200ML+ PIPETTE GRADUEE EN KG/ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTILIUM 10MG COMP.PELLI. B/40 ", "Img": "https://pharmnet-dz.com//img/medics/2869.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2869", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "MOTILIUM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 10 F 046 /98/12", "Code DCI": "10F046", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/40 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTILIUM 1MG/ML SUSP.BUV. FL/200ML + SERING. P. ADMINIST. ORALE. DE 5ML GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medics/2877.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2877", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "MOTILIUM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 10 F 047 /98/14", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL/200ML + SERING. P. ADMINIST. ORALE. DE 5ML GRADUEE EN KG", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTION 15MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " MIDDLE EAST PHARMACEUTICAL AND CHEMICAL INDUSTRIES,MEDICAL APPLIANCES Co", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MELOXICAM", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MOTION", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "226/ 04 B 058 /08", "Code DCI": "04B058", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTRINEX 10MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medics/2131.png", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MOTRINEX", "Tarif de reference": "2400 DA", "PPA": "2466.00 DA", "Num Enregistrement": "055/ 20 A 211/ 13", "Code DCI": "20A211", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTRINEX 4MG COMP. A CROQUER B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MOTRINEX", "Tarif de reference": "2400 DA", "PPA": "2487.00 DA", "Num Enregistrement": "055/ 20 A 225 /13", "Code DCI": "20A225", "Forme": "COMP. A CROQ.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOTRINEX 5MG COMP. A CROQUER B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MOTRINEX", "Tarif de reference": "2400 DA", "PPA": "N/A", "Num Enregistrement": "055/ 20 A 226 /13", "Code DCI": "20A226", "Forme": "COMP. A CROQ.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOVEN 15MG GLES. B/10 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MELOXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOVEN", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B  058 /09", "Code DCI": "04B058", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/10 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOVEN 7,5MG GLES. B/10 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MELOXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOVEN", "Tarif de reference": "70 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B  060 /09", "Code DCI": "04B060", "Forme": "COMP.", "Dosage": "7,5MG", "Conditionnement": "B/10 ET B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOXONIDINE BEKER  0,2MG COMP. PELLI. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4585.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOXONIDINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOXONIDINE BEKER ", "Tarif de reference": "551.93 DA", "PPA": "551.93 DA", "Num Enregistrement": "447/06E143/16", "Code DCI": "06E143", "Forme": "COMP. PELLI.", "Dosage": "0,2MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "MOXONIDINE BEKER  0,4MG  COMP. PELLI. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4528.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOXONIDINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MOXONIDINE BEKER ", "Tarif de reference": "946.01 DA", "PPA": "946.01 DA", "Num Enregistrement": "447/06E144/16", "Code DCI": "06E144", "Forme": "COMP. PELLI.", "Dosage": "0,4MG ", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "MP 16 16MG COMP SECABLE B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " API", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MP 16", "Tarif de reference": "283.4 DA", "PPA": "N/A", "Num Enregistrement": "348/09H092/16", "Code DCI": "09H092", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "MP4 4MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " API", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MP4", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "348/09H033/16", "Code DCI": "09H033", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "MUCOLYSE AD. 0.05 SOL. BUV. F/150ML", "Img": "https://pharmnet-dz.com//img/medics/1317.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1317", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "MUCOLYSE AD.", "Tarif de reference": "0 DA", "PPA": "139.00 DA", "Num Enregistrement": "073/ 20 D 042 /06", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "F/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MUCOLYSE ENFANT 0.02 SOL. BUV. FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/1307.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1307", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "MUCOLYSE ENFANT", "Tarif de reference": "0 DA", "PPA": "119.00 DA", "Num Enregistrement": "073/ 20 D 041 /06", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MUCOREX 0.003 SOL. BUV. FL/150ML", "Img": "https://pharmnet-dz.com//img/medics/1328.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1328", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MUCOREX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "073/ 20 D 064 /07", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": "0.003", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MUCOTEC 150MG GLES. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " ERDOSTEINE", "Pays": "JORDANIE", "Nom Commercial": "MUCOTEC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 20 D 112 /05/11", "Code DCI": "20D112", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "MUCOTEC 300MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " ERDOSTEINE", "Pays": "JORDANIE", "Nom Commercial": "MUCOTEC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 20 D 113 /04/11", "Code DCI": "20D113", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "MULTIBIC 2 MMOL/L POTASSIUM COMPARTIMENT A (0,25 L) ,COMPARTIMENT B (4,75 L ) SOLUTION POUR HEMOFILTRATION POCHE DE 05 L ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " FRESINIUS MEDICAL CARE", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "MULTIBIC 2 MMOL/L POTASSIUM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "332/25G073", "Code DCI": "N/D", "Forme": "SOL. INHAL.", "Dosage": "COMPARTIMENT A (0,25 L) ,COMPARTIMENT B (4,75 L )", "Conditionnement": "POCHE DE 05 L ", "Commercialisation": true, "Remboursable": null}, {"Nom": "MULTILOAD Cu 375  DISPOSITIF INTRA-UTERIN  I.U.D. (INTRA UTERINE DEVICE) B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " ORGANON", "C.Pharmacologique": " DISPOSITIFS INTRA-UTERINS", "C.Therapeutique": " GYNECOLOGIE", "Info": " STERILET EN FORME D'ANCRE AVEC STERILET ANCRE 375", "Pays": "PAYS BAS", "Nom Commercial": "MULTILOAD Cu 375", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "005/ 11 J 036 /97", "Code DCI": "11J036", "Forme": "DISPOSITIF", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "MUXOL SANS SUCRE 0,3%** SOL. BUV. FL/180 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "MUXOL SANS SUCRE", "Tarif de reference": " N/A", "PPA": "186.00 DA", "Num Enregistrement": "026/ 20 D 064 /97/09", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": "0,3%**", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "MYCINAD 250MG COMP . PEL B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCINAD", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "468/ 13 E 176/13", "Code DCI": "13E176", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCINAD 500MG COMP . PEL. SEC B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCINAD", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "468/ 13 E 299/ 13", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOCIDE 1,5MUI/15MG/37,5MG/15G PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1681.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1681", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " NYSTATINE / TRIAMCINOLONE / NEOMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOCIDE", "Tarif de reference": "120 DA", "PPA": "120 DA", "Num Enregistrement": "003/ 07 C 020 /97/09", "Code DCI": "07C020", "Forme": "PDE. DERM.", "Dosage": "1,5MUI/15MG/37,5MG/15G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOCINE 10 MUI / 0,1G / 0,25G / 100G PDE,DERM, T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " NYSTATINE / TRIAMCINOLONE / NEOMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOCINE", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "088/ 07 C 020 /03", "Code DCI": "07C020", "Forme": "PDE. DERM.", "Dosage": "10 MUI / 0,1G / 0,25G / 100G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCODERM 1% ( 1g/100 g) CREME T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CICLOPIROX", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCODERM", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "07D148", "Forme": "CR\u00c8ME", "Dosage": "1%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOFLUCON 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOFLUCON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 R 258 /07", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOFLUCON 50MG GLES. B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOFLUCON", "Tarif de reference": "219 DA", "PPA": "219.00 DA", "Num Enregistrement": "003/ 13 R 155 /09", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOMAZOLE 0.01 CREME DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1690.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1690", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOTRIMAZOLE", "Pays": "ALGERIE", "Nom Commercial": "MYCOMAZOLE", "Tarif de reference": "0 DA", "PPA": "175.00 DA", "Num Enregistrement": "366/ 07 D 024 /09", "Code DCI": "07D024", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOMEX 10MUI/0,1G/0,25G PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " NYSTATINE / TRIAMCINOLONE / NEOMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOMEX", "Tarif de reference": "120.00 DA", "PPA": " DA", "Code DCI": "07C020", "Forme": "PDE. DERM.", "Dosage": "10MUI/0,1G/0,25G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOSTATINE 100 000UI COMP.GYNECO. B/12 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " NYSTATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MYCOSTATINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 11 A 004 /96", "Code DCI": "11A004", "Forme": "COMP. VAG.", "Dosage": "100 000UI", "Conditionnement": "B/12 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "MYCOSTER 0,08 SOL. FILMOGENE APPLI. LOCALE F/3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CICLOPIROX", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MYCOSTER", "Tarif de reference": "364,8 DA", "PPA": " DA", "Code DCI": "07D151", "Forme": "SOL. APP. LOCALE", "Dosage": "8%", "Conditionnement": "F/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOSTER 0.01 CREME T/30G", "Img": "https://pharmnet-dz.com//img/medics/474.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=474", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CICLOPIROX OLAMINE", "Pays": "FRANCE", "Nom Commercial": "MYCOSTER", "Tarif de reference": "400.16 DA", "PPA": "N/A", "Num Enregistrement": "186/ 07 D 148 /06", "Code DCI": "07D148", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOSTER 0.01 SOL. APPL. CUTANEE FL./30ML", "Img": "https://pharmnet-dz.com//img/medics/475.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=475", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CICLOPIROX OLAMINE", "Pays": "FRANCE", "Nom Commercial": "MYCOSTER", "Tarif de reference": "372.1 DA", "PPA": "N/A", "Num Enregistrement": "186/ 07 D 149 /06", "Code DCI": "07D149", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOSTER 0.08 SOL. FILMOGENE APPLI. LOCALE F/3ML", "Img": "https://pharmnet-dz.com//img/medics/476.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=476", "Laboratoire": " PIERRE FABRE DERMATOLOGIE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CICLOPIROX", "Pays": "FRANCE", "Nom Commercial": "MYCOSTER", "Tarif de reference": "364.8 DA", "PPA": "N/A", "Num Enregistrement": "186/ 07 D 151 /07", "Code DCI": "07D151", "Forme": "SOL. APP. LOCALE", "Dosage": "0.08", "Conditionnement": "F/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOTEN 0.01 CREME DERM. T/20G", "Img": "https://pharmnet-dz.com//img/medics/1691.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1691", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOTRIMAZOLE", "Pays": "PALESTINE", "Nom Commercial": "MYCOTEN", "Tarif de reference": "291.11 DA", "PPA": "N/A", "Num Enregistrement": "406/ 07 D 024 /13", "Code DCI": "07D024", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOTEN 1.  500MG COMP. VAG. B/01 + 01APPLICATEUR", "Img": "https://pharmnet-dz.com//img/medics/3015.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3015", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " CLOTRIMAZOLE", "Pays": "PALESTINE", "Nom Commercial": "MYCOTEN 1. ", "Tarif de reference": "300 DA", "PPA": "N/A", "Num Enregistrement": "406/ 11 A 083 /09", "Code DCI": "11A083", "Forme": "COMP. VAG.", "Dosage": "500MG", "Conditionnement": "B/01 + 01APPLICATEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOTEN 3.  200MG COMP. VAG. B/03COMP. + 03APPLICATEURS", "Img": "https://pharmnet-dz.com//img/medics/3014.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3014", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " CLOTRIMAZOLE", "Pays": "PALESTINE", "Nom Commercial": "MYCOTEN 3. ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "406/ 11 A 082 /09", "Code DCI": "11A082", "Forme": "COMP. VAG.", "Dosage": "200MG", "Conditionnement": "B/03COMP. + 03APPLICATEURS", "Commercialisation": true, "Remboursable": false}, {"Nom": "MYCOTEN III 0.02 CREME VAG. T/20G + 03APPLICATEURS", "Img": "https://pharmnet-dz.com//img/medics/3013.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3013", "Laboratoire": " BEIT JALA PHARMACEUTICALS Co", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " CLOTRIMAZOLE", "Pays": "PALESTINE", "Nom Commercial": "MYCOTEN III", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "406/ 11 A 081 /09", "Code DCI": "11A081", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/20G + 03APPLICATEURS", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOTINE 100 000 UI/G PDE DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/459.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=459", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " NYSTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOTINE", "Tarif de reference": "100 DA", "PPA": "100 DA", "Num Enregistrement": "003/ 07 D 032 /97", "Code DCI": "07D032", "Forme": "PDE. DERM.", "Dosage": "100 000 UI/G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOZAN 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medics/3574.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3574", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOZAN", "Tarif de reference": "0 DA", "PPA": "240.00 DA", "Num Enregistrement": "447/ 13 R 258 /11", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOZAN 50MG GLES. B/03 ", "Img": "https://pharmnet-dz.com//img/medics/3555.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3555", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOZAN", "Tarif de reference": "219 DA", "PPA": "218.99 DA", "Num Enregistrement": "447/ 13 R 155 /11", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYCOZOL 0.02 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYCOZOL", "Tarif de reference": "198.9 DA", "PPA": "186.00 DA", "Num Enregistrement": "418/ 07 D 028 /11", "Code DCI": "07D028", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYDOCALM 150MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1425", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " MYORELAXANTS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " TOLPERISONE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYDOCALM", "Tarif de reference": "929.93 DA", "PPA": "N/A", "Num Enregistrement": "418/ 21 E 060 /13", "Code DCI": "21E060", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYDOSED  150MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MYORELAXANTS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " TOLPERISONE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "MYDOSED ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "001/21E060/16", "Code DCI": "21E060", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYDRIATICUM 0.005 COLLY. EN SOL. FL./10ML", "Img": "https://pharmnet-dz.com//img/medics/1998.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1998", "Laboratoire": " THEA", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TROPICAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "MYDRIATICUM", "Tarif de reference": "210.42 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 H 062 /99/15", "Code DCI": "17H062", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYDRICOL 0.005 COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/1999.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1999", "Laboratoire": " UNIMED", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TROPICAMIDE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "MYDRICOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 17 H 062 /07/14", "Code DCI": "17H062", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "MYOGARD 10MG CAPS B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NIFEDIPINE ", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "MYOGARD", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "174/ 06 B 017/98", "Code DCI": "06B017", "Forme": "CAPS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}], "N": [{"Nom": "N PLATE 250\u00b5G/FL. DE PDRE. PDRE. P. SOL. INJ. SC B/01 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/4337.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4337", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " ROMIPLOSTIM", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "N PLATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/12L179/16", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "250\u00b5G/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "N PLATE 500\u00b5G/FL. DE PDRE. PDRE. P. SOL. INJ. SC B/01 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1855", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ROMIPLOSTIM", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "N PLATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 12 L 180 /15", "Code DCI": "12L180", "Forme": "PDRE. INJ.", "Dosage": "500\u00b5G/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAABAK 4,9G/100ML COLLY. EN SOL. (SANS CONSERVATEUR) FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2342.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2342", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACIDE N-ACETYL ASPARTYL GLUTAMIQUE (SOUS FORME DE SEL DE SODIUM)**", "Pays": "FRANCE", "Nom Commercial": "NAABAK", "Tarif de reference": "159 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 B 100 /09", "Code DCI": "17B100", "Forme": "COLLY. SOL.", "Dosage": "4,9G/100ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAAXIA 4,9G/100ML** COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/2343.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2343", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACIDE N-ACETYL ASPARTYL GLUTAMIQUE (SOUS FORME DE SEL DE SODIUM)**", "Pays": "FRANCE", "Nom Commercial": "NAAXIA", "Tarif de reference": "227.48 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 B 100 /97/08", "Code DCI": "17B100", "Forme": "COLLY. SOL.", "Dosage": "4,9G/100ML**", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NABUTIL 2,5MG COMP. B/50 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NABUTIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 20 A 021 /98", "Code DCI": "20A021", "Forme": "COMP.", "Dosage": "2,5MG", "Conditionnement": "B/50 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NABYOL FORTE 100MG COMP. ENRO. B/50", "Img": "https://pharmnet-dz.com//img/medics/1190.png", "Laboratoire": " BOTTU S.A.", "C.Pharmacologique": " ANTI-INFECTIEUX URINAIRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " NITROXOLINE", "Liste": "Liste I", "Pays": "MAROC", "Nom Commercial": "NABYOL FORTE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "491/ 25 E 015 /15", "Code DCI": "25E015", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "NADCORTYL 5MG COMP. SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3749", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NADCORTYL", "Tarif de reference": "150 DA", "PPA": " DA", "Num Enregistrement": "468/ 09 H 038 /13", "Code DCI": "09H038", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NADEC 10MG COMP. PELLI. SEC B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NADEC", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "468/01A003/15", "Code DCI": "01A003", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": null}, {"Nom": "NADIXA 0.01 CREME DERM. T/25G", "Img": "https://pharmnet-dz.com//img/medics/4484.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "NADIXA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "207/07C182/16", "Code DCI": "N/D", "Forme": "CR\u00c8ME", "Dosage": "1%", "Conditionnement": "T/25G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NADLORIC 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1393.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1393", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NADLORIC", "Tarif de reference": "194.6 DA", "PPA": "N/A", "Num Enregistrement": "468/ 21 B 007 /13", "Code DCI": "21B007", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAFTILENE 100MG  GLES  B/30 ", "Img": "https://pharmnet-dz.com//img/medics/1491.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1491", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NAFTIDROFURYL ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAFTILENE", "Tarif de reference": "0 DA", "PPA": "398.05 DA", "Num Enregistrement": "447/ 06 J 100 /14", "Code DCI": "06J100", "Forme": "GLES.", "Dosage": "100MG ", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAFTIRETARD LP 200MG GLES. A \u00b5GRLES. LP B/20", "Img": "https://pharmnet-dz.com//img/medics/1493.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1493", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NAFTIDROFURYL HYDROGENO-OXALATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAFTIRETARD LP", "Tarif de reference": "396.7 DA", "PPA": "N/A", "Num Enregistrement": "418/ 06 J 101 /11", "Code DCI": "06J101", "Forme": "COMP. PELLI. LP", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAGLAZYME 1MG/ML (OU 5MG/5ML) CONC. PERF. B/1FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/3480.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3480", "Laboratoire": " BIOMARIN EUROPE LTD", "C.Pharmacologique": " N/D", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GALSULFASE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "NAGLAZYME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "439/ 14 N 331 /09", "Code DCI": "14N331", "Forme": "SOL. PERF.", "Dosage": "1MG/ML (OU 5MG/5ML)", "Conditionnement": "B/1FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAGOXIN 0,25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NAGOXIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 06 G 079 /98/14", "Code DCI": "06G079", "Forme": "COMP. SEC.", "Dosage": "0,25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "NALOXONE 0,4MG/ML SOL. INJ. IM/IV /SC B/10AMP.  DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1144", "Laboratoire": " MYLAN", "C.Pharmacologique": " ANTAGONISTES DES MORPHINIQUES", "C.Therapeutique": " TOXICOLOGIE", "Info": " NALOXONE CHLORHYDRATE ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NALOXONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 24 B 016 /06", "Code DCI": "24B016", "Forme": "SOL. INJ.", "Dosage": "0,4MG/ML", "Conditionnement": "B/10AMP.  DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NAPROLGIC 275MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAPROLGIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 04 B 019 /15", "Code DCI": "04B019", "Forme": "COMP. PELLI.", "Dosage": "275MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "NAPROLGIC 550MG COMP. PELLI. SEC. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " N/D", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAPROLGIC", "Tarif de reference": "434 DA", "PPA": "N/A", "Num Enregistrement": "317/04B020/16", "Code DCI": "04B020", "Forme": "COMP. SEC.", "Dosage": "550MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAPROX 275MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAPROX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "097/04B019/17", "Code DCI": "04B019", "Forme": "COMP. PELLI.", "Dosage": "275MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAPROX 550MG COMP.PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAPROX", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "04B020", "Forme": "COMP. PELLI.", "Dosage": "550MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAQUINE 200MG DRG. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " HYDROXYCHLOROQUINE", "Pays": "ITALIE", "Nom Commercial": "NAQUINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 21 D 020 /99", "Code DCI": "21D020", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NARAMIG 2,5MG COMP B/6", "Img": "https://pharmnet-dz.com//img/medics/2470.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2470", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " NARATRIPTAN", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "NARAMIG", "Tarif de reference": "1257.9 DA", "PPA": " DA", "Num Enregistrement": "112/ 15 B 054 /02", "Code DCI": "15B054", "Forme": "\u2026", "Dosage": "2,5MG", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAREX 275MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PETRA PHARM ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAREX", "Tarif de reference": "104.8 DA", "PPA": "N/A", "Num Enregistrement": "258/ 04 B 019 /04", "Code DCI": "04B019", "Forme": "COMP. PELLI.", "Dosage": "275MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NARUFENE 2% 20MG/ML (100MG/5ML) SUSP. BUV. GO\u00dbT P\u00caCHE B/1FL. DE 125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NARUFENE 2%", "Tarif de reference": " N/A", "PPA": "199.00 DA", "Num Enregistrement": "318/ 04 B 042 /07/13", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "B/1FL. DE 125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NASABEC 50\u00b5G/DOSE SUSP. P. PULVERIS. NASALE B/01 FL. PULVERIS. DE 100 DOSES", "Img": "https://pharmnet-dz.com//img/medics/2063.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BECLOMETASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NASABEC", "Tarif de reference": "346 DA", "PPA": "N/A", "Num Enregistrement": "235/ 20 A 004 /14", "Code DCI": "20A004", "Forme": "SUSP.NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "B/01 FL. PULVERIS. DE 100 DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "NASACET 55\u00b5G/DOSE SUSP. P.PULV. NAS. EN FL. PULVERISATEUR FL/120 DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIAMCINOLONE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "NASACET", "Tarif de reference": "829,20 DA", "PPA": " DA", "Code DCI": "22E028", "Forme": "SUSP.NAS.", "Dosage": "55\u00b5G/DOSE", "Conditionnement": "FL/120 DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "NASACORT 55\u00b5G/DOSE SUSP. P.PULV. NAS. EN FL. PULVERISATEUR B/01FL. DE 120 PULVERISATIONS (15ML)  + POMPE DOSEUSE + EMBOUT NASAL", "Img": "https://pharmnet-dz.com//img/medics/1940.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1940", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIAMCINOLONE ACETONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NASACORT", "Tarif de reference": "829.2 DA", "PPA": "N/A", "Num Enregistrement": "230/ 22 E 028 /00/15", "Code DCI": "22E028", "Forme": "SPRAY NAS.", "Dosage": "55\u00b5G/DOSE", "Conditionnement": "B/01FL. DE 120 PULVERISATIONS (15ML)  + POMPE DOSEUSE + EMBOUT NASAL", "Commercialisation": true, "Remboursable": true}, {"Nom": "NASONEX 50\u00b5G/DOSE SUSP. P. PULV. NAS. FL./120DOSES AVEC POMPE DOSEUSE", "Img": "https://pharmnet-dz.com//img/medics/1942.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1942", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " MOMETASONE FUROATE ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NASONEX", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "027/ 22 E 036 /08", "Code DCI": "22E036", "Forme": "SPRAY NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL./120DOSES AVEC POMPE DOSEUSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "NATAZINE 5MG COMP. SEC B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " MEQUITAZINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NATAZINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 01 A 009 /98/10", "Code DCI": "01A009", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "NATIFEN 0,50MG (PIZOTIFENE MALEATE 0,73MG) COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " PIZOTIFENE (SOUS FORME DE MALATE)", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "NATIFEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 15 B 022 /98", "Code DCI": "15B022", "Forme": "COMP. PELLI.", "Dosage": "0,50MG (PIZOTIFENE MALEATE 0,73MG)", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "NATRIPACK 0.1 SOLUTION INJECTABLE A DILUER B/50 AMPOULES DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NATRIPACK", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "280/14G080/15", "Code DCI": "14G080", "Forme": "SOL. INJ.", "Dosage": "10%", "Conditionnement": "B/50 AMPOULES DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NATRIXAL 1,5MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " INDAPAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NATRIXAL", "Tarif de reference": "690 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 H 163 /12", "Code DCI": "06H163", "Forme": "COMP. PELLI. LP", "Dosage": "1,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAUSEDIUM 10MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAUSEDIUM", "Tarif de reference": "195.3 DA", "PPA": "195.00 DA", "Num Enregistrement": "003/ 10 F 157 /11", "Code DCI": "10F157", "Forme": "COMP. ORODISPERS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAUSEDIUM 1MG/ML SUSP. BUV. FL./200ML + PIPETTE DOSEUSE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAUSEDIUM", "Tarif de reference": "224 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 047 /09", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL./200ML + PIPETTE DOSEUSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAUSETRON 16 MG SUPPO, B/02", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " ONDANSETRON", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NAUSETRON", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "366/10F205/16", "Code DCI": "N/D", "Forme": "SUPPO.", "Dosage": "16 MG", "Conditionnement": "B/02", "Commercialisation": true, "Remboursable": null}, {"Nom": "NAUSETRON 4MG/5ML SIROP FL 50ML + CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NAUSETRON", "Tarif de reference": "714 DA", "PPA": "N/A", "Num Enregistrement": "503/10F187/16", "Code DCI": "10F187", "Forme": "SIROP", "Dosage": "4MG/5ML", "Conditionnement": "FL 50ML + CUILLERE MESURE", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAVELBINE 10MG/ML SOL.INJ. B/10", "Img": "https://pharmnet-dz.com//img/medics/998.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=998", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " VINORELBINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NAVELBINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 05 A 068 /99", "Code DCI": "05A068", "Forme": "SOL. INJ.", "Dosage": "10MG/ML", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAVELBINE 20MG CAPS. MOLLES B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=13", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " VINORELBINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NAVELBINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 05 G 114 /06", "Code DCI": "05G114", "Forme": "CAPS. MOLLE", "Dosage": "20MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": null}, {"Nom": "NAVELBINE 30MG CAPS. MOLLES B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=14", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " VINORELBINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NAVELBINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 05 G 115 /06", "Code DCI": "05G115", "Forme": "CAPS. MOLLE", "Dosage": "30MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": null}, {"Nom": "NAVELBINE 50MG/5ML SOL.INJ. B/10", "Img": "https://pharmnet-dz.com//img/medics/1000.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1000", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " VINORELBINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NAVELBINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 05 A 069 /99", "Code DCI": "05A069", "Forme": "SOL. INJ.", "Dosage": "50MG/5ML", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAXOLIN 100MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medics/1191.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1191", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTI-INFECTIEUX URINAIRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " NITROXOLINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NAXOLIN", "Tarif de reference": "218 DA", "PPA": "N/A", "Num Enregistrement": "013/ 25 E 015 /98/14", "Code DCI": "25E015", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAXOLIN 50MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1189", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTI-INFECTIEUX URINAIRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " NITROXOLINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NAXOLIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "013/ 25 E 014 /98/14", "Code DCI": "25E014", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAZEPAM 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " HYPNOTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " NITRAZEPAM", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NAZEPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 16 C 052 /98", "Code DCI": "16C052", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NAZID 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIPIZIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NAZID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 14 A 005 /98", "Code DCI": "14A005", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEFRAXIL 0.03 PDE. DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE NIFLUMIQUE", "Pays": "ALGERIE", "Nom Commercial": "NEFRAXIL", "Tarif de reference": "60 DA", "PPA": "N/A", "Num Enregistrement": "026/ 21 A 001 /07", "Code DCI": "21A001", "Forme": "PDE. DERM.", "Dosage": "0.03", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NENATAL  PDRE B/400G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NUTRICIA S A", "C.Pharmacologique": " LAITS & FARINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LAIT SPECIAL PREMATURES", "Pays": "FRANCE", "Nom Commercial": "NENATAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "288/ 14 L 133 /03", "Code DCI": "14L133", "Forme": "PDRE.", "Conditionnement": "B/400G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEO-CODION 25MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/2153.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2153", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CODEINE ", "Pays": "FRANCE", "Nom Commercial": "NEO-CODION", "Tarif de reference": "202.2 DA", "PPA": "N/A", "Num Enregistrement": "269/ 20 B 069 /99", "Code DCI": "20B069", "Forme": "COMP.", "Dosage": "25MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEO-CODION ADULTE 0,1722G/100ML (CODEINE BASE  15,4MG/CUILLERE A SOUPE) SIROP FL/180 ML", "Img": "https://pharmnet-dz.com//img/medics/2150.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2150", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CODEINE ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "NEO-CODION ADULTE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "269/ 20 B 053 /98", "Code DCI": "20B053", "Forme": "SIROP", "Dosage": "0,1722G/100ML (CODEINE BASE  15,4MG/CUILLERE A SOUPE)", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEO-CODION ENFANT 3,285MG/61MG/5ML SIROP  FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/2152.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2152", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CODEINE CAMPHOSULFONATE EXPRIME EN CODEINE / BENZOATE DE SODIUM ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "NEO-CODION ENFANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "269/ 20 B 054 /98/07", "Code DCI": "20B054", "Forme": "SIROP", "Dosage": "3,285MG/61MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEO-CODION NOURRISSONS 74,1MG/30,8MG/32,964MG/CUILLERE A CAFE SIROP  FL/125 ML", "Img": "https://pharmnet-dz.com//img/medics/2166.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2166", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BENZOATE DE SODIUM / TEINTURE DE GRINDELIA / SIROP DE POLYGALA", "Pays": "FRANCE", "Nom Commercial": "NEO-CODION NOURRISSONS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "269/ 20 C 036 /98/07", "Code DCI": "20C036", "Forme": "SIROP", "Dosage": "74,1MG/30,8MG/32,964MG/CUILLERE A CAFE", "Conditionnement": "FL/125 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEODEX 100MG/350000UI/100ML COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2383.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "NEODEX", "Tarif de reference": "344 DA", "PPA": " DA", "Num Enregistrement": "165/ 17 D 024 /98", "Code DCI": "17D024", "Forme": "COLLY.", "Dosage": "100MG/350000UI/100ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEODRON 1MG/3,5MG COLLYRE B/01 FL 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ALEPPO PHARMACEUTICAL INDUSTRIES (ALPHA)", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE", "Pays": "SYRIE", "Nom Commercial": "NEODRON", "Tarif de reference": "172 DA", "PPA": "N/A", "Num Enregistrement": "119/ 17 D 024 /14", "Code DCI": "17D024", "Forme": "COLLY.", "Dosage": "1MG/3,5MG", "Conditionnement": "B/01 FL 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOFEN 400MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEOFEN", "Tarif de reference": "157 DA", "PPA": "157.00 DA", "Num Enregistrement": "418/ 04 B 010 /14", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOFEN 600MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEOFEN", "Tarif de reference": "235.5 DA", "PPA": "235.00 DA", "Num Enregistrement": "418/ 04 B 044 /14", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOGASTRIC 20MG GLES. A MICROG. GASTRORESIST. B/14+B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEOGASTRIC", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "418/10A001/09/16", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14+B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEOMIXIN 0.005 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NEOMYCINE/POLYMYXINE B", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "NEOMIXIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "165/ 17 D 027 /98", "Code DCI": "17D027", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOMYC 1%** COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NEOMYCINE (SOUS FORME DE SULFATE)**", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "NEOMYC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 D 023 /99/09", "Code DCI": "17D023", "Forme": "COLLY.", "Dosage": "1%**", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEONORM 1MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEONORM", "Tarif de reference": "370,8 DA", "PPA": "N/A", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEONORM 2MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEONORM", "Tarif de reference": "390.00 DA", "PPA": "N/A", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOPHOS 1000MG PDRE.SOL.INJ. B/1FL", "Img": "https://pharmnet-dz.com//img/medics/1011.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYCLOPHOSPHAMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "NEOPHOS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 104 /05", "Code DCI": "05A104", "Forme": "PDRE. SOL. INJ.", "Dosage": "1000MG", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEOPHOS 200MG PDRE.SOL.INJ. B/01FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYCLOPHOSPHAMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "NEOPHOS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 009 /03", "Code DCI": "05A009", "Forme": "PDRE. SOL. INJ.", "Dosage": "200MG", "Conditionnement": "B/01FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEOPHOS 500MG PDRE.SOL.INJ. B/01FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " CYCLOPHOSPHAMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "NEOPHOS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 A 010 /03", "Code DCI": "05A010", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/01FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEOPOLI 0.005 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NEOMYCINE/POLYMYXINE B", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NEOPOLI", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 17 D 027 /99", "Code DCI": "17D027", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEORAL 100MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1028", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NEORAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 B 049 /98", "Code DCI": "05B049", "Forme": "CAPS.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEORAL 100MG/ML SOL .BUV. FL/50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1021", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NEORAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 B 047 /99", "Code DCI": "05B047", "Forme": "SOL. INJ.", "Dosage": "100MG/ML", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEORAL 25MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1025", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NEORAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 B 048 /98", "Code DCI": "05B048", "Forme": "CAPS.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEORAL 50MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1032", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NEORAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 B 082 /98", "Code DCI": "05B082", "Forme": "CAPS.", "Dosage": "50MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEOSTIGMINE METHYLSULFATE 0,5MG/ML SOL.INJ B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " ANTIMYASTHENIQUES", "C.Therapeutique": " NEUROLOGIE", "Info": " NEOSTIGMINE METHYLSULFATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NEOSTIGMINE METHYLSULFATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 15 C 024 /00", "Code DCI": "15C024", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOSYNEPHRINE FAURE 10% 0.1 COLLY. EN SOL. FL/5 ML", "Img": "https://pharmnet-dz.com//img/medics/1997.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1997", "Laboratoire": " EUROPHTA", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PHENYLEPHRINE ", "Pays": "MONACO", "Nom Commercial": "NEOSYNEPHRINE FAURE 10%", "Tarif de reference": "0 DA", "PPA": "257.00 DA", "Num Enregistrement": "316/ 17 H 061 /97/07", "Code DCI": "17H061", "Forme": "COLLY.", "Dosage": "0.1", "Conditionnement": "FL/5 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOTADINE 10MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEOTADINE", "Tarif de reference": "60 DA", "PPA": "161.00 DA", "Num Enregistrement": "418/ 01 A 033 /09", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEOVEC 4MG/FL. DE LYOPH. LYOPH. ET SOLV. SOL. INJ. IV B/01FL. DE PDRE. + 01AMP. DE 2ML DE SOLV.(EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " GLAND PHARMA LIMITED ", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " VECURONIUM BROMURE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "NEOVEC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "463/ 02 D 038 /10", "Code DCI": "02D038", "Forme": "SOL. INJ.", "Dosage": "4MG/FL. DE LYOPH.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 2ML DE SOLV.(EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEOXETINE 20MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " FLUOXETINE CHLORHYDRATE EXPRIME EN FLUOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEOXETINE", "Tarif de reference": "260.6 DA", "PPA": "N/A", "Num Enregistrement": "418/ 16 A 078 /09", "Code DCI": "16A078", "Forme": "GLES.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NETROMICINE PEDIATRIQUE 25MG/ML (25MG/1ML ET 50MG/2ML) SOL. INJ. IM/IV  B/1AMP. DE 1ML ET  B/1AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " NETILMICINE  (SULFATE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NETROMICINE PEDIATRIQUE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "027/ 13 A 282 /05", "Code DCI": "13A282", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (25MG/1ML ET 50MG/2ML)", "Conditionnement": "B/1AMP. DE 1ML ET  B/1AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUPAX 200MG  COMP SEC  B/30", "Img": "https://pharmnet-dz.com//img/medics/3502.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUPAX", "Tarif de reference": "261 DA", "PPA": "261.00 DA", "Num Enregistrement": "263/ 15 A 004 /14", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUPAX 20MG/ML SUSP. BUV. B/01 FL. 180 ML + SERINGUE P. ADMIN. ORALE DE 10ML GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/3508.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUPAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "263/ 15 A 006 /14", "Code DCI": "15A006", "Forme": "SUSP. BUV.", "Dosage": "20MG/ML", "Conditionnement": "B/01 FL. 180 ML + SERINGUE P. ADMIN. ORALE DE 10ML GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUPOGEN 300\u00b5G SOL.INJ. B/5 Flacons  de 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " HOFFMAN LAROCHE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FILGRASTIM", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "NEUPOGEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "128/ 12 E 065 /99", "Code DCI": "12E065", "Forme": "SOL. INJ.", "Dosage": "300\u00b5G", "Conditionnement": "B/5 Flacons  de 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEUPOGEN 480\u00b5G SOL.INJ. B/5 Flacons de 1,6ML      ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " HOFFMAN LAROCHE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FILGRASTIM", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "NEUPOGEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "128/ 12 E 066 /99", "Code DCI": "12E066", "Forme": "SOL. INJ.", "Dosage": "480\u00b5G", "Conditionnement": "B/5 Flacons de 1,6ML      ", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEUPREN 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/908.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUPREN", "Tarif de reference": "120 DA", "PPA": "120.00 DA", "Num Enregistrement": "235/ 04 B 040 /08", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUPREN 20MG/ML (100MG/5ML) SOL. BUV. FL/200 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEUPREN", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "235/04B042/16", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL/200 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEUPREN 400MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2730.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUPREN", "Tarif de reference": "157 DA", "PPA": "170.00 DA", "Num Enregistrement": "235/ 04 B 010 /11", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUPREN 600MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/927.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUPREN", "Tarif de reference": "235.5 DA", "PPA": "N/A", "Num Enregistrement": "235/ 04 B 044 /11", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEURALDOL 2MG/ML SOL. BUV. GTTES. B/1FL. COMPT. GTTES. DE 30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEURALDOL", "Tarif de reference": "180.6 DA", "PPA": "N/A", "Num Enregistrement": "457/ 16 D 085 /11", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML", "Conditionnement": "B/1FL. COMPT. GTTES. DE 30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEURALGIN  300MG GLES. B/90", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " GABAPENTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEURALGIN ", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "318/15A086/15", "Code DCI": "15A086", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEURAXON  50MG  GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEURAXON ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "097/15A066/16", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEURAXON 150 150MG GLES B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEURAXON 150", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "097/15A068/16", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEURICA 150MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2422.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEURICA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 15 A 068 /15", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEURICA 50MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2415.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEURICA", "Tarif de reference": " N/A", "PPA": "1866.00 DA", "Num Enregistrement": "263/ 15 A 066 /15", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEURICA 75MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2456.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEURICA", "Tarif de reference": " N/A", "PPA": "1999.00 DA", "Num Enregistrement": "263/ 15 A 101 /15", "Code DCI": "15A101", "Forme": "GLES.", "Dosage": "75MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEUROLAL 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PHENOBARBITAL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUROLAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 014 /05", "Code DCI": "15A014", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUROLAL 50MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PHENOBARBITAL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUROLAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 013 /05", "Code DCI": "15A013", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUROVIT 250MG/250MG COMP. B/20 ", "Img": "https://pharmnet-dz.com//img/medics/3438.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3438", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE CHLORHYDRATE / PYRIDOXINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "NEUROVIT", "Tarif de reference": "135 DA", "PPA": "198 DA", "Num Enregistrement": "003/ 14 H 112 /97/09", "Code DCI": "14H112", "Forme": "COMP.", "Dosage": "250MG/250MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEUROZEPINE 200MG COMP. SEC. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NEUROZEPINE", "Tarif de reference": "435 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 004 /09", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEVIMUNE  200MG COMP. SEC. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " NEVIRAPINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "NEVIMUNE ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 278 /05", "Code DCI": "13P278", "Forme": "COMP. SEC.", "Dosage": "200MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEVROSTA 2,5MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEVROSTA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 043 /10", "Code DCI": "16B043", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEVROSTAT 1MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEVROSTAT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 042 /06", "Code DCI": "16B042", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEXAVAR 200MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/1046.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1046", "Laboratoire": " BAYER", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " SORAFENIB TOSYLATE EXPRIME EN SORAFENIB", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "NEXAVAR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 05 C 128 /08", "Code DCI": "05C128", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEXECOR 1000MG COMP. PELLI. SEC. B/90", "Img": "https://pharmnet-dz.com//img/medics/3708.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3708", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEXECOR", "Tarif de reference": "520.2 DA", "PPA": "520.19 DA", "Num Enregistrement": "447/ 14 A 224 /12", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEXECOR 500MG COMP. PELLI. B/98", "Img": "https://pharmnet-dz.com//img/medics/3620.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3620", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEXECOR", "Tarif de reference": "356.72 DA", "PPA": "356.72 DA", "Num Enregistrement": "447/ 14 A 006 /10", "Code DCI": "14A006", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/98", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEXECOR 850MG COMP. PELLI. B/30 - B/90", "Img": "https://pharmnet-dz.com//img/medics/3632.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3632", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NEXECOR", "Tarif de reference": "442.80 DA", "PPA": "442.79 DA", "Num Enregistrement": "447/ 14 A 007 /10", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30 - B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "NEXORPAN 275MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "NEXORPAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 04 B 019 /98/15", "Code DCI": "04B019", "Forme": "COMP. PELLI.", "Dosage": "275MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "NEXORPAN 550MG COMP.PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "NEXORPAN", "Tarif de reference": "434 DA", "PPA": "N/A", "Num Enregistrement": "166/ 04 B 020 /98", "Code DCI": "04B020", "Forme": "COMP. PELLI.", "Dosage": "550MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NHUPAIN 275MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2757.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NHUPAIN", "Tarif de reference": "209.6 DA", "PPA": "209.00 DA", "Num Enregistrement": "380/ 04 B 019 /14", "Code DCI": "04B019", "Forme": "COMP. PELLI.", "Dosage": "275MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NHUPAIN 550MG COMP. PELLI. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medics/2761.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NHUPAIN", "Tarif de reference": "217 DA", "PPA": "217.00 DA", "Num Enregistrement": "380/ 04 B 020 /14", "Code DCI": "04B020", "Forme": "COMP. PELLI.", "Dosage": "550MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NICARDEX 1MG/ML (10MG/10ML) SOL INJ IV  B/05 AMPS DE 10ML ", "Img": "https://pharmnet-dz.com//img/medics/60.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NICARDEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 06 B 016 /14", "Code DCI": "06B016", "Forme": "SOL. INJ.", "Dosage": "1MG/ML (10MG/10ML)", "Conditionnement": "B/05 AMPS DE 10ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "NICARDIL LP 50MG GLES. MICROGRANULES LP B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NICARDIL LP", "Tarif de reference": "612 DA", "PPA": "611.00 DA", "Num Enregistrement": "418/ 06 B 015 /10", "Code DCI": "06B015", "Forme": "COMP. LP", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "NICARDIPINE BIOCARE LP 50MG GLES. A MICROGRANULES LP B/60", "Img": "https://pharmnet-dz.com//img/medics/56.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=56", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NICARDIPINE BIOCARE LP", "Tarif de reference": "612 DA", "PPA": "612.00 DA", "Num Enregistrement": "293/ 06 B 015 /10", "Code DCI": "06B015", "Forme": "COMP. LP", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "NICOPASS SANS SUCRE  1,5 MG** PASTILLE GO\u00dbT MENTHE  FRAICHEUR ET PASTILLE GO\u00dbT REGLISSE-MENTHE  B/36 PASTILLES GO\u00dbT MENTHE FRAICHEUR  -  B/36 PASTILLES GO\u00dbT REGLISSE-MENTHE ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2338", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " PSYCHIATRIE", "C.Therapeutique": " NICOTINE **  (SOUS FORME DE CATIORESINE CARBOXYLATE)", "Pays": "FRANCE", "Nom Commercial": "NICOPASS SANS SUCRE ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 16 F 135 /09", "Code DCI": "16F135", "Forme": "PASTILLE", "Dosage": "1,5 MG**", "Conditionnement": "B/36 PASTILLES GO\u00dbT MENTHE FRAICHEUR  -  B/36 PASTILLES GO\u00dbT REGLISSE-MENTHE ", "Commercialisation": true, "Remboursable": null}, {"Nom": "NICOPATCH  17,5MG/DISPOSITIF DE 10CM2 (27MG/24H)    DISPOSITIF TRANSDERMIQUE  B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2330", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " PSYCHIATRIE", "C.Therapeutique": " NICOTINE ", "Pays": "FRANCE", "Nom Commercial": "NICOPATCH ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 16 F 116 /09", "Code DCI": "16F116", "Forme": "DISPOSITIF", "Dosage": "17,5MG/DISPOSITIF DE 10CM2 (27MG/24H)   ", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "NICOPATCH  52,5MG/DISPOSITIF DE 30CM2 (21MG/24H)    DISPOSITIF TRANSDERMIQUE  B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2334", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " PSYCHIATRIE", "C.Therapeutique": " NICOTINE ", "Pays": "FRANCE", "Nom Commercial": "NICOPATCH ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 16 F 118 /09", "Code DCI": "16F118", "Forme": "DISPOSITIF", "Dosage": "52,5MG/DISPOSITIF DE 30CM2 (21MG/24H)   ", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "NICOPATCH 35MG/DISPOSITIF DE 20CM2 (14MG/24H)  DISPOSITIF TRANSDERMIQUE  B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2332", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " PSYCHIATRIE", "C.Therapeutique": " NICOTINE ", "Pays": "FRANCE", "Nom Commercial": "NICOPATCH", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 16 F 117 /09", "Code DCI": "16F117", "Forme": "DISPOSITIF", "Dosage": "35MG/DISPOSITIF DE 20CM2 (14MG/24H) ", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "NICOTINELL 14MG/24H (SOIT 35MG DE S(-) NICOTINE TOTALE/DISPOSITIF DE 20CM2) DISPOSITIF TRANSDERMIQUE  EN PATCHS B/07 ET B/28", "Img": "https://pharmnet-dz.com//img/medics/2333.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2333", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " PSYCHIATRIE", "Info": " NICOTINE ", "Pays": "FRANCE", "Nom Commercial": "NICOTINELL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "267/ 16 F 117 /08", "Code DCI": "16F117", "Forme": "DISPOSITIF", "Dosage": "14MG/24H (SOIT 35MG DE S(-) NICOTINE TOTALE/DISPOSITIF DE 20CM2)", "Conditionnement": "B/07 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "NICOTINELL 21MG/24H (SOIT 52,5MG DE S(-) NICOTINE TOTALE/DISPOSITIF DE 30CM2 ) DISPOSITIF TRANSDERMIQUE  EN PATCHS B/07 ET B/28", "Img": "https://pharmnet-dz.com//img/medics/2335.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2335", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " PSYCHIATRIE", "Info": " NICOTINE ", "Pays": "FRANCE", "Nom Commercial": "NICOTINELL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "267/ 16 F 118 /08", "Code DCI": "16F118", "Forme": "DISPOSITIF", "Dosage": "21MG/24H (SOIT 52,5MG DE S(-) NICOTINE TOTALE/DISPOSITIF DE 30CM2 )", "Conditionnement": "B/07 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "NICOTINELL 7MG/24H  (SOIT 17,5MG DE S(-) NICOTINE TOTALE/DISPOSITIF DE 10CM2)  DISPOSITIF TRANSDERMIQUE  EN PATCHS B/07 ET B/28", "Img": "https://pharmnet-dz.com//img/medics/2331.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2331", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " PSYCHIATRIE", "Info": " NICOTINE ", "Pays": "FRANCE", "Nom Commercial": "NICOTINELL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "267/ 16 F 116 /08", "Code DCI": "16F116", "Forme": "DISPOSITIF", "Dosage": "7MG/24H  (SOIT 17,5MG DE S(-) NICOTINE TOTALE/DISPOSITIF DE 10CM2) ", "Conditionnement": "B/07 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIDAZOLE  250MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "NIDAZOLE ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 F 039 /97/06", "Code DCI": "13F039", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "NIDAZOLE 125MG/5ML SUSP.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "NIDAZOLE", "Tarif de reference": "115 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 F 040 /97", "Code DCI": "13F040", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIDAZOLE 200MG/5ML SUSP. BUV. B/1FL DE 100ML+ BOUCHON DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE BENZOATE EXPRIME EN METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NIDAZOLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 F 225 /06/12", "Code DCI": "13F225", "Forme": "SUSP. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "B/1FL DE 100ML+ BOUCHON DOSEUR", "Commercialisation": true, "Remboursable": null}, {"Nom": "NIDAZOLE 500MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "NIDAZOLE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 F 199 /07/14", "Code DCI": "13F199", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "NIDILAT 10MG CAPS. B/30", "Img": "https://pharmnet-dz.com//img/medics/64.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANOFI DOGU", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NIFEDIPINE ", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "NIDILAT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "250/ 06 B 017 /01", "Code DCI": "06B017", "Forme": "CAPS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIDREL 10MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NITRENDIPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NIDREL", "Tarif de reference": "285.6 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 E 223 /06", "Code DCI": "06E223", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIDREL 20MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NITRENDIPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NIDREL", "Tarif de reference": "571.48 DA", "PPA": "N/A", "Num Enregistrement": "273/ 06 E 224 /06", "Code DCI": "06E224", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFAZID 220MG/5ML SUSP.BUV. FL/90ML", "Img": "https://pharmnet-dz.com//img/medics/3934.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3934", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFAZID", "Tarif de reference": "0 DA", "PPA": "149 DA", "Num Enregistrement": "003/ 10 C 018 /01", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "220MG/5ML", "Conditionnement": "FL/90ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "NIFAZIDE 220MG/5ML SUSP.BUV. FL/90ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFAZIDE", "Tarif de reference": "-- DA", "PPA": " DA", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "220MG/5ML", "Conditionnement": "FL/90ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLUGEL 0.025 GEL DERM. T/60G", "Img": "https://pharmnet-dz.com//img/medics/1383.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1383", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE NIFLUMIQUE", "Pays": "FRANCE", "Nom Commercial": "NIFLUGEL", "Tarif de reference": "174 DA", "PPA": "N/A", "Num Enregistrement": "017/ 21 A 031 /99/15", "Code DCI": "21A031", "Forme": "GEL DERM.", "Dosage": "0.025", "Conditionnement": "T/60G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLUMATE 400MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLUMATE", "Tarif de reference": " N/A", "PPA": "135.00 DA", "Num Enregistrement": "003/ 04 B 031 /02/10", "Code DCI": "04B031", "Forme": "SUPPO.", "Dosage": "400MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "NIFLUMATE 700MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2789", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLUMATE", "Tarif de reference": "171.4 DA", "PPA": "N/A", "Num Enregistrement": "003/ 04 B 030 /06/14", "Code DCI": "04B030", "Forme": "SUPPO.", "Dosage": "700MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLUMENE 200MG SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medics/954.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=954", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLUMENE", "Tarif de reference": "54.16 DA", "PPA": "140.00 DA", "Num Enregistrement": "231/ 04 B 064 /09", "Code DCI": "04B064", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLUMENE 250MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2788.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2788", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ACIDE NIFLUMIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLUMENE", "Tarif de reference": "118.5 DA", "PPA": "170.00 DA", "Num Enregistrement": "231/ 04 B 029 /08", "Code DCI": "04B029", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLUMENE 400MG SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medics/2795.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2795", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLUMENE", "Tarif de reference": "108.4 DA", "PPA": "160.00 DA", "Num Enregistrement": "231/ 04 B 031 /06", "Code DCI": "04B031", "Forme": "SUPPO.", "Dosage": "400MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLUMENE 700MG SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medics/2790.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2790", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLUMENE", "Tarif de reference": "137.12 DA", "PPA": "200.00 DA", "Num Enregistrement": "231/ 04 B 030 /09", "Code DCI": "04B030", "Forme": "SUPPO.", "Dosage": "700MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLURIC 0.025 GEL DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1384.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1384", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE NIFLUMIQUE", "Pays": "ALGERIE", "Nom Commercial": "NIFLURIC", "Tarif de reference": "116 DA", "PPA": "N/A", "Num Enregistrement": "366/ 21 A 031 /08", "Code DCI": "21A031", "Forme": "GEL DERM.", "Dosage": "0.025", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLURIC 0.03 PDE.DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1365.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1365", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE NIFLUMIQUE", "Pays": "ALGERIE", "Nom Commercial": "NIFLURIC", "Tarif de reference": "60 DA", "PPA": "N/A", "Num Enregistrement": "366/ 21 A 001 /07/13", "Code DCI": "21A001", "Forme": "PDE. DERM.", "Dosage": "0.03", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLURIC 200MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/955.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=955", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLURIC", "Tarif de reference": "67.7 DA", "PPA": "N/A", "Num Enregistrement": "366/ 04 B 064 /10", "Code DCI": "04B064", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFLURIC 400MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLURIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "366/ 04 B 031 /07/13", "Code DCI": "04B031", "Forme": "SUPPO.", "Dosage": "400MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "NIFLURIC 700MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFLURIC", "Tarif de reference": "171.4 DA", "PPA": "200.00 DA", "Num Enregistrement": "366/ 04 B 030  /10", "Code DCI": "04B030", "Forme": "SUPPO.", "Dosage": "700MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFUROXAZIDE 0.04 SUSP. BUV FL/90ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3935", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFUROXAZIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "088/ 10 C 018 /02", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "0.04", "Conditionnement": "FL/90ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "NIFUROXAZIDE AFRO 0.04 SUSP,BUV, FL /90ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFUROXAZIDE AFRO", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "503/10C018/16", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "4%", "Conditionnement": "FL /90ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NIFUROXAZIDE IVAL 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFUROXAZIDE IVAL", "Tarif de reference": "185.1 DA", "PPA": "N/A", "Num Enregistrement": "195/ 10 C 017 /07", "Code DCI": "10C017", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NIFUROXAZIDE PHYSIOPHARM 0.04 SUSP,BUV, FL /90ML", "Img": "https://pharmnet-dz.com//img/medics/4576.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4576", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFUROXAZIDE PHYSIOPHARM", "Tarif de reference": "0 DA", "PPA": "176.78 DA", "Num Enregistrement": "462/10C018/16", "Code DCI": "10C018", "Forme": "SUSP. BUV.", "Dosage": "4%", "Conditionnement": "FL /90ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "NIFUROXAZIDE PHYSIOPHARM 200MG GLES B/30", "Img": "https://pharmnet-dz.com//img/medics/3929.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NIFUROXAZIDE PHYSIOPHARM", "Tarif de reference": "185.1 DA", "PPA": "185.00 DA", "Num Enregistrement": "462/ 10 C 017/13", "Code DCI": "10C017", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NITROCINE 10MG/10ML SOL. P. PERF. IV B/10 AMP.DE  10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " GLYCERYL TRINITRATE ", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "NITROCINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "273/ 06 C 206 /05", "Code DCI": "06C206", "Forme": "SOL. PERF.", "Dosage": "10MG/10ML", "Conditionnement": "B/10 AMP.DE  10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NIVAQUINE 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/2054.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2054", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " ANTI-PALUDEENS", "C.Therapeutique": " PARASITOLOGIE", "Info": " CHLOROQUINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "NIVAQUINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 19 C 014 /96", "Code DCI": "19C014", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NO URIC 100MG COMP. B/50 ", "Img": "https://pharmnet-dz.com//img/medics/1394.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1394", "Laboratoire": " EIPICO ", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "NO URIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "109/ 21 B 007 /99", "Code DCI": "21B007", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/50 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NO URIC 300MG COMP. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1398", "Laboratoire": " EIPICO ", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "NO URIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "109/ 21 B 008 /99", "Code DCI": "21B008", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOBAC ADULTE  -  NOBAC NOURRISSON 50MG/26,7MG/ML SUSP. BUV. B/1FL. DE 250ML (ADULTE)  ET  B/1FL. DE 150ML +UNE SERING. GRADUEE (NOURRISSON)  ", "Img": "https://pharmnet-dz.com//img/medics/2916.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2916", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-REFLUX GASTRO-OESOPHAGIEN", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ALGINATE DE SODIUM / BICARBONATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "NOBAC ADULTE  -  NOBAC NOURRISSON", "Tarif de reference": "210 DA", "PPA": "N/A", "Num Enregistrement": "263/ 10 G 054 /11", "Code DCI": "10G054", "Forme": "SUSP. BUV.", "Dosage": "50MG/26,7MG/ML", "Conditionnement": "B/1FL. DE 250ML (ADULTE)  ET  B/1FL. DE 150ML +UNE SERING. GRADUEE (NOURRISSON)  ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NODILOF 1G/FL. DE PDRE. PDRE. P. SOL. INJ. IM/IV B/01 FL. DE PDRE. + 01 AMP. DE 10ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " JERUSALEM PHARMACEUTICALS CO LTD", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "PALESTINE", "Nom Commercial": "NODILOF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "369/ 13 B 012 /15", "Code DCI": "13B012", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE. + 01 AMP. DE 10ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOLIB 100MG COMP.PELL B/50", "Img": "https://pharmnet-dz.com//img/medics/4397.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTI-INFECTIEUX URINAIRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " NITROXOLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOLIB", "Tarif de reference": "218 DA", "PPA": "218 DA", "Num Enregistrement": "462/25E015/16", "Code DCI": "25E015", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOLVADEX 10MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/603.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=603", "Laboratoire": " ZENECA PHARMA", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TAMOXIFENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NOLVADEX", "Tarif de reference": "0 DA", "PPA": "643.00 DA", "Num Enregistrement": "171/ 09 B 004 /99", "Code DCI": "09B004", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOLVADEX 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/606.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=606", "Laboratoire": " ZENECA PHARMA", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TAMOXIFENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NOLVADEX", "Tarif de reference": "645.6 DA", "PPA": "N/A", "Num Enregistrement": "171/ 09 B 075 /99", "Code DCI": "09B075", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NONAN  SOL.INJ. B/25 FL de 50 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " OLIGOELEMENTS", "Pays": "FRANCE", "Nom Commercial": "NONAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "075/ 14 G 056 /98", "Code DCI": "14G056", "Forme": "SOL. INJ.", "Conditionnement": "B/25 FL de 50 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOPAIN 125MG/5ML SUSP. BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "NOPAIN", "Tarif de reference": "235 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 047 /06", "Code DCI": "04B047", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOPAIN 275MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/2758.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2758", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "NOPAIN", "Tarif de reference": "209.6 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 019 /97/09", "Code DCI": "04B019", "Forme": "COMP. PELLI.", "Dosage": "275MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOPAIN DS 550MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/2762.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2762", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "NOPAIN DS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 020 /97/09", "Code DCI": "04B020", "Forme": "COMP. PELLI.", "Dosage": "550MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "NORADRENALINE 8MG/4ML SOL.INJ. B/50 AMP. DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ADRENALINE TARTRATE EXPRIME EN ADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NORADRENALINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "075/ 06 A 008 /01", "Code DCI": "06A008", "Forme": "SOL. INJ.", "Dosage": "8MG/4ML", "Conditionnement": "B/50 AMP. DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NORADRENALINE RENAUDIN  2MG/ML SOL. INJ.A DILUER PERF.  B/10AMP. DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANALEPTIQUES CIRCULATOIRES & ANTI-HYPOTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ADRENALINE TARTRATE EXPRIME EN ADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NORADRENALINE RENAUDIN ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 06 A 008 /05", "Code DCI": "06A008", "Forme": "SOL. INJ.", "Dosage": "2MG/ML", "Conditionnement": "B/10AMP. DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NORDITROPINE NORDILET 5MG/1,5ML SOL. INJ.  S.C. EN STYLO PREREMPLI B/1STYLO  PRE REMPLI  DE 1,5ML", "Img": "https://pharmnet-dz.com//img/medics/3796.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3796", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " SOMATROPINE", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "NORDITROPINE NORDILET", "Tarif de reference": "6500 DA", "PPA": "6877.00 DA", "Num Enregistrement": "069/ 09 J 147 /06", "Code DCI": "09J147", "Forme": "PDRE. SOL. INJ.", "Dosage": "5MG/1,5ML", "Conditionnement": "B/1STYLO  PRE REMPLI  DE 1,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NORFLOXAL 400 MG CP  PELL  B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " NORFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NORFLOXA", "Tarif de reference": "- DA", "PPA": " DA", "Num Enregistrement": "039/13K229/17", "Code DCI": "13K229", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "NORGALAX 0,12G/10G GEL.RECT.EN RECIPIENT UNIDOSE B/06 RECIPIENTS UNIDOSE DE 10 G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOCUSATE SODIQUE", "Pays": "FRANCE", "Nom Commercial": "NORGALAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 10 M 063 /98/09", "Code DCI": "10M063", "Forme": "GEL RECTAL", "Dosage": "0,12G/10G", "Conditionnement": "B/06 RECIPIENTS UNIDOSE DE 10 G", "Commercialisation": true, "Remboursable": null}, {"Nom": "NORLEVO 750\u00b5G (OU 0,75MG) COMP B/2", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NORLEVO", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/ 11 H 064 / 01", "Code DCI": "11H064", "Forme": "COMP.", "Dosage": "750\u00b5G (OU 0,75MG)", "Conditionnement": "B/2", "Commercialisation": true, "Remboursable": true}, {"Nom": "NORMACOL 61G/100G DE GRLES. GRLES. ENRO.  B/375G DE GRLES.  -  B/30 SACHETS DE 10G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " GOMME DE STERCULIA ", "Pays": "FRANCE", "Nom Commercial": "NORMACOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 10 M 065 /98/09", "Code DCI": "10M065", "Forme": "GRLES.", "Dosage": "61G/100G DE GRLES.", "Conditionnement": "B/375G DE GRLES.  -  B/30 SACHETS DE 10G", "Commercialisation": true, "Remboursable": null}, {"Nom": "NORMACOL LAVEMENT ADULTE 23,66G/10,40G/130ML SOL.RECT.ADULTE FL.UNIDOSE DE 130ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIHYDROGENOPHOSPHATE DE SODIUM HYDRATE / HYDROGENOPHOSPHATE DE SODIUM DODECAHYDRATE", "Pays": "FRANCE", "Nom Commercial": "NORMACOL LAVEMENT ADULTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 10 M 115 /02/09", "Code DCI": "10M115", "Forme": "SOL. RECTAL", "Dosage": "23,66G/10,40G/130ML", "Conditionnement": "FL.UNIDOSE DE 130ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NORMACOL LAVEMENT ENFANT 10,92G/4,80G/60ML SOL.RECT.ENFANT FL. UNIDOSE DE 60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHEMICAL FARMA", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIHYDROGENOPHOSPHATE DE SODIUM HYDRATE / HYDROGENOPHOSPHATE DE SODIUM DODECAHYDRATE", "Pays": "FRANCE", "Nom Commercial": "NORMACOL LAVEMENT ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "437/ 10 M 121 /02/09", "Code DCI": "10M121", "Forme": "SOL. RECTAL", "Dosage": "10,92G/4,80G/60ML", "Conditionnement": "FL. UNIDOSE DE 60ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NORTA 50MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/166.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=166", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NORTA", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "317/ 06 E 126 /10", "Code DCI": "06E126", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NORTA FORT 100MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3178.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3178", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NORTA FORT", "Tarif de reference": "1204 DA", "PPA": "1204.00 DA", "Num Enregistrement": "317/ 06 E 240 /11", "Code DCI": "06E240", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOSITRON 2MG/ML** (OU 4MG/2ML) SOL. INJ. IV B/05AMP. DE 2ML - B/50AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOSITRON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 048 /09", "Code DCI": "10F048", "Forme": "SOL. INJ.", "Dosage": "2MG/ML** (OU 4MG/2ML)", "Conditionnement": "B/05AMP. DE 2ML - B/50AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOSITRON 4MG COMP. ORODISPERS. B/04", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOSITRON", "Tarif de reference": "285.6 DA", "PPA": "N/A", "Num Enregistrement": "003/ 05 K 154 /10", "Code DCI": "05K154", "Forme": "COMP. ORODISPERS.", "Dosage": "4MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOSITRON 4MG/5ML SIROP FL./50ML+GOBLET DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NOSITRON", "Tarif de reference": "714 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 187 /09", "Code DCI": "10F187", "Forme": "SIROP", "Dosage": "4MG/5ML", "Conditionnement": "FL./50ML+GOBLET DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOSITRON 8MG COMP. ORODISPERS. B/04", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOSITRON", "Tarif de reference": "457.2 DA", "PPA": "N/A", "Num Enregistrement": "003/ 05 K 155 /10", "Code DCI": "05K155", "Forme": "COMP. ORODISPERS.", "Dosage": "8MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOTOREX 200MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOTOREX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 04 B 036 /15", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVACARBIN 200MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "NOVACARBIN", "Tarif de reference": "435 DA", "PPA": "N/A", "Num Enregistrement": "013/ 15 A 004 /99", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVACLOVIR  200MG  COMP. B/25", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVACLOVIR ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "149/13P097/16", "Code DCI": "13P097", "Forme": "COMP.", "Dosage": "200MG ", "Conditionnement": "B/25", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVACLOVIR 0.05 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/483.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIHERPETIQUES & ANTIVIRAUX LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVACLOVIR", "Tarif de reference": "472.5 DA", "PPA": " DA", "Num Enregistrement": "149/ 07 E 033 /13", "Code DCI": "07E033", "Forme": "CR\u00c8ME", "Dosage": "0.05", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVACORT 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVACORT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 09 H 033 /98", "Code DCI": "09H033", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAKOD 10MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CODEINE PHOSPHATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVAKOD", "Tarif de reference": "202.2 DA", "PPA": "N/A", "Num Enregistrement": "013/ 20 B 029 /98", "Code DCI": "20B029", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVALIS 20MG COMP. PELLI. B/02", "Img": "https://pharmnet-dz.com//img/medics/1230.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVALIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "149/ 25 N 052 /15", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/02", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVANTRONE 10MG/5ML SOL.INJ. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " MITOXANTRONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NOVANTRONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 05 A 065 /99", "Code DCI": "05A065", "Forme": "SOL. INJ.", "Dosage": "10MG/5ML", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVANTRONE 20MG/10ML SOL.INJ. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " MITOXANTRONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NOVANTRONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 05 A 066 /99", "Code DCI": "05A066", "Forme": "SOL. INJ.", "Dosage": "20MG/10ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVAPAM 5MG COMP. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " DIAZEPAM", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVAPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 16 B 027 /98", "Code DCI": "16B027", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAPOXID 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORDIAZEPOXIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVAPOXID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 16 B 019 /99", "Code DCI": "16B019", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAPREXA  10mg COMP . ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVAPREXA ", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "149/16D101/15", "Code DCI": "16D101", "Forme": "COMP. DISPERS.", "Dosage": "10mg", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAPREXA  10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVAPREXA ", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "149/16D100/16", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAPROST 50MG CAPS. MOLLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " EXTRAIT  DE PYGEUM AFRICANUM", "Pays": "ITALIE", "Nom Commercial": "NOVAPROST", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 25 B 003 /98/10", "Code DCI": "25B003", "Forme": "CAPS.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVARMIN 500MG COMP. A CROQ. B/4", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " NICLOSAMIDE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "NOVARMIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 19 B 008 /99", "Code DCI": "19B008", "Forme": "COMP. A CROQ.", "Dosage": "500MG", "Conditionnement": "B/4", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAROL 4MG COMP. SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACENOCOUMAROL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVAROL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 12 A 001 /99/10", "Code DCI": "12A001", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVASMIL 250MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " HEMOSTATIQUES GENERAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ETAMSYLATE", "Pays": "ITALIE", "Nom Commercial": "NOVASMIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 12 H 040 /99", "Code DCI": "12H040", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVASON 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISONE BASE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVASON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "013/ 09 H 037 /98", "Code DCI": "09H037", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVASTERIDE 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Pharmacologique": " UROLOGIE ET NEPHROLOGIE", "C.Therapeutique": " FINASTERIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVASTERIDE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "504/25B023/16", "Code DCI": "25B023", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVATRIL 2MG COMP. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CLONAZEPAM", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVATRIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 15 A 008 /99/14", "Code DCI": "15A008", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVAVALZ PLUS 160MG/12,5MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVAVALZ PLUS", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "149/ 06 E 237 /14", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAVALZ PLUS 160MG/25MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVAVALZ PLUS", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "149/ 06 E 238 /14", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAVALZ PLUS 80MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVAVALZ PLUS", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "149/ 06 E 158 /14", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAVIT B1 250MG COMP.SEC. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE (OU VITAMINE B1)", "Pays": "ITALIE", "Nom Commercial": "NOVAVIT B1", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "013/ 14 H 109 /99/07", "Code DCI": "14H109", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVAZIN 100MG COMP.ENRO. B/20 - B/500", "Img": "https://pharmnet-dz.com//img/medics/2205.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2205", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LEVOMEPROMAZINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVAZIN", "Tarif de reference": "442.8 DA", "PPA": "N/A", "Num Enregistrement": "013/ 16 D 058 /99/15", "Code DCI": "16D058", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20 - B/500", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVAZIN 25MG COMP.ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/2203.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2203", "Laboratoire": " NOVA ARGENTIA SPA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LEVOMEPROMAZINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "NOVAZIN", "Tarif de reference": "194.51 DA", "PPA": "N/A", "Num Enregistrement": "013/ 16 D 057 /96/09", "Code DCI": "16D057", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVECIN 200MG COMP B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "NOVECIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "174/ 13 K 086 /98", "Code DCI": "13K086", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVITAL 250MG/250MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE CHLORHYDRATE / PYRIDOXINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "NOVITAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 14 H 112 /00/14", "Code DCI": "14H112", "Forme": "COMP.", "Dosage": "250MG/250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOVO FER 100MG COMP. A SUCER B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " ANTI-ANEMIQUES", "C.Pharmacologique": " HEMATOLOGIE ET HEMOSTASE", "C.Therapeutique": " FER FERRIQUE** (SOUS FORME DE COMPLEXE D'HYDROXYDE FERRIQUE POLYMALTOSE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVO FER", "Tarif de reference": "72 DA", "PPA": "N/A", "Num Enregistrement": "504/12E149/16", "Code DCI": "12E149", "Forme": "COMP. A SUCER", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVO FER PLUS 100MG/0,35MG COMP A SUCER B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " ANTI-ANEMIQUES", "C.Pharmacologique": " HEMATOLOGIE ET HEMOSTASE", "C.Therapeutique": " COMPLEXE HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE / ACIDE FOLIQUE   ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVO FER PLUS", "Tarif de reference": "253.2 DA", "PPA": "N/A", "Num Enregistrement": "504/12E133/16", "Code DCI": "12E133", "Forme": "COMP. A SUCER", "Dosage": "100MG/0,35MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOFORMINE 1000MG COMP. PELLI. B/30 - B/60", "Img": "https://pharmnet-dz.com//img/medics/3709.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3709", "Laboratoire": " ALDAPH SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVOFORMINE", "Tarif de reference": "173.4 DA", "PPA": "N/A", "Num Enregistrement": "368/ 14 A 224 /10", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/30 - B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOFORMINE 500MG COMP. PELLI. B/30 ET B/50", "Img": "https://pharmnet-dz.com//img/medics/3622.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3622", "Laboratoire": " ALDAPH SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVOFORMINE", "Tarif de reference": "109.2 DA", "PPA": "N/A", "Num Enregistrement": "368/ 14 A 006 /07/13", "Code DCI": "14A006", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/30 ET B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOFORMINE 850MG COMP. PELLI. B/30 ET B/50", "Img": "https://pharmnet-dz.com//img/medics/3633.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3633", "Laboratoire": " ALDAPH SPA", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOVOFORMINE", "Tarif de reference": "147.6 DA", "PPA": "N/A", "Num Enregistrement": "368/ 14 A 007 /07/13", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30 ET B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOMIX 30 FLEXPEN 100UI/ML  SUSP. INJ. B/05 STYLOS MULTIDOSES PRE-REMPLIS JETABLES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3310.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3310", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE ASPARTE / INSULINE ASPARTE PROTAMINE 30/70%", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "NOVOMIX 30 FLEXPEN", "Tarif de reference": "0 DA", "PPA": "5156.00 DA", "Num Enregistrement": "069/ 14 B 225 /06", "Code DCI": "14B225", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML ", "Conditionnement": "B/05 STYLOS MULTIDOSES PRE-REMPLIS JETABLES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOMIX 30 PENFILL 100UI/ML  SUSP. INJ. B/05 CARTOUCHES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3311.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3311", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE ASPARTE / INSULINE ASPARTE PROTAMINE 30/70%", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "NOVOMIX 30 PENFILL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 B 226 /06", "Code DCI": "14B226", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML ", "Conditionnement": "B/05 CARTOUCHES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVONORM 0,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3689.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3689", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "NOVONORM", "Tarif de reference": "355.8 DA", "PPA": "N/A", "Num Enregistrement": "069/ 14 A 200 /01", "Code DCI": "14A200", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVONORM 1MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3693.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3693", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "NOVONORM", "Tarif de reference": "370.8 DA", "PPA": "N/A", "Num Enregistrement": "069/ 14 A 201 /01", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVONORM 2MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3698.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3698", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "NOVONORM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 A 202 /01", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVORAPID FLEXPEN 100UI/ML  SOL. INJ. B/05 STYLOS MULTIDOSES PRE-REMPLIS JETABLES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3308.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3308", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE ASPARTE", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "NOVORAPID FLEXPEN", "Tarif de reference": "0 DA", "PPA": "5143.00 DA", "Num Enregistrement": "069/ 14 B 223 /06", "Code DCI": "14B223", "Forme": "SOL. INJ.", "Dosage": "100UI/ML ", "Conditionnement": "B/05 STYLOS MULTIDOSES PRE-REMPLIS JETABLES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVORAPID PENFILL 100UI/ML  SOL. INJ. B/05 CARTOUCHES DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/3309.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3309", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE ASPARTE", "Liste": "Liste II", "Pays": "DANEMARK", "Nom Commercial": "NOVORAPID PENFILL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 14 B 224 /06", "Code DCI": "14B224", "Forme": "SOL. INJ.", "Dosage": "100UI/ML ", "Conditionnement": "B/05 CARTOUCHES DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOSEVEN 1MG/FL. DE PDRE. (50KUI/FL. DE PDRE.) PDRE. LYOPH. ET SOLV. P. SOL. INJ.  B/1FL. DE PDRE. + 1FL. DE SOLVT. ", "Img": "https://pharmnet-dz.com//img/medics/1844.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1844", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPTACOG ALFA (ACTIVE)", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "NOVOSEVEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 12 J 160 /13", "Code DCI": "12J160", "Forme": "PDRE. INJ.", "Dosage": "1MG/FL. DE PDRE. (50KUI/FL. DE PDRE.)", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE SOLVT. ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOSEVEN 2MG/FL. DE PDRE. (100KUI/FL. DE PDRE.) PDRE. LYOPH. ET SOLV. P. SOL. INJ.  B/1FL. DE PDRE. + 1FL. DE SOLVT. ", "Img": "https://pharmnet-dz.com//img/medics/1845.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1845", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPTACOG ALFA (ACTIVE)", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "NOVOSEVEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 12 J 161 /13", "Code DCI": "12J161", "Forme": "PDRE. INJ.", "Dosage": "2MG/FL. DE PDRE. (100KUI/FL. DE PDRE.)", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE SOLVT. ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOVOSEVEN 5MG/FL. DE PDRE. (250KUI/FL. DE PDRE.) PDRE. LYOPH. ET SOLV. P. SOL. INJ.  B/1FL. DE PDRE. + 1FL. DE SOLVT. ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1846", "Laboratoire": " NOVO NORDISK", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPTACOG ALFA (ACTIVE)", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "NOVOSEVEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "069/ 12 J 162 /13", "Code DCI": "12J162", "Forme": "PDRE. INJ.", "Dosage": "5MG/FL. DE PDRE. (250KUI/FL. DE PDRE.)", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE SOLVT. ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOXEN 250MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "NOXEN", "Tarif de reference": "209.6 DA", "PPA": "N/A", "Num Enregistrement": "043/ 04 B 055 /07", "Code DCI": "04B055", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOXEN 500MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "NOXEN", "Tarif de reference": "217 DA", "PPA": "N/A", "Num Enregistrement": "043/ 04 B 056 /07", "Code DCI": "04B056", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOZEUM 1MG/ML SIROP  FL DE 200 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LGPA", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "NOZEUM", "Tarif de reference": "224.00 DA", "PPA": "N/A", "Code DCI": "10F047", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL/200 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOZINAN 0.04 SOL.BUV.GTTES. FL./30ML", "Img": "https://pharmnet-dz.com//img/medics/2208.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LEVOMEPROMAZINE CHLORHYDRATE EXPRIME EN LEVOMEPROMAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NOZINAN", "Tarif de reference": " N/A", "PPA": "250.00 DA", "Num Enregistrement": "263/ 16 D 059 /96/09", "Code DCI": "16D059", "Forme": "SOL. BUV. GTTES.", "Dosage": "0.04", "Conditionnement": "FL./30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "NOZINAN 100MG COMP.PELLI. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/2206.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2206", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LEVOMEPROMAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NOZINAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 16 D 058 /97", "Code DCI": "16D058", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOZINAN 25MG COMP.PELLI. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/2204.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2204", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LEVOMEPROMAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NOZINAN", "Tarif de reference": "140.92 DA", "PPA": "N/A", "Num Enregistrement": "016/ 16 D 057 /96 ", "Code DCI": "16D057", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "NOZINAN 25MG/ML SOL.INJ. B/5 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2202", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LEVOMEPROMAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "NOZINAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 16 D 056 /96", "Code DCI": "16D056", "Forme": "SOL. INJ.", "Dosage": "25MG/ML", "Conditionnement": "B/5 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "NUTRILON AR 1er AGE  PDRE B/400G", "Img": "https://pharmnet-dz.com//img/medics/3474.png", "Laboratoire": " NUTRICIA S A", "C.Pharmacologique": " LAITS & FARINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LAIT POUR NOURRISSON A LA FARINE DE GRAINES DE CAROUBE", "Pays": "FRANCE", "Nom Commercial": "NUTRILON AR 1er AGE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "288/ 14 L 208 /03", "Code DCI": "14L208", "Forme": "PDRE.", "Dosage": "0", "Conditionnement": "B/400G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NUTRILON AR 2\u00e8me AGE  PDRE B/400G", "Img": "https://pharmnet-dz.com//img/medics/3475.png", "Laboratoire": " NUTRICIA S A", "C.Pharmacologique": " LAITS & FARINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LAIT POUR NOURRISSON A LA FARINE DE GRAINES DE CAROUBE", "Pays": "FRANCE", "Nom Commercial": "NUTRILON AR 2\u00e8me AGE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "288/ 14 L 209 /03", "Code DCI": "14L209", "Forme": "PDRE.", "Dosage": "0", "Conditionnement": "B/400G", "Commercialisation": true, "Remboursable": true}, {"Nom": "NYSTAR 100 000UI SUSP. BUV. GTTES. FL. GTTES. 30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " NYSTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "NYSTAR", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "321/ 13 R 303 /06", "Code DCI": "13R303", "Forme": "SUSP. BUV. GTTES.", "Dosage": "100 000UI", "Conditionnement": "FL. GTTES. 30ML", "Commercialisation": true, "Remboursable": true}], "O": [{"Nom": "O. ZN+ 27G/20G/100G PDE. DERM T./40G", "Img": "https://pharmnet-dz.com//img/medics/1643.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1643", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " OXYDE DE ZINC / HUILE DE FOIE DE MORUE", "Pays": "ALGERIE", "Nom Commercial": "O. ZN+", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "366/ 07 A 006 /08", "Code DCI": "07A006", "Forme": "PDE.", "Dosage": "27G/20G/100G", "Conditionnement": "T./40G", "Commercialisation": true, "Remboursable": false}, {"Nom": "OBARCORT RETARD 40MG SUSP INJ  B/1", "Img": "https://pharmnet-dz.com//img/medics/3760.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3760", "Laboratoire": " OUBARI PHARMA ", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TRIAMCINOLONE ACETONIDE", "Liste": "Liste I", "Pays": "SYRIE", "Nom Commercial": "OBARCORT RETARD", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "071/ 09 H 091 /97", "Code DCI": "09H091", "Forme": "SUSP. INJ.", "Dosage": "40MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "OCTAGAM 50MG/ML (  5G/100ML ) SOL. P. PERF. IV  B/ 1FL DE 100 ML  ", "Img": "https://pharmnet-dz.com//img/medics/5984.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " OCTAPHARM PHARMAZEUTICA PRODUKTIONSGES,m,b,H", "C.Pharmacologique": " SERUMS & GAMMA GLOBULINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " IMMUNOGLOBULINE HUMAINE NORMALE 1G IV", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OCTAGAM", "Tarif de reference": "000 DA", "PPA": " DA", "Num Enregistrement": "469/13V471/17", "Code DCI": "13V471", "Forme": "SOL. INJ. PERF.", "Dosage": " 50MG/ML     (  5G/100ML )", "Conditionnement": " B/ 1FL DE100 ML  ", "Commercialisation": true, "Remboursable": true}, {"Nom": "OCTAGAM 50MG/ML ( 10G/200ML) SOL. P. PERF. IV B/1  FL DE 200 M", "Img": "https://pharmnet-dz.com//img/medics/5987.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " OCTAPHARM PHARMAZEUTICA PRODUKTIONSGES,m,b,H", "C.Pharmacologique": " SERUMS & GAMMA GLOBULINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " IMMUNOGLOBULINE HUMAINE NORMALE 1G IV", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OCTAGAM", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "469/13V471/17", "Code DCI": "13V471", "Forme": "SOL. INJ. PERF.", "Dosage": "50MG/ML (  10G/200ML)", "Conditionnement": " B/1   FL DE 200 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OCTAGAM 50MG/ML (2,5G/50ML ) SOL. P. PERF. IV B/1 FL DE 50 ML", "Img": "https://pharmnet-dz.com//img/medics/5983.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " OCTAPHARM PHARMAZEUTICA PRODUKTIONSGES,m,b,H", "C.Pharmacologique": " SERUMS & GAMMA GLOBULINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " IMMUNOGLOBULINE HUMAINE NORMALE 1G IV", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OCTAGAM", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "469/13V471/17", "Code DCI": "13V471", "Forme": "SOL. INJ. PERF.", "Dosage": " 50 MG/ ML  (2.5MG/50ML)", "Conditionnement": "B/1 FL DE 50 ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "OCTANATE  500UI/FL. DE  POUDRE  POUDRE. ET SOLV. P. PREPARATION INJ. IV B/1FL. DE PDRE. + 1FL. DE 10ML DE SOLV. (EPPI)+ DISPOSITIF D'INJECTION", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " FACTEURS SANGUINS", "C.Pharmacologique": " HEMATOLOGIE ET HEMOSTASE", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OCTANATE ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "469/12J044/16", "Code DCI": "12J044", "Forme": "PDRE. SOL. INJ.", "Dosage": "500UI/FL. DE  POUDRE ", "Conditionnement": "B/1FL. DE PDRE. + 1FL. DE 10ML DE SOLV. (EPPI)+ DISPOSITIF D'INJECTION", "Commercialisation": true, "Remboursable": null}, {"Nom": "OCTREOTIDE BIOINDUSTRIA L.I.M 100\u00b5G/ML SOLUTION INJECTABLE POUR PERFUSION IV ET S/C B/10AMPOULES DE 1ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " DIVERS", "C.Pharmacologique": " ENDOCRINOLOGIE ET HORMONES", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "OCTREOTIDE BIOINDUSTRIA L.I.M", "Tarif de reference": "8874.9 DA", "PPA": "N/A", "Num Enregistrement": "505/09P109/16", "Code DCI": "09P109", "Forme": "SOL. INJ.", "Dosage": "100\u00b5G/ML", "Conditionnement": "B/10AMPOULES DE 1ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "OCTREOTIDE BIOINDUSTRIA L.I.M 500\u00b5G/ML SOLUTION INJECTABLE POUR PERFUSION IV ET S/C B/10AMPOULES DE 1ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " DIVERS", "C.Pharmacologique": " ENDOCRINOLOGIE ET HORMONES", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "OCTREOTIDE BIOINDUSTRIA L.I.M", "Tarif de reference": "9468 DA", "PPA": "N/A", "Num Enregistrement": "505/09P110/16", "Code DCI": "09P110", "Forme": "SOL. INJ.", "Dosage": "500\u00b5G/ML", "Conditionnement": "B/10AMPOULES DE 1ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "OESTRODOSE 60MG/100G                           GEL POUR APPLICATION CUTANEE EN FLACON                FLACON AVEC POMPE DOSEUSE  DE 64 DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=622", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ESTRADIOL ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "OESTRODOSE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "169/ 09 G 009 /99", "Code DCI": "09G009", "Forme": "GEL. APP. LOCALE", "Dosage": "60MG/100G                          ", "Conditionnement": "FLACON AVEC POMPE DOSEUSE  DE 64 DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "OESTROGEL 60MG/100G                           GEL POUR APPLICATION CUTANEE EN TUBE                    T/80 G", "Img": "https://pharmnet-dz.com//img/medics/623.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=623", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ESTRADIOL ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "OESTROGEL", "Tarif de reference": "301.83 DA", "PPA": "N/A", "Num Enregistrement": "169/ 09 G 009 /99", "Code DCI": "09G009", "Forme": "GEL. APP. LOCALE", "Dosage": "60MG/100G                          ", "Conditionnement": "T/80 G", "Commercialisation": true, "Remboursable": true}, {"Nom": "OFLACIN 200MG COMP. B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "OFLACIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 13 K 086 /98", "Code DCI": "13K086", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "OFLAX 200MG COMP. PELLI. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OFLAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "321/ 13 K 086 /06", "Code DCI": "13K086", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "OFLAX 400MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OFLAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "321/ 13 K 271 /05", "Code DCI": "13K271", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "OFLO 200 5MG/ML (OU 200MG/40ML) SOL.INJ. PERF. IV B/1FL. DE 40ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OFLO 200", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 13 K 087 /08", "Code DCI": "13K087", "Forme": "SOL. INJ.", "Dosage": "5MG/ML (OU 200MG/40ML)", "Conditionnement": "B/1FL. DE 40ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OFLOCET 200MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ROUSSEL", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OFLOCET", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "033/ 13 K 086 /97", "Code DCI": "13K086", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "OFLOCET 200MG/40ML SOL.INJ. FL/40ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=359", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OFLOCET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 13 K 087 /97", "Code DCI": "13K087", "Forme": "SOL. INJ.", "Dosage": "200MG/40ML", "Conditionnement": "FL/40ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OFLOXACINE MYLAN 5MG/ML (200MG/40ML) SOL. INJ. PERF. IV B/20POCHES PVC DE 40ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=360", "Laboratoire": " MYLAN", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OFLOXACINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 13 K 087 /08", "Code DCI": "13K087", "Forme": "SOL. INJ.", "Dosage": "5MG/ML (200MG/40ML)", "Conditionnement": "B/20POCHES PVC DE 40ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OFRAMAX 1G PDRE. ET SOLV. SOL INJ  IM/IV  B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RANBAXY", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "OFRAMAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "216/ 13 B 019 /05", "Code DCI": "13B019", "Forme": "PDRE. INJ.", "Dosage": "1G", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": null}, {"Nom": "OKAG\u00e9 5G/SACHET-DOSE PDRE. P. SOL. BUV. OU GASTRO-ENTERALE B/10 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NUTRITION ENTERALE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " OXOGLURATE D'ORNITHINE EXPRIME EN OXOGLURATE DE L(+)ORNITHINE MONOHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OKAG\u00e9", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "235/14J173/15", "Code DCI": "14J173", "Forme": "PDRE. SUSP. BUV.", "Dosage": "5G/SACHET-DOSE", "Conditionnement": "B/10 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "OLANZA 10MG COMP. PELLI. B/07 ", "Img": "https://pharmnet-dz.com//img/medics/2279.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2279", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZA", "Tarif de reference": "1400 DA", "PPA": "1400 DA", "Num Enregistrement": "447/ 16 D 100 /10", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/07 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZA 5MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/2270.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2270", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZA", "Tarif de reference": "2800.00 DA", "PPA": "2800.00 DA", "Num Enregistrement": "447/ 16 D 099 /09", "Code DCI": "16D099", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZA ORO 10MG COMP. ORODISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medics/2281.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2281", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZA ORO", "Tarif de reference": "5600.00 DA", "PPA": "5600.00 DA", "Num Enregistrement": "447/ 16 D 101 /13", "Code DCI": "16D101", "Forme": "COMP. ORODISPERS.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZA ORO 5MG COMP. ORODISPERS. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/4369.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZA ORO", "Tarif de reference": "3000 DA", "PPA": "3000 DA", "Num Enregistrement": "447/16D155/16", "Code DCI": "16D155", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZAPINE MM 10MG COMP. PELLI. B/07 ET B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZAPINE MM", "Tarif de reference": "1638 DA", "PPA": "5716.00 DA", "Num Enregistrement": "470/ 16 D 100 /13", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/07 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZAPINE NAD 10MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZAPINE NAD", "Tarif de reference": "6552 DA", "PPA": "5600.00 DA", "Num Enregistrement": "468/ 16 D 100 /14", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZEX 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2275.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZEX", "Tarif de reference": "7020 DA", "PPA": "6000.00 DA", "Num Enregistrement": "268/ 16 D 100 /09", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZOMAX  10MG COMP ORODISPERSIBLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZOMAX ", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "263/16D101/16", "Code DCI": "16D101", "Forme": "COMP. DISPERS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLANZOMAX  5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLANZOMAX ", "Tarif de reference": "3510 DA", "PPA": "N/A", "Num Enregistrement": "263/16D155/16", "Code DCI": "16D155", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLICLINOMEL N4- 550E 5,5%/20%/10% EMULSION PERF. IV POCHE/2000ML (3COMPART.800ML/800ML/400ML)", "Img": "https://pharmnet-dz.com//img/medics/3469.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3469", "Laboratoire": " CLINTEC PARENTERAL S.A.", "C.Pharmacologique": " ALIMENTATION PARENTERALE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDES AMINES / GLUCOSE / LIPIDES", "Pays": "FRANCE", "Nom Commercial": "OLICLINOMEL N4- 550E", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "427/ 14 K 322 /08", "Code DCI": "14K322", "Forme": "EMULSION PERF.", "Dosage": "5,5%/20%/10%", "Conditionnement": "POCHE/2000ML (3COMPART.800ML/800ML/400ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLICLINOMEL N7-1000 E 10%/40%/20% EMULSION PERF. IV POCHE/1000ML (3COMPART.400ML/400ML/200ML) ET POCHE/2000ML (3COMPART.800ML/800ML/400ML)", "Img": "https://pharmnet-dz.com//img/medics/3470.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3470", "Laboratoire": " CLINTEC PARENTERAL S.A.", "C.Pharmacologique": " ALIMENTATION PARENTERALE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDES AMINES / GLUCOSE / LIPIDES", "Pays": "FRANCE", "Nom Commercial": "OLICLINOMEL N7-1000 E", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "427/ 14 K 323 /08", "Code DCI": "14K323", "Forme": "EMULSION PERF.", "Dosage": "10%/40%/20%", "Conditionnement": "POCHE/1000ML (3COMPART.400ML/400ML/200ML) ET POCHE/2000ML (3COMPART.800ML/800ML/400ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLMETEC 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3199.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3199", "Laboratoire": " DAIICHI SANKYO FRANCE SAS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " OLMESARTAN MEDOXOMIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OLMETEC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "307/ 06 E 260 /09", "Code DCI": "06E260", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLMETEC 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3200.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3200", "Laboratoire": " DAIICHI SANKYO FRANCE SAS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " OLMESARTAN MEDOXOMIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OLMETEC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "307/ 06 E 261 /09", "Code DCI": "06E261", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLMETEC 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3201.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3201", "Laboratoire": " DAIICHI SANKYO FRANCE SAS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " OLMESARTAN MEDOXOMIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OLMETEC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "307/ 06 E 262 /09", "Code DCI": "06E262", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLPREXA  10MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLPREXA ", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "035/16D101/16", "Code DCI": "16D101", "Forme": "COMP. ORODISPERS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OLSERAZ 0,4MG GLES. A MICROGRANULES LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLSERAZ", "Tarif de reference": " N/A", "PPA": "1481.00 DA", "Num Enregistrement": "286/ 25 B 047 /15", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "OLZANID 10MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANDOZ", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OLZANID", "Tarif de reference": "7020 DA", "PPA": "7200.00 DA", "Num Enregistrement": "050/ 16 D 100 /11", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMED RGO  10MG  GELULE A MICROGRANULES GASTRO-RESISTANTS B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMED RGO", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "286/ 10 A 113 /14", "Code DCI": "10A113", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": " 10MG ", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMED-20 20MG GLES. A MICROG. GASTRORESIST. B/14 EN STRIP - B/14 EN BLISTER ET PILULIER  DE 14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMED-20", "Tarif de reference": " N/A", "PPA": "196.00 DA", "Num Enregistrement": "286/ 10 A 001 /03/10", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14 EN STRIP - B/14 EN BLISTER ET PILULIER  DE 14", "Commercialisation": true, "Remboursable": null}, {"Nom": "OMEDAR 20MG COMP. PELLI. GASTRORESIST. B/30", "Img": "https://pharmnet-dz.com//img/medics/3841.png", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "OMEDAR", "Tarif de reference": "0 DA", "PPA": "420.00 DA", "Num Enregistrement": "055/ 10 A 001 /02/13", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMEPRAMEX 20MG MICROGRANULES GASTRO-RESISTANTS/GELULE  B/14", "Img": "https://pharmnet-dz.com//img/medics/3842.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMEPRAMEX", "Tarif de reference": "196 DA", "PPA": "197.00 DA", "Num Enregistrement": "400/ 10 A 001 /14", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMEPRAZOLE GEBER 10MG MICRGLES. GASTRORESIST. EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEBER HEALTH", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMEPRAZOLE GEBER", "Tarif de reference": "420 DA", "PPA": "N/A", "Num Enregistrement": "472/ 10 A 113 /13", "Code DCI": "10A113", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMEPRAZOLE GEBER 20MG MICRGLES. GASTRORESIST. EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEBER HEALTH", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMEPRAZOLE GEBER", "Tarif de reference": "420 DA", "PPA": "N/A", "Num Enregistrement": "472/ 10 A 001 /13", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMEPRAZOLE MM 20MG MICROGLES. GASTRORESIST. EN GLES. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMEPRAZOLE MM", "Tarif de reference": "196 DA", "PPA": "196.00 DA", "Num Enregistrement": "470/ 10 A 001 /12", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMEPRAZOLE NOVAGENERICS 20MG  MICROGRANULES GASTRO-RESISTANTS/GELULE  B/01 PILULIER 14", "Img": "https://pharmnet-dz.com//img/medics/3845.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMEPRAZOLE NOVAGENERICS", "Tarif de reference": "196 DA", "PPA": " DA", "Num Enregistrement": "149/ 10 A 001 /14", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG ", "Conditionnement": "B/01 PILULIER 14", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMIND 20MG GLES. A MICROG. GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medics/3846.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3846", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OMIND", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 10 A 001 /03/10", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "OMNICEF 125MG/5ML SUSP. BUV. FL./40ML ET FL./80ML", "Img": "https://pharmnet-dz.com//img/medics/746.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=746", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFDINIR", "Pays": "JORDANIE", "Nom Commercial": "OMNICEF", "Tarif de reference": "1024 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 319 /07/14", "Code DCI": "13B319", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL./40ML ET FL./80ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMNICEF 300MG CAPS. B/10", "Img": "https://pharmnet-dz.com//img/medics/745.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=745", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFDINIR", "Pays": "JORDANIE", "Nom Commercial": "OMNICEF", "Tarif de reference": "2200 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 318 /07", "Code DCI": "13B318", "Forme": "CAPS.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMNIFAL 300MG GELULES  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFDINIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OMNIFAL", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "13B318", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "OMNIPAQUE I =300MG/ML SOL.INJ FL/10 ML,50ML,100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " GE HEALTHCARE", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOHEXOL", "Liste": "Liste I", "Pays": "NORVEGE", "Nom Commercial": "OMNIPAQUE", "Tarif de reference": " N/A", "PPA": "2870.00 DA", "Num Enregistrement": "212/ 08 C 017 /99/04", "Code DCI": "08C017", "Forme": "SOL. INJ.", "Dosage": "I =300MG/ML", "Conditionnement": "FL/10 ML,50ML,100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OMNIPAQUE I =350MG/ML SOL.INJ FL/50 ML, 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " GE HEALTHCARE", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOHEXOL", "Liste": "Liste I", "Pays": "NORVEGE", "Nom Commercial": "OMNIPAQUE", "Tarif de reference": " N/A", "PPA": "3114.00 DA", "Num Enregistrement": "212/ 08 C 018 /99/04", "Code DCI": "08C018", "Forme": "SOL. INJ.", "Dosage": "I =350MG/ML", "Conditionnement": "FL/50 ML, 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OMNISCAN I =287MG/ML (OU 0,5MMOL/ML) SOL.INJ I.V FL/10 ML - 15ML - 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " GE HEALTHCARE", "C.Pharmacologique": " I.R.M.", "C.Therapeutique": " DIAGNOSTIC", "Info": " GADODIAMIDE", "Liste": "Liste I", "Pays": "NORVEGE", "Nom Commercial": "OMNISCAN", "Tarif de reference": " N/A", "PPA": "3568.00 DA", "Num Enregistrement": "212/ 08 A 039 /99/08", "Code DCI": "08A039", "Forme": "SOL. INJ.", "Dosage": "I =287MG/ML (OU 0,5MMOL/ML)", "Conditionnement": "FL/10 ML - 15ML - 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ONCODOX 10MG/FL. DE LYOPH. LYOPH. P. SOL. INJ. IV B/1FL. DE LYOPH.", "Img": "https://pharmnet-dz.com//img/medics/1097.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DAUNORUBICINE CHLORHYDRATE EXPRIME EN DAUNORUBICINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ONCODOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 015 /13", "Code DCI": "05G015", "Forme": "LYOPH. SOL. INJ.", "Dosage": "10MG/FL. DE LYOPH.", "Conditionnement": "B/1FL. DE LYOPH.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ONCODOX 50MG/FL. DE LYOPH. LYOPH. P. SOL. INJ. IV B/1FL. DE LYOPH.", "Img": "https://pharmnet-dz.com//img/medics/1098.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " DOXORUBICINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ONCODOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 016 /13", "Code DCI": "05G016", "Forme": "LYOPH. SOL. INJ.", "Dosage": "50MG/FL. DE LYOPH.", "Conditionnement": "B/1FL. DE LYOPH.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ONCOMOX 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TAMOXIFENE CITRATE EXPRIME EN TAMOXIFENE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ONCOMOX", "Tarif de reference": "345.6 DA", "PPA": "N/A", "Num Enregistrement": "330/ 05 E 135 /09", "Code DCI": "05E135", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ONCOTAM 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=609", "Laboratoire": " MAYOLY SPINDLER", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TAMOXIFENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ONCOTAM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "067/ 09 B 075 /99", "Code DCI": "09B075", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ONCOTREX 2,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " METHOTREXATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ONCOTREX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "330/ 05 G 032 /09", "Code DCI": "05G032", "Forme": "COMP.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ONDANSETRON INPHA-MEDIS 4MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/2900.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ONDANSETRON INPHA-MEDIS", "Tarif de reference": "714 DA", "PPA": "714.00 DA", "Num Enregistrement": "317/ 10 F 093 /12", "Code DCI": "10F093", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ONDANSETRON INPHA-MEDIS 8MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/2902.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ONDANSETRON INPHA-MEDIS", "Tarif de reference": "1143 DA", "PPA": "1143.00 DA", "Num Enregistrement": "317/ 10 F 094 /12", "Code DCI": "10F094", "Forme": "COMP. PELLI.", "Dosage": "8MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ONDANSETRON-4 2MG/ML (OU 4MG/2ML) SOL. INJ.IV B/50 AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EMPRESSA LABORATORIOS AICA", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON", "Liste": "Liste I", "Pays": "CUBA", "Nom Commercial": "ONDANSETRON-4", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "435/ 10 F 048 /09", "Code DCI": "10F048", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (OU 4MG/2ML)", "Conditionnement": "B/50 AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OPATANOL 1MG/ML** (OU 5MG/5ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2347.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2347", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " OLOPATADINE**(SOUS FORME DE CHLORHYDRATE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "OPATANOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 B 150 /09", "Code DCI": "17B150", "Forme": "COLLY. SOL.", "Dosage": "1MG/ML** (OU 5MG/5ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "OPHTAMESONE 1MG/ML  COLLY. - SOL AURIC. -  SOL. NAS. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " BETAMETHASONE SODIUM PHOSPHATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OPHTAMESONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "272/ 17 G 143 /06", "Code DCI": "17G143", "Forme": "COLLY.", "Dosage": "1MG/ML ", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OPHTAMESONE N 1MG/5MG/ML COLLY. , SOL AURIC. ,SOL. NAS. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " BETAMETHASONE SODIUM PHOSPHATE / NEOMYCINE SULFATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OPHTAMESONE N", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "272/ 17 D 144 /06", "Code DCI": "17D144", "Forme": "COLLY.", "Dosage": "1MG/5MG/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OPHTAMOLOL 0.0025 COLLY. F/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OPHTAMOLOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "272/ 17 C 012 /98/09", "Code DCI": "17C012", "Forme": "COLLY. SOL.", "Dosage": "0.0025", "Conditionnement": "F/5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OPHTAMOLOL 0.005 COLLY. F/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OPHTAMOLOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "272/ 17 C 013 /98/09", "Code DCI": "17C013", "Forme": "COLLY. SOL.", "Dosage": "0.005", "Conditionnement": "F/5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OPHTAMYCIN 0,35% COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " NEOMYCINE (SULFATE) ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OPHTAMYCIN", "Tarif de reference": "111.7 DA", "PPA": "N/A", "Num Enregistrement": "272/ 17 D 022 /06", "Code DCI": "17D022", "Forme": "COLLY.", "Dosage": "0,35%", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OPHTAPRED 0.005 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OPHTAPRED", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "272/ 17 G 142 /06", "Code DCI": "17G142", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OPHTAZOLIN 5MG/0,25MG/ML COLLY. STERILE FL./10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JORAS PHARMACEUTICAL S.P.A.", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ANTAZOLINE  (SULFATE) / NAPHAZOLINE (NITRATE)", "Pays": "ALGERIE", "Nom Commercial": "OPHTAZOLIN", "Tarif de reference": "121.6 DA", "PPA": "N/A", "Num Enregistrement": "272/ 17 B 120 /07", "Code DCI": "17B120", "Forme": "COLLY. SOL.", "Dosage": "5MG/0,25MG/ML", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OPRACIDE 20MG MICRO-GRANUL. GASTRO-RESIST. EN GLES. PILULIER/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OPRACIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 10 A 001 /15", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "PILULIER/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "OPRACIDE 40MG/FL. DE PDRE. PDRE. LYOPH. P. PERF. IV B/01FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE SODIQUE EXPRIME EN OMEPRAZOLE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "OPRACIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 10 A 087 /06/15", "Code DCI": "10A087", "Forme": "LYOPH. SOL. INJ.", "Dosage": "40MG/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "OPTIDEX-T 0,3% / 0,1% COLLY. EN SUSP. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/1959.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1959", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TOBRAMYCINE / DEXAMETHASONE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "OPTIDEX-T", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "386/ 17 D 159 /09", "Code DCI": "17D159", "Forme": "COLLY.", "Dosage": "0,3% / 0,1%", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "OPTIF JAM 0.001 COLLY. EN SOL.  FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/1979.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1979", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " FLUOROMETHOLONE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "OPTIF JAM", "Tarif de reference": "185.4 DA", "PPA": "N/A", "Num Enregistrement": "389/ 17 G 134 /12", "Code DCI": "17G134", "Forme": "COLLY.", "Dosage": "0.001", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OPTIF PLUS 1MG / 20MG**/ML SUSP. OPHT. B/01FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " OPHTALMOLOGIE", "C.Therapeutique": " FLUOROMETHOLONE / CROMOGLYCATE DE SODIUM", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "OPTIF PLUS", "Tarif de reference": " N/A", "PPA": "220.00 DA", "Num Enregistrement": "386/ 17 R 166 /12", "Code DCI": "17R166", "Forme": "SUSP. OPHT.", "Dosage": "1MG / 20MG**/ML", "Conditionnement": "B/01FL. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OPTIFLOX 0.003 COLLY. EN SOL.  FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/1958.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1958", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "OPTIFLOX", "Tarif de reference": "161.95 DA", "PPA": "N/A", "Num Enregistrement": "386/ 17 D 157 /12", "Code DCI": "17D157", "Forme": "COLLY.", "Dosage": "0.003", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OPTIPRED 0.01 COLLY. EN SUSP. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PREDNISOLONE (SOUS FORME D'ACETATE)**", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "OPTIPRED", "Tarif de reference": "0 DA", "PPA": "250.00 DA", "Num Enregistrement": "386/ 17 G 167/12 ", "Code DCI": "17G167", "Forme": "COLLY.", "Dosage": "0.01", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORALCAN 0,15MG/0,03MG COMP B/3X21", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " FAMY CARE ", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ORALCAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "291/ 11 H 040 /04", "Code DCI": "11H040", "Forme": "COMP.", "Dosage": "0,15MG/0,03MG", "Conditionnement": "B/3X21", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORALVEX 0.001 SOL. P. BAIN DE BOUCHE B/1FL. DE 125ML", "Img": "https://pharmnet-dz.com//img/medics/1131.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1131", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " HEXETIDINE", "Pays": "ALGERIE", "Nom Commercial": "ORALVEX", "Tarif de reference": "0 DA", "PPA": "195.00 DA", "Num Enregistrement": "285/ 23 B 012 /12", "Code DCI": "23B012", "Forme": "SOL. BAIN BOUCHE", "Dosage": "0.001", "Conditionnement": "B/1FL. DE 125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORAPEN 1 500 000UI COMP. SEC. B/12", "Img": "https://pharmnet-dz.com//img/medics/347.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=347", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORAPEN", "Tarif de reference": "275.88 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 306 /09", "Code DCI": "13G306", "Forme": "COMP. SEC.", "Dosage": "1 500 000UI", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORAPEN 1000 000UI COMP. B/12 ", "Img": "https://pharmnet-dz.com//img/medics/270.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=270", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORAPEN", "Tarif de reference": "252 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 072 /96/09", "Code DCI": "13G072", "Forme": "COMP. PELLI.", "Dosage": "1000 000UI", "Conditionnement": "B/12 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORAPEN 250 000UI/5ML PDRE.SUSP.OR. FL/60 ML", "Img": "https://pharmnet-dz.com//img/medics/268.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=268", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORAPEN", "Tarif de reference": "126 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 071 /99", "Code DCI": "13G071", "Forme": "PDRE. SOL. BUV.", "Dosage": "250 000UI/5ML", "Conditionnement": "FL/60 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORBENINE 500MG GLES B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=324", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLOXACILLNE SODIQUE MONOHYDRATEE EXPRIME EN CLOXAILLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ORBENINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "374/ 13 G 250 /03/09", "Code DCI": "13G250", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "ORELOX 100MG** COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/753.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=753", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFPODOXIME** (SOUS FORME DE CEFPODOXIME PROXETIL)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ORELOX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 13 B 332 /08", "Code DCI": "13B332", "Forme": "COMP.", "Dosage": "100MG**", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORELOX ENFANTS ET NOURRISSONS 40MG/5ML (OU 8MG/ML)** GRLES.SUSP. BUV. B/1FL.DE 100ML", "Img": "https://pharmnet-dz.com//img/medics/754.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=754", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFPODOXIME** (SOUS FORME DE CEFPODOXIME PROXETIL)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ORELOX ENFANTS ET NOURRISSONS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 13 B 333 /08", "Code DCI": "13B333", "Forme": "GRLES. SOL. BUV.", "Dosage": "40MG/5ML (OU 8MG/ML)**", "Conditionnement": "B/1FL.DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORENCIA 250MG/FL. DE PDRE. PDRE. P./SOL. A DILUER P./PERF. IV B/01 FL.  DE PDRE. + 01 SERINGUE SANS SILICONE", "Img": "https://pharmnet-dz.com//img/medics/1453.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1453", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " N/D", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ABATACEPT", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ORENCIA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 21 J 067 /15", "Code DCI": "21J067", "Forme": "PDRE.", "Dosage": "250MG/FL. DE PDRE.", "Conditionnement": "B/01 FL.  DE PDRE. + 01 SERINGUE SANS SILICONE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORGALUTRAN 0,5MG/ML (0,25MG/0,5ML) SOL. INJ. SC EN SERING. PREREMPL. B/1SERING. PREREMPLIES DE 5ML ET B/5SERING. PREREMPLIES DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " ORGANON", "C.Pharmacologique": " INFERTILITE, PRODUITS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " GANIRELIX", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ORGALUTRAN", "Tarif de reference": "0 DA", "PPA": "2769.00 DA", "Num Enregistrement": "005/ 11 N 079 /09", "Code DCI": "11N079", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML (0,25MG/0,5ML)", "Conditionnement": "B/1SERING. PREREMPLIES DE 5ML ET B/5SERING. PREREMPLIES DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORGAMETRIL 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3818.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3818", "Laboratoire": " ORGANON", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LYNESTRENOL", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "ORGAMETRIL", "Tarif de reference": "315.77 DA", "PPA": "N/A", "Num Enregistrement": "005/ 09 N 063 /96", "Code DCI": "09N063", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORICALM 4G/1G SOLUTION AURIC F/15 ML SOIT 16G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " OTOLOGIE", "Info": " PHENAZONE/CHLORHYDRATE DE LIDOCAINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORICALM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "318/18D020/16", "Code DCI": "18D020", "Forme": "SOL. AURIC.", "Dosage": "4G/1G", "Conditionnement": "F/15 ML SOIT 16G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORIN 10MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/3996.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3996", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ORIN", "Tarif de reference": "60 DA", "PPA": " DA", "Num Enregistrement": "242/ 01 A 033 /12", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORIN 1MG/ML SIROP FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/4005.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4005", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ORIN", "Tarif de reference": "96.6 DA", "PPA": "N/A", "Num Enregistrement": "242/ 01 A 034 /09", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORNISID 500MG COMP. VAGINAL B/03", "Img": "https://pharmnet-dz.com//img/medics/3016.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3016", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ORNIDAZOLE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "ORNISID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "177/ 11 A 084 /12", "Code DCI": "11A084", "Forme": "COMP. VAG.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": false}, {"Nom": "OROFER 10MG/ML (50MG/5ML) SIROP FL./100ML + GOBELET DOSEUR ", "Img": "https://pharmnet-dz.com//img/medics/1785.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1785", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERRIQUE** (SOUS FORME DE COMPLEXE D'HYDROXYDE FERRIQUE POLYMALTOSE)", "Pays": "ALGERIE", "Nom Commercial": "OROFER", "Tarif de reference": "160 DA", "PPA": " DA", "Num Enregistrement": "317/ 12 E 109 /09", "Code DCI": "12E109", "Forme": "SIROP", "Dosage": "10MG/ML (50MG/5ML)", "Conditionnement": "FL./100ML + GOBELET DOSEUR ", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROFER PLUS 20MG/ML (100MG/5ML) SIROP FL./100ML + GOBELET DOSEUR  DE 15ML", "Img": "https://pharmnet-dz.com//img/medics/1811.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1811", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE", "Pays": "ALGERIE", "Nom Commercial": "OROFER PLUS", "Tarif de reference": "320 DA", "PPA": " DA", "Num Enregistrement": "317/ 12 E 152 /11", "Code DCI": "12E152", "Forme": "SIROP", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./100ML + GOBELET DOSEUR  DE 15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROGYL 750 000UI/125MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/842.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=842", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE / METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OROGYL", "Tarif de reference": "387.4 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 E 300 /06/12", "Code DCI": "13E300", "Forme": "COMP. PELLI.", "Dosage": "750 000UI/125MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROKAL 200MG COMP.PELL B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OROKAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "039/13B201/16", "Code DCI": "13B201", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROKEN 100MG GRLES.SUSP.BUV. SACHET B/8", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=694", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OROKEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 13 B 200 /99", "Code DCI": "13B200", "Forme": "GRLES. SOL. BUV.", "Dosage": "100MG", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROKEN 200MG COMP. PELLI. B/08", "Img": "https://pharmnet-dz.com//img/medics/697.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=697", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OROKEN", "Tarif de reference": "1341.85 DA", "PPA": "N/A", "Num Enregistrement": "376/ 13 B 201 /99/14", "Code DCI": "13B201", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROKEN 40MG GRLES.SUSP.BUV. SACHET B/8", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OROKEN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "016/ 13 B 199 /99", "Code DCI": "13B199", "Forme": "GRLES. SOL. BUV.", "Dosage": "40MG", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROKEN ENF 100MG/5ML PDRE.SUSP.BUV. FL/13,3G", "Img": "https://pharmnet-dz.com//img/medics/689.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=689", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OROKEN ENF", "Tarif de reference": "849.37 DA", "PPA": "N/A", "Num Enregistrement": "230/ 13 B 198 /99", "Code DCI": "13B198", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "FL/13,3G", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROKEN NOUR 40MG/5ML PDRE.SUSP.BUV. FL/13,3G", "Img": "https://pharmnet-dz.com//img/medics/687.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=687", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OROKEN NOUR", "Tarif de reference": "549.29 DA", "PPA": "N/A", "Num Enregistrement": "230/ 13 B 197 /99", "Code DCI": "13B197", "Forme": "PDRE. SUSP. BUV.", "Dosage": "40MG/5ML", "Conditionnement": "FL/13,3G", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROKEN NOUR 40MG/5ML PDRE.SUSP.BUV. FL/13,3G", "Img": "https://pharmnet-dz.com//img/medics/4273.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4273", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OROKEN NOUR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/13B197/99/15", "Code DCI": "13B197", "Forme": "PDRE. SUSP. BUV.", "Dosage": "40MG/5ML", "Conditionnement": "FL/13,3G", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROMONE 2MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ESTRADIOL (17 \u03b2 ESTRADIOL)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "OROMONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "031/ 09 G 115 /99", "Code DCI": "09G115", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROPRED  20MG  COMP ORODISPERSIBLE B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " API", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OROPRED", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "348/09H144/16", "Code DCI": "09H144", "Forme": "COMP. DISPERS.", "Dosage": " 20MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROPRED 20MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OROPRED", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "317/ 09 H 144 /15", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROPRED 30MG COMP SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OROPRED", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/09H163/16", "Code DCI": "N/D", "Forme": "COMP. SEC.", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "OROPRED 5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OROPRED", "Tarif de reference": "257.4 DA", "PPA": "N/A", "Num Enregistrement": "317/09H143/16", "Code DCI": "09H143", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OROSPASM  80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " API", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " N/D", "Info": " PHLOROGLUCINOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OROSPASM ", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "348/10E108/17", "Code DCI": "10E108", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORTHOCAM 0.005 GEL DERM. T/25G", "Img": "https://pharmnet-dz.com//img/medics/1378.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1378", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORTHOCAM", "Tarif de reference": "72 DA", "PPA": "N/A", "Num Enregistrement": "352/ 21 A 005 /09", "Code DCI": "21A005", "Forme": "GEL DERM.", "Dosage": "0.005", "Conditionnement": "T/25G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORTHOCAM 20MG CP DISPERSIBLE SEC B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORTHOCAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORYACTINE 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Pays": "ALGERIE", "Nom Commercial": "ORYACTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "418/ 14 F 025 /12", "Code DCI": "14F025", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ORZEPAM 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2841.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORZEPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "065/ 16 B 042 /07", "Code DCI": "16B042", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ORZEPAM 2,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ORZEPAM", "Tarif de reference": " N/A", "PPA": "157.00 DA", "Num Enregistrement": "065/ 16 B 043 /04/12", "Code DCI": "16B043", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "OSMOTOL 0.001 SOL. P. INST. AURC. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/5718.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5718", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " OTOLOGIE", "Info": " RESORCINOL / EPHEDRINE (CHLORHYDRATE)", "Pays": "FRANCE", "Nom Commercial": "OSMOTOL", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "18D015", "Forme": "SOL. P. INST. AURC.", "Dosage": "0.001", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSPEN 400.000UI/5ML GRLES. SUSP. BUV  FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANDOZ", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OSPEN", "Tarif de reference": "201.6 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 G 305 /06", "Code DCI": "13G305", "Forme": "GRLES. SOL. BUV.", "Dosage": "400.000UI/5ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSPEXIN 125MG/5ML GRLES.SUSP.OR. FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OSPEXIN", "Tarif de reference": "92.4 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 B 011 /98", "Code DCI": "13B011", "Forme": "GRLES. SOL. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSPEXIN 250MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OSPEXIN", "Tarif de reference": "166.8 DA", "PPA": "247.00 DA", "Num Enregistrement": "080/ 13 B 009 /98", "Code DCI": "13B009", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSPEXIN 250MG/5ML GRLES.SUSP.OR. FL/60ML", "Img": "https://pharmnet-dz.com//img/medics/678.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=678", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OSPEXIN", "Tarif de reference": "186.6 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 B 156 /98", "Code DCI": "13B156", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSPEXIN 500MG COMP. B/12", "Img": "https://pharmnet-dz.com//img/medics/1893.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1893", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OSPEXIN", "Tarif de reference": "333.6 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 B 010 /98", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSPORIX 70MG COMP. B/04", "Img": "https://pharmnet-dz.com//img/medics/4442.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4442", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OSPORIX", "Tarif de reference": "1760.00 DA", "PPA": "1760.00 DA", "Num Enregistrement": "447/21G050/16", "Code DCI": "21G050", "Forme": "COMP.", "Dosage": "70MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSSE D3 400UI/500MG COMP. A SUCER B DE 1 FLACON DE 60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OSSE D3", "Tarif de reference": "810 DA", "PPA": "N/A", "Num Enregistrement": "235/14G175/15", "Code DCI": "14G175", "Forme": "COMP. A SUCER", "Dosage": "400UI/500MG", "Conditionnement": "B DE 1 FLACON DE 60", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSTEOS 30MG  COMP  B/30", "Img": "https://pharmnet-dz.com//img/medics/1412.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE SEL MONOSODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OSTEOS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "317/ 21 C 041 /14", "Code DCI": "21C041", "Forme": "COMP. PELLI.", "Dosage": "30MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSTEOS 35MG  COMP PELL  B/04", "Img": "https://pharmnet-dz.com//img/medics/1420.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE MONOSODIQUE HEMIPENTAHYDRATE EXPRIME EN ACIDE RIDEDRONIQUE MONOSODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OSTEOS", "Tarif de reference": "1760 DA", "PPA": "N/A", "Num Enregistrement": "317/ 21 D 046 /14", "Code DCI": "21D046", "Forme": "COMP. PELLI.", "Dosage": "35MG ", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSTEOS 5MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medics/1416.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE SEL MONOSODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OSTEOS", "Tarif de reference": "2035.5 DA", "PPA": "N/A", "Num Enregistrement": "317/ 21 D 040 /14", "Code DCI": "21D040", "Forme": "COMP. PELLI.", "Dosage": "5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSTEPAM 15MG/ML (90MG/6ML) SOL. A DILUER POUR PERF. B/04FL. DE 1ML ET B/1FL.DE 6ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " NORDIC PHARMA", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " PAMIDRONATE DE SODIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OSTEPAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "420/ 05 F 127 /08 ", "Code DCI": "05F127", "Forme": "SOL. PERF.", "Dosage": "15MG/ML (90MG/6ML)", "Conditionnement": "B/04FL. DE 1ML ET B/1FL.DE 6ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OSTOMAX 70MG COMP. B/04", "Img": "https://pharmnet-dz.com//img/medics/1433.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OSTOMAX", "Tarif de reference": "0 DA", "PPA": "1760.00 DA", "Num Enregistrement": "149/ 21 G 050 /15", "Code DCI": "21G050", "Forme": "COMP.", "Dosage": "70MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "OSTONEL ONCE A WEEK 35MG COMP. PELLI. B/04", "Img": "https://pharmnet-dz.com//img/medics/1421.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1421", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE MONOSODIQUE HEMIPENTAHYDRATE EXPRIME EN ACIDE RIDEDRONIQUE MONOSODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OSTONEL ONCE A WEEK", "Tarif de reference": "1760.00 DA", "PPA": "1760.00 DA", "Num Enregistrement": "447/ 21 D 046 /13", "Code DCI": "21D046", "Forme": "COMP. PELLI.", "Dosage": "35MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "OTIPAX 4G/1G pour 100G de solution SOL. AURIC. FL/15ML", "Img": "https://pharmnet-dz.com//img/medics/2037.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2037", "Laboratoire": " BIOCODEX", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " OTOLOGIE", "Info": " PHENAZONE/CHLORHYDRATE DE LIDOCAINE", "Pays": "FRANCE", "Nom Commercial": "OTIPAX", "Tarif de reference": "0 DA", "PPA": "209.00 DA", "Num Enregistrement": "101/ 18 D 020 /00", "Code DCI": "18D020", "Forme": "SOL. AURIC.", "Dosage": "4G/1G pour 100G de solution", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OTOCINE 2MG/ML (1MG/0,5ML) SOL. AURI. STERILE B/20 RECIPIENTS UNIDOSES DE 0,5ML", "Img": "https://pharmnet-dz.com//img/medics/2021.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-INFECTIEUX SANS CORTICOIDES", "C.Therapeutique": " OTOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Pays": "ALGERIE", "Nom Commercial": "OTOCINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "268/ 18 A 026 /08", "Code DCI": "18A026", "Forme": "SOL. AURIC. GTTES.", "Dosage": "2MG/ML (1MG/0,5ML)", "Conditionnement": "B/20 RECIPIENTS UNIDOSES DE 0,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OTOCROVIS 0,025% / 0,35% / 1 000 000UI/100ML SOL AURIC . GTTES FL/10 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTI-INFECTIEUX AVEC CORTICOIDES", "C.Therapeutique": " OTOLOGIE", "Info": " FLUOCINOLONE  ACETONIDE /  NEOMYCINE  SULFATE / POLYMYXINE B SULFATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "OTOCROVIS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 18 B 004 /98/14", "Code DCI": "18B004", "Forme": "SOL. AURIC. GTTES.", "Dosage": "0,025% / 0,35% / 1 000 000UI/100ML", "Conditionnement": "FL/10 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OTOFA 2,6G/100ML SOL AURIC . GTTES FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2020.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2020", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTI-INFECTIEUX SANS CORTICOIDES", "C.Therapeutique": " OTOLOGIE", "Info": " RIFAMYCINE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OTOFA", "Tarif de reference": "0 DA", "PPA": "252.00 DA", "Num Enregistrement": "269/ 18 A 002 /98/15", "Code DCI": "18A002", "Forme": "SOL. AURIC. GTTES.", "Dosage": "2,6G/100ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OVESTIN 0,5MG OVULES B/15", "Img": "https://pharmnet-dz.com//img/medics/3009.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " ORGANON", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ESTRIOL", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "OVESTIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "005/ 11 A 046 /99", "Code DCI": "11A046", "Forme": "OVULE ", "Dosage": "0,5MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "OVESTIN 1MG COMP .SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/626.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ORGANON", "C.Pharmacologique": " OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ESTRIOL", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "OVESTIN", "Tarif de reference": "524.4 DA", "PPA": "N/A", "Num Enregistrement": "005/ 09 G 085 /97", "Code DCI": "09G085", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OVITRELLE 250\u00b5G/0,5ML (6500UI/0,5ML) SOL. INJ. EN SERINGUE PREREMPLIE S/C  B/1SERINGUE PREREMPLIE DE 0,5ML", "Img": "https://pharmnet-dz.com//img/medics/3794.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3794", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " CHORIOGONADOTROPINE ALFA (HCG RECOMBINANTE)", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "OVITRELLE", "Tarif de reference": "0 DA", "PPA": "2408.00 DA", "Num Enregistrement": "062/ 09 J 140 /06/12", "Code DCI": "09J140", "Forme": "SOL. INJ.", "Dosage": "250\u00b5G/0,5ML (6500UI/0,5ML)", "Conditionnement": "B/1SERINGUE PREREMPLIE DE 0,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXACARE 1G/FL. DE PDRE. PDRE. ET SOLV. P. SOL. INJ. IM/IV B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI) ET  B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/266.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=266", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXACARE", "Tarif de reference": "111.24 DA", "PPA": " DA", "Num Enregistrement": "293/ 13 G 069 /10", "Code DCI": "13G069", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV. (EPPI) ET  B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXACARE 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/274.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXACARE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "293/ 13 G 160 /05/10", "Code DCI": "13G160", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXACIL HUP 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/275.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=275", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXACIL HUP", "Tarif de reference": "199 DA", "PPA": "N/A", "Num Enregistrement": "380/ 13 G 160 /11", "Code DCI": "13G160", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXADEX 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXADEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "323/ 13 G 160 /12", "Code DCI": "13G160", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXAL 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 13 G 160 /00/08", "Code DCI": "13G160", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXALINE 1G/FL. DE PDRE. PDRE.SOL.INJ. B/01+01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXALINE", "Tarif de reference": "111.24 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 069 /98", "Code DCI": "13G069", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/01+01", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXALINE 250MG/5ML PDRE. SIROP FL/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXALINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 161 /06", "Code DCI": "13G161", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXALINE 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/278.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=278", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXALINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 160 /01", "Code DCI": "13G160", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": false}, {"Nom": "OXALINE 500MG PDRE.SOL.INJ. B/01+01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXALINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 G 068 /99", "Code DCI": "13G068", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG", "Conditionnement": "B/01+01", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXALIPLATIN EBEWE 5MG/ML  (OU 50MG/10ML ET 100MG/20ML) PDRE. SOL. INJ. IV B/01FL.10ML  ET B/01FL. 20ML", "Img": "https://pharmnet-dz.com//img/medics/1007.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1007", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " OXALIPLATINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "OXALIPLATIN EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 089 /07", "Code DCI": "05A089", "Forme": "SOL. INJ.", "Dosage": "5MG/ML  (OU 50MG/10ML ET 100MG/20ML)", "Conditionnement": "B/01FL.10ML  ET B/01FL. 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXALIPLATINE MYLAN 100MG/FL. DE PDRE. (5MG/ML DE SOL. RECONSTITUEE) PDRE. P. SOL. P. PERF. B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/1123.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1123", "Laboratoire": " MYLAN", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " OXALIPLATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OXALIPLATINE MYLAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "450/ 05 G 090 /12", "Code DCI": "05G090", "Forme": "LYOPH. SOL. INJ.", "Dosage": "100MG/FL. DE PDRE. (5MG/ML DE SOL. RECONSTITUEE)", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXALIPLATINE MYLAN 50MG/FL. DE PDRE. (5MG/ML DE SOL. RECONSTITUEE) PDRE. P. SOL. P. PERF. B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/1120.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1120", "Laboratoire": " MYLAN", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " OXALIPLATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OXALIPLATINE MYLAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "450/ 05 G 089 /12", "Code DCI": "05G089", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG/FL. DE PDRE. (5MG/ML DE SOL. RECONSTITUEE)", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXAMEX 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXACILLINE SODIQUE EXPRIME EN OXACILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXAMEX", "Tarif de reference": "157.92 DA", "PPA": "N/A", "Num Enregistrement": "400/ 13 G 160 /09", "Code DCI": "13G160", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXEOL 10MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2119.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2119", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BAMBUTEROL CHLORHYDRATE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "OXEOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 20 A 080 /04/14", "Code DCI": "20A080", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXIMAL 15MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MELOXICAM", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "OXIMAL", "Tarif de reference": "420 DA", "PPA": "N/A", "Num Enregistrement": "043/ 04 B 058 /08", "Code DCI": "04B058", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXIMAL 7,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MELOXICAM", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "OXIMAL", "Tarif de reference": "210 DA", "PPA": "N/A", "Num Enregistrement": "043/ 04 B 060 /08", "Code DCI": "04B060", "Forme": "COMP.", "Dosage": "7,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXIPLAT 100MG/FL. DE CONC. (5MG/ML OU 100MG/20ML) CONC. A DILUER P. PERF. IV B/1FL. DE CONC. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " OXALIPLATINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "OXIPLAT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 05 G 090 /12", "Code DCI": "05G090", "Forme": "LYOPH. SOL. INJ.", "Dosage": "100MG/FL. DE CONC. (5MG/ML OU 100MG/20ML)", "Conditionnement": "B/1FL. DE CONC. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXIPLAT 50MG/FL. DE CONC. (5MG/ML OU 50MG/10ML) CONC. A DILUER P. PERF. IV B/1FL. DE CONC. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " OXALIPLATINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "OXIPLAT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 05 G 089 /12", "Code DCI": "05G089", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG/FL. DE CONC. (5MG/ML OU 50MG/10ML)", "Conditionnement": "B/1FL. DE CONC. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXOGLURATE D'ORNITHINE MYLAN 5G/SACHET-DOSE PDRE. P. SOL. BUV. OU GASTRO-ENTERALE B/10 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3467", "Laboratoire": " MYLAN", "C.Pharmacologique": " NUTRITION ENTERALE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " OXOGLURATE D'ORNITHINE EXPRIME EN OXOGLURATE DE L(+)ORNITHINE MONOHYDRATE", "Pays": "FRANCE", "Nom Commercial": "OXOGLURATE D'ORNITHINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 14 J 173 /15", "Code DCI": "14J173", "Forme": "PDRE. SOL. BUV.", "Dosage": "5G/SACHET-DOSE", "Conditionnement": "B/10 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXOMEMAZINE 1MG/ML SOL.BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/2167.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2167", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " OXOMEMAZINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OXOMEMAZINE", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "073/ 20 C 055 /97", "Code DCI": "20C055", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXOMERAL 1MG/ML SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " OXOMEMAZINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OXOMERAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 20 C 055 /02/09", "Code DCI": "20C055", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXYDAZOLE 100MG/5ML (2%) SUSP.BUV. FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " FLUBENDAZOLE", "Pays": "ALGERIE", "Nom Commercial": "OXYDAZOLE", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "19B005", "Forme": "SUSP. BUV.", "Dosage": "100MG/5ML (2%)", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXYDERM 10 V  RPP 10 V , FLACON DE 1000 ML PET SOL. USAGE EXTERNE F/1000 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RIADH PHARM", "C.Pharmacologique": " ASEPSIE & DESINFECTION", "C.Therapeutique": " DIVERS", "Info": " PEROXYDE D' HYDROGENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXYDERM 10 V  RPP", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "314/26B015/15", "Code DCI": "26B015", "Forme": "SOL. EXTERNE", "Dosage": "10 V , FLACON DE 1000 ML PET", "Conditionnement": "F/1000 ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXYDEX 0,5%/0,1% PDE. OPHT TUBE/3G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " OXYTETRACYCLINE CHLORHYDRATE/ DEXAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXYDEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 17 D 172/13", "Code DCI": "17D172", "Forme": "PDE. OPHT.", "Dosage": "0,5%/0,1%", "Conditionnement": "TUBE/3G", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXYGENE MEDICAL  BOUTEILLE BOUTEILLE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ENGI", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " OXYGENE  PURETE 99,50 %  SOUS PRESSION DE 10 BAR A 15 BAR  DE -155\u00b0 C A -145 \u00b0 C", "Pays": "ALGERIE", "Nom Commercial": "OXYGENE MEDICAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "054/ 02 B 014 /97", "Code DCI": "02B014", "Forme": "GAZ POUR INHAL", "Conditionnement": "BOUTEILLE", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXYGENE MEDICINAL LIQUIDE AIR LIQUIDE  GAZ POUR INHAL RESRVOIR CRYOGENIQUE MOBILE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SIDAL SPA", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " OXYGENE  PURETE 99,50 %  SOUS PRESSION DE 10 BAR A 15 BAR  DE -155\u00b0 C A -145 \u00b0 C", "Pays": "ALGERIE", "Nom Commercial": "OXYGENE MEDICINAL LIQUIDE AIR LIQUIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "483/02 B 014/13", "Code DCI": "02B014", "Forme": "GAZ POUR INHAL", "Conditionnement": "RESRVOIR CRYOGENIQUE MOBILE", "Commercialisation": true, "Remboursable": null}, {"Nom": "OXYMED 250MG GLES B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " CYCLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OXYTETRACYCLINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OXYMED", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 C 023 /98", "Code DCI": "13C023", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXYPLASTINE 0.46 PDE T/65G", "Img": "https://pharmnet-dz.com//img/medics/1644.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1644", "Laboratoire": " CS DERMATOLOGIE", "C.Pharmacologique": " ADJUVANTS DE LA CICATRISATION", "C.Therapeutique": " DERMATOLOGIE", "Info": " OXYDE DE ZINC", "Pays": "FRANCE", "Nom Commercial": "OXYPLASTINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "143/ 07 A 130 /98", "Code DCI": "07A130", "Forme": "PDE.", "Dosage": "0.46", "Conditionnement": "T/65G", "Commercialisation": true, "Remboursable": false}, {"Nom": "OXYTOCINE 5UI/ML SOL.INJ. B/3", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " OCYTOCIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " OXYTOCINE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "OXYTOCINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 11 E 019 /01", "Code DCI": "11E019", "Forme": "SOL. INJ.", "Dosage": "5UI/ML", "Conditionnement": "B/3", "Commercialisation": true, "Remboursable": true}, {"Nom": "OXYZOL 400MG COMP. PELLI. SEC. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " ALBENDAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "OXYZOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "321/ 19 B 030 /06", "Code DCI": "19B030", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "OZAFLOX 500MG COMP. ENRO. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANDOZ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OZAFLOX", "Tarif de reference": "804 DA", "PPA": "794.00 DA", "Num Enregistrement": "050/ 13 K 253 /11", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "OZAFLOX 750MG COMP. ENRO. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANDOZ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "OZAFLOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 13 K 254 /11", "Code DCI": "13K254", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}], "P": [{"Nom": "P.N.D. 100MG/350000UI/600000UI/100ML COLLY. EN SOL. FL/3ML", "Img": "https://pharmnet-dz.com//img/medics/1973.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " UNIMED", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE / NEOMYCINE / POLYMYXINE B", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "P.N.D.", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 17 G 048 /99/15", "Code DCI": "17G048", "Forme": "COLLY.", "Dosage": "100MG/350000UI/600000UI/100ML", "Conditionnement": "FL/3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PACET 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PACET", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "418/ 03 B 005 /09", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PACET EXTRA 500MG/65MG COMP. SEC. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CAFEINE", "Pays": "ALGERIE", "Nom Commercial": "PACET EXTRA", "Tarif de reference": " N/A", "PPA": "125.00 DA", "Num Enregistrement": "418/ 03 B 088 /13", "Code DCI": "03B088", "Forme": "COMP. SEC.", "Dosage": "500MG/65MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "PACLITAX 6MG/ML (30MG/5ML - 100MG/16,5ML - 300MG/50ML) SOL. A DILUER P. PERF. B/1FL/5ML -  B/1FL/16,7ML ET B/1FL. DE 50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " PACLITAXEL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "PACLITAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 100 /04/13", "Code DCI": "05G100", "Forme": "SOL. PERF.", "Dosage": "6MG/ML (30MG/5ML - 100MG/16,5ML - 300MG/50ML)", "Conditionnement": "B/1FL/5ML -  B/1FL/16,7ML ET B/1FL. DE 50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PACLITAXEL EBEWE 6MG/ML (OU 30MG/5ML, 100MG/16,7ML,150MG/25ML, ET 300MG/50ML) SOL INJ  FL/5ML  -  FL/16,7ML -  FL/25ML  -  FL /50ML.", "Img": "https://pharmnet-dz.com//img/medics/1001.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1001", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " PACLITAXEL", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "PACLITAXEL EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 05 A 070 /05", "Code DCI": "05A070", "Forme": "SOL. INJ.", "Dosage": "6MG/ML (OU 30MG/5ML, 100MG/16,7ML,150MG/25ML, ET 300MG/50ML)", "Conditionnement": "FL/5ML  -  FL/16,7ML -  FL/25ML  -  FL /50ML.", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAINOXAM 20MG SUPPO. B/15", "Img": "https://pharmnet-dz.com//img/medics/2777.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2777", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAINOXAM", "Tarif de reference": "210 DA", "PPA": "N/A", "Num Enregistrement": "263/ 04 B 023 /06", "Code DCI": "04B023", "Forme": "SUPPO.", "Dosage": "20MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAKEDAL 200MG/ML SOL.BUV. FL/100 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PAKEDAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "318/15A003/17", "Code DCI": "15A003", "Forme": "SUSP. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL/100 ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAMIDOL I =300MG/ML SOL. INJ. FL./50ML - FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " UNIQUE PHARMACETICAL ", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOPAMIDOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "PAMIDOL", "Tarif de reference": "0 DA", "PPA": "2907.00 DA", "Num Enregistrement": "276/ 08 C 020 /09", "Code DCI": "08C020", "Forme": "SOL. INJ.", "Dosage": "I =300MG/ML", "Conditionnement": "FL./50ML - FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAMIDOL I =370MG/ML SOL. INJ. FL./50ML - FL./100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=588", "Laboratoire": " UNIQUE PHARMACETICAL ", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOPAMIDOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "PAMIDOL", "Tarif de reference": "0 DA", "PPA": "1380.00 DA", "Num Enregistrement": "276/ 08 C 021 /09", "Code DCI": "08C021", "Forme": "SOL. INJ.", "Dosage": "I =370MG/ML", "Conditionnement": "FL./50ML - FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAMIDRIA 90MG/FL. PDRE LYOPHILISEE P/INJ EN PERF IV B/01 FL. DE LYOPHILISAT+ 01 AMP. DE SOLVANT DE 10ML (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIPAGETIQUES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PAMIDRONATE SODIUM", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "PAMIDRIA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 21 C 034 /14", "Code DCI": "21C034", "Forme": "PDRE. SOL.", "Dosage": "90MG/FL.", "Conditionnement": "B/01 FL. DE LYOPHILISAT+ 01 AMP. DE SOLVANT DE 10ML (EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "PANADOL 1G COMP. PELLI. SEC. B/08", "Img": "https://pharmnet-dz.com//img/medics/2634.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2634", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PANADOL", "Tarif de reference": "40 DA", "PPA": "N/A", "Num Enregistrement": "309/ 03 B 081 /12", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "PANADOL 500MG COMP.EFFER. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PANADOL", "Tarif de reference": "30 DA", "PPA": "N/A", "Num Enregistrement": "050/ 03 B 010 /98", "Code DCI": "03B010", "Forme": "COMP. EFFERV.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PANADOL EXTRA 500MG/65MG COMP. PELLI.  B/16", "Img": "https://pharmnet-dz.com//img/medics/2643.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2643", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CAFEINE", "Pays": "ALGERIE", "Nom Commercial": "PANADOL EXTRA", "Tarif de reference": "125 DA", "PPA": "N/A", "Num Enregistrement": "309/ 03 B 088 /07/12", "Code DCI": "03B088", "Forme": "COMP. SEC.", "Dosage": "500MG/65MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "PANADOL RHUME + GRIPPE 500MG/25MG/5MG** COMP. PELLI.  B/16", "Img": "https://pharmnet-dz.com//img/medics/1470.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1470", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / CAFEINE / PHENYLEPHRINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "PANADOL RHUME + GRIPPE", "Tarif de reference": "238 DA", "PPA": "N/A", "Num Enregistrement": "309/ 22 A 042 /12", "Code DCI": "22A042", "Forme": "COMP. PELLI.", "Dosage": "500MG/25MG/5MG**", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "PANOP 40MG GLES. A MICROGRANULES GASTRORESIST. PILULIER/14 ET PILULIER/28", "Img": "https://pharmnet-dz.com//img/medics/3874.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3874", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PANTOPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PANOP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 10 A 134 /04/11", "Code DCI": "10A134", "Forme": "COMP. ENRO.", "Dosage": "40MG", "Conditionnement": "PILULIER/14 ET PILULIER/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "PANOTILE 1000 000UI /1G/ 0,1G / 4G SOL AURIC . GTTES FL/8ML", "Img": "https://pharmnet-dz.com//img/medics/2024.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2024", "Laboratoire": " ZAMBON", "C.Pharmacologique": " ANTI-INFECTIEUX AVEC CORTICOIDES", "C.Therapeutique": " OTOLOGIE", "Info": " POLYMYXINE /NEOMYCINE/ACETATE DE FLUDROCORTISONE/LIDOCAINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PANOTILE", "Tarif de reference": "0 DA", "PPA": "174.00 DA", "Num Enregistrement": "093/ 18 B 023 /02", "Code DCI": "18B023", "Forme": "SOL. AURIC. GTTES.", "Dosage": "1000 000UI /1G/ 0,1G / 4G", "Conditionnement": "FL/8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PANOXYL 0.05 GEL.DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1650.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1650", "Laboratoire": " STIEFEL LIMITED", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "IRELAND", "Nom Commercial": "PANOXYL", "Tarif de reference": "150 DA", "PPA": " DA", "Num Enregistrement": "125/ 07 B 013 /98", "Code DCI": "07B013", "Forme": "GEL. DERM.", "Dosage": "0.05", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PANOXYL 0.1 GEL. DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medics/1653.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1653", "Laboratoire": " STIEFEL LIMITED", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "IRELAND", "Nom Commercial": "PANOXYL", "Tarif de reference": "162.8 DA", "PPA": " DA", "Num Enregistrement": "125/ 07 B 014 /98", "Code DCI": "07B014", "Forme": "GEL. DERM.", "Dosage": "0.1", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PANTODAR 40MG COMP. GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medics/3875.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3875", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PANTOPRAZOLE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "PANTODAR", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "055/ 10 A 134 /09 ", "Code DCI": "10A134", "Forme": "COMP. ENRO.", "Dosage": "40MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAPAVERINE 40MG/ML SOL. INJ. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PAPAVERINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PAPAVERINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 06 J 103 /98", "Code DCI": "06J103", "Forme": "SOL. INJ.", "Dosage": "40MG/ML", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARAC-CO 400MG/20MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARAC-CO", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "077/03B026/17", "Code DCI": "03B026", "Forme": "COMP.", "Dosage": "400MG/20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAL 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 03 B 005 /98/07", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARACETAMOL BIOCARE 100MG GRLES. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4152.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4152", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL BIOCARE", "Tarif de reference": "102.24 DA", "PPA": "152.00 DA", "Num Enregistrement": "293/ 03 B 006 /10", "Code DCI": "03B006", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL BIOCARE 150MG PDRE. SOL. BUV. EN SACH. B/12", "Img": "https://pharmnet-dz.com//img/medics/4221.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4221", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL BIOCARE", "Tarif de reference": "102.24 DA", "PPA": " DA", "Num Enregistrement": "293/03B044/15", "Code DCI": "03B044", "Forme": "PDRE. SUSP. BUV.", "Dosage": "150MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL BIOCARE 200MG GRLES. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4191.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4191", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL BIOCARE", "Tarif de reference": "110.28 DA", "PPA": " DA", "Num Enregistrement": "293/ 03 B 045 /10", "Code DCI": "03B045", "Forme": "PDRE. SOL. BUV.", "Dosage": "200MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL BIOCARE 300MG GRLES. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/4195.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4195", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL BIOCARE", "Tarif de reference": "120 DA", "PPA": "120.00 DA", "Num Enregistrement": "293/ 03 B 046 /10", "Code DCI": "03B046", "Forme": "PDRE. SOL. BUV.", "Dosage": "300MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL BIOCARE 500MG GRLES. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medics/2620.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2620", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL BIOCARE", "Tarif de reference": "30 DA", "PPA": "152.00 DA", "Num Enregistrement": "293/ 03 B 066 /10", "Code DCI": "03B066", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL IVAL 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL IVAL", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "195/ 03 B 005 /06", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL PHARMAGHREB 10MG/ML (500MG/50ML) (1000MG/100ML) SOL. INJ. P. PERF. IV. B/12 FL. DE 50ML , B/12 FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHARMAGHREB", "Tarif de reference": " N/A", "PPA": "160.00 DA", "Num Enregistrement": "088/ 03 B 067 /15", "Code DCI": "03B067", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (500MG/50ML) (1000MG/100ML)", "Conditionnement": "B/12 FL. DE 50ML , B/12 FL. DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARACETAMOL PHYSIOPHARM 1000MG POUDRE POUR SOLUT BUVABLE EN SACHET  B/12 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHYSIOPHARM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "462/03B123/16", "Code DCI": "N/D", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1000MG", "Conditionnement": "B/12 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARACETAMOL PHYSIOPHARM 100MG PDRE. P. SOL. BUV. EN SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHYSIOPHARM", "Tarif de reference": "102.24 DA", "PPA": "N/A", "Num Enregistrement": "462/03B006/15", "Code DCI": "03B006", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL PHYSIOPHARM 150MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHYSIOPHARM", "Tarif de reference": "102.24 DA", "PPA": "N/A", "Num Enregistrement": "462/03B044/15", "Code DCI": "03B044", "Forme": "PDRE. SUSP. BUV.", "Dosage": "150MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL PHYSIOPHARM 1G COMP  B/08", "Img": "https://pharmnet-dz.com//img/medics/2635.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHYSIOPHARM", "Tarif de reference": "40 DA", "PPA": "65.00 DA", "Num Enregistrement": "462/ 03 B 081 /14", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL PHYSIOPHARM 200MG PDRE. P. SOL. BUV. SACH.-DOSE B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHYSIOPHARM", "Tarif de reference": "110.28 DA", "PPA": "N/A", "Num Enregistrement": "462/03B045/16", "Code DCI": "03B045", "Forme": "PDRE. SUSP. BUV.", "Dosage": "200MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL PHYSIOPHARM 500MG COMP  B/20", "Img": "https://pharmnet-dz.com//img/medics/4141.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHYSIOPHARM", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "462/ 03 B 005 /15", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL PHYSIOPHARM 500MG POUDRE POUR SOLUT BUVABLE EN SACHET  B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL PHYSIOPHARM", "Tarif de reference": "30 DA", "PPA": "N/A", "Num Enregistrement": "462/03B066/16", "Code DCI": "03B066", "Forme": "PDRE. SUSP. BUV.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARACETAMOL RAZES 10MG/ML (500MG/50ML) (1000MG/100ML) SOL. INJ. P. PERF. IV FL./50ML (CAISSE DE 12 FL.) - FL./100ML (CAISSE DE 12 FL.)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARACETAMOL RAZES", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 03 B 067 /10", "Code DCI": "03B067", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (500MG/50ML) (1000MG/100ML)", "Conditionnement": "FL./50ML (CAISSE DE 12 FL.) - FL./100ML (CAISSE DE 12 FL.)", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARADIPAL 500MG/60MG** COMP. DE JOUR ET 500MG/25MG** COMP. DE NUIT COMP. SEC.  B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** COMP. DE JOUR  ET PARACETAMOL / DIPHENHYDRAMINE (SOUS FORME DE CHLORHYDRATE)**  COMP. DE NUIT", "Pays": "ALGERIE", "Nom Commercial": "PARADIPAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 22 A 041 /11", "Code DCI": "22A041", "Forme": "COMP. SEC.", "Dosage": "500MG/60MG** COMP. DE JOUR ET 500MG/25MG** COMP. DE NUIT", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARALGAN 1000MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": " N/A", "PPA": "64.00 DA", "Num Enregistrement": "003/ 03 B 086 /07", "Code DCI": "03B086", "Forme": "SUPPO.", "Dosage": "1000MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARALGAN 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 007 /08", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARALGAN 120MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 007 /06", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "120MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARALGAN 120MG/5ML SOL.BUV. B/01FL. DE 125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 117 /99/13", "Code DCI": "03B117", "Forme": "SOL. BUV.", "Dosage": "120MG/5ML", "Conditionnement": "B/01FL. DE 125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARALGAN 160MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": "63.4 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 091 /07", "Code DCI": "03B091", "Forme": "COMP. ORODISPERS.", "Dosage": "160MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARALGAN 170MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 096 /97/10", "Code DCI": "03B096", "Forme": "SUPPO.", "Dosage": "170MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PARALGAN 1G COMP. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 081 /13", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARALGAN 500MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/4142.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4142", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": "50 DA", "PPA": "60 DA", "Num Enregistrement": "003/ 03 B 005 /96/12", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARALGAN 600MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": "100 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 101 /08", "Code DCI": "03B101", "Forme": "SUPPO.", "Dosage": "600MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARALGAN 80MG COMP. ORODISPERS. SEC. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": "40.64 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 087 /07", "Code DCI": "03B087", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARALGAN 80MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARALGAN", "Tarif de reference": "59 DA", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 100 /07", "Code DCI": "03B100", "Forme": "SUPPO.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARAMOL 1G COMP. SEC. B/10 ET B/25", "Img": "https://pharmnet-dz.com//img/medics/2637.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2637", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARAMOL", "Tarif de reference": "0 DA", "PPA": "150.00 DA", "Num Enregistrement": "231/ 03 B 081 /06/15", "Code DCI": "03B081", "Forme": "COMP. SEC.", "Dosage": "1G", "Conditionnement": "B/10 ET B/25", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARAMOL 500MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/4143.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4143", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PARAMOL", "Tarif de reference": "50 DA", "PPA": "65.00 DA", "Num Enregistrement": "231/ 03 B 005 /04", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARAMOL EXTRA 500MG/50MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/2653.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL/ CAFEINE ANHYDRE", "Pays": "ALGERIE", "Nom Commercial": "PARAMOL EXTRA", "Tarif de reference": "0 DA", "PPA": "65.00 DA", "Num Enregistrement": "231/ 03 B 114 /14", "Code DCI": "03B114", "Forme": "COMP.", "Dosage": "500MG/50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARAMOL RHUME 500MG/30MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL /  PSEUDOEPHEDRINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARAMOL RHUME", "Tarif de reference": "-- DA", "PPA": " DA", "Num Enregistrement": "231/03B057/17", "Code DCI": "03B057", "Forme": "COMP.", "Dosage": "500MG/30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARAPSYLLIUM 3,333G/3,333G PDRE SOL BUV SACHET B/10SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IPRAD", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TEGUMENTS MUCILAGINEUX PULVERISES DE GRAINES DE PSYLLIUM   / PARAFFINE LIQUIDE", "Pays": "FRANCE", "Nom Commercial": "PARAPSYLLIUM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "240/ 10 L 126 /02", "Code DCI": "10L126", "Forme": "PDRE. SOL. BUV.", "Dosage": "3,333G/3,333G", "Conditionnement": "B/10SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAREXAT 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAREXAT", "Tarif de reference": "1620.00 DA", "PPA": "N/A", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARKIDYL 2MG COMP.SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/2487.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2487", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " TRIHEXYPHENIDYLE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARKIDYL", "Tarif de reference": "102.31 DA", "PPA": "N/A", "Num Enregistrement": "235/ 15 D 093 /09", "Code DCI": "15D093", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARKIDYL 5MG COMP.SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/2483.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2483", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " TRIHEXYPHENIDYLE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARKIDYL", "Tarif de reference": "152.5 DA", "PPA": "N/A", "Num Enregistrement": "235/ 15 D 062 /05", "Code DCI": "15D062", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARKINANE  LP 2MG GLES.LP B/50", "Img": "https://pharmnet-dz.com//img/medics/2481.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2481", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " TRIHEXYPHENIDYLE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARKINANE  LP", "Tarif de reference": "200 DA", "PPA": "N/A", "Num Enregistrement": "285/ 15 D 033 /98/07", "Code DCI": "15D033", "Forme": "GLES. LP", "Dosage": "2MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARKINANE  LP 5MG GLES.LP B/20", "Img": "https://pharmnet-dz.com//img/medics/2482.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2482", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " TRIHEXYPHENIDYLE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PARKINANE  LP", "Tarif de reference": "200 DA", "PPA": "N/A", "Num Enregistrement": "285/ 15 D 034 /98/07", "Code DCI": "15D034", "Forme": "GLES. LP", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PARLODEL 2,5MG COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/615.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=615", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-PROLACTINE", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BROMOCRIPTINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PARLODEL", "Tarif de reference": "684.9 DA", "PPA": "641.00 DA", "Num Enregistrement": "068/ 09 D 006 /97", "Code DCI": "09D006", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROL  100MG SUPPO, B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROL ", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "263/03B007/16", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROL  150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROL ", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "263/03B041/16", "Code DCI": "03B041", "Forme": "SUPPO.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROL  300MG SUPP0. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROL ", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "263/03B043/16", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROL 200MG SUPPO.  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROL", "Tarif de reference": "85 DA", "PPA": "N/A", "Num Enregistrement": "263/03B042/16", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROXETIL BGL 10MG COMP PELLICULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROXETIL BGL", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "16A154", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROXETINE BEKER 20MG COMP. PELLI. SEC. B/14 - B/30", "Img": "https://pharmnet-dz.com//img/medics/2556.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2556", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROXETINE BEKER", "Tarif de reference": "1620 DA", "PPA": "1620 DA", "Num Enregistrement": "447/ 16 A 095 /13", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROXETINE GL  20MG COMP. PELLI. SEC.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROXETINE GL ", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAROXINAD 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAROXINAD", "Tarif de reference": "1620 DA", "PPA": "N/A", "Num Enregistrement": "468/ 16 A 095 /14", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PAVULON 2MG/ML (4MG/2ML) SOL.INJ.IV B/50AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ORGANON", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PANCURONIUM BROMURE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "PAVULON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "005/ 02 D 036 /97", "Code DCI": "02D036", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (4MG/2ML)", "Conditionnement": "B/50AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PAXETINE 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " PAROXETINE CHLORHYDRATE EXPRIME EN PAROXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PAXETINE", "Tarif de reference": "1620.00 DA", "PPA": "N/A", "Code DCI": "16A095", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PECTOSAN EXPECTORAN ENFANT 2% (OU 2G/100ML) SIROP FL./150ML", "Img": "https://pharmnet-dz.com//img/medics/1308.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "PECTOSAN EXPECTORAN ENFANT", "Tarif de reference": " N/A", "PPA": "180.00 DA", "Num Enregistrement": "263/ 20 D 041 /09", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "2% (OU 2G/100ML)", "Conditionnement": "FL./150ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PECTOSAN EXPECTORANT ADULTE 0.05 SIROP FL./250ML", "Img": "https://pharmnet-dz.com//img/medics/1318.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "PECTOSAN EXPECTORANT ADULTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 20 D 042 /09", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL./250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PEDIAMOL 0.03 SOL.BUV. FL./125ML+ SERINGUE GRADUEE EN KG-ML", "Img": "https://pharmnet-dz.com//img/medics/2618.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "PEDIAMOL", "Tarif de reference": " N/A", "PPA": "145.00 DA", "Num Enregistrement": "077/ 03 B 061 /03/14", "Code DCI": "03B061", "Forme": "SOL. BUV.", "Dosage": "0.03", "Conditionnement": "FL./125ML+ SERINGUE GRADUEE EN KG-ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PEFLOQUIN 400MG COMP. B/02 et B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HAYAT PHARMACEUTICAL INDUSTRIES Co LTD", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PEFLOQUIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "098/ 13 K 166 /98", "Code DCI": "13K166", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/02 et B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PEFLOX 400MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEFLOXACINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PEFLOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 13 K 166 /98", "Code DCI": "13K166", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PEGASYS  180\u00b5G/0,5ML (OU 360\u00b5G/ML) SOL. INJ. SC EN SERING. PRE-REMPLIE B/01 SERINGUE DE 0,5ML", "Img": "https://pharmnet-dz.com//img/medics/448.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=448", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEGINTERFERON ALPHA 2A", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "PEGASYS ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 13 P 289 /06", "Code DCI": "13P289", "Forme": "SOL. INJ.", "Dosage": "180\u00b5G/0,5ML (OU 360\u00b5G/ML)", "Conditionnement": "B/01 SERINGUE DE 0,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PEITEL  0.0025 CREME .DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/4407.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "PEITEL ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "207/07H183/16", "Code DCI": "N/D", "Forme": "CR\u00c8ME", "Dosage": "0.25%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENAMOX 125MG/5ML PDRE. P. SUSP. BUV. B/1FL/60ML DE SUSP. BUV. APRES  RECONST.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENAMOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 046 /97/08", "Code DCI": "13G046", "Forme": "PDRE. SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "B/1FL/60ML DE SUSP. BUV. APRES  RECONST.", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENAMOX 1G COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENAMOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 221 /04/09", "Code DCI": "13G221", "Forme": "COMP. PELLI.", "Dosage": "1G", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENAMOX 250MG/5ML  PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONSTIT. + 01 CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENAMOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 047 /97/10", "Code DCI": "13G047", "Forme": "PDRE. SUSP. BUV.", "Dosage": "250MG/5ML ", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONSTIT. + 01 CUILLERE MESURE", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENAMOX 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENAMOX", "Tarif de reference": " N/A", "PPA": "139.00 DA", "Num Enregistrement": "001/ 13 G 045 /97/10", "Code DCI": "13G045", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENAMOX 500MG/5ML  PDRE P/ SUSP BUV  B/01 FL 60ML APRES RECONSTITUTION+CUILLERE MEUSURE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENAMOX", "Tarif de reference": "205.2 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 220 /14", "Code DCI": "13G220", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/5ML ", "Conditionnement": "B/01 FL 60ML APRES RECONSTITUTION+CUILLERE MEUSURE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENAMOX D 1G COMP. DISPERS. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENAMOX D", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 230 /15", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENAMOX D 500MG COMP. DISPERS. SEC. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENAMOX D", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 G 301 /15", "Code DCI": "13G301", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENI G BIOCARE 1 000 000UI/FL.DE PDRE. PDRE. P. SOL. INJ. IM/IV B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/264.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=264", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " BENZYLPENICILLINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENI G BIOCARE", "Tarif de reference": "107 DA", "PPA": " DA", "Num Enregistrement": "293/ 13 G 063 /11", "Code DCI": "13G063", "Forme": "PDRE. SOL. INJ.", "Dosage": "1 000 000UI/FL.DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 5ML DE SOLV.(EPPI) ET B/50FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENICILLINE-CIMEX 1 000 000UI** COMP. PELLI. B/12", "Img": "https://pharmnet-dz.com//img/medics/271.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENICILLINE-CIMEX", "Tarif de reference": "0 DA", "PPA": "257.00 DA", "Num Enregistrement": "400/ 13 G 072 /04/11", "Code DCI": "13G072", "Forme": "COMP. PELLI.", "Dosage": "1 000 000UI**", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENICILLINE-CIMEX 250 000UI/5ML PDRE. P. SUSP. BUV. B/1FL. DE 60ML DE SUSP. BUV. APRES RECONSTITUTION +UNE CUILLERE MESURE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENICILLINE-CIMEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "400/ 13 G 071 /06/11", "Code DCI": "13G071", "Forme": "PDRE. SOL. BUV.", "Dosage": "250 000UI/5ML", "Conditionnement": "B/1FL. DE 60ML DE SUSP. BUV. APRES RECONSTITUTION +UNE CUILLERE MESURE", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENIVAL 1 000 000UI COMP. SEC. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE POTASSIQUE EXPRIME EN PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENIVAL", "Tarif de reference": " N/A", "PPA": "183.00 DA", "Num Enregistrement": "039/ 13 G 072 /98/13", "Code DCI": "13G072", "Forme": "COMP. PELLI.", "Dosage": "1 000 000UI", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENIVAL 1 500 000UI COMP. SEC. B/12", "Img": "https://pharmnet-dz.com//img/medics/348.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PHENOXYMETHYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENIVAL", "Tarif de reference": "275.88 DA", "PPA": " DA", "Num Enregistrement": "039/ 13 G 306 /12", "Code DCI": "13G306", "Forme": "COMP. SEC.", "Dosage": "1 500 000UI", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTASA 1G SUPPO. B/15", "Img": "https://pharmnet-dz.com//img/medics/2981.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2981", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "FRANCE", "Nom Commercial": "PENTASA", "Tarif de reference": "0 DA", "PPA": "3161.00 DA", "Num Enregistrement": "275/ 10 N 131 /04", "Code DCI": "10N131", "Forme": "SUPPO.", "Dosage": "1G", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTASA 1G/100ML SUSP. RECT. B/05 RECIPIENTS UNIDOSES EN FLACON PE DE 100ML AVEC CANULE", "Img": "https://pharmnet-dz.com//img/medics/2979.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2979", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "FRANCE", "Nom Commercial": "PENTASA", "Tarif de reference": "2138.75 DA", "PPA": " DA", "Num Enregistrement": "275/ 10 N 077 /04/15", "Code DCI": "10N077", "Forme": "SOL. RECTAL", "Dosage": "1G/100ML", "Conditionnement": "B/05 RECIPIENTS UNIDOSES EN FLACON PE DE 100ML AVEC CANULE", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTASA 1G/SACH. GRLES. SACH. B/120SACH.", "Img": "https://pharmnet-dz.com//img/medics/2982.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2982", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "FRANCE", "Nom Commercial": "PENTASA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/ 10 N 176 /09", "Code DCI": "10N176", "Forme": "GRLES.", "Dosage": "1G/SACH.", "Conditionnement": "B/120SACH.", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTASA 500MG COMP. LP B/100", "Img": "https://pharmnet-dz.com//img/medics/2975.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2975", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "ALLEMAGNE", "Nom Commercial": "PENTASA", "Tarif de reference": "4656.19 DA", "PPA": " DA", "Num Enregistrement": "275/ 10 N 075 /03/15", "Code DCI": "10N075", "Forme": "COMP. LP", "Dosage": "500MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTAZINE LP 1G/SACH. MICROGRANULES LP EN SACHETS B/120SACH.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PENTAZINE LP", "Tarif de reference": "2104,20 DA", "PPA": " DA", "Code DCI": "10N176", "Forme": "MICROGRANULES LP. GLES.", "Dosage": "1G/SACH", "Conditionnement": "B/120SACH", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTAZINE LP 500MG/SACHET MICRO-GRLES. LP EN SACHET-DOSE B/60 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/2983.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "ALGERIE", "Nom Commercial": "PENTAZINE LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "289/ 10 N 202 /15", "Code DCI": "10N202", "Forme": "MICROGRANULES LP. GLES.", "Dosage": "500MG/SACHET", "Conditionnement": "B/60 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "PENTOLATE 0.005 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " AMMAN PHARMACEUTICAL INDUSTRIE", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CYCLOPENTOLATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PENTOLATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "165/ 17 H 059 /98", "Code DCI": "17H059", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTORENTAL 400MG COMP. PELLI. LP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PENTOXIFYLLINE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PENTORENTAL", "Tarif de reference": "- DA", "PPA": " DA", "Code DCI": "06J105", "Forme": "COMP. PELLI. LP", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTOXIFYLLINE MYLAN 400MG COMP. PELLI. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/1496.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1496", "Laboratoire": " MYLAN", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PENTOXIFYLLINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PENTOXIFYLLINE MYLAN", "Tarif de reference": "324.49 DA", "PPA": "N/A", "Num Enregistrement": "450/ 06 J 105 /09", "Code DCI": "06J105", "Forme": "COMP. PELLI. LP", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PENTUSSIL 6,75 MG/5ML SIROP FL/180 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PENTOXYVERINE", "Pays": "ALGERIE", "Nom Commercial": "PENTUSSIL", "Tarif de reference": "181.8 DA", "PPA": "N/A", "Num Enregistrement": "003/ 20 C 035 /97", "Code DCI": "20C035", "Forme": "SIROP", "Dosage": "6,75 MG/5ML", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PEPSANE 300MG/4MG CAPS. B/30", "Img": "https://pharmnet-dz.com//img/medics/3920.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3920", "Laboratoire": " ROSA - PHYTOPHARMA", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIMETICONE / GAIZULENE", "Pays": "FRANCE", "Nom Commercial": "PEPSANE", "Tarif de reference": "0 DA", "PPA": "336.00 DA", "Num Enregistrement": "265/ 10 B 170 /07", "Code DCI": "10B170", "Forme": "CAPS.", "Dosage": "300MG/4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PEPSANE 3G/0,004G/SACHET GEL BUV EN SACHETS-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3912.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3912", "Laboratoire": " ROSA - PHYTOPHARMA", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIMETICONE / GAIZULENE", "Pays": "FRANCE", "Nom Commercial": "PEPSANE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "265/ 10 B 125 /02/14", "Code DCI": "10B125", "Forme": "GEL. BUV.", "Dosage": "3G/0,004G/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": false}, {"Nom": "PERAZ 1 000MG/FL. DE PDRE.** PDRE. P. SOL. INJ. IM/IV GRDE. BOITE CONTENANT 100BOITES DE 1FLACON DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CPCM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOPERAZONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERAZ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 13 B 320 /12", "Code DCI": "13B320", "Forme": "PDRE. SOL.", "Dosage": "1 000MG/FL. DE PDRE.**", "Conditionnement": "GRDE. BOITE CONTENANT 100BOITES DE 1FLACON DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "PERAZ 2 000MG/FL. DE PDRE.** PDRE. P. SOL. INJ. IM/IV GRDE. BOITE CONTENANT 100BOITES DE 1FLACON DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CPCM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOPERAZONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERAZ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 13 B 321 /12", "Code DCI": "13B321", "Forme": "PDRE. SOL.", "Dosage": "2 000MG/FL. DE PDRE.**", "Conditionnement": "GRDE. BOITE CONTENANT 100BOITES DE 1FLACON DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "PERCUTALGINE 0,005% / 2% / 10% GEL DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1367", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DEXAMETHASONE ACETATE / SALICYLAMIDE / SALICYLATE D'HYDROXYETHYLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PERCUTALGINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "169/ 21 A 003 /99", "Code DCI": "21A003", "Forme": "GEL DERM.", "Dosage": "0,005% / 2% / 10%", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERCUTALGINE SPRAY 0,05% / 8,5% / 10% SOL.DERM. FLACON PRESSURISE DE 40ML AVEC POMPE DOSEUSE ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1390", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DEXAMETHASONE  /  SALICYLAMIDE  / SALICYLATE D''HYDROXYETHYLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PERCUTALGINE SPRAY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "169/ 21 A 035 /00", "Code DCI": "21A035", "Forme": "SOL. DERM.", "Dosage": "0,05% / 8,5% / 10%", "Conditionnement": "FLACON PRESSURISE DE 40ML AVEC POMPE DOSEUSE ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERFALGAN ADULTES 10MG/ML (1000MG/100ML) SOL. INJ. P. PERF.  B/12FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2624", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "FRANCE", "Nom Commercial": "PERFALGAN ADULTES", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 03 B 067 /05", "Code DCI": "03B067", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (1000MG/100ML)", "Conditionnement": "B/12FL. DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERFALGAN ENFANTS / NOURRISSONS 10MG/ML (500MG/50ML) SOL. INJ. P. PERF.  B/12FL. DE 50ML", "Img": "https://pharmnet-dz.com//img/medics/2625.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2625", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "FRANCE", "Nom Commercial": "PERFALGAN ENFANTS / NOURRISSONS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 03 B 068 /05", "Code DCI": "03B068", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (500MG/50ML)", "Conditionnement": "B/12FL. DE 50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERIACTINE 4MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3337.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3337", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " OREXIGENES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Pays": "ALGERIE", "Nom Commercial": "PERIACTINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "285/ 14 F 025 /99/14", "Code DCI": "14F025", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "PERIAMEX 2MG/5ML SIROP FL/100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CYPROHEPTADINE CHLORHYDRATE EXPRIME EN CYPROHEPTADINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERIAMEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "400/01A053/17", "Code DCI": "01A053", "Forme": "SIROP", "Dosage": "2MG/5ML", "Conditionnement": "FL/100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PERIDIUM 10MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PERIDIUM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 10 F 046 /03/10", "Code DCI": "10F046", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "PERIDYS 1MG/ML SUSP.BUV. FL/200ML + SERING. P. ADMINIST. ORALE. DE 5ML GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2879", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PERIDYS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 10 F 047 /98/12", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL/200ML + SERING. P. ADMINIST. ORALE. DE 5ML GRADUEE EN KG", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERINDOPRIL 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3084.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3084", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL TER-BUTYLAMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERINDOPRIL", "Tarif de reference": "659.7 DA", "PPA": "659.00 DA", "Num Enregistrement": "447/ 06 E 165 /12", "Code DCI": "06E165", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERINDOPRIL 8MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/3179.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3179", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL TER-BUTYLAMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERINDOPRIL", "Tarif de reference": "823.80 DA", "PPA": "823.80 DA", "Num Enregistrement": "447/ 06 E 246 /12", "Code DCI": "06E246", "Forme": "COMP. PELLI.", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERINDOSYL 4MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERINDOSYL", "Tarif de reference": "659.7 DA", "PPA": "N/A", "Num Enregistrement": "352/06E165/16", "Code DCI": "06E165", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERINDOSYL 8MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medics/3180.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL TER-BUTYLAMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERINDOSYL", "Tarif de reference": "965.4 DA", "PPA": "894.00 DA", "Num Enregistrement": "352/ 06 E 246 /14", "Code DCI": "06E246", "Forme": "COMP. PELLI.", "Dosage": "8MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERMANGANATE DE POTASSIUM 250MG COMP.SEC. T/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PERMANGANATE DE POTASSIUM", "Pays": "ALGERIE", "Nom Commercial": "PERMANGANATE DE POTASSIUM", "Tarif de reference": " N/A", "PPA": "250.00 DA", "Num Enregistrement": "235/ 07 P 075 /00", "Code DCI": "07P075", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "T/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PERMIDOL  10MG/ML SOLUTION POUR PERFUSION IV 10MG/ML  B/01 FLACON DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PERMIDOL ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "323/03B067/16", "Code DCI": "03B067", "Forme": "SOL. INJ. PERF.", "Dosage": "10MG/ML", "Conditionnement": "B/01 FLACON DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PERMIXON 160MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/1156.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1156", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SERENOA REPENS", "Pays": "FRANCE", "Nom Commercial": "PERMIXON", "Tarif de reference": "1297.2 DA", "PPA": "1596.00 DA", "Num Enregistrement": "099/ 25 B 006 /98", "Code DCI": "25B006", "Forme": "GLES.", "Dosage": "160MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERSANTINE 10MG/2ML SOL.INJ. IV B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=589", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " N/D", "C.Therapeutique": " DIAGNOSTIC", "Info": " DIPYRIDAMOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PERSANTINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 08 F 034 /98", "Code DCI": "08F034", "Forme": "SOL. INJ.", "Dosage": "10MG/2ML", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERSANTINE 75MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3067", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " DIPYRIDAMOLE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PERSANTINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "152/ 12 A 003 /98", "Code DCI": "12A003", "Forme": "COMP.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PERYDONE 1MG/ML SUSP. BUV. FL./180ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOMPERIDONE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PERYDONE", "Tarif de reference": "201.6 DA", "PPA": "N/A", "Num Enregistrement": "088/ 10 F 047 /09", "Code DCI": "10F047", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "FL./180ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "PEVARYL 1G% LAIT DERMIQUE FL/30ML", "Img": "https://pharmnet-dz.com//img/medics/1697.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1697", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ECONAZOLE", "Pays": "FRANCE", "Nom Commercial": "PEVARYL", "Tarif de reference": "124.5 DA", "PPA": "N/A", "Num Enregistrement": "095/ 07 D 026 /98", "Code DCI": "07D026", "Forme": "LAIT DERMIQUE", "Dosage": "1G%", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PEVARYL 1G% LOTION FL/30G", "Img": "https://pharmnet-dz.com//img/medics/1698.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1698", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ECONAZOLE", "Pays": "FRANCE", "Nom Commercial": "PEVARYL", "Tarif de reference": "387.4 DA", "PPA": "N/A", "Num Enregistrement": "095/ 07 D 027 /98", "Code DCI": "07D027", "Forme": "LOTION", "Dosage": "1G%", "Conditionnement": "FL/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHANAZOL 0.01 CREME.DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1694.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1694", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ECONAZOLE (NITRATE)", "Pays": "ALGERIE", "Nom Commercial": "PHANAZOL", "Tarif de reference": "120 DA", "PPA": "120 DA", "Num Enregistrement": "003/ 07 D 025 /00/09", "Code DCI": "07D025", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHARMATEX 1,2% CREME VAG. T/72G", "Img": "https://pharmnet-dz.com//img/medics/3036.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3036", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " CONTRACEPTIFS LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " BENZALKONIUM CHLORURE", "Pays": "FRANCE", "Nom Commercial": "PHARMATEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "087/ 11 G 024 /98", "Code DCI": "11G024", "Forme": "CR\u00c8ME", "Dosage": "1,2%", "Conditionnement": "T/72G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHARMATEX 18,9MG OVULES B/10", "Img": "https://pharmnet-dz.com//img/medics/3035.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3035", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " CONTRACEPTIFS LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " BENZALKONIUM CHLORURE", "Pays": "FRANCE", "Nom Commercial": "PHARMATEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "087/ 11 G 023 /98", "Code DCI": "11G023", "Forme": "OVULE ", "Dosage": "18,9MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHARMEXIN 250MG/5ML GRLES. SUSP. BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHARMEXIN", "Tarif de reference": "311 DA", "PPA": "N/A", "Num Enregistrement": "304/ 13 B 156 /06", "Code DCI": "13B156", "Forme": "PDRE. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHENOBARBIAL 40MG PDRE. P. SOL. INJ. B/1AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PHENOBARBITAL  (SOUS FORME SODIQUE)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PHENOBARBIAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 15 A 012 /98", "Code DCI": "15A012", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG", "Conditionnement": "B/1AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHENOCEPT 500MG  COMP. PELLI. B/100", "Img": "https://pharmnet-dz.com//img/medics/1268.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1266", "Laboratoire": " EL KENDI", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " MYCOPHENOLATE MOFETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHENOCEPT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 27 A 002 /14", "Code DCI": "27A002", "Forme": "COMP. PELLI.", "Dosage": "500MG ", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "PHENOXAL 100MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3519.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3519", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PHENOBARBITAL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PHENOXAL", "Tarif de reference": "103 DA", "PPA": "N/A", "Num Enregistrement": "235/ 15 A 014 /07/13", "Code DCI": "15A014", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHLOCINAL 10MG/0,01MG/1ML (40MG/0,04MG/4ML) SOL INJ IM/IV B/06 AMPS 4ML ET B/100 AMPS 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL HYDRATE/ TRIMETHYLPHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "PHLOCINAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "039/ 10 E 038 /14", "Code DCI": "10E038", "Forme": "SOL. INJ.", "Dosage": "10MG/0,01MG/1ML (40MG/0,04MG/4ML)", "Conditionnement": "B/06 AMPS 4ML ET B/100 AMPS 4ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHLOGOREN 0.01 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PHLOGOREN", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "319/ 21 A 004 /09", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHLOGOREN 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PHLOGOREN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "319/ 04 B 009 /05", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PHLOGOREN ENFANT 25MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PHLOGOREN ENFANT", "Tarif de reference": "56.8 DA", "PPA": "N/A", "Num Enregistrement": "319/ 04 B 008 /08", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHLOROGLUCINOL BGL 80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "PHLOROGLUCINOL BGL", "Tarif de reference": " N/A", "PPA": "228.00 DA", "Num Enregistrement": "235/ 10 E 108 /15", "Code DCI": "10E108", "Forme": "COMP. DISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PHLOROGLUCINOL HUP 80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medics/3969.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3969", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "PHLOROGLUCINOL HUP", "Tarif de reference": "101.8 DA", "PPA": "N/A", "Num Enregistrement": "380/ 10 E 108 /11", "Code DCI": "10E108", "Forme": "COMP. DISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHLOROGLUCINOL IVAL 80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "PHLOROGLUCINOL IVAL", "Tarif de reference": " N/A", "PPA": "152.00 DA", "Num Enregistrement": "195/ 10 E 108 /09/15", "Code DCI": "10E108", "Forme": "COMP. DISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PHLOROGLUCINOL MM 80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "PHLOROGLUCINOL MM", "Tarif de reference": "101.8 DA", "PPA": "182.00 DA", "Num Enregistrement": "470/ 10 E 108 /13", "Code DCI": "10E108", "Forme": "COMP. DISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHLOROXIM 80MG COMP. DISPERS. ET ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "PHLOROXIM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "293/ 10 E 108 /15", "Code DCI": "10E108", "Forme": "COMP. DISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PHLOSPASM 80MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " TAPHCO SPA", "C.Pharmacologique": " N/D", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "PHLOSPASM", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "N/D", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHOSPHALUGEL 20G SUSP BUV SACHET - DOSE B/26SACHETS ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PHOSPHATE D'ALUMINIUM", "Pays": "FRANCE", "Nom Commercial": "PHOSPHALUGEL", "Tarif de reference": "261.3 DA", "PPA": "N/A", "Num Enregistrement": "152/ 10 B 014 /98", "Code DCI": "10B014", "Forme": "SUSP. BUV.", "Dosage": "20G", "Conditionnement": "B/26SACHETS ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHOSPHALUGEL 61,90 G/100 G SUSP BUV FL/250G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PHOSPHATE D'ALUMINIUM", "Pays": "FRANCE", "Nom Commercial": "PHOSPHALUGEL", "Tarif de reference": "167.5 DA", "PPA": "N/A", "Num Enregistrement": "152/ 10 B 111 /99", "Code DCI": "10B111", "Forme": "SUSP. BUV.", "Dosage": "61,90 G/100 G", "Conditionnement": "FL/250G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHOSPHALUMINE 2,47G/SACH. (13,38G/SACH. SOUS FORME DE GEL COLLOIDAL 20%) SUSP. BUV . SACH.-DOSE B/26 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3900.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3900", "Laboratoire": " HYSA SARL", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PHOSPHATE D'ALUMINIUM", "Pays": "ALGERIE", "Nom Commercial": "PHOSPHALUMINE", "Tarif de reference": "261.3 DA", "PPA": "N/A", "Num Enregistrement": "388/ 10 B 014 /11", "Code DCI": "10B014", "Forme": "SUSP. BUV.", "Dosage": "2,47G/SACH. (13,38G/SACH. SOUS FORME DE GEL COLLOIDAL 20%)", "Conditionnement": "B/26 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOL 0.009 SOL.INJ. B/10 FLACONS DE 5ML       ", "Img": "https://pharmnet-dz.com//img/medics/3373.png", "Laboratoire": " UNIMED", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "TUNISIE", "Nom Commercial": "PHYSIOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 14 G 075 /96", "Code DCI": "14G075", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "B/10 FLACONS DE 5ML       ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOL 0.009 SOL.INJ. B/15FL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/3376.png", "Laboratoire": " UNIMED", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM CHLORURE", "Pays": "TUNISIE", "Nom Commercial": "PHYSIOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 14 G 076 /96", "Code DCI": "14G076", "Forme": "SOL. INJ.", "Dosage": "0.009", "Conditionnement": "B/15FL. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOLONE 200MG/ML SOL.BUV. FL/100 ML +SERINGUE DOSEUSE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOLONE", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL/100 ML +SERINGUE DOSEUSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOLONE 20MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medics/4228.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOLONE", "Tarif de reference": "392 DA", "PPA": " DA", "Num Enregistrement": "462/09H144/15", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOLONE 5MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medics/4388.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOLONE", "Tarif de reference": "257.4 DA", "PPA": " DA", "Num Enregistrement": "462/09H143/16", "Code DCI": "09H143", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOPHORMINE 1000MG COMP. PELLI. B/30 - B/60 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/3710.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOPHORMINE", "Tarif de reference": "173.4 DA", "PPA": "173.00 DA", "Num Enregistrement": "462/ 14 A 224 /13", "Code DCI": "14A224", "Forme": "COMP. PELLI.", "Dosage": "1000MG", "Conditionnement": "B/30 - B/60 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOPHORMINE 1000MG/SACHET PDRE. P. SOL. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/4206.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOPHORMINE", "Tarif de reference": "173.4 DA", "PPA": " DA", "Num Enregistrement": "462/14A353/15", "Code DCI": "14A224", "Forme": "PDRE. SUSP. BUV.", "Dosage": "1000MG/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOPHORMINE 500MG COMP. PELLI. B/50", "Img": "https://pharmnet-dz.com//img/medics/3621.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOPHORMINE", "Tarif de reference": "182 DA", "PPA": "181.00 DA", "Num Enregistrement": "462/ 14 A 006 /13", "Code DCI": "14A006", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOPHORMINE 500MG/SACHET PDRE. P. SOL. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3729.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOPHORMINE", "Tarif de reference": " N/A", "PPA": "109.00 DA", "Num Enregistrement": "462/ 14 A 351 /15", "Code DCI": "14A351", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "PHYSIOPHORMINE 850MG COMP. PELLI. B/30, B/90 ET B/120 ", "Img": "https://pharmnet-dz.com//img/medics/3634.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOPHORMINE", "Tarif de reference": "442.8 DA", "PPA": "444.00 DA", "Num Enregistrement": "462/ 14 A 007 /10", "Code DCI": "14A007", "Forme": "COMP. PELLI.", "Dosage": "850MG", "Conditionnement": "B/30, B/90 ET B/120 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOPHORMINE 850MG/SACHET PDRE. P. SOL. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/4210.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " METFORMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PHYSIOPHORMINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "462/14A352/15", "Code DCI": "N/D", "Forme": "PDRE. SUSP. BUV.", "Dosage": "850MG/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOTENS 0,2MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/192.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=192", "Laboratoire": " ABBOTT", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOXONIDINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PHYSIOTENS", "Tarif de reference": "1,191.88 DA", "PPA": "1,191.88 DA", "Num Enregistrement": "147/ 06 E 143 /99/08", "Code DCI": "06E143", "Forme": "COMP. PELLI.", "Dosage": "0,2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYSIOTENS 0,4MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/193.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=193", "Laboratoire": " ABBOTT", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOXONIDINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PHYSIOTENS", "Tarif de reference": "2,159.85 DA", "PPA": "2,159.85  DA", "Num Enregistrement": "147/ 06 E 144 /99/08", "Code DCI": "06E144", "Forme": "COMP. PELLI.", "Dosage": "0,4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PHYTOMENADINE 10MG/ML (20MG/2ML) SOL .INJ IM - IV B/05AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " VITAMINES K", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " PHYTOMENADIONE", "Pays": "ITALIE", "Nom Commercial": "PHYTOMENADINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 12 D 015 /00", "Code DCI": "12D015", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (20MG/2ML)", "Conditionnement": "B/05AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIASCLEDINE 300 100MG/200MG (TOTAL 300MG D'INSAPONIFIABLES AVOCAT-SOJA) GLES. B/15", "Img": "https://pharmnet-dz.com//img/medics/1441.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1441", "Laboratoire": " EXPANSCIENCE", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " RHUMATOLOGIE", "Info": " INSAPONIFIABLE D'HUILE D'AVOCAT /  INSAPONIFIABLE D'HUILE DE SOJA ", "Pays": "FRANCE", "Nom Commercial": "PIASCLEDINE 300", "Tarif de reference": "0 DA", "PPA": "573.00 DA", "Num Enregistrement": "210/ 21 H 037 /01/10", "Code DCI": "21H037", "Forme": "GLES.", "Dosage": "100MG/200MG (TOTAL 300MG D'INSAPONIFIABLES AVOCAT-SOJA)", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "PICOPREP 10MG/3,5MG/12G /SACHET POUDRE POUR SOLUTION BUVABLE EN SACHET  B/2", "Img": "https://pharmnet-dz.com//img/medics/4269.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4269", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PICOPREP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/10L203/15", "Code DCI": "N/D", "Forme": "PDRE. SUSP. BUV.", "Dosage": "10MG/3,5MG/12G /SACHET", "Conditionnement": "B/2", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIDOGREL 75MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1511.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIDOGREL", "Tarif de reference": "1800 DA", "PPA": "1800.00 DA", "Num Enregistrement": "317/ 06 J 159 /10", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PILO 1     . 0.01 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CHAUVIN", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PILOCARPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PILO 1     .", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "096/ 17 C 009 /98", "Code DCI": "17C009", "Forme": "COLLY. SOL.", "Dosage": "0.01", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PILOLOL 1G/0,5G COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/2357.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2357", "Laboratoire": " UNIMED", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PILOCARPINE / TIMOLOL", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "PILOLOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 17 C 116 /01", "Code DCI": "17C116", "Forme": "COLLY. SOL.", "Dosage": "1G/0,5G", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIMAG 1,5G/10ML SOL. BUV. B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM PIDOLATE", "Pays": "ALGERIE", "Nom Commercial": "PIMAG", "Tarif de reference": "160 DA", "PPA": "350.00 DA", "Num Enregistrement": "026/ 14 G 054 /06", "Code DCI": "14G054", "Forme": "SOL. BUV.", "Dosage": "1,5G/10ML", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PINAQUINE 200MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2321.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PINAQUINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 16 D 150 /14", "Code DCI": "16D150", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "PINAQUINE 50MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2328.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PINAQUINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 16 D 162 /14", "Code DCI": "16D162", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "PINAQUINE LP 200MG COMP. PELLI. LP B/60", "Img": "https://pharmnet-dz.com//img/medics/2329.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PINAQUINE LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 16 D 164 /15", "Code DCI": "16D164", "Forme": "COMP. PELLI. LP", "Dosage": "200MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "PINATEL 100MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3964.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3964", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PINAVERIUM BROMURE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PINATEL", "Tarif de reference": "285.04 DA", "PPA": "289 DA", "Num Enregistrement": "447/ 10 E 104 /13", "Code DCI": "10E104", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "PINAVERIUM GENERICLAB 100MG COMP.PELL B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PINAVERIUM BROMURE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PINAVERIUM GENERICLAB", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 10 E 104 /14", "Code DCI": "10E104", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PINAVERIUM NOVAGENERICS 100MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PINAVERIUM BROMURE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PINAVERIUM NOVAGENERICS", "Tarif de reference": "305.4 DA", "PPA": "N/A", "Num Enregistrement": "149/ 10 E 104 /13", "Code DCI": "10E104", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PINAVERIUM NOVAGENERICS 50MG COMP.PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " N/D", "Info": " PINAVERIUM BROMURE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PINAVERIUM NOVAGENERICS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "149/10E036/16", "Code DCI": "10E036", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PIPERACILLINE MERCK 4G PDRE.SOL.INJ. B/10FL DE 50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MERCK GENERIQUE FRANCE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PIPERACILLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PIPERACILLINE MERCK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "239/ 13 G 162 /01", "Code DCI": "13G162", "Forme": "PDRE. SOL. INJ.", "Dosage": "4G", "Conditionnement": "B/10FL DE 50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PIPORTIL 10MG COMP. PELLI.SEC. B/20 ", "Img": "https://pharmnet-dz.com//img/medics/2209.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2209", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " PIPOTIAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PIPORTIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 16 D 060 /96", "Code DCI": "16D060", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIRAMYL 1MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3649.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIRAMYL", "Tarif de reference": "250.8 DA", "PPA": "N/A", "Num Enregistrement": "352/ 14 A 187 /08", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIRAMYL 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3662.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIRAMYL", "Tarif de reference": "480 DA", "PPA": "N/A", "Num Enregistrement": "352/ 14 A 188 /08", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIRAMYL 3MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3673.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIRAMYL", "Tarif de reference": "720 DA", "PPA": "N/A", "Num Enregistrement": "352/ 14 A 189 /08", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIRAMYL 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3686.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIRAMYL", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "352/ 14 A 190 /08", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXAL 20MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medics/2778.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXAL", "Tarif de reference": "140 DA", "PPA": " DA", "Num Enregistrement": "231/ 04 B 023 /00", "Code DCI": "04B023", "Forme": "SUPPO.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXEN 20MG COMP. DISPERS. B/12", "Img": "https://pharmnet-dz.com//img/medics/2769.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2769", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXEN", "Tarif de reference": "171.6 DA", "PPA": " DA", "Num Enregistrement": "317/ 04 B 022 /10", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXEN 20MG/ML SOL. INJ. IM B/02 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/2783.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2783", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXEN", "Tarif de reference": "127.6 DA", "PPA": " DA", "Num Enregistrement": "317/ 04 B 024 /12 ", "Code DCI": "04B024", "Forme": "SOL. INJ.", "Dosage": "20MG/ML", "Conditionnement": "B/02 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXENE 0.005 GEL DERM. T./40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXENE", "Tarif de reference": "116 DA", "PPA": "N/A", "Num Enregistrement": "366/ 21 A 005 /08", "Code DCI": "21A005", "Forme": "GEL DERM.", "Dosage": "0.005", "Conditionnement": "T./40G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXICAM LPA 0.005 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXICAM LPA", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "026/ 21 A 005 /09", "Code DCI": "21A005", "Forme": "GEL DERM.", "Dosage": "0.005", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXICAM NOVAGENERICS 0.005 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medics/1380.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXICAM NOVAGENERICS", "Tarif de reference": "145 DA", "PPA": " DA", "Num Enregistrement": "149/ 21 A 005 /12", "Code DCI": "21A005", "Forme": "GEL DERM.", "Dosage": "0.005", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXICAM NOVAGENERICS 20MG  GLES. PILULIER/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXICAM NOVAGENERICS", "Tarif de reference": "214.5 DA", "PPA": "N/A", "Num Enregistrement": "149/ 04 B 022 /14", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG ", "Conditionnement": "PILULIER/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXICAM PHYSIOPHARM 20MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medics/2771.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXICAM PHYSIOPHARM", "Tarif de reference": "143 DA", "PPA": "N/A", "Num Enregistrement": "462/ 04 B 022 /13", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIROXICAM SANDOZ 20MG COMP. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2776", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PIROXICAM SANDOZ", "Tarif de reference": "143 DA", "PPA": "N/A", "Num Enregistrement": "050/ 04 B 022 /08", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PIRUCIN 2MG/ML (10MG/5ML - 50MG/25ML ET 200MG/100ML) SOL. P. PERF. IV B/01FL. DE 5ML - B/01FL. DE 25ML ET B/01FL. DE 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " EPIRUBICINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PIRUCIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 05 G 103 /13", "Code DCI": "05G103", "Forme": "SOL. PERF.", "Dosage": "2MG/ML (10MG/5ML - 50MG/25ML ET 200MG/100ML)", "Conditionnement": "B/01FL. DE 5ML - B/01FL. DE 25ML ET B/01FL. DE 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PIZOFEN 0,50MG (PIZOTIFENE MALEATE 0,73MG) COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " PIZOTIFENE (SOUS FORME DE MALATE)", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "PIZOFEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "043/ 15 B 022 /98", "Code DCI": "15B022", "Forme": "COMP. PELLI.", "Dosage": "0,50MG (PIZOTIFENE MALEATE 0,73MG)", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "PKU ANAMIX INFANT  PDRE. P. NOURRISSON AGE DE 0 A 1AN B/400G", "Img": "https://pharmnet-dz.com//img/medics/3471.png", "Laboratoire": " NUTRICIA NUTRITION CLINIQUE", "C.Pharmacologique": " LAITS & FARINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LAIT SANS PHENYLALANINE", "Pays": "FRANCE", "Nom Commercial": "PKU ANAMIX INFANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "288/ 14 L 130 /12", "Code DCI": "14L130", "Forme": "PDRE.", "Dosage": "400MG", "Conditionnement": "B/400G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PLAGREL 75MG COMP. ENRO. B/28", "Img": "https://pharmnet-dz.com//img/medics/1512.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PLAGREL", "Tarif de reference": "1680 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 J 159 /10", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "PLANADIX ADVANCE 325MG / 37,5MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PLANADIX ADVANCE", "Tarif de reference": "193.6 DA", "PPA": "N/A", "Num Enregistrement": "468/ 03 F 115 /14", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PLANADIX CONFORT + 500MG/30MG COMP B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CODEINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PLANADIX CONFORT +", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "468/03B028/16", "Code DCI": "03B028", "Forme": "COMP.", "Dosage": "500MG/30MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "PLANADIX EXTRA 500MG/65MG COMP. SEC. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2644", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / CAFEINE", "Pays": "ALGERIE", "Nom Commercial": "PLANADIX EXTRA", "Tarif de reference": "0 DA", "PPA": "161.00 DA", "Num Enregistrement": "468/ 03 B 088 /12", "Code DCI": "03B088", "Forme": "COMP. SEC.", "Dosage": "500MG/65MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "PLANADIX LIQUIZ 300MG/STICK SUS BUV EN STICK UNIDOSE B/15 STICK DE 7,5 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PLANADIX LIQUIZ", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "03B066", "Forme": "SUSP. BUV.", "Dosage": "300MG/STICK", "Conditionnement": "B/15 STICK DE 7,5 ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PLANADIX RHUME  500MG/30MG COMP B/16 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PLANADIX RHUME ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "468/03B057/16", "Code DCI": "03B057", "Forme": "COMP.", "Dosage": "500MG/30MG", "Conditionnement": "B/16 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "PLAQUENIL 200MG COMP.ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1414", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " HYDROXYCHLOROQUINE", "Pays": "FRANCE", "Nom Commercial": "PLAQUENIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 21 D 020 /98", "Code DCI": "21D020", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PLASMION 3% 3G / 0,5382G / 0,0305G / 0,0373G / 0,3360G / 100ML SOL. INJ. POUR PERF.IV POCHE DE 500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1835", "Laboratoire": " FRESENIUS KABI", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " GELATINE FLUIDE  MODIFIEE EXPRIMEE EN GELATINE ANHYDRE / CHLORURE DE SODIUM / CHLORURE DE MAGNESIUM HEXAHYDRATE / CHLORURE DE POTASSIUM / LACTATE DE SODIUM EN SOLUTION ", "Pays": "FRANCE", "Nom Commercial": "PLASMION 3%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "332/ 12 J 047 /08", "Code DCI": "12J047", "Forme": "SOL. INJ.", "Dosage": "3G / 0,5382G / 0,0305G / 0,0373G / 0,3360G / 100ML", "Conditionnement": "POCHE DE 500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PLAVIX 75MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1513.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1513", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PLAVIX", "Tarif de reference": "0 DA", "PPA": "1680.00 DA", "Num Enregistrement": "392/ 06 J 159 /02/10", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "PMS-BOSENTAN 125MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMASCIENCE INC", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN", "Liste": "Liste I", "Pays": "CANADA", "Nom Commercial": "PMS-BOSENTAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "495/ 06 N 306 /15", "Code DCI": "06N306", "Forme": "COMP. PELLI.", "Dosage": "125MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "PMS-BOSENTAN 62,5MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMASCIENCE INC", "C.Pharmacologique": " CARDIOLOGIE ET ANGEIOLOGIE", "C.Therapeutique": " BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN", "Liste": "Liste I", "Pays": "CANADA", "Nom Commercial": "PMS-BOSENTAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "495/ 06 N 305 /15", "Code DCI": "06N305", "Forme": "COMP. PELLI.", "Dosage": "62,5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "POLARAMINE 5MG/ML SOL.INJ. B/05 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DEXCHLORPHENIRAMINE MALEATE", "Pays": "FRANCE", "Nom Commercial": "POLARAMINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 01 A 004 /97", "Code DCI": "01A004", "Forme": "SOL. INJ.", "Dosage": "5MG/ML", "Conditionnement": "B/05 AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "POLERY ADULTE 11,8MG/443MG/15ML SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CODEINE/EXTRAIT FLUIDE D'ERYSIUM", "Pays": "ALGERIE", "Nom Commercial": "POLERY ADULTE", "Tarif de reference": "202 DA", "PPA": "N/A", "Num Enregistrement": "235/ 20 B 203 /04", "Code DCI": "20B203", "Forme": "SIROP", "Dosage": "11,8MG/443MG/15ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "POLERY ENFANTS 1MG/29,6MG SIROP FL./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PHOLCODINE/EXTRAIT FLUIDE D'ERYSIMUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "POLERY ENFANTS", "Tarif de reference": "137.5 DA", "PPA": "N/A", "Num Enregistrement": "235/ 20 C 202 /05", "Code DCI": "20C202", "Forme": "SIROP", "Dosage": "1MG/29,6MG", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "POLIPIROX 20MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "POLIPIROX", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "026/ 04 B 023 /01", "Code DCI": "04B023", "Forme": "SUPPO.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "POLYDEXA 650.000UI/1000.000UI/0,100G/100ML SOL AURIC . GTTES FL/10,5ML", "Img": "https://pharmnet-dz.com//img/medics/2023.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2023", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTI-INFECTIEUX AVEC CORTICOIDES", "C.Therapeutique": " OTOLOGIE", "Info": " NEOMYCINE SULFATE/POLYMYXINE B SULFATE/ DEXAMETHASONE METASULFOBENZOATE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "POLYDEXA", "Tarif de reference": "0 DA", "PPA": "168.00 DA", "Num Enregistrement": "269/ 18 B 022 /03/15", "Code DCI": "18B022", "Forme": "SOL. AURIC. GTTES.", "Dosage": "650.000UI/1000.000UI/0,100G/100ML", "Conditionnement": "FL/10,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "POLYGYNAX 35 000UI/35 000UI/100 000UI CAPS. VAGI. MOLLES B/6 ET  B/12", "Img": "https://pharmnet-dz.com//img/medics/3006.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3006", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " NEOMYCINE/POLIMYXINE B/NYSTATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "POLYGYNAX", "Tarif de reference": "0 DA", "PPA": "671.00 DA", "Num Enregistrement": "087/ 11 A 003 /98", "Code DCI": "11A003", "Forme": "CAPS. MOLLE", "Dosage": "35 000UI/35 000UI/100 000UI", "Conditionnement": "B/6 ET  B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "POLYPHENE 20MG/ML SUSP. BUV. FL/100ML +PIPETTE GRADU\u00e9E EN KG  ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES", "C.Therapeutique": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "POLYPHENE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "503/04B042/16", "Code DCI": "04B042", "Forme": "SUSP. BUV.", "Dosage": "20MG/ML", "Conditionnement": "FL/100ML +PIPETTE GRADU\u00e9E EN KG  ", "Commercialisation": true, "Remboursable": null}, {"Nom": "POLYSILANE DELALANDE 250MG/500MG COMP. A CROQ. OU A SUCER B/32", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3897", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " SIMETICONE / OXYDE D'ALUMINIUM HYDRATE", "Pays": "FRANCE", "Nom Commercial": "POLYSILANE DELALANDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 10 B 012 /97", "Code DCI": "10B012", "Forme": "COMP. A CROQ.", "Dosage": "250MG/500MG", "Conditionnement": "B/32", "Commercialisation": true, "Remboursable": true}, {"Nom": "POLYSILANE NOUR JOULLIE 50MG/250MG GRLES. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIMETICONE ACTIVEE/GOMME DE CAROUBE", "Pays": "FRANCE", "Nom Commercial": "POLYSILANE NOUR JOULLIE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "255/ 10 B 103 /97", "Code DCI": "10B103", "Forme": "GRLES.", "Dosage": "50MG/250MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "PONCTUEL 0,75G/100ML SOL. BUV. B/1FL. COMPT.-GTTES. DE 30ML", "Img": "https://pharmnet-dz.com//img/medics/2953.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2953", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PICOSULFATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "PONCTUEL", "Tarif de reference": "198.39 DA", "PPA": "N/A", "Num Enregistrement": "318/ 10 L 191 /09", "Code DCI": "10L191", "Forme": "SOL. BUV.", "Dosage": "0,75G/100ML", "Conditionnement": "B/1FL. COMPT.-GTTES. DE 30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "POROSIMAX 70MG COMP. B/04", "Img": "https://pharmnet-dz.com//img/medics/1434.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1434", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "POROSIMAX", "Tarif de reference": "1760 DA", "PPA": "N/A", "Num Enregistrement": "289/ 21 G 050 /07/14", "Code DCI": "21G050", "Forme": "COMP.", "Dosage": "70MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "POROSIMAX PLUS 70MG/5600UI COMP. B/04", "Img": "https://pharmnet-dz.com//img/medics/1440.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE ALENDRONIQUE MONOSODIQUE TRIHYDRATE EXPRIME EN ACIDE ALENDRONIQUE / COLECALCIFEROL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "POROSIMAX PLUS", "Tarif de reference": " N/A", "PPA": "1760.00 DA", "Num Enregistrement": "289/ 21 G 066 /15", "Code DCI": "21G066", "Forme": "COMP.", "Dosage": "70MG/5600UI", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "POSIDAN 20MG/ML (OU 100MG/5ML) SOL. INJ. B/10FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " ETOPOSIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "POSIDAN", "Tarif de reference": " N/A", "PPA": "1760.00 DA", "Num Enregistrement": "352/ 05 G 019 /09", "Code DCI": "05G019", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (OU 100MG/5ML)", "Conditionnement": "B/10FL. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "POSTUITRIN 5UI/ML SOL.INJ.EN AMP B/3AMP. DE 1ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " LABORATOIRE ULAGAY,ILAC SANAYI TURK", "C.Pharmacologique": " OCYTOCIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " OXYTOCINE", "Liste": "Liste II", "Pays": "TURQUIE", "Nom Commercial": "POSTUITRIN", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "11E019", "Forme": "SOL. INJ.", "Dosage": "5UI/ML", "Conditionnement": "B/3AMP. DE 1ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "POTASSIUM GLUCONATE 0.05 SOL.INJ. B/100AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " POTASSIUM GLUCONATE", "Pays": "FRANCE", "Nom Commercial": "POTASSIUM GLUCONATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 060 /98", "Code DCI": "14G060", "Forme": "SOL. INJ.", "Dosage": "0.05", "Conditionnement": "B/100AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "POTONEX 40MG COMP. A ENRO. GASTRORESIST. B/14 ET B/28", "Img": "https://pharmnet-dz.com//img/medics/3876.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3876", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PANTOPRAZOLE", "Liste": "Liste II", "Pays": "TURQUIE", "Nom Commercial": "POTONEX", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "177/ 10 A 134 /08", "Code DCI": "10A134", "Forme": "COMP. ENRO.", "Dosage": "40MG", "Conditionnement": "B/14 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "POVIP 0.1 SOL.DERM. FL/50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "POVIP", "Tarif de reference": "50 DA", "PPA": "N/A", "Num Enregistrement": "003/ 07 P 077 /00", "Code DCI": "07P077", "Forme": "SOL. DERM.", "Dosage": "0.1", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRADOL 325MG / 37,5MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRADOL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "235/03F115/16", "Code DCI": "03F115", "Forme": "COMP. PELLI.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PRANOK 50MG/02ML SOL. INJ. B/100 AMP. 02ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GLOBAL PHARMATECH PRIVATE LIMITED", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " PROMETHAZINE CHLORHYDRATE EXPRIME EN PROMETHAZINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "PRANOK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "487/ 01 A 011 /06/14", "Code DCI": "01A011", "Forme": "SOL. INJ.", "Dosage": "50MG/02ML", "Conditionnement": "B/100 AMP. 02ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PRASIVAST 10MG COMP. PILULIER DE 30", "Img": "https://pharmnet-dz.com//img/medics/1624.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PRAVASTATINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRASIVAST", "Tarif de reference": "630 DA", "PPA": "620.00 DA", "Num Enregistrement": "352/ 06 M 295 /12", "Code DCI": "06M295", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "PILULIER DE 30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRASIVAST 20MG COMP. PILULIER DE 30", "Img": "https://pharmnet-dz.com//img/medics/1539.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PRAVASTATINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRASIVAST", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 134 /12", "Code DCI": "06M134", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "PILULIER DE 30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRASIVAST 40MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1623.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PRAVASTATINE SODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRASIVAST", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 294 /12", "Code DCI": "06M294", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRAVASOR 75MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CLOPIDOGREL BISULFATE EXPRIME EN CLOPIDOGREL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRAVASOR", "Tarif de reference": "1800 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 J 159 /09", "Code DCI": "06J159", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRAXILENE 100MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/1492.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1492", "Laboratoire": " MERCK LIPHA SANTE ", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NAFTIDROFURYL ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PRAXILENE", "Tarif de reference": "0 DA", "PPA": "281.00 DA", "Num Enregistrement": "062/ 06 J 100 /97", "Code DCI": "06J100", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRAXILENE 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/1494.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1494", "Laboratoire": " MERCK SANTE S.A.S", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NAFTIDROFURYL HYDROGENO-OXALATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PRAXILENE", "Tarif de reference": "506.67 DA", "PPA": "N/A", "Num Enregistrement": "062/ 06 J 101 /97/10", "Code DCI": "06J101", "Forme": "COMP. PELLI. LP", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRAZEPAM GS 10MG COMP. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " PRAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRAZEPAM GS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/16B078/17", "Code DCI": "16B078", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRAZEPAM GS 15MG/ML SOL .BUV .GTTES. + PIPETTE GRADUEE FL/20ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " PRAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRAZEPAM GS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "242/16B080/16", "Code DCI": "16B080", "Forme": "SOL. BUV. GTTES.", "Dosage": "15MG/ML", "Conditionnement": "FL/20ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "PRECORTYL 10MG COMP. SEC. B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRECORTYL", "Tarif de reference": "126 DA", "PPA": "N/A", "Num Enregistrement": "003/ 09 H 161 /08", "Code DCI": "09H161", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRECORTYL 20MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRECORTYL", "Tarif de reference": "252 DA", "PPA": "N/A", "Num Enregistrement": "003/ 09 H 162 /08", "Code DCI": "09H162", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRECORTYL 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3750.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3750", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRECORTYL", "Tarif de reference": "150 DA", "PPA": "150 DA", "Num Enregistrement": "003/ 09 H 038 /97", "Code DCI": "09H038", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNAL 20MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3774.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREDNAL", "Tarif de reference": "392 DA", "PPA": " DA", "Num Enregistrement": "039/ 09 H 144 /13", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNAMEX 20MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREDNAMEX", "Tarif de reference": "392.00 DA", "PPA": "N/A", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNAMEX 5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREDNAMEX", "Tarif de reference": "257,40 DA", "PPA": "N/A", "Code DCI": "09H143", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNICORT 20MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREDNICORT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "468/ 09 H 144 /15", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PREDNICORT 5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREDNICORT", "Tarif de reference": " N/A", "PPA": "257.00 DA", "Num Enregistrement": "468/ 09 H 143 /15", "Code DCI": "09H143", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "PREDNISOLONE MM ORO 20MG COMP ORO DISPER B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREDNISOLONE MM ORO", "Tarif de reference": "392 DA", "PPA": "392.00 DA", "Num Enregistrement": "470/ 09 H 144 /14", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNISOLONE MM ORO 5MG COMP ORODISPERSIBLE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREDNISOLONE MM ORO", "Tarif de reference": "257.4 DA", "PPA": "N/A", "Num Enregistrement": "470/09H143/16", "Code DCI": "09H143", "Forme": "COMP. DISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNOL - L 20MG PDRE.SOL.INJ.  B/1+1 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "PREDNOL - L", "Tarif de reference": "116.82 DA", "PPA": "N/A", "Num Enregistrement": "176/ 09 H 029 /98", "Code DCI": "09H029", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG", "Conditionnement": "B/1+1 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNOL - L 40MG PDRE.SOL.INJ.  B/01+01 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "PREDNOL - L", "Tarif de reference": "129 DA", "PPA": "N/A", "Num Enregistrement": "176/ 09 H 030 /98", "Code DCI": "09H030", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG", "Conditionnement": "B/01+01 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNOL 16MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3762.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "PREDNOL", "Tarif de reference": "283.4 DA", "PPA": " DA", "Num Enregistrement": "176/ 09 H 092 /07", "Code DCI": "09H092", "Forme": "COMP.", "Dosage": "16MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDNOL 4MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/673.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "PREDNOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "176/ 09 H 033 /98", "Code DCI": "09H033", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREDSOL 0.0025 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "PREDSOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 17 G 053 /99", "Code DCI": "17G053", "Forme": "COLLY.", "Dosage": "0.0025", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABA 150MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABA", "Tarif de reference": "2151 DA", "PPA": "2151.00 DA", "Num Enregistrement": "035/ 15 A 068 /14", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABA 25MG  GLES  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/ 15 A 065 /14", "Code DCI": "15A065", "Forme": "GLES.", "Dosage": "25MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABA 300MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABA", "Tarif de reference": "4260 DA", "PPA": "N/A", "Num Enregistrement": "035/ 15 A 069 /14", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABA 50MG  GLES  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABA", "Tarif de reference": "999.9 DA", "PPA": "2151.00 DA", "Num Enregistrement": "035/ 15 A 066 /14", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABALINE BEKER  75MG GLES B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABALINE BEKER ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "447/15A101/16", "Code DCI": "15A101", "Forme": "GLES.", "Dosage": "75MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "PREGABALINE BEKER 150MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2424.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2424", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABALINE BEKER", "Tarif de reference": "4302 DA", "PPA": "4302 DA", "Num Enregistrement": "447/ 15 A 068 /13", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABALINE BEKER 300MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2431.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2431", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABALINE BEKER", "Tarif de reference": "8520 DA", "PPA": "8520 DA", "Num Enregistrement": "447 / 15 A 069 /13", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABALINE BEKER 50MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2417.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2417", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABALINE BEKER", "Tarif de reference": "2000.00 DA", "PPA": "2000.00 DA", "Num Enregistrement": "447/ 15 A 066 /13", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABALINE LDM 150MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABALINE LDM", "Tarif de reference": "4302 DA", "PPA": "N/A", "Num Enregistrement": "309/ 15 A 068 /13", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABALINE LDM 300MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABALINE LDM", "Tarif de reference": "8520 DA", "PPA": "N/A", "Num Enregistrement": "309/ 15 A 069 /13", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGABALINE LDM 50MG GLES.  B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREGABALINE LDM", "Tarif de reference": "1999.8 DA", "PPA": "N/A", "Num Enregistrement": "309/ 15 A 066 /13", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREGNON 0,75MG (OU 750\u00b5G) COMP. B/2", "Img": "https://pharmnet-dz.com//img/medics/3054.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " FAMY CARE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " LEVONORGESTREL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "PREGNON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "291/ 11 H 064 /08", "Code DCI": "11H064", "Forme": "COMP.", "Dosage": "0,75MG (OU 750\u00b5G)", "Conditionnement": "B/2", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRELDENE 20MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medics/2772.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRELDENE", "Tarif de reference": "143 DA", "PPA": "N/A", "Num Enregistrement": "380/ 04 B 022 /12", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRELDENE 20MG/ML SOL. INJ. IM B/02 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRELDENE", "Tarif de reference": "127.6 DA", "PPA": "N/A", "Num Enregistrement": "380/ 04 B 024 /14", "Code DCI": "04B024", "Forme": "SOL. INJ.", "Dosage": "20MG/ML", "Conditionnement": "B/02 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRERICA 150MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2426.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRERICA", "Tarif de reference": "0 DA", "PPA": "4302.00 DA", "Num Enregistrement": "149/ 15 A 068 /15", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRERICA 50MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2419.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRERICA", "Tarif de reference": "0 DA", "PPA": "1866.00 DA", "Num Enregistrement": "149/ 15 A 066 /15", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRETERAX ARGININE 2,5MG/0,625MG COMP. PELLI. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/3222.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3222", "Laboratoire": " SERVIER", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PERINDOPRIL ARGININE / INDAPAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PRETERAX ARGININE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "040/ 06 E 300 /13", "Code DCI": "06E300", "Forme": "COMP. PELLI.", "Dosage": "2,5MG/0,625MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREXET 100 MG/ FLACON (20mg/ ml)           POUDRE LYOPHILIS\u00e9 POUR SOLUTION \u00e0 DILUER POUR PERFUSION IV    boite de 1 flacon de poudre de 5ml", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "PREXET", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "176/05G152/15", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "100 MG/ FLACON (20mg/ ml)          ", "Conditionnement": "   boite de 1 flacon de poudre de 5ml", "Commercialisation": true, "Remboursable": null}, {"Nom": "PREXET 500MG/FL. DE PDRE. PDRE. LYOPH. P. SOL. A DILUER P. PERF. IV. B/01 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " PEMETREXED DISODIQUE EXPRIME EN PEMETREXED", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "PREXET", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "176/ 05 G 102 /15", "Code DCI": "05G102", "Forme": "LYOPH. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/01 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "PREZIVA 10MG COMP. B/40", "Img": "https://pharmnet-dz.com//img/medics/2172.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2172", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " PRAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PREZIVA", "Tarif de reference": "0 DA", "PPA": "142.00 DA", "Num Enregistrement": "235/ 16 B 078 /10", "Code DCI": "16B078", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIAZIDE 50MG/25MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/188.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=188", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRIAZIDE", "Tarif de reference": "502.2 DA", "PPA": " DA", "Num Enregistrement": "231/ 06 E 137 /12", "Code DCI": "06E137", "Forme": "COMP. SEC.", "Dosage": "50MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRILENAP 20MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "PRILENAP", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "161/ 06 E 060 /98", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRILENAP 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HEMOFARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "YOUGOSLAVIE", "Nom Commercial": "PRILENAP", "Tarif de reference": "184 DA", "PPA": "N/A", "Num Enregistrement": "161/ 06 E 059 /98", "Code DCI": "06E059", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIMALAN 1,25MG/2,5ML SIROP FL/60ML", "Img": "https://pharmnet-dz.com//img/medics/3986.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3986", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " MEQUITAZINE", "Pays": "FRANCE", "Nom Commercial": "PRIMALAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "099/ 01 A 032 /07", "Code DCI": "01A032", "Forme": "SIROP", "Dosage": "1,25MG/2,5ML", "Conditionnement": "FL/60ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "PRIMALAN 10MG COMP. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medics/4034.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4034", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " MEQUITAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PRIMALAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "099/ 01 A 051 /13", "Code DCI": "01A051", "Forme": "COMP SEC.", "Dosage": "10MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": false}, {"Nom": "PRIMALAN 5MG COMP. B/14", "Img": "https://pharmnet-dz.com//img/medics/3984.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3984", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " MEQUITAZINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PRIMALAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "099/ 01 A 009 /98", "Code DCI": "01A009", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": false}, {"Nom": "PRIMAZOL 200MG/40MG/5ML SUSP. BUV. F./125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRIMAZOL", "Tarif de reference": "181.26 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 M 090 /07", "Code DCI": "13M090", "Forme": "SUSP. BUV.", "Dosage": "200MG/40MG/5ML", "Conditionnement": "F./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIMAZOL 400MG/80MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRIMAZOL", "Tarif de reference": " N/A", "PPA": "115.00 DA", "Num Enregistrement": "003/ 13 M 092 /97/09", "Code DCI": "13M092", "Forme": "COMP.", "Dosage": "400MG/80MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PRIMPERAN 0.001 SOL.BUV.  EDULCOREE A LA SACCHARINE SODIQUE B/1FL. DE 200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2865", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PRIMPERAN", "Tarif de reference": "136 DA", "PPA": "N/A", "Num Enregistrement": "428/ 10 F 044 /97/10", "Code DCI": "10F044", "Forme": "SOL. BUV.", "Dosage": "0.001", "Conditionnement": "B/1FL. DE 200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIMPERAN 10MG/2ML SOL.INJ B/12AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2859", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " METOCLOPRAMIDE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PRIMPERAN", "Tarif de reference": "0 DA", "PPA": "137.00 DA", "Num Enregistrement": "255/ 10 F 042 /97", "Code DCI": "10F042", "Forme": "SOL. INJ.", "Dosage": "10MG/2ML", "Conditionnement": "B/12AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIVIGEN 100MG/ML  SOL P/ PERF IV  FL/25ML (2,5G)+FL/50ML (5G) ET FL/100ML (10G)", "Img": "https://pharmnet-dz.com//img/medics/3597.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3597", "Laboratoire": " CSL BEHRING AG", "C.Pharmacologique": " SERUMS & GAMMA GLOBULINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " IMMUNOGLOBULINE HUMAINE NORMALE 1G IV", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "PRIVIGEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "485/ 13 V 451 /14", "Code DCI": "13V451", "Forme": "SOL. INJ.", "Dosage": "100MG/ML ", "Conditionnement": "FL/25ML (2,5G)+FL/50ML (5G) ET FL/100ML (10G)", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIXAM 0.005 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medics/1381.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRIXAM", "Tarif de reference": "145 DA", "PPA": "120.00 DA", "Num Enregistrement": "003/ 21 A 005 /09", "Code DCI": "21A005", "Forme": "GEL DERM.", "Dosage": "0.005", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIXAM 20MG COMP. DISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRIXAM", "Tarif de reference": "143 DA", "PPA": "127.00 DA", "Num Enregistrement": "003/ 04 B 022 /06", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIXAM 20MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRIXAM", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "003/ 04 B 023 /99", "Code DCI": "04B023", "Forme": "SUPPO.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRIXAM 20MG/ML SOL. INJ. IM B/02 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/2785.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRIXAM", "Tarif de reference": "127.6 DA", "PPA": "127.6 DA", "Num Enregistrement": "003/ 04 B 024 /07", "Code DCI": "04B024", "Forme": "SOL. INJ.", "Dosage": "20MG/ML", "Conditionnement": "B/02 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROCAINE 0.01 SOL .INJ. B/100 AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PROCAINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PROCAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 02 C 032 /98", "Code DCI": "02C032", "Forme": "SOL. INJ.", "Dosage": "0.01", "Conditionnement": "B/100 AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROCAINE 0.02 SOL .INJ. B/100AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PROCAINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PROCAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 02 C 033 /98", "Code DCI": "02C033", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/100AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROCLO JAM 0.0005 PDE. DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/525.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=525", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " CLOBETASOL PROPIONATE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "PROCLO JAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "386/ 07 H 176 /12 ", "Code DCI": "07H176", "Forme": "PDE. DERM.", "Dosage": "0.0005", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": false}, {"Nom": "PROCORALAN 5MG COMP. PELLI. B/56", "Img": "https://pharmnet-dz.com//img/medics/122.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SERVIER", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IVABRADINE CHLORHYDRATE EXPRIME EN IVABRADINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PROCORALAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "040/ 06 C 280 /09", "Code DCI": "06C280", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROCORALAN 7,5MG COMP. PELLI. B/56", "Img": "https://pharmnet-dz.com//img/medics/123.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SERVIER", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IVABRADINE CHLORHYDRATE EXPRIME EN IVABRADINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PROCORALAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "040/ 06 C 282 /09", "Code DCI": "06C282", "Forme": "COMP. PELLI.", "Dosage": "7,5MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROCTOLON 120MG/10MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2988.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2988", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE / RUSCOGENINES", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROCTOLON", "Tarif de reference": "0 DA", "PPA": "200.00 DA", "Num Enregistrement": "231/ 10 P 084 /01", "Code DCI": "10P084", "Forme": "SUPPO.", "Dosage": "120MG/10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRODOL 10MG  COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRODOL", "Tarif de reference": "585 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 F 162 /13", "Code DCI": "06F162", "Forme": "COMP. PELLI.", "Dosage": "10MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRODOL 5MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BISOPROLOL FUMARATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PRODOL", "Tarif de reference": "290.1 DA", "PPA": "298.00 DA", "Num Enregistrement": "035/ 06 F 267 /13", "Code DCI": "06F267", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROF 20MG/ML (100MG/5ML) SUSP. BUV. FL./100ML + BOUCHON DOSEUR", "Img": "https://pharmnet-dz.com//img/medics/914.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=914", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROF", "Tarif de reference": "98 DA", "PPA": "114.00 DA", "Num Enregistrement": "352/ 04 B 042 /07", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./100ML + BOUCHON DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROF 400MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2731.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2731", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROF", "Tarif de reference": "240 DA", "PPA": "N/A", "Num Enregistrement": "352/ 04 B 010 /06", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROFEN LP 200MG GLES. A MICROGRLES. LP B/20", "Img": "https://pharmnet-dz.com//img/medics/2799.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROFEN LP", "Tarif de reference": " N/A", "PPA": "345.00 DA", "Num Enregistrement": "035/ 04 B 032 /98/07", "Code DCI": "04B032", "Forme": "COMP. ENRO. LP", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROFENID 100MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2807.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2807", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Pays": "ALGERIE", "Nom Commercial": "PROFENID", "Tarif de reference": "244.2 DA", "PPA": "N/A", "Num Enregistrement": "392/ 04 B 034 /99/11", "Code DCI": "04B034", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROFENID 100MG SUPPO. B/12", "Img": "https://pharmnet-dz.com//img/medics/2748.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2748", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROFENID", "Tarif de reference": "166.08 DA", "PPA": "N/A", "Num Enregistrement": "392/ 04 B 017 /96/10", "Code DCI": "04B017", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROFENID 50MG/ML (100MG/2ML) SOL.INJ.IM B/06 AMP. DE 2ML ", "Img": "https://pharmnet-dz.com//img/medics/2753.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2753", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PROFENID", "Tarif de reference": "282.72 DA", "PPA": "N/A", "Num Enregistrement": "376/ 04 B 018 /96/09", "Code DCI": "04B018", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (100MG/2ML)", "Conditionnement": "B/06 AMP. DE 2ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROFENID ENFANT ET NOURRISON 1MG/ML SIROP B/01FL. DE 150ML + 01 SERING. P. ADMINIST. ORAL. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROFENID ENFANT ET NOURRISON", "Tarif de reference": "147 DA", "PPA": "N/A", "Num Enregistrement": "392/ 04 B 068 /13", "Code DCI": "04B068", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "B/01FL. DE 150ML + 01 SERING. P. ADMINIST. ORAL. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROFENID LP 200MG  COMP. ENRO. LP B/14", "Img": "https://pharmnet-dz.com//img/medics/2800.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2800", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROFENID LP", "Tarif de reference": "227.92 DA", "PPA": "N/A", "Num Enregistrement": "392/ 04 B 032 /99/12", "Code DCI": "04B032", "Forme": "COMP. ENRO. LP", "Dosage": "200MG ", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROFLOX 250MG COMP. ENRO. B/10", "Img": "https://pharmnet-dz.com//img/medics/376.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROFLOX", "Tarif de reference": "453.4 DA", "PPA": "N/A", "Num Enregistrement": "035/ 13 K 252 /06", "Code DCI": "13K252", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROFLOX 500MG COMP. ENRO. B/10", "Img": "https://pharmnet-dz.com//img/medics/386.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROFLOX", "Tarif de reference": "804 DA", "PPA": "N/A", "Num Enregistrement": "035/ 13 K 253 /06", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROGESTERONE MYLAN 100MG CAPS. MOLLE OU CAPS. MOLLE VAG. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3821", "Laboratoire": " MYLAN", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PROGESTERONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PROGESTERONE MYLAN", "Tarif de reference": "0 DA", "PPA": "460.00 DA", "Num Enregistrement": "450/ 09 N 109 /09", "Code DCI": "09N109", "Forme": "CAPS. MOLLE", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROGESTERONE RETARD PHARLON 500MG/2/ML SOL.INJ. IM B/3AMP. ", "Img": "https://pharmnet-dz.com//img/medics/3817.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3817", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROXYPROGESTERONE CAPROATE ", "Pays": "FRANCE", "Nom Commercial": "PROGESTERONE RETARD PHARLON", "Tarif de reference": "772.08 DA", "PPA": " DA", "Num Enregistrement": "070/ 09 N 062 /98", "Code DCI": "09N062", "Forme": "SOL. INJ.", "Dosage": "500MG/2/ML", "Conditionnement": "B/3AMP. ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROGESTOGEL 1G% GEL pour applicat cutan\u00e9e                    T/80G", "Img": "https://pharmnet-dz.com//img/medics/3819.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3819", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PROGESTERONE", "Pays": "FRANCE", "Nom Commercial": "PROGESTOGEL", "Tarif de reference": "326.74 DA", "PPA": "N/A", "Num Enregistrement": "169/ 09 N 067 /99", "Code DCI": "09N067", "Forme": "GEL. APP. LOCALE", "Dosage": "1G%", "Conditionnement": "T/80G", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROGEVA 100MG CAPS.MOLLE ORA. OU VAGI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Pharmacologique": " ENDOCRINOLOGIE ET HORMONES", "C.Therapeutique": " PROGESTERONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PROGEVA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "515/09N109/16", "Code DCI": "09N109", "Forme": "CAPS. MOLLE", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROGEVA 200MG CAPS.MOLLE ORA. OU VAGI. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Pharmacologique": " ENDOCRINOLOGIE ET HORMONES", "C.Therapeutique": " PROGESTERONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PROGEVA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "515/09N155/16", "Code DCI": "09N155", "Forme": "CAPS. MOLLE", "Dosage": "200MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROGRAF 0,5MG GLES. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PROGRAF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 05 B 101 /08", "Code DCI": "05B101", "Forme": "GLES.", "Dosage": "0,5MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROGRAF 1MG GLES. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PROGRAF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 05 B 092 /01/09", "Code DCI": "05B092", "Forme": "GLES.", "Dosage": "1MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROGRAF 5MG GLES. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PROGRAF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 05 B 093 /01/09", "Code DCI": "05B093", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROGYNOVA 2 2MG COMP.ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/625.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=625", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " ESTRADIOL (VALERATE) ", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PROGYNOVA 2", "Tarif de reference": "0 DA", "PPA": "345.00 DA", "Num Enregistrement": "070/ 09 G 014 /97", "Code DCI": "09G014", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROLIA 60MG/ML SOL. INJ. SC EN SERINGUE PREREMPLIE B/01 SERINGUE PREREMPLIE SECURISEE DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/1439.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1439", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DENOSUMAB", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "PROLIA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 21 G 065 /15", "Code DCI": "21G065", "Forme": "SOL. INJ.", "Dosage": "60MG/ML", "Conditionnement": "B/01 SERINGUE PREREMPLIE SECURISEE DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROLINATE 25MG/ML SOL. INJ. B./05AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " FLUPHENAZINE DECANOATE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "PROLINATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "330/ 16 D 083 /07", "Code DCI": "16D083", "Forme": "SOL. INJ.", "Dosage": "25MG/ML", "Conditionnement": "B./05AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROMAZ 0.04 SOL. OR. EN GTTES. FL/30ML", "Img": "https://pharmnet-dz.com//img/medics/2201.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2201", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROMAZ", "Tarif de reference": "0 DA", "PPA": "200.00 DA", "Num Enregistrement": "242/ 16 D 055 /06", "Code DCI": "16D055", "Forme": "SUSP. BUV. GTTES.", "Dosage": "0.04", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROMAZ 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/2198.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2198", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CHLORPROMAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROMAZ", "Tarif de reference": "173.2 DA", "PPA": "N/A", "Num Enregistrement": "242/ 16 D 054 /03", "Code DCI": "16D054", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROPIOSOD 0.05 SOL.OPHT. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTISEPTIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PROPIONATE DE SODIUM", "Pays": "ITALIE", "Nom Commercial": "PROPIOSOD", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "012/ 17 E 041 /99", "Code DCI": "17E041", "Forme": "SOL. OPHT.", "Dosage": "0.05", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROPOFOL FRESENIUS 1% 1% (OU 10MG/ML) ( OU 200MG/20ML) EMULSION  INJ. IV ET POUR PERF.IV B/5AMP./20ML (200MG/20ML)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4056", "Laboratoire": " FRESENIUS KABI", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PROPOFOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PROPOFOL FRESENIUS 1%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "332/ 02 B 011 /08", "Code DCI": "02B011", "Forme": "SOL. INJ.", "Dosage": "1% (OU 10MG/ML) ( OU 200MG/20ML)", "Conditionnement": "B/5AMP./20ML (200MG/20ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROSTACARE 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HAYAT PHARMACEUTICAL INDUSTRIES Co LTD", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " FINASTERIDE", "Pays": "JORDANIE", "Nom Commercial": "PROSTACARE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "098/ 25 B 023 /98/08", "Code DCI": "25B023", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROSTALOZINE LP 0,4MG  GLES. A MICROGRANULES  LP            B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROSTALOZINE LP", "Tarif de reference": "1500 DA", "PPA": "N/A", "Num Enregistrement": "320/ 25 B 047 /10", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROSTAM LP 0,4MG  MICROGRLES. LP EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROSTAM LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 25 B 047 /11", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROSTAMED 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1160.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1160", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " FINASTERIDE", "Pays": "ALGERIE", "Nom Commercial": "PROSTAMED", "Tarif de reference": "1628.11 DA", "PPA": "N/A", "Num Enregistrement": "426/ 25 B 023 /09", "Code DCI": "25B023", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROSTASIR LP 0,4MG  MICROGRLES. LP EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1173.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1173", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROSTASIR LP", "Tarif de reference": "1500 DA", "PPA": "1399.00 DA", "Num Enregistrement": "289/ 25 B 047 /12", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROSTAX LP 10MG COMP. LP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1181.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1181", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " ALFUZOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROSTAX LP", "Tarif de reference": "616.39 DA", "PPA": "N/A", "Num Enregistrement": "352/ 25 B 057 /10", "Code DCI": "25B057", "Forme": "COMP. LP", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROTOGYN 500MG COMP. B/4", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " HAYAT PHARMACEUTICAL INDUSTRIES Co LTD", "C.Pharmacologique": " AUTRES ANTI-PARASITAIRES", "C.Therapeutique": " PARASITOLOGIE", "Info": " TINIDAZOLE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "PROTOGYN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "098/ 19 D 026 /98", "Code DCI": "19D026", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/4", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROTON 10MG GLES A  MICROG. GASTRORESIST. FL./28", "Img": "https://pharmnet-dz.com//img/medics/3873.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3873", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROTON", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "035/ 10 A 113 /07", "Code DCI": "10A113", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "10MG", "Conditionnement": "FL./28", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROTON 20MG GLES. A MICROG. GASTRORESIST. B/07-  B/14 - B/28", "Img": "https://pharmnet-dz.com//img/medics/3848.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3848", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROTON", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "035/ 10 A 001 /97/08", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/07-  B/14 - B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROTOS 2G/SACHET GRLES. SUSP. BUV. EN SACHET-DOSE B/07 ET B/28 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/1429.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1429", "Laboratoire": " SERVIER", "C.Pharmacologique": " OSTEOPOROSES", "C.Therapeutique": " RHUMATOLOGIE", "Info": " RANELATE DE STRONTIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PROTOS", "Tarif de reference": "4174.32 DA", "PPA": " DA", "Num Enregistrement": "040/ 21 G 049 /07", "Code DCI": "21G049", "Forme": "GRLES. SOL. BUV.", "Dosage": "2G/SACHET", "Conditionnement": "B/07 ET B/28 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROTOXYDE D'AZOTE  BOUTEILLE BOUTEILLE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ENGI", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PROTOXYDE D'AZOTE", "Pays": "ALGERIE", "Nom Commercial": "PROTOXYDE D'AZOTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "054/ 02 B 015 /97", "Code DCI": "02B015", "Forme": "BOUTEILLE", "Conditionnement": "BOUTEILLE", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROVIRON 25MG COMP.SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/1212.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1212", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " MEDICAMENTS DE L'HYPOGONADISME MASCULIN", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " MESTEROLONE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "PROVIRON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "070/ 25 H 021 /97", "Code DCI": "25H021", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "PROVIVE 1% (OU 10MG/ML) EMULSION IV PERF. FL./20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PROPOFOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PROVIVE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 02 B 011 /07", "Code DCI": "02B011", "Forme": "SOL. INJ.", "Dosage": "1% (OU 10MG/ML)", "Conditionnement": "FL./20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROXIDOL  275MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HAYAT PHARMACEUTICAL INDUSTRIES Co LTD", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "PROXIDOL ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "098/ 04 B 019 /98/08", "Code DCI": "04B019", "Forme": "COMP. PELLI.", "Dosage": "275MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROXIDOL DS 550MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HAYAT PHARMACEUTICAL INDUSTRIES Co LTD", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " NAPROXENE SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "PROXIDOL DS", "Tarif de reference": " N/A", "PPA": "256.00 DA", "Num Enregistrement": "098/ 04 B 020 /98/08", "Code DCI": "04B020", "Forme": "COMP. PELLI.", "Dosage": "550MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "PROXIUM 20MG  MICROGRANULES GASTRORESIST. EN GLES  FL/14", "Img": "https://pharmnet-dz.com//img/medics/3885.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE MAGNESIUM TRIHYDRATE EXPRIME EN ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROXIUM", "Tarif de reference": "196 DA", "PPA": "400.00 DA", "Num Enregistrement": "149/ 10 A 180 /14", "Code DCI": "10A180", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG ", "Conditionnement": "FL/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROXIUM 40MG MICROGLES. GASTRORESIST. EN GLES. B/14 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROXIUM", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10A181", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "40MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROXIUM 40MG MICROGLES. GASTRORESIST. EN GLES. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ESOMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROXIUM", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10A181", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "40MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "PROZOL 20MG GLES. MICROG. GASTRO.RESIST. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "PROZOL", "Tarif de reference": "196 DA", "PPA": "168.00 DA", "Num Enregistrement": "003/ 10 A 001 /07", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "PRURAX 0.1 CREME DERM. T/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIPRURIGINEUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CROTAMITON", "Pays": "ALGERIE", "Nom Commercial": "PRURAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 07 G 036 /10", "Code DCI": "07G036", "Forme": "CR\u00c8ME", "Dosage": "0.1", "Conditionnement": "T/40G", "Commercialisation": true, "Remboursable": null}, {"Nom": "PSYCHOLANZ ODT 10MG COMP. ORODISPERS. B/30 ET B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PSYCHOLANZ ODT", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "286/ 16 D 101 /14", "Code DCI": "16D101", "Forme": "COMP. ORODISPERS.", "Dosage": "10MG", "Conditionnement": "B/30 ET B/07", "Commercialisation": true, "Remboursable": true}, {"Nom": "PSYCHOLANZ ODT 5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PSYCHOLANZ ODT", "Tarif de reference": "3510 DA", "PPA": "N/A", "Num Enregistrement": "286/ 16 D 155 /14", "Code DCI": "16D155", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "PSYDAL ODT 1MG COMP. ORODISPERS B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PSYDAL ODT", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16D142/16", "Code DCI": "16D142", "Forme": "COMP. ORODISPERS.", "Dosage": "1MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "PSYDAL ODT 2MG COMP. ORODISPERS. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PSYDAL ODT", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16D143/16", "Code DCI": "16D143", "Forme": "COMP. ORODISPERS.", "Dosage": "2MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "PSYDAL ODT 4MG COMP. ORODISPERS. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PSYDAL ODT", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16D145/16", "Code DCI": "16D145", "Forme": "COMP. ORODISPERS.", "Dosage": "4MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": null}, {"Nom": "PULMICORT 0,5MG/2ML SUSP. P.  INHAL. PAR NEBULISEUR EN RECIPIENT UNIDOSE B/04ETUIS DE 05 RECIPIENTS UNIDOSES", "Img": "https://pharmnet-dz.com//img/medics/2120.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2120", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PULMICORT", "Tarif de reference": "0 DA", "PPA": "3006.00 DA", "Num Enregistrement": "256/ 20 A 081 /01/14", "Code DCI": "20A081", "Forme": "SUSP. INHAL.", "Dosage": "0,5MG/2ML", "Conditionnement": "B/04ETUIS DE 05 RECIPIENTS UNIDOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "PULMICORT 1MG/ 2ML SUSP. P.  INHAL. PAR NEBULISEUR EN RECIPIENT UNIDOSE B/04ETUIS DE 05 RECIPIENTS UNIDOSES", "Img": "https://pharmnet-dz.com//img/medics/2121.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2121", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PULMICORT", "Tarif de reference": "0 DA", "PPA": "1851.00 DA", "Num Enregistrement": "256/ 20 A 082 /01", "Code DCI": "20A082", "Forme": "SUSP. INHAL.", "Dosage": "1MG/ 2ML", "Conditionnement": "B/04ETUIS DE 05 RECIPIENTS UNIDOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "PULMICORT TURBUHALER 200\u00b5G/DOSE PDRE POUR INHAL BUCCALE FL/200 DOSES", "Img": "https://pharmnet-dz.com//img/medics/2123.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2123", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PULMICORT TURBUHALER", "Tarif de reference": "596 DA", "PPA": " DA", "Num Enregistrement": "256/ 20 A 089 /01", "Code DCI": "20A089", "Forme": "PDRE. INHAL.", "Dosage": "200\u00b5G/DOSE", "Conditionnement": "FL/200 DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "PULMOFOR ADULTES 0.05 SOL. BUV. FL./125ML", "Img": "https://pharmnet-dz.com//img/medics/1323.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1323", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "PULMOFOR ADULTES", "Tarif de reference": " N/A", "PPA": "147.00 DA", "Num Enregistrement": "242/ 20 D 042 /06", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PULMOFOR ENFANT 0.02 SOL. BUV. FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/1309.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1309", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "PULMOFOR ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 20 D 041 /06", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "PULSAGEN LP 50MG GLES. A MICROGRANULES LP B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NICARDIPINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "PULSAGEN LP", "Tarif de reference": "612 DA", "PPA": "612.00 DA", "Num Enregistrement": "065/ 06 B 015 /12", "Code DCI": "06B015", "Forme": "COMP. LP", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "PUREGON  100UI/ML (50UI/0,5ML) SOL INJ. B/1FL. DE 0,5ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ORGANON", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "PUREGON ", "Tarif de reference": " N/A", "PPA": "3639.00 DA", "Num Enregistrement": "005/ 09 J 118 /99/08", "Code DCI": "09J118", "Forme": "SOL. INJ.", "Dosage": "100UI/ML (50UI/0,5ML)", "Conditionnement": "B/1FL. DE 0,5ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "PUREGON  300UI/0,36ML SOLUTION INJECTABLE EN CARTOUCHE POUR STYLO  B/01 CARTOUCHE AVEC 06 AIGUILLES ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4449", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "PUREGON ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/09J175/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "300UI/0,36ML", "Conditionnement": "B/01 CARTOUCHE AVEC 06 AIGUILLES ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PUREGON 200UI/ML (100UI/0,5ML) SOL INJ. B/1FL. DE 0,5ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ORGANON", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " FOLLITROPINE ALFA (HORMONE FOLLICULOSTIMULATE HUMAINE RECOMBINANTE (FSH RECOMBINANTE)", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "PUREGON", "Tarif de reference": " N/A", "PPA": "2539.00 DA", "Num Enregistrement": "005/ 09 J 119 /99/08", "Code DCI": "09J119", "Forme": "SOL. INJ.", "Dosage": "200UI/ML (100UI/0,5ML)", "Conditionnement": "B/1FL. DE 0,5ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "PUREGON 600UI/0,72ML SOLUTION INJECTABLE EN CARTOUCHE POUR STYLO B/01 CARTOUCHE AVEC 06 AIGUILLES ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4450", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "PUREGON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/09J176/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "600UI/0,72ML", "Conditionnement": "B/01 CARTOUCHE AVEC 06 AIGUILLES ", "Commercialisation": true, "Remboursable": true}, {"Nom": "PURINETHOL 50MG COMP.SEC. B/25", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " MERCAPTOPURINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PURINETHOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 05 A 025 /99", "Code DCI": "05A025", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/25", "Commercialisation": true, "Remboursable": null}, {"Nom": "PYOSTACINE 500MG COMP.PELLI.SEC. B/16", "Img": "https://pharmnet-dz.com//img/medics/787.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=787", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PRISTINAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "PYOSTACINE", "Tarif de reference": "0 DA", "PPA": "1847.00 DA", "Num Enregistrement": "376/ 13 E 030 /96/09", "Code DCI": "13E030", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "PYRIDOXINE  CHLORHYDRATE 250MG/5ML SOL.INJ. B/10AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " PYRIDOXINE (CHLORHYDRATE) (OU VITAMINE B6)", "Pays": "FRANCE", "Nom Commercial": "PYRIDOXINE  CHLORHYDRATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 14 H 101 /00", "Code DCI": "14H101", "Forme": "SOL. INJ.", "Dosage": "250MG/5ML", "Conditionnement": "B/10AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "PYRIDOXINE API 250MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/3430.png", "Laboratoire": " API", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " PYRIDOXINE", "Pays": "ALGERIE", "Nom Commercial": "PYRIDOXINE API", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "348/ 14 H 102 /08", "Code DCI": "14H102", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "PYROMAG 0,15G/ML**  (15%) (750MG/5ML)** (EQUIV. 12,2MG/ML DE MAGNESIUM) SOL. BUV. B/20AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MAGNESIUM PIDOLATE", "Pays": "ALGERIE", "Nom Commercial": "PYROMAG", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "319/ 14 G 054 /08", "Code DCI": "14G054", "Forme": "SOL. BUV.", "Dosage": "0,15G/ML**  (15%) (750MG/5ML)** (EQUIV. 12,2MG/ML DE MAGNESIUM)", "Conditionnement": "B/20AMP. DE 10ML", "Commercialisation": true, "Remboursable": true}], "Q": [{"Nom": "Q-PINE ALEMBIC MAMI 300MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ALEMBIC MAMI SPA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "Q-PINE ALEMBIC MAMI", "Tarif de reference": "3060,90 DA", "PPA": "N/A", "Code DCI": "16D151", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "Q-PINE ALEMBIC MAMI 50MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ALEMBIC MAMI SPA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "Q-PINE ALEMBIC MAMI", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "16D162", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "QUETAL LP 200MG COMP. PELLI. LP B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "QUETAL LP", "Tarif de reference": "2340.00 DA", "PPA": "N/A", "Code DCI": "16D164", "Forme": "COMP. PELLI. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "QUINAPRIL / HYDROCHLOROTHIAZIDE WINTHROP 20MG/12,5MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=185", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " QUINAPRIL CHLORHYDRATE EXPRIME EN QUINAPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "QUINAPRIL / HYDROCHLOROTHIAZIDE WINTHROP", "Tarif de reference": "1029.6 DA", "PPA": " DA", "Num Enregistrement": "376/ 06 E 131 /13", "Code DCI": "06E131", "Forme": "COMP. PELLI.", "Dosage": "20MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "QUINOX 500MG COMP. ENRO. B/10", "Img": "https://pharmnet-dz.com//img/medics/387.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=387", "Laboratoire": " EL KENDI", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "QUINOX", "Tarif de reference": "804 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 K 253 /07", "Code DCI": "13K253", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "QUINOX 750MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=392", "Laboratoire": " EL KENDI", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYDRATE (EXPRIME EN CIPROFLOXACINE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "QUINOX", "Tarif de reference": "1050 DA", "PPA": " DA", "Num Enregistrement": "352/ 13 K 254 /12", "Code DCI": "13K254", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "QUINOX LP 1G COMP. LP B/05", "Img": "https://pharmnet-dz.com//img/medics/398.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CIPROFLOXACINE CHLORHYRATE MONOHYDRATE EXPRIME EN CIPROFLOXACINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "QUINOX LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 K 467 /12", "Code DCI": "13K467", "Forme": "COMP. LP", "Dosage": "1G", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": null}], "R": [{"Nom": "RABWALYSE 0,40MG/ML OU 2MG/5ML SIROP FL/150ML", "Img": "https://pharmnet-dz.com//img/medics/2082.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2082", "Laboratoire": " ISOPHARM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RABWALYSE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "073/ 20 A 016 /05", "Code DCI": "20A016", "Forme": "SOL. BUV.", "Dosage": "0,40MG/ML OU 2MG/5ML", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RADIOSELCTAN URINAIRE ET VASCULAIRE 76% I= 370MG/ML SOL.INJ  I.V. F/60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=575", "Laboratoire": " SCHERING SA", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " AMIDOTRIZOATE DE SODIUM / AMIDOTRIZOATE DE MEGLUMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RADIOSELCTAN URINAIRE ET VASCULAIRE 76%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "070/ 08 C 010 /00", "Code DCI": "08C010", "Forme": "SOL. INJ.", "Dosage": "I= 370MG/ML", "Conditionnement": "F/60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMINORM 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMINORM", "Tarif de reference": "1087.5 DA", "PPA": "967.00 DA", "Num Enregistrement": "050/ 06 E 201 /12", "Code DCI": "06E201", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMINORM 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMINORM", "Tarif de reference": "965.4 DA", "PPA": "N/A", "Num Enregistrement": "050/ 06 E 128 /12", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMIPRIL IVAL 2,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMIPRIL IVAL", "Tarif de reference": "659.7 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 127 /11", "Code DCI": "06E127", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMIPRIL IVAL 5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMIPRIL IVAL", "Tarif de reference": "965.4 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 E 128 /11", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMIPRIL WINTHROP 10MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMIPRIL WINTHROP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "428/ 06 E 201 /09", "Code DCI": "06E201", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "RAMIPRIL WINTHROP 2,5MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMIPRIL WINTHROP", "Tarif de reference": "615.72 DA", "PPA": "N/A", "Num Enregistrement": "428/ 06 E 127 /09", "Code DCI": "06E127", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMIPRIL WINTHROP 5MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMIPRIL WINTHROP", "Tarif de reference": "901.04 DA", "PPA": "N/A", "Num Enregistrement": "428/ 06 E 128 /09", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMITEC 10MG COMP. QUADRISEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMITEC", "Tarif de reference": "1087.5 DA", "PPA": "N/A", "Num Enregistrement": "231/ 06 E 201 /10", "Code DCI": "06E201", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMITEC 2,5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMITEC", "Tarif de reference": "659.7 DA", "PPA": "N/A", "Num Enregistrement": "231/ 06 E 127 /08", "Code DCI": "06E127", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMITEC 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RAMITEC", "Tarif de reference": "965.4 DA", "PPA": "N/A", "Num Enregistrement": "231/ 06 E 128 /08", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMOXIN 125MG/5ML SUSP.OR. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RAMOXIN", "Tarif de reference": "154 DA", "PPA": "N/A", "Num Enregistrement": "166/ 13 B 011 /98", "Code DCI": "13B011", "Forme": "GRLES. SOL. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMOXIN 250MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RAMOXIN", "Tarif de reference": "278 DA", "PPA": "N/A", "Num Enregistrement": "166/ 13 B 009 /98", "Code DCI": "13B009", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAMOXIN 500MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RAMOXIN", "Tarif de reference": "556 DA", "PPA": "N/A", "Num Enregistrement": "166/ 13 B 010 /98", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RANACID 75MG COMP.PELLI. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANACID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 10 A 151 /06", "Code DCI": "10A151", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "RANICARE 150 MG COMP. PELL. B/30", "Img": "https://pharmnet-dz.com//img/medics/4199.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4199", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANICARE", "Tarif de reference": "103.2 DA", "PPA": " DA", "Num Enregistrement": "293/10A003/04/15", "Code DCI": "10A003", "Forme": "COMP. PELLI.", "Dosage": "150 MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RANIMEX 150MG COMP. PELL.  B/30", "Img": "https://pharmnet-dz.com//img/medics/3860.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANIMEX", "Tarif de reference": "154.8 DA", "PPA": "195.00 DA", "Num Enregistrement": "400/10 A 003/13", "Code DCI": "10A003", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RANIMEX 300MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANIMEX", "Tarif de reference": "228.6 DA", "PPA": "N/A", "Num Enregistrement": "400/ 10 A 102 /13", "Code DCI": "10A102", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RANITEX 150MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/3861.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANITEX", "Tarif de reference": " N/A", "PPA": "139.00 DA", "Num Enregistrement": "035/ 10 A 003 /97/07", "Code DCI": "10A003", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "RANITEX 300MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/3870.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE CHLORHYDRATE EXPRIME EN RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANITEX", "Tarif de reference": " N/A", "PPA": "149.00 DA", "Num Enregistrement": "035/ 10 A 102 /97/07", "Code DCI": "10A102", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "RANITEX 50MG/2ML (OU 25MG/ML) SOL INJ B/05AMP. 2ML", "Img": "https://pharmnet-dz.com//img/medics/3853.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANITEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035/ 10 A 002 /00/07", "Code DCI": "10A002", "Forme": "SOL. INJ.", "Dosage": "50MG/2ML (OU 25MG/ML)", "Conditionnement": "B/05AMP. 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RANITIDAL 150 MG COMP. PELL. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " N/D", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANITIDAL", "Tarif de reference": "103.2 DA", "PPA": "N/A", "Num Enregistrement": "039/10A003/98/15", "Code DCI": "10A003", "Forme": "COMP. PELLI.", "Dosage": "150 MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RANITIDAL 25MG/ML (50MG/2ML)** SOL. INJ. B/5AMP. DE 2ML ET B/100AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANITIDAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "039/ 10 A 002 /12", "Code DCI": "10A002", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (50MG/2ML)**", "Conditionnement": "B/5AMP. DE 2ML ET B/100AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RANITIDINE 25MG/ML (50MG/2ML) SOL. INJ. IM/IV B/100 FL. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EMPRESSA LABORATORIOS AICA", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "CUBA", "Nom Commercial": "RANITIDINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "435/ 10 A 002 /09", "Code DCI": "10A002", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (50MG/2ML)", "Conditionnement": "B/100 FL. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RANITIDINE MABO 150MG COMP. PELLI. B/30 - B/60", "Img": "https://pharmnet-dz.com//img/medics/3862.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE ", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RANITIDINE MABO", "Tarif de reference": " N/A", "PPA": "397.00 DA", "Num Enregistrement": "268/ 10 A 003 /98/15", "Code DCI": "10A003", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30 - B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "RAPICORT 100MG/AMP. DE LYOPH, LYOPH. ET SOLV. P. SOL.INJ. IV B/05 AMP. DE LYOPH. + 05 AMP. DE 2ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ISTITUTO FARMACOBIOLOGICO MALESCI SPA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " HYDROCORTISONE SUCCINATE SODIQUE EXPRIME EN HYDROCORTISONE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "RAPICORT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "458/ 09 H 026 /99/15", "Code DCI": "09H026", "Forme": "SOL. INJ.", "Dosage": "100MG/AMP. DE LYOPH,", "Conditionnement": "B/05 AMP. DE LYOPH. + 05 AMP. DE 2ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "RAPIDUS 50MG COMP.ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medics/952.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=952", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC POTASSIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RAPIDUS", "Tarif de reference": "300 DA", "PPA": "N/A", "Num Enregistrement": "352/ 04 B 063 /06", "Code DCI": "04B063", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAPIFEN 1MG/2ML SOL.INJ. B/05", "Img": "https://pharmnet-dz.com//img/medics/4043.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4043", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES POUR ANESTHESIE", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ALFENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "RAPIFEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 02 A 001 /98", "Code DCI": "02A001", "Forme": "SOL. INJ.", "Dosage": "1MG/2ML", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAPIFEN 5MG/10ML SOL.INJ. B/10", "Img": "https://pharmnet-dz.com//img/medics/4048.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4048", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES POUR ANESTHESIE", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ALFENTANYL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "RAPIFEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 02 A 050 /98", "Code DCI": "02A050", "Forme": "SOL. INJ.", "Dosage": "5MG/10ML", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "RATIDEX 25MG/ML (50MG/2ML) SOL. INJ. IM/IV B/5AMP. DE 2ML ET B/50AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/3856.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RATIDEX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "433/ 10 A 002 /13", "Code DCI": "10A002", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (50MG/2ML)", "Conditionnement": "B/5AMP. DE 2ML ET B/50AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RAZOLIX 20MG/2ML SOL. INJ. IV./IM. B/05 AMP. DE 2ML , B/50 AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/3285.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " FUROSEMIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RAZOLIX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "433/ 06 H 087 /15", "Code DCI": "06H087", "Forme": "SOL. INJ.", "Dosage": "20MG/2ML", "Conditionnement": "B/05 AMP. DE 2ML , B/50 AMP. DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RAZON 40MG COMP. ENRO. GASTRORESIST. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PANTOPRAZOLE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "RAZON", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "043/ 10 A 134 /08", "Code DCI": "10A134", "Forme": "COMP. ENRO.", "Dosage": "40MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "REBETOL 200MG GLES. B/84 - B/140 - B/168", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=442", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " RIBAVIRINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "REBETOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 13 P 281 /12 ", "Code DCI": "13P281", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/84 - B/140 - B/168", "Commercialisation": true, "Remboursable": true}, {"Nom": "REBIF 22\u00b5G/0,5ML (6MUI/0,5ML) SOL. INJ. SC. EN SERINGUE PREREMPLIE B/12 SERINGUES PREREMPLIES DE 0,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2504", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " SCLEROSE EN PLAQUE", "C.Therapeutique": " NEUROLOGIE", "Info": " INTERFERON BETA 1A", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "REBIF", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "062/ 15 G 078 /07/15", "Code DCI": "15G078", "Forme": "SOL. INJ.", "Dosage": "22\u00b5G/0,5ML (6MUI/0,5ML)", "Conditionnement": "B/12 SERINGUES PREREMPLIES DE 0,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "REBIF 44\u00b5G/0,5ML (12MUI/0,5ML) SOL. INJ. SC. B/12 SERINGUES PREREMPLIES DE 0,5ML", "Img": "https://pharmnet-dz.com//img/medics/2502.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2502", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " SCLEROSE EN PLAQUE", "C.Therapeutique": " NEUROLOGIE", "Info": " INTERFERON BETA 1A", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "REBIF", "Tarif de reference": "0 DA", "PPA": "81828.00 DA", "Num Enregistrement": "062/ 15 G 055 /02/15", "Code DCI": "15G055", "Forme": "SOL. INJ.", "Dosage": "44\u00b5G/0,5ML (12MUI/0,5ML)", "Conditionnement": "B/12 SERINGUES PREREMPLIES DE 0,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RECOFOL 200MG/20ML SOL.INJ.IV. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SCHERING OY", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PROPOFOL", "Liste": "Liste I", "Pays": "FINLANDE", "Nom Commercial": "RECOFOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "189/ 02 B 011 /98", "Code DCI": "02B011", "Forme": "SOL. INJ.", "Dosage": "200MG/20ML", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": null}, {"Nom": "RECOMBINATE 500UI/FL. DE PDRE. PDRE. ET SOLVT. SOL. INJ. IV B/1FL. DE PDRE. + 1AMP. DE SOLVT. (E.P.P.I.) DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BAXTER", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FACTEUR HUMAIN VIII  ANTI HEMOPHILIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RECOMBINATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 12 J 044 /09", "Code DCI": "12J044", "Forme": "PDRE. INJ.", "Dosage": "500UI/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE SOLVT. (E.P.P.I.) DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RECORMON  2 000UI/0,3ML SOL INJ  B/6 Seringues pr\u00e9remplies ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1776", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE BETA (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "RECORMON ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 12 E 101 /02", "Code DCI": "12E101", "Forme": "SOL. INJ.", "Dosage": "2 000UI/0,3ML", "Conditionnement": "B/6 Seringues pr\u00e9remplies ", "Commercialisation": true, "Remboursable": true}, {"Nom": "RECORMON  5 000UI/0,3ML SOL INJ  B/6 Seringues pr\u00e9remplies ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1777", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE BETA (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "RECORMON ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 12 E 102 /02", "Code DCI": "12E102", "Forme": "SOL. INJ.", "Dosage": "5 000UI/0,3ML", "Conditionnement": "B/6 Seringues pr\u00e9remplies ", "Commercialisation": true, "Remboursable": true}, {"Nom": "RECORMON 10.000UI/0,6ML SOL INJ  B/6 Seringues pr\u00e9remplies ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1778", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE BETA (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "RECORMON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 12 E 103 /02", "Code DCI": "12E103", "Forme": "SOL. INJ.", "Dosage": "10.000UI/0,6ML", "Conditionnement": "B/6 Seringues pr\u00e9remplies ", "Commercialisation": true, "Remboursable": true}, {"Nom": "RECORMON 30 000UI/0,6ML SOL. INJ. SC OU IV B/04 SERINGUES. PREREMPLIES DE 0,6ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1807", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE BETA (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "RECORMON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 12 E 148 /09", "Code DCI": "12E148", "Forme": "SOL. INJ.", "Dosage": "30 000UI/0,6ML", "Conditionnement": "B/04 SERINGUES. PREREMPLIES DE 0,6ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "REDNILEF 20MG COMP EFFERV PILULIER/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REDNILEF", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "001/ 09 H 035 /14", "Code DCI": "09H035", "Forme": "COMP. EFFERV.", "Dosage": "20MG", "Conditionnement": "PILULIER/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "REDNILEF 5MG COMP EFFERV PILULIER/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE METASULFOBENZOATE SODIQUE EXPRIME EN PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REDNILEF", "Tarif de reference": "257.4 DA", "PPA": "N/A", "Num Enregistrement": "001/ 09 H 034 /14", "Code DCI": "09H034", "Forme": "COMP. EFFERV.", "Dosage": "5MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "REDUPAR 100MG COMP. PELLI. B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REDUPAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 21 J 044 /15", "Code DCI": "21J044", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": null}, {"Nom": "REDUPAR 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REDUPAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 21 J 042 /15", "Code DCI": "21J042", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "REDUPAR 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REDUPAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 21 J 043 /15", "Code DCI": "21J043", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "REGAB 150MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REGAB", "Tarif de reference": "4015.2 DA", "PPA": "N/A", "Num Enregistrement": "001/ 15 A 068 /13", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "REGAB 300MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REGAB", "Tarif de reference": "7952 DA", "PPA": "N/A", "Num Enregistrement": "001/ 15 A 069 /13", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "REGAB 50MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REGAB", "Tarif de reference": "1866.48 DA", "PPA": "1866.00 DA", "Num Enregistrement": "001/ 15 A 066 /13", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "REGAB 75MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REGAB", "Tarif de reference": " N/A", "PPA": "1866.00 DA", "Num Enregistrement": "001/ 15 A 101 /13", "Code DCI": "15A101", "Forme": "GLES.", "Dosage": "75MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": null}, {"Nom": "REGULAX 0,12G/10G GEL RECTAL B/06TUBES CANULES DE 10G", "Img": "https://pharmnet-dz.com//img/medics/2955.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2955", "Laboratoire": " LGPA", "C.Pharmacologique": " MUCILAGES & MEDICAMENTS DE LA CONSTIPATION", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DOCUSATE SODIQUE", "Pays": "ALGERIE", "Nom Commercial": "REGULAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "311/ 10 M 063 /13", "Code DCI": "10M063", "Forme": "GEL RECTAL", "Dosage": "0,12G/10G", "Conditionnement": "B/06TUBES CANULES DE 10G", "Commercialisation": true, "Remboursable": false}, {"Nom": "REHYDRAX 1,5G/1G/0,5G/0,5G/27,5G/500ML SOLUTE DE REHYDRATATION PAR VOIE PARENTERALE CARTON /12FL/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE SODIUM/CHLORURE DE POTASSIUM/ CHLORURE DE MAGNESIUM/ GLUCONATE DE CALCIUM /GLUCOSE MONOHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "REHYDRAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 301 /06", "Code DCI": "14G301", "Forme": "SOL.", "Dosage": "1,5G/1G/0,5G/0,5G/27,5G/500ML", "Conditionnement": "CARTON /12FL/500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "REHYDRAX 2,6G/ 1,5G /2,9G**/ 13,5G / SACH. DE 20,5G PDRE.OR.SACH. B/100SACH. DE 20,5G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE SODIUM/CHLORURE DE POTASSIUM/CITRATE DE SODIUM (SOUS FORME TRISODIQUE DIHYDRATEE)**/GLUCOSE ANHYDRE", "Pays": "ALGERIE", "Nom Commercial": "REHYDRAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 065 /97/05", "Code DCI": "14G065", "Forme": "PDRE.", "Dosage": "2,6G/ 1,5G /2,9G**/ 13,5G / SACH. DE 20,5G", "Conditionnement": "B/100SACH. DE 20,5G", "Commercialisation": true, "Remboursable": null}, {"Nom": "RELAXAN 4MG COMP  B/10", "Img": "https://pharmnet-dz.com//img/medics/4644.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4644", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RELAXAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/21E070/16", "Code DCI": "N/D", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "RELIPOIETIN 10 000UI/ML SOL. INJ. SC/ IV B/1SERING. PREREMPLIE DE 1ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RELIPOIETIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 12 E 063 /12", "Code DCI": "12E063", "Forme": "LYOPH. SOL. INJ.", "Dosage": "10 000UI/ML", "Conditionnement": "B/1SERING. PREREMPLIE DE 1ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "RELIPOIETIN 2 000UI/0,5ML SOL. INJ. SC OU IV B/1SERING. PREREMPLIE DE 0,5ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RELIPOIETIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 12 E 061 /12", "Code DCI": "12E061", "Forme": "SOL. INJ.", "Dosage": "2 000UI/0,5ML", "Conditionnement": "B/1SERING. PREREMPLIE DE 0,5ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "RELIPOIETIN 4 000UI/0,4ML SOL. INJ. SC OU IV B/1SERING. PREREMPLIE DE 0,4ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " EPOETINE ALFA  (OU ERYTHROPOIETINE HUMAINE RECOMBINANTE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RELIPOIETIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 12 E 062 /12", "Code DCI": "12E062", "Forme": "SOL. INJ.", "Dosage": "4 000UI/0,4ML", "Conditionnement": "B/1SERING. PREREMPLIE DE 0,4ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "RELPAX 20MG COMP. PELLI. B/03", "Img": "https://pharmnet-dz.com//img/medics/2472.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " ELETRIPTAN HYDROBROMURE EXPRIME EN ELETRIPTAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "RELPAX", "Tarif de reference": "840 DA", "PPA": " DA", "Num Enregistrement": "045/ 15 B 070 /09", "Code DCI": "15B070", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "RELPAX 40MG COMP. PELLI. B/03", "Img": "https://pharmnet-dz.com//img/medics/2473.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2473", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " ELETRIPTAN HYDROBROMURE EXPRIME EN ELETRIPTAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "RELPAX", "Tarif de reference": "840 DA", "PPA": "1002.00 DA", "Num Enregistrement": "045/ 15 B 071 /09", "Code DCI": "15B071", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "REMERON 30MG COMP. ENRO. B30", "Img": "https://pharmnet-dz.com//img/medics/2552.png", "Laboratoire": " ORGANON", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " MIRTAZAPINE", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "REMERON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "005/ 16 A 086 /00", "Code DCI": "16A086", "Forme": "COMP. PELLI.", "Dosage": "30MG", "Conditionnement": "B30", "Commercialisation": true, "Remboursable": true}, {"Nom": "REMICADE 100MG/FL (10MG/ML APRES RECONSTITUTION) PDRE P. SOL A DILUER P. PERF IV B/01FL", "Img": "https://pharmnet-dz.com//img/medics/1065.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " INFLIXIMAB", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "REMICADE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 05 D 170 /14", "Code DCI": "05D170", "Forme": "SOL. PERF.", "Dosage": "100MG/FL (10MG/ML APRES RECONSTITUTION)", "Conditionnement": "B/01FL", "Commercialisation": true, "Remboursable": true}, {"Nom": "REMIFENTANIL MYLAN  2MG/ FLACON  POUDRE POUR SOL INJ OU POUR PERF IV  BOITE DE 10 FLACONS DE 5 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4241", "Laboratoire": " MYLAN", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "REMIFENTANIL MYLAN ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "450/02A062/15", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "2MG/ FLACON ", "Conditionnement": "BOITE DE 10 FLACONS DE 5 ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "REMIFENTANIL MYLAN  5MG/FLACON  POUDRE POUR SOL INJ OU POUR PERF IV  BOITE DE 10 FLACONS DE 10 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4242", "Laboratoire": " MYLAN", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "REMIFENTANIL MYLAN ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "450/02A063/15", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "5MG/FLACON ", "Conditionnement": "BOITE DE 10 FLACONS DE 10 ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "REMOFEN 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "REMOFEN", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 040 /11", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "REMOFEN 20MG/ML (100MG/5ML) SOL. BUV. FL/120ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "REMOFEN", "Tarif de reference": "117.6 DA", "PPA": "125.00 DA", "Num Enregistrement": "001/ 04 B 042 /06", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL/120ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "REMSIMA 100MG/FL  PDRE P. SOL A DILUER P. PERF  IV B/01FL DE POUDRE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " INFLIXIMAB", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "REMSIMA", "Tarif de reference": "00 DA", "PPA": " DA", "Num Enregistrement": "001/05D170/17", "Code DCI": "05D170", "Forme": "SOL. PERF.", "Dosage": "100MG/FL ", "Conditionnement": "B/01FL DE POUDRE", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENACID A13  SOL. P. HEMODIALYSE BIDON 10L.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE  POUDRE", "Pays": "ALGERIE", "Nom Commercial": "RENACID A13", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 25 G 056 /07", "Code DCI": "25G056", "Forme": "SOL. DIALYSE", "Conditionnement": "BIDON 10L.", "Commercialisation": true, "Remboursable": null}, {"Nom": "RENACID A14 RENABIC L14  SOL. POUR HEMODIALYSE BIDON DE SOL. CONCENTREE ACIDE DE 10L ET BIDON DE SOL. AU BICARBONATE DE 10L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CONCENTRE ACIDE POUR HEMODIALYSE AU BICARBONATE LIQUIDE", "Pays": "ALGERIE", "Nom Commercial": "RENACID A14 RENABIC L14", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 25 G 020 /06", "Code DCI": "25G020", "Forme": "SOL. DIALYSE", "Conditionnement": "BIDON DE SOL. CONCENTREE ACIDE DE 10L ET BIDON DE SOL. AU BICARBONATE DE 10L", "Commercialisation": true, "Remboursable": null}, {"Nom": "RENAGEL 800MG COMP. PELLI. PILULIER DE 180", "Img": "https://pharmnet-dz.com//img/medics/1214.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1214", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SEVELAMER", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "RENAGEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 25 M 059 /09", "Code DCI": "25M059", "Forme": "COMP. PELLI.", "Dosage": "800MG", "Conditionnement": "PILULIER DE 180", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENIBON 680MG/80MG COMP.A CROQUER B/20", "Img": "https://pharmnet-dz.com//img/medics/3918.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3918", "Laboratoire": " OUBARI PHARMA ", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CALCIUM CARBONATE  / MAGNESIUM CARBONATE LOURD", "Pays": "SYRIE", "Nom Commercial": "RENIBON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "071/ 10 B 166 /07", "Code DCI": "10B166", "Forme": "COMP. A CROQ.", "Dosage": "680MG/80MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENIPRIL 1,25MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RENIPRIL", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 E 139 /06", "Code DCI": "06E139", "Forme": "COMP. SEC.", "Dosage": "1,25MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENIPRIL 10MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medics/3115.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RENIPRIL", "Tarif de reference": "1450 DA", "PPA": "1450.00 DA", "Num Enregistrement": "003/ 06 E 201 /06", "Code DCI": "06E201", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENIPRIL 2,5MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medics/170.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RENIPRIL", "Tarif de reference": "879.6 DA", "PPA": "878.00 DA", "Num Enregistrement": "003/ 06 E 127 /06", "Code DCI": "06E127", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENIPRIL 5MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medics/178.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RENIPRIL", "Tarif de reference": "1287.2 DA", "PPA": "1284.00 DA", "Num Enregistrement": "003/ 06 E 128 /06", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENITEC 20MG COMP.SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=160", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RENITEC", "Tarif de reference": "448 DA", "PPA": " DA", "Num Enregistrement": "024/ 06 E 060 /99", "Code DCI": "06E060", "Forme": "COMP. SEC.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENITEC 5MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=151", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ENALAPRIL MALEATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RENITEC", "Tarif de reference": "257.6 DA", "PPA": " DA", "Num Enregistrement": "024/ 06 E 059 /99", "Code DCI": "06E059", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "RENNIE 680MG/80MG COMP. A CROQUER B/48", "Img": "https://pharmnet-dz.com//img/medics/3919.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3919", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CALCIUM CARBONATE  / MAGNESIUM CARBONATE LOURD", "Pays": "FRANCE", "Nom Commercial": "RENNIE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "395/ 10 B 166 /07", "Code DCI": "10B166", "Forme": "COMP. A CROQ.", "Dosage": "680MG/80MG", "Conditionnement": "B/48", "Commercialisation": true, "Remboursable": false}, {"Nom": "RENNIE DEFLATINE 680MG/80MG/25MG COMPRIME A CROQUER SANS SUCRE B/18", "Img": "https://pharmnet-dz.com//img/medics/3923.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3923", "Laboratoire": " BAYER", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CALCIUM CARBONATE / CARBONATE DE MAGNESIUM LOURD / DIMETICONE (DCI) ACTIVE ", "Pays": "FRANCE", "Nom Commercial": "RENNIE DEFLATINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "395/ 10 B 182 /09", "Code DCI": "10B182", "Forme": "COMP. A CROQ.", "Dosage": "680MG/80MG/25MG", "Conditionnement": "B/18", "Commercialisation": true, "Remboursable": false}, {"Nom": "REPAGLINIDE BEKER  0,5MG COMP B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4692.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REPAGLINIDE BEKER ", "Tarif de reference": "355.80 DA", "PPA": "355.80 DA", "Num Enregistrement": "447/14A200/17", "Code DCI": "14A200", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "REPAGLINIDE BEKER 1MG COMP B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4672.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REPAGLINIDE BEKER", "Tarif de reference": "370.80 DA", "PPA": "370.80 DA", "Num Enregistrement": "447/14A201/17", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "REPAGLINIDE BEKER 2MG COMP B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4683.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REPAGLINIDE BEKER", "Tarif de reference": "390.00 DA", "PPA": "390.00 DA", "Num Enregistrement": "447/14A202/17", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "REPAGLINIDE GL 2MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REPAGLINIDE GL", "Tarif de reference": " N/A", "PPA": "390.00 DA", "Num Enregistrement": "065/ 14 A 202 /15", "Code DCI": "14A202", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "REPANIDE 100MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/2447.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REPANIDE", "Tarif de reference": "0 DA", "PPA": "2806.00 DA", "Num Enregistrement": "035/ 15 A 083 /11", "Code DCI": "15A083", "Forme": "COMP. ENRO.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "REPANIDE 25MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/2445.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REPANIDE", "Tarif de reference": "0 DA", "PPA": "820.00 DA", "Num Enregistrement": "035/ 15 A 081 /11", "Code DCI": "15A081", "Forme": "COMP. ENRO.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "REPANIDE 50MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "REPANIDE", "Tarif de reference": "0 DA", "PPA": "1124.00 DA", "Num Enregistrement": "035/ 15 A 082 /11", "Code DCI": "15A082", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RESDONE 1MG/ML SOL.BUV. F/60ML +PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RESDONE", "Tarif de reference": "2520 DA", "PPA": "N/A", "Num Enregistrement": "317/16D092/16", "Code DCI": "16D092", "Forme": "SOL. BUV.", "Dosage": "1MG/ML", "Conditionnement": "F/60ML +PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "RESPIBIEN 0,5MG/ML** SOL.NAS. FL/15ML", "Img": "https://pharmnet-dz.com//img/medics/1943.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1943", "Laboratoire": " CINFA", "C.Pharmacologique": " RHINOLOGIE", "C.Therapeutique": " OXYMETAZOLINE (SOUS FORME DE CHLORHYDRATE)**", "Liste": "Liste II", "Pays": "ESPAGNE", "Nom Commercial": "RESPIBIEN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "157/ 22 F 018 /99/08", "Code DCI": "22F018", "Forme": "SOL. NAS.", "Dosage": "0,5MG/ML**", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "RESPINHAL 0,5MG/ML** (OU 0,05%) SOL. PULV. NASALE FL./15ML", "Img": "https://pharmnet-dz.com//img/medics/1944.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1944", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " RHINOLOGIE", "C.Therapeutique": " OXYMETAZOLINE (SOUS FORME DE CHLORHYDRATE)**", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RESPINHAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/ 22 F 018 /09", "Code DCI": "22F018", "Forme": "SOL. NAS.", "Dosage": "0,5MG/ML** (OU 0,05%)", "Conditionnement": "FL./15ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "RESPIROX 1MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RESPIROX", "Tarif de reference": "858.4 DA", "PPA": "620.00 DA", "Num Enregistrement": "001/ 16 D 089 /08", "Code DCI": "16D089", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RESPIROX 2MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/2249.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RESPIROX", "Tarif de reference": "2000 DA", "PPA": "1380.00 DA", "Num Enregistrement": "001/ 16 D 090 /08", "Code DCI": "16D090", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RESPIROX 4MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RESPIROX", "Tarif de reference": "2640 DA", "PPA": "2280.00 DA", "Num Enregistrement": "001/ 16 D 091 /08", "Code DCI": "16D091", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RESTAMINE 10MG COMP. B/10 -  B/20", "Img": "https://pharmnet-dz.com//img/medics/3997.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3997", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "RESTAMINE", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "001/ 01 A 033 /00/07", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/10 -  B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RESTAMINE 1MG/ML SIROP FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "RESTAMINE", "Tarif de reference": "96.6 DA", "PPA": "N/A", "Num Enregistrement": "001/ 01 A 034 /02", "Code DCI": "01A034", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RESTILON  1,5MG GELULE B/ 1 FL DE 60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " EL KENDI", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RESTILON ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/15F106/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "1,5MG", "Conditionnement": "B/ 1 FL DE 60", "Commercialisation": true, "Remboursable": null}, {"Nom": "RESTILON  2MG/ML SOLUTION BUV B/1 FL DE 120ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " EL KENDI", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RESTILON ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/15F099/16,", "Code DCI": "N/D", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "B/1 FL DE 120ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "RESTILON  3MG GELULE B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " EL KENDI", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RESTILON ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/15F107/17", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "3MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "RESTILON  4,5MG GELULE B/1 FL DE 60 GELULES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " EL KENDI", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RESTILON ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "352/15F108/17", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "4,5MG", "Conditionnement": "B/1 FL DE 60 GELULES", "Commercialisation": true, "Remboursable": null}, {"Nom": "RETA 160MG COMP PELL B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RETA", "Tarif de reference": "1491 DA", "PPA": "1491.00 DA", "Num Enregistrement": "317/ 06 E 166 /14", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "RETA 80MG  COMP PELL SEC B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RETA", "Tarif de reference": "1491 DA", "PPA": "1491.00 DA", "Num Enregistrement": "317/ 06 E 147 /14", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "RETANE 20MG CAPS. MOLLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " ASIA PHARMACEUTICALS", "C.Pharmacologique": " KERATOLYTIQUES ET REDUCTEURS", "C.Therapeutique": " DERMATOLOGIE", "Info": " ISOTRETINOINE", "Liste": "Liste I", "Pays": "SYRIE", "Nom Commercial": "RETANE", "Tarif de reference": "2022 DA", "PPA": "N/A", "Num Enregistrement": "121/ 07 L 059 /07", "Code DCI": "07L059", "Forme": "CAPS. MOLLE", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RETARCILINE 1 200 000UI/FL. DE PDRE. PRDE. SOL. INJ. B/01+01  ET B/20FL.", "Img": "https://pharmnet-dz.com//img/medics/261.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " BENZATHINE BENZYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RETARCILINE", "Tarif de reference": "130 DA", "PPA": "130 DA", "Num Enregistrement": "003/ 13 G 061 /05", "Code DCI": "13G061", "Forme": "PDRE. SOL. INJ.", "Dosage": "1 200 000UI/FL. DE PDRE.", "Conditionnement": "B/01+01  ET B/20FL.", "Commercialisation": true, "Remboursable": true}, {"Nom": "RETARCILINE 600 000UI/FL. DE PDRE. PRDE. SOL. INJ. B/01+01  ET B/20FL.", "Img": "https://pharmnet-dz.com//img/medics/259.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " BENZATHINE BENZYLPENICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RETARCILINE", "Tarif de reference": "115 DA", "PPA": "115.00 DA", "Num Enregistrement": "003/ 13 G 060 /05", "Code DCI": "13G060", "Forme": "PDRE. SOL. INJ.", "Dosage": "600 000UI/FL. DE PDRE.", "Conditionnement": "B/01+01  ET B/20FL.", "Commercialisation": true, "Remboursable": true}, {"Nom": "RETISOL-A 0.00025 CREME T/25G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " STIEFEL CANADA INC", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE TRETINOIQUE AVEC ECRANS SOLAIRES", "Liste": "Liste I", "Pays": "CANADA", "Nom Commercial": "RETISOL-A", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "125/ 07 B 111 /00", "Code DCI": "07B111", "Forme": "CR\u00c8ME", "Dosage": "0.00025", "Conditionnement": "T/25G", "Commercialisation": true, "Remboursable": null}, {"Nom": "RETISOL-A 0.0005 CREME T/25G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " STIEFEL CANADA INC", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE TRETINOIQUE AVEC ECRANS SOLAIRES", "Liste": "Liste I", "Pays": "CANADA", "Nom Commercial": "RETISOL-A", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "125/ 07 B 112 /00", "Code DCI": "07B112", "Forme": "CR\u00c8ME", "Dosage": "0.0005", "Conditionnement": "T/25G", "Commercialisation": true, "Remboursable": null}, {"Nom": "REVLIMID 10MG GELULE B/21", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "REVLIMID", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "506/05L182/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": null}, {"Nom": "REVLIMID 15MG GELULE B/21", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "REVLIMID", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "506/05L183/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "15MG", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": null}, {"Nom": "REVLIMID 25MG GELULE B/21", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "REVLIMID", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "506/05L184/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "25MG", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": null}, {"Nom": "REVLIMID 5MG GELULE B/21", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "REVLIMID", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "506/05L181/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINAAXIA 6G/100ML SOL. PULV. NASALE FL./13ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " RHINOLOGIE", "C.Therapeutique": " ACIDE N-ACETYL ASPARTYL GLUTAMIQUE,SEL DE MAGNESIUM ", "Pays": "ALGERIE", "Nom Commercial": "RHINAAXIA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 22 F 038 /09 ", "Code DCI": "22F038", "Forme": "SOL. NAS.", "Dosage": "6G/100ML", "Conditionnement": "FL./13ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINASTINE 0.02 SIROP  ENFANT FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINASTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 D 041 /00", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINASTINE 0.05 SIROP ADULTE FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINASTINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 D 042 /00", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINATHIOL  ADULTE 0.05 SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INSTITUT MEDICAL ALGERIEN", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINATHIOL  ADULTE", "Tarif de reference": " N/A", "PPA": "165.00 DA", "Num Enregistrement": "049/ 20 D 042 /97", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINATHIOL AD SANS SUCRE 0.05 SIROP FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INSTITUT MEDICAL ALGERIEN", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINATHIOL AD SANS SUCRE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "049/ 20 D 108 /04", "Code DCI": "20D108", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINATHIOL AD TOUX SECHE 0.0012 SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INSTITUT MEDICAL ALGERIEN", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PHOLCODINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RHINATHIOL AD TOUX SECHE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "049/ 20 B 110 /04", "Code DCI": "20B110", "Forme": "SIROP", "Dosage": "0.0012", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINATHIOL ENFANT 0.02 SIROP FL/125 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INSTITUT MEDICAL ALGERIEN", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINATHIOL ENFANT", "Tarif de reference": " N/A", "PPA": "154.00 DA", "Num Enregistrement": "049/ 20 D 041 /97", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL/125 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINATHIOL SANS SUCRE ENFANTS ET NOURRISSONS 0.02 SIROP B/1FL 125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INSTITUT MEDICAL ALGERIEN", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINATHIOL SANS SUCRE ENFANTS ET NOURRISSONS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "049/ 20 D 208 /05", "Code DCI": "20D208", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "B/1FL 125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINEDAL 200MG/30MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " IBUPROFENE / PSEUDOEPHEDRINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RHINEDAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 22 A 043 /13", "Code DCI": "22A043", "Forme": "COMP. PELLI.", "Dosage": "200MG/30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHINOCORT 64\u00b5G/DOSE SUSP. P. PULV. NAS. FL/120DOSES", "Img": "https://pharmnet-dz.com//img/medics/1946.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1946", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " RHINOLOGIE", "C.Therapeutique": " BUDESONIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RHINOCORT", "Tarif de reference": "829.2 DA", "PPA": "N/A", "Num Enregistrement": "256/ 22 F  039 /06", "Code DCI": "22F039", "Forme": "SOL. NAS.", "Dosage": "64\u00b5G/DOSE", "Conditionnement": "FL/120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "RHINOFLUIMUCIL 100MG/50MG/1,25MG/10ML SOL. PULV.NASALE FL./10ML", "Img": "https://pharmnet-dz.com//img/medics/1476.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1476", "Laboratoire": " ZAMBON", "C.Pharmacologique": " ANTI-INFECTIEUX SANS CORTICOIDES", "C.Therapeutique": " RHINOLOGIE", "Info": " ACETYLCYSTEINE/TUAMINOHEPTANE/CHLORURE DE BENZALKONIUM", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "RHINOFLUIMUCIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "093/ 22 B 031 /07", "Code DCI": "22B031", "Forme": "SOL. NAS.", "Dosage": "100MG/50MG/1,25MG/10ML", "Conditionnement": "FL./10ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "RHINOLACTOL 0.05 SIROP ADULTE FL./150ML", "Img": "https://pharmnet-dz.com//img/medics/1324.png", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINOLACTOL", "Tarif de reference": "0 DA", "PPA": "140.00 DA", "Num Enregistrement": "285/ 20 D 042 /08", "Code DCI": "20D042", "Forme": "SIROP", "Dosage": "0.05", "Conditionnement": "FL./150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RHINOLACTOL ENFANT 0.02 SIROP FL./125ML", "Img": "https://pharmnet-dz.com//img/medics/1312.png", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " CARBOCISTEINE", "Pays": "ALGERIE", "Nom Commercial": "RHINOLACTOL ENFANT", "Tarif de reference": "0 DA", "PPA": "116.00 DA", "Num Enregistrement": "285/ 20 D 041 /08", "Code DCI": "20D041", "Forme": "SIROP", "Dosage": "0.02", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RHINYL 0.0125 SOL.NAS. FL/15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " FRAMYCETINE", "Pays": "FRANCE", "Nom Commercial": "RHINYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 22 E 014 /98", "Code DCI": "22E014", "Forme": "SOL. NAS.", "Dosage": "0.0125", "Conditionnement": "FL/15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHITENE 10MG COMP. PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RHITENE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "235/01A003/16", "Code DCI": "01A003", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHITENE 10MG/ML  SOL BUV EN GTTES  B/01FL COMPTE GTTES DE 15ML", "Img": "https://pharmnet-dz.com//img/medics/4023.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4023", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RHITENE", "Tarif de reference": "240.15 DA", "PPA": "N/A", "Num Enregistrement": "235/ 01 A 041 /14", "Code DCI": "01A041", "Forme": "SOL. BUV. GTTES.", "Dosage": "10MG/ML ", "Conditionnement": "B/01FL COMPTE GTTES DE 15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RHOPHYLAC 300 150\u03bcG/ML (300\u03bcG/2ML OU 1500UI/2ML) SOL. INJ. EN SERING. PREREMPL. IM/IV B/01SERING. PREREMPL. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/1848.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1848", "Laboratoire": " CSL BEHRING AG", "C.Pharmacologique": " FACTEURS SANGUINS", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " IMMUNOGLOBULINE HUMAINE  (ANTI D)", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "RHOPHYLAC 300", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "485/ 12 J 171 /14", "Code DCI": "12J171", "Forme": "PDRE. INJ.", "Dosage": "150\u03bcG/ML (300\u03bcG/2ML OU 1500UI/2ML)", "Conditionnement": "B/01SERING. PREREMPL. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RHUM 'NET  MECHE IMPREGNEE DANS 1ML DE SOLUTION INHALATEUR AVEC MECHE IMPREGNEE DANS 1ML DE SOLUTION", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " MEDICAMENTS DES AFFECTIONS RESPIRATOIRES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BALSAMIQUES POUR INHALATION", "Pays": "ALGERIE", "Nom Commercial": "RHUM 'NET", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 20 E 043 /98", "Code DCI": "20E043", "Forme": "SOL. INHAL.", "Conditionnement": "INHALATEUR AVEC MECHE IMPREGNEE DANS 1ML DE SOLUTION", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHUMAFED 1,25MG/25MG/ 125MG /5ML** SOL .BUV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)**  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** / PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "RHUMAFED", "Tarif de reference": " N/A", "PPA": "145.00 DA", "Num Enregistrement": "003/ 22 A 002 /00/09", "Code DCI": "22A002", "Forme": "SOL. BUV.", "Dosage": "1,25MG/25MG/ 125MG /5ML**", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHUMAFED 2,5MG/50MG/300MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1455.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1455", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)**  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** / PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "RHUMAFED", "Tarif de reference": "0 DA", "PPA": "145 DA", "Num Enregistrement": "003/ 22 A 001 /01/14", "Code DCI": "22A001", "Forme": "COMP.", "Dosage": "2,5MG/50MG/300MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "RHUMAFRO  1,25MG/25MG/ 125MG /5ML SOL .BUV. FLACON DE 100 ML + GOBELET DOSEUR ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " ANTICORYZA PAR VOIE GENERALE", "C.Pharmacologique": " RHINOLOGIE", "C.Therapeutique": " TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)**  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** / PARACETAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RHUMAFRO ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "503/22A002/16", "Code DCI": "22A002", "Forme": "SOL. BUV.", "Dosage": "1,25MG/25MG/ 125MG /5ML", "Conditionnement": "FLACON DE 100 ML + GOBELET DOSEUR ", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHUMEDRINE 500MG/30MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL /  PSEUDOEPHEDRINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "RHUMEDRINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 03 B 057 /06", "Code DCI": "03B057", "Forme": "COMP. SEC.", "Dosage": "500MG/30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "RHUMOFEBRAL 1,25MG/25MG/125MG/5ML SOL. BUV. F/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)**  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** / PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "RHUMOFEBRAL", "Tarif de reference": " N/A", "PPA": "147.00 DA", "Num Enregistrement": "077/ 22 A 002 /03", "Code DCI": "22A002", "Forme": "SOL. BUV.", "Dosage": "1,25MG/25MG/125MG/5ML", "Conditionnement": "F/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIABAL 2MG/0,4ML SOL.BUV. FL/50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PRIFINIUM BROMURE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RIABAL", "Tarif de reference": " N/A", "PPA": "225.00 DA", "Num Enregistrement": "092/ 10 D 090 /98", "Code DCI": "10D090", "Forme": "SOL. BUV.", "Dosage": "2MG/0,4ML", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIABAL 30MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PRIFINIUM BROMURE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RIABAL", "Tarif de reference": " N/A", "PPA": "203.00 DA", "Num Enregistrement": "001/ 10 D 135 /04/09", "Code DCI": "10D135", "Forme": "COMP. PELLI.", "Dosage": "30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIABAL 7,5MG/ML (15MG/2ML) SOL. INJ. B/06AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/3938.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3938", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PRIFINIUM BROMURE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RIABAL", "Tarif de reference": "174.98 DA", "PPA": "N/A", "Num Enregistrement": "001/ 10 D 028 /01/09", "Code DCI": "10D028", "Forme": "SOL. INJ.", "Dosage": "7,5MG/ML (15MG/2ML)", "Conditionnement": "B/06AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIABAL COMPOUND 30MG/325MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PRIFINIUM BROMURE / PARACETAMOL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RIABAL COMPOUND", "Tarif de reference": " N/A", "PPA": "225.00 DA", "Num Enregistrement": "001/ 10 D 136 /04/09", "Code DCI": "10D136", "Forme": "COMP. PELLI.", "Dosage": "30MG/325MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIBAVIRINE BEKER 200MG GLES. B/170", "Img": "https://pharmnet-dz.com//img/medics/5715.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " RIBAVIRINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIBAVIRINE BEKER ", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "13P281", "Forme": "GLES.", "Dosage": "200MG ", "Conditionnement": "B/170", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIBOMUNYL  AERO. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " IMMUNOTHERAPIE & ANTI-ALLERGIQUES", "C.Therapeutique": " RHINOLOGIE", "Info": " FRACTIONS RIBOSOMALES/FRACTIONS MEMBRANAIRES", "Pays": "FRANCE", "Nom Commercial": "RIBOMUNYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "099/ 22 C 009 /98", "Code DCI": "22C009", "Forme": "AERO.", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIBOMUNYL  SOL.INJ. FL/1AMP de 0,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " IMMUNOTHERAPIE & ANTI-ALLERGIQUES", "C.Therapeutique": " RHINOLOGIE", "Info": " FRACTIONS RIBOSOMALES/FRACTIONS MEMBRANAIRES", "Pays": "FRANCE", "Nom Commercial": "RIBOMUNYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "099/ 22 C 007 /98", "Code DCI": "22C007", "Forme": "SOL. INJ.", "Conditionnement": "FL/1AMP de 0,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIBOMUSTIN 2,5MG/ML (APRES RECONSTITUTION) PDRE. P. SOL. A DILIER P. PERF. IV. B/05 FL. DE 25MG -B/01 FL. DE 100MG - B/05 FL. DE 100MG", "Img": "https://pharmnet-dz.com//img/medics/28.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " BENDAMUSTINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "RIBOMUSTIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "374/ 05 G 173 /14", "Code DCI": "05G173", "Forme": "PDRE. SOL. INJ.", "Dosage": "2,5MG/ML (APRES RECONSTITUTION)", "Conditionnement": "B/05 FL. DE 25MG -B/01 FL. DE 100MG - B/05 FL. DE 100MG", "Commercialisation": true, "Remboursable": true}, {"Nom": "RICABALINE 150MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2428.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RICABALINE", "Tarif de reference": "4302 DA", "PPA": "4302.00 DA", "Num Enregistrement": "289/ 15 A 068 /12", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RICABALINE 300MG MICROGRANULES EN GLES  B/60", "Img": "https://pharmnet-dz.com//img/medics/2434.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RICABALINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "289/ 15 A 069 /15", "Code DCI": "15A069", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "RICABALINE 50MG MICROGLES. EN GLES. B/60", "Img": "https://pharmnet-dz.com//img/medics/2421.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RICABALINE", "Tarif de reference": "1999.8 DA", "PPA": "1866.00 DA", "Num Enregistrement": "289/ 15 A 066 /12", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIFADIN 300MG GLES. B/1000", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GRUPPO LEPETIT", "C.Pharmacologique": " ANTITUBERCULEUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " RIFAMPICINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "RIFADIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "059/ 13 T 127 /00", "Code DCI": "13T127", "Forme": "GLES.", "Dosage": "300MG", "Conditionnement": "B/1000", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIFAMYCINE CHIBRET 1 000 000 UI/100ML COLLY. EN SOL. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2392.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2392", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " RIFAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RIFAMYCINE CHIBRET", "Tarif de reference": "213.28 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 D 033 /99/15", "Code DCI": "17D033", "Forme": "COLLY. SOL.", "Dosage": "1 000 000 UI/100ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIFAMYCINE CHIBRET 1000 000UI/100G (OU 1%) PDE.OPHT. T/5G", "Img": "https://pharmnet-dz.com//img/medics/2393.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2393", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " RIFAMYCINE SODIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RIFAMYCINE CHIBRET", "Tarif de reference": "214.05 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 D 034 /99/08", "Code DCI": "17D034", "Forme": "PDE. OPHT.", "Dosage": "1000 000UI/100G (OU 1%)", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIFATER 120MG/50MG/300 MG COMP. B/1000", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GRUPPO LEPETIT", "C.Pharmacologique": " ANTITUBERCULEUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " RIFAMPICINE/ISONIAZIDE/PYRAZINAMIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "RIFATER", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "059/ 13 T 131 /97", "Code DCI": "13T131", "Forme": "COMP.", "Dosage": "120MG/50MG/300 MG", "Conditionnement": "B/1000", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIFEX 120MG  COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/4015.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4015", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RIFEX", "Tarif de reference": "304 DA", "PPA": "N/A", "Num Enregistrement": "268/ 01 A 039 /07/12", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIFEX 180MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/4020.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4020", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RIFEX", "Tarif de reference": "358.6 DA", "PPA": "N/A", "Num Enregistrement": "268/ 01 A 040 /07/12", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIFINAH 150MG/100MG DRG. B/1000", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GRUPPO LEPETIT", "C.Pharmacologique": " ANTITUBERCULEUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " RIFAMPICINE/ISONIAZIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "RIFINAH", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "059/ 13 T 129 /97", "Code DCI": "13T129", "Forme": "DRG.", "Dosage": "150MG/100MG", "Conditionnement": "B/1000", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIFINAH 300MG/150MG DRG. B/1000", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GRUPPO LEPETIT", "C.Pharmacologique": " ANTITUBERCULEUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " RIFAMPICINE/ISONIAZIDE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "RIFINAH", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "059/ 13 T 130 /97", "Code DCI": "13T130", "Forme": "DRG.", "Dosage": "300MG/150MG", "Conditionnement": "B/1000", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIMETAZE LM 35MG COMP. PELLI. LM B/60", "Img": "https://pharmnet-dz.com//img/medics/1516.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1516", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RIMETAZE LM", "Tarif de reference": "470.4 DA", "PPA": " DA", "Num Enregistrement": "235/ 06 J 226 /11 ", "Code DCI": "06J226", "Forme": "COMP. PELLI.", "Dosage": "35MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RINOCLENIL 100\u00b5G/DOSE SUSP. EN SPRAY NASALE FL./200DOSES", "Img": "https://pharmnet-dz.com//img/medics/1941.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " BECLOMETASONE DIPROPIONATE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "RINOCLENIL", "Tarif de reference": "681.82 DA", "PPA": "N/A", "Num Enregistrement": "092/ 22 E 030 /08", "Code DCI": "22E030", "Forme": "SPRAY NAS.", "Dosage": "100\u00b5G/DOSE", "Conditionnement": "FL./200DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "RINOSPAN 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-ENURETIQUES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " OXYBUTYNINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RINOSPAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "304/ 25 D 008 /05", "Code DCI": "25D008", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIPERAL 1MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/2243.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2243", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIPERAL", "Tarif de reference": "930 DA", "PPA": "N/A", "Num Enregistrement": "352/ 16 D 089 /10", "Code DCI": "16D089", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIPERAL 1MG/ML SOL. BUV. GTTES. B/1FL. DE 30ML ET B/1FL. DE 120ML (AVEC BOUCHON DE SECURITE ENFANT ET UNE SERING. ORALE GRADUEE EN ML)", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIPERAL", "Tarif de reference": "1260 DA", "PPA": "929.00 DA", "Num Enregistrement": "352/ 16 D 092 /13", "Code DCI": "16D092", "Forme": "SOL. BUV. GTTES.", "Dosage": "1MG/ML", "Conditionnement": "B/1FL. DE 30ML ET B/1FL. DE 120ML (AVEC BOUCHON DE SECURITE ENFANT ET UNE SERING. ORALE GRADUEE EN ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIPERAL 2MG COMP. ENRO.  B/30", "Img": "https://pharmnet-dz.com//img/medics/2250.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2250", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIPERAL", "Tarif de reference": "3000 DA", "PPA": "2070.00 DA", "Num Enregistrement": "352/ 16 D 090 /10", "Code DCI": "16D090", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIPERAL 4MG COMP. ENRO.  B/30", "Img": "https://pharmnet-dz.com//img/medics/2257.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2257", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIPERAL", "Tarif de reference": "3960 DA", "PPA": "3150.00 DA", "Num Enregistrement": "352/ 16 D 091 /10", "Code DCI": "16D091", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIPSYZEN 1MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2244.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIPSYZEN", "Tarif de reference": "1287.6 DA", "PPA": "930.00 DA", "Num Enregistrement": "035/ 16 D 089 /11", "Code DCI": "16D089", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIPSYZEN 2MG COMP. ENRO. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2251.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIPSYZEN", "Tarif de reference": "6000 DA", "PPA": "2070.00 DA", "Num Enregistrement": "035 / 16 D 090 /11", "Code DCI": "16D090", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIPSYZEN 4MG COMP. ENRO. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2258.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIPSYZEN", "Tarif de reference": "3960 DA", "PPA": "3150.00 DA", "Num Enregistrement": "035/ 16 D 091 /11", "Code DCI": "16D091", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISALDENE 35MG COMP. PELLI.  B/04", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE MONOSODIQUE HEMIPENTAHYDRATE EXPRIME EN ACIDE RIDEDRONIQUE MONOSODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISALDENE", "Tarif de reference": "1760 DA", "PPA": "1760.00 DA", "Num Enregistrement": "001/ 21 D 046 /12 ", "Code DCI": "21D046", "Forme": "COMP. PELLI.", "Dosage": "35MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISEK 40MG/FL. DE PDRE. PDRE. LYOPH. P. SOL. INJ. PERF. B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE SODIQUE EXPRIME EN OMEPRAZOLE", "Liste": "Liste II", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "RISEK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "329/ 10 A 087 /13", "Code DCI": "10A087", "Forme": "LYOPH. SOL. INJ.", "Dosage": "40MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "RISONATE 35MG COMP PELLI B/04", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ACIDE RISEDRONIQUE MONOSODIQUE HEMIPENTAHYDRATE EXPRIME EN ACIDE RIDEDRONIQUE MONOSODIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISONATE", "Tarif de reference": "1760 DA", "PPA": "N/A", "Num Enregistrement": "352/21D046/15", "Code DCI": "21D046", "Forme": "COMP. PELLI.", "Dosage": "35MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISORDAN LP. 20MG COMP. LP B/60 ", "Img": "https://pharmnet-dz.com//img/medics/111.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=111", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ISOSORBIDE DINITRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "RISORDAN LP.", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 06 C 026 /96", "Code DCI": "06C026", "Forme": "COMP. LP", "Dosage": "20MG", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPAL 1MG COMP. PELLI. SEC. B/60", "Img": "https://pharmnet-dz.com//img/medics/2245.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2245", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPAL", "Tarif de reference": "2575.2 DA", "PPA": " DA", "Num Enregistrement": "263/ 16 D 089 /10", "Code DCI": "16D089", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPAL 2MG COMP. PELLI. SEC. B/60", "Img": "https://pharmnet-dz.com//img/medics/2252.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2252", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPAL", "Tarif de reference": "6000 DA", "PPA": " DA", "Num Enregistrement": "263/ 16 D 090 /10", "Code DCI": "16D090", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPAL 4MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2259.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2259", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPAL", "Tarif de reference": "3960 DA", "PPA": " DA", "Num Enregistrement": "263/ 16 D 091 /10", "Code DCI": "16D091", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPED  2MG COMP. PELLI. SEC B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPED ", "Tarif de reference": "2000 DA", "PPA": "N/A", "Num Enregistrement": "149/16D090/15", "Code DCI": "16D090", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPEED  1MG  COMP PELL SEC  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPEED ", "Tarif de reference": "858.4 DA", "PPA": "N/A", "Num Enregistrement": "149/16D089/16", "Code DCI": "16D089", "Forme": "COMP. SEC.", "Dosage": "1MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPEED  4MG COMP PELL SEC  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPEED ", "Tarif de reference": "2640 DA", "PPA": "N/A", "Num Enregistrement": "149/16D091/16", "Code DCI": "16D091", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERDAL 1MG/ML SOL.BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/2263.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2263", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDAL", "Tarif de reference": "2520 DA", "PPA": " DA", "Num Enregistrement": "095/ 16 D 092 /06", "Code DCI": "16D092", "Forme": "SOL. BUV. GTTES.", "Dosage": "1MG/ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERDAL CONSTA LP 25MG/2ML 12,5MG/ML  PDRE. ET SOLV.SUSP. INJ. L.P. B/1FL. PDRE. + 1SERING. PRE REMPLIE DE 2ML . DE SOLV.", "Img": "https://pharmnet-dz.com//img/medics/2297.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2297", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDAL CONSTA LP 25MG/2ML", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 16 D 119 /08", "Code DCI": "16D119", "Forme": "PDRE. SUSP. INJ", "Dosage": "12,5MG/ML ", "Conditionnement": "B/1FL. PDRE. + 1SERING. PRE REMPLIE DE 2ML . DE SOLV.", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERDAL CONSTA LP 37,5MG/2ML 18,75MG/ML PDRE. ET SOLV.SUSP. INJ. L.P. B/1FL. PDRE. + 1SERING. PRE REMPLIE DE 2ML . DE SOLV.", "Img": "https://pharmnet-dz.com//img/medics/2298.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2298", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDAL CONSTA LP 37,5MG/2ML", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 16 D 120 /08", "Code DCI": "16D120", "Forme": "PDRE. SUSP. INJ", "Dosage": "18,75MG/ML", "Conditionnement": "B/1FL. PDRE. + 1SERING. PRE REMPLIE DE 2ML . DE SOLV.", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERDAL CONSTA LP 50MG/2ML 25MG/ML PDRE. ET SOLV.SUSP. INJ. L.P. B/1FL. PDRE. + 1SERING. PRE REMPLIE DE 2ML . DE SOLV.", "Img": "https://pharmnet-dz.com//img/medics/2299.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2299", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDAL CONSTA LP 50MG/2ML", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 16 D 121 /08", "Code DCI": "16D121", "Forme": "PDRE. SUSP. INJ", "Dosage": "25MG/ML", "Conditionnement": "B/1FL. PDRE. + 1SERING. PRE REMPLIE DE 2ML . DE SOLV.", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERDALORO 0,5MG COMP. ORODISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2310", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDALORO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 16 D 141 /09", "Code DCI": "16D141", "Forme": "COMP. ORODISPERS.", "Dosage": "0,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "RISPERDALORO 1MG COMP. ORODISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2311", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDALORO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 16 D 142 /09", "Code DCI": "16D142", "Forme": "COMP. ORODISPERS.", "Dosage": "1MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "RISPERDALORO 2MG COMP. ORODISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2312", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDALORO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 16 D 143 /09", "Code DCI": "16D143", "Forme": "COMP. ORODISPERS.", "Dosage": "2MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "RISPERDALORO 3MG COMP. ORODISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2314", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDALORO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 16 D 144 /09", "Code DCI": "16D144", "Forme": "COMP. ORODISPERS.", "Dosage": "3MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "RISPERDALORO 4MG COMP. ORODISPERS. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2315", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RISPERDALORO", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 16 D 145 /09", "Code DCI": "16D145", "Forme": "COMP. ORODISPERS.", "Dosage": "4MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "RISPERIDONE BEKER 1MG COMP. PELLI. SEC. B/30 ET B/60", "Img": "https://pharmnet-dz.com//img/medics/2246.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2246", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BEKER", "Tarif de reference": "930.00 DA", "PPA": "930.00 DA", "Num Enregistrement": "447/ 16 D 089 /15", "Code DCI": "16D089", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30 ET B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BEKER 2MG COMP. PELLI. SEC B/60", "Img": "https://pharmnet-dz.com//img/medics/2253.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2253", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BEKER", "Tarif de reference": "4140.00 DA", "PPA": "4140.00 DA", "Num Enregistrement": "447/ 16 D 090 /12", "Code DCI": "16D090", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BEKER 4MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2260.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2260", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BEKER", "Tarif de reference": "3150.00 DA", "PPA": "3150.00 DA", "Num Enregistrement": "447/ 16 D 091 /12", "Code DCI": "16D091", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BEKER ORO 2MG COMP. ORODISPERS. B/60", "Img": "https://pharmnet-dz.com//img/medics/2313.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2313", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BEKER ORO", "Tarif de reference": "4140.00 DA", "PPA": "4140.00 DA", "Num Enregistrement": "447/ 16 D 143 /15", "Code DCI": "16D143", "Forme": "COMP. ORODISPERS.", "Dosage": "2MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BEKER ORO 4MG  COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medics/2316.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2316", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BEKER ORO", "Tarif de reference": "3150.00 DA", "PPA": "3150.00 DA", "Num Enregistrement": "447/ 16 D 145 /14", "Code DCI": "16D145", "Forme": "COMP. ORODISPERS.", "Dosage": "4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BGL 1MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medics/2247.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2247", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BGL", "Tarif de reference": "1287.6 DA", "PPA": "1172.00 DA", "Num Enregistrement": "235/ 16 D 089 /14", "Code DCI": "16D089", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BGL 1MG/ML SOL BUV B/01FL DE 60ML + SERINGUE GRADUEE EN MG/ML", "Img": "https://pharmnet-dz.com//img/medics/2264.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2264", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BGL", "Tarif de reference": "2520 DA", "PPA": "1860.00 DA", "Num Enregistrement": "235/ 16 D 092 /14", "Code DCI": "16D092", "Forme": "SOL. BUV. GTTES.", "Dosage": "1MG/ML", "Conditionnement": "B/01FL DE 60ML + SERINGUE GRADUEE EN MG/ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BGL 2MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2254.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2254", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BGL", "Tarif de reference": "0 DA", "PPA": "4140.00 DA", "Num Enregistrement": "235/ 16 D 090 /15", "Code DCI": "16D090", "Forme": "COMP. PELLI.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERIDONE BGL 4MG COMP PELLI B/30", "Img": "https://pharmnet-dz.com//img/medics/2261.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2261", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERIDONE BGL", "Tarif de reference": "3960 DA", "PPA": "3150.00 DA", "Num Enregistrement": "235/ 16 D 091 /14", "Code DCI": "16D091", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERNAD 1MG  COMP PELL SEC  B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERNAD", "Tarif de reference": "2575.2 DA", "PPA": "N/A", "Num Enregistrement": "468/ 16 D 089 /14", "Code DCI": "16D089", "Forme": "COMP. PELLI.", "Dosage": "1MG ", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERNAD 2MG  COMP PELL SEC  B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERNAD", "Tarif de reference": "6000 DA", "PPA": "N/A", "Num Enregistrement": "468/ 16 D 090 /14", "Code DCI": "16D090", "Forme": "COMP. PELLI.", "Dosage": "2MG ", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERNAD 4MG  COMP PELL SEC  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERNAD", "Tarif de reference": "3960 DA", "PPA": "N/A", "Num Enregistrement": "468/ 16 D 091 /14", "Code DCI": "16D091", "Forme": "COMP. PELLI.", "Dosage": "4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RISPERONE 3MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " RISPERIDONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RISPERONE", "Tarif de reference": "4660.2 DA", "PPA": "N/A", "Num Enregistrement": "321/ 16 D 122 /08", "Code DCI": "16D122", "Forme": "COMP.", "Dosage": "3MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "RITADOLE 10MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medics/3998.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3998", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RITADOLE", "Tarif de reference": "120 DA", "PPA": "119.00 DA", "Num Enregistrement": "235/ 01 A 033 /09", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "RITHRODAL 250MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RITHRODAL", "Tarif de reference": "280 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 244 /08", "Code DCI": "13E244", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "RITHRODAL 250MG/5ML PDRE. P. SUSP. BUV. FL./70ML + GOBLET DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RITHRODAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 297 /10", "Code DCI": "13E297", "Forme": "GRLES. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL./70ML + GOBLET DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "RITHRODAL 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RITHRODAL", "Tarif de reference": "574 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 215 /08", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIVASTI  3MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIVASTI ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/15F107/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIVASTI  4,5MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIVASTI ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/15F108/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "4,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIVASTI 1,5MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIVASTI", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "263/15F106/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "1,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "RIVASTIG 2MG/ML SOL. BUV. B/1FL. DE 125ML + SERING. DOSEUSE DE 3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " RIVASTIGMINE HYDROGENOTARTRATE EXPRIME EN RIVASTIGMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIVASTIG", "Tarif de reference": "4002.5 DA", "PPA": "N/A", "Num Enregistrement": "318/ 15 F 099 /11", "Code DCI": "15F099", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "B/1FL. DE 125ML + SERING. DOSEUSE DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RIVOMED 2MG COMP. SEC. B/40", "Img": "https://pharmnet-dz.com//img/medics/3512.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3512", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CLONAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RIVOMED", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "097/ 15 A 008 /09", "Code DCI": "15A008", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROFENAC LP  100MG CP PELL LP B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "ROFENAC LP", "Tarif de reference": "140 DA", "PPA": "N/A", "Code DCI": "04B007", "Forme": "COMP. PELLI. LP", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROFERON - A 3MUI/0,5ML SOL.INJ.SC B/1 Seringue pr\u00e9remplie ", "Img": "https://pharmnet-dz.com//img/medics/430.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=430", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "ROFERON - A", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 13 P 101 /99", "Code DCI": "13P101", "Forme": "PDRE. SOL. INJ.", "Dosage": "3MUI/0,5ML", "Conditionnement": "B/1 Seringue pr\u00e9remplie ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROFERON - A 9MUI/0,5ML SOL.INJ.SC B/1 seringue pr\u00e9remplie ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=426", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " INTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "ROFERON - A", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 13 P 100 /99", "Code DCI": "13P100", "Forme": "PDRE. SOL. INJ.", "Dosage": "9MUI/0,5ML", "Conditionnement": "B/1 seringue pr\u00e9remplie ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROLAN  25MG/ML (50MG/2ML) SOL. INJ. IM/IV  B/05 AMP.2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RANITIDINE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "ROLAN ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 10 A 002 /05/13", "Code DCI": "10A002", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (50MG/2ML)", "Conditionnement": "B/05 AMP.2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "RONIDAZ 250 250MG COMP,SECA B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MERINAL", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RONIDAZ 250", "Tarif de reference": "107 DA", "PPA": "N/A", "Num Enregistrement": "268/13F039/16", "Code DCI": "13F039", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RONIDAZ 500 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MERINAL", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RONIDAZ 500", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "268/13F199/16", "Code DCI": "13F199", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "RONIUM 50MG/5ML ( 10 MG/ML)  SOL.INJ. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ROCURONIUM BROMURE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RONIUM", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "02D049", "Forme": "SOL. INJ.", "Dosage": "50MG/5ML ( 10 MG/ML) ", "Conditionnement": "B/10 FL", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROSAL 20MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2551.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " FLUOXETINE CHLORHYDRATE EXPRIME EN FLUOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROSAL", "Tarif de reference": "390.9 DA", "PPA": "N/A", "Num Enregistrement": "317/ 16 A 078 /11", "Code DCI": "16A078", "Forme": "GLES.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROSUVASTOR 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROSUVASTOR", "Tarif de reference": "837,6 DA", "PPA": "N/A", "Code DCI": "06M269", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROSUVASTOR 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/5803.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ROSUVASTOR", "Tarif de reference": "1247,4 DA", "PPA": " DA", "Code DCI": "06M270", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROSUVASTOR 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROSUVASTOR", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06M296", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROVADAL 0,375MUI/5ML SIROP FL./150ML", "Img": "https://pharmnet-dz.com//img/medics/798.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=798", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROVADAL", "Tarif de reference": "250 DA", "PPA": "250 DA", "Num Enregistrement": "003/ 13 E 154 /09", "Code DCI": "13E154", "Forme": "SIROP", "Dosage": "0,375MUI/5ML", "Conditionnement": "FL./150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROVADAL 1 500 000UI COMP. B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROVADAL", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 031 /09", "Code DCI": "13E031", "Forme": "COMP. PELLI.", "Dosage": "1 500 000UI", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROVADAL 3 000 000UI COMP. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROVADAL", "Tarif de reference": "615 DA", "PPA": "550.00 DA", "Num Enregistrement": "003 / 13 E 032 /09", "Code DCI": "13E032", "Forme": "COMP. PELLI.", "Dosage": "3 000 000UI", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROVAGYL 1,5MUI/250MG COMP. DISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE / METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROVAGYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 E 331 /08", "Code DCI": "13E331", "Forme": "COMP. DISPERS.", "Dosage": "1,5MUI/250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "ROVAMYCINE 1 500 000UI COMP.PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medics/789.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=789", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROVAMYCINE", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "428/ 13 E 031 /96/10", "Code DCI": "13E031", "Forme": "COMP. PELLI.", "Dosage": "1 500 000UI", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROVAMYCINE 3 000 000UI COMP.PELLI. B/10 ET B/16", "Img": "https://pharmnet-dz.com//img/medics/794.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=794", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROVAMYCINE", "Tarif de reference": "656 DA", "PPA": "N/A", "Num Enregistrement": "428/ 13 E 032 /96/10", "Code DCI": "13E032", "Forme": "COMP. PELLI.", "Dosage": "3 000 000UI", "Conditionnement": "B/10 ET B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROVAZINE 500MG SUPPO. B/30", "Img": "https://pharmnet-dz.com//img/medics/2977.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2977", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "ALGERIE", "Nom Commercial": "ROVAZINE", "Tarif de reference": "1849.97 DA", "PPA": "N/A", "Num Enregistrement": "366/ 10 N 076 /10", "Code DCI": "10N076", "Forme": "SUPPO.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROVERON 25MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ASIA PHARMACEUTICALS", "C.Pharmacologique": " MEDICAMENTS DE L'HYPOGONADISME MASCULIN", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " MESTEROLONE", "Liste": "Liste II", "Pays": "SYRIE", "Nom Commercial": "ROVERON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "121/ 25 H 021 /06", "Code DCI": "25H021", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ROWASA 500MG COMP GASTRO RESIST. B/90 ", "Img": "https://pharmnet-dz.com//img/medics/2976.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2976", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "FRANCE", "Nom Commercial": "ROWASA", "Tarif de reference": "4988.64 DA", "PPA": "N/A", "Num Enregistrement": "031/ 10 N 075 /97", "Code DCI": "10N075", "Forme": "COMP. LP", "Dosage": "500MG", "Conditionnement": "B/90 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROWASA 500MG SUPPO. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Pays": "FRANCE", "Nom Commercial": "ROWASA", "Tarif de reference": "0 DA", "PPA": "4950.00 DA", "Num Enregistrement": "031/ 10 N 076 /97", "Code DCI": "10N076", "Forme": "SUPPO.", "Dosage": "500MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROXAMED 150MG COMP. ENRO. B/10", "Img": "https://pharmnet-dz.com//img/medics/807.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " DAR AL DAWA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ROXITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ROXAMED", "Tarif de reference": " N/A", "PPA": "348.00 DA", "Num Enregistrement": "055/ 13 E 185 /01/13", "Code DCI": "13E185", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "ROXIBACT ALEMBIC MAMI 150MG COMP PELLICULE B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ALEMBIC MAMI SPA", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ROXITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROXIBACT ALEMBIC MAMI", "Tarif de reference": "314,80 DA", "PPA": " DA", "Code DCI": "13E185", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROXICAM 20MG  GLES  B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " PIROXICAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROXICAM", "Tarif de reference": "143 DA", "PPA": "143.00 DA", "Num Enregistrement": "418/ 04 B 022 /14", "Code DCI": "04B022", "Forme": "COMP. DISPERS.", "Dosage": "20MG ", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROXID 150MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/808.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=808", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ROXITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROXID", "Tarif de reference": "314.8 DA", "PPA": "N/A", "Num Enregistrement": "035/ 13 E 185 /98/10", "Code DCI": "13E185", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROXITHROMYCINE HUP 150MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ROXITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROXITHROMYCINE HUP", "Tarif de reference": "314.8 DA", "PPA": "314.00 DA", "Num Enregistrement": "380/ 13 E 185 /12", "Code DCI": "13E185", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROZEMIDE 1MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3647.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROZEMIDE", "Tarif de reference": "250.8 DA", "PPA": "250.00 DA", "Num Enregistrement": "035/ 14 A 187 /06", "Code DCI": "14A187", "Forme": "COMP. SEC.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROZEMIDE 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3661.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROZEMIDE", "Tarif de reference": "480 DA", "PPA": "480.00 DA", "Num Enregistrement": "035/ 14 A 188 /06", "Code DCI": "14A188", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROZEMIDE 3MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3674.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROZEMIDE", "Tarif de reference": "720 DA", "PPA": "N/A", "Num Enregistrement": "035/ 14 A 189 /06", "Code DCI": "14A189", "Forme": "COMP. SEC.", "Dosage": "3MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROZEMIDE 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3683.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " GLIMEPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ROZEMIDE", "Tarif de reference": "750 DA", "PPA": "728.00 DA", "Num Enregistrement": "035/ 14 A 190 /11", "Code DCI": "14A190", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ROZEX 0.0075 GEL.DERM. T/30G", "Img": "https://pharmnet-dz.com//img/medics/1679.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1679", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ROZEX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "123/ 07 C 018 /98/14", "Code DCI": "07C018", "Forme": "GEL. DERM.", "Dosage": "0.0075", "Conditionnement": "T/30G", "Commercialisation": true, "Remboursable": false}, {"Nom": "RUBIDEX 2MG/ML ( 10MG/5ML) ET (50MG/25ML) SOL INJ POUR PER IV B DE 1 FL 5ML ET B DE 1 FL 25 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " CONTINENTAL PHARM", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RUBIDEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "323/05G180/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "2MG/ML ( 10MG/5ML) ET (50MG/25ML)", "Conditionnement": "B DE 1 FL 5ML ET B DE 1 FL 25 ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "RUMABREX 100MG GLES. B/24", "Img": "https://pharmnet-dz.com//img/medics/2818.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2818", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RUMABREX", "Tarif de reference": "624 DA", "PPA": "N/A", "Num Enregistrement": "352/ 04 B 035 /12", "Code DCI": "04B035", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": true}, {"Nom": "RUMABREX 200MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/2831.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2831", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " CELECOXIB", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RUMABREX", "Tarif de reference": "624 DA", "PPA": "N/A", "Num Enregistrement": "352/ 04 B 036 /12", "Code DCI": "04B036", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "RUMAVA 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1444.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " EL KENDI", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RUMAVA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 21 J 042 /14", "Code DCI": "21J042", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RUMAVA 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1448.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " EL KENDI", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEFLUNOMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RUMAVA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 21 J 043 /15", "Code DCI": "21J043", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "RUMIFEN 100MG/5ML SUSP. BUV. FL./145ML + PIPETTE DE 5ML GRADUEE EN KG", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " LGPA", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RUMIFEN", "Tarif de reference": " N/A", "PPA": "168.00 DA", "Num Enregistrement": "311/ 04 B 042 /15", "Code DCI": "04B042", "Forme": "SOL. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "FL./145ML + PIPETTE DE 5ML GRADUEE EN KG", "Commercialisation": true, "Remboursable": null}, {"Nom": "RUPAFIN 10MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/4026.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4026", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " RUPATADINE FUMARATE EXPRIME EN RUPATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RUPAFIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 01 A 043 /09", "Code DCI": "01A043", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "RUSCOLOG 120MG/10MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE / RUSCOGENINES", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "RUSCOLOG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 10 P 084 /06", "Code DCI": "10P084", "Forme": "SUPPO.", "Dosage": "120MG/10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "RYNZA 750MG/20MG/10MG/30MG/SACH. DE 5G PDRE. SOL. BUV. EN SACH.-DOSE  B/05 SACH. DE 5G", "Img": "https://pharmnet-dz.com//img/medics/1467.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1467", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / MALEATE DE PHENIRAMINE / PHENYLEPHRINE HYDROCHLORIDE / CAFEINE", "Pays": "ALGERIE", "Nom Commercial": "RYNZA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "263/ 22 A 034 /08/14", "Code DCI": "22A034", "Forme": "PDRE. SOL. BUV.", "Dosage": "750MG/20MG/10MG/30MG/SACH. DE 5G", "Conditionnement": "B/05 SACH. DE 5G", "Commercialisation": true, "Remboursable": false}, {"Nom": "RYTHMODAN LP 250MG COMP. ENRO. LP B/20 ", "Img": "https://pharmnet-dz.com//img/medics/135.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=135", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DISOPYRAMIDE LP", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "RYTHMODAN LP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 06 D 044 /97/09", "Code DCI": "06D044", "Forme": "COMP. ENRO. LP", "Dosage": "250MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "RYTHROMAC 200MG/5ML SUSP.BUV. FL/125 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ERYTHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "RYTHROMAC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "166/ 13 E 028 /98", "Code DCI": "13E028", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG/5ML", "Conditionnement": "FL/125 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "RYVOL 15MG COMP. PELLI B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "RYVOL", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "12F167", "Forme": "COMP. PELLI.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "RYVOL 15MG COMP. PELLI. B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Pays": "ALGERIE", "Nom Commercial": "RYVOL", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "12F167", "Forme": "COMP. PELLI.", "Dosage": "15MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}], "S": [{"Nom": "SAIFEN 0.025 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SAIFEN", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "003/ 21 A 032 /09", "Code DCI": "21A032", "Forme": "GEL DERM.", "Dosage": "0.025", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAIFEN 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " KETOPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SAIFEN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 04 B 017 /01/10", "Code DCI": "04B017", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SAIFLU 75MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OSELTAMIVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIFLU", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 13 P 290 /06", "Code DCI": "13P290", "Forme": "GLES.", "Dosage": "75MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAIFLU ENFANT 45MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OSELTAMIVIR PHOSPHATE EXPRIME EN OSELTAMIVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIFLU ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 P 442 /09", "Code DCI": "13P442", "Forme": "GLES.", "Dosage": "45MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SAIFLU NOURRISSON 30MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OSELTAMIVIR PHOSPHATE EXPRIME EN OSELTAMIVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIFLU NOURRISSON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 13 P 441 /09", "Code DCI": "13P441", "Forme": "GLES.", "Dosage": "30MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SAIFOXYL 1G COMP. DISPERS. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " APU", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIFOXYL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "287/ 13 G 230 /07/13 ", "Code DCI": "13G230", "Forme": "COMP. DISPERS.", "Dosage": "1G", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "SAIFOXYL 500MG COMP. SEC. DISPERS. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " APU", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATEE EXPRIME EN AMOXICILLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIFOXYL", "Tarif de reference": "127.92 DA", "PPA": "N/A", "Num Enregistrement": "287/ 13 G 301 /09", "Code DCI": "13G301", "Forme": "COMP. DISPERS.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAILOX 3,50G/4,00G/100ML SUSP. BUV. FL/250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "ALGERIE", "Nom Commercial": "SAILOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 B 010 /06", "Code DCI": "10B010", "Forme": "SUSP. BUV.", "Dosage": "3,50G/4,00G/100ML", "Conditionnement": "FL/250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SAILOX 400MG/400MG COMP. A CROQUER B/40", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " HYDROXYDE D'ALUMINIUM / HYDROXYDE DE MAGNESIUM", "Pays": "ALGERIE", "Nom Commercial": "SAILOX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 B 137 /05", "Code DCI": "10B137", "Forme": "COMP. A CROQ.", "Dosage": "400MG/400MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAIPRIL 25MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIPRIL", "Tarif de reference": "148.8 DA", "PPA": "107.00 DA", "Num Enregistrement": "003/ 06 E 052 /02", "Code DCI": "06E052", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAIPRIL 50MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIPRIL", "Tarif de reference": "285 DA", "PPA": "498.00 DA", "Num Enregistrement": "003/ 06 E 053 /04", "Code DCI": "06E053", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAIPRIL PLUS 50MG/25MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medics/189.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=189", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAIPRIL PLUS", "Tarif de reference": "502.2 DA", "PPA": "496 DA", "Num Enregistrement": "003/ 06 E 137 /06", "Code DCI": "06E137", "Forme": "COMP. SEC.", "Dosage": "50MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAIZEN CLICKEASY 8MG/1,37ML PDRE.ET SOLVT. SOL. INJ. SC MULTIDOSE B/01FL PDRE.+01CART. SOLVT. PRE-ASSEMBLES DANS UN DISPOSITIF DE RECONSTITUTION CLICK EASY", "Img": "https://pharmnet-dz.com//img/medics/3795.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3795", "Laboratoire": " MERCK SERONO", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " SOMATROPINE OU HORMONE DE CROISSANCE HUMAINE RECOMBINANTE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "SAIZEN CLICKEASY", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "062/ 09 J 141 /06/14", "Code DCI": "09J141", "Forme": "PDRE. SOL. INJ.", "Dosage": "8MG/1,37ML", "Conditionnement": "B/01FL PDRE.+01CART. SOLVT. PRE-ASSEMBLES DANS UN DISPOSITIF DE RECONSTITUTION CLICK EASY", "Commercialisation": true, "Remboursable": true}, {"Nom": "SALAZA 500MG SUPPO. B/15", "Img": "https://pharmnet-dz.com//img/medics/4409.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4409", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MESALAZINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SALAZA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/10N076/16", "Code DCI": "10N076", "Forme": "SUPPO.", "Dosage": "500MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "SALAZOPYRIN EN 500MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2980", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " MEDICAMENTS DE LA RECTOCOLITE HEMORRAGIQUE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " SALAZOSULFAPYRIDINE", "Pays": "FRANCE", "Nom Commercial": "SALAZOPYRIN EN", "Tarif de reference": "1213.82 DA", "PPA": "N/A", "Num Enregistrement": "076/ 10 N 078 /99", "Code DCI": "10N078", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "SALBULAM 2MG/5ML SOL. BUV. SANS SUCRE FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SALBULAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 20 A 016 /98/14", "Code DCI": "20A016", "Forme": "SOL. BUV.", "Dosage": "2MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SALBUMEX 2MG/5ML SOL BUV FL/150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL** (SOUS FORME DE SULFATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SALBUMEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "400/20A016/16", "Code DCI": "20A016", "Forme": "SOL. BUV.", "Dosage": "2MG/5ML", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SALBUTAMOL  PHYSIOPHARM 2MG/5ML SOL, BUV B/01 FLACON DE 125ML", "Img": "https://pharmnet-dz.com//img/medics/4526.png", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SALBUTAMOL  PHYSIOPHARM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "462/20A016/16", "Code DCI": "20A016", "Forme": "SOL. BUV.", "Dosage": "2MG/5ML", "Conditionnement": "B/01 FLACON DE 125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SALBUTAMOL 0,5MG/ML SOL.INJ B/10AMP. DE 1ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "SALBUTAMOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 20 A 014 /00", "Code DCI": "20A014", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML", "Conditionnement": "B/10AMP. DE 1ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "SALBUTAMOL 2MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EIPICO ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "EGYPTE", "Nom Commercial": "SALBUTAMOL", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "109/ 20 A 015 /99", "Code DCI": "20A015", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SALBUTAMOL LPA 2MG/5ML** SOL. BUV. FL./150ML+UNE CUILLERE MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SALBUTAMOL LPA", "Tarif de reference": " N/A", "PPA": "151.00 DA", "Num Enregistrement": "026/ 20 A 016 /06/12", "Code DCI": "20A016", "Forme": "SOL. BUV.", "Dosage": "2MG/5ML**", "Conditionnement": "FL./150ML+UNE CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SALBUTAMOL SAIDAL 2MG/5ML** SIROP FL/150ML", "Img": "https://pharmnet-dz.com//img/medics/2085.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SALBUTAMOL SAIDAL", "Tarif de reference": "151 DA", "PPA": "168.00 DA", "Num Enregistrement": "003/ 20 A 016 /97/09", "Code DCI": "20A016", "Forme": "SOL. BUV.", "Dosage": "2MG/5ML**", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SALITIN 500MG/FL. DE PDRE. PDRE. SOL. INJ. IM/IV B/05 FL.DE PDRE.+05AMP. DE 5ML DE SOLV.(EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " EL KENDI", "C.Pharmacologique": " SALICYLES", "C.Therapeutique": " ANTALGIQUES", "Info": " ACETYLSALICYLATE DE DL LYSINE EXPRIME EN ACIDE ACETYLSALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "SALITIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 03 A 004 /08", "Code DCI": "03A004", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/05 FL.DE PDRE.+05AMP. DE 5ML DE SOLV.(EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "SANDIMMUN 100MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medics/1029.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1029", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 05 B 049 /97", "Code DCI": "05B049", "Forme": "CAPS.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "SANDIMMUN 100MG/ML SOL.BUV. FL/50ML", "Img": "https://pharmnet-dz.com//img/medics/1022.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1022", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 05 B 047 /97", "Code DCI": "05B047", "Forme": "SOL. INJ.", "Dosage": "100MG/ML", "Conditionnement": "FL/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SANDIMMUN 25MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1026", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 B 048 /97", "Code DCI": "05B048", "Forme": "CAPS.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "SANDIMMUN 50MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1033", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 B 082 /98", "Code DCI": "05B082", "Forme": "CAPS.", "Dosage": "50MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "SANDIMMUN 50MG/ML SOL.INJ. B/10FL./1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1020", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 05 B 045 /97", "Code DCI": "05B045", "Forme": "SOL. INJ.", "Dosage": "50MG/ML", "Conditionnement": "B/10FL./1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SANDIMMUN NEORAL 100MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medics/4297.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4297", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN NEORAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/27A008/98/15", "Code DCI": "N/D", "Forme": "CAPS.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "SANDIMMUN NEORAL 25MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medics/4295.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4295", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN NEORAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/27A006/98/15", "Code DCI": "N/D", "Forme": "CAPS.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "SANDIMMUN NEORAL 50MG CAPS. B/50", "Img": "https://pharmnet-dz.com//img/medics/4296.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4296", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " CICLOSPORINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDIMMUN NEORAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/27A007/98/15", "Code DCI": "N/D", "Forme": "CAPS.", "Dosage": "50MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "SANDOSTATINE 100\u00b5G/ML SOL.INJ B/6 AMP DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3827", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " OCTREOTIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDOSTATINE", "Tarif de reference": "8874.9 DA", "PPA": "N/A", "Num Enregistrement": "068/ 09 P 109 /00", "Code DCI": "09P109", "Forme": "SOL. INJ.", "Dosage": "100\u00b5G/ML", "Conditionnement": "B/6 AMP DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SANDOSTATINE 50\u00b5G/ML SOL.INJ. B/6 AMP", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3826", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " OCTREOTIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDOSTATINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 09 P 071 /96", "Code DCI": "09P071", "Forme": "SOL. INJ.", "Dosage": "50\u00b5G/ML", "Conditionnement": "B/6 AMP", "Commercialisation": true, "Remboursable": null}, {"Nom": "SANDOSTATINE 500\u00b5G/ML SOL.INJ B/6 AMP DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3828", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " OCTREOTIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SANDOSTATINE", "Tarif de reference": "9468 DA", "PPA": "N/A", "Num Enregistrement": "068/ 09 P 110 /00", "Code DCI": "09P110", "Forme": "SOL. INJ.", "Dosage": "500\u00b5G/ML", "Conditionnement": "B/6 AMP DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SANMIGRAN 0,50MG (PIZOTIFENE MALEATE 0,73MG) COMP.ENRO B/50", "Img": "https://pharmnet-dz.com//img/medics/2467.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2467", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " PIZOTIFENE (SOUS FORME DE MALATE)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "SANMIGRAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 15 B 022 /97", "Code DCI": "15B022", "Forme": "COMP. PELLI.", "Dosage": "0,50MG (PIZOTIFENE MALEATE 0,73MG)", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPBRIDATE 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/2889.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SAPBRIDATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "289/ 10 F 051 /04/14", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SAPBUFEN  600MG GRANULES P/SOL. BUV. EN SACHET ADULTE B/12 ", "Img": "https://pharmnet-dz.com//img/medics/4422.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SAPBUFEN ", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "289/04B072/16", "Code DCI": "N/D", "Forme": "GRLES. SOL. BUV.", "Dosage": "600MG", "Conditionnement": "B/12 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPOFEN 400MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "SAPOFEN", "Tarif de reference": "157.00 DA", "PPA": " DA", "Num Enregistrement": "190/04B010/98/17", "Code DCI": "04B010", "Forme": "COMP.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPOFEN 600MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SPIMACO SOCIETE SAOUDIENNE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "SAPOFEN ", "Tarif de reference": "235.50 DA", "PPA": " DA", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPOMEX 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SAPOMEX", "Tarif de reference": "120 DA", "PPA": "N/A", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPOMEX 600MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SAPOMEX", "Tarif de reference": "235.50 DA", "PPA": "N/A", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPRAMOL 100MG PDRE. SOL. BUV. EN SACH. B/12", "Img": "https://pharmnet-dz.com//img/medics/4153.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4153", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SAPRAMOL", "Tarif de reference": "102.24 DA", "PPA": "102.00 DA", "Num Enregistrement": "289/ 03 B 006 /06", "Code DCI": "03B006", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPRAMOL 150MG PDRE. SOL. BUV. EN SACH. B/12", "Img": "https://pharmnet-dz.com//img/medics/4189.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4189", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SAPRAMOL", "Tarif de reference": "102.24 DA", "PPA": " DA", "Num Enregistrement": "289/ 03 B 044 /06", "Code DCI": "03B044", "Forme": "PDRE. SOL. BUV.", "Dosage": "150MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPRAMOL 200MG PDRE. SOL. BUV. EN SACH. B/12", "Img": "https://pharmnet-dz.com//img/medics/4192.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SAPRAMOL", "Tarif de reference": "110.28 DA", "PPA": "110.00 DA", "Num Enregistrement": "289/ 03 B 045 /06", "Code DCI": "03B045", "Forme": "PDRE. SOL. BUV.", "Dosage": "200MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPRAMOL 300MG PDRE. SOL. BUV. EN SACH. B/12", "Img": "https://pharmnet-dz.com//img/medics/4194.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4194", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SAPRAMOL", "Tarif de reference": "120 DA", "PPA": " DA", "Num Enregistrement": "289/ 03 B 046 /06", "Code DCI": "03B046", "Forme": "PDRE. SOL. BUV.", "Dosage": "300MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPRAMOL 500MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SAPRAMOL", "Tarif de reference": "50 DA", "PPA": "168.00 DA", "Num Enregistrement": "289/ 03 B 005 /04", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SAPRAMOL 500MG PDRE. SOL. BUV. EN SACHETS B/12", "Img": "https://pharmnet-dz.com//img/medics/2621.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2621", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SAPRAMOL", "Tarif de reference": "30 DA", "PPA": " DA", "Num Enregistrement": "289/ 03 B 066 /06", "Code DCI": "03B066", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARCAND 16MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3156.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARCAND", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "352/ 06 E 234/14", "Code DCI": "06E234", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARCAND 4MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3104.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARCAND", "Tarif de reference": "699.6 DA", "PPA": "699.00 DA", "Num Enregistrement": "352/ 06 E 196 /14", "Code DCI": "06E196", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARCAND 8MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/3109.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARCAND", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "352/ 06 E 197/14", "Code DCI": "06E197", "Forme": "COMP. SEC.", "Dosage": "8MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARGENINE 1G COMP.EFFER. B/01 TUBE DE 20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " API", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARGENINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "348/14H171/16", "Code DCI": "N/D", "Forme": "COMP. EFFERV.", "Dosage": "1G", "Conditionnement": "B/01 TUBE DE 20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SARGENOR 1G/5ML SOL. BUV. AMP. B/20 AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/3449.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3449", "Laboratoire": " MEDA PHARMA ", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ARGININE ASPARTATE", "Pays": "FRANCE", "Nom Commercial": "SARGENOR", "Tarif de reference": "0 DA", "PPA": "330.00 DA", "Num Enregistrement": "459/ 14 H 172 /99/09", "Code DCI": "14H172", "Forme": "SOL. BUV. AMP.", "Dosage": "1G/5ML", "Conditionnement": "B/20 AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARGENOR ENFANT 0,5G/5ML SOL. BUV. AMP. B/20AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/3462.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3462", "Laboratoire": " MEDA PHARMA ", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ARGININE ASPARTATE", "Pays": "FRANCE", "Nom Commercial": "SARGENOR ENFANT", "Tarif de reference": "0 DA", "PPA": "285.00 DA", "Num Enregistrement": "459/ 14 H 302 /06", "Code DCI": "14H302", "Forme": "SOL. BUV. AMP.", "Dosage": "0,5G/5ML", "Conditionnement": "B/20AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARGENOR VITAMINE C 1,5G/0,5G/5ML SOL.BUV. AMP. B/20AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/3453.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3453", "Laboratoire": " MEDA PHARMA ", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ARGININE ASPARTATE / ACIDE ASCORBIQUE", "Pays": "FRANCE", "Nom Commercial": "SARGENOR VITAMINE C", "Tarif de reference": "0 DA", "PPA": "398.00 DA", "Num Enregistrement": "459/ 14 H 207 /03/09", "Code DCI": "14H207", "Forme": "AMP. BUV.", "Dosage": "1,5G/0,5G/5ML", "Conditionnement": "B/20AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARTEG 160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3087.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARTEG", "Tarif de reference": "1597.5 DA", "PPA": "1597.00 DA", "Num Enregistrement": "352/ 06 E 166 /10", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARTEG 320MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3225.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARTEG", "Tarif de reference": " N/A", "PPA": "1597.00 DA", "Num Enregistrement": "352 / 06 E 308 /14", "Code DCI": "06E308", "Forme": "COMP. PELLI.", "Dosage": "320MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SARTEG 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/197.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARTEG", "Tarif de reference": "1597.5 DA", "PPA": "1597.00 DA", "Num Enregistrement": "352/ 06 E 147 /10", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARTIX 16MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARTIX", "Tarif de reference": "1204 DA", "PPA": "1204.00 DA", "Num Enregistrement": "003/ 06 E 234 /11", "Code DCI": "06E234", "Forme": "COMP. SEC.", "Dosage": "16MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SARTIX 8MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SARTIX", "Tarif de reference": "1204 DA", "PPA": "1204.00 DA", "Num Enregistrement": "003/ 06 E 197 /11", "Code DCI": "06E197", "Forme": "COMP. SEC.", "Dosage": "8MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SCANDICAINE 0.02 CARPULE B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4091.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SEPTODENT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " MEPIVACAINE/NORADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SCANDICAINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "044/ 02 C 029 /98", "Code DCI": "02C029", "Forme": "CARPULE", "Dosage": "0.02", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SCANDICAINE 0.03 SOL.INJ B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4093.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SEPTODENT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " MEPIVACAINE", "Pays": "FRANCE", "Nom Commercial": "SCANDICAINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "044/ 02 C 030 /97", "Code DCI": "02C030", "Forme": "SOL. INJ.", "Dosage": "0.03", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SCANDICAINE 2% / 1/100 000  (OU 2G/ 0,001G/100ML) SOL.INJ B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SEPTODENT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " MEPIVACAINE  (CHLORHYDRATE) / ADRENALINE (TARTRATE) ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SCANDICAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "044/ 02 C 028 /97", "Code DCI": "02C028", "Forme": "SOL. INJ.", "Dosage": "2% / 1/100 000  (OU 2G/ 0,001G/100ML)", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SCHIZOPIN 10MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SCHIZOPIN", "Tarif de reference": "7020 DA", "PPA": "6000.00 DA", "Num Enregistrement": "001/ 16 D 101 /11", "Code DCI": "16D101", "Forme": "COMP. ORODISPERS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SCHIZOPIN 5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SCHIZOPIN", "Tarif de reference": "3510 DA", "PPA": "3000.00 DA", "Num Enregistrement": "001/ 16 D 155 /12", "Code DCI": "16D155", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEACAL CALCIUM 500MG COMP. PELLI. FL./60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CALCIUM CARBONATE", "Pays": "ALGERIE", "Nom Commercial": "SEACAL CALCIUM", "Tarif de reference": "465 DA", "PPA": "N/A", "Num Enregistrement": "352/ 14 G 141 /08", "Code DCI": "14G141", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "FL./60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEBIPROX 1,5% SOL. FL/100ML", "Img": "https://pharmnet-dz.com//img/medics/471.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=471", "Laboratoire": " STIEFEL", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " CICLOPIROX OLAMINE", "Pays": "IRELAND", "Nom Commercial": "SEBIPROX", "Tarif de reference": "458 DA", "PPA": " DA", "Num Enregistrement": "125/ 07 D 140 /04", "Code DCI": "07D140", "Forme": "SOL. DERM.", "Dosage": "1,5%", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEBUTOL 200MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3230.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SEBUTOL", "Tarif de reference": " N/A", "PPA": "314.00 DA", "Num Enregistrement": "268/ 06 F 067 /06/13", "Code DCI": "06F067", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SECNIDOLEX 2G/SACHET- DOSE MICROGRANULES  EN SACHET- DOSE B/01", "Img": "https://pharmnet-dz.com//img/medics/4275.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SECNIDAZOLE ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SECNIDOLEX", "Tarif de reference": "168 DA", "PPA": " DA", "Num Enregistrement": "289/13F330/15", "Code DCI": "13F330", "Forme": "MICROGRANULES", "Dosage": "2G/SACHET- DOSE", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "SECNOL 2G/SACHET- DOSE MICROGRANULES  EN SACHET- DOSE B/01", "Img": "https://pharmnet-dz.com//img/medics/877.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=877", "Laboratoire": " IPRAD", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SECNIDAZOLE ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SECNOL", "Tarif de reference": "168 DA", "PPA": "N/A", "Num Enregistrement": "240/ 13 F 330 /08", "Code DCI": "13F330", "Forme": "MICROGRANULES", "Dosage": "2G/SACHET- DOSE", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "SECTRAL  200MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SECTRAL ", "Tarif de reference": " N/A", "PPA": "487.00 DA", "Num Enregistrement": "428/ 06 F 067 /96/09", "Code DCI": "06F067", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SECTRAL  400MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ACEBUTOLOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SECTRAL ", "Tarif de reference": " N/A", "PPA": "906.00 DA", "Num Enregistrement": "428/ 06 F 068 /96/09", "Code DCI": "06F068", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SEDACORON 200MG COMP. SEC. B/50", "Img": "https://pharmnet-dz.com//img/medics/132.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "AUTRICHE", "Nom Commercial": "SEDACORON", "Tarif de reference": "0 DA", "PPA": "622.00 DA", "Num Enregistrement": "141/ 06 D 041 /98/09", "Code DCI": "06D041", "Forme": "COMP SEC.", "Dosage": "200MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEDACORON 50MG/ML (150MG/3ML) SOL.INJ.IV. B/05 AMP. DE 3ML", "Img": "https://pharmnet-dz.com//img/medics/126.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "AUTRICHE", "Nom Commercial": "SEDACORON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 06 D 040 /98/08", "Code DCI": "06D040", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (150MG/3ML)", "Conditionnement": "B/05 AMP. DE 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEFAZOL 1G/FL. DE PDRE. PDRE.SOL.INJ. IM B/1FL. DE LYOPH.+1 AMP. DE 4ML DE SOLV. (LIDOCAINE)", "Img": "https://pharmnet-dz.com//img/medics/1907.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "SEFAZOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "176/ 13 B 013 /98/15", "Code DCI": "13B013", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE LYOPH.+1 AMP. DE 4ML DE SOLV. (LIDOCAINE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEFAZOL 1G/FL. DE PDRE. PDRE.SOL.INJ. IV B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CUKUROVA DIS TICARET AS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "SEFAZOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "196/ 13 B 012 /01", "Code DCI": "13B012", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": null}, {"Nom": "SEFAZOL 500MG PDRE.SOL.INJ.IM/IV B/1+1 ", "Img": "https://pharmnet-dz.com//img/medics/680.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "SEFAZOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "176/ 13 B 157 /01", "Code DCI": "13B157", "Forme": "PDRE. INJ.", "Dosage": "500MG", "Conditionnement": "B/1+1 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEGLOR 2MG/ML SOL. BUV. EN GTTES. FL/75ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SCHWARZ PHARMA", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " DIHYDROERGOTAMINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "SEGLOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "273/ 15 B 021/98", "Code DCI": "15B021", "Forme": "SOL. BUV.", "Dosage": "2MG/ML", "Conditionnement": "FL/75ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SELOFER FOL 100MG** / 0,35MG COMP. A SUCER B/30", "Img": "https://pharmnet-dz.com//img/medics/1796.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1796", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE / ACIDE FOLIQUE   ", "Pays": "ALGERIE", "Nom Commercial": "SELOFER FOL", "Tarif de reference": "253.2 DA", "PPA": "N/A", "Num Enregistrement": "426/ 12 E 133 /13", "Code DCI": "12E133", "Forme": "COMP. A SUCER", "Dosage": "100MG** / 0,35MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SELOFER-100 100MG** (750MG D'HYDROXYDE FERRIQUE POLYMALTOSE) COMP. A SUCER B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERRIQUE** (SOUS FORME DE COMPLEXE D'HYDROXYDE FERRIQUE POLYMALTOSE)", "Pays": "ALGERIE", "Nom Commercial": "SELOFER-100", "Tarif de reference": "72 DA", "PPA": "365.00 DA", "Num Enregistrement": "426/ 12 E 149 /09", "Code DCI": "12E149", "Forme": "COMP. A SUCER", "Dosage": "100MG** (750MG D'HYDROXYDE FERRIQUE POLYMALTOSE)", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SELOFER-100 20MG/ML (100MG/5ML) SIROP FL./150ML + 1CUILLERE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE", "Pays": "ALGERIE", "Nom Commercial": "SELOFER-100", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "426/ 12 E 152 /08/15", "Code DCI": "12E152", "Forme": "SIROP", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "FL./150ML + 1CUILLERE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "SELOFER-50 10MG/ML (50MG/5ML) SIROP B/1FL./150ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERRIQUE** (SOUS FORME DE COMPLEXE D'HYDROXYDE FERRIQUE POLYMALTOSE)", "Pays": "ALGERIE", "Nom Commercial": "SELOFER-50", "Tarif de reference": " N/A", "PPA": "322.00 DA", "Num Enregistrement": "426/ 12 E 109 /08/15", "Code DCI": "12E109", "Forme": "SIROP", "Dosage": "10MG/ML (50MG/5ML)", "Conditionnement": "B/1FL./150ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "SELOPRESS 100MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SELOPRESS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16D149/16", "Code DCI": "16D149", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "SELOPRESS 200MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SELOPRESS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16D150/16", "Code DCI": "16D150", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "SELOPRESS 25MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SELOPRESS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16D148/16", "Code DCI": "16D148", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "SELOPRESS 300MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SELOPRESS", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16D151/16", "Code DCI": "16D151", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "SELTRANS 64G / 1,68G /1,46G  /0,75G PDRE. OR. B/ 04SACHETS DE 74G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 4000 / SULFATE DE SODIUM ANHYDRE / BICARBONATE DE SODIUM ANHYDRE    / CHLORURE DE SODIUM ANHYDRE / CHLORURE DE POTASSIUM", "Pays": "ALGERIE", "Nom Commercial": "SELTRANS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 R 086 /05", "Code DCI": "10R086", "Forme": "PDRE. SOL. BUV.", "Dosage": "64G / 1,68G /1,46G  /0,75G", "Conditionnement": "B/ 04SACHETS DE 74G", "Commercialisation": true, "Remboursable": true}, {"Nom": "SENORM 5 5MG/ML  SOL. INJ. B/5AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "SENORM 5", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 16 D 084 /08", "Code DCI": "16D084", "Forme": "SOL. INJ.", "Dosage": "5MG/ML ", "Conditionnement": "B/5AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SEPTANEST ADRENALINE 1/100000 4G/1MG/100ML SOL INJ B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4101.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SEPTODENT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ARTICAINE CHLORHYDRATE / ADRENALINE TARTRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SEPTANEST ADRENALINE 1/100000", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "044/ 02 C 053 /03", "Code DCI": "02C053", "Forme": "SOL. INJ.", "Dosage": "4G/1MG/100ML", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEPTANEST ADRENALINE 1/200000 4G/0,5MG/100ML SOL.INJ. B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4102.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SEPTODENT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ARTICAINE CHLORHYDRATE / ADRENALINE TARTRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SEPTANEST ADRENALINE 1/200000", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "044/ 02 C 054 /03", "Code DCI": "02C054", "Forme": "SOL. INJ.", "Dosage": "4G/0,5MG/100ML", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEPTHOL 260MG/125MG/15MG/50MG/50G GEL APPLI. CUTANEE T/50G", "Img": "https://pharmnet-dz.com//img/medics/1426.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1426", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " LEVOMENTHOL / VERATROLE / RESORCINOL / ACIDE SALICYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "SEPTHOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "088/ 21 F 048 /09", "Code DCI": "21F048", "Forme": "GEL", "Dosage": "260MG/125MG/15MG/50MG/50G", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": false}, {"Nom": "SEPTHOL 260MG/260MG/21MG/10,5MG SOL.DERM. ET BAIN DE BOUCHE FL/225ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " LEVOMENTHOL/VERATOL/RESORCINOL/ACIDE SALYCYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "SEPTHOL", "Tarif de reference": " N/A", "PPA": "199.00 DA", "Num Enregistrement": "088/ 23 B 008 /04", "Code DCI": "23B008", "Forme": "SOL. DERM.", "Dosage": "260MG/260MG/21MG/10,5MG", "Conditionnement": "FL/225ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SEPTIDINE 0.1 SOL.DERM. FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " POLYVIDONE IODEE", "Pays": "ALGERIE", "Nom Commercial": "SEPTIDINE", "Tarif de reference": "125 DA", "PPA": "187.00 DA", "Num Enregistrement": "088/ 07 P 077 /98", "Code DCI": "07P077", "Forme": "SOL. DERM.", "Dosage": "0.1", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SERC 8MG COMP. B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2033", "Laboratoire": " SOLVAY PHARMA", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " BETAHISTINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SERC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "031/ 18 C 007 /97/03", "Code DCI": "18C007", "Forme": "COMP.", "Dosage": "8MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "SERETIDE DISKUS 100\u00b5G/50\u00b5G/DOSE PDRE. P. INHAL. F/60DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2127", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE EXPRIME EN SALMETEROL", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SERETIDE DISKUS", "Tarif de reference": "1500 DA", "PPA": "N/A", "Num Enregistrement": "112/ 20 A 104 /03", "Code DCI": "20A104", "Forme": "PDRE. INHAL.", "Dosage": "100\u00b5G/50\u00b5G/DOSE", "Conditionnement": "F/60DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "SERETIDE DISKUS 250\u00b5G/50\u00b5G/DOSE PDRE. P. INHAL. F/60DOSES", "Img": "https://pharmnet-dz.com//img/medics/2128.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2128", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE EXPRIME EN SALMETEROL", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SERETIDE DISKUS", "Tarif de reference": "2100 DA", "PPA": " DA", "Num Enregistrement": "112/ 20 A 105 /03", "Code DCI": "20A105", "Forme": "PDRE. INHAL.", "Dosage": "250\u00b5G/50\u00b5G/DOSE", "Conditionnement": "F/60DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "SERETIDE DISKUS 500\u00b5G/50\u00b5G/DOSE PDRE. P. INHAL. F/60DOSES", "Img": "https://pharmnet-dz.com//img/medics/2129.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2129", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE PROPIONATE / SALMETEROL XINAFOATE EXPRIME EN SALMETEROL", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SERETIDE DISKUS", "Tarif de reference": "2580 DA", "PPA": " DA", "Num Enregistrement": "112/ 20 A 106 /03", "Code DCI": "20A106", "Forme": "PDRE. INHAL.", "Dosage": "500\u00b5G/50\u00b5G/DOSE", "Conditionnement": "F/60DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEREVENT 25\u00b5G/ BOUFFEE SUSP.INHAL. FL/120DOSES", "Img": "https://pharmnet-dz.com//img/medics/2093.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2093", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALMETEROL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SEREVENT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 20 A 019 /98", "Code DCI": "20A019", "Forme": "SUSP.INHAL.", "Dosage": "25\u00b5G/ BOUFFEE", "Conditionnement": "FL/120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "SERLOFT 50MG  GLES  B/30", "Img": "https://pharmnet-dz.com//img/medics/4597.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SERLOFT", "Tarif de reference": "1290 DA", "PPA": " DA", "Num Enregistrement": "289/16A099/16", "Code DCI": "16A099", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEROFLO 100\u00b5G**/50\u00b5G**/GELE. PDRE. INHAL. EN GLES. + INHALATEUR B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE (SOUS FORME DE PROPIONATE)** / SALMETEROL**(SOUS FORME DE XINAFOATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SEROFLO", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "263/ 20 F 104 /09", "Code DCI": "20F104", "Forme": "PDRE. INHAL.", "Dosage": "100\u00b5G**/50\u00b5G**/GELE.", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEROFLO 250\u00b5G/50\u00b5G/GLE.** PDRE. INHAL. EN GLES. + INHALATEUR B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " FLUTICASONE(SOUS FORME DE PROPIONATE)** / SALMETEROL**(SOUS FORME DE XINAFOATE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SEROFLO", "Tarif de reference": "1050 DA", "PPA": "N/A", "Num Enregistrement": "263/ 20 F 105 /09", "Code DCI": "20F105", "Forme": "PDRE. INHAL.", "Dosage": "250\u00b5G/50\u00b5G/GLE.**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEROQUEL 100MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2320.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2320", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SEROQUEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 16 D 149 /09", "Code DCI": "16D149", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEROQUEL 200MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/2322.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2322", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SEROQUEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 16 D 150 /09", "Code DCI": "16D150", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEROQUEL 25MG COMP. ENRO. B/60", "Img": "https://pharmnet-dz.com//img/medics/2319.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2319", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SEROQUEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 16 D 148 /09", "Code DCI": "16D148", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEROQUEL 300MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2323", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " QUETIAPINE FUMARATE EXPRIME EN QUETIAPINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SEROQUEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/ 16 D 151 /09", "Code DCI": "16D151", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SERPENS 160MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LISAPHARMA SPA", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SERENOA REPENS", "Pays": "ITALIE", "Nom Commercial": "SERPENS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "011/ 25 B 006 /99/10", "Code DCI": "25B006", "Forme": "GLES.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SERTAZOLE  300MG OVULE B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SERTAZOLE ", "Tarif de reference": "300 DA", "PPA": "N/A", "Num Enregistrement": "366/11A085/16", "Code DCI": "11A085", "Forme": "OVULE ", "Dosage": "300MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "SERVAL 25MG  GLES  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SERVAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "317/ 16 A 159 /14", "Code DCI": "16A159", "Forme": "GLES.", "Dosage": "25MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SERVAL 50MG  GLES  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SERVAL", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "317/ 16 A 099 /14", "Code DCI": "16A099", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SETREME 4MG COMP. PELLI. B/07 ET B/28", "Img": "https://pharmnet-dz.com//img/medics/2901.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2901", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SETREME", "Tarif de reference": "2000.00 DA", "PPA": "2000.00 DA", "Num Enregistrement": "447/ 10 F 093 /10", "Code DCI": "10F093", "Forme": "COMP. PELLI.", "Dosage": "4MG", "Conditionnement": "B/07 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SETREME 8MG COMP. PELLI. B/07 ", "Img": "https://pharmnet-dz.com//img/medics/2903.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2903", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON CHLORHYDRATE DIHYDRATE EXPRIME EN ONDANSETRON", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SETREME", "Tarif de reference": "800.1 DA", "PPA": "800.00 DA", "Num Enregistrement": "447/ 10 F 094 /10", "Code DCI": "10F094", "Forme": "COMP. PELLI.", "Dosage": "8MG", "Conditionnement": "B/07  B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SETRON 2MG/ML (OU 4MG/2ML ET 8MG/4ML) SOL INJ B/5AMP  2ML ET 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "SETRON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 10 F 048 /05", "Code DCI": "10F048", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (OU 4MG/2ML ET 8MG/4ML)", "Conditionnement": "B/5AMP  2ML ET 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SEVOFLURANE USP  100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR LIQUIDE P. INHAL. PAR VAPEUR CARTON DE 06 FL. DE 250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4324", "Laboratoire": " BAXTER", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " SEVOFLURANE", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "SEVOFLURANE USP ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "298/02B057/16", "Code DCI": "02B057", "Forme": "LIQUIDE P. INHAL", "Dosage": "100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR", "Conditionnement": "CARTON DE 06 FL. DE 250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SEVORANE 100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR LIQUIDE P. INHAL. PAR VAPEUR FL/250ML AVEC SYST\u00c8ME DE FERMETURE FIXE QUIK-FIL", "Img": "https://pharmnet-dz.com//img/medics/4068.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4068", "Laboratoire": " ABBOTT", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " SEVOFLURANE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SEVORANE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "147/ 02 B 057 /05", "Code DCI": "02B057", "Forme": "LIQUIDE P. INHAL", "Dosage": "100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR", "Conditionnement": "FL/250ML AVEC SYST\u00c8ME DE FERMETURE FIXE QUIK-FIL", "Commercialisation": true, "Remboursable": true}, {"Nom": "SEVORANE 100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR LIQUIDE P. INHAL. PAR VAPEUR FL/250ML AVEC SYST\u00c8ME DE FERMETURE FIXE QUIK-FIL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ANESTHESIQUES GENERAUX & GAZ", "C.Pharmacologique": " ANESTHESIOLOGIE", "C.Therapeutique": " SEVOFLURANE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SEVORANE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "498/02B057/05/16", "Code DCI": "02B057", "Forme": "LIQUIDE P. INHAL", "Dosage": "100ML/100ML DE LIQUIDE POUR INHALATION PAR VAPEUR", "Conditionnement": "FL/250ML AVEC SYST\u00c8ME DE FERMETURE FIXE QUIK-FIL", "Commercialisation": true, "Remboursable": null}, {"Nom": "SICCAFLUID 2,5MG/G GEL OPHT. FL. COMPT. GTTES. 10G", "Img": "https://pharmnet-dz.com//img/medics/2013.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2013", "Laboratoire": " THEA", "C.Pharmacologique": " SUPPLEANCE LACRYMALE", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CARBOMERE 974P", "Pays": "FRANCE", "Nom Commercial": "SICCAFLUID", "Tarif de reference": "311.31 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 N 145 /07", "Code DCI": "17N145", "Forme": "GEL. OPHT.", "Dosage": "2,5MG/G", "Conditionnement": "FL. COMPT. GTTES. 10G", "Commercialisation": true, "Remboursable": true}, {"Nom": "SILDEFAL 50MG  COMP. PELLI. B/01 ET B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SILDEFAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 25 N 045 /13", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/01 ET B/03", "Commercialisation": true, "Remboursable": null}, {"Nom": "SILDENAFIL ZENTIVA 50MG  COMP. PELLI. B/04", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SILDENAFIL ZENTIVA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "428/ 25 N 045 /13", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "SILVEGRA 50MG MICROGLES. EN GLES. B/03 ET B/07", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SILVEGRA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "418/ 25 N 045 /13", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/03 ET B/07", "Commercialisation": true, "Remboursable": null}, {"Nom": "SIMULECT  20MG /FLACON   POUDRE ET SOLVANT POUR SOLUTION INJECTABLE OU POUR PERF, IV B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT 5ML", "Img": "https://pharmnet-dz.com//img/medics/4372.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4372", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "SIMULECT ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/27A012/16", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG /FLACON  ", "Conditionnement": "B/01 FLACON DE POUDRE + 01 FLACON DE SOLVANT 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SIMVACOR 10MG COMP. ENRO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVACOR", "Tarif de reference": "226.3 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 205 /07", "Code DCI": "06M205", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SIMVACOR 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVACOR", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 136 /07", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SIMVACOR 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVACOR", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 M 203 /09", "Code DCI": "06M203", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SIMVASTAL 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVASTAL", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "039/ 06 M 136 /11", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SIMVASTATINE BIOCARE 20MG GLES.A  \u00b5GRLES. B/28", "Img": "https://pharmnet-dz.com//img/medics/1543.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1543", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVASTATINE BIOCARE", "Tarif de reference": "1164.24 DA", "PPA": " DA", "Num Enregistrement": "293/ 06 M 136 /11", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SIMVASTATINE LDM 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVASTATINE LDM", "Tarif de reference": " N/A", "PPA": "1190.00 DA", "Num Enregistrement": "309/ 06 M 136 /07/13", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SIMVASTATINE LDM 40MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVASTATINE LDM", "Tarif de reference": " N/A", "PPA": "2085.00 DA", "Num Enregistrement": "309/ 06 M 203 /07/13", "Code DCI": "06M203", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SIMVASTATINE WINTHROP 20MG COMP.PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIMVASTATINE WINTHROP", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "428/ 06 M 136 /14", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINECOD 0,15% 1,5MG/ML SIROP FL./200ML", "Img": "https://pharmnet-dz.com//img/medics/1301.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1301", "Laboratoire": " NOVARTIS CONSUMER HEALTH SCHWEIZ AG", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUTAMIRATE CITRATE", "Pays": "SUISSE", "Nom Commercial": "SINECOD 0,15%", "Tarif de reference": "202 DA", "PPA": "N/A", "Num Enregistrement": "068/ 20 C 233 /08", "Code DCI": "20C233", "Forme": "SIROP", "Dosage": "1,5MG/ML", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINGASM  10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SINGASM ", "Tarif de reference": "2400 DA", "PPA": "N/A", "Num Enregistrement": "001/20A211/16", "Code DCI": "20A211", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINGASM 4MG COMP. A CROQUER  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SINGASM", "Tarif de reference": "2400 DA", "PPA": "N/A", "Num Enregistrement": "001/20A225/16", "Code DCI": "20A225", "Forme": "COMP. A CROQ.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINGASM 5MG COMP. A CROQUER B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SINGASM", "Tarif de reference": "2400 DA", "PPA": "N/A", "Num Enregistrement": "001/20A226/16", "Code DCI": "20A226", "Forme": "COMP. A CROQ.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINGULAIR 10MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/2132.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2132", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "SINGULAIR", "Tarif de reference": "2240 DA", "PPA": "N/A", "Num Enregistrement": "024/ 20 A 211 /06", "Code DCI": "20A211", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINGULAIR 4MG COMP. A CROQUER B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2136", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "SINGULAIR", "Tarif de reference": "2400 DA", "PPA": "2566.00 DA", "Num Enregistrement": "024/ 20 A 225 /07", "Code DCI": "20A225", "Forme": "COMP. A CROQ.", "Dosage": "4MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINGULAIR 4MG/SACHET GRLES. EN SACHET-DOSE B/28 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2146", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "SINGULAIR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 20 A 245 /15", "Code DCI": "20A245", "Forme": "GRLES.", "Dosage": "4MG/SACHET", "Conditionnement": "B/28 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINGULAIR 5MG COMP. A CROQUER B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2140", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " MONTELUKAST SODIQUE EXPRIME EN MONTELUKAST", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "SINGULAIR", "Tarif de reference": "2240 DA", "PPA": " DA", "Num Enregistrement": "024/ 20 A 226 /07", "Code DCI": "20A226", "Forme": "COMP. A CROQ.", "Dosage": "5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SINTROM 4MG COMP.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3066.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3066", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTICOAGULANTS ORAUX", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACENOCOUMAROL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SINTROM", "Tarif de reference": "0 DA", "PPA": "188.00 DA", "Num Enregistrement": "068/ 12 A 001 /98", "Code DCI": "12A001", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SITAGLIPTINE BEKER 100MG COMP. PELLI. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4592.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SITAGLIPTINE BEKER", "Tarif de reference": "0 DA", "PPA": "2610.00 DA", "Num Enregistrement": "447/14A342/16", "Code DCI": "14A342", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": false, "Remboursable": false}, {"Nom": "SITANORM 100MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SITAGLIPTINE PHOSPHATE MONOHYDRATE EXPRIME EN SITAGLIPTINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SITANORM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "235/14A342/16", "Code DCI": "14A342", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "SIVACOR 20MG COMP. PELLI. B/10 ET B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SIVACOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 06 M 136 /00/13", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/10 ET B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SKENAN LP  100MG  MICROGRANULES LP EN GLES  B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " MORPHINE SULFATE", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "SKENAN LP ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 03 B 122 /14", "Code DCI": "03B122", "Forme": "MICROGRANULES LP. GLES.", "Dosage": "100MG ", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "SKENAN LP  10MG  MICROGRANULES LP EN GLES  B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " MORPHINE SULFATE", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "SKENAN LP ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 03 B 119 /14", "Code DCI": "03B119", "Forme": "MICROGRANULES LP. GLES.", "Dosage": "10MG ", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "SKENAN LP  30MG  MICROGRANULES LP EN GLES  B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " MORPHINE SULFATE", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "SKENAN LP ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 03 B 120 /14", "Code DCI": "03B120", "Forme": "MICROGRANULES LP. GLES.", "Dosage": "30MG ", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "SKENAN LP  60MG  MICROGRANULES LP EN GLES  B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " MORPHINE SULFATE", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "SKENAN LP ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 03 B 121 /14", "Code DCI": "03B121", "Forme": "MICROGRANULES LP. GLES.", "Dosage": "60MG ", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "SKIACOL 0.005 COLLY. FL/5ML", "Img": "https://pharmnet-dz.com//img/medics/1995.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1995", "Laboratoire": " ALCON", "C.Pharmacologique": " MYDRIATIQUES", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " CYCLOPENTOLATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SKIACOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "028/ 17 H 059 /97", "Code DCI": "17H059", "Forme": "COLLY.", "Dosage": "0.005", "Conditionnement": "FL/5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SMECTA 3G/SACHET PDRE. P. SUSP. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3901.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3901", "Laboratoire": " AT PHARMA SPA", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIOSMECTITE", "Pays": "ALGERIE", "Nom Commercial": "SMECTA", "Tarif de reference": "319.8 DA", "PPA": "N/A", "Num Enregistrement": "020/ 10 B 015 /97/14", "Code DCI": "10B015", "Forme": "SUSP. BUV.", "Dosage": "3G/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "SMECTA FRAISE 3G/SACHET PDRE. P. SUSP. BUV. EN SACHET-DOSE B/18 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AT PHARMA SPA", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIOSMECTITE", "Pays": "ALGERIE", "Nom Commercial": "SMECTA FRAISE", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10B015", "Forme": "PDRE. SUSP. BUV.", "Dosage": "3G/SACHET", "Conditionnement": "B/18 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "SMECTA ORANGE-VANILLE 3G/SACHET PDRE. P. SUSP. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AT PHARMA SPA", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIOSMECTITE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SMECTA ORANGE-VANILLE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "486/10B015/97/14", "Code DCI": "10B015", "Forme": "PDRE. SUSP. BUV.", "Dosage": "3G/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "SMEDYL 3G/SACHET PDRE. P. SUSP. BUV. EN SACHET-DOSE B/30 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/3902.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " DIOSMECTITE", "Pays": "ALGERIE", "Nom Commercial": "SMEDYL", "Tarif de reference": "0 DA", "PPA": "320.00 DA", "Num Enregistrement": "268/ 10 B 015 /15", "Code DCI": "10B015", "Forme": "SUSP. BUV.", "Dosage": "3G/SACHET", "Conditionnement": "B/30 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOCOB 20MG COMP. PELLI. SEC. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/1547.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1547", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOCOB", "Tarif de reference": "1247.4 DA", "PPA": "1247.4 DA", "Num Enregistrement": "447/ 06 M 136 /09", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30 - B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOCOB 40MG COMP. ENRO. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/1574.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1574", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOCOB", "Tarif de reference": "1980.00 DA", "PPA": "1980.00 DA", "Num Enregistrement": "447/ 06 M 203 /09", "Code DCI": "06M203", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "SODIUM BICARBONATE 0.084 SOL.INJ B/100AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM BICARBONATE", "Pays": "FRANCE", "Nom Commercial": "SODIUM BICARBONATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 072 /98", "Code DCI": "14G072", "Forme": "SOL. INJ.", "Dosage": "0.084", "Conditionnement": "B/100AMP. DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SODIUM BICARBONATE 0.084 SOL.INJ B/100AMP. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM BICARBONATE", "Pays": "FRANCE", "Nom Commercial": "SODIUM BICARBONATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 14 G 073 /98", "Code DCI": "14G073", "Forme": "SOL. INJ.", "Dosage": "0.084", "Conditionnement": "B/100AMP. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SODIUM BICARBONATE 0.084 SOL.INJ B/50AMP. DE 20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " SODIUM BICARBONATE", "Pays": "ALGERIE", "Nom Commercial": "SODIUM BICARBONATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 G 073 /98", "Code DCI": "14G073", "Forme": "SOL. INJ.", "Dosage": "0.084", "Conditionnement": "B/50AMP. DE 20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOFABIC 23,53G/69,95G/L SOL.CONC. POUR HEMODIALYSE FORMULE BASIQUE AU BICARBONATE BIDON/10L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOFARM SARL", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CHLORURE DE SODIUM / BICARBONATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "SOFABIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "405/ 25 G 053 /08", "Code DCI": "25G053", "Forme": "SOL. DIALYSE", "Dosage": "23,53G/69,95G/L", "Conditionnement": "BIDON/10L", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOFACID A1 170,06G/5,49G/9,48G/5,62G/8,85G/L SOL. CONC. ACIDE POUR HEMODIALYSE BIDON DE 10L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOFARM SARL", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CHLORURE DE SODIUM / CHLORURE DE POTASSIUM / CHLORURE DE CALCIUM / CHLORURE DE MAGNESIUM / ACIDE ACETIQUE ", "Pays": "ALGERIE", "Nom Commercial": "SOFACID A1", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "405/ 25 G 048 /08", "Code DCI": "25G048", "Forme": "SOL. DIALYSE", "Dosage": "170,06G/5,49G/9,48G/5,62G/8,85G/L", "Conditionnement": "BIDON DE 10L", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOFACID A2 210,70G/5,22G/9,00G/3,56G/6,31G/G SOL. CONC. ACIDE POUR HEMODIALYSE BIDON/10L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOFARM SARL", "C.Pharmacologique": " EPURATION EXTRA-RENALE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " CHLORURE DE SODIUM / CHLORURE DE POTASSIUM / CHLORURE DE CALCIUM / CHLORURE DE MAGNESIUM / ACIDE ACETIQUE ", "Pays": "ALGERIE", "Nom Commercial": "SOFACID A2", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "405/ 25 G 048 /08", "Code DCI": "25G048", "Forme": "SOL. DIALYSE", "Dosage": "210,70G/5,22G/9,00G/3,56G/6,31G/G", "Conditionnement": "BIDON/10L", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOFOS 400MG COMP PELL  B/28", "Img": "https://pharmnet-dz.com//img/medics/4220.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4220", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOFOS", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "447/13P475/15", "Code DCI": "N/D", "Forme": "COMP. SEC.", "Dosage": "400MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOFOSLED 400MG COMP PELL  B/28", "Img": "https://pharmnet-dz.com//img/medics/4421.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOFOSLED", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "447/13P476/16", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOFRAMICINE 0.0125 SOL.NAS. FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " ROUSSEL", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " FRAMYCETINE", "Pays": "FRANCE", "Nom Commercial": "SOFRAMICINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "033/ 22 E 014 /97", "Code DCI": "22E014", "Forme": "SOL. NAS.", "Dosage": "0.0125", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOLIAN 200MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2267.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2267", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOLIAN", "Tarif de reference": "2040 DA", "PPA": "N/A", "Num Enregistrement": "392/ 16 D 094 /06/15", "Code DCI": "16D094", "Forme": "COMP. SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLIAN 400MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2326.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2326", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOLIAN", "Tarif de reference": "0 DA", "PPA": "3482.00 DA", "Num Enregistrement": "392/ 16 D 160 /14", "Code DCI": "16D160", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLIFENACINE GL 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " N/D", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SOLIFENACINE SUCCINATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SOLIFENACINE GL", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "25P069", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLIRIS  10MG/ML (300MG/30ML) SOLUTION \u00e0 DILUER POUR PERFUSION IV B/01 FLACON 30 ml ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOLIRIS ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "509/27A013/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (300MG/30ML)", "Conditionnement": "B/01 FLACON 30 ml ", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOLMUCOL 200MG GRLES. SOL. BUV. SACH-DOSE B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " N-ACETYLCYSTEINE", "Pays": "ALGERIE", "Nom Commercial": "SOLMUCOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "195/ 20 D 083 /09", "Code DCI": "20D083", "Forme": "GRLES. SOL. BUV.", "Dosage": "200MG", "Conditionnement": "B/20 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOLOPRED HUP 20MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOLOPRED HUP", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "380/09H144/16", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLOTIK 100MG**  COMP. SEC. PILULIER/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE** (SOUS FORME DE CHLORHYDRATE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "SOLOTIK", "Tarif de reference": "1290 DA", "PPA": "992.00 DA", "Num Enregistrement": "001/ 16 A 115 /08", "Code DCI": "16A115", "Forme": "COMP SEC.", "Dosage": "100MG** ", "Conditionnement": "PILULIER/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLOTIK 50MG  COMP. SEC. PILULIER/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "SOLOTIK", "Tarif de reference": "645 DA", "PPA": "645.00 DA", "Num Enregistrement": "001/ 16 A 099 /08", "Code DCI": "16A099", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "PILULIER/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLUG\u00e9 20MG COMP.SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " CPCM", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOLUG\u00e9", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 09 H 144 /06/11", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOLUGEL 0.04 GEL T/45G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " STIEFEL CANADA INC", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " PEROXYDE DE BENZOYLE", "Liste": "Liste II", "Pays": "CANADA", "Nom Commercial": "SOLUGEL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "125/ 07 B 122 /01", "Code DCI": "07B122", "Forme": "GEL", "Dosage": "0.04", "Conditionnement": "T/45G", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLU-MEDROL 120MG/2ML PDRE.SOL.INJ.  B/01+01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOLU-MEDROL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "076/ 09 H 031 /99", "Code DCI": "09H031", "Forme": "PDRE. SOL. INJ.", "Dosage": "120MG/2ML", "Conditionnement": "B/01+01", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLU-MEDROL 20MG/2ML PDRE.SOL.INJ.  B/1+1", "Img": "https://pharmnet-dz.com//img/medics/658.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOLU-MEDROL", "Tarif de reference": "116.82 DA", "PPA": "N/A", "Num Enregistrement": "076/ 09 H 029 /98", "Code DCI": "09H029", "Forme": "PDRE. SOL. INJ.", "Dosage": "20MG/2ML", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLU-MEDROL 40MG PDRE.SOL.INJ.  B/01+01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOLU-MEDROL", "Tarif de reference": "129 DA", "PPA": "173.00 DA", "Num Enregistrement": "076/ 09 H 030 /98", "Code DCI": "09H030", "Forme": "PDRE. SOL. INJ.", "Dosage": "40MG", "Conditionnement": "B/01+01", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLU-MEDROL 500MG/8ML PDRE.SOL.INJ.  B/01+01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOLU-MEDROL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "076/ 09 H 032 /99", "Code DCI": "09H032", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/8ML", "Conditionnement": "B/01+01", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLUPRED ORO 20MG COMP. ORODISPERS. B/20", "Img": "https://pharmnet-dz.com//img/medics/3778.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3778", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOLUPRED ORO", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "392/ 09 H 144 /11", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLUPRED ORO 5MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medics/3770.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3770", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOLUPRED ORO", "Tarif de reference": "257.4 DA", "PPA": "N/A", "Num Enregistrement": "392/ 09 H 143 /11", "Code DCI": "09H143", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLUTION EVACUANTE BOHM 64G PDR. SOL.BUV B/16 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BOHM . S.A", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " MACROGOL 4000 / SULFATE DE SODIUM ANHYDRE / BICARBONATE DE SODIUM ANHYDRE    / CHLORURE DE SODIUM ANHYDRE / CHLORURE DE POTASSIUM", "Pays": "ESPAGNE", "Nom Commercial": "SOLUTION EVACUANTE BOHM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "158/ 10 R 086 /99", "Code DCI": "10R086", "Forme": "PDRE. SOL. BUV.", "Dosage": "64G", "Conditionnement": "B/16 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOLUXOL 0.003 SOL. BUV. FL./200ML", "Img": "https://pharmnet-dz.com//img/medics/1332.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " FLUIDIFIANTS BRONCHIQUES & MUCOREGULATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " AMBROXOL", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SOLUXOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035/ 20 D 064 /08", "Code DCI": "20D064", "Forme": "SOL. BUV.", "Dosage": "0.003", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOMACOLINE 100MG/ML** SOL. BUV. GTTES. FL./30ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/2511.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLOGIE", "C.Therapeutique": " CITICOLINE** (SOUS FORME MONOSODIQUE)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOMACOLINE", "Tarif de reference": "489 DA", "PPA": "469.00 DA", "Num Enregistrement": "352/ 15 K 045 /09", "Code DCI": "15K045", "Forme": "SOL. BUV. GTTES.", "Dosage": "100MG/ML**", "Conditionnement": "FL./30ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMALGINE 10MG/5ML SIROP B/1FL DE 125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SOMALGINE", "Tarif de reference": "0 DA", "PPA": "191.00 DA", "Num Enregistrement": "457/ 10 D 032 /10", "Code DCI": "10D032", "Forme": "SOL. BUV.", "Dosage": "10MG/5ML", "Conditionnement": "B/1FL DE 125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMATULINE LP 120MG/SERING. DE 0,5ML SOL. INJ. SC PROFONDE LP  EN SERING. PREREMPL. B/01SERINGUE PREREMPLIE DE 0,5ML AVEC UN SYST\u00c8ME DE SECURITE + AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/3832.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3832", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTI-HORMONE DE CROISSANCE", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LANREOTIDE ACETATE EXPRIME EN LANREOTIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOMATULINE LP", "Tarif de reference": "0 DA", "PPA": "140671.00 DA", "Num Enregistrement": "020/ 09 R 158 /08/15", "Code DCI": "09R158", "Forme": "SOL. INJ. LP", "Dosage": "120MG/SERING. DE 0,5ML", "Conditionnement": "B/01SERINGUE PREREMPLIE DE 0,5ML AVEC UN SYST\u00c8ME DE SECURITE + AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMATULINE LP 30MG PDRE SOL INJ IM LP B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3829", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LANREOTIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOMATULINE LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "020/ 09 P 124 /02 ", "Code DCI": "09P124", "Forme": "PDRE. SOL. INJ.", "Dosage": "30MG", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMATULINE LP 60MG/SERING. DE 0,5ML SOL. INJ. SC PROFONDE LP EN SERING. PREREMPL.  B/01SERINGUE PREREMPLIE DE 0,5ML AVEC UN SYST\u00c8ME DE SECURITE + AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/3830.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3830", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTI-HORMONE DE CROISSANCE", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LANREOTIDE ACETATE EXPRIME EN LANREOTIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOMATULINE LP", "Tarif de reference": "0 DA", "PPA": "103906.00 DA", "Num Enregistrement": "020/ 09 R 156 /08/15", "Code DCI": "09R156", "Forme": "SOL. INJ. LP", "Dosage": "60MG/SERING. DE 0,5ML", "Conditionnement": "B/01SERINGUE PREREMPLIE DE 0,5ML AVEC UN SYST\u00c8ME DE SECURITE + AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMATULINE LP 90MG/SERING. DE 0,5ML SOL. INJ. SC PROFONDE LP  EN SERING. PREREMPL. B/01SERINGUE PREREMPLIE DE 0,5ML AVEC UN SYST\u00c8ME DE SECURITE + AIGUILLE", "Img": "https://pharmnet-dz.com//img/medics/3831.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3831", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTI-HORMONE DE CROISSANCE", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " LANREOTIDE ACETATE EXPRIME EN LANREOTIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SOMATULINE LP", "Tarif de reference": "0 DA", "PPA": "129820.00 DA", "Num Enregistrement": "020/ 09 R 157 /08/15", "Code DCI": "09R157", "Forme": "SOL. INJ. LP", "Dosage": "90MG/SERING. DE 0,5ML", "Conditionnement": "B/01SERINGUE PREREMPLIE DE 0,5ML AVEC UN SYST\u00c8ME DE SECURITE + AIGUILLE", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMAZINA 100MG/ML*(10G/100ML) SOL. BUV. GTTES.  B/1FL DE 30ML + SERINGUE DOSEUSE ", "Img": "https://pharmnet-dz.com//img/medics/2512.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " NEUROLOGIE", "Info": " CITICOLINE** (SOUS FORME MONOSODIQUE)", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "SOMAZINA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "207/ 15 K 045 /00/11", "Code DCI": "15K045", "Forme": "SOL. BUV. GTTES.", "Dosage": "100MG/ML*(10G/100ML)", "Conditionnement": "B/1FL DE 30ML + SERINGUE DOSEUSE ", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMAZINA 125MG/ML  (OU 500MG/4ML ) SOL.INJ.IM IV B/5AMP DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " ANTIMIGRAINEUX", "C.Therapeutique": " NEUROLOGIE", "Info": " CITICOLINE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "SOMAZINA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "207/ 15 B 044 /00/08", "Code DCI": "15B044", "Forme": "SOL. INJ.", "Dosage": "125MG/ML  (OU 500MG/4ML )", "Conditionnement": "B/5AMP DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOMAZINA 250MG/ML** (OU 1000MG/4ML) SOL. INJ. B/03AMP. DE 4ML  -  B/10AMP. DE 4ML", "Img": "https://pharmnet-dz.com//img/medics/2513.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " FERRER INTERNATIONAL", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " NEUROLOGIE", "Info": " CITICOLINE** (SOUS FORME DE SEL DE SODIUM)", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "SOMAZINA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "207/ 15 K 094 /09", "Code DCI": "15K094", "Forme": "SOL. INJ.", "Dosage": "250MG/ML** (OU 1000MG/4ML)", "Conditionnement": "B/03AMP. DE 4ML  -  B/10AMP. DE 4ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SOMIFED 2,5MG/50MG/300MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " SOMEDIAL", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)**  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** / PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SOMIFED", "Tarif de reference": " N/A", "PPA": "157.00 DA", "Num Enregistrement": "457/ 22 A 001 /11", "Code DCI": "22A001", "Forme": "COMP.", "Dosage": "2,5MG/50MG/300MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOUFRANE 2% 2,34G/100 ML (2%) SOL.NAS. FL. PULVERISATEUR DE 15 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-INFECTIEUX SANS CORTICOIDES", "C.Therapeutique": " RHINOLOGIE", "Info": " THIOPHENE (SOUS FORME DE CARBOXYLATE DE SODIUM)", "Pays": "FRANCE", "Nom Commercial": "SOUFRANE 2%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "376/ 22 B 004 /98/09", "Code DCI": "22B004", "Forme": "SOL. NAS.", "Dosage": "2,34G/100 ML (2%)", "Conditionnement": "FL. PULVERISATEUR DE 15 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOWEL 2MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/2488.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2488", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " TRIHEXYPHENIDYLE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOWEL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 15 D 093 /10", "Code DCI": "15D093", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SOWEL 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/2484.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2484", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTIPARKINSONIENS", "C.Therapeutique": " NEUROLOGIE", "Info": " TRIHEXYPHENIDYLE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SOWEL", "Tarif de reference": "150 DA", "PPA": "N/A", "Num Enregistrement": "242/ 15 D 062 /10", "Code DCI": "15D062", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPACYL 80MG COMP. ORODISPERS. B/10 ET B/20", "Img": "https://pharmnet-dz.com//img/medics/2848.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "SPACYL", "Tarif de reference": " N/A", "PPA": "182.00 DA", "Num Enregistrement": "268/ 10 E 108 /15", "Code DCI": "10E108", "Forme": "COMP. DISPERS.", "Dosage": "80MG", "Conditionnement": "B/10 ET B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SPALVERINE 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SPALVERINE", "Tarif de reference": "217.2 DA", "PPA": "307.00 DA", "Num Enregistrement": "418/ 10 E 116 /12", "Code DCI": "10E116", "Forme": "GLES. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPASCOL 100MG MICROGRANULES  EN GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SPASCOL", "Tarif de reference": "217.2 DA", "PPA": "217.00 DA", "Num Enregistrement": "065/ 10 E 035 /14", "Code DCI": "10E035", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPASCOL LP 200MG GLES. A MICROGRANULES LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SPASCOL LP", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 10 E 116 /08/15", "Code DCI": "10E116", "Forme": "GLES. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SPASFOMEX 80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medics/4513.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " N/D", "Info": " PHLOROGLUCINOL DIHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPASFOMEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "400/10E108/16", "Code DCI": "10E108", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPASLAM 80MG COMP. ORODISPERS. B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " N/D", "Info": " PHLOROGLUCINOL DIHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPASLAM", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "077/10E108/16", "Code DCI": "10E108", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/10 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "SPASMEFF 80MG COMP. EFFERV. T/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " API", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "SPASMEFF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "348/ 10 E 190 /11", "Code DCI": "10E190", "Forme": "COMP. EFFERV.", "Dosage": "80MG", "Conditionnement": "T/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SPASMEX 10MG/ML (40MG/4ML) SOL.INJ. IM/IV B/10AMP. DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SCHARPER SPA ", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL DIHYDRATE", "Pays": "ITALIE", "Nom Commercial": "SPASMEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "259/ 10 E 198 /02/13", "Code DCI": "10E198", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (40MG/4ML)", "Conditionnement": "B/10AMP. DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SPASMINE 150MG/150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "SPASMINE", "Tarif de reference": "147.5 DA", "PPA": "N/A", "Num Enregistrement": "366/ 10 E 039 /08", "Code DCI": "10E039", "Forme": "SUPPO.", "Dosage": "150MG/150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPASMODYL 10MG/0,01MG/1ML (40MG/0,04MG/4ML) SOL INJ IM/IV B/05 AMP DE 4ML ET B/50 AMP DE 4ML ", "Img": "https://pharmnet-dz.com//img/medics/3958.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL HYDRATE/ TRIMETHYLPHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "SPASMODYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "433/ 10 E 038 /14", "Code DCI": "10E038", "Forme": "SOL. INJ.", "Dosage": "10MG/0,01MG/1ML (40MG/0,04MG/4ML)", "Conditionnement": "B/05 AMP DE 4ML ET B/50 AMP DE 4ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPASMODYL 80MG COMP. ORODISPERS. B/10 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " N/D", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "SPASMODYL", "Tarif de reference": "101.80 DA", "PPA": " DA", "Code DCI": "10E108", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPASMOL 150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/3960.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3960", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " PHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "SPASMOL", "Tarif de reference": "147.5 DA", "PPA": "N/A", "Num Enregistrement": "231/ 10 E 039 /03", "Code DCI": "10E039", "Forme": "SUPPO.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPASMOL 80MG COMP. ORODISPERS. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " N/D", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " PHLOROGLUCINOL", "Pays": "ALGERIE", "Nom Commercial": "SPASMOL", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10E108", "Forme": "COMP. ORODISPERS.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRA  1 500 000UI COMP. PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medics/792.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRA ", "Tarif de reference": "320 DA", "PPA": "320.00 DA", "Num Enregistrement": "263/ 13 E 031 /08", "Code DCI": "13E031", "Forme": "COMP. PELLI.", "Dosage": "1 500 000UI", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRA 3 000 000UI COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/797.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRA", "Tarif de reference": "410 DA", "PPA": "410.00 DA", "Num Enregistrement": "263/ 13 E 032 /08", "Code DCI": "13E032", "Forme": "COMP. PELLI.", "Dosage": "3 000 000UI", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRACARE 1 500 000UI COMP.PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medics/790.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=790", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRACARE", "Tarif de reference": "320 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 E 031 /05/12", "Code DCI": "13E031", "Forme": "COMP. PELLI.", "Dosage": "1 500 000UI", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRACARE 3 000 000UI COMP.PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/795.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=795", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRACARE", "Tarif de reference": "410 DA", "PPA": "N/A", "Num Enregistrement": "293/ 13 E 032 /05/12", "Code DCI": "13E032", "Forme": "COMP. PELLI.", "Dosage": "3 000 000UI", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRADENT 750. 000UI/125MG COMP. PELLI  B/20", "Img": "https://pharmnet-dz.com//img/medics/843.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE / METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRADENT", "Tarif de reference": "387.4 DA", "PPA": "N/A", "Num Enregistrement": "263/ 13 E 300 /07", "Code DCI": "13E300", "Forme": "COMP. PELLI.", "Dosage": "750. 000UI/125MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRAMYCINE AFRO 0,375MUI/5ML SIROP FL./150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " N/D", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRAMYCINE AFRO", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "13E154", "Forme": "SIROP", "Dosage": "0,375MUI/5ML", "Conditionnement": " FL./150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRAMYNAL 1 500 000UI COMP.PELLI. B/16", "Img": "https://pharmnet-dz.com//img/medics/791.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRAMYNAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "039/ 13 E 031 /05/15", "Code DCI": "13E031", "Forme": "COMP. PELLI.", "Dosage": "1 500 000UI", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRAMYNAL 3000 000UI COMP.PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/796.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SPIRAMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SPIRAMYNAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "039/ 13 E 032 /04/15", "Code DCI": "13E032", "Forme": "COMP. PELLI.", "Dosage": "3000 000UI", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRIVA 18\u00b5G PDRE. P. INHALATION EN GLES. B/30 ET B/30+INHALATEUR (HanDihaler)", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BOEHRINGER INGELHEIM ", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TIOTROPIUM BROMURE MONOHYDRATE EXPRIME EN TIOTROPIUM", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "SPIRIVA", "Tarif de reference": "2700 DA", "PPA": "N/A", "Num Enregistrement": "152/ 20 A 234 /08", "Code DCI": "20A234", "Forme": "PDRE. INHAL.", "Dosage": "18\u00b5G", "Conditionnement": "B/30 ET B/30+INHALATEUR (HanDihaler)", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPIRONOLONE 75MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1482.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1482", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SPIRONOLACTONE MICRONISEE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SPIRONOLONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "235/ 06 H 095 /09", "Code DCI": "06H095", "Forme": "COMP. PELLI.", "Dosage": "75MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SPIROZIDE 25MG/15MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1484.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1484", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SPIRONOLACTONE / ALTIZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SPIROZIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/ 06 H 096 /13", "Code DCI": "06H096", "Forme": "COMP. PELLI.", "Dosage": "25MG/15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPRYCEL 20MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/1048.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1048", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " DASATINIB MONOHYDRATEE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SPRYCEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 05 C 144 /09", "Code DCI": "05C144", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPRYCEL 50MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/1049.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1049", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " DASATINIB MONOHYDRATEE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SPRYCEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 05 C 145 /09", "Code DCI": "05C145", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SPRYCEL 70MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/1050.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1050", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " DASATINIB MONOHYDRATEE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SPRYCEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "017/ 05 C 146 /09", "Code DCI": "05C146", "Forme": "COMP. PELLI.", "Dosage": "70MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "SRILANE 0.05 CREME T/60G", "Img": "https://pharmnet-dz.com//img/medics/1391.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1391", "Laboratoire": " MERCK LIPHA SANTE ", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " IDROCILAMIDE", "Pays": "FRANCE", "Nom Commercial": "SRILANE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "062/ 21 A 036 /01", "Code DCI": "21A036", "Forme": "CR\u00c8ME", "Dosage": "0.05", "Conditionnement": "T/60G", "Commercialisation": true, "Remboursable": true}, {"Nom": "STAGID 700MG COMP .SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3635.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3635", "Laboratoire": " MERCK LIPHA SANTE ", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " METFORMINE EMBONATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "STAGID", "Tarif de reference": "62.1 DA", "PPA": "N/A", "Num Enregistrement": "062/ 14 A 008 /99/09", "Code DCI": "14A008", "Forme": "COMP. SEC.", "Dosage": "700MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "STALORAL 10+100+300 IR/ML - 300 IR/ML SOLUTION SUBLINGUALE D'UN MELANGE D'EXTRAITS ALLERGENIQUE POUR IMMUNOTHERAPIE SPECIFIQUE COFFRET DE 03 FL. DE 10ML DE SOLUTION (10+100+300 IR/ML) - COFFRET DE 01 FL. DE 10ML DE SOLUTION (300 IR/ML)", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " STALLERGENES S.A.", "C.Pharmacologique": " ALLERGENES A USAGE THERAPEUTIQUE", "C.Therapeutique": " ALLERGOLOGIE", "Info": " EXTRAITS ALLERGENIQUES DERMARTOPHAGOIDES PTERONYSSINUS / DERMATOPHAGOIDES FARINEA (50/50)", "Pays": "FRANCE", "Nom Commercial": "STALORAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "130/ 01 D 052 /15", "Code DCI": "01D052", "Forme": "SOL.", "Dosage": "10+100+300 IR/ML - 300 IR/ML", "Conditionnement": "COFFRET DE 03 FL. DE 10ML DE SOLUTION (10+100+300 IR/ML) - COFFRET DE 01 FL. DE 10ML DE SOLUTION (300 IR/ML)", "Commercialisation": true, "Remboursable": null}, {"Nom": "STEDIRIL 0,50MG/0,05MG COMP. B/21 ", "Img": "https://pharmnet-dz.com//img/medics/3042.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3042", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " DL-NORGESTREL / ETHINYLESTRADIOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "STEDIRIL", "Tarif de reference": "120.06 DA", "PPA": "N/A", "Num Enregistrement": "030/ 11 H 032 /98", "Code DCI": "11H032", "Forme": "COMP.", "Dosage": "0,50MG/0,05MG", "Conditionnement": "B/21 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "STERDEX 0,267MG/1,335MG/RECIPIENT UNIDOSE PDE .OPHT.EN RECIPIENT UNIDOSE B/12 RECIPIENTS UNIDOSE", "Img": "https://pharmnet-dz.com//img/medics/1948.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1948", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DEXAMETHASONE/OXYTETRACYCLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "STERDEX", "Tarif de reference": "0 DA", "PPA": "197.00 DA", "Num Enregistrement": "022/ 17 D 117 /00/13", "Code DCI": "17D117", "Forme": "PDE. OPHT.", "Dosage": "0,267MG/1,335MG/RECIPIENT UNIDOSE", "Conditionnement": "B/12 RECIPIENTS UNIDOSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "STIEVAMYCIN 0,025 %/4% GEL.DERM. T/25G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " STIEFEL CANADA INC", "C.Pharmacologique": " ANTI-ACNEIQUES, ANTI-ALOPECIQUES ET ANTI-SEBORRHEIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE TRETINOIQUE / ERYTHROMYCINE", "Liste": "Liste I", "Pays": "CANADA", "Nom Commercial": "STIEVAMYCIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "125/ 07 B 009 /98", "Code DCI": "07B009", "Forme": "GEL. DERM.", "Dosage": "0,025 %/4%", "Conditionnement": "T/25G", "Commercialisation": true, "Remboursable": true}, {"Nom": "STILNOX 10MG COMP. PELLI. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medics/2191.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2191", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " HYPNOTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ZOLPIDEM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "STILNOX", "Tarif de reference": "0 DA", "PPA": "267.00 DA", "Num Enregistrement": "255/ 16 C 095 /06", "Code DCI": "16C095", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "STIMOL 1G/10ML SOL. BUV.  B/18AMP.", "Img": "https://pharmnet-dz.com//img/medics/3457.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3457", "Laboratoire": " BIOCODEX", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " MALATE DE CITRILLUNE", "Pays": "FRANCE", "Nom Commercial": "STIMOL", "Tarif de reference": "0 DA", "PPA": "437.00 DA", "Num Enregistrement": "101/ 14 H 221 /06", "Code DCI": "14H221", "Forme": "SOL. BUV.", "Dosage": "1G/10ML", "Conditionnement": "B/18AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "STIVARGRA 40MG  COMP. PELLI. B/1 FLACON DE 28  B/3 FLACONS DE 28", "Img": "https://pharmnet-dz.com//img/medics/4290.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " BAYER", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "STIVARGRA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/05C179/15", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "40MG ", "Conditionnement": "B/1 FLACON DE 28  B/3 FLACONS DE 28", "Commercialisation": true, "Remboursable": true}, {"Nom": "STOCALM 250,4MG/250,4MG/20MG/9,6MG SOL.DERM. ET BAIN DE BOUCHE FL/250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " LEVOMENTHOL/VERATOL/RESORCINOL/ACIDE SALYCYLIQUE", "Pays": "ALGERIE", "Nom Commercial": "STOCALM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 23 B 008 /04", "Code DCI": "23B008", "Forme": "SOL. DERM.", "Dosage": "250,4MG/250,4MG/20MG/9,6MG", "Conditionnement": "FL/250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "STOCRIN 200MG COMP. PELL. B/1FL./90", "Img": "https://pharmnet-dz.com//img/medics/444.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=444", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " EFAVIRENZ", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "STOCRIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 13 P 286 /06", "Code DCI": "13P286", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/1FL./90", "Commercialisation": true, "Remboursable": true}, {"Nom": "STOCRIN 600MG COMP. PELL. B/1FL./30", "Img": "https://pharmnet-dz.com//img/medics/446.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=446", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " EFAVIRENZ", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "STOCRIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 13 P 287 /06", "Code DCI": "13P287", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/1FL./30", "Commercialisation": true, "Remboursable": true}, {"Nom": "STRATTERA 10MG** (ATOMOXETINE HYDROCHLORIDE 11,43MG) GLES. GASTRO-RESIST. B/28", "Img": "https://pharmnet-dz.com//img/medics/2292.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2292", "Laboratoire": " LILLY S.A", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE", "Pays": "ESPAGNE", "Nom Commercial": "STRATTERA", "Tarif de reference": "0 DA", "PPA": "11148.00 DA", "Num Enregistrement": "034/ 16 D 110 /08", "Code DCI": "16D110", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "10MG** (ATOMOXETINE HYDROCHLORIDE 11,43MG)", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "STRATTERA 18MG** (ATOMOXETINE HYDROCHLORIDE 20,57MG) GLES. GASTRO-RESIST. B/28", "Img": "https://pharmnet-dz.com//img/medics/2293.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2293", "Laboratoire": " LILLY S.A", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE", "Pays": "ESPAGNE", "Nom Commercial": "STRATTERA", "Tarif de reference": "0 DA", "PPA": "11148.00 DA", "Num Enregistrement": "034/ 16 D 111 /08", "Code DCI": "16D111", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "18MG** (ATOMOXETINE HYDROCHLORIDE 20,57MG)", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "STRATTERA 25MG** (ATOMOXETINE HYDROCHLORIDE 28,57MG) GLES. GASTRO-RESIST. B/28", "Img": "https://pharmnet-dz.com//img/medics/2294.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2294", "Laboratoire": " LILLY S.A", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE", "Pays": "ESPAGNE", "Nom Commercial": "STRATTERA", "Tarif de reference": "0 DA", "PPA": "11225.00 DA", "Num Enregistrement": "034/ 16 D 112 /08", "Code DCI": "16D112", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "25MG** (ATOMOXETINE HYDROCHLORIDE 28,57MG)", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "STRATTERA 40MG** (ATOMOXETINE HYDROCHLORIDE 45,71MG) GLES. GASTRO-RESIST. B/28", "Img": "https://pharmnet-dz.com//img/medics/2295.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2295", "Laboratoire": " LILLY S.A", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE", "Pays": "ESPAGNE", "Nom Commercial": "STRATTERA", "Tarif de reference": "0 DA", "PPA": "11225.00 DA", "Num Enregistrement": "034/ 16 D 113 /08", "Code DCI": "16D113", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "40MG** (ATOMOXETINE HYDROCHLORIDE 45,71MG)", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "STRATTERA 60MG** (ATOMOXETINE HYDROCHLORIDE 68,56MG) GLES. GASTRO-RESIST. B/28", "Img": "https://pharmnet-dz.com//img/medics/2296.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2296", "Laboratoire": " LILLY S.A", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ATOMOXETINE CHLORHYDRATE EXPRIME EN ATOMOXETINE", "Pays": "ESPAGNE", "Nom Commercial": "STRATTERA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 16 D 114 /08", "Code DCI": "16D114", "Forme": "GLES. GASTRO-RESIST.", "Dosage": "60MG** (ATOMOXETINE HYDROCHLORIDE 68,56MG)", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "STRESAM 50MG GLES. B/24 ET B/60", "Img": "https://pharmnet-dz.com//img/medics/2178.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2178", "Laboratoire": " BIOCODEX", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ETIFOXINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "STRESAM", "Tarif de reference": "0 DA", "PPA": "226.00 DA", "Num Enregistrement": "101/ 16 B 093 /04", "Code DCI": "16B093", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/24 ET B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "STRUCTUM 500MG GLES. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1442", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " RHUMATOLOGIE", "C.Therapeutique": " SULFATE DE CHONDRO\u00cfTINE SODIQUE", "Pays": "FRANCE", "Nom Commercial": "STRUCTUM", "Tarif de reference": " N/A", "PPA": "1643.00 DA", "Num Enregistrement": "099/ 21 H 051 /09", "Code DCI": "21H051", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUCRONORME 0,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUCRONORME ", "Tarif de reference": "00 DA", "PPA": " DA", "Code DCI": "14A200", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUCRONORME 1MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIDIABETIQUES ORAUX", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " REPAGLINIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUCRONORME", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "14A201", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUFENTA 250\u00b5G/5ML SOL INJ  IV OU PERIDURALE B/10AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4047", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES POUR ANESTHESIE", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " SUFENTANIL CITRATE EXPRIME EN SUFENTANIL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "SUFENTA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 02 A 041 /99/15", "Code DCI": "02A041", "Forme": "SOL. INJ.", "Dosage": "250\u00b5G/5ML", "Conditionnement": "B/10AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUFENTA 5\u00b5G/ML (10\u00b5G/2ML - 50\u00b5G/10ML) SOL INJ IV OU PERIDURALE B/5AMP. DE 2ML - B/10AMP.DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/4049.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4049", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES POUR ANESTHESIE", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " SUFENTANIL CITRATE EXPRIME EN SUFENTANIL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "SUFENTA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 02 A 055 /05", "Code DCI": "02A055", "Forme": "SOL. INJ.", "Dosage": "5\u00b5G/ML (10\u00b5G/2ML - 50\u00b5G/10ML)", "Conditionnement": "B/5AMP. DE 2ML - B/10AMP.DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUFENTA 50\u00b5G/ML SOL INJ  IV OU PERIDURALE B/5AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4046", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " ANALGESIQUES POUR ANESTHESIE", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " SUFENTANIL CITRATE EXPRIME EN SUFENTANIL", "Liste": "Stup\u00e9fiants", "Pays": "FRANCE", "Nom Commercial": "SUFENTA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "095/ 02 A 040 /99", "Code DCI": "02A040", "Forme": "SOL. INJ.", "Dosage": "50\u00b5G/ML", "Conditionnement": "B/5AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SULAMINE 6,25MG/5ML SIROP FL/125 ML", "Img": "https://pharmnet-dz.com//img/medics/3982.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DOXYLAMINE SUCCINATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SULAMINE", "Tarif de reference": "0 DA", "PPA": "175 DA", "Num Enregistrement": "003/ 01 A 008 /97", "Code DCI": "01A008", "Forme": "SIROP", "Dosage": "6,25MG/5ML", "Conditionnement": "FL/125 ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "SULAN  50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " TAPHCO SPA", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULAN ", "Tarif de reference": "140,10 DA", "PPA": "N/A", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULFADIAZINE NOVAGENERICS 0.01 CREME DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medics/556.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=556", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTISEPTIQUES", "C.Therapeutique": " DERMATOLOGIE", "Info": " SULFADIAZINE ARGENTIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULFADIAZINE NOVAGENERICS", "Tarif de reference": "263.6 DA", "PPA": "N/A", "Num Enregistrement": "149/ 07 P 079 /15", "Code DCI": "07P079", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULMATIL 25MG/5ML OU 0,5% SOL. BUV. FL/180 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULMATIL", "Tarif de reference": "106.2 DA", "PPA": "156.00 DA", "Num Enregistrement": "319/ 16 D 067 /06", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML OU 0,5%", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULOZIR LP 0,4MG  GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULOZIR LP", "Tarif de reference": "1500 DA", "PPA": "1500.00 DA", "Num Enregistrement": "035/ 25 B 047 /14", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULPIDAL 50MG GLES B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULPIDAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 16 D 066 /14", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SULPIMEX 25MG/5ML (0,5G/100ML) SOL BUV SANS SUCRE FL./200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULPIMEX", "Tarif de reference": "118.00 DA", "PPA": "N/A", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML ", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULPIRED 25MG/5ML SOL.BUV. FL/200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LPA (LABORATOIRE PHARMACEUTIQUE ALGERIEN)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULPIRED", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "026/ 16 D 067 /02/09", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SULPIRIDE LS 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2213.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2213", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULPIRIDE LS", "Tarif de reference": "0 DA", "PPA": "140.00 DA", "Num Enregistrement": "231/ 16 D 066 /09", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULPIRIDE MERINAL 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2214.png", "Laboratoire": " MERINAL", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULPIRIDE MERINAL", "Tarif de reference": " N/A", "PPA": "170.00 DA", "Num Enregistrement": "268/ 16 D 066 /05/10", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SULPRIM 200MG/40MG/5ML SUSP.BUV. FL/100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " SULFAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " SULFAMETHOXAZOLE / TRIMETHOPRIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "SULPRIM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 M 090 /98/06", "Code DCI": "13M090", "Forme": "SUSP. BUV.", "Dosage": "200MG/40MG/5ML", "Conditionnement": "FL/100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SULPUREN 25MG/5ML (OU 0,5%) SOL.BUV. FL/180 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULPUREN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 16 D 067 /97/09", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML (OU 0,5%)", "Conditionnement": "FL/180 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SULPUREN 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2215.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2215", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULPUREN", "Tarif de reference": "140.1 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 D 066 /96/13", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULRID 0,5G/100ML SOL. BUV. FL./200ML", "Img": "https://pharmnet-dz.com//img/medics/2226.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULRID", "Tarif de reference": "118 DA", "PPA": "157.00 DA", "Num Enregistrement": "035/ 16 D 067 /08", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "0,5G/100ML", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SULRID 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2216.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SULRID", "Tarif de reference": " N/A", "PPA": "153.00 DA", "Num Enregistrement": "035/ 16 D 066 /00/08", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUMO 100MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/3955.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3955", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " GASTRO-ENTEROLOGIE", "C.Therapeutique": " MEBEVERINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "SUMO", "Tarif de reference": "217.2 DA", "PPA": "N/A", "Num Enregistrement": "242/ 10 E 035 /10", "Code DCI": "10E035", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUNADIL 0,5G/100ML SOLUTION BUVABLE  FL /200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUNADIL", "Tarif de reference": "118 DA", "PPA": "N/A", "Num Enregistrement": "317/16D067/16", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "0,5G/100ML", "Conditionnement": "FL /200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPERSTAT 10MG COMP. PELLI. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/1615.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1615", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPERSTAT", "Tarif de reference": "837.6 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 M 269 /15", "Code DCI": "06M269", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPERSTAT 20MG COMP. PELLI. B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/1618.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1618", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ROSUVASTATINE  CALCIQUE EXPRIME EN ROSUVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPERSTAT", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 M 270 /15", "Code DCI": "06M270", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPPFADOL 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SUPPFADOL", "Tarif de reference": " N/A", "PPA": "99.00 DA", "Num Enregistrement": "366/ 03 B 007 /07/13", "Code DCI": "03B007", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPPFADOL 150MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SUPPFADOL", "Tarif de reference": " N/A", "PPA": "104.00 DA", "Num Enregistrement": "366/ 03 B 041 /07/13", "Code DCI": "03B041", "Forme": "SUPPO.", "Dosage": "150MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPPFADOL 170MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SUPPFADOL", "Tarif de reference": " N/A", "PPA": "108.00 DA", "Num Enregistrement": "366/ 03 B 096 /07/13", "Code DCI": "03B096", "Forme": "SUPPO.", "Dosage": "170MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPPFADOL 200MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SUPPFADOL", "Tarif de reference": " N/A", "PPA": "114.00 DA", "Num Enregistrement": "366/ 03 B 042 /07/13", "Code DCI": "03B042", "Forme": "SUPPO.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPPFADOL 300MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SUPPFADOL", "Tarif de reference": " N/A", "PPA": "118.00 DA", "Num Enregistrement": "366/ 03 B 043 /07/13", "Code DCI": "03B043", "Forme": "SUPPO.", "Dosage": "300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPPFADOL 80MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "SUPPFADOL", "Tarif de reference": "59 DA", "PPA": "85.00 DA", "Num Enregistrement": "366/ 03 B 100 /08", "Code DCI": "03B100", "Forme": "SUPPO.", "Dosage": "80MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPPLIN 250MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANDOZ", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPPLIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 13 F 039 /02/10", "Code DCI": "13F039", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPPLIN 500MG SOL.INJ.IV. FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " NITRO-5-IMIDAZOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " METRONIDAZOLE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "SUPPLIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "080/ 13 F 038 /98", "Code DCI": "13F038", "Forme": "SOL. INJ.", "Dosage": "500MG", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPRADOLEX 325MG / 37,5MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRADOLEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "289/03F115/16", "Code DCI": "03F115", "Forme": "GLES.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPRAMADOL 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRAMADOL", "Tarif de reference": " N/A", "PPA": "289.00 DA", "Num Enregistrement": "289/ 03 F 047 /07", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPRAMADOL 50MG/ML  SOL. INJ.IM/IV . B/05 ET B/50 AMPOULE DE 02ML (100MG/2ML)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRAMADOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "433/03F111/16", "Code DCI": "03F111", "Forme": "SOL. INJ.", "Dosage": "50MG/ML ", "Conditionnement": "B/05 ET B/50 AMPOULE DE 02ML (100MG/2ML)", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPRAXIME 100MG/5ML** APRES  RECONSTITUTION PDRE. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=690", "Laboratoire": " SANAMED", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRAXIME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "097/ 13 B 198 /10", "Code DCI": "13B198", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG/5ML** APRES  RECONSTITUTION", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPRAXIME 200MG** COMP. PELLI. B/8", "Img": "https://pharmnet-dz.com//img/medics/698.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=698", "Laboratoire": " SANAMED", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRAXIME", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "097/ 13 B 201 /10", "Code DCI": "13B201", "Forme": "COMP. PELLI.", "Dosage": "200MG**", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPRIL 25MG/5ML (0,5G/100ML) SOL.BUV. FL./200ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "077/ 16 D 067 /03/14", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML (0,5G/100ML)", "Conditionnement": "FL./200ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SUPRIMIDE 200MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/2268.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRIMIDE", "Tarif de reference": "0 DA", "PPA": "1924.00 DA", "Num Enregistrement": "352/ 16 D 094 /11", "Code DCI": "16D094", "Forme": "COMP. SEC.", "Dosage": "200MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUPRIMIDE 400MG COMP.. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMISULPRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SUPRIMIDE", "Tarif de reference": "3482,40 DA", "PPA": " DA", "Code DCI": "16D160", "Forme": "COMP SEC.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SURGESTONE 0,5MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/3823.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " ROUSSEL", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PROMEGESTONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SURGESTONE", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "033/ 09 N 111 /99", "Code DCI": "09N111", "Forme": "COMP.", "Dosage": "0,5MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "SURMONTIL 0.04 SOL.BUV.GTTES. FL.COMPTE GTTES./30ML", "Img": "https://pharmnet-dz.com//img/medics/2547.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " TRIMIPRAMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SURMONTIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "263/ 16 A 018 /96/10", "Code DCI": "16A018", "Forme": "SOL. BUV. GTTES.", "Dosage": "0.04", "Conditionnement": "FL.COMPTE GTTES./30ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "SURMONTIL 25MG COMP. SEC. B/50", "Img": "https://pharmnet-dz.com//img/medics/2546.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2546", "Laboratoire": " RHONE POULENC RORER", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " TRIMIPRAMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SURMONTIL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "016/ 16 A 017 /96", "Code DCI": "16A017", "Forme": "COMP.", "Dosage": "25MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUTENT 12,5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1043", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " SUNITINIB MALATE EXPRIME EN SUNITINIB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SUTENT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 05 C 118 /07/13", "Code DCI": "05C118", "Forme": "GLES.", "Dosage": "12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUTENT 25MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1044", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " SUNITINIB MALATE EXPRIME EN SUNITINIB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SUTENT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 05 C 119 /07/13", "Code DCI": "05C119", "Forme": "GLES.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SUTENT 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1045", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " SUNITINIB MALATE EXPRIME EN SUNITINIB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "SUTENT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 05 C 120 /07/14", "Code DCI": "05C120", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SWOR 20MG COMP. ORODISPERS. SEC. PILUL./20", "Img": "https://pharmnet-dz.com//img/medics/3779.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3779", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SWOR", "Tarif de reference": "392 DA", "PPA": "N/A", "Num Enregistrement": "320/ 09 H 144 /07/13", "Code DCI": "09H144", "Forme": "COMP. ORODISPERS.", "Dosage": "20MG", "Conditionnement": "PILUL./20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SWOR 5MG COMP. ORODISPERS. PILUL./30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3771", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SWOR", "Tarif de reference": "0 DA", "PPA": "292.00 DA", "Num Enregistrement": "320/ 09 H 143 /07/12", "Code DCI": "09H143", "Forme": "COMP. ORODISPERS.", "Dosage": "5MG", "Conditionnement": "PILUL./30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYMBICORT TURBUHALER 100\u00b5G/6\u00b5G/DOSE PDRE. P. INHAL. FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medics/1354.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1354", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SYMBICORT TURBUHALER", "Tarif de reference": "2469.6 DA", "PPA": " DA", "Num Enregistrement": "036/ 20 F 228 /07", "Code DCI": "20F228", "Forme": "PDRE. INHAL.", "Dosage": "100\u00b5G/6\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYMBICORT TURBUHALER 200\u00b5G/6\u00b5G/DOSE PDRE. P. INHAL. FL./120DOSES", "Img": "https://pharmnet-dz.com//img/medics/1356.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1356", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SYMBICORT TURBUHALER", "Tarif de reference": "2599.2 DA", "PPA": " DA", "Num Enregistrement": "036/ 20 F 229 /07", "Code DCI": "20F229", "Forme": "PDRE. INHAL.", "Dosage": "200\u00b5G/6\u00b5G/DOSE", "Conditionnement": "FL./120DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYMBICORT TURBUHALER 400\u00b5G/12\u00b5G/DOSE PDRE. P. INHAL. FL./60DOSES", "Img": "https://pharmnet-dz.com//img/medics/1357.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1357", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " CORTICOIDES AVEC BRONCHODILATATEURS", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BUDESONIDE / FORMOTEROL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "SYMBICORT TURBUHALER", "Tarif de reference": "2599.2 DA", "PPA": "3088.00 DA", "Num Enregistrement": "036/ 20 F 230 /07", "Code DCI": "20F230", "Forme": "PDRE. INHAL.", "Dosage": "400\u00b5G/12\u00b5G/DOSE", "Conditionnement": "FL./60DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNED 25MG/5ML OU 0,5% SOL. BUV. FL./125ML", "Img": "https://pharmnet-dz.com//img/medics/2224.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2224", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SYNED", "Tarif de reference": "73.75 DA", "PPA": "80.00 DA", "Num Enregistrement": "242/ 16 D 067 /06", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML OU 0,5%", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNED 50MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medics/2217.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2217", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SYNED", "Tarif de reference": "93.4 DA", "PPA": "N/A", "Num Enregistrement": "242/ 16 D 066 /11", "Code DCI": "16D066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNEDIL G\u00e9 25MG/5ML SOL. BUV. FL/200ML", "Img": "https://pharmnet-dz.com//img/medics/2225.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2225", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " SULPIRIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SYNEDIL G\u00e9", "Tarif de reference": "118 DA", "PPA": "168.00 DA", "Num Enregistrement": "285/ 16 D 067 /06", "Code DCI": "16D067", "Forme": "SOL. BUV.", "Dosage": "25MG/5ML", "Conditionnement": "FL/200ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNOSIA 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2500.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SYNOSIA", "Tarif de reference": "0 DA", "PPA": "4350.00 DA", "Num Enregistrement": "263/ 15 F 075 /14", "Code DCI": "15F075", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNOSIA 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2495.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " MALADIE D'\u0092ALZHEIMER", "C.Therapeutique": " NEUROLOGIE", "Info": " DONEPEZIL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "SYNOSIA", "Tarif de reference": "0 DA", "PPA": "4950.00 DA", "Num Enregistrement": "263/ 15 F 074 /14", "Code DCI": "15F074", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNTHOL 0,26G/0,26G/0,021G/0,0105G/100G SOL.DERM. ET BAIN DE BOUCHE FL/225 ML", "Img": "https://pharmnet-dz.com//img/medics/1129.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1142", "Laboratoire": " SMITHKLINE BEECHAM", "C.Pharmacologique": " PRODUIT LOCAL GINGIVO-DENTAIRE & BUCCO-PHARYNGE", "C.Therapeutique": " STOMATOLOGIE", "Info": " LEVOMENTHOL/VERATOL/RESORCINOL/ACIDE SALYCYLIQUE", "Pays": "ROYAUME UNI", "Nom Commercial": "SYNTHOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "042/ 23 B 008 /97", "Code DCI": "23B008", "Forme": "SOL. DERM.", "Dosage": "0,26G/0,26G/0,021G/0,0105G/100G", "Conditionnement": "FL/225 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNTHOL GEL 0,52G/0,25G/0,03G/0,1G/100G GEL T/100G", "Img": "https://pharmnet-dz.com//img/medics/1427.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1427", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " N/D", "C.Therapeutique": " RHUMATOLOGIE", "Info": " LEVOMENTHOL / VERATROLE / RESORCINOL / ACIDE SALICYLIQUE", "Pays": "FRANCE", "Nom Commercial": "SYNTHOL GEL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 21 F 048 /06", "Code DCI": "21F048", "Forme": "GEL", "Dosage": "0,52G/0,25G/0,03G/0,1G/100G", "Conditionnement": "T/100G", "Commercialisation": true, "Remboursable": true}, {"Nom": "SYNTOCINON 5UI/ML SOL.INJ. B/3AMP. DE 1ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " OCYTOCIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " OXYTOCINE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "SYNTOCINON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 11 E 019 /99/13", "Code DCI": "11E019", "Forme": "SOL. INJ.", "Dosage": "5UI/ML", "Conditionnement": "B/3AMP. DE 1ML ", "Commercialisation": true, "Remboursable": null}], "T": [{"Nom": "TABETA 0,5MG/ML (0,05%) SOL. BUV. GTTES. F/30ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/641.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " EL KENDI", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " BETAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TABETA", "Tarif de reference": "0 DA", "PPA": "124.00 DA", "Num Enregistrement": "352/ 09 H 020 /10", "Code DCI": "09H020", "Forme": "SOL. BUV. GTTES.", "Dosage": "0,5MG/ML (0,05%)", "Conditionnement": "F/30ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABETA 0.001 PDE. DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/521.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=521", "Laboratoire": " EL KENDI", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE DIPROPIONATE EXPRIME EN BETHAMETHASONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TABETA", "Tarif de reference": "150 DA", "PPA": "N/A", "Num Enregistrement": "352/ 07 H 165 /09", "Code DCI": "07H165", "Forme": "PDE. DERM.", "Dosage": "0.001", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABICLOR 125MG/5ML SUSP BUV  FL/75ML", "Img": "https://pharmnet-dz.com//img/medics/729.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "TABICLOR", "Tarif de reference": "0 DA", "PPA": "449.00 DA", "Num Enregistrement": "173/ 13 B 259 /03", "Code DCI": "13B259", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/75ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABICLOR 250MG GLES B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "TABICLOR", "Tarif de reference": "0 DA", "PPA": "671.00 DA", "Num Enregistrement": "173/ 13 B 261 /03", "Code DCI": "13B261", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABICLOR 250MG/5ML SUSP BUV FL/75ML", "Img": "https://pharmnet-dz.com//img/medics/732.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=732", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "TABICLOR", "Tarif de reference": "742.88 DA", "PPA": "N/A", "Num Enregistrement": "173/ 13 B 260 /03", "Code DCI": "13B260", "Forme": "SUSP. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL/75ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABICLOR 375MG/5ML PDRE. SUSP. BUV. FL./75ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TABICLOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 192 /08", "Code DCI": "13B192", "Forme": "PDRE. SUSP. BUV.", "Dosage": "375MG/5ML", "Conditionnement": "FL./75ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TABICLOR 500MG GLES B/15", "Img": "https://pharmnet-dz.com//img/medics/736.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " TABUK", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "TABICLOR", "Tarif de reference": "0 DA", "PPA": "1448.00 DA", "Num Enregistrement": "173/ 13 B 262 /03", "Code DCI": "13B262", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABICLOR M.R. 750MG** COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFACLOR (ANHYDRE)**", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TABICLOR M.R.", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 293 /08", "Code DCI": "13B293", "Forme": "COMP. PELLI.", "Dosage": "750MG**", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "TABIFLEX COOL 0.01 GEL  EMULSION DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medics/1374.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1374", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TABIFLEX COOL", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "352/ 21 A 004 /98/09", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABUKLAV 1G/200MG PDRE. ET SOLV. SOL. INJ. B/01FL. DE PDRE + 01AMP. DE 20 ML DE SOLVANT", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TABUKLAV", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 G 182 /08", "Code DCI": "13G182", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/200MG", "Conditionnement": "B/01FL. DE PDRE + 01AMP. DE 20 ML DE SOLVANT", "Commercialisation": true, "Remboursable": true}, {"Nom": "TABUKLAV 500MG/100MG PDRE. ET SOLV. SOL. INJ. B/1FL. DE PDRE + 1AMP. DE 10 ML DE SOLVANT", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE/ ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TABUKLAV", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 G 280 /08", "Code DCI": "13G280", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/100MG", "Conditionnement": "B/1FL. DE PDRE + 1AMP. DE 10 ML DE SOLVANT", "Commercialisation": true, "Remboursable": true}, {"Nom": "TACROLIMUS CINFA 0,5MG GLES B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CINFA", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "TACROLIMUS CINFA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "157/ 05 B 101 /14", "Code DCI": "05B101", "Forme": "GLES.", "Dosage": "0,5MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "TACROLIMUS CINFA 1MG GLES B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CINFA", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "TACROLIMUS CINFA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "157/ 05 B 092 /14", "Code DCI": "05B092", "Forme": "GLES.", "Dosage": "1MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "TACROLIMUS CINFA 5MG GLES B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CINFA", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "TACROLIMUS CINFA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "157/ 05 B 093 /14", "Code DCI": "05B093", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "TADALIS 20MG COMP. PELLI. SEC. B/02 ", "Img": "https://pharmnet-dz.com//img/medics/1231.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1231", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TADALIS", "Tarif de reference": "0 DA", "PPA": "608.24 DA", "Num Enregistrement": "447/ 25 N 052 /09", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/02   B/08", "Commercialisation": true, "Remboursable": false}, {"Nom": "TADALIS 5MG COMP PELL B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4581.png", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TADALIS", "Tarif de reference": "0 DA", "PPA": "2280.90 DA", "Num Enregistrement": "447/25N076/16", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": false}, {"Nom": "TADENAN 50MG CAPS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FOURNIER", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " EXTRAIT  DE PYGEUM AFRICANUM", "Pays": "FRANCE", "Nom Commercial": "TADENAN", "Tarif de reference": "900 DA", "PPA": "N/A", "Num Enregistrement": "019/ 25 B 003 /99", "Code DCI": "25B003", "Forme": "CAPS.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAFIALYS 20MG COMP. PELLI. SEC. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAFIALYS", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": false}, {"Nom": "TAHOR 10MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1564.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1564", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAHOR", "Tarif de reference": "781.76 DA", "PPA": "N/A", "Num Enregistrement": "045/ 06 M 198 /02/09", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAHOR 20MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1587.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1587", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAHOR", "Tarif de reference": "1164.24 DA", "PPA": "N/A", "Num Enregistrement": "045/ 06 M 225 /07", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAHOR 40MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/1600.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1600", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAHOR", "Tarif de reference": "1848 DA", "PPA": "N/A", "Num Enregistrement": "045/ 06 M 232 /07", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TALIN 0,3MG/ML SIROP FL/100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TALIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "043/ 20 A 049 /98", "Code DCI": "20A049", "Forme": "SIROP", "Dosage": "0,3MG/ML", "Conditionnement": "FL/100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TALIN 2,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TALIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "043/ 20 A 021 /98", "Code DCI": "20A021", "Forme": "COMP.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TALIN 5MG COMP. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " JPM (JORDANIAN PHARMACEUTICAL MANIFACTURING)", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TALIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "043/ 20 A 048 /99", "Code DCI": "20A048", "Forme": "COMP. LP", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TALOPREX 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2567.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2567", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " ESCITALOPRAM OXALATE EXPRIME EN ESCITALOPRAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TALOPREX", "Tarif de reference": "390.9 DA", "PPA": "N/A", "Num Enregistrement": "352/ 16 A 105 /12", "Code DCI": "16A105", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMIFLU 75MG GLES B/10", "Img": "https://pharmnet-dz.com//img/medics/450.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=450", "Laboratoire": " ROCHE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OSELTAMIVIR", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "TAMIFLU", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 13 P 290 /05", "Code DCI": "13P290", "Forme": "GLES.", "Dosage": "75MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMOCIT 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TAMOXIFENE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TAMOCIT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 09 B 004 /98", "Code DCI": "09B004", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TAMOCIT 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TAMOXIFENE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TAMOCIT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 09 B 075 /98", "Code DCI": "09B075", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TAMOXIFEN EBEWE  10MG COMP. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/605.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TAMOXIFENE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "TAMOXIFEN EBEWE ", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 09 B 004 /98/08", "Code DCI": "09B004", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMOXIFEN EBEWE 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/608.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " ANTI-OESTROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TAMOXIFENE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "TAMOXIFEN EBEWE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "141/ 09 B 075 /98/08", "Code DCI": "09B075", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMOXIFENE MYLAN 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1070", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TAMOXIFENE CITRATE EXPRIME EN TAMOXIFENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TAMOXIFENE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 E 135 /07", "Code DCI": "05E135", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TAMOXIFENE MYLAN 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1072", "Laboratoire": " MYLAN", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TAMOXIFENE CITRATE EXPRIME EN TAMOXIFENE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TAMOXIFENE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 05 E 136 /07/15", "Code DCI": "05E136", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TAMSIR LP 0,4MG  MICROGRLES. LP EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1175.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1175", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAMSIR LP", "Tarif de reference": "1850 DA", "PPA": "N/A", "Num Enregistrement": "352/ 25 B 047 /12 ", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMSULIX LP 0,4MG  MICROGRANULES LP EN GLES  B/30", "Img": "https://pharmnet-dz.com//img/medics/1176.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1176", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAMSULIX LP", "Tarif de reference": "1500 DA", "PPA": "N/A", "Num Enregistrement": "149/ 25 B 047 /14", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMSULOSINE BEKER LP 0,4MG GLES \u00e0 MICROGRANULES \u00e0 LIB\u00e9RATION PROLONG\u00e9e B/30 ET B/90", "Img": "https://pharmnet-dz.com//img/medics/4237.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4237", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAMSULOSINE BEKER LP ", "Tarif de reference": "1500.00 DA", "PPA": "1500.00 DA", "Num Enregistrement": "447/25B047/15", "Code DCI": "25B047", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "0,4MG", "Conditionnement": "B/30 ET B/90", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMSULOSINE MM LP 0,4MG  MICROGRLES. EN GLES. LP  B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAMSULOSINE MM LP", "Tarif de reference": "1500 DA", "PPA": "1500.00 DA", "Num Enregistrement": "470/ 25 B 047 /12", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMSULOSINE WINTHROP LP 0,4MG  GLES. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1178", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TAMSULOSINE WINTHROP LP", "Tarif de reference": "1500 DA", "PPA": "1500.00 DA", "Num Enregistrement": "376/ 25 B 047 /09", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAMSUMED LP 0,4MG  MICROGRLES. LP EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1179.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1179", "Laboratoire": " REMEDE PHARMA", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TAMSULOSINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAMSUMED LP", "Tarif de reference": "1500 DA", "PPA": "N/A", "Num Enregistrement": "426/ 25 B 047 /12", "Code DCI": "25B047", "Forme": "GLES.", "Dosage": "0,4MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANAKAN 40MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/2032.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2032", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " EXTRAIT DE GINKGO STANDARDISE", "Pays": "FRANCE", "Nom Commercial": "TANAKAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "020/ 18 C 021 /02", "Code DCI": "18C021", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANAKAN 40MG/ML SOL.BUV. FL/30ML", "Img": "https://pharmnet-dz.com//img/medics/2031.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2031", "Laboratoire": " IPSEN PHARMA ", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " EXTRAIT DE GINKO BILOBA TITRE A 24% D'HETEROSIDES DE GINKGO BILOBA ET 6% DE GINKOLIDES-BILOBALIDE", "Pays": "FRANCE", "Nom Commercial": "TANAKAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "020/ 18 C 019 /97", "Code DCI": "18C019", "Forme": "SOL. BUV.", "Dosage": "40MG/ML", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "TANATRIL  10MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TANATRIL ", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "06E201", "Forme": "COMP SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANATRIL + 5MG/12,5MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TANATRIL +", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E277", "Forme": "COMP.", "Dosage": "5MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANATRIL + TANATRIL + 10MG/12,5MG COMP. B/30COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TANATRIL +", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "06E289", "Forme": "COMP.", "Dosage": "10MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANATRIL + TANATRIL + 10MG/25MG COMP B/30 COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RANELATE DE STRONTIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TANATRIL +", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E278", "Forme": "COMP.", "Dosage": "10MG/25MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANATRIL 1,25MG COMP.SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMASCIENCE INC", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TANATRIL", "Tarif de reference": "240.00 DA", "PPA": "N/A", "Code DCI": "06E139", "Forme": "COMP SEC.", "Dosage": "1.25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANATRIL 2,5MG  COMP SEC  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TANATRIL ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "06E127", "Forme": "COMP SEC.", "Dosage": "2,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANATRIL 5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TANATRIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANGANIL 500MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2026.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2026", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " ACETYL- DL- LEUCINE", "Pays": "FRANCE", "Nom Commercial": "TANGANIL", "Tarif de reference": "339.73 DA", "PPA": "N/A", "Num Enregistrement": "099/ 18 C 006 /98", "Code DCI": "18C006", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TANGANIL 500MG/5ML SOL.INJ. B/5AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/2025.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2025", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTIVERTIGINEUX", "C.Therapeutique": " OTOLOGIE", "Info": " ACETYL- DL- LEUCINE", "Pays": "FRANCE", "Nom Commercial": "TANGANIL", "Tarif de reference": "0 DA", "PPA": "333.00 DA", "Num Enregistrement": "099/ 18 C 005 /98", "Code DCI": "18C005", "Forme": "SOL. INJ.", "Dosage": "500MG/5ML", "Conditionnement": "B/5AMP. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TARDEN 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1565.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "TARDEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "177/ 06 M 198 /06/12", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TARDEN 20MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1588.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "TARDEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "177/ 06 M 225 /06/12", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TARDEN 40MG COMP.PELLI.SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/1601.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "TARDEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "177/ 06 M 232 /08/13", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TARDYFERON 80MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/1793.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1793", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERREUX (DCI)   (SOUS FORME DE SULFATE FERREUX)", "Pays": "FRANCE", "Nom Commercial": "TARDYFERON", "Tarif de reference": "57.6 DA", "PPA": "N/A", "Num Enregistrement": "099/ 12 E 128 /07", "Code DCI": "12E128", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TARDYFERON B9 50MG / 0,35MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1775.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1775", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " SULFATE FERREUX EXPRIME EN FER FERREUX / ACIDE FOLIQUE", "Pays": "FRANCE", "Nom Commercial": "TARDYFERON B9", "Tarif de reference": "253.2 DA", "PPA": "N/A", "Num Enregistrement": "099/ 12 E 078 /99/13", "Code DCI": "12E078", "Forme": "COMP. PELLI.", "Dosage": "50MG / 0,35MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAREG 160MG COMP.PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3088", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "TAREG", "Tarif de reference": " N/A", "PPA": "2315.00 DA", "Num Enregistrement": "068/ 06 E 166 /02/09", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "TAREG 80MG COMP.PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=198", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "TAREG", "Tarif de reference": " N/A", "PPA": "1646.00 DA", "Num Enregistrement": "068/ 06 E 147 /99/09", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "TARGOCID 200MG/FL.DE PDRE. LYOPH. ET SOLV. P. USAGE PARENTERAL IM/IV B/01FL. DE PDRE. + 01AMP. DE 3,2ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medics/3605.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3605", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TEICOPLANINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TARGOCID", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 13 X 339 /09", "Code DCI": "13X339", "Forme": "LYOPH. SOL. INJ.", "Dosage": "200MG/FL.DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 3,2ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "TARGOCID 400MG/FL.DE PDRE. LYOPH. ET SOLV. P. USAGE PARENTERAL IM/IV B/01FL. DE PDRE. + 01AMP. DE 3,2ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medics/3607.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3607", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TEICOPLANINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TARGOCID", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 13 X 340 /09", "Code DCI": "13X340", "Forme": "LYOPH. SOL. INJ.", "Dosage": "400MG/FL.DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 3,2ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "TARGOPLANIN 200MG/FL. DE LYOPH LYOPH. P. USAGE PARENT. IM/IV/IP B/1FL. DE LYOPH.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " INFECTIOLOGIE", "C.Therapeutique": " TEICOPLANINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TARGOPLANIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 X 339 /10", "Code DCI": "13X339", "Forme": "LYOPH. SOL. INJ.", "Dosage": "200MG/FL. DE LYOPH", "Conditionnement": "B/1FL. DE LYOPH.", "Commercialisation": true, "Remboursable": null}, {"Nom": "TASIGNA 200MG GLES. B/28", "Img": "https://pharmnet-dz.com//img/medics/1051.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1051", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " NILOTINIB CHLORHYDRATE MONOHYDRATE EXPRIME EN NILOTINIB", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "TASIGNA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 05 C 148 /13", "Code DCI": "05C148", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TASONEX 50\u00b5G/DOSE SPRAY NASAL FL/120DOSES ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " TABUK", "C.Pharmacologique": " PRODUITS LOCAUX", "C.Therapeutique": " RHINOLOGIE", "Info": " MOMETASONE FUROATE ANHYDRE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "TASONEX", "Tarif de reference": "750 DA", "PPA": "N/A", "Num Enregistrement": "173/22E036/16", "Code DCI": "22E036", "Forme": "SUSP.NAS.", "Dosage": "50\u00b5G/DOSE", "Conditionnement": "FL/120DOSES ", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAVANIC 250MG COMP.PELLI. SEC. B/05", "Img": "https://pharmnet-dz.com//img/medics/364.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=364", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "TAVANIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 13 K 227 /00/08", "Code DCI": "13K227", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAVANIC 500MG COMP.PELLI. SEC. B/05", "Img": "https://pharmnet-dz.com//img/medics/367.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=367", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LEVOFLOXACINE HEMIHYDRATE EXPRIME EN LEVOFLOXACINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "TAVANIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 13 K 228 /00/08", "Code DCI": "13K228", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAVER 200MG COMP. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "CHYPRE", "Nom Commercial": "TAVER", "Tarif de reference": "435 DA", "PPA": "N/A", "Num Enregistrement": "178/ 15 A 004 /99", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAXOTERE 20MG/FL. DE 1ML SOL. A DILUER P. PERF IV B/1FL. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/1107.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1107", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " DOCETAXEL ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TAXOTERE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 05 G 071 /97/13", "Code DCI": "05G071", "Forme": "LYOPH. SOL. INJ.", "Dosage": "20MG/FL. DE 1ML", "Conditionnement": "B/1FL. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAXOTERE 80MG/FL. DE 4ML SOL. A DILUER P. PERF IV B/1FL. DE 4ML", "Img": "https://pharmnet-dz.com//img/medics/1110.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1110", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " DOCETAXEL ANHYDRE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TAXOTERE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 05 G 072 /97/13", "Code DCI": "05G072", "Forme": "LYOPH. SOL. INJ.", "Dosage": "80MG/FL. DE 4ML", "Conditionnement": "B/1FL. DE 4ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TAZOLINE 200MG/ML OU 1000MG/5ML)** PDRE. ET SOLV. (LIDOCAINE) SOL.INJ. IM B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV.(LIDOCAINE)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TAZOLINE", "Tarif de reference": "181 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 013 /09", "Code DCI": "13B013", "Forme": "PDRE. INJ.", "Dosage": "200MG/ML OU 1000MG/5ML)**", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV.(LIDOCAINE)", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEDEMA LP 37,5MG MICROGRANULES LP  EN GLES  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TEDEMA LP", "Tarif de reference": "870.6 DA", "PPA": "N/A", "Num Enregistrement": "317/16A125/15", "Code DCI": "16A125", "Forme": "MICROGRANULES", "Dosage": "37,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEGRETOL 100MG/5ML SUSP.BUV. FL/150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3509", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "TEGRETOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 15 A 006 /97", "Code DCI": "15A006", "Forme": "SUSP. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEGRETOL 200MG COMP.SEC. B/50", "Img": "https://pharmnet-dz.com//img/medics/3506.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3506", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "TEGRETOL", "Tarif de reference": "435 DA", "PPA": "N/A", "Num Enregistrement": "068/ 15 A 004 /98/15", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEGRETOL LP 400MG COMP. PELLI. SEC. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2398.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2398", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "TEGRETOL LP", "Tarif de reference": "363 DA", "PPA": "N/A", "Num Enregistrement": "068/ 15 A 036 /97", "Code DCI": "15A036", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEKAMEN 20MG/ML (40MG/2ML) (100MG/5ML) SOL. P. PERF. IV B/01FL. DE 2 ML ET B/01FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/1115.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " IRINOTECAN CHLORHYDRATE TRIHYDRATE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "TEKAMEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "176/ 05 G 076 /14", "Code DCI": "05G076", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (40MG/2ML) (100MG/5ML)", "Conditionnement": "B/01FL. DE 2 ML ET B/01FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELEBRIX 30 MEGLUMINE 660,3MG/ML (I=300MG/ML) SOL INJ  FL/50ML - 100ML", "Img": "https://pharmnet-dz.com//img/medics/582.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=582", "Laboratoire": " GUERBET", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOXITALAMATE DE MEGLUMINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TELEBRIX 30 MEGLUMINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "168/ 08 C 047 /98/13", "Code DCI": "08C047", "Forme": "SOL. INJ.", "Dosage": "660,3MG/ML (I=300MG/ML)", "Conditionnement": "FL/50ML - 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELEBRIX 35 650,9MG/96,6MG/ML (I=350MG/ML) SOL. INJ. FL./50ML - FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/587.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=587", "Laboratoire": " GUERBET", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOXITALAMATE DE MEGLUMINE  / IOXITALAMATE DE SODIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TELEBRIX 35", "Tarif de reference": "0 DA", "PPA": "1648.00 DA", "Num Enregistrement": "168/ 08 C 064 /00/15", "Code DCI": "08C064", "Forme": "SOL. INJ.", "Dosage": "650,9MG/96,6MG/ML (I=350MG/ML)", "Conditionnement": "FL./50ML - FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELFADINE 120MG  COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TELFADINE", "Tarif de reference": "120 DA", "PPA": "0 DA", "Code DCI": "01A039", "Forme": "COMP.", "Dosage": "120 MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELFAST 120MG  COMP PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medics/4016.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4016", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TELFAST", "Tarif de reference": "228 DA", "PPA": "N/A", "Num Enregistrement": "392/ 01 A 039 /00/15", "Code DCI": "01A039", "Forme": "COMP. PELLI.", "Dosage": "120MG ", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELFAST 180MG COMP PELLI. B/15", "Img": "https://pharmnet-dz.com//img/medics/4021.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4021", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TELFAST", "Tarif de reference": "268.95 DA", "PPA": "N/A", "Num Enregistrement": "392/ 01 A 040 /00/15", "Code DCI": "01A040", "Forme": "COMP. PELLI.", "Dosage": "180MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELFAST 30MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4033.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4033", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " FEXOFENADINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TELFAST", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "392/ 01 A 050 /14", "Code DCI": "01A050", "Forme": "COMP. PELLI.", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELGENE 50MG/ML  POUDRE + SOLVANT POUR PREPARATION INJ POUR PERFUSION FLACON DE POUDRE DE 5g ou de 10g et flacon de solvant de 100 ml ou 200 ml avec syst\u00e9me d'un transfert muni d'un \u00e9vent \u00e0 filtre st\u00e9rilisant  ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SERUMS & GAMMA GLOBULINES", "C.Pharmacologique": " INFECTIOLOGIE", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TELGENE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "513/13V471/16", "Code DCI": "13V471", "Forme": "PDRE. SOL. INJ.", "Dosage": "50MG/ML ", "Conditionnement": "FLACON DE POUDRE DE 5g ou de 10g et flacon de solvant de 100 ml ou 200 ml avec syst\u00e9me d'un transfert muni d'un \u00e9vent \u00e0 filtre st\u00e9rilisant  ", "Commercialisation": true, "Remboursable": null}, {"Nom": "TELMIDIS 40MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3203.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TELMIDIS", "Tarif de reference": " N/A", "PPA": "1290.00 DA", "Num Enregistrement": "289 / 06 E 263 /15", "Code DCI": "06E263", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TELMIDIS 80MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/4567.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TELMIDIS", "Tarif de reference": "1204 DA", "PPA": " DA", "Num Enregistrement": "289/06E264/16", "Code DCI": "06E264", "Forme": "COMP.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELMISARTAN ZENTIVA 40MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TELMISARTAN ZENTIVA", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "428/06E263/16", "Code DCI": "06E263", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELMISARTAN ZENTIVA 80MG  COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TELMISARTAN ZENTIVA", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "428/06E264/16", "Code DCI": "06E264", "Forme": "COMP.", "Dosage": "80MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELMISARTE 40MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TELMISARTE", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E263", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELMISARTE 80MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TELMISARTE", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E264", "Forme": "COMP.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TELMISARTE+ 80MG/12,5MG COMP.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TELMISARTE+", "Tarif de reference": "2190.00 DA", "PPA": "N/A", "Code DCI": "06E266", "Forme": "COMP.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEMERIT 5MG COMP. QUADRISEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/3265.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3265", "Laboratoire": " BERLIN CHEMIE AG", "C.Pharmacologique": " BETA-BLOQUANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " NEBIVOLOL CHLORHYDRATE EXPRIME EN NEBIVOLOL", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "TEMERIT", "Tarif de reference": "0 DA", "PPA": "1224.00 DA", "Num Enregistrement": "431/ 06 F 273 /09", "Code DCI": "06F273", "Forme": "COMP. SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEMESTA 1MG COMP. SEC. B/30 ", "Img": "https://pharmnet-dz.com//img/medics/2840.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2840", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TEMESTA", "Tarif de reference": "146.77 DA", "PPA": "N/A", "Num Enregistrement": "231/ 16 B 042 /98/15", "Code DCI": "16B042", "Forme": "COMP. PELLI.", "Dosage": "1MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEMESTA 2,5MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/2845.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2845", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " LORAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TEMESTA", "Tarif de reference": "204.24 DA", "PPA": "N/A", "Num Enregistrement": "231/ 16 B 043 /98/15", "Code DCI": "16B043", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEMGESIC 0,2MG COMP.SUB-LING. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " BUPRENORPHINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TEMGESIC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "027/ 03 F 029 /98", "Code DCI": "03F029", "Forme": "COMP. SUB-LING.", "Dosage": "0,2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEMGESIC 0,3 MG/ML SOL.INJ. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " BUPRENORPHINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TEMGESIC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "027/ 03 F 013 /97", "Code DCI": "03F013", "Forme": "SOL. INJ.", "Dosage": "0,3 MG/ML", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEMOSIDE 100MG GLES. B/05", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TEMOZOLOMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "TEMOSIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 130 /09", "Code DCI": "05G130", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": null}, {"Nom": "TEMOSIDE 20MG GLES. B/1PILUL. DE 05", "Img": "https://pharmnet-dz.com//img/medics/27.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TEMOZOLOMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "TEMOSIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 159 /13", "Code DCI": "05G159", "Forme": "GLES.", "Dosage": "20MG", "Conditionnement": "B/1PILUL. DE 05", "Commercialisation": true, "Remboursable": null}, {"Nom": "TEMOSIDE 250MG GLES. B/05", "Img": "https://pharmnet-dz.com//img/medics/18.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " TEMOZOLOMIDE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "TEMOSIDE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 131 /09", "Code DCI": "05G131", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": null}, {"Nom": "TENOBIOTIC ADULTE 285MG/110MG SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS", "Pays": "ALGERIE", "Nom Commercial": "TENOBIOTIC ADULTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 C 117 /06", "Code DCI": "20C117", "Forme": "SUPPO.", "Dosage": "285MG/110MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": null}, {"Nom": "TENOBIOTIC ENFANTS 190MG/75MG SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS", "Pays": "ALGERIE", "Nom Commercial": "TENOBIOTIC ENFANTS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 C 205 /06", "Code DCI": "20C205", "Forme": "SUPPO.", "Dosage": "190MG/75MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": null}, {"Nom": "TENOBIOTIC NOURRISSONS 95MG/44MG SUPPO. B/8", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "TENOBIOTIC NOURRISSONS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 20 C 100 /06", "Code DCI": "20C100", "Forme": "SUPPO.", "Dosage": "95MG/44MG", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": null}, {"Nom": "TENORDATE 50MG/20MG GLES B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4662", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATENOLOL / NIFEDIPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TENORDATE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "256/06E207/05/16", "Code DCI": "06E207", "Forme": "GLES.", "Dosage": "50MG/20MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TENSIONORM 4MG COMP SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CANDESARTAN CILEXETIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSIONORM", "Tarif de reference": "699,6 DA", "PPA": "N/A", "Code DCI": "06E196", "Forme": "COMP SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TENSIOPRIL 50MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LAD PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSIOPRIL", "Tarif de reference": "190.00 DA", "PPA": "N/A", "Code DCI": "06E053", "Forme": "COMP.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TENSODIPINE 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/92.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSODIPINE", "Tarif de reference": "663 DA", "PPA": "N/A", "Num Enregistrement": "289/ 06 B 243 /07", "Code DCI": "06B243", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TENSODIPINE 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/78.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESYLATE EXPRIME EN AMLODIPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSODIPINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "289/ 06 B 123 /07", "Code DCI": "06B123", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TENSOPREL 25MG COMP. QUADRISEC. B/60 ", "Img": "https://pharmnet-dz.com//img/medics/138.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSOPREL", "Tarif de reference": " N/A", "PPA": "297.00 DA", "Num Enregistrement": "268/ 06 E 052 /98/09", "Code DCI": "06E052", "Forme": "COMP. SEC.", "Dosage": "25MG", "Conditionnement": "B/60 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "TENSOPREL 50MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/142.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " CAPTOPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSOPREL", "Tarif de reference": " N/A", "PPA": "285.00 DA", "Num Enregistrement": "268/ 06 E 053 /98/09", "Code DCI": "06E053", "Forme": "COMP. SEC.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TENSOTEL  40MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TELMISARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSOTEL ", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "352/06E263/16", "Code DCI": "06E263", "Forme": "COMP.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TENSOTEL  80MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TENSOTEL ", "Tarif de reference": "1204 DA", "PPA": "N/A", "Num Enregistrement": "352/06E264/16", "Code DCI": "06E264", "Forme": "COMP.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEOLAR 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TEOLAR", "Tarif de reference": "837.6 DA", "PPA": "837.00 DA", "Num Enregistrement": "035/ 06 M 198 /13", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEOLAR 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TEOLAR", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 M 225 /13", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEOLAR 40MG COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TEOLAR", "Tarif de reference": "1980 DA", "PPA": "1980.00 DA", "Num Enregistrement": "035/ 06 M 232 /14", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TEOLAR 80MG COMP . PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TEOLAR", "Tarif de reference": "2040 DA", "PPA": "2040.00 DA", "Num Enregistrement": "035/ 06 M 233 /14", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERAPRED  4MG COMP.SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE ACETATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TERAPRED ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "09H033", "Forme": "COMP SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERAPRED 16MG COMP PELL B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " GLUCOCORTICOIDES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " METHYLPREDNISOLONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TERAPRED", "Tarif de reference": "283,4 DA", "PPA": "N/A", "Code DCI": "09H092", "Forme": "COMP. PELLI.", "Dosage": "16MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERBIDAL 1% 0.01 SOL P. APPLIC. LOCALE B/01 FLACON PULVERISATEUR DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBIDAL 1%", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "318/ 07 D 156 /14", "Code DCI": "07D156", "Forme": "SOL. APP. LOCALE", "Dosage": "0.01", "Conditionnement": "B/01 FLACON PULVERISATEUR DE 15ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TERBIFINE  0.01 CREME T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBIFINE ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "035/07D094/15", "Code DCI": "07D094", "Forme": "CR\u00c8ME", "Dosage": "1%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "TERBIFINE 250MG  COMP SEC  B/10 ET B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBIFINE", "Tarif de reference": "750 DA", "PPA": "1499.00 DA", "Num Enregistrement": "035/ 13 R 172 /14", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG ", "Conditionnement": "B/10 ET B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERBIL 0.01 CREME T/15G", "Img": "https://pharmnet-dz.com//img/medics/463.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=463", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBIL", "Tarif de reference": "210 DA", "PPA": "N/A", "Num Enregistrement": "418/ 07 D 094 /08", "Code DCI": "07D094", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERBIL 250MG COMP. SEC. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBIL", "Tarif de reference": " N/A", "PPA": "749.00 DA", "Num Enregistrement": "418/ 13 R 172 /15", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "TERBINAFINE BEKER 250MG COMP SECABLE B/20", "Img": "https://pharmnet-dz.com//img/medics/4570.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBINAFINE BEKER", "Tarif de reference": "1500.00 DA", "PPA": "1500.00 DA", "Num Enregistrement": "447/13R172/16", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERBINAFINE LDM 250MG COMP. SEC. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBINAFINE LDM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "309/ 13 R 172 /08/15", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": null}, {"Nom": "TERBINAN 0.01 CREME T/15G", "Img": "https://pharmnet-dz.com//img/medics/464.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBINAN", "Tarif de reference": " N/A", "PPA": "210.00 DA", "Num Enregistrement": "263/ 07 D 094 /15", "Code DCI": "07D094", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "TERBINAN 250MG  COMP SEC  B/14", "Img": "https://pharmnet-dz.com//img/medics/3564.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERBINAN", "Tarif de reference": "1050 DA", "PPA": "1015.00 DA", "Num Enregistrement": "263/ 13 R 172 /14", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG ", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERBUTALINE SULFATE 0,5MG/ML SOL .INJ.  B/8AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TERBUTALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TERBUTALINE SULFATE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 20 A 020 /98", "Code DCI": "20A020", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML", "Conditionnement": "B/8AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERCYD 0.01 CREME T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERCYD", "Tarif de reference": "210 DA", "PPA": "N/A", "Num Enregistrement": "088/ 07 D 094 /09", "Code DCI": "07D094", "Forme": "CR\u00c8ME", "Dosage": "0.01", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERCYD 250MG COMP. SEC. B/15", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERCYD", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 13 R 172 /10", "Code DCI": "13R172", "Forme": "COMP. SEC.", "Dosage": "250MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": null}, {"Nom": "TERFINEX 0.01 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/4330.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERFINEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "149/07D094/15", "Code DCI": "07D094", "Forme": "CR\u00c8ME", "Dosage": "1%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERFINEX 250MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " TERBINAFINE CHLORHYDRATE EXPRIME EN TERBINAFINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TERFINEX", "Tarif de reference": "1500 DA", "PPA": "N/A", "Num Enregistrement": "149/13R172/16", "Code DCI": "13R172", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TERGYNAN 500MG/65000UI/100000UI COMP. VAGINAL B/10", "Img": "https://pharmnet-dz.com//img/medics/3010.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3010", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " METRONIDAZOLE / NEOMYCINE SULFATE / NYSTATINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TERGYNAN", "Tarif de reference": "294.24 DA", "PPA": "N/A", "Num Enregistrement": "269/ 11 A 067 /03/15", "Code DCI": "11A067", "Forme": "COMP. VAG.", "Dosage": "500MG/65000UI/100000UI", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TESTO ENANT 250MG/ML SOL.INJ B/1AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " GEYMONAT S.P.A", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TESTOSTERONE (ENANTHATE)", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "TESTO ENANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "220/ 09 A 003 /99/07", "Code DCI": "09A003", "Forme": "SOL. INJ.", "Dosage": "250MG/ML", "Conditionnement": "B/1AMP. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TESTOSTERONE 250MG/ML SOL.INJ. B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=668", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " ANDROGENES & ANTI-ANDROGENES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " TESTOSTERONE (ENANTHATE)", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "TESTOSTERONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "002/ 09 A 003 /97", "Code DCI": "09A003", "Forme": "SOL. INJ.", "Dosage": "250MG/ML", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "TETRALYSAL 150MG GLES B/16", "Img": "https://pharmnet-dz.com//img/medics/764.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=764", "Laboratoire": " GALDERMA INTERNATIONAL", "C.Pharmacologique": " CYCLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LYMECYCLINE (EXPRIME EN TETRACYCLINE BASE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TETRALYSAL", "Tarif de reference": "306.78 DA", "PPA": "N/A", "Num Enregistrement": "123/ 13 C 246 /03/14", "Code DCI": "13C246", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "THEOPHYLLINE 240MG/4ML SOL.INJ B/05AMP. DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " THEOPHYLLINE", "Pays": "FRANCE", "Nom Commercial": "THEOPHYLLINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "002/ 20 A 025 /98", "Code DCI": "20A025", "Forme": "SOL. INJ.", "Dosage": "240MG/4ML", "Conditionnement": "B/05AMP. DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "THEOSTAT LP 200MG COMP. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2100.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2100", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " THEOPHYLLINE", "Pays": "FRANCE", "Nom Commercial": "THEOSTAT LP", "Tarif de reference": "146.4 DA", "PPA": "189.00 DA", "Num Enregistrement": "099/ 20 A 024 /98", "Code DCI": "20A024", "Forme": "COMP. LP", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "THEOSTAT LP 300MG COMP. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2111", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " THEOPHYLLINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "THEOSTAT LP", "Tarif de reference": "0 DA", "PPA": "311.00 DA", "Num Enregistrement": "099/ 20 A 052 /99", "Code DCI": "20A052", "Forme": "COMP. LP", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "THERGIN 0,2MG/ML SOL.INJ. B/05AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " EL KENDI", "C.Pharmacologique": " UTEROTONIQUES", "C.Therapeutique": " GYNECOLOGIE", "Info": " METHYLERGOMETRINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "THERGIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 11 C 011 /09", "Code DCI": "11C011", "Forme": "SOL. INJ.", "Dosage": "0,2MG/ML", "Conditionnement": "B/05AMP.", "Commercialisation": true, "Remboursable": null}, {"Nom": "THIAMINE 100MG/2ML SOL.INJ. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RENAUDIN", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE (OU VITAMINE B1)", "Pays": "FRANCE", "Nom Commercial": "THIAMINE", "Tarif de reference": "80.85 DA", "PPA": "N/A", "Num Enregistrement": "002/ 14 H 108 /98", "Code DCI": "14H108", "Forme": "SOL. INJ.", "Dosage": "100MG/2ML", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIAMINE API 250MG COMP.  B/20", "Img": "https://pharmnet-dz.com//img/medics/3434.png", "Laboratoire": " API", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE (OU VITAMINE B1)", "Pays": "ALGERIE", "Nom Commercial": "THIAMINE API", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "348/ 14 H 109 /08", "Code DCI": "14H109", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIAMINE CHLORHYDRATE 100MG/2ML SOL INJ  B/10AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE (OU VITAMINE B1)", "Pays": "ITALIE", "Nom Commercial": "THIAMINE CHLORHYDRATE", "Tarif de reference": "161.7 DA", "PPA": "N/A", "Num Enregistrement": "084/ 14 H 108 /02", "Code DCI": "14H108", "Forme": "SOL. INJ.", "Dosage": "100MG/2ML", "Conditionnement": "B/10AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIA-VALSAN 160MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "THIA-VALSAN", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "320/ 06 E 237 /09", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIA-VALSAN 160MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "THIA-VALSAN", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "320/ 06 E 238 /09", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIA-VALSAN 80MG/12,5MG COMP.PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "THIA-VALSAN", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "320/ 06 E 158 /08", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIAZARTAN 50MG/12,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GEOPHARM", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LOSARTAN POTASSIQUE /  HYDROCHLOROTHIAZIDE ", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "THIAZARTAN", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E167", "Forme": "COMP. PELLI.", "Dosage": "50MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIOPENTAL 0,5G ROTEXMEDICA 0,5G PDRE. SOL. INJ. B/50FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ROTEXMEDICA GmbH", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " THIOPENTAL SODIQUE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "THIOPENTAL 0,5G ROTEXMEDICA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "415/ 02 B 012 /08", "Code DCI": "02B012", "Forme": "PDRE. SOL. BUV.", "Dosage": "0,5G", "Conditionnement": "B/50FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "THIOPENTAL 1G PDRE.SOL.INJ. B/25FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " BIOCHEMIE GmbH", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " THIOPENTAL SODIQUE", "Liste": "Liste II", "Pays": "AUTRICHE", "Nom Commercial": "THIOPENTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "080/ 02 B 013 /98", "Code DCI": "02B013", "Forme": "PDRE. SUSP. INJ", "Dosage": "1G", "Conditionnement": "B/25FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "THIOPENTAL 1G ROTEXMEDICA 1G PDRE. SOL. INJ. B/50FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ROTEXMEDICA GmbH", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " THIOPENTAL SODIQUE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "THIOPENTAL 1G ROTEXMEDICA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "415/ 02 B 013 /08", "Code DCI": "02B013", "Forme": "PDRE. SUSP. INJ", "Dosage": "1G", "Conditionnement": "B/50FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "THIOPENTAL 500MG PDRE.SOL.INJ B/25FL.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " THIOPENTAL SODIQUE", "Liste": "Liste II", "Pays": "AUTRICHE", "Nom Commercial": "THIOPENTAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "080/ 02 B 012 /01", "Code DCI": "02B012", "Forme": "PDRE. SOL. BUV.", "Dosage": "500MG", "Conditionnement": "B/25FL.", "Commercialisation": true, "Remboursable": null}, {"Nom": "THIOPENTAL SODIQUE 0,5G PDRE.SOL.INJ B/50FL. ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " PHARMADRUG PRODUCTION Gmbh", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " THIOPENTAL SODIQUE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "THIOPENTAL SODIQUE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "180/ 02 B 012 /01", "Code DCI": "02B012", "Forme": "PDRE. SOL. BUV.", "Dosage": "0,5G", "Conditionnement": "B/50FL. ", "Commercialisation": true, "Remboursable": null}, {"Nom": "THIOPENTAL SODIQUE 1G PDRE.SOL.INJ B/25FL. ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " PHARMADRUG PRODUCTION Gmbh", "C.Pharmacologique": " ANESTHESIQUES GENERAUX & GAZ", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " THIOPENTAL SODIQUE", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "THIOPENTAL SODIQUE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "180/ 02 B 013 /01", "Code DCI": "02B013", "Forme": "PDRE. SUSP. INJ", "Dosage": "1G", "Conditionnement": "B/25FL. ", "Commercialisation": true, "Remboursable": null}, {"Nom": "THIOPHENICOL 250MG COMP.ENRO. B/16 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=351", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " PHENICOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " THIAMPHENICOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "THIOPHENICOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 13 H 083 /98", "Code DCI": "13H083", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/16 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "THIOPHENICOL 750MG/FL. DE PDRE. LYOPH. ET SOLV. P. SOL. INJ. B/1FL. DE LYOPH. + 1AMP. DE 5ML DE SOLV.", "Img": "https://pharmnet-dz.com//img/medics/350.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=350", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " PHENICOLES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " THIAMPHENICOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "THIOPHENICOL", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "255/ 13 H 082 /97", "Code DCI": "13H082", "Forme": "LYOPH. SOL. INJ.", "Dosage": "750MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE LYOPH. + 1AMP. DE 5ML DE SOLV.", "Commercialisation": true, "Remboursable": true}, {"Nom": "THYMOGLOBULINE 25MG/FL. DE PDRE. (5MG/ML DE SOL. APRES RECONST.) PDRE. P. SOL. P. PERF. B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/1270.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1270", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "Info": " IMMUNOGLOBULINE DE LAPIN ANTI-THYMOCYTES HUMAINS", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "THYMOGLOBULINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 27 A 004 /13", "Code DCI": "27A004", "Forme": "SOL. INJ.", "Dosage": "25MG/FL. DE PDRE. (5MG/ML DE SOL. APRES RECONST.)", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "THYNORES PLUS ENFANT 130MG/75MG/300MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "THYNORES PLUS ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "366/ 20 C 119 /09", "Code DCI": "20C119", "Forme": "SUPPO.", "Dosage": "130MG/75MG/300MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "THYROGEN 0,9MG PDRE. SOL. INJ. B/02FL.DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/590.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=590", "Laboratoire": " GENZYME EUROPE BV ", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " DIAGNOSTIC", "Info": " THYROTROPINE ALFA", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "THYROGEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "339/ 08 G 068 /08", "Code DCI": "08G068", "Forme": "PDRE. SOL. BUV.", "Dosage": "0,9MG", "Conditionnement": "B/02FL.DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIALYZ 200MG CPS B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ACIDE URSODESOXYCHOLIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TIALYZ", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10R101", "Forme": "CAPS.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TICLID 250MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/1498.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1498", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TICLOPIDINE   (SOUS FORME DE CHLORHYDRATE)**", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TICLID", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 06 J 106 /97/08", "Code DCI": "06J106", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIENAM 500MG/500MG/FL.DE PDRE.** PDRE. PERF. IV B/1FL. DE PDRE. DE CONTENANCE 20ML  ET  B/10FL. DE PDRE .DE CONTENANCE 20ML", "Img": "https://pharmnet-dz.com//img/medics/3602.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3602", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " INFECTIOLOGIE", "Info": " IMIPENEM**(SOUS FORME MONOHYDRATEE) / CILASTATINE (ACIDE)** (SOUS FORME SODIQUE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TIENAM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/ 13 W 187/99/09", "Code DCI": "13W187", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/500MG/FL.DE PDRE.**", "Conditionnement": "B/1FL. DE PDRE. DE CONTENANCE 20ML  ET  B/10FL. DE PDRE .DE CONTENANCE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIFEN 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2064.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2064", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE** (SOUS FORME DE FUMARATE)", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIFEN", "Tarif de reference": "179.4 DA", "PPA": "N/A", "Num Enregistrement": "035/ 20 A 012 /97/08", "Code DCI": "20A012", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIFEN 1MG/5ML SIROP FL/100 ML", "Img": "https://pharmnet-dz.com//img/medics/2069.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIFEN", "Tarif de reference": " N/A", "PPA": "186.00 DA", "Num Enregistrement": "035/ 20 A 013 /97/08", "Code DCI": "20A013", "Forme": "SOL. BUV.", "Dosage": "1MG/5ML", "Conditionnement": "FL/100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TILDIEM 60MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=49", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TILDIEM", "Tarif de reference": "0 DA", "PPA": "376.00 DA", "Num Enregistrement": "255/ 06 B 009 /97", "Code DCI": "06B009", "Forme": "COMP.", "Dosage": "60MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIM  0,5MG  GLES B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TIM ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/27A009/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "0,5MG ", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "TIM  1MG GLES B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TIM ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/27A010/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "1MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "TIM  5MG GLES B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TIM ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/27A011/16", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "TIMADLINE 10MG/5ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIMADLINE", "Tarif de reference": "0 DA", "PPA": "198.00 DA", "Num Enregistrement": "077/ 10 D 032 /05", "Code DCI": "10D032", "Forme": "SOL. BUV.", "Dosage": "10MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIMOFEROL 50MG/30MG GLES  B/24", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER FERREUX (SOUS FORME DE SULFATE) / ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "TIMOFEROL", "Tarif de reference": "29.52 DA", "PPA": "N/A", "Num Enregistrement": "318/ 12 E 120 /05", "Code DCI": "12E120", "Forme": "GLES.", "Dosage": "50MG/30MG", "Conditionnement": "B/24", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIMONAL 10MG/5ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3945", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIMONAL", "Tarif de reference": "199 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 D 032 /99/12", "Code DCI": "10D032", "Forme": "SOL. BUV.", "Dosage": "10MG/5ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIMONAL 20MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIMONAL", "Tarif de reference": "103 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 D 031 /99", "Code DCI": "10D031", "Forme": "SUPPO.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIMONAL 5MG/2ML SOL INJ. IM/IV B/5AMP. DE 2ML - B/50AMP.DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIMONAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 D 030 /01/09", "Code DCI": "10D030", "Forme": "SOL. INJ.", "Dosage": "5MG/2ML", "Conditionnement": "B/5AMP. DE 2ML - B/50AMP.DE 2ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TIMOZINE 10MG/5ML SIROP FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/3946.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3946", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIMOZINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/ 10 D 032 /09", "Code DCI": "10D032", "Forme": "SOL. BUV.", "Dosage": "10MG/5ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TINUVIN 200MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "TINUVIN", "Tarif de reference": "354 DA", "PPA": "N/A", "Num Enregistrement": "178/ 13 R 113 /99", "Code DCI": "13R113", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIOPAM NOURISSONS 10MG/SACH. PDRE. ORALE EN SACHET DOSE B/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RACECADOTRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TIOPAM NOURISSONS", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "10H177", "Forme": "PDRE. SOL. BUV.", "Dosage": "10MG/SACH", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIORFAN 100MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2928", "Laboratoire": " BIOPROJET PHARMA ", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RACECADOTRIL", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "TIORFAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "407/ 10 H 179 /09", "Code DCI": "10H179", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TIORFAN ENFANT 30MG/SACH. PDRE. ORALE B/30", "Img": "https://pharmnet-dz.com//img/medics/2927.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2927", "Laboratoire": " BIOPROJET PHARMA ", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RACECADOTRIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TIORFAN ENFANT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "407/ 10 H 178 /08", "Code DCI": "10H178", "Forme": "PDRE. SOL. BUV.", "Dosage": "30MG/SACH.", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "TIORFAN NOURRISSON 10MG/SACH. PDRE. ORALE B/16", "Img": "https://pharmnet-dz.com//img/medics/2926.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2926", "Laboratoire": " BIOPROJET PHARMA ", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " RACECADOTRIL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TIORFAN NOURRISSON", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "407/ 10 H 177 /08", "Code DCI": "10H177", "Forme": "PDRE. SOL. BUV.", "Dosage": "10MG/SACH.", "Conditionnement": "B/16", "Commercialisation": true, "Remboursable": false}, {"Nom": "TIRLOR 10MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/3999.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3999", "Laboratoire": " SANDOZ", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " LORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TIRLOR", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "050/ 01 A 033 /02", "Code DCI": "01A033", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TITANOREINE 0,3G/0,2G/0,4G SUPPO. B/12", "Img": "https://pharmnet-dz.com//img/medics/2991.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2991", "Laboratoire": " MARTIN-JOHNSON&JOHNSON-MSD", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CARRAGHENATES/DIOXYDE DE TITANE/OXYDE DE ZINC", "Pays": "FRANCE", "Nom Commercial": "TITANOREINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "179/ 10 P 123 / 01", "Code DCI": "10P123", "Forme": "SUPPO.", "Dosage": "0,3G/0,2G/0,4G", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": false}, {"Nom": "TITANOREINE A LA LIDOCAINE 2% 2,5G/2G/2G/2G/100G CREME T/20G", "Img": "https://pharmnet-dz.com//img/medics/2990.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2990", "Laboratoire": " MARTIN-JOHNSON&JOHNSON-MSD", "C.Pharmacologique": " PROCTOLOGIE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " CARRAGHENATES/DIOXYDE DE TITANE/OXYDE DE ZINC/LIDOCAINE", "Pays": "FRANCE", "Nom Commercial": "TITANOREINE A LA LIDOCAINE 2%", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "179/ 10 P 122 / 01", "Code DCI": "10P122", "Forme": "CR\u00c8ME", "Dosage": "2,5G/2G/2G/2G/100G", "Conditionnement": "T/20G", "Commercialisation": true, "Remboursable": false}, {"Nom": "TIZO  1 000MG/FL. DE PDRE. PDRE. P. SOL. INJ. IM/IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CPCM", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTIZOXIME SODIQUE EXPRIME EN CEFTIZOXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TIZO ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "286/ 13 B 463 /12", "Code DCI": "13B463", "Forme": "PDRE. SOL. INJ.", "Dosage": "1 000MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "TOBREX 300 000UI COLLY. FL/5ML+COMPTE GOUTTE", "Img": "https://pharmnet-dz.com//img/medics/1949.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1949", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TOBRAMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TOBREX", "Tarif de reference": "194.75 DA", "PPA": "N/A", "Num Enregistrement": "028/ 17 D 122 /01", "Code DCI": "17D122", "Forme": "COLLY.", "Dosage": "300 000UI", "Conditionnement": "FL/5ML+COMPTE GOUTTE", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOPAAL 0,2G/0,03G/0,04G/0,13G COMP. B/42", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3925", "Laboratoire": " PIERRE FABRE MEDICAMENT", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ACIDE ALGINIQUE / HYDROXYDE D'ALUMINIUM COLLOIDAL / HYDROCARBONATE DE MAGNESIUM / SILICE HYDRATEE,PRECIPITEE,AMORPHE", "Pays": "FRANCE", "Nom Commercial": "TOPAAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 10 B 192 /09", "Code DCI": "10B192", "Forme": "COMP.", "Dosage": "0,2G/0,03G/0,04G/0,13G", "Conditionnement": "B/42", "Commercialisation": true, "Remboursable": null}, {"Nom": "TOPAAL 4MG/0,6MG/0,8MG/2,6MG/100ML SUSP.BUV. FL/210 ML", "Img": "https://pharmnet-dz.com//img/medics/3911.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3911", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " ANTI-ACIDES & PROTECTEURS GASTRO-INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ACIDE ALGINIQUE/HYDROXYDE D'ALUMINIUM COLLOIDAL/CARBONATE DE MAGNESIUM/SILICE HYDRATEE", "Pays": "FRANCE", "Nom Commercial": "TOPAAL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "099/ 10 B 120 /99", "Code DCI": "10B120", "Forme": "SUSP. BUV.", "Dosage": "4MG/0,6MG/0,8MG/2,6MG/100ML", "Conditionnement": "FL/210 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOPICLOMAX 100MG COMP. ENRO. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TOPICLOMAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/15A083/16", "Code DCI": "15A083", "Forme": "COMP. ENRO.", "Dosage": "100MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOPICLOMAX 200 MG COMP PELL B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TOPICLOMAX", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "15A084", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOPICLOMAX 25MG COMP PELL B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TOPICLOMAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/15A081/16", "Code DCI": "15A081", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOPICLOMAX 50MG COMP. ENRO. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " TOPIRAMATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TOPICLOMAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/15A082/16", "Code DCI": "15A082", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOPLEX 1MG/ML SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " OXOMEMAZINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TOPLEX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 20 C 055 /02/15", "Code DCI": "20C055", "Forme": "SIROP", "Dosage": "1MG/ML", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TOPLEXIL 0,33MG/ML SIROP FL/150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " OXOMEMAZINE", "Pays": "ALGERIE", "Nom Commercial": "TOPLEXIL", "Tarif de reference": " N/A", "PPA": "116.00 DA", "Num Enregistrement": "428/ 20 C 223 /96/07", "Code DCI": "20C223", "Forme": "SIROP", "Dosage": "0,33MG/ML", "Conditionnement": "FL/150ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TORENTAL  LP 400MG COMP. ENRO. LP B/20", "Img": "https://pharmnet-dz.com//img/medics/1497.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1497", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " PENTOXIFYLLINE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TORENTAL  LP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "230/ 06 J 105 /98", "Code DCI": "06J105", "Forme": "COMP. PELLI. LP", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVAPINE 10MG/10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1626.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TORVAPINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 297 /12", "Code DCI": "06M297", "Forme": "COMP. PELLI.", "Dosage": "10MG/10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TORVAPINE 5MG/10MG COMP. PELLI.  B/30", "Img": "https://pharmnet-dz.com//img/medics/1621.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / ATORVASTATINE CALCIQUE TRIHYDRATEE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TORVAPINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 290 /12", "Code DCI": "06M290", "Forme": "COMP. PELLI.", "Dosage": "5MG/10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TORVAST 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1567.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1567", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TORVAST", "Tarif de reference": "837.6 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 M 198 /07", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVAST 20MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/1590.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1590", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TORVAST", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "001/ 06 M 225 /07", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVAST 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TORVAST", "Tarif de reference": "1980 DA", "PPA": "1744.00 DA", "Num Enregistrement": "001/ 06 M 232 /07", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVAST 80MG COMP . PELLI. PILULIER / 30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TORVAST", "Tarif de reference": "2040 DA", "PPA": "2039.00 DA", "Num Enregistrement": "001/06 M 233/13", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "PILULIER / 30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVASTATINE 10MG COMP. PELLI.  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TORVASTATINE", "Tarif de reference": "837.6 DA", "PPA": "N/A", "Num Enregistrement": "380/06M198/16", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVASTATINE 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TORVASTATINE", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "380/06M225/16", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVASTATINE 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TORVASTATINE", "Tarif de reference": "1980 DA", "PPA": "N/A", "Num Enregistrement": "380/06M232/16", "Code DCI": "06M232", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVASTATINE 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TORVASTATINE", "Tarif de reference": "1904 DA", "PPA": "N/A", "Num Enregistrement": "380/06M233/17", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TORVASTATINE 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TORVASTATINE", "Tarif de reference": "--- DA", "PPA": "N/A", "Code DCI": "06M233", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOT'HEMA 50MG/1,33MG/0,70MG/10ML** SOL. BUV. B/20AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/1804.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1804", "Laboratoire": " INNOTECH INTERNATIONAL", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " FER** (SOUS FORME DE GLUCONATE) /  MANGANESE** (SOUS FORME DE GLUCONATE) / CUIVRE**(SOUS FORME DE GLUCONATE)", "Pays": "FRANCE", "Nom Commercial": "TOT'HEMA", "Tarif de reference": "0 DA", "PPA": "544.00 DA", "Num Enregistrement": "087/ 12 E 137 /08", "Code DCI": "12E137", "Forme": "SOL. BUV.", "Dosage": "50MG/1,33MG/0,70MG/10ML**", "Conditionnement": "B/20AMP. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOTILAM 1MG/5ML SIROP FL/125 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TOTILAM", "Tarif de reference": "167.5 DA", "PPA": "174.00 DA", "Num Enregistrement": "077/ 20 A 013 /98", "Code DCI": "20A013", "Forme": "SOL. BUV.", "Dosage": "1MG/5ML", "Conditionnement": "FL/125 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOTINAL 1MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2065.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2065", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE** (SOUS FORME DE FUMARATE)", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "TOTINAL", "Tarif de reference": "179.4 DA", "PPA": "N/A", "Num Enregistrement": "001/ 20 A 012 /96/09", "Code DCI": "20A012", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TOTINAL 1MG/5ML SIROP FL/100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "TOTINAL", "Tarif de reference": " N/A", "PPA": "161.00 DA", "Num Enregistrement": "001/ 20 A 013 /97/06", "Code DCI": "20A013", "Forme": "SOL. BUV.", "Dosage": "1MG/5ML", "Conditionnement": "FL/100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRACLEER 125MG COMP.PELLI. B/56", "Img": "https://pharmnet-dz.com//img/medics/1635.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1635", "Laboratoire": " ACTELION PHARMACEUTICALS LIMITED", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "TRACLEER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "482/ 06 N 306 /13", "Code DCI": "06N306", "Forme": "COMP. PELLI.", "Dosage": "125MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRACLEER 62,5MG COMP.PELLI. B/56", "Img": "https://pharmnet-dz.com//img/medics/1632.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1632", "Laboratoire": " ACTELION PHARMACEUTICALS LIMITED", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " BOSENTAN MONOHYDRATE EXPRIME EN BOSENTAN", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "TRACLEER", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "482/ 06 N 305 /13", "Code DCI": "06N305", "Forme": "COMP. PELLI.", "Dosage": "62,5MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRACRIUM 50MG/5ML SOL.INJ B/5", "Img": "https://pharmnet-dz.com//img/medics/4109.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4109", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " ATRACURIUM", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRACRIUM", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "112/ 02 D 047 /99", "Code DCI": "02D047", "Forme": "SOL. INJ.", "Dosage": "50MG/5ML", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRACTOCILE 7,5MG/ML (37,5MG/5ML) SOL. A DILUER P. PERF. IV B/01 FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/3019.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3019", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " GYNECOLOGIE", "Info": " ATOSIBAN ACETATE EXPRIME EN ATOSIBAN", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "TRACTOCILE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/ 11 B 088 /15", "Code DCI": "11B088", "Forme": "SOL. INJ.", "Dosage": "7,5MG/ML (37,5MG/5ML)", "Conditionnement": "B/01 FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRACTOCILE 7,5MG/ML (6,75MG/0,9ML) SOL. INJ. IV. B/01 FL. DE 0,9ML", "Img": "https://pharmnet-dz.com//img/medics/3018.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3018", "Laboratoire": " FERRING SAS", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " GYNECOLOGIE", "Info": " ATOSIBAN ACETATE EXPRIME EN ATOSIBAN", "Liste": "Liste I", "Pays": "DANEMARK", "Nom Commercial": "TRACTOCILE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "275/ 11 B 087 /15", "Code DCI": "11B087", "Forme": "SOL. INJ.", "Dosage": "7,5MG/ML (6,75MG/0,9ML)", "Conditionnement": "B/01 FL. DE 0,9ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADINE 100MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "366/03F049/16", "Code DCI": "03F049", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADIS 50MG GLES. B/10", "Img": "https://pharmnet-dz.com//img/medics/2668.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2668", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADIS", "Tarif de reference": "96.4 DA", "PPA": "124.00 DA", "Num Enregistrement": "317/ 03 F 047 /12", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADIS 50MG/ML (100MG/2ML) SOL. INJ. IV / PERF. IV B/05 AMP. DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2680", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "317/ 03 F 111 /12", "Code DCI": "03F111", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (100MG/2ML)", "Conditionnement": "B/05 AMP. DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADOL  BEKER LP", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADOL  BEKER LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "03F107", "Forme": "COMP. PELLI. LP", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADOL BEKER 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/5717.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5717", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADOL BEKER", "Tarif de reference": "289,2 DA", "PPA": "270 DA", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADOL LS 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2675.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2675", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADOL LS", "Tarif de reference": "250 DA", "PPA": "N/A", "Num Enregistrement": "231/ 03 F 049 /05", "Code DCI": "03F049", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADOL LS 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2674.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2674", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADOL LS", "Tarif de reference": "289.2 DA", "PPA": "240.00 DA", "Num Enregistrement": "231/ 03 F 047 /08", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADOL NOVAGENERICS 50MG GELULE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NOVAPHARM TRADING", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADOL NOVAGENERICS", "Tarif de reference": "289.2 DA", "PPA": "350.00 DA", "Num Enregistrement": "149/ 03 F 047 /14", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADOL PLUS 325MG / 37,5MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medics/4300.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADOL PLUS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/03F115/16", "Code DCI": "03F115", "Forme": "GLES.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMADOL SANDOZ 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2670.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2670", "Laboratoire": " SANDOZ", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMADOL SANDOZ", "Tarif de reference": "289.2 DA", "PPA": " DA", "Num Enregistrement": "050/ 03 F 047 /09", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMAL 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMAL", "Tarif de reference": "289.2 DA", "PPA": "N/A", "Num Enregistrement": "418/ 03 F 047 /13", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMEX 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/4243.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAMEX", "Tarif de reference": "289.2 DA", "PPA": " DA", "Num Enregistrement": "100/03F047/15", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAMGESIC 50MG/ML (100MG/2ML) SOL. INJ. B/05 AMP.DE 2ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " CADILA HEALTHCARE LIMITED", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "TRAMGESIC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "358/ 03 F 111 /09", "Code DCI": "03F111", "Forme": "SOL. INJ.", "Dosage": "50MG/ML (100MG/2ML)", "Conditionnement": "B/05 AMP.DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANOXANE 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2598", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRANOXANE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "097/ 16 B 024 /08", "Code DCI": "16B024", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANOXANE 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2595.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2595", "Laboratoire": " SANAMED", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRANOXANE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "097/ 16 B 023 /08", "Code DCI": "16B023", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANSACALM 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANDOZ", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRANSACALM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 10 F 051 /96/13", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRANSOMIL 1,5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRANSOMIL", "Tarif de reference": "70 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 108 /08", "Code DCI": "16B108", "Forme": "COMP.", "Dosage": "1,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANSOMIL 3MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRANSOMIL", "Tarif de reference": "95 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 109 /08", "Code DCI": "16B109", "Forme": "COMP.", "Dosage": "3MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANSOMIL 6MG COMP. QUADRI-SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " BROMAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRANSOMIL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 098 /06", "Code DCI": "16B098", "Forme": "COMP. SEC.", "Dosage": "6MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRANXENE 10MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2597.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2597", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRANXENE", "Tarif de reference": "179.92 DA", "PPA": "N/A", "Num Enregistrement": "376/ 16 B 024 /97/09", "Code DCI": "16B024", "Forme": "GLES.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANXENE 20MG/2ML LYOPHILISAT B/5+5", "Img": "https://pharmnet-dz.com//img/medics/2591.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2591", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRANXENE", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "255/ 16 B 021 /98", "Code DCI": "16B021", "Forme": "LYOPHILISAT", "Dosage": "20MG/2ML", "Conditionnement": "B/5+5", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANXENE 50MG /2,5 ML LYOPHILISAT B/5+5", "Img": "https://pharmnet-dz.com//img/medics/2592.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2592", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRANXENE", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "255/ 16 B 022 /98", "Code DCI": "16B022", "Forme": "LYOPHILISAT", "Dosage": "50MG /2,5 ML", "Conditionnement": "B/5+5", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRANXENE 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2594.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2594", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLORAZEPATE DIPOTASSIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRANXENE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 16 B 023 /97/08", "Code DCI": "16B023", "Forme": "GLES.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAPAL 325MG / 37,5MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRAPAL", "Tarif de reference": "193.6 DA", "PPA": "N/A", "Num Enregistrement": "039/ 03 F 115 /11", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRAVATAN 40\u00b5G/ML COLLY.  EN SOL. FL 2,5ML", "Img": "https://pharmnet-dz.com//img/medics/2364.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " ALCON", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " TRAVOPROST ", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "TRAVATAN", "Tarif de reference": "0 DA", "PPA": "1885.00 DA", "Num Enregistrement": "028/ 17C 139 /05", "Code DCI": "17C139", "Forme": "COLLY. SOL.", "Dosage": "40\u00b5G/ML", "Conditionnement": "FL 2,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIACOR 2,5MG/2,5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3219.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / FELODIPINE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "TRIACOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "230/ 06 E 287 /10", "Code DCI": "06E287", "Forme": "COMP. PELLI.", "Dosage": "2,5MG/2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIAMPEX 2,5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/171.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIAMPEX", "Tarif de reference": "659.7 DA", "PPA": "659.00 DA", "Num Enregistrement": "289/ 06 E 127 /07", "Code DCI": "06E127", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIAMPEX 5MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/181.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIAMPEX", "Tarif de reference": " N/A", "PPA": "965.00 DA", "Num Enregistrement": "289/ 06 E 128 /07 ", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIANIL 25MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " CLOMIPRAMINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TRIANIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "166/ 16 A 006 /98", "Code DCI": "16A006", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIATEC  1,25MG COMP. B/28 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=190", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIATEC ", "Tarif de reference": "0 DA", "PPA": "224.00 DA", "Num Enregistrement": "392/ 06 E 139 /99/09", "Code DCI": "06E139", "Forme": "COMP. SEC.", "Dosage": "1,25MG", "Conditionnement": "B/28 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIATEC 10MG COMP. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3116.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3116", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIATEC", "Tarif de reference": "1015 DA", "PPA": "N/A", "Num Enregistrement": "392/ 06 E 201 /04/09", "Code DCI": "06E201", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIATEC 2,5MG COMP.SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/172.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=172", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIATEC", "Tarif de reference": "615.72 DA", "PPA": "N/A", "Num Enregistrement": "392/ 06 E 127 /99/09", "Code DCI": "06E127", "Forme": "COMP. SEC.", "Dosage": "2,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIATEC 5MG COMP. SEC. B/28 ", "Img": "https://pharmnet-dz.com//img/medics/179.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=179", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIATEC", "Tarif de reference": "0 DA", "PPA": "901.00 DA", "Num Enregistrement": "392 06 E 128 /99/10", "Code DCI": "06E128", "Forme": "COMP SEC.", "Dosage": "5MG", "Conditionnement": "B/28 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIAXONE 0,5 100MG/ML** (OU 500MG/5ML) PDRE. ET SOLV. INJ. IM B/1FL. DE PDRE + 1 AMP. DE SOLV. DE 5ML  (LIDOCAINE CHLORHYDRATE 1%) ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE** (SOUS FORME DE CEFTRIAXONE SODIUM)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIAXONE 0,5", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 326 /08", "Code DCI": "13B326", "Forme": "PDRE. SOL. INJ.", "Dosage": "100MG/ML** (OU 500MG/5ML)", "Conditionnement": "B/1FL. DE PDRE + 1 AMP. DE SOLV. DE 5ML  (LIDOCAINE CHLORHYDRATE 1%) ", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIAXONE 1G/FL. DE PDRE.** PDRE. ET SOLVT. SOL. INJ . IV B/1FL. DE PDRE. + 1AMP. DE 10ML DE SOLV.(E.P.P.I.)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIAXONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 019 /01/09", "Code DCI": "13B019", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.**", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 10ML DE SOLV.(E.P.P.I.)", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIAXONE 200MG COMP SEC  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-ARYTHMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMIODARONE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIAXONE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/06D041/15", "Code DCI": "06D041", "Forme": "COMP. SEC.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIAXONE 500MG/FL. DE PDRE. PDRE. ET SOLV. SOL. INJ. IV B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLVT. (E.P.P.I.)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTRIAXONE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIAXONE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 158 /01/09", "Code DCI": "13B158", "Forme": "PDRE. INJ.", "Dosage": "500MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLVT. (E.P.P.I.)", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRI-B 200MG/100MG/1MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE MONONITRATE / PYRIDOXINE CHLORHYDRATE / CYANOCOBALAMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRI-B", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "317/14H220/15", "Code DCI": "14H220", "Forme": "COMP. PELLI.", "Dosage": "200MG/100MG/1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIBEMEX 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIBEMEX", "Tarif de reference": "273 DA", "PPA": "N/A", "Num Enregistrement": "400/10F193/16", "Code DCI": "10F193", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRI-B-VIT HUP 200MG/100MG/1MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3456.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3456", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE MONONITRATE / PYRIDOXINE CHLORHYDRATE / CYANOCOBALAMINE", "Pays": "ALGERIE", "Nom Commercial": "TRI-B-VIT HUP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "380/ 14 H 220 /15", "Code DCI": "14H220", "Forme": "COMP. PELLI.", "Dosage": "200MG/100MG/1MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "TRICEF 1G/FL. DE PDRE. PDRE.SOL.INJ.IV B/01FL. DE PDRE. ET B/10FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "TRICEF", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 014 /97/15", "Code DCI": "13B014", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/01FL. DE PDRE. ET B/10FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIFED PLUS 1,25MG** / 25MG**/ 125MG / 5ML SIROP FL/100 ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)**  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** / PARACETAMOL", "Pays": "JORDANIE", "Nom Commercial": "TRIFED PLUS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 22 A 002 /97/06", "Code DCI": "22A002", "Forme": "SOL. BUV.", "Dosage": "1,25MG** / 25MG**/ 125MG / 5ML", "Conditionnement": "FL/100 ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIFED PLUS 2,5MG/50MG/300MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " TRIPROLIDINE (SOUS FORME DE CHLORHYDRATE)**  / PSEUDOEPHEDRINE (SOUS FORME DE CHLORHYDRATE)** / PARACETAMOL", "Pays": "JORDANIE", "Nom Commercial": "TRIFED PLUS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 22 A 001 /97/09", "Code DCI": "22A001", "Forme": "COMP.", "Dosage": "2,5MG/50MG/300MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIFER FOL 100MG/0,35MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1797.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1797", "Laboratoire": " ABDI IBRAHIM", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE HYDROXYDE FERRIQUE POLYMALTOSE EXPRIME EN FER FERRIQUE / ACIDE FOLIQUE   ", "Pays": "TURQUIE", "Nom Commercial": "TRIFER FOL", "Tarif de reference": "253.2 DA", "PPA": "N/A", "Num Enregistrement": "177/ 12 E 133 /07", "Code DCI": "12E133", "Forme": "COMP. A SUCER", "Dosage": "100MG/0,35MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIFLUCAN 2MG/ML SOL INJ IV F/50ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3537", "Laboratoire": " PFIZER", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRIFLUCAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 13 R 107/98", "Code DCI": "13R107", "Forme": "SOL. INJ.", "Dosage": "2MG/ML", "Conditionnement": "F/50ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIGESTREL 0,03MG/0,05MG - 0,04MG/0,075MG - 0,03MG/0,125MG COMP. B/63 (3BLISTERS DE 21)", "Img": "https://pharmnet-dz.com//img/medics/3050.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " FAMY CARE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL / LEVONORGESTREL", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "TRIGESTREL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "291/ 11 H 050 /08", "Code DCI": "11H050", "Forme": "COMP. PELLI.", "Dosage": "0,03MG/0,05MG - 0,04MG/0,075MG - 0,03MG/0,125MG", "Conditionnement": "B/63 (3BLISTERS DE 21)", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRILEPTAL 150MG COMP. PELLI. B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2443", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " OXCARBAZEPINE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "TRILEPTAL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "068/ 15 A 076 /07", "Code DCI": "15A076", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE B 0,787G/100G GRLES. SUSP. BUV. FL./250ML CONTENANT 152,5G DE GRLES. + GOBELET DOSEUR", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE B", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/ 10 F 052 /09", "Code DCI": "10F052", "Forme": "PDRE. SUSP. BUV.", "Dosage": "0,787G/100G", "Conditionnement": "FL./250ML CONTENANT 152,5G DE GRLES. + GOBELET DOSEUR", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE B 100MG COMP B/20", "Img": "https://pharmnet-dz.com//img/medics/2891.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2891", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE B", "Tarif de reference": " N/A", "PPA": "182.00 DA", "Num Enregistrement": "235/ 10 F 051 /02/14", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIMEBUTINE B 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2912.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2912", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE B", "Tarif de reference": "273 DA", "PPA": "250.00 DA", "Num Enregistrement": "235/ 10 F 193 /13", "Code DCI": "10F193", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE BIOCARE 100MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2892.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2892", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE BIOCARE", "Tarif de reference": "182 DA", "PPA": "181.00 DA", "Num Enregistrement": "293/ 10 F 051 /13", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE BIOCARE 200MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/2913.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2913", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE BIOCARE", "Tarif de reference": "0 DA", "PPA": "257.00 DA", "Num Enregistrement": "293/ 10 F 193 /15", "Code DCI": "10F193", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE HUP 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2893.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE HUP", "Tarif de reference": "273 DA", "PPA": "N/A", "Num Enregistrement": "380/ 10 F 051 /09", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE IVAL 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE IVAL", "Tarif de reference": "182 DA", "PPA": "N/A", "Num Enregistrement": "195/ 10 F 051 /06", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE SAIDAL 74,4MG/SACHET- DOSE GRLES. SUSP. BUV. EN SACHET-DOSE  B/20 -  B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE SAIDAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 150 /06/14", "Code DCI": "10F150", "Forme": "GRLES. SOL. BUV.", "Dosage": "74,4MG/SACHET- DOSE", "Conditionnement": "B/20 -  B/30 ", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIMEBUTINE SAIDAL ENFANTS ET NOURRISSONS 24MG GRLES. P. SUSP. BUV. SACH. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE SAIDAL ENFANTS ET NOURRISSONS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 196 /12", "Code DCI": "10F196", "Forme": "GRLES. SOL. BUV.", "Dosage": "24MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE SAIDAL NOURRISSONS 12MG GRLES. P. SUSP. BUV. SACH. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE SAIDAL NOURRISSONS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 10 F 195 /12", "Code DCI": "10F195", "Forme": "GRLES. SOL. BUV.", "Dosage": "12MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEBUTINE-AGD 100MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE MALEATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMEBUTINE-AGD", "Tarif de reference": "182 DA", "PPA": "N/A", "Num Enregistrement": "320/ 10 F 051 /05", "Code DCI": "10F051", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEDAT 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "TRIMEDAT", "Tarif de reference": "128.4 DA", "PPA": "N/A", "Num Enregistrement": "010/ 10 F 095 /99", "Code DCI": "10F095", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMEDAT 24MG/5ML (0,7870G POUR 100G) GRLES.SUSP. BUV. EN FLACON FL/250ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TRIMEBUTINE", "Liste": "Liste II", "Pays": "ITALIE", "Nom Commercial": "TRIMEDAT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 10 F 052 /99/14", "Code DCI": "10F052", "Forme": "PDRE. SUSP. BUV.", "Dosage": "24MG/5ML (0,7870G POUR 100G)", "Conditionnement": "FL/250ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIMETAZIDINE B 20MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/1502.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE DICHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "TRIMETAZIDINE B", "Tarif de reference": "390 DA", "PPA": "470.00 DA", "Num Enregistrement": "235/ 06 J 107 /08", "Code DCI": "06J107", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMETAZIDINE IVAL 20MG COMP.PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMA IVAL", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE DICHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "TRIMETAZIDINE IVAL", "Tarif de reference": "390 DA", "PPA": "N/A", "Num Enregistrement": "195/ 06 J 107 /07", "Code DCI": "06J107", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMETAZIDINE UPC 20MG/ML SOL. BUV. GTTES. FL/60ML AVEC  PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "TRIMETAZIDINE UPC", "Tarif de reference": "390 DA", "PPA": "N/A", "Num Enregistrement": "285/ 06 J 215 /06", "Code DCI": "06J215", "Forme": "SOL. BUV. GTTES.", "Dosage": "20MG/ML", "Conditionnement": "FL/60ML AVEC  PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIMIANIN 0.04 SOL.BUV.GTTES FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CROVIS PHILCOM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " TRIMIPRAMINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "TRIMIANIN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "012/ 16 A 018 /99", "Code DCI": "16A018", "Forme": "SOL. BUV. GTTES.", "Dosage": "0.04", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRINORDIOL 30\u00b5G/0,05MG/6JRS - 40\u00b5G/0,075MG/5JRS - 30\u00b5G/0,125MG/10JRS COMP. ENRO. B/21", "Img": "https://pharmnet-dz.com//img/medics/3049.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=3062", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " CONTRACEPTIFS HORMONAUX", "C.Therapeutique": " GYNECOLOGIE", "Info": " ETHINYLESTRADIOL / LEVONORGESTREL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRINORDIOL", "Tarif de reference": "427 DA", "PPA": "N/A", "Num Enregistrement": "030/ 11 H 050 /97", "Code DCI": "11H050", "Forme": "COMP. PELLI.", "Dosage": "30\u00b5G/0,05MG/6JRS - 40\u00b5G/0,075MG/5JRS - 30\u00b5G/0,125MG/10JRS", "Conditionnement": "B/21", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRIPARACETAL 500MG/60MG**/2,5MG** COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1940", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " PARACETAMOL / PSEUDOEPHEDRINE CHLORHYDRATE  / TRIPROLIDINE CHLORHYDRATE                       ", "Pays": "ALGERIE", "Nom Commercial": "TRIPARACETAL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "039/ 22 A 044 /13", "Code DCI": "22A044", "Forme": "COMP.", "Dosage": "500MG/60MG**/2,5MG**", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRIPTAMYL 4% (40MG/ML) SOL. BUV. FL. COMPT.GTTES DE  20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRIPTAMYL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 A 003 /09", "Code DCI": "16A003", "Forme": "SOL. BUV. GTTES.", "Dosage": "4% (40MG/ML)", "Conditionnement": "FL. COMPT.GTTES DE  20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRITAZIDE 10MG/12,5MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRITAZIDE", "Tarif de reference": "969.92 DA", "PPA": "N/A", "Num Enregistrement": "392/ 06 E 289 /10 ", "Code DCI": "06E289", "Forme": "COMP.", "Dosage": "10MG/12,5MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRITAZIDE 10MG/25MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRITAZIDE", "Tarif de reference": " N/A", "PPA": "1134.00 DA", "Num Enregistrement": "392/ 06 E 278 /10/15", "Code DCI": "06E278", "Forme": "COMP.", "Dosage": "10MG/25MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "TRITAZIDE 5MG/12,5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/3213.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3213", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " RAMIPRIL / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRITAZIDE", "Tarif de reference": "1029.6 DA", "PPA": "910.00 DA", "Num Enregistrement": "376/ 06 E 277 /10", "Code DCI": "06E277", "Forme": "COMP.", "Dosage": "5MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROIS B 125MG/125MG/0,55MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/4305.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4305", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE / PYRIDOXINE / CYANOCOBALAMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TROIS B", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/14H212/06/16", "Code DCI": "14H212", "Forme": "COMP. ENRO.", "Dosage": "125MG/125MG/0,55MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROMBIX 10MG COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medics/4542.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TROMBIX", "Tarif de reference": "0 DA", "PPA": "8914.43 DA", "Num Enregistrement": "447/12F159/16", "Code DCI": "12F159", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "TROMBIX 15MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4533.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TROMBIX", "Tarif de reference": "0 DA", "PPA": "9519.45 DA", "Num Enregistrement": "447/12F167/16", "Code DCI": "12F167", "Forme": "COMP. PELLI.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "TROMBIX 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4623.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TROMBIX", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "447/12F168/16", "Code DCI": "12F168", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "TRONOTHANE 0.01 GEL.DERM. T/30 G", "Img": "https://pharmnet-dz.com//img/medics/4094.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4094", "Laboratoire": " ABBOTT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " PRAMOCAINE CHLORHYDRATE", "Pays": "FRANCE", "Nom Commercial": "TRONOTHANE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "147/ 02 C 031 /99", "Code DCI": "02C031", "Forme": "GEL", "Dosage": "0.01", "Conditionnement": "T/30 G", "Commercialisation": true, "Remboursable": false}, {"Nom": "TROPHIRES COMPOSE ADULTES 0,200G / 0,110G / 0,450G SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL", "Pays": "FRANCE", "Nom Commercial": "TROPHIRES COMPOSE ADULTES", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "255/ 20 C 200 /05", "Code DCI": "20C200", "Forme": "SUPPO.", "Dosage": "0,200G / 0,110G / 0,450G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROPHIRES COMPOSE ENFANTS 0,130G / 0,075G / 0,300G SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1288", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL", "Pays": "FRANCE", "Nom Commercial": "TROPHIRES COMPOSE ENFANTS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 20 C 119 /05", "Code DCI": "20C119", "Forme": "SUPPO.", "Dosage": "0,130G / 0,075G / 0,300G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROPHIRES COMPOSE NOURRISSONS 0,065G / 0,044G / 0,150G SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL", "Pays": "FRANCE", "Nom Commercial": "TROPHIRES COMPOSE NOURRISSONS", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "255/ 20 C 118 /05", "Code DCI": "20C118", "Forme": "SUPPO.", "Dosage": "0,065G / 0,044G / 0,150G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROPHIRES-ADULTES 0,285G/0,110G SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1284", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS", "Pays": "FRANCE", "Nom Commercial": "TROPHIRES-ADULTES", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 20 C 117 /05", "Code DCI": "20C117", "Forme": "SUPPO.", "Dosage": "0,285G/0,110G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROPHIRES-ENFANTS 0,190G / 0,075G SUPPO. B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1293", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS", "Pays": "FRANCE", "Nom Commercial": "TROPHIRES-ENFANTS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "255/ 20 C 205 /05", "Code DCI": "20C205", "Forme": "SUPPO.", "Dosage": "0,190G / 0,075G", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROPHIRES-NOURRISSONS 0,095G/0,044G SUPPO. B/8", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SANOFI SYNTHELABO", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "TROPHIRES-NOURRISSONS", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "255/ 20 C 100 /05", "Code DCI": "20C100", "Forme": "SUPPO.", "Dosage": "0,095G/0,044G", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": null}, {"Nom": "TROPHYL E 190MG SUPPO.ENF B/8", "Img": "https://pharmnet-dz.com//img/medics/1278.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1278", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "TROPHYL E", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/ 20 C 101 /03", "Code DCI": "20C101", "Forme": "SUPPO.", "Dosage": "190MG", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROPHYL N 95MG SUPPO.NOUR B/8", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM", "Pays": "ALGERIE", "Nom Commercial": "TROPHYL N", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "231/ 20 C 100 /03", "Code DCI": "20C100", "Forme": "SUPPO.", "Dosage": "95MG", "Conditionnement": "B/8", "Commercialisation": true, "Remboursable": null}, {"Nom": "TROPHYL PLUS E 0,130G / 0,075G / 300MG SUPPO. ENFANT B/08", "Img": "https://pharmnet-dz.com//img/medics/1289.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1289", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "TROPHYL PLUS E", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "231/ 20 C 119 /05", "Code DCI": "20C119", "Forme": "SUPPO.", "Dosage": "0,130G / 0,075G / 300MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "TROPHYL PLUS N 0,065G / 0,044G / 150MG SUPPO. NOURRISSON B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM/HUILE ESSENTIELLE D'EUCALYPTUS/PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "TROPHYL PLUS N", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "231/ 20 C 118 /05", "Code DCI": "20C118", "Forme": "SUPPO.", "Dosage": "0,065G / 0,044G / 150MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRUSAMID 2% (20MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TRUSAMID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "380/17C121/16", "Code DCI": "17C121", "Forme": "COLLY. SOL.", "Dosage": "2% (20MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TRUSOPT 2% (20MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2359.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2359", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "TRUSOPT", "Tarif de reference": "660.76 DA", "PPA": "N/A", "Num Enregistrement": "024/ 17 C 121 /00", "Code DCI": "17C121", "Forme": "COLLY. SOL.", "Dosage": "2% (20MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TULOS 10G/15ML SOL. BUV. FL./125ML", "Img": "https://pharmnet-dz.com//img/medics/2935.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2935", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " LAXATIFS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " LACTULOSE", "Pays": "ALGERIE", "Nom Commercial": "TULOS", "Tarif de reference": "107.5 DA", "PPA": "150.00 DA", "Num Enregistrement": "242/ 10 L 062 /07", "Code DCI": "10L062", "Forme": "SOL. BUV.", "Dosage": "10G/15ML", "Conditionnement": "FL./125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TUSSIDEX  0,1G/100ML (OU 5MG/5ML) SIROP FL./125ML + GOBELET DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TUSSIDEX ", "Tarif de reference": "137.5 DA", "PPA": "N/A", "Num Enregistrement": "317/20B207/16", "Code DCI": "20B207", "Forme": "SIROP", "Dosage": "0,1G/100ML (OU 5MG/5ML)", "Conditionnement": "FL./125ML + GOBELET DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "TUSSIDEX 0,133G/100ML (OU 20MG/15ML ) SIROP FL./125ML + GOBELET DOSEUR GRADUE", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " ANTITUSSIFS OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " DEXTROMETHORPHANE BROMHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TUSSIDEX", "Tarif de reference": "126.25 DA", "PPA": "N/A", "Num Enregistrement": "317/20B240/16", "Code DCI": "20B240", "Forme": "SIROP", "Dosage": "0,133G/100ML (OU 20MG/15ML )", "Conditionnement": "FL./125ML + GOBELET DOSEUR GRADUE", "Commercialisation": true, "Remboursable": true}, {"Nom": "TUSSO RHINATHIOL TOUX SECHE ENFANT 0,06% SIROP F/125ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INSTITUT MEDICAL ALGERIEN", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " PHOLCODINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "TUSSO RHINATHIOL TOUX SECHE ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "049/ 20 C 111 /05", "Code DCI": "20C111", "Forme": "SIROP", "Dosage": "0,06%", "Conditionnement": "F/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TYKERB 250MG COMP. PELLI. B/70", "Img": "https://pharmnet-dz.com//img/medics/1047.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " LAPATINIB DITOSYLATE EXPRIME EN LAPATINIB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "TYKERB", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 05 C 137 /09", "Code DCI": "05C137", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/70", "Commercialisation": true, "Remboursable": true}, {"Nom": "TYLENOL 3% (150MG/5ML) SIROP FL/125ML", "Img": "https://pharmnet-dz.com//img/medics/2619.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2619", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "TYLENOL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "242/ 03 B 061 /09", "Code DCI": "03B061", "Forme": "SOL. BUV.", "Dosage": "3% (150MG/5ML)", "Conditionnement": "FL/125ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "TYLENOL 500MG COMP. SEC. B/20 ET B/100", "Img": "https://pharmnet-dz.com//img/medics/4146.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4146", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " PARACETAMOL ET DERIVES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL", "Pays": "ALGERIE", "Nom Commercial": "TYLENOL", "Tarif de reference": " N/A", "PPA": "50.00 DA", "Num Enregistrement": "242/ 03 B 005 /03/09", "Code DCI": "03B005", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20 ET B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "TYMER 0,3%** COLLY. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/1957.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1957", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-INFECTIEUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " GATIFLOXACINE** (SOUS FORME DE GATIFLOXACINE SESQUIHYDRATE)", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "TYMER", "Tarif de reference": "717.64 DA", "PPA": "N/A", "Num Enregistrement": "386/ 17 D 155 / 08", "Code DCI": "17D155", "Forme": "COLLY.", "Dosage": "0,3%**", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "TYNORES ENFANT 0,190G/0,075G SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " TENOATE DE SODIUM / HUILE ESSENTIELLE D'EUCALYPTUS", "Pays": "ALGERIE", "Nom Commercial": "TYNORES ENFANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "366/ 20 C 205 /09", "Code DCI": "20C205", "Forme": "SUPPO.", "Dosage": "0,190G/0,075G", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "TYSABRI 300MG/FL. DE CONC. (20MG/ML) CONCENTRE A DILUER P. PERF.  B/01FL. DE 15ML", "Img": "https://pharmnet-dz.com//img/medics/4320.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4320", "Laboratoire": " BIOGEN IDEC LIMITED", "C.Pharmacologique": " SCLEROSE EN PLAQUE", "C.Therapeutique": " NEUROLOGIE", "Info": " NATALIZUMAB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "TYSABRI", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "375/15G091/09/16", "Code DCI": "15G091", "Forme": "PDRE. SOL. INJ.", "Dosage": "300MG/FL. DE CONC. (20MG/ML)", "Conditionnement": "B/01FL. DE 15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "TYSABRI 300MG/FL. DE CONC. (20MG/ML) CONCENTRE A DILUER P. PERF.  B/01FL. DE 15ML", "Img": "https://pharmnet-dz.com//img/medics/2505.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2505", "Laboratoire": " ELAN PHARMA INTERNATIONAL LTD", "C.Pharmacologique": " SCLEROSE EN PLAQUE", "C.Therapeutique": " NEUROLOGIE", "Info": " NATALIZUMAB", "Liste": "Liste I", "Pays": "IRELAND", "Nom Commercial": "TYSABRI", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "448/ 15 G 091 /09", "Code DCI": "15G091", "Forme": "SOL. INJ.", "Dosage": "300MG/FL. DE CONC. (20MG/ML)", "Conditionnement": "B/01FL. DE 15ML", "Commercialisation": true, "Remboursable": true}], "U": [{"Nom": "UBACTIVE 200MG  COMP PELL SEC  B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "UBACTIVE", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "468/ 04 B 040 /14", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "UBACTIVE 400MG  COMP PELL B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "UBACTIVE", "Tarif de reference": "157 DA", "PPA": "N/A", "Num Enregistrement": "468/ 04 B 010 /14", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "UBACTIVE 600MG  COMP PELL  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NADPHARMADIC PRODUCTION", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "UBACTIVE", "Tarif de reference": "235.5 DA", "PPA": "212.00 DA", "Num Enregistrement": "468/ 04 B 044 /14", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "UDINE 5MG COMP. PELLI.  B/15 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "UDINE", "Tarif de reference": "90 DA", "PPA": "N/A", "Code DCI": "01A047", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}, {"Nom": "UDINE 5MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " DESLORATADINE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "UDINE", "Tarif de reference": "60 DA", "PPA": " DA", "Code DCI": "01A047", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ULTIMOX 500MG / 125MG COMP. PELLI. SEC. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIOVITAL", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE (TRIHYDRATE) / ACIDE CLAVULANIQUE  (SEL DE POTASSIUM)", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ULTIMOX", "Tarif de reference": "392.64 DA", "PPA": "N/A", "Num Enregistrement": "321/ 13 G 050 /06", "Code DCI": "13G050", "Forme": "COMP. PELLI.", "Dosage": "500MG / 125MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "ULTRAGENT 80MG/2ML SOL.INJ. B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " AMINOSIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " GENTAMICINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ULTRAGENT", "Tarif de reference": "61 DA", "PPA": "N/A", "Num Enregistrement": "118/ 13 A 005 /98", "Code DCI": "13A005", "Forme": "SOL. INJ.", "Dosage": "80MG/2ML", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "ULTRA-LEVURE 100MG PDRE. SOL ORALE B/14 SACHETS", "Img": "https://pharmnet-dz.com//img/medics/2923.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2923", "Laboratoire": " BIOCODEX", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " SACCHAROMYCES BOULARDII", "Pays": "FRANCE", "Nom Commercial": "ULTRA-LEVURE", "Tarif de reference": "0 DA", "PPA": "204.00 DA", "Num Enregistrement": "101/ 10 H 133 /04", "Code DCI": "10H133", "Forme": "PDRE. SOL. BUV.", "Dosage": "100MG", "Conditionnement": "B/14 SACHETS", "Commercialisation": true, "Remboursable": true}, {"Nom": "ULTRA-LEVURE 200MG GLES B/10", "Img": "https://pharmnet-dz.com//img/medics/2922.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2922", "Laboratoire": " BIOCODEX", "C.Pharmacologique": " ANTIDIARRHEIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " SACCHAROMYCES BOULARDII", "Pays": "FRANCE", "Nom Commercial": "ULTRA-LEVURE", "Tarif de reference": "0 DA", "PPA": "283.00 DA", "Num Enregistrement": "101/ 10 H 132 /04", "Code DCI": "10H132", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ULTRALINC 600MG SOL.INJ. B/1 AMP", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ARAB PHARM", "C.Pharmacologique": " LINCOSAMIDES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " LINCOMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ULTRALINC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "118/ 13 D 026 /98", "Code DCI": "13D026", "Forme": "SOL. INJ.", "Dosage": "600MG", "Conditionnement": "B/1 AMP", "Commercialisation": true, "Remboursable": null}, {"Nom": "ULTRAVIST 300 623,4MG/ML (TENEUR EN IODE 300MG/ML) SOL. INJ   B/1FL.  DE 50ML - B/1FL.  DE 100 ML - B/10FL.  DE 50ML - B/10FL.  DE 100ML", "Img": "https://pharmnet-dz.com//img/medics/583.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=583", "Laboratoire": " BAYER", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOPROMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ULTRAVIST 300", "Tarif de reference": "1616 DA", "PPA": "N/A", "Num Enregistrement": "424/ 08 C 055 /00/13", "Code DCI": "08C055", "Forme": "SOL. INJ.", "Dosage": "623,4MG/ML (TENEUR EN IODE 300MG/ML)", "Conditionnement": "B/1FL.  DE 50ML - B/1FL.  DE 100 ML - B/10FL.  DE 50ML - B/10FL.  DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ULTRAVIST 370 768,86MG/ML (TENEUR EN IODE 370MG/ML) SOL. INJ.   B/1FL.  DE 50ML - B/1FL.  DE 100 ML - B/10FL.  DE 50ML - B/10FL.  DE 100ML", "Img": "https://pharmnet-dz.com//img/medics/584.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=584", "Laboratoire": " BAYER", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOPROMIDE", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "ULTRAVIST 370", "Tarif de reference": "0 DA", "PPA": "2235.00 DA", "Num Enregistrement": "424/ 08 C 056 /00/13", "Code DCI": "08C056", "Forme": "SOL. INJ.", "Dosage": "768,86MG/ML (TENEUR EN IODE 370MG/ML)", "Conditionnement": "B/1FL.  DE 50ML - B/1FL.  DE 100 ML - B/10FL.  DE 50ML - B/10FL.  DE 100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "UMULINE NPH 100UI/ML SUSP INJ IM/SC B/1FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/3742.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3742", "Laboratoire": " LILLY DEUTSCHLAND GmBH", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) ISOPHANE ", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "UMULINE NPH", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 14 B 193 /00/08", "Code DCI": "14B193", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "UMULINE PROFIL 30 100UI/ML SUSP  INJ  B/5 CART. 3ML", "Img": "https://pharmnet-dz.com//img/medics/3745.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3745", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE INTERMEDIAIRE BIPHASIQUE / INSULINE HUMAINE RAPIDE / INTERMEDiAIRE 30%/70%", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "UMULINE PROFIL 30", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 14 B 196 /00", "Code DCI": "14B196", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART. 3ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "UMULINE PROFIL 30 100UI/ML SUSP. INJ.  B/1FL DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/3737.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3737", "Laboratoire": " LILLY DEUTSCHLAND GmBH", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) 30% / INSULINE HUMAINE ISOPHANE 70%", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "UMULINE PROFIL 30", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 14 B 192 /00/09", "Code DCI": "14B192", "Forme": "SUSP. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/1FL DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "UMULINE RAPIDE 100UI/ML SOL INJ  B/5 CART. DE 3 ML ", "Img": "https://pharmnet-dz.com//img/medics/3732.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3732", "Laboratoire": " ELI LILLY", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE RAPIDE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "UMULINE RAPIDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 14 B 153 /98", "Code DCI": "14B153", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "B/5 CART. DE 3 ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "UMULINE RAPIDE 100UI/ML SOL. INJ IM/SC FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/3299.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3299", "Laboratoire": " LILLY DEUTSCHLAND GmBH", "C.Pharmacologique": " INSULINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " INSULINE HUMAINE (rDNA) RAPIDE ", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "UMULINE RAPIDE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "034/ 14 B 197 /00/08", "Code DCI": "14B197", "Forme": "SOL. INJ.", "Dosage": "100UI/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "UN-ALFA 0,25 \u00b5G CAPS.ORALE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3419", "Laboratoire": " LEO", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ALFACALCIDOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "UN-ALFA", "Tarif de reference": "0 DA", "PPA": "587.00 DA", "Num Enregistrement": "083/ 14 H 089 /98/15", "Code DCI": "14H089", "Forme": "CAPS.", "Dosage": "0,25 \u00b5G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "UN-ALFA 1\u00b5G CAPS.ORALE B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3418", "Laboratoire": " LEO", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ALFACALCIDOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "UN-ALFA", "Tarif de reference": "0 DA", "PPA": "1352.00 DA", "Num Enregistrement": "083/ 14 H 088 /98/15", "Code DCI": "14H088", "Forme": "CAPS.", "Dosage": "1\u00b5G", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "UNICAINE 0.02 SOL.INJ. B/10AMP DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/4078.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4078", "Laboratoire": " UNIMED", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "TUNISIE", "Nom Commercial": "UNICAINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 02 C 019 /96", "Code DCI": "02C019", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/10AMP DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "UNICAINE 1% 0.01 SOL.INJ. B/50 AMP. DE 10ML", "Img": "https://pharmnet-dz.com//img/medics/4073.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4073", "Laboratoire": " UNIMED", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "TUNISIE", "Nom Commercial": "UNICAINE 1%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 02 C 018 /96/15", "Code DCI": "02C018", "Forme": "SOL. INJ.", "Dosage": "0.01", "Conditionnement": "B/50 AMP. DE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "UNILEXIN 250MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "UNILEXIN", "Tarif de reference": "278 DA", "PPA": "N/A", "Num Enregistrement": "174/ 13 B 009 /99", "Code DCI": "13B009", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "UNILEXIN 500MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFALEXINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "UNILEXIN", "Tarif de reference": "556 DA", "PPA": "586.00 DA", "Num Enregistrement": "174/ 13 B 010 /99", "Code DCI": "13B010", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "UNIRETIC 5MG**/50MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " DIURETIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMILORIDE (SOUS FORME DE CHLORHYDRATE)**/HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "UNIRETIC", "Tarif de reference": "137 DA", "PPA": "N/A", "Num Enregistrement": "174/ 06 H 094 /99", "Code DCI": "06H094", "Forme": "COMP.", "Dosage": "5MG**/50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "UPFEN 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/4404.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4404", "Laboratoire": " PROPHARMAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "UPFEN", "Tarif de reference": "192 DA", "PPA": " DA", "Num Enregistrement": "201/04B040/00/16", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "UPTONIC 25MG COMP. ENRO. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "UPTONIC", "Tarif de reference": "285 DA", "PPA": "N/A", "Num Enregistrement": "010/ 16 A 001 /99", "Code DCI": "16A001", "Forme": "COMP. PELLI.", "Dosage": "25MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "UPTONIC 50MG COMP . ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " AMITRIPTYLINE CHLORHYDRATE EXPRIME EN AMITRIPTYLINE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "UPTONIC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "010/ 16 A 002 /99", "Code DCI": "16A002", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "URICARE 3G/SACHET GRLES. P. SOL. BUV. B/01 SACHET", "Img": "https://pharmnet-dz.com//img/medics/1193.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1193", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " ANTI-INFECTIEUX URINAIRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " FOSFOMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "URICARE", "Tarif de reference": "761.07 DA", "PPA": "N/A", "Num Enregistrement": "293/ 25 E 058 /14", "Code DCI": "25E058", "Forme": "GRLES. SOL. BUV.", "Dosage": "3G/SACHET", "Conditionnement": "B/01 SACHET", "Commercialisation": true, "Remboursable": true}, {"Nom": "URICLAR 100MG COMP.  B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "URICLAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 21 B 007 /99/07", "Code DCI": "21B007", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "URICLAR 300MG COMP.  B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "URICLAR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 21 B 008/ 99/07", "Code DCI": "21B008", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": null}, {"Nom": "URILAX 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4655.png", "Laboratoire": " TABUK", "C.Pharmacologique": " N/D", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SOLIFENACINE SUCCINATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "URILAX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "173/25P069/16", "Code DCI": "25P069", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "URILAX 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4654.png", "Laboratoire": " TABUK", "C.Pharmacologique": " N/D", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SOLIFENACINE SUCCINATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "URILAX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "173/25P068/16", "Code DCI": "25P068", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "URO 3000 GLYCOCOLLE AGUETTANT 0.015 SOL. P. IRRIGATION VESICALE B/4 POCH. DE 3000ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " PRODUITS-SOLUTIONS-BANDELETTES REACTIVES", "C.Therapeutique": " DIVERS", "Info": " GLYCOCOLLE ", "Pays": "FRANCE", "Nom Commercial": "URO 3000 GLYCOCOLLE AGUETTANT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "075/ 26 A 007 /98", "Code DCI": "26A007", "Forme": "SOL.", "Dosage": "0.015", "Conditionnement": "B/4 POCH. DE 3000ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "URO 3000CHLORURE DE SODIUM 0,9% 0.009 SOL. P. IRRIGATION VESICALE CARTON DE 4 POCH. EN PVC DE 3L", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " CHLORURE DE SODIUM", "Pays": "FRANCE", "Nom Commercial": "URO 3000CHLORURE DE SODIUM 0,9%", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "075/ 14 G 170 /00", "Code DCI": "14G170", "Forme": "SOL.", "Dosage": "0.009", "Conditionnement": "CARTON DE 4 POCH. EN PVC DE 3L", "Commercialisation": true, "Remboursable": true}, {"Nom": "UROBACID 400MG COMP. ENRO. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANDOZ", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " NORFLOXACINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "UROBACID", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "080/ 13 K 229 /00", "Code DCI": "13K229", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "UROMITEXAN 100MG/ML (400MG/4ML) SOL. INJ. IV B/05AMP. DE 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=31", "Laboratoire": " BAXTER", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " MESNA", "Liste": "Liste II", "Pays": "ALLEMAGNE", "Nom Commercial": "UROMITEXAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "298/ 05 J 149 /12", "Code DCI": "05J149", "Forme": "SOL. INJ.", "Dosage": "100MG/ML (400MG/4ML)", "Conditionnement": "B/05AMP. DE 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "UROPIMID 400MG GLES. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LIFEPHARMA", "C.Pharmacologique": " ANTI-INFECTIEUX URINAIRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " ACIDE PIPEMIDIQUE TRIHYDRATEE EXPRIME EN ACIDE PIPEMIDIQUE", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "UROPIMID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "010/ 25 E 011 /99/09", "Code DCI": "25E011", "Forme": "GLES.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "URSOLVAN 200MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2994.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2994", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ACIDE URSODESOXYCHOLIQUE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "URSOLVAN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "376/ 10 R 101 /98/15", "Code DCI": "10R101", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "USENIL 400MG SUPPO. SEC.ENFANT B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2796", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "USENIL", "Tarif de reference": "108.4 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 031 /09", "Code DCI": "04B031", "Forme": "SUPPO.", "Dosage": "400MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "USENIL 700MG SUPPO. ADULTE B/08", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2792", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " MORNIFLUMATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "USENIL", "Tarif de reference": "137.12 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 030 /09", "Code DCI": "04B030", "Forme": "SUPPO.", "Dosage": "700MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "UTORAL 50MG/ML SOL INJ B/10 FL DE 20ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "COREE", "Nom Commercial": "UTORAL", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "516/05G059/16", "Code DCI": "N/D", "Forme": "SOL. INJ.", "Dosage": "50MG/ML", "Conditionnement": "B/10 FL DE 20ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "UTROGESTAN 100MG CAPS.MOLLE ORA. OU VAGI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3822", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PROGESTERONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "UTROGESTAN", "Tarif de reference": "0 DA", "PPA": "728.00 DA", "Num Enregistrement": "169/ 09 N 109 /99", "Code DCI": "09N109", "Forme": "CAPS. MOLLE", "Dosage": "100MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "UTROGESTAN 200MG CAPS. MOLLE  ORA. ET  VAGI. B/15", "Img": "https://pharmnet-dz.com//img/medics/3824.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3824", "Laboratoire": " BESINS INTERNATIONAL", "C.Pharmacologique": " PROGESTATIFS (SAUF CONTRACEPTIFS)", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " PROGESTERONE MICRONISEE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "UTROGESTAN", "Tarif de reference": "806.72 DA", "PPA": "N/A", "Num Enregistrement": "169/ 09 N 155 /07", "Code DCI": "09N155", "Forme": "CAPS. MOLLE", "Dosage": "200MG", "Conditionnement": "B/15", "Commercialisation": true, "Remboursable": true}], "V": [{"Nom": "VAAMOX ADULTE 1G/200MG PDRE. SOL. INJ. I.V. OU PERF. B/01FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/292.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=292", "Laboratoire": " UNIMED", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE SODIQUE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE POTASSIQUE EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "VAAMOX ADULTE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 13 G 182 /08", "Code DCI": "13G182", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/200MG", "Conditionnement": "B/01FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAAMOX ENFANT ET NOURRISSON 500MG/50MG PDRE. SOL. INJ. I.V. OU PERF. B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/233.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=233", "Laboratoire": " UNIMED", "C.Pharmacologique": " PENICILLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AMOXICILLINE TRIHYDRATE EXPRIME EN AMOXICILLINE / ACIDE CLAVULANIQUE SEL DE POTASSIUM EXPRIME EN ACIDE CLAVULANIQUE", "Liste": "Liste I", "Pays": "TUNISIE", "Nom Commercial": "VAAMOX ENFANT ET NOURRISSON", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "023/ 13 G 049 /08", "Code DCI": "13G049", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/50MG", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "VACCIN ANTI-ROUGEOLE 0,5ML/ DOSE SOL.INJ B/50FL/10DOSES DE 10ML + 50FL DE SOLVANT DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SERUM INSTITUTE OF INDIA", "C.Pharmacologique": " VACCINS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VACCIN ANTI ROUGEOLEUX VIVANT ATTENUE LYOPHILISE", "Pays": "INDE", "Nom Commercial": "VACCIN ANTI-ROUGEOLE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "209/ 13 U 140 /99", "Code DCI": "13U140", "Forme": "SOL. INJ.", "Dosage": "0,5ML/ DOSE", "Conditionnement": "B/50FL/10DOSES DE 10ML + 50FL DE SOLVANT DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAINCOR 10MG COMP. PELLI. B/7 - B/28", "Img": "https://pharmnet-dz.com//img/medics/2277.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VAINCOR", "Tarif de reference": "1638 DA", "PPA": "5600.00 DA", "Num Enregistrement": "317/ 16 D 100 /10", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/7 - B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALACLOR 160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALACLOR", "Tarif de reference": " N/A", "PPA": "1597.00 DA", "Num Enregistrement": "035 / 06 E 166 /15", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VALACLOR 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALACLOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035 / 06 E 146 /15", "Code DCI": "06E146", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VALACLOR 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALACLOR", "Tarif de reference": " N/A", "PPA": "1597.00 DA", "Num Enregistrement": "035 / 06 E 147 /15", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VALACLOR PLUS 160MG/12,5MG COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALACLOR PLUS", "Tarif de reference": "2044 DA", "PPA": "N/A", "Num Enregistrement": "035/06E237/16", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALACLOR PLUS 160MG/25MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALACLOR PLUS", "Tarif de reference": "2190 DA", "PPA": "N/A", "Num Enregistrement": "035/06E238/16", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALACLOR PLUS 80MG/12,5MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALACLOR PLUS", "Tarif de reference": "2044 DA", "PPA": "N/A", "Num Enregistrement": "035/06E158/16", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALAMLO ALEMBIC MAMI 5MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ALEMBIC MAMI SPA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALAMLO ALEMBIC MAMI", "Tarif de reference": "0 DA", "PPA": " DA", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALASTAN 160MG COMP. PELLI. B/28 - B/98", "Img": "https://pharmnet-dz.com//img/medics/3090.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3090", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALASTAN", "Tarif de reference": "1491.00 DA", "PPA": "1491.00 DA", "Num Enregistrement": "447/ 06 E 166 /09", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/28 - B/98", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALASTAN 80MG COMP. PELLI. B/28 - B/98", "Img": "https://pharmnet-dz.com//img/medics/200.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=200", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALASTAN", "Tarif de reference": "1491.00 DA", "PPA": "1491.00 DA", "Num Enregistrement": "447/ 06 E 147 /11", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/28 - B/98", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALCARD ALEMBIC MAMI 320MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " ALEMBIC MAMI SPA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALCARD ALEMBIC MAMI", "Tarif de reference": "1380.00 DA", "PPA": "N/A", "Code DCI": "06E308", "Forme": "COMP. PELLI.", "Dosage": "320MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALEX 160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/3091.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALEX", "Tarif de reference": "1597.5 DA", "PPA": "1597.00 DA", "Num Enregistrement": "268/ 06 E 166 /12", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALEX 80MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/201.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALEX", "Tarif de reference": "1597.5 DA", "PPA": "1597.00 DA", "Num Enregistrement": "268/ 06 E 147 /12", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALIREC 200MG/5ML** (OU 40MG/ML) SIROP FL./150ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " ACIDE VALPROIQUE (SOUS FORME DE VALPROATE DE SODIUM)**", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VALIREC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 15 A 092 /09", "Code DCI": "15A092", "Forme": "SIROP", "Dosage": "200MG/5ML** (OU 40MG/ML)", "Conditionnement": "FL./150ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "VALKINE 200MG/ML SOL.BUV. FL./60ML AVEC SERINGUE DOSEUSE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VALKINE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 15 A 003 /06", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL./60ML AVEC SERINGUE DOSEUSE", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALPROATE AFRO 200MG/ML SOL. BUV. FL 40ML,60ML,100ML PIPETTE GRADu\u00e9e", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Pharmacologique": " NEUROLOGIE", "C.Therapeutique": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VALPROATE AFRO", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "503/15A003/15", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "FL 40ML,60ML,100ML PIPETTE GRADu\u00e9e", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALPROATE DE SODIUM BGL 200MG/ML SOL. BUV. B/1FL. DE 40ML + 1SERING. GRADUEE", "Img": "https://pharmnet-dz.com//img/medics/3494.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3494", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VALPROATE DE SODIUM BGL", "Tarif de reference": "0 DA", "PPA": "419.00 DA", "Num Enregistrement": "235/ 15 A 003 /12", "Code DCI": "15A003", "Forme": "SOL. BUV.", "Dosage": "200MG/ML", "Conditionnement": "B/1FL. DE 40ML + 1SERING. GRADUEE", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALPROCIDE GS CHRONO 500MG** (333MG D'ACIDE VALPROIQUE SEL SODIIQUE + 147MG D'ACIDE VALPROIQUE) COMP. SEC. LP B/30", "Img": "https://pharmnet-dz.com//img/medics/2401.jpg", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2401", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " VALPROATE DE SODIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VALPROCIDE GS CHRONO", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "242/ 15 A 043 /09", "Code DCI": "15A043", "Forme": "COMP. SEC.", "Dosage": "500MG** (333MG D'ACIDE VALPROIQUE SEL SODIIQUE + 147MG D'ACIDE VALPROIQUE)", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSAN 160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSAN", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "320/ 06 E 166 /08", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSAN 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " AGD PHARMA", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSAN", "Tarif de reference": " N/A", "PPA": "1850.00 DA", "Num Enregistrement": "320/ 06 E 147 /08/13 ", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VALSARTAL 160MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSARTAL", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "039/ 06 E 166 /11", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSARTAL 80MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SOPHAL (SOCIETE PHARMACEUTIQUE ALGERIENNE)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSARTAL", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "039/ 06 E 147 /11", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSARTAN LDM 160MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSARTAN LDM", "Tarif de reference": "1597.5 DA", "PPA": "N/A", "Num Enregistrement": "309/ 06 E 166 /13", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSARTAN LDM 80MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSARTAN LDM", "Tarif de reference": "1597.5 DA", "PPA": "1850.00 DA", "Num Enregistrement": "309/ 06 E 147 /13", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSARTAN/ HYDROCHLOROTHIAZIDE LDM 160MG/12,5MG  COMP PELL B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSARTAN/ HYDROCHLOROTHIAZIDE LDM", "Tarif de reference": "2044 DA", "PPA": "2044.00 DA", "Num Enregistrement": "309/ 06 E 237 /14", "Code DCI": "06E237", "Forme": "COMP. PELLI.", "Dosage": "160MG/12,5MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSARTAN+HCTZ LDM 80MG/12,5MG  COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSARTAN+HCTZ LDM", "Tarif de reference": "2190 DA", "PPA": "1850.00 DA", "Num Enregistrement": "309/ 06 E 158 /14", "Code DCI": "06E158", "Forme": "COMP. PELLI.", "Dosage": "80MG/12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSIS 160MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/3094.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSIS", "Tarif de reference": "1491 DA", "PPA": "1491.00 DA", "Num Enregistrement": "003/ 06 E 166 /11", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALSIS 80MG COMP. PELLI. SEC. B/28", "Img": "https://pharmnet-dz.com//img/medics/204.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALSIS", "Tarif de reference": "1491 DA", "PPA": "1491.00 DA", "Num Enregistrement": "003/ 06 E 147 /11", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALZEPAM 10MG  COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " DIAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALZEPAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 028 /97", "Code DCI": "16B028", "Forme": "COMP.", "Dosage": "10MG ", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "VALZEPAM 10MG/2ML SOL.INJ. B/5", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " DIAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALZEPAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 025 /01", "Code DCI": "16B025", "Forme": "SOL. INJ.", "Dosage": "10MG/2ML", "Conditionnement": "B/5", "Commercialisation": true, "Remboursable": true}, {"Nom": "VALZEPAM 5MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " DIAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VALZEPAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 16 B 027 /97/09", "Code DCI": "16B027", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "VANCOLON 500MG** PDRE. SOL. INJ. IV B/1FL. DE PDRE ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " GULF PHARMACEUTICAL INDUSTRIES  (JULPHAR)", "C.Pharmacologique": " AUTRES ANTIBIOTIQUES & ANTIBACTERIENS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VANCOMYCINE", "Liste": "Liste I", "Pays": "EMIRATS ARABES UNIS", "Nom Commercial": "VANCOLON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "329/ 13 N 096 /08", "Code DCI": "13N096", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG**", "Conditionnement": "B/1FL. DE PDRE ", "Commercialisation": true, "Remboursable": null}, {"Nom": "VANCOMYCINE MYLAN 500MG/FL DE PDRE.** PDRE. SOL. PERF.  B/1FL.DE PDRE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3604", "Laboratoire": " MYLAN", "C.Pharmacologique": " INFECTIOLOGIE", "C.Therapeutique": " VANCOMYCINE** (SOUS FORME DE CHLORHYDRATE)", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VANCOMYCINE MYLAN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "450/ 13 X 096 /07", "Code DCI": "13X096", "Forme": "PDRE. SOL. INJ.", "Dosage": "500MG/FL DE PDRE.**", "Conditionnement": "B/1FL.DE PDRE", "Commercialisation": true, "Remboursable": null}, {"Nom": "VANCOMYCINE WYETH LEDERL 500 MG/10ML PDRE.SOL.INJ. FL/10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " WYETH LEDERLE", "C.Pharmacologique": " AUTRES ANTIBIOTIQUES & ANTIBACTERIENS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VANCOMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VANCOMYCINE WYETH LEDERL", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "030/ 13 N 096 /99", "Code DCI": "13N096", "Forme": "PDRE. SOL. INJ.", "Dosage": "500 MG/10ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "VANLAXOR LP 75 MG GLES LP  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VANLAXOR LP", "Tarif de reference": "1741.2 DA", "PPA": "N/A", "Num Enregistrement": "289/16A126/16", "Code DCI": "16A126", "Forme": "GLES. LP", "Dosage": "75 MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VANTAMED 2MG COMP. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " ASIA PHARMACEUTICALS", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "SYRIE", "Nom Commercial": "VANTAMED", "Tarif de reference": "110 DA", "PPA": "N/A", "Num Enregistrement": "121/ 20 A 015 /06", "Code DCI": "20A015", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAPORHUM  BAUME POT/40G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " MEDICAMENTS DES AFFECTIONS RESPIRATOIRES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " BALSAMIQUES POUR INHALATION", "Pays": "ALGERIE", "Nom Commercial": "VAPORHUM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "088/ 20 E 076 /99", "Code DCI": "20E076", "Forme": "BAUME", "Conditionnement": "POT/40G", "Commercialisation": true, "Remboursable": null}, {"Nom": "VASKOL 10MG COMP.PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1568.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VASKOL", "Tarif de reference": " N/A", "PPA": "837.00 DA", "Num Enregistrement": "268/ 06 M 198 /08/15", "Code DCI": "06M198", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VASKOL 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1591.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " ATORVASTATINE CALCIQUE TRIHYDRATE EXPRIME EN ATORVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VASKOL", "Tarif de reference": "1247.4 DA", "PPA": "1247.00 DA", "Num Enregistrement": "268/ 06 M 225 /12", "Code DCI": "06M225", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VASTA 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VASTA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 06 M 205 /06", "Code DCI": "06M205", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VASTA 20MG COMP. ENRO. B/30", "Img": "https://pharmnet-dz.com//img/medics/1548.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " EL KENDI", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VASTA", "Tarif de reference": "1247.4 DA", "PPA": "1247.00 DA", "Num Enregistrement": "352/ 06 M 136 /06", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VASTAREL 35MG COMP. PELLI. LM B/60", "Img": "https://pharmnet-dz.com//img/medics/1517.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1517", "Laboratoire": " SERVIER", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "VASTAREL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "040/ 06 J 226 /07/15", "Code DCI": "06J226", "Forme": "COMP. PELLI.", "Dosage": "35MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "VASTOR 20MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE DICHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "VASTOR", "Tarif de reference": "390 DA", "PPA": "390.00 DA", "Num Enregistrement": "035/ 06 J 107 /07", "Code DCI": "06J107", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAVO 0.02 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/452.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=452", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VAVO", "Tarif de reference": "183 DA", "PPA": "N/A", "Num Enregistrement": "352/ 07 D 028 /11", "Code DCI": "07D028", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAVO SHAMPOO 0.02 SHAMPOING FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/473.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=473", "Laboratoire": " TABUK", "C.Pharmacologique": " ANTIFONGIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " KETOCONAZOLE", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "VAVO SHAMPOO", "Tarif de reference": "458 DA", "PPA": "N/A", "Num Enregistrement": "173/ 07 D 141 /07", "Code DCI": "07D141", "Forme": "SHAMPOING", "Dosage": "0.02", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAXIGRIP 0,5ML SUSP.INJ.  B/1SERINGUE PRE- REMPLIE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SANOFI PASTEUR S.A", "C.Pharmacologique": " VACCINS", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VACCIN GRIPPAL INACTIVE A VIRION FRAGMENTE ", "Pays": "FRANCE", "Nom Commercial": "VAXIGRIP", "Tarif de reference": "0 DA", "PPA": "ACTIVE A VIRION FRAGMENTE ", "Num Enregistrement": "345/ 13 U 135 /05", "Code DCI": "13U135", "Forme": "SUSP. INJ.", "Dosage": "0,5ML", "Conditionnement": "B/1SERINGUE PRE- REMPLIE", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAZOTEK 2MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/97.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VAZOTEK", "Tarif de reference": "0 DA", "PPA": "217.00 DA", "Num Enregistrement": "268/ 06 C 022 /10", "Code DCI": "06C022", "Forme": "COMP. SEC.", "Dosage": "2MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VAZOTEK 4MG COMP. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medics/103.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-ANGOREUX", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " MOLSIDOMINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VAZOTEK", "Tarif de reference": "0 DA", "PPA": "450.00 DA", "Num Enregistrement": "268/ 06 C 023 /10", "Code DCI": "06C023", "Forme": "COMP. SEC.", "Dosage": "4MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VECTIBIX 20MG/ML (100MG/5ML) (400MG/20ML) SOL. A DILUER P. PERF. IV B/01 FL. DE 5ML , B/01 FL. DE 20ML", "Img": "https://pharmnet-dz.com//img/medics/1064.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1064", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " PANITUMUMAB", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "VECTIBIX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 05 D 169 /15", "Code DCI": "05D169", "Forme": "SOL. PERF.", "Dosage": "20MG/ML (100MG/5ML) (400MG/20ML)", "Conditionnement": "B/01 FL. DE 5ML , B/01 FL. DE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VECURON 4MG/FL. DE LYOPH. LYOPH. ET SOLV. P. SOL. INJ. IV B/10FL. DE LYOPH.+ 10AMP. DE 2ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CURARISANTS", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " VECURONIUM BROMURE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "VECURON", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 02 D 038 /12", "Code DCI": "02D038", "Forme": "SOL. INJ.", "Dosage": "4MG/FL. DE LYOPH.", "Conditionnement": "B/10FL. DE LYOPH.+ 10AMP. DE 2ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": null}, {"Nom": "VEFLAT 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VEFLAT", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/ 13 R 258 /09", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "VEFLAT 50MG GLES. B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VEFLAT", "Tarif de reference": "219 DA", "PPA": "249.00 DA", "Num Enregistrement": "235/ 13 R 155 /09", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "VEINOTREL 20MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medics/1501.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " PHYSIOPHARM SARL", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE DICHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "VEINOTREL", "Tarif de reference": "390 DA", "PPA": "N/A", "Num Enregistrement": "462/ 06 J 107 /11", "Code DCI": "06J107", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "VELBASTINE 10 MG POUDRE ET SOLVANT POUR SOL INJ IV  B/1 FLACON DE POUDRE ET 1 AMP DE 10 ML DE SOLVANT", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "COREE", "Nom Commercial": "VELBASTINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "516/05G038/17", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "10 MG", "Conditionnement": "B/1 FLACON DE POUDRE ET 1 AMP DE 10 ML DE SOLVANT", "Commercialisation": true, "Remboursable": null}, {"Nom": "VELCADE 3,5MG/FL. DE PDRE. (OU 1MG/ML DE SOL. RECONSTITUEE) PDRE. SOL. INJ. IV B/1FL. DE PDRE. DE CONTENANCE 10ML", "Img": "https://pharmnet-dz.com//img/medics/23.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=23", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " BORTEZOMIB ESTER BORONIQUE DE MANNITOL EXPRIME EN BORTEZOMIB", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "VELCADE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 05 G 147 /09", "Code DCI": "05G147", "Forme": "PDRE. SOL. INJ.", "Dosage": "3,5MG/FL. DE PDRE. (OU 1MG/ML DE SOL. RECONSTITUEE)", "Conditionnement": "B/1FL. DE PDRE. DE CONTENANCE 10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VELITEN 200MG / 50MG / 200MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medics/2010.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2010", "Laboratoire": " ZAMBON", "C.Pharmacologique": " MEDICAMENTS PAR VOIE ORALE", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACIDE ASCORBIQUE / VITAMINE E /RUTOSIDE ", "Pays": "FRANCE", "Nom Commercial": "VELITEN", "Tarif de reference": "283.8 DA", "PPA": "N/A", "Num Enregistrement": "093/ 17 L 082 /98", "Code DCI": "17L082", "Forme": "COMP.", "Dosage": "200MG / 50MG / 200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "VENACINE 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " N/D", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SOLIFENACINE SUCCINATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VENACINE", "Tarif de reference": "-- DA", "PPA": "N/A", "Code DCI": "25P069", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENEXOR  37,5MG** COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE**  (SOUS FORME DE VENLAFAXINE  CHLORHYDRATE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "VENEXOR ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "174/ 16 D 123 /08", "Code DCI": "16D123", "Forme": "COMP.", "Dosage": "37,5MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VENEXOR  75MG** COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE**  (SOUS FORME DE VENLAFAXINE  CHLORHYDRATE)", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "VENEXOR ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "174/ 16 D 124 /08", "Code DCI": "16D124", "Forme": "COMP.", "Dosage": "75MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VENLAFAXINE GEBER 37,5MG  GLES LP  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEBER HEALTH", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VENLAFAXINE GEBER", "Tarif de reference": "870.6 DA", "PPA": "870.00 DA", "Num Enregistrement": "472/ 16 A 125 /14", "Code DCI": "16A125", "Forme": "GLES. LP", "Dosage": "37,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENLAFAXINE GEBER 75MG  GLES LP  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GEBER HEALTH", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VENLAFAXINE GEBER", "Tarif de reference": "1741.2 DA", "PPA": "1741.00 DA", "Num Enregistrement": "472/ 16 A 126 /14", "Code DCI": "16A126", "Forme": "GLES. LP ", "Dosage": "75MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENLAXOR LP 37,5MG GLES LP  B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " VENLAFAXINE CHLORHYDRATE EXPRIME EN VENLAFAXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VENLAXOR LP", "Tarif de reference": "870.6 DA", "PPA": "N/A", "Num Enregistrement": "289/16A125/16", "Code DCI": "16A125", "Forme": "GLES.", "Dosage": "37,5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENOFER 20MG/ML (100MG/5ML) SOL. INJ. PERF. IV OU EN INJ. DANS LE DIALYSEUR B/05AMP. DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " VIFOR INTERNATIONAL INC", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " COMPLEXE D'HYDROXIDE FERRIQUE-SACCHAROSE EXPRIME EN FER FERRIQUE", "Pays": "SUISSE", "Nom Commercial": "VENOFER", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "393/ 12 E 135 /07/14", "Code DCI": "12E135", "Forme": "SOL. INJ.", "Dosage": "20MG/ML (100MG/5ML)", "Conditionnement": "B/05AMP. DE 5ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "VENOSMIL 200MG GLES B/20", "Img": "https://pharmnet-dz.com//img/medics/1529.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1529", "Laboratoire": " FAES", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " HYDROSMINE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "VENOSMIL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "211/ 06 K 193 /02", "Code DCI": "06K193", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": false}, {"Nom": "VENOSMINE 150MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GEYMONAT S.P.A", "C.Pharmacologique": " VASCULOPROTECTEURS & VEINOTONIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIOSMINE", "Pays": "ITALIE", "Nom Commercial": "VENOSMINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "220/ 06 K 108 /00", "Code DCI": "06K108", "Forme": "COMP.", "Dosage": "150MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VENTAVIS 10 UG/ML SOLUTION POUR INHALATION PAR NEBULISEUR B/30 AMP DE 2ML", "Img": "https://pharmnet-dz.com//img/medics/4687.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4687", "Laboratoire": " BAYER", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "VENTAVIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/06N314/16", "Code DCI": "N/D", "Forme": "SUSP. INHAL.", "Dosage": "10 UG/ML", "Conditionnement": "B/30 AMP DE 2ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENTMAX 100\u00b5G/DOSE AERO. FL/200DOSES", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CHIESI S.A.", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ITALIE", "Nom Commercial": "VENTMAX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "092/ 20 A 017 /98", "Code DCI": "20A017", "Forme": "AERO.", "Dosage": "100\u00b5G/DOSE", "Conditionnement": "FL/200DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENTOLINE 0,5MG/ML SOL.INJ.S/C B/6AMP", "Img": "https://pharmnet-dz.com//img/medics/2074.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2074", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VENTOLINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 20 A 014 /99", "Code DCI": "20A014", "Forme": "SOL. INJ.", "Dosage": "0,5MG/ML", "Conditionnement": "B/6AMP", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENTOLINE 100\u00b5G/DOSE AERO. FL/200DOSES", "Img": "https://pharmnet-dz.com//img/medics/2090.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2090", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VENTOLINE", "Tarif de reference": "258.78 DA", "PPA": " DA", "Num Enregistrement": "262/ 20 A 017 /98", "Code DCI": "20A017", "Forme": "AERO.", "Dosage": "100\u00b5G/DOSE", "Conditionnement": "FL/200DOSES", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENTOLINE 2MG COMP. B/40", "Img": "https://pharmnet-dz.com//img/medics/2080.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2080", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "VENTOLINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 20 A 015 /98", "Code DCI": "20A015", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/40", "Commercialisation": true, "Remboursable": true}, {"Nom": "VENTOLINE 5MG/ML SOL.NEB. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2092.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2092", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " SALBUTAMOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VENTOLINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 20 A 018 /99", "Code DCI": "20A018", "Forme": "AERO.", "Dosage": "5MG/ML", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VERMAZOL 100MG COMP. B/6", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " UNITED PHARMACEUTICAL MANUFACTURING (UPM)", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " MEBENDAZOLE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "VERMAZOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "174/ 19 B 006 /99", "Code DCI": "19B006", "Forme": "COMP. A CROQ.", "Dosage": "100MG", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "VERTEN 400 MG COMP B/1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " ALBENDAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VERTEN", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "235/19B030/16", "Code DCI": "19B030", "Forme": "COMP.", "Dosage": "400 MG", "Conditionnement": "B/1", "Commercialisation": true, "Remboursable": true}, {"Nom": "VESICARE 10MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1237.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1237", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " UROLOGIE ET NEPHROLOGIE", "C.Therapeutique": " SOLIFENACINE SUCCINATE", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "VESICARE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "347/ 25 P 069 /15", "Code DCI": "25P069", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "VESICARE 5MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1236.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1236", "Laboratoire": " ASTELLAS PHARMA", "C.Pharmacologique": " UROLOGIE ET NEPHROLOGIE", "C.Therapeutique": " SOLIFENACINE SUCCINATE", "Liste": "Liste II", "Pays": "PAYS BAS", "Nom Commercial": "VESICARE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "347/ 25 P 068 /15", "Code DCI": "25P068", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": false}, {"Nom": "VESTAG 160MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VESTAG", "Tarif de reference": "1597.5 DA", "PPA": "1391.00 DA", "Num Enregistrement": "470/ 06 E 166 /12", "Code DCI": "06E166", "Forme": "COMP. PELLI.", "Dosage": "160MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "VESTAG 80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VESTAG", "Tarif de reference": "1597.5 DA", "PPA": "1568.00 DA", "Num Enregistrement": "470/ 06 E 147 /12", "Code DCI": "06E147", "Forme": "COMP. PELLI.", "Dosage": "80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VESTAMOL 10MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VESTAMOL", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "470/06E259/16", "Code DCI": "06E259", "Forme": "COMP. PELLI.", "Dosage": "10MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VESTAMOL 5MG/160MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VESTAMOL", "Tarif de reference": "1650 DA", "PPA": "1623.00 DA", "Num Enregistrement": "470/ 06 E 258 /13", "Code DCI": "06E258", "Forme": "COMP. PELLI.", "Dosage": "5MG/160MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VESTAMOL 5MG/80MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " AMLODIPINE BESILATE EXPRIME EN AMLODIPINE / VALSARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VESTAMOL", "Tarif de reference": "1650 DA", "PPA": "N/A", "Num Enregistrement": "470/06E257/16", "Code DCI": "06E257", "Forme": "COMP. PELLI.", "Dosage": "5MG/80MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VETRAM 100MG/ML SIROP B/1FL. DE 120ML + SERING. DOSEUSE GRADU. EN MG", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VETRAM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 15 A 100 /13", "Code DCI": "15A100", "Forme": "SIROP", "Dosage": "100MG/ML", "Conditionnement": "B/1FL. DE 120ML + SERING. DOSEUSE GRADU. EN MG", "Commercialisation": true, "Remboursable": null}, {"Nom": "VETRAM 250MG COMP. PELLI. SEC. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VETRAM", "Tarif de reference": "0 DA", "PPA": "848.00 DA", "Num Enregistrement": "001/ 15 A 072 /13", "Code DCI": "15A072", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VETRAM 500MG COMP. PELL. SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VETRAM", "Tarif de reference": " N/A", "PPA": "1694.00 DA", "Num Enregistrement": "001/ 15 A 073/ 13", "Code DCI": "15A073", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VETRAM 750MG COMP. PELL. SEC B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VETRAM", "Tarif de reference": " N/A", "PPA": "2310.00 DA", "Num Enregistrement": "001/ 15 A 102/ 13", "Code DCI": "15A102", "Forme": "COMP. PELLI.", "Dosage": "750MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VETRAM LP 500 MG COMP PELL LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " LEVETIRACETAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VETRAM LP", "Tarif de reference": "1775,1 DA", "PPA": "N/A", "Code DCI": "15A073", "Forme": "COMP. PELLI. LP", "Dosage": "500 MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VEXOL 0.01 COLLY. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/1982.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1982", "Laboratoire": " ALCON", "C.Pharmacologique": " CORTICOIDES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " RIMEXOLONE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VEXOL", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "028/ 17 G 148 /09", "Code DCI": "17G148", "Forme": "COLLY.", "Dosage": "0.01", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VFEND 200MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3582.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3582", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VORICONAZOLE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "VFEND", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 13 R 338 /09", "Code DCI": "13R338", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VFEND 200MG/FL. DE PDRE. (OU 10MG/ML DE SOL. RECONSTITUEE) PDRE. SOL PERF.IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3581.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3581", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VORICONAZOLE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "VFEND", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 13 R 337 /09", "Code DCI": "13R337", "Forme": "PDRE. SOL. INJ.", "Dosage": "200MG/FL. DE PDRE. (OU 10MG/ML DE SOL. RECONSTITUEE)", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "VFEND 50MG COMP. PELLI. B/28", "Img": "https://pharmnet-dz.com//img/medics/3583.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3583", "Laboratoire": " PFIZER LIMITED", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VORICONAZOLE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "VFEND", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 13 R 443 /09", "Code DCI": "13R443", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIABEK 100MG COMP. PELLI. B/04", "Img": "https://pharmnet-dz.com//img/medics/1234.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1234", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIABEK", "Tarif de reference": "0 DA", "PPA": "1440.00 DA", "Num Enregistrement": "447/ 25 N 060 /13", "Code DCI": "25N060", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/04", "Commercialisation": true, "Remboursable": false}, {"Nom": "VIABEK 50MG  COMP. PELLI. SEC B/02 ", "Img": "https://pharmnet-dz.com//img/medics/1223.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1223", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIABEK", "Tarif de reference": "0 DA", "PPA": "300.00 DA", "Num Enregistrement": "447/ 25 N 045 /12", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/02   B/08", "Commercialisation": true, "Remboursable": false}, {"Nom": "VIACTAL 50MG  COMP. B/02  -  B/08", "Img": "https://pharmnet-dz.com//img/medics/1224.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1224", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIACTAL", "Tarif de reference": "0 DA", "PPA": "320 DA", "Num Enregistrement": "003/ 25 N 045 /07", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/02  -  B/08", "Commercialisation": true, "Remboursable": false}, {"Nom": "VIADIS 50MG  COMP. PELLI. B/02 ET B/04", "Img": "https://pharmnet-dz.com//img/medics/1225.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1225", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIADIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "317/ 25 N 045 /10", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/02 ET B/04", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIAGNAFIL  50MG  COMP PELL  B/02 ET B/04", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIAGNAFIL ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "380/25N045/16", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/02 ET B/04", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIAGRA 50MG  COMP. PELLI. B/02", "Img": "https://pharmnet-dz.com//img/medics/1226.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1226", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIAGRA", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "045/ 25 N 045 /99/09", "Code DCI": "25N045", "Forme": "COMP. PELLI.", "Dosage": "50MG ", "Conditionnement": "B/02", "Commercialisation": true, "Remboursable": false}, {"Nom": "VIALEBEX 200MG/ML ( 20%)  SOLUTION POUR PERFUSION IV BOITE DE 01 FLACON DE 50ML (10G/50ML) , BOITE DE 01 FLACON DE 100ML (20G/100ML) ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5844", "Laboratoire": " FACTEURS SANGUINS", "C.Pharmacologique": " HEMATOLOGIE ET HEMOSTASE", "C.Therapeutique": " ALBUMINE HUMAINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VIALEBEX", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "513/12J042/16", "Code DCI": "12J042", "Forme": "SOL. INJ. PERF.", "Dosage": "200MG/ML ( 20%) ", "Conditionnement": "BOITE DE 01 FLACON DE 50ML (10G/50ML) , BOITE DE 01 FLACON DE 100ML (20G/100ML) ", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIANAFIL 100MG COMP. PELLI. B/04 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " SILDENAFIL CITRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIANAFIL", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "25N060", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/04 ", "Commercialisation": true, "Remboursable": false}, {"Nom": "VIBRAMYCINE 100MG COMP. SEC. B/05", "Img": "https://pharmnet-dz.com//img/medics/762.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=762", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " CYCLINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " DOXYCYCLINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIBRAMYCINE", "Tarif de reference": "93 DA", "PPA": "N/A", "Num Enregistrement": "045/ 13 C 020 /98/09", "Code DCI": "13C020", "Forme": "COMP. SEC.", "Dosage": "100MG", "Conditionnement": "B/05", "Commercialisation": true, "Remboursable": true}, {"Nom": "VICTOZA 6MG/ML  SOL INJ S/C EN STYLO PREREMPLIE MULTIDOSE  B/02 STYLOS DE 3ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NOVONORDISK", "C.Pharmacologique": " METABOLISME NUTRITION DIABETE", "C.Therapeutique": " LIRAGLUTIDE", "Pays": "DANEMARK", "Nom Commercial": "VICTOZA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "069/ 14 P 346 /14", "Code DCI": "14P346", "Forme": "SOL. INJ.", "Dosage": "6MG/ML ", "Conditionnement": "B/02 STYLOS DE 3ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "VICTRELIS 200 MG GELULE B/336", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4276", "Laboratoire": " MERCK SCHARP & DOHME LTD", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "VICTRELIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "024/13P472/15", "Code DCI": "N/D", "Forme": "GLES.", "Dosage": "200 MG", "Conditionnement": "B/336", "Commercialisation": true, "Remboursable": true}, {"Nom": "VILBAR 2MG/ML SOL.BUV.GTTES. B/1FL. COMPT. GTTES. DE 30ML", "Img": "https://pharmnet-dz.com//img/medics/2239.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " HALOPERIDOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VILBAR", "Tarif de reference": "180.6 DA", "PPA": "N/A", "Num Enregistrement": "263/ 16 D 085 /13", "Code DCI": "16D085", "Forme": "SOL. BUV. GTTES.", "Dosage": "2MG/ML", "Conditionnement": "B/1FL. COMPT. GTTES. DE 30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VINCRISTINE PIERRE FABRE 1MG SOL.INJ. B/1FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " PIERRE FABRE", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " VINCRISTINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VINCRISTINE PIERRE FABRE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "099/ 05 A 039 /98", "Code DCI": "05A039", "Forme": "SOL. INJ.", "Dosage": "1MG", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "VINGRAF 1MG GLES B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EMCURE PHARMACEUTICALS LTD", "C.Pharmacologique": " IMMUNOSUPPRESSEURS", "C.Therapeutique": " CANCEROLOGIE", "Info": " TACROLIMUS MONOHYDRATE EXPRIME EN TACROLIMUS", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "VINGRAF", "Tarif de reference": "-- DA", "PPA": " DA", "Code DCI": "05B092", "Forme": "GLES.", "Dosage": " 1MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VINORELBIN EBEWE 10MG/ML (10MG/ML ET 50MG/5ML) SOL. INJ. IV B/1FL. DE 1ML ET B/1FL. DE 5ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " EBEWE PHARMA", "C.Pharmacologique": " CYTOSTATIQUES", "C.Therapeutique": " CANCEROLOGIE", "Info": " VINORELBINE", "Liste": "Liste I", "Pays": "AUTRICHE", "Nom Commercial": "VINORELBIN EBEWE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "141/ 05 A 068 /07", "Code DCI": "05A068", "Forme": "SOL. INJ.", "Dosage": "10MG/ML (10MG/ML ET 50MG/5ML)", "Conditionnement": "B/1FL. DE 1ML ET B/1FL. DE 5ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIRAFERONPEG 100\u00b5G/STYLO PDRE. ET SOLV. SOL. INJ. SC EN STYLO PREREMPLI B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEGINTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "VIRAFERONPEG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 448 /09", "Code DCI": "13P448", "Forme": "PDRE. SOL. INJ.", "Dosage": "100\u00b5G/STYLO", "Conditionnement": "B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIRAFERONPEG 120\u00b5G/STYLO PDRE. ET SOLV. SOL. INJ. SC EN STYLO PREREMPLI B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEGINTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "VIRAFERONPEG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 449 /09", "Code DCI": "13P449", "Forme": "PDRE. SOL. INJ.", "Dosage": "120\u00b5G/STYLO", "Conditionnement": "B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIRAFERONPEG 150\u00b5G/STYLO PDRE. ET SOLV. SOL. INJ. SC EN STYLO PREREMPLI B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEGINTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "VIRAFERONPEG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 450 /09", "Code DCI": "13P450", "Forme": "PDRE. SOL. INJ.", "Dosage": "150\u00b5G/STYLO", "Conditionnement": "B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIRAFERONPEG 50\u00b5G/STYLO PDRE. ET SOLV. SOL. INJ. SC EN STYLO PREREMPLI B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEGINTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "VIRAFERONPEG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 446 /09", "Code DCI": "13P446", "Forme": "PDRE. SOL. INJ.", "Dosage": "50\u00b5G/STYLO", "Conditionnement": "B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIRAFERONPEG 80\u00b5G/STYLO PDRE. ET SOLV. SOL. INJ. SC EN STYLO PREREMPLI B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " SCHERING PLOUGH", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " PEGINTERFERON ALPHA 2B", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "VIRAFERONPEG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "027/ 13 P 447 /09", "Code DCI": "13P447", "Forme": "PDRE. SOL. INJ.", "Dosage": "80\u00b5G/STYLO", "Conditionnement": "B/01STYLO. PREREMPLI DE 0,5ML (CARTOUCHE BI COMPARTIMENTEE)+UNE AIGUILLE + DEUX TAMPONS NETTOYANTS", "Commercialisation": true, "Remboursable": null}, {"Nom": "VIRAM 200MG COMP. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "VIRAM", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "166/ 13 P 097 /98", "Code DCI": "13P097", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIRCET 100MG GLES. B/07", "Img": "https://pharmnet-dz.com//img/medics/3538.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIRCET", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/ 13 R 108 /10", "Code DCI": "13R108", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIRCET 150MG GLES. B/01", "Img": "https://pharmnet-dz.com//img/medics/3577.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIRCET", "Tarif de reference": "0 DA", "PPA": "250.00 DA", "Num Enregistrement": "035/ 13 R 258 /10", "Code DCI": "13R258", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/01", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIRCET 200MG GLES. B/07", "Img": "https://pharmnet-dz.com//img/medics/3558.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIRCET", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "035/ 13 R 170 /10", "Code DCI": "13R170", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIRCET 50MG GLES. B/07", "Img": "https://pharmnet-dz.com//img/medics/3557.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " FLUCONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIRCET", "Tarif de reference": "511 DA", "PPA": "511.00 DA", "Num Enregistrement": "035/ 13 R 155 /10", "Code DCI": "13R155", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/07", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIRGAN 0,15%. GEL.OPHT T/5G", "Img": "https://pharmnet-dz.com//img/medics/1970.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1970", "Laboratoire": " THEA", "C.Pharmacologique": " ANTIVIRAUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " GANCICLOVIR", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VIRGAN", "Tarif de reference": "0 DA", "PPA": "964.00 DA", "Num Enregistrement": "022/ 17 F 130 /01", "Code DCI": "17F130", "Forme": "GEL. OPHT.", "Dosage": "0,15%.", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIRODAL 0.05 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=568", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIHERPETIQUES & ANTIVIRAUX LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIRODAL", "Tarif de reference": "472.5 DA", "PPA": "N/A", "Num Enregistrement": "003/ 07 E 033 /06", "Code DCI": "07E033", "Forme": "CR\u00c8ME", "Dosage": "0.05", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "VIROZEL 75MG GLES PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/3522.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OSELTAMIVIR", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VIROZEL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 P 290 /14", "Code DCI": "13P290", "Forme": "GLES.", "Dosage": "75MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VISANNE 2MG  COMP  B/28", "Img": "https://pharmnet-dz.com//img/medics/3064.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3064", "Laboratoire": " BAYER", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " GYNECOLOGIE", "Info": " DIENOGEST", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "VISANNE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 11 P 086 /14", "Code DCI": "11P086", "Forme": "COMP.", "Dosage": "2MG ", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VISCERAL 20MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " 4A SANTE INDUSTRIE SARL", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VISCERAL", "Tarif de reference": "103 DA", "PPA": "150.00 DA", "Num Enregistrement": "366/ 10 D 031 /09", "Code DCI": "10D031", "Forme": "SUPPO.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VISCERALENE 20MG SUPPO B/10", "Img": "https://pharmnet-dz.com//img/medics/3942.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3942", "Laboratoire": " LABORATOIRES SALEM", "C.Pharmacologique": " ANTISPASMODIQUES, ANTISECRETOIRES ET ANTICHOLINERGIQUES", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " TIEMONIUM  METHYLSULFATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VISCERALENE", "Tarif de reference": "103 DA", "PPA": "180.00 DA", "Num Enregistrement": "231/ 10 D 031 /00", "Code DCI": "10D031", "Forme": "SUPPO.", "Dosage": "20MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VISUDYNE 15MG PDRE.SOL.INJ. IV B/01FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/2009.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2009", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " VERTEPORFINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "VISUDYNE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 17 K 137 /05", "Code DCI": "17K137", "Forme": "PDRE. SOL. INJ.", "Dosage": "15MG", "Conditionnement": "B/01FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITABACT 0.0005 COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/1966.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1966", "Laboratoire": " THEA", "C.Pharmacologique": " ANTISEPTIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " PICLOXYDINE CHLORHYDRATE", "Pays": "FRANCE", "Nom Commercial": "VITABACT", "Tarif de reference": "163.57 DA", "PPA": "N/A", "Num Enregistrement": "022/ 17 E 119 /00/14", "Code DCI": "17E119", "Forme": "COLLY.", "Dosage": "0.0005", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITA-C  500MG**  ( sel 167MG+375MG) COMP. A SUCER B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "VITA-C ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 14 H 115 /08", "Code DCI": "14H115", "Forme": "COMP. A CROQ.", "Dosage": "500MG**  ( sel 167MG+375MG)", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "VITA-C 500MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "VITA-C", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 H 086 /97/09", "Code DCI": "14H086", "Forme": "COMP.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "VITAFORM  SOL.BUV.GTTES FL/20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COMPLEXE VITAMINIQUE", "Pays": "ALGERIE", "Nom Commercial": "VITAFORM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 14 H 097 /97", "Code DCI": "14H097", "Forme": "SOL. BUV.", "Conditionnement": "FL/20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "VITALIS 20MG COMP. PELLI. SEC. B/02", "Img": "https://pharmnet-dz.com//img/medics/1232.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1232", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " TADALAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VITALIS", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "317/ 25 N 052 /10", "Code DCI": "25N052", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/02", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAM  SIROP F/125ML", "Img": "https://pharmnet-dz.com//img/medics/3425.png", "Laboratoire": " GROUPE SANTE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COMPLEXE VITAMINIQUE", "Pays": "ALGERIE", "Nom Commercial": "VITAM", "Tarif de reference": "146.25 DA", "PPA": " DA", "Num Enregistrement": "242/ 14 H 097 /06", "Code DCI": "14H097", "Forme": "SOL. BUV.", "Dosage": "0", "Conditionnement": "F/125ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE  C 500MG COMP.EFFER. T/16", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3446", "Laboratoire": " SANDOZ", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "VITAMINE  C", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "050/ 14 H 168 /99", "Code DCI": "14H168", "Forme": "COMP. EFFERV.", "Dosage": "500MG", "Conditionnement": "T/16", "Commercialisation": true, "Remboursable": null}, {"Nom": "VITAMINE A FAURE 150 000UI COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/2007.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2007", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " RETINOL", "Pays": "FRANCE", "Nom Commercial": "VITAMINE A FAURE", "Tarif de reference": "164.2 DA", "PPA": "N/A", "Num Enregistrement": "068/ 17 K 078 /97", "Code DCI": "17K078", "Forme": "COLLY.", "Dosage": "150 000UI", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE A FAURE 150 000UI COLLY. FL/10ML", "Img": "https://pharmnet-dz.com//img/medics/4665.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4665", "Laboratoire": " EUROPHTA", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " RETINOL", "Liste": "Liste I", "Pays": "MONACO", "Nom Commercial": "VITAMINE A FAURE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "316/17K078/98/16", "Code DCI": "17K078", "Forme": "COLLY.", "Dosage": "150 000UI", "Conditionnement": "FL/10ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE B1 B6 BGL 250MG/250MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE CHLORHYDRATE / PYRIDOXINE CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "VITAMINE B1 B6 BGL", "Tarif de reference": " N/A", "PPA": "198.00 DA", "Num Enregistrement": "235/ 14 H 112 /15", "Code DCI": "14H112", "Forme": "COMP.", "Dosage": "250MG/250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "VITAMINE B12 RAZES  500 \u00b5G/ML (OU 1000\u00b5G/2ML) SOL.INJ. ET BUV B/5AMP", "Img": "https://pharmnet-dz.com//img/medics/5844.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=5844", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " CYANOCOBALAMINE (OU VIT.B12)", "Pays": "ALLEMAGNE", "Nom Commercial": "VITAMINE B12 RAZES ", "Tarif de reference": "220.00 DA", "PPA": "220.00 DA", "Code DCI": "12E142", "Forme": "SOL. INJ.", "Dosage": "500 \u00b5G/ML (OU 1000\u00b5G/2ML)", "Conditionnement": "B/5AMP", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE C 500MG/5ML SOL.INJ. B/100AMP. DE 5ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " AGUETTANT", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "FRANCE", "Nom Commercial": "VITAMINE C", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "075/ 14 H 085 /98", "Code DCI": "14H085", "Forme": "SOL. INJ.", "Dosage": "500MG/5ML", "Conditionnement": "B/100AMP. DE 5ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE C 500MG/5ML SOL.INJ. B/10AMP.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOLOGICI", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ITALIE", "Nom Commercial": "VITAMINE C", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "084/ 14 H 085 /98", "Code DCI": "14H085", "Forme": "SOL. INJ.", "Dosage": "500MG/5ML", "Conditionnement": "B/10AMP.", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE C PHARMALLIANCE 500MG GLES. \u00c0 MICROGRLES. LP B/20", "Img": "https://pharmnet-dz.com//img/medics/3450.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "VITAMINE C PHARMALLIANCE", "Tarif de reference": " N/A", "PPA": "232.00 DA", "Num Enregistrement": "035/ 14 H 176 /99/11", "Code DCI": "14H176", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "VITAMINE C UPSA 500MG COMP. A CROQUER B/30", "Img": "https://pharmnet-dz.com//img/medics/3444.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3444", "Laboratoire": " UPSA CONSEIL", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "FRANCE", "Nom Commercial": "VITAMINE C UPSA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "008/ 14 H 115 /96", "Code DCI": "14H115", "Forme": "COMP. A CROQ.", "Dosage": "500MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE C UPSA EFFERVESCENTE 1G COMP. EFFERV.  B/20", "Img": "https://pharmnet-dz.com//img/medics/3460.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3460", "Laboratoire": " PROPHARMAL", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " ACIDE ASCORBIQUE", "Pays": "ALGERIE", "Nom Commercial": "VITAMINE C UPSA EFFERVESCENTE", "Tarif de reference": "0 DA", "PPA": "237.00 DA", "Num Enregistrement": "201/ 14 H 222 /07/13", "Code DCI": "14H222", "Forme": "COMP. EFFERV.", "Dosage": "1G", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAMINE D3 B.O.N 200 000UI/ML SOL.INJ. IM. ET SOL. BUV. B/01 AMP. DE 1ML", "Img": "https://pharmnet-dz.com//img/medics/3422.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " COLECALCIFEROL", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "VITAMINE D3 B.O.N", "Tarif de reference": "112,26 DA", "PPA": "124.00 DA", "Num Enregistrement": "269/ 14 H 095 /97/15", "Code DCI": "14H095", "Forme": "SOL. INJ.", "Dosage": "200 000UI/ML", "Conditionnement": "B/01 AMP. DE 1ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VITAZYME 250MG/250MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " INPHA MEDIS", "C.Pharmacologique": " VITAMINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " THIAMINE MONONITRATE / PYRIDOXINE CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VITAZYME", "Tarif de reference": "135 DA", "PPA": "N/A", "Num Enregistrement": "317/14H112/16", "Code DCI": "14H112", "Forme": "COMP. PELLI.", "Dosage": "250MG/250MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "VLASARTAN+HCTZ LDM 160MG/25MG COMP. PELLI. B/28 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " LDM (LABORATOIRE DE DIAGNOSTIC MAGHREBINS)", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " VALSARTAN / HYDROCHLOROTHIAZIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VLASARTAN+HCTZ LDM", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "06E238", "Forme": "COMP. PELLI.", "Dosage": "160MG/25MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTAFENE 25MG/ML (75MG/3ML) SOL INJ IM  B/02 AMP. DE 3ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTAFENE", "Tarif de reference": "81.6 DA", "PPA": "N/A", "Num Enregistrement": "380/ 04 B 004 /14", "Code DCI": "04B004", "Forme": "SOL. INJ.", "Dosage": "25MG/ML (75MG/3ML)", "Conditionnement": "B/02 AMP. DE 3ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTAMEX 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " KPMA LABORATOIRES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTAMEX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "400/04B009/16", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTARENE  25MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "VOLTARENE ", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "068/ 04 B 008 /97/11", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "VOLTARENE 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/2725.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2725", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "VOLTARENE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 04 B 009 /97/09", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTARENE 12,5MG 12,5MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medics/921.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "VOLTARENE 12,5MG", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 04 B 043 /10", "Code DCI": "04B043", "Forme": "SUPPO.", "Dosage": "12,5MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTARENE DOLO 12,5MG  COMP ENRO  B/30", "Img": "https://pharmnet-dz.com//img/medics/949.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=949", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC POTASSIQUE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "VOLTARENE DOLO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "267/ 04 B 061 /14", "Code DCI": "04B061", "Forme": "COMP. ENRO.", "Dosage": "12,5MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTARENE EMULGEL 0.01 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medics/1375.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1375", "Laboratoire": " NOVARTIS SANTE FAMILIALE", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "VOLTARENE EMULGEL", "Tarif de reference": "145 DA", "PPA": "N/A", "Num Enregistrement": "267/ 21 A 004 /99/06", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTENAC 0.01 GEL DERM. T/50G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " PHARMAGHREB", "C.Pharmacologique": " ANALGESIQUES ANTIRHUMATISMAUX EXTERNES BAUMES REVULSIFS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTENAC", "Tarif de reference": "145 DA", "PPA": "143.00 DA", "Num Enregistrement": "088/ 21 A 004 /04", "Code DCI": "21A004", "Forme": "GEL DERM.", "Dosage": "0.01", "Conditionnement": "T/50G", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTUM 100MG GLES. A \u00b5GRLES. LP B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTUM", "Tarif de reference": " N/A", "PPA": "180.00 DA", "Num Enregistrement": "035/ 04 B 007 /98/06", "Code DCI": "04B007", "Forme": "GLES. LP", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "VOLTUM 100MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2726", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTUM", "Tarif de reference": "87.6 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 009 /97/08", "Code DCI": "04B009", "Forme": "SUPPO.", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTUM 25MG COMP.GASTRORESIST. B/30", "Img": "https://pharmnet-dz.com//img/medics/2699.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2699", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTUM", "Tarif de reference": "138 DA", "PPA": "N/A", "Num Enregistrement": "035/ 04 B 005 /00/07", "Code DCI": "04B005", "Forme": "COMP. ENRO.", "Dosage": "25MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTUM 25MG SUPPO. ENFANTS B/10", "Img": "https://pharmnet-dz.com//img/medics/2716.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTUM", "Tarif de reference": "56.8 DA", "PPA": "137.00 DA", "Num Enregistrement": "035/ 04 B 008 /09", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOLTUM 50MG COMP. GASTRORESIST. B/30", "Img": "https://pharmnet-dz.com//img/medics/2703.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOLTUM", "Tarif de reference": " N/A", "PPA": "177.00 DA", "Num Enregistrement": "035/ 04 B 006 /00/10", "Code DCI": "04B006", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VOLUVEN 6% 6G / 0,9G / 100ML SOL. PERF. IV POCHE/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1850", "Laboratoire": " FRESENIUS KABI", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " HYDROXYETHYLAMIDON 130 000 / CHLORURE DE SODIUM ", "Pays": "FRANCE", "Nom Commercial": "VOLUVEN 6%", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "332/ 12 K 153 /09", "Code DCI": "12K153", "Forme": "SOL. PERF.", "Dosage": "6G / 0,9G / 100ML", "Conditionnement": "POCHE/500ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "VORICONAZOLE BEKER 200MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4645.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VORICONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VORICONAZOLE BEKER", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "447/13R338/16", "Code DCI": "13R338", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VORICONAZOLE BEKER 50MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/4646.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BEKER LABORATOIRES", "C.Pharmacologique": " ANTIFONGIQUES SYSTEMIQUES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " VORICONAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "VORICONAZOLE BEKER", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "447/13R443/16", "Code DCI": "13R443", "Forme": "COMP. PELLI.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTREX 12,5MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "VOTREX", "Tarif de reference": "63.5 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 043 /06", "Code DCI": "04B043", "Forme": "SUPPO.", "Dosage": "12,5MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTREX 25MG SUPPO. B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "VOTREX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 008 /03/10", "Code DCI": "04B008", "Forme": "SUPPO.", "Dosage": "25MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "VOTREX 50MG COMP. GASTRORESIST. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2704", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "VOTREX", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 006 /97/10", "Code DCI": "04B006", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTREX 50MG SUPPO. B/12", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "VOTREX", "Tarif de reference": "106.2 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 046 /06", "Code DCI": "04B046", "Forme": "SUPPO.", "Dosage": "50MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTREX 75MG COMP. PELLI. LP B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOTREX", "Tarif de reference": "244.4 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 037 /12", "Code DCI": "04B037", "Forme": "GLES. MICROGRLES. LP", "Dosage": "75MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTREX RAPID 50MG COMP. ENRO. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " JAZEERA PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC POTASSIQUE", "Liste": "Liste II", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "VOTREX RAPID", "Tarif de reference": "300 DA", "PPA": "139.00 DA", "Num Enregistrement": "225/ 04 B 063 /12", "Code DCI": "04B063", "Forme": "COMP. ENRO.", "Dosage": "50MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTREX RAPID 50MG/SACHET GRANULES P/SOL. BUV. EN SACHET ADULTE B/10 SACHETS", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC POTASSIUM", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "VOTREX RAPID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 073 /15", "Code DCI": "04B073", "Forme": "GRLES. SOL. BUV.", "Dosage": "50MG/SACHET", "Conditionnement": "B/10 SACHETS", "Commercialisation": true, "Remboursable": null}, {"Nom": "VOTREX RETARD 100MG COMP. PELLI. LP B/10", "Img": "https://pharmnet-dz.com//img/medics/2710.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2710", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " DICLOFENAC SODIQUE", "Liste": "Liste II", "Pays": "JORDANIE", "Nom Commercial": "VOTREX RETARD", "Tarif de reference": "140 DA", "PPA": "N/A", "Num Enregistrement": "001/ 04 B 007 /97/10", "Code DCI": "04B007", "Forme": "GLES. LP", "Dosage": "100MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTRIENT 200MG COMP. PELLI. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medics/1053.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " PAZOPANIB CHLORHYDRATE EXPRIME EN PAZOPANIB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "VOTRIENT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 05 C 166 /14", "Code DCI": "05C166", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "VOTRIENT 400MG  COMP. PELLI. PILULIER/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " PAZOPANIB CHLORHYDRATE EXPRIME EN PAZOPANIB", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "VOTRIENT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 05 C 167 /14", "Code DCI": "05C167", "Forme": "COMP. PELLI.", "Dosage": "400MG ", "Conditionnement": "PILULIER/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "VPRIV 400 U DE VELAGLUCERASE ALFA / FL. DE PDRE. (100U DE VELAGLUCERASE /ML APRES RECONSTITUTION) PDRE. P. SOL. P. PERF. IV B/01 FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medics/3483.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3483", "Laboratoire": " SHIRE HUMAN GENETIC THERAPIES INC (SHIRE HGT)", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " VELAGLUCERASE ALFA", "Liste": "Liste I", "Pays": "ETATS UNIS D'AMERIQUE", "Nom Commercial": "VPRIV", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "493/ 14 N 350 /15", "Code DCI": "14N350", "Forme": "SOL. PERF.", "Dosage": "400 U DE VELAGLUCERASE ALFA / FL. DE PDRE. (100U DE VELAGLUCERASE /ML APRES RECONSTITUTION)", "Conditionnement": "B/01 FL. DE PDRE.", "Commercialisation": true, "Remboursable": true}], "W": [{"Nom": "WARTEC 0.0015 CREME T/5G", "Img": "https://pharmnet-dz.com//img/medics/486.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=486", "Laboratoire": " STIEFEL", "C.Pharmacologique": " ANTIMITOTIQUES LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " PODOPHYLLOTOXINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "WARTEC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "125/ 07 F 155 /07", "Code DCI": "07F155", "Forme": "CR\u00c8ME", "Dosage": "0.0015", "Conditionnement": "T/5G", "Commercialisation": true, "Remboursable": true}, {"Nom": "WAZTORON 20MG COMP. PELLI. B/60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " VASODILATATEURS & ANTI-ISCHEMIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " TRIMETAZIDINE DICHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "WAZTORON", "Tarif de reference": "390 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 J 107 /10", "Code DCI": "06J107", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "WI PACK FL/500ML  FL/500ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " EAU POUR PREPARATION INJECTABLE IM/IV", "Pays": "ALGERIE", "Nom Commercial": "WI PACK", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "280/ 14 G 042 /13", "Code DCI": "14G042", "Forme": "\u2026", "Dosage": "FL/500ML", "Conditionnement": "FL/500ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "WILFACTIN  1000 UI/ 10 ML  POUDRE ET SOLVANT POUR SOLUTION INJECTABLE IV B/ 01 FLACON DE POUDRE DE 10 G + 01 FLACON DE SOL DE 10ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " N/D", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "WILFACTIN ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "513/12J181/16", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "1000 UI/ 10 ML ", "Conditionnement": "B/ 01 FLACON DE POUDRE DE 10 G + 01 FLACON DE SOL DE 10ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "WINEX 100MG/5ML** PDRE. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "WINEX", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 198 /09", "Code DCI": "13B198", "Forme": "PDRE. SUSP. BUV.", "Dosage": "100MG/5ML**", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "WINEX 200MG GLES. B/08", "Img": "https://pharmnet-dz.com//img/medics/699.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=699", "Laboratoire": " TABUK ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME TRIHYDRATE EXPRIME EN CEFIXIME ANHYDRE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "WINEX", "Tarif de reference": "960.53 DA", "PPA": "N/A", "Num Enregistrement": "173/ 13 B 201 /07", "Code DCI": "13B201", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/08", "Commercialisation": true, "Remboursable": true}, {"Nom": "WINEX 400MG GLES. B/06", "Img": "https://pharmnet-dz.com//img/medics/739.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=739", "Laboratoire": " TABUK ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFIXIME", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "WINEX", "Tarif de reference": "1074 DA", "PPA": "1560.00 DA", "Num Enregistrement": "173/ 13 B 294 /07", "Code DCI": "13B294", "Forme": "GLES.", "Dosage": "400MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "WIPACK AMPOULE DE 10 ML  SOLUTION POUR DILUTION DE M\u00e9DICAMENT DESTIN\u00e9S A ETRE INJECT\u00e9S EN IM /IV  B/50 AMP, DE 10ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "WIPACK", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "280/14G186/15", "Code DCI": "14G186", "Forme": "SOL. INJ.", "Dosage": "AMPOULE DE 10 ML ", "Conditionnement": "B/50 AMP, DE 10ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "WIPACK AMPOULE DE 5 ML  SOLUTION POUR DILUTION DE M\u00e9DICAMENT DESTIN\u00e9S A ETRE INJECT\u00e9S EN IM /IV  B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " IMC ( INDUSTRIE MEDICO-CHIRURGICALES)  ", "C.Pharmacologique": " ELEMENTS MINERAUX & EQUILIBRE HYDRO-ELECTROLYTIQUE", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " N/D", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "WIPACK", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "280/14G185/15", "Code DCI": "14G185", "Forme": "SOL. INJ.", "Dosage": "AMPOULE DE 5 ML ", "Conditionnement": "B/50", "Commercialisation": true, "Remboursable": null}, {"Nom": "WORMAZOL 100MG COMP. A CROQUER B/6", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " TABUK", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " MEBENDAZOLE", "Liste": "Liste II", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "WORMAZOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "173/ 19 B 006 /98 ", "Code DCI": "19B006", "Forme": "COMP. A CROQ.", "Dosage": "100MG", "Conditionnement": "B/6", "Commercialisation": true, "Remboursable": true}, {"Nom": "WORMAZOL 100MG/5ML SUSP.BUV. FL/30ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=2056", "Laboratoire": " TABUK", "C.Pharmacologique": " ANTI-HELMINTIQUES", "C.Therapeutique": " PARASITOLOGIE", "Info": " MEBENDAZOLE", "Liste": "Liste II", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "WORMAZOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "173/ 19 B 007 /98", "Code DCI": "19B007", "Forme": "SUSP. BUV.", "Dosage": "100MG/5ML", "Conditionnement": "FL/30ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "WYSERIN  30MG MICRO-GRANUL. EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "WYSERIN ", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "286/16A106/16", "Code DCI": "16A106", "Forme": "MICROGRANULES", "Dosage": "30MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "WYSERIN  60MG  MICRO-GRANUL. EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " DULOXETINE CHLORHYDRATE EXPRIME EN DULOXETINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "WYSERIN ", "Tarif de reference": "390.9 DA", "PPA": "N/A", "Num Enregistrement": "286/16A107/16", "Code DCI": "16A107", "Forme": "MICROGRANULES", "Dosage": "60MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}], "X": [{"Nom": "XALACOM 50\u03bcG/5MG/ML (0,005%/0,5%) COLLYRE FL./2,5ML", "Img": "https://pharmnet-dz.com//img/medics/2370.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2370", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " LATANOPROST / TIMOLOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "XALACOM", "Tarif de reference": "0 DA", "PPA": "1456.00 DA", "Num Enregistrement": "045/ 17 C 162 /14", "Code DCI": "17C162", "Forme": "COLLY.", "Dosage": "50\u03bcG/5MG/ML (0,005%/0,5%)", "Conditionnement": "FL./2,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XALATAN 50\u00b5G/ML (0,005%) COLLY. F/2,5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " PHARMACIA UPJOHN", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " LATANOPROST", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "XALATAN", "Tarif de reference": "0 DA", "PPA": "1321.00 DA", "Num Enregistrement": "076/ 17 C 127 /01", "Code DCI": "17C127", "Forme": "COLLY. SOL.", "Dosage": "50\u00b5G/ML (0,005%)", "Conditionnement": "F/2,5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XALDOL 325MG / 37,5MG GELULE B/20 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4612", "Laboratoire": " PHARMIDAL", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Pays": "ALGERIE", "Nom Commercial": "XALDOL", "Tarif de reference": "0 DA", "PPA": "N/A", "Code DCI": "03F115", "Forme": "GLES.", "Dosage": "325MG / 37,5MG", "Conditionnement": "BT/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "XAMADOL 325MG / 37,5MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2686.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2686", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " PARACETAMOL / TRAMADOL CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "XAMADOL", "Tarif de reference": "193.6 DA", "PPA": "N/A", "Num Enregistrement": "263/ 03 F 115 /10", "Code DCI": "03F115", "Forme": "COMP. SEC.", "Dosage": "325MG / 37,5MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "XARELTO 10MG COMP. PELLI. B/05 - B/10 - B/30 - B/100", "Img": "https://pharmnet-dz.com//img/medics/1818.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1818", "Laboratoire": " BAYER", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "XARELTO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 12 F 159 /09", "Code DCI": "12F159", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/05 - B/10 - B/30 - B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "XARELTO 15MG COMP. PELLI. B/14 - B/42 - B/100", "Img": "https://pharmnet-dz.com//img/medics/1819.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1819", "Laboratoire": " BAYER", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "XARELTO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 12 F 167 /13", "Code DCI": "12F167", "Forme": "COMP. PELLI.", "Dosage": "15MG", "Conditionnement": "B/14 - B/42 - B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "XARELTO 20MG COMP. PELLI. B/28 - B/100", "Img": "https://pharmnet-dz.com//img/medics/1820.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1820", "Laboratoire": " BAYER", "C.Pharmacologique": " THROMBOLYTIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " RIVAROXABAN", "Liste": "Liste I", "Pays": "ALLEMAGNE", "Nom Commercial": "XARELTO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "424/ 12 F 168 /13", "Code DCI": "12F168", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/28 - B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "XARIA 200MG COMP PELL B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " CPCM", "C.Pharmacologique": " ANTIRHUMATISMAUX DIVERS", "C.Therapeutique": " RHUMATOLOGIE", "Info": " HYDROXYCHLOROQUINE", "Pays": "ALGERIE", "Nom Commercial": "XARIA", "Tarif de reference": "- DA", "PPA": " DA", "Code DCI": "21D020", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "XATRAL LP 5MG COMP. PELLI. LP B/56", "Img": "https://pharmnet-dz.com//img/medics/1158.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1158", "Laboratoire": " SANOFI AVENTIS  ", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " ALFUZOSINE CHLORHYDRATE", "Pays": "FRANCE", "Nom Commercial": "XATRAL LP", "Tarif de reference": "0 DA", "PPA": "1813.00 DA", "Num Enregistrement": "376/ 25 B 022 /98/10", "Code DCI": "25B022", "Forme": "COMP. PELLI. LP", "Dosage": "5MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "XAVEL 1% (OU 10MG/ML) SOL. BUV. GTTES. B/1FL. COMPT. GTTES DE 20ML", "Img": "https://pharmnet-dz.com//img/medics/2605.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2605", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANXIOLYTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " DIAZEPAM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "XAVEL", "Tarif de reference": "0 DA", "PPA": "200.00 DA", "Num Enregistrement": "235/ 16 B 029 /10", "Code DCI": "16B029", "Forme": "SOL. BUV. GTTES.", "Dosage": "1% (OU 10MG/ML)", "Conditionnement": "B/1FL. COMPT. GTTES DE 20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XEFURYL 200MG GLES. B/28", "Img": "https://pharmnet-dz.com//img/medics/3930.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3930", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " ANTISEPTIQUES & ANTI-INFECTIEUX INTESTINAUX", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " NIFUROXAZIDE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "XEFURYL", "Tarif de reference": "172.76 DA", "PPA": "185.00 DA", "Num Enregistrement": "235/ 10 C 017 /08", "Code DCI": "10C017", "Forme": "GLES.", "Dosage": "200MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "XELODA 500MG COMP. PELLI. B/120", "Img": "https://pharmnet-dz.com//img/medics/10.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=10", "Laboratoire": " ROCHE", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " CAPECITABINE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "XELODA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "128/ 05 G 108 /05", "Code DCI": "05G108", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/120", "Commercialisation": true, "Remboursable": true}, {"Nom": "XENETIX I=300MG/ML SOL. INJ. INTRA-VASC. ET INTRA-CAVITAIRE FL./50ML ET FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/585.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=585", "Laboratoire": " GUERBET", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOBITRIDOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "XENETIX", "Tarif de reference": "0 DA", "PPA": "3218.00 DA", "Num Enregistrement": "168/ 08 C 061 /00/15", "Code DCI": "08C061", "Forme": "SOL. INJ.", "Dosage": "I=300MG/ML", "Conditionnement": "FL./50ML ET FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XENETIX I=350MG/ML SOL. INJ. INTRA-VASC. ET INTRA-CAVITAIRE FL./50ML ET FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/586.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=586", "Laboratoire": " GUERBET", "C.Pharmacologique": " OPACIFIANTS IODES A ELIMINATION RENALE", "C.Therapeutique": " DIAGNOSTIC", "Info": " IOBITRIDOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "XENETIX", "Tarif de reference": "3464.7 DA", "PPA": " DA", "Num Enregistrement": "168/ 08 C 062 /00/15", "Code DCI": "08C062", "Forme": "SOL. INJ.", "Dosage": "I=350MG/ML", "Conditionnement": "FL./50ML ET FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XGEVA 70MG/ML (120MG/1,7ML) SOL. INJ. SC B/01 FL. USAGE UNIQUE 1,7ML", "Img": "https://pharmnet-dz.com//img/medics/1087.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1087", "Laboratoire": " AMGEN EUROPE B.V.", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " DENOSUMAB", "Liste": "Liste I", "Pays": "PAYS BAS", "Nom Commercial": "XGEVA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "481/ 05 F 176 /15", "Code DCI": "05F176", "Forme": "SOL. INJ.", "Dosage": "70MG/ML (120MG/1,7ML)", "Conditionnement": "B/01 FL. USAGE UNIQUE 1,7ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XILONIBSA 0.02 SOL.INJ. B/100CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4084.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " INIBSA S.A.", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE CHLORHYDRATE / ADRENALINE", "Liste": "Liste I", "Pays": "ESPAGNE", "Nom Commercial": "XILONIBSA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "299/ 02 C 022 /04", "Code DCI": "02C022", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/100CART. DE 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XIMALEX 20 000 U CEIP/100ML SIROP FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/966.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=961", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ENZYMES A VISEE ANTI-INFLAMMAT.& ANTI-OEDEMATEUSE", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " ALPHA-AMYLASE", "Pays": "ALGERIE", "Nom Commercial": "XIMALEX", "Tarif de reference": "0 DA", "PPA": "160.00 DA", "Num Enregistrement": "003/ 04 C 027 /10", "Code DCI": "04C027", "Forme": "SIROP", "Dosage": "20 000 U CEIP/100ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": false}, {"Nom": "XINECOR 0,05MG/ML SOL. BUV. FL./50ML + PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " GENCOPHARM", "C.Pharmacologique": " CARDIOTONIQUES & CARDIO-ACCELERATEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DIGOXINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "XINECOR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "455/ 06 G 080 /99/15", "Code DCI": "06G080", "Forme": "SOL. BUV.", "Dosage": "0,05MG/ML", "Conditionnement": "FL./50ML + PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "XOLA JAM 2% (20MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "XOLA JAM", "Tarif de reference": "0 DA", "PPA": "605.00 DA", "Num Enregistrement": "386/ 17 C 121 /09", "Code DCI": "17C121", "Forme": "COLLY. SOL.", "Dosage": "2% (20MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XOLAIR 150MG/FL POUDRE ET SOLVANT POUR PREPARATION INJECTABLE S/C B/01 FLACON DE  POUDRE DE 5ML ET SOLV 2ML ", "Img": "https://pharmnet-dz.com//img/medics/4445.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4445", "Laboratoire": " NOVARTIS  S.A.S", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "XOLAIR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/20A246/16", "Code DCI": "N/D", "Forme": "PDRE. SOL. INJ.", "Dosage": "150MG/FL", "Conditionnement": "B/01 FLACON DE  POUDRE DE 5ML ET SOLV 2ML ", "Commercialisation": true, "Remboursable": true}, {"Nom": "XOLAMOL 20MG/5MG/ML COLLY.EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medics/2367.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2367", "Laboratoire": " JAMJOOM PHARMACEUTICAL INDUSTRY", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "XOLAMOL", "Tarif de reference": "753.4 DA", "PPA": "N/A", "Num Enregistrement": "386/ 17 C 141 /09", "Code DCI": "17C141", "Forme": "COLLY. SOL.", "Dosage": "20MG/5MG/ML", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XP MAXAMAID  PDRE.P. ENFANT AGE DE 1AN A 8ANS. B/500G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NUTRICIA NUTRITION CLINIQUE", "C.Pharmacologique": " LAITS & FARINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LAIT SANS PHENYLALANINE", "Pays": "FRANCE", "Nom Commercial": "XP MAXAMAID", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "288/ 14 L 343 /13", "Code DCI": "14L343", "Forme": "PDRE.", "Conditionnement": "B/500G", "Commercialisation": true, "Remboursable": null}, {"Nom": "XP MAXAMUM  PDRE. P ENFANTS DES 8ANS, ADOLESCENTS ET ADULTES DONT LES FEMMES ENCEINTES B/500G", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " NUTRICIA NUTRITION CLINIQUE", "C.Pharmacologique": " LAITS & FARINES", "C.Therapeutique": " METABOLISME NUTRITION DIABETE", "Info": " LAIT SANS PHENYLALANINE", "Pays": "FRANCE", "Nom Commercial": "XP MAXAMUM", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "288/ 14 L 344 /13", "Code DCI": "14L344", "Forme": "PDRE.", "Conditionnement": "B/500G", "Commercialisation": true, "Remboursable": null}, {"Nom": "XYCARE 5 MG COMP. PELLI. B/14 ET B/28", "Img": "https://pharmnet-dz.com//img/medics/4240.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4240", "Laboratoire": " BIOCARE LABORATOIRES", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " N/D", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "XYCARE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "293/01A054/15", "Code DCI": "N/D", "Forme": "COMP. PELLI.", "Dosage": "5 MG", "Conditionnement": "B/14 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYDOL 200MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/907.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=907", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "XYDOL", "Tarif de reference": "120 DA", "PPA": "N/A", "Num Enregistrement": "268/ 04 B 040 /05/12", "Code DCI": "04B040", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYDOL 400MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2733.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2733", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "XYDOL", "Tarif de reference": "157 DA", "PPA": "N/A", "Num Enregistrement": "268/ 04 B 010 /12", "Code DCI": "04B010", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYDOL 600MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/929.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=929", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " IBUPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "XYDOL", "Tarif de reference": "235.5 DA", "PPA": "N/A", "Num Enregistrement": "268/ 04 B 044 /15", "Code DCI": "04B044", "Forme": "COMP. PELLI.", "Dosage": "600MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYDOL GYN 100MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/2805.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2805", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-INFLAMMATOIRES NON STEROIDIENS", "C.Therapeutique": " ANTI-INFLAMMATOIRES", "Info": " FLURBIPROFENE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "XYDOL GYN", "Tarif de reference": "179.2 DA", "PPA": "N/A", "Num Enregistrement": "268/ 04 B 033 /15", "Code DCI": "04B033", "Forme": "COMP. PELLI.", "Dosage": "100MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYDOL RHUME 200MG/30MG COMP. PELLI. B/20", "Img": "https://pharmnet-dz.com//img/medics/1472.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1472", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTICORYZA PAR VOIE GENERALE", "C.Therapeutique": " RHINOLOGIE", "Info": " IBUPROFENE / PSEUDOEPHEDRINE CHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "XYDOL RHUME", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "268/ 22 A 043 /13", "Code DCI": "22A043", "Forme": "COMP. PELLI.", "Dosage": "200MG/30MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYLOCAINE 0.01 SOL.INJ. FL/20ML", "Img": "https://pharmnet-dz.com//img/medics/4074.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4074", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "XYLOCAINE", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "036/ 02 C 018 /98", "Code DCI": "02C018", "Forme": "SOL. INJ.", "Dosage": "0.01", "Conditionnement": "FL/20ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYLOCAINE 0.02 SOL.INJ. FL/20ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "XYLOCAINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "036/ 02 C 019 /98", "Code DCI": "02C019", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "FL/20ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "XYLOCAINE NAPHAZOLINE 5% / 0,02% SOL.NON.INJ. FL/24ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE/NAPHAZOLINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "XYLOCAINE NAPHAZOLINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "036/ 02 C 025 /98", "Code DCI": "02C025", "Forme": "SOL. NON. INJ.", "Dosage": "5% / 0,02%", "Conditionnement": "FL/24ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "XYLOCAINE VISQUEUSE 0.02 GEL ORAL T/100G", "Img": "https://pharmnet-dz.com//img/medics/4088.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4088", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE VISQUEUSE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "XYLOCAINE VISQUEUSE", "Tarif de reference": "0 DA", "PPA": "248.00 DA", "Num Enregistrement": "036/ 02 C 027 /98", "Code DCI": "02C027", "Forme": "GEL", "Dosage": "0.02", "Conditionnement": "T/100G", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYLOCONTACT 7,48G/100G CREME P. USAGE DENTAIRE T/15G", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " PRODUITS DENTAIRES PIERRE ROLLAND", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "XYLOCONTACT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "246/ 02 C 052 /01", "Code DCI": "02C052", "Forme": "CR\u00c8ME", "Dosage": "7,48G/100G", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "XYLONOR 1,8ML CARPULE B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medics/4085.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " SEPTODENT", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE/NORADRENALINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "XYLONOR", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "044/ 02 C 024 /98", "Code DCI": "02C024", "Forme": "CARPULE", "Dosage": "1,8ML", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "XYLOROLLAND AVEC NORADRENALINE 2G/0,00125G/100ML SOL. INJ. B/50CART. DE 1,8ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " PRODUITS DENTAIRES PIERRE ROLLAND", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE CHLORHYDRATE/NORADRENALINE TARTRATE ", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "XYLOROLLAND AVEC NORADRENALINE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "246/ 02 C 051 /01", "Code DCI": "02C051", "Forme": "SOL. INJ.", "Dosage": "2G/0,00125G/100ML", "Conditionnement": "B/50CART. DE 1,8ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "XYLOROLLAND SANS VASOCONTRICTEUR 0.02 SOL.INJ. B/50CART DE 1.8ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4103", "Laboratoire": " PRODUITS DENTAIRES PIERRE ROLLAND", "C.Pharmacologique": " ANESTHESIQUES LOCAUX ET REGIONAUX", "C.Therapeutique": " ANESTHESIOLOGIE", "Info": " LIDOCAINE  CHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "XYLOROLLAND SANS VASOCONTRICTEUR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "246/ 02 C 019 /02", "Code DCI": "02C019", "Forme": "SOL. INJ.", "Dosage": "0.02", "Conditionnement": "B/50CART DE 1.8ML", "Commercialisation": true, "Remboursable": null}], "Y": [{"Nom": "YRICAL 150MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "YRICAL", "Tarif de reference": "4015,2 DA", "PPA": "N/A", "Code DCI": "15A068", "Forme": "GLES.", "Dosage": "150MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}, {"Nom": "YRICAL 50MG GLES. B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " NEOMEDIC", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " PREGABALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "YRICAL", "Tarif de reference": "1866,48 DA", "PPA": "N/A", "Code DCI": "15A066", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": true}], "Z": [{"Nom": "ZADITEN 1MG/5ML SIROP SANS ALCOOL B/1FL. DE 150ML + UNE CUILLERE. MESURE DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/2072.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2072", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " BRONCHODILATATEURS & ANTI-ASTHMATIQUES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " KETOTIFENE", "Liste": "Liste II", "Pays": "SUISSE", "Nom Commercial": "ZADITEN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "068/ 20 A 013 /97/12", "Code DCI": "20A013", "Forme": "SOL. BUV.", "Dosage": "1MG/5ML", "Conditionnement": "B/1FL. DE 150ML + UNE CUILLERE. MESURE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZALAXAN LP 120MG \u00b5GRLES. EN GLES. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZALAXAN LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 B 141 /11", "Code DCI": "06B141", "Forme": "GLES. LP", "Dosage": "120MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZALAXAN LP 180MG \u00b5GRLES. EN GLES. LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZALAXAN LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 B 142 /11", "Code DCI": "06B142", "Forme": "GLES. LP", "Dosage": "180MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZALAXAN LP 300MG 300MG MICROGLES. LP EN GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZALAXAN LP 300MG", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "003/ 06 B 010 /12", "Code DCI": "06B010", "Forme": "COMP. LP", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZALAXAN LP 90MG GLES. A \u00b5GRLES LP B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTAGONISTES CALCIQUES", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " DILTIAZEM CHLORHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZALAXAN LP", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "003/ 06 B 140 /11", "Code DCI": "06B140", "Forme": "GLES. LP", "Dosage": "90MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZALERG 0,25MG/ML COLLYRE EN SOL. SANS CONSERVATEUR B/1FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/2348.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2348", "Laboratoire": " THEA", "C.Pharmacologique": " ANTI-ALLERGIQUES LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " KETOTIFENE HYDROGENOFUMARATE EXPRIME EN KETOTIFENE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ZALERG", "Tarif de reference": "0 DA", "PPA": "652.00 DA", "Num Enregistrement": "022/ 17 B 171 /13", "Code DCI": "17B171", "Forme": "COLLY. SOL.", "Dosage": "0,25MG/ML", "Conditionnement": "B/1FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZANIDIP 10MG COMP PELL SEC B/28", "Img": "https://pharmnet-dz.com//img/medics/3102.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3102", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " LERCANIDIPINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZANIDIP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "269/ 06 E 168 /01", "Code DCI": "06E168", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZANITRA 5MG COMP. B/60", "Img": "https://pharmnet-dz.com//img/medics/1751.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1751", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ZANITRA", "Tarif de reference": "170 DA", "PPA": "170 DA", "Num Enregistrement": "003/ 12 E 020 /97/09", "Code DCI": "12E020", "Forme": "COMP.", "Dosage": "5MG", "Conditionnement": "B/60", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZANITRA PLUS 49,297MG/0,50MG  GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/1791.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1791", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTI-ANEMIQUES", "C.Therapeutique": " HEMATOLOGIE ET HEMOSTASE", "Info": " SULFATE FERREUX EXPRIME EN FER FERREUX / ACIDE FOLIQUE", "Pays": "ALGERIE", "Nom Commercial": "ZANITRA PLUS", "Tarif de reference": "253.2 DA", "PPA": "253.2 DA", "Num Enregistrement": "003/ 12 E 125 /07", "Code DCI": "12E125", "Forme": "GLES.", "Dosage": "49,297MG/0,50MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZANOCIN 200MG COMP. B/10", "Img": "https://pharmnet-dz.com//img/medics/357.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " RANBAXY", "C.Pharmacologique": " QUINOLONES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " OFLOXACINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZANOCIN", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "216/ 13 K 086 /01", "Code DCI": "13K086", "Forme": "COMP. PELLI.", "Dosage": "200MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZANURIC 100MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ZANURIC", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "166/ 21 B 007 /98", "Code DCI": "21B007", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZANURIC 300MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " RAM PHARMACEUTICAL INDUSTRIES", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ZANURIC", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "166/ 21 B 008 /98/15", "Code DCI": "21B008", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZECLAR 125MG/5ML GRLES. SUSP. BUV. FL./100ML", "Img": "https://pharmnet-dz.com//img/medics/849.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=849", "Laboratoire": " ABBOTT", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZECLAR", "Tarif de reference": "777.92 DA", "PPA": "N/A", "Num Enregistrement": "147/ 13 E 323 /08", "Code DCI": "13E323", "Forme": "GRLES. SOL. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL./100ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZECLAR 250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/827.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=827", "Laboratoire": " ABBOTT", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZECLAR", "Tarif de reference": "200 DA", "PPA": "N/A", "Num Enregistrement": "147/ 13 E 244 /01/13", "Code DCI": "13E244", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZECLAR 250MG/5ML GRLES. SUSP. BUV. FL./60ML", "Img": "https://pharmnet-dz.com//img/medics/832.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=832", "Laboratoire": " ABBOTT", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZECLAR", "Tarif de reference": "793.95 DA", "PPA": "N/A", "Num Enregistrement": "147/ 13 E 297 /08", "Code DCI": "13E297", "Forme": "GRLES. SOL. BUV.", "Dosage": "250MG/5ML", "Conditionnement": "FL./60ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZECLAR 500MG COMP. B/14", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=820", "Laboratoire": " ABBOTT", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CLARITHROMYCINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZECLAR", "Tarif de reference": "574 DA", "PPA": "1886.00 DA", "Num Enregistrement": "147/ 13 E 215 /00", "Code DCI": "13E215", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZECUF AVEC SUCRE 100MG / 60MG / 50MG / 10MG / 60MG / 20MG / 20MG / 10MG / 20MG / 50MG / 06MG par 10ML SIROP A BASE  DE ONZE PLANTES MEDICINALES FL/120ML", "Img": "https://pharmnet-dz.com//img/medics/1273.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " OCIMUM SANCTUM / GLYCERRHIZA GLABRA / CURCUMA LONGA / ZINGIBER OFFICINAL / ADHATODA VASICA / SOLANUM INDICUM / INULA RACEMOSA  / PIPER CUBEBA / TERMINALIA BELERICA / ALOE BARBADENSIS / MENTHOL.", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZECUF AVEC SUCRE", "Tarif de reference": " N/A", "PPA": "203.00 DA", "Num Enregistrement": "263/ 20 C 099 /03/09", "Code DCI": "20C099", "Forme": "SIROP", "Dosage": "100MG / 60MG / 50MG / 10MG / 60MG / 20MG / 20MG / 10MG / 20MG / 50MG / 06MG par 10ML", "Conditionnement": "FL/120ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZECUF SANS SUCRE 100MG / 60MG / 50MG / 10MG / 60MG / 20MG / 20MG / 10MG / 20MG / 50MG / 06MG PAR 10ML SIROP A BASE  DE ONZE PLANTES MEDICINALES F/120ML", "Img": "https://pharmnet-dz.com//img/medics/1274.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " ANTITUSSIFS NON OPIACES", "C.Therapeutique": " PNEUMOLOGIE", "Info": " OCIMUM SANCTUM / GLYCERRHIZA GLABRA / CURCUMA LONGA / ZINGIBER OFFICINAL / ADHATODA VASICA / SOLANUM INDICUM / INULA RACEMOSA  / PIPER CUBEBA / TERMINALIA BELERICA / ALOE BARBADENSIS / MENTHOL.", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZECUF SANS SUCRE", "Tarif de reference": " N/A", "PPA": "203.00 DA", "Num Enregistrement": "263/ 20 C 099 /09", "Code DCI": "20C099", "Forme": "SIROP", "Dosage": "100MG / 60MG / 50MG / 10MG / 60MG / 20MG / 20MG / 10MG / 20MG / 50MG / 06MG PAR 10ML", "Conditionnement": "F/120ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZECYTE 100MG/ML SOL. INJ. IV B/1FL. DE 1ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " CYTARABINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZECYTE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 05 G 156 /13", "Code DCI": "05G156", "Forme": "SOL. INJ.", "Dosage": "100MG/ML", "Conditionnement": "B/1FL. DE 1ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZEEFRA GE 500MG GLES. B/12", "Img": "https://pharmnet-dz.com//img/medics/685.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=685", "Laboratoire": " BOUCHARA-RECORDATI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFRADINE", "Pays": "FRANCE", "Nom Commercial": "ZEEFRA GE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "269/ 13 B 193 /99", "Code DCI": "13B193", "Forme": "GLES.", "Dosage": "500MG", "Conditionnement": "B/12", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZELDOX 20MG/FL. DE PDRE.** (20MG/ML APRES RECONSTITUTION) PDRE. ET SOLVT. SOL. INJ. IM B/01FL. DE PDRE. + 01AMP. DE 1,2ML DE SOLVT.", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ZIPRASIDONE** (SOUS FORME DE MESYLATE)", "Pays": "ALLEMAGNE", "Nom Commercial": "ZELDOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "045/ 16 D 137 /09", "Code DCI": "16D137", "Forme": "PDRE. SUSP. INJ", "Dosage": "20MG/FL. DE PDRE.** (20MG/ML APRES RECONSTITUTION)", "Conditionnement": "B/01FL. DE PDRE. + 01AMP. DE 1,2ML DE SOLVT.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZELDOX 40MG** GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PFIZER GMBH", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ZIPRASIDONE** (SOUS FORME DE CHLORHYDRATE MONOHYDRATE)", "Pays": "ALLEMAGNE", "Nom Commercial": "ZELDOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "045/ 16 D 138 /09", "Code DCI": "16D138", "Forme": "GLES.", "Dosage": "40MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZELDOX 60MG** GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PFIZER GMBH", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ZIPRASIDONE** (SOUS FORME DE CHLORHYDRATE MONOHYDRATE)", "Pays": "ALLEMAGNE", "Nom Commercial": "ZELDOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "045/ 16 D 139 /09", "Code DCI": "16D139", "Forme": "GLES.", "Dosage": "60MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZELDOX 80MG** GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PFIZER GMBH", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ZIPRASIDONE** (SOUS FORME DE CHLORHYDRATE MONOHYDRATE)", "Pays": "ALLEMAGNE", "Nom Commercial": "ZELDOX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "045/ 16 D 140 /09", "Code DCI": "16D140", "Forme": "GLES.", "Dosage": "80MG**", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZEPILEN 1G/FL. DE PDRE. PDRE.SOL.INJ. IM B/1+1", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MEDOCHEMIE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFAZOLINE", "Liste": "Liste I", "Pays": "CHYPRE", "Nom Commercial": "ZEPILEN", "Tarif de reference": "181 DA", "PPA": "194.00 DA", "Num Enregistrement": "178/ 13 B 013 /99", "Code DCI": "13B013", "Forme": "PDRE. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1+1", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZEPTOL 200MG COMP. B/50 ET B/100", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "INDE", "Nom Commercial": "ZEPTOL", "Tarif de reference": "435 DA", "PPA": "N/A", "Num Enregistrement": "330/ 15 A 004 /07", "Code DCI": "15A004", "Forme": "COMP.", "Dosage": "200MG", "Conditionnement": "B/50 ET B/100", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZEPTOL CR 400 400MG COMP. LP B/30 ET B/50", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=5882", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " ANTI-EPILEPTIQUES & ANTI-CONVULSIVANTS", "C.Therapeutique": " NEUROLOGIE", "Info": " CARBAMAZEPINE", "Liste": "Liste II", "Pays": "INDE", "Nom Commercial": "ZEPTOL CR 400", "Tarif de reference": "605 DA", "PPA": "N/A", "Num Enregistrement": "330/ 15 A 036 /05", "Code DCI": "15A036", "Forme": "COMP. PELLI.", "Dosage": "400MG", "Conditionnement": "B/30 ET B/50", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZERIT 30MG GLES  B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " STAVUDINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ZERIT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 13 P 272 /05", "Code DCI": "13P272", "Forme": "GLES.", "Dosage": "30MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZERIT 40MG GLES  B/56", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " BRISTOL MYERS SQUIBB", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " STAVUDINE", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ZERIT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "017/ 13 P 273 /05", "Code DCI": "13P273", "Forme": "GLES.", "Dosage": "40MG", "Conditionnement": "B/56", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZETA 0.02 CREME DERM. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1677.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1677", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZETA", "Tarif de reference": "166.65 DA", "PPA": "N/A", "Num Enregistrement": "352/ 07 C 017 /06", "Code DCI": "07C017", "Forme": "CR\u00c8ME", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZETA 0.02 PDE. T/15G", "Img": "https://pharmnet-dz.com//img/medics/1673.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1673", "Laboratoire": " EL KENDI", "C.Pharmacologique": " ANTI-BACTERIENS LOCAUX", "C.Therapeutique": " DERMATOLOGIE", "Info": " ACIDE FUSIDIQUE SOUS FORME DE FUSIDATE DE SODIUM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZETA", "Tarif de reference": "135.13 DA", "PPA": "N/A", "Num Enregistrement": "352/ 07 C 016 /06", "Code DCI": "07C016", "Forme": "PDE. DERM.", "Dosage": "0.02", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZETA-CORT 0,1%/2% CREME T/15G", "Img": "https://pharmnet-dz.com//img/medics/522.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=522", "Laboratoire": " EL KENDI", "C.Pharmacologique": " DERMOCORTICOIDES", "C.Therapeutique": " DERMATOLOGIE", "Info": " BETAMETHASONE VALERATE EXPRIME EN BETAMETHASONE / ACIDE FUSIDIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZETA-CORT", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 07 H 169 /09", "Code DCI": "07H169", "Forme": "CR\u00c8ME", "Dosage": "0,1%/2%", "Conditionnement": "T/15G", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZETIREC 10MG/ML SOL. BUV. GTTES. B/01FL COMPTE GTTES DE 15ML", "Img": "https://pharmnet-dz.com//img/medics/4024.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4024", "Laboratoire": " UPC (UNION PHARMACEUTIQUE CONSTANTINOISE)", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ZETIREC", "Tarif de reference": "240.15 DA", "PPA": "545.00 DA", "Num Enregistrement": "285/ 01 A 041 /13", "Code DCI": "01A041", "Forme": "SOL. BUV. GTTES.", "Dosage": "10MG/ML", "Conditionnement": "B/01FL COMPTE GTTES DE 15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZETRON 250MG GLES. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZETRON", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "352/13E176/06/15", "Code DCI": "13E176", "Forme": "GLES.", "Dosage": "250MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZETRON 500MG COMP. PELLI. B/03", "Img": "https://pharmnet-dz.com//img/medics/838.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZETRON", "Tarif de reference": " N/A", "PPA": "552.00 DA", "Num Enregistrement": "352/ 13 E 299 /15", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZEXIL 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZEXIL", "Tarif de reference": "1290 DA", "PPA": "992.00 DA", "Num Enregistrement": "035/ 16 A 099 /11", "Code DCI": "16A099", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZIBRAT 150MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZIBRAT", "Tarif de reference": "1290 DA", "PPA": "1280.00 DA", "Num Enregistrement": "470/ 06 E 156 /12", "Code DCI": "06E156", "Forme": "COMP. PELLI.", "Dosage": "150MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZIBRAT 300MG COMP. PELLI. B/30 ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=93", "Laboratoire": " MM LABORATOIRES", "C.Pharmacologique": " ANTI-HYPERTENSEURS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " IRBESARTAN", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZIBRAT", "Tarif de reference": "1290 DA", "PPA": "1290.00 DA", "Num Enregistrement": "470/ 06 E 157 /12", "Code DCI": "06E157", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": "B/30 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZIDIME 1G/FL. DE PDRE. PDRE. SOL. INJ. IM/IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTAZIDIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZIDIME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 213 /01/09", "Code DCI": "13B213", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZIDIME 2G** PDRE. SOL. INJ. IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFTAZIDIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZIDIME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 295 /08", "Code DCI": "13B295", "Forme": "PDRE. SOL. INJ.", "Dosage": "2G**", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZIDOHOPE 300 300 MG COMP. PELLI  PILLULIER DE 60", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " ANTIVIRAUX", "C.Pharmacologique": " INFECTIOLOGIE", "C.Therapeutique": " ZIDOVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZIDOHOPE 300", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "508/13P288/16", "Code DCI": "13P288", "Forme": "COMP. PELLI.", "Dosage": "300 MG", "Conditionnement": "PILLULIER DE 60", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZIDONE OS  10MG/ML (50MG/5ML) SOL BUV  B/1FL 240 ML + SERINGUE DOSEUSE DE 10 ML + PIPETTE DOSEUSE DE 1,5 ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " MSD SP LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ZIDOVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZIDONE OS ", "Tarif de reference": "-- DA", "PPA": " DA", "Num Enregistrement": "524/13P274/17", "Code DCI": "13P274", "Forme": "SOL. BUV.", "Dosage": "10MG/ML ", "Conditionnement": "FL 240 ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZIDOVIR 100MG GLES. B/100", "Img": "https://pharmnet-dz.com//img/medics/431.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ZIDOVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZIDOVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 103 /03", "Code DCI": "13P103", "Forme": "GLES.", "Dosage": "100MG", "Conditionnement": "B/100", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZIDOVIR 10MG/ML (50MG/5ML) SOL BUV  B/1FL 100ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ZIDOVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZIDOVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 274 /05", "Code DCI": "13P274", "Forme": "SOL. BUV.", "Dosage": "10MG/ML (50MG/5ML)", "Conditionnement": "B/1FL 100ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZIDOVIR 300MG COMP. PELL.  B/40 ET B/60", "Img": "https://pharmnet-dz.com//img/medics/447.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ZIDOVUDINE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZIDOVIR", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "182/ 13 P 288 /05", "Code DCI": "13P288", "Forme": "COMP. PELLI.", "Dosage": "300MG", "Conditionnement": " B/40 ET B/60", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZIMOR 20MG GLES. A MICROG. GASTRORESIST. B/14 ET B/28", "Img": "https://pharmnet-dz.com//img/medics/3849.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3849", "Laboratoire": " MERINAL", "C.Pharmacologique": " ANTI-ULCEREUX & ANTI-H2", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " OMEPRAZOLE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ZIMOR", "Tarif de reference": "196 DA", "PPA": "N/A", "Num Enregistrement": "268/ 10 A 001 /98/09", "Code DCI": "10A001", "Forme": "GLES. A MICROG. GASTRORESIST.", "Dosage": "20MG", "Conditionnement": "B/14 ET B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZINACEF 750MG** PDRE .SOL.INJ. IM/I.V B/5FL", "Img": "https://pharmnet-dz.com//img/medics/711.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=711", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME SODIQUE EXPRIME EN CEFUROXIME", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ZINACEF", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "112/ 13 B 210 /00", "Code DCI": "13B210", "Forme": "PDRE. SOL. INJ.", "Dosage": "750MG**", "Conditionnement": "B/5FL", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZINNAT 125MG COMP. B/14", "Img": "https://pharmnet-dz.com//img/medics/702.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=702", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME AXETIL EXPRIME EN CEFUROXIME", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ZINNAT", "Tarif de reference": "0 DA", "PPA": "653.00 DA", "Num Enregistrement": "112/ 13 B 207 /00", "Code DCI": "13B207", "Forme": "COMP.", "Dosage": "125MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZINNAT 125MG/5ML SUSP. BUV. FL/70ML", "Img": "https://pharmnet-dz.com//img/medics/723.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=723", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME AXETIL", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ZINNAT", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "112/ 13 B 224 /00", "Code DCI": "13B224", "Forme": "SUSP. BUV.", "Dosage": "125MG/5ML", "Conditionnement": "FL/70ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZINNAT 250MG COMP. B/14", "Img": "https://pharmnet-dz.com//img/medics/706.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=706", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME ", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ZINNAT", "Tarif de reference": "555.66 DA", "PPA": "537.00 DA", "Num Enregistrement": "112/ 13 B 208 /00", "Code DCI": "13B208", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZINOXIME 1,5G/FL. DE PDRE.** PDRE SOL INJ IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME SODIQUE EXPRIME EN CEFUROXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZINOXIME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 211 /02/09", "Code DCI": "13B211", "Forme": "PDRE. SOL. INJ.", "Dosage": "1,5G/FL. DE PDRE.**", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZINOXIME 750MG/FL. DE PDRE.** PDRE.SOL.INJ.IM/IV B/1FL. DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " EL KENDI", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME SODIQUE EXPRIME EN CEFUROXIME", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZINOXIME", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "352/ 13 B 210 /01/09", "Code DCI": "13B210", "Forme": "PDRE. SOL. INJ.", "Dosage": "750MG/FL. DE PDRE.**", "Conditionnement": "B/1FL. DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZINOXIMOR 250MG COMP. PELLI. B/10", "Img": "https://pharmnet-dz.com//img/medics/707.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=707", "Laboratoire": " TABUK ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME ", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "ZINOXIMOR", "Tarif de reference": "555.66 DA", "PPA": " DA", "Num Enregistrement": "173/ 13 B 208 /06", "Code DCI": "13B208", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZINOXIMOR 500MG COMP. PELLI. B/14", "Img": "https://pharmnet-dz.com//img/medics/742.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=742", "Laboratoire": " TABUK ", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFUROXIME AXETIL", "Liste": "Liste I", "Pays": "ARABIE SAOUDITE", "Nom Commercial": "ZINOXIMOR", "Tarif de reference": "1111.32 DA", "PPA": "N/A", "Num Enregistrement": "173/ 13 B 296 /06", "Code DCI": "13B296", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/14", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZITHROMAX 500MG COMP. PELLI. SEC.  B/03", "Img": "https://pharmnet-dz.com//img/medics/839.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=839", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZITHROMAX", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "045/ 13 E 299 /06/13", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOBONE 4MG/FL. DE LYOPH. LYOPH. P. SOL. INJ. IV B/01FL. DE LYOPH. DE CONTENANCE DE 5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " ACIDE ZOLEDRONIQUE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZOBONE", "Tarif de reference": "12140 DA", "PPA": "N/A", "Num Enregistrement": "330/ 05 F 123 /12", "Code DCI": "05F123", "Forme": "SOL. PERF.", "Dosage": "4MG/FL. DE LYOPH.", "Conditionnement": "B/01FL. DE LYOPH. DE CONTENANCE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZODID 50MG GLES. B/30", "Img": "https://pharmnet-dz.com//img/medics/2672.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2672", "Laboratoire": " BIO-GALENIC", "C.Pharmacologique": " AUTRES ANALGESIQUES", "C.Therapeutique": " ANTALGIQUES", "Info": " TRAMADOL CHLORHYDRATE EXPRIME EN TRAMADOL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZODID", "Tarif de reference": "289.2 DA", "PPA": "N/A", "Num Enregistrement": "235/ 03 F 047 /10", "Code DCI": "03F047", "Forme": "GLES.", "Dosage": "50MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZODURA 1MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1163.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZODURA", "Tarif de reference": "270 DA", "PPA": "N/A", "Num Enregistrement": "352/ 25 B 041 /13", "Code DCI": "25B041", "Forme": "COMP.", "Dosage": "1MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZODURA 2MG COMP.  B/20", "Img": "https://pharmnet-dz.com//img/medics/1166.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZODURA", "Tarif de reference": "550 DA", "PPA": "N/A", "Num Enregistrement": "352/ 25 B 042 /13", "Code DCI": "25B042", "Forme": "COMP.", "Dosage": "2MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZODURA 4MG COMP. B/20", "Img": "https://pharmnet-dz.com//img/medics/1169.png", "Laboratoire": " EL KENDI", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZODURA", "Tarif de reference": "1100 DA", "PPA": "N/A", "Num Enregistrement": "352/ 25 B 043 /13", "Code DCI": "25B043", "Forme": "COMP.", "Dosage": "4MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOFER 2MG/ML (OU 4MG/2ML ET 8MG/4ML) SOL. INJ. IV B/5AMP. 2ML  - B/5AMP. DE 4ML ", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SUN PHARMACEUTICAL INDUSTRIES LTD", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZOFER", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "330/ 10 F 048 /08", "Code DCI": "10F048", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (OU 4MG/2ML ET 8MG/4ML)", "Conditionnement": "B/5AMP. 2ML  - B/5AMP. DE 4ML ", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOLADEX 10,8MG IMPLANT S.C. EN SERINGUE PRE REMPLIE B/01 SERINGUE AVEC SYST\u00c8ME DE SECURITE", "Img": "https://pharmnet-dz.com//img/medics/3793.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3793", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " GOSERELINE ACETATE EXPRIME EN GOSERELINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZOLADEX", "Tarif de reference": "0 DA", "PPA": "47191.00 DA", "Num Enregistrement": "256/ 09 J 138 /05/15", "Code DCI": "09J138", "Forme": "IMPLANT", "Dosage": "10,8MG", "Conditionnement": "B/01 SERINGUE AVEC SYST\u00c8ME DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLADEX 3,6MG IMPLANT S.C. EN SERINGUE PRE REMPLIE B/01 SERINGUE AVEC SYST\u00c8ME DE SECURITE", "Img": "https://pharmnet-dz.com//img/medics/3789.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=3789", "Laboratoire": " ASTRAZENECA", "C.Pharmacologique": " HORMONES HYPOTHALAMIQUES & HYPOPHYSAIRES", "C.Therapeutique": " ENDOCRINOLOGIE ET HORMONES", "Info": " GOSERELINE ACETATE EXPRIME EN GOSERELINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZOLADEX", "Tarif de reference": "0 DA", "PPA": "16150.00 DA", "Num Enregistrement": "256/ 09 J 095 /99/15", "Code DCI": "09J095", "Forme": "IMPLANT", "Dosage": "3,6MG", "Conditionnement": "B/01 SERINGUE AVEC SYST\u00c8ME DE SECURITE", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLAMIDE + 20MG/5MG/ML COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE / TIMOLOL MALEATE EXPRIME EN TIMOLOL", "Liste": "Liste I", "Pays": "ARGENTINE", "Nom Commercial": "ZOLAMIDE +", "Tarif de reference": "00 DA", "PPA": "N/A", "Code DCI": "17C141", "Forme": "COLLY. SOL.", "Dosage": "20MG/5MG/ML ", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLAMIDE 2% (20MG/ML) COLLY. EN SOL. FL./5ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4665", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " ANTI-GLAUCOMATEUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " DORZOLAMIDE CHLORHYDRATE EXPRIME EN DORZOLAMIDE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLAMIDE", "Tarif de reference": "0 DA", "PPA": "N/A", "Num Enregistrement": "065/17C121/17", "Code DCI": "17C121", "Forme": "COLLY. SOL.", "Dosage": "2% (20MG/ML)", "Conditionnement": "FL./5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLAMPINE 10MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLAMPINE", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 D 100 /08", "Code DCI": "16D100", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLAMPINE 10MG COMP. ORODISPERS. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLAMPINE", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 D 101 /10", "Code DCI": "16D101", "Forme": "COMP. ORODISPERS.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLAMPINE 5MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " OLANZAPINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLAMPINE", "Tarif de reference": "3510 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 D 099 /08", "Code DCI": "16D099", "Forme": "COMP. PELLI.", "Dosage": "5MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLDRIA 4MG/FL. DE PDRE. LYOPH. ET SOLV. P. SOL. A DILUER P. PERF. IV B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " CANCEROLOGIE", "C.Therapeutique": " ACIDE ZOLEDRONIQUE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZOLDRIA", "Tarif de reference": "12140 DA", "PPA": "12899.00 DA", "Num Enregistrement": "182/ 05 F 123 /10", "Code DCI": "05F123", "Forme": "SOL. PERF.", "Dosage": "4MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLDRIA 4MG/FL. DE PDRE. LYOPH. ET SOLV. P. SOL. A DILUER P. PERF. IV B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI)", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " CIPLA LIMITED ", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " ACIDE ZOLEDRONIQUE MONOHYDRATEE EXPRIME EN ACIDE ZOLEDRONIQUE ANHYDRE", "Liste": "Liste I", "Pays": "INDE", "Nom Commercial": "ZOLDRIA", "Tarif de reference": "12140 DA", "PPA": "N/A", "Num Enregistrement": "128/05F123/10/16", "Code DCI": "05F123", "Forme": "PDRE. SOL. INJ.", "Dosage": "4MG/FL. DE PDRE.", "Conditionnement": "B/1FL. DE PDRE. + 1AMP. DE 5ML DE SOLV. (EPPI)", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLENAT 4MG/FL. DE CONC. SOL. CONC. P. PERF. IV B/01FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/1081.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " MUSTAFA NEVZAT", "C.Pharmacologique": " A.T.U.(AUTORISATION TEMPORAIRE D'UTILISATION )", "C.Therapeutique": " CANCEROLOGIE", "Info": " ACIDE ZOLEDRONIQUE", "Liste": "Liste I", "Pays": "TURQUIE", "Nom Commercial": "ZOLENAT", "Tarif de reference": "12140 DA", "PPA": "12141.00 DA", "Num Enregistrement": "176/ 05 F 123 /12", "Code DCI": "05F123", "Forme": "SOL. PERF.", "Dosage": "4MG/FL. DE CONC.", "Conditionnement": "B/01FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLIDRATE 10MG COMP. PELLI. SEC. B/20", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " GENERIC LAB", "C.Pharmacologique": " HYPNOTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ZOLPIDEM", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLIDRATE", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "065/ 16 C 095 /14", "Code DCI": "16C095", "Forme": "COMP. PELLI.", "Dosage": "10MG", "Conditionnement": "B/20", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOLIDRO 0,8MG/ML (4MG/5ML) SOL. A DILUER P. PERF. IV B/01 FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/1082.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=998", "Laboratoire": " FRATER RAZES ", "C.Pharmacologique": " DIVERS", "C.Therapeutique": " CANCEROLOGIE", "Info": " ACIDE ZOLEDRONIQUE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLIDRO", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "433/ 05 F 123 /15", "Code DCI": "05F123", "Forme": "SOL. PERF.", "Dosage": "0,8MG/ML (4MG/5ML)", "Conditionnement": "B/01 FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLIFY 10MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/2287.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLIFY", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "263/ 16 D 103 /14", "Code DCI": "16D103", "Forme": "COMP.", "Dosage": "10MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLIFY 15MG COMP. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLIFY", "Tarif de reference": "7020 DA", "PPA": "N/A", "Num Enregistrement": "263/16D104/16", "Code DCI": "16D104", "Forme": "COMP.", "Dosage": "15MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOLIFY 20MG COMP B/30", "Img": "https://pharmnet-dz.com//img/medics/2327.png", "Laboratoire": " BIOPHARM", "C.Pharmacologique": " NEUROLEPTIQUES", "C.Therapeutique": " PSYCHIATRIE", "Info": " ARIPIPRAZOLE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLIFY", "Tarif de reference": " N/A", "PPA": "6510.00 DA", "Num Enregistrement": "263/ 16 D 161 /14", "Code DCI": "16D161", "Forme": "COMP.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOLOFT 50MG  GLES. B/14 ", "Img": "https://pharmnet-dz.com//img/medics/2562.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2562", "Laboratoire": " PFIZER PHARM ALGERIE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOLOFT", "Tarif de reference": "0 DA", "PPA": "602.00 DA", "Num Enregistrement": "045/ 16 A 099 /99/11", "Code DCI": "16A099", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "B/14 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOMAX 40MG/ML** (200MG/5ML ET 300MG/7,5ML)** PDRE. P. SUSP. BUV. B/1FL. DE 15ML APRES RECONSTIT. (200MG/5ML)+UNE AMP. D'EAU PURIFIEE + UNE CUILLERE MESURE DE 5ML ET  B/1FL. DE 22,5ML APRES RECONSTIT.(300MG/7,5ML)+UNE AMP. D'EAU PURIFIEE + UNE CUILLERE MES", "Img": "https://pharmnet-dz.com//img/medics/805.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=805", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ZOMAX", "Tarif de reference": "648 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 E 177 /05/11", "Code DCI": "13E177", "Forme": "PDRE. SOL. BUV.", "Dosage": "40MG/ML** (200MG/5ML ET 300MG/7,5ML)**", "Conditionnement": "B/1FL. DE 15ML APRES RECONSTIT. (200MG/5ML)+UNE AMP. D'EAU PURIFIEE + UNE CUILLERE MESURE DE 5ML ET  B/1FL. DE 22,5ML APRES RECONSTIT.(300MG/7,5ML)+UNE AMP. D'EAU PURIFIEE + UNE CUILLERE MESURE DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOMAX 500MG COMP. B/03 ", "Img": "https://pharmnet-dz.com//img/medics/840.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=840", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ZOMAX", "Tarif de reference": "549.96 DA", "PPA": "N/A", "Num Enregistrement": "001/ 13 E 299 /07", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03 ", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOMETA 0,8MG/ML (4MG/5ML) SOL. A DILUER PERF.IV B/01FL. DE 5ML", "Img": "https://pharmnet-dz.com//img/medics/1083.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1083", "Laboratoire": " NOVARTIS PHARAM", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " ACIDE ZOLEDRONIQUE", "Liste": "Liste I", "Pays": "SUISSE", "Nom Commercial": "ZOMETA", "Tarif de reference": "12140 DA", "PPA": " DA", "Num Enregistrement": "068/ 05 F 123 /08", "Code DCI": "05F123", "Forme": "SOL. PERF.", "Dosage": "0,8MG/ML (4MG/5ML)", "Conditionnement": "B/01FL. DE 5ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOPHREN 2MG/ML (OU 4MG/2ML ET 8MG/4ML) SOL .INJ. B/5AMP  2ML ET 4ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=2886", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " MEDICAMENTS DE LA MOTRICITE DIGESTIVE", "C.Therapeutique": " GASTRO-ENTEROLOGIE", "Info": " ONDANSETRON", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZOPHREN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "262/ 10 F 048 /00", "Code DCI": "10F048", "Forme": "SOL. INJ.", "Dosage": "2MG/ML (OU 4MG/2ML ET 8MG/4ML)", "Conditionnement": "B/5AMP  2ML ET 4ML", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOSTINE 20MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1549.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1549", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOSTINE", "Tarif de reference": "1247.4 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 M 136 /01/10", "Code DCI": "06M136", "Forme": "COMP. PELLI.", "Dosage": "20MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOSTINE 40MG COMP. PELLI. B/30", "Img": "https://pharmnet-dz.com//img/medics/1575.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1575", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " HYPOLIPIDEMIANTS", "C.Therapeutique": " CARDIOLOGIE ET ANGEIOLOGIE", "Info": " SIMVASTATINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOSTINE", "Tarif de reference": "1980 DA", "PPA": "N/A", "Num Enregistrement": "035/ 06 M 203 /06", "Code DCI": "06M203", "Forme": "COMP. PELLI.", "Dosage": "40MG", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOTRIX 250MG COMP. PELLI. B/06", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOTRIX", "Tarif de reference": " N/A", "PPA": "549.00 DA", "Num Enregistrement": "035/ 13 E 176 /15", "Code DCI": "13E176", "Forme": "COMP. PELLI.", "Dosage": "250MG", "Conditionnement": "B/06", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOTRIX 40MG/ML PDRE. P. SUSP. BUV. B/01 FL. DE 15ML DE SUSP. BUV. APRES RECONSTITUTION + 01 PIPETTE GRADUEE", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOTRIX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "035/ 13 E 177 /15", "Code DCI": "13E177", "Forme": "PDRE. SOL. BUV.", "Dosage": "40MG/ML", "Conditionnement": "B/01 FL. DE 15ML DE SUSP. BUV. APRES RECONSTITUTION + 01 PIPETTE GRADUEE", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOTRIX 500MG COMP. PELLI. SEC. B/03", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " PHARMALLIANCE", "C.Pharmacologique": " MACROLIDES & SYNERGISTINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " AZITHROMYCINE DIHYDRATE EXPRIME EN AZITHROMYCINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOTRIX", "Tarif de reference": " N/A", "PPA": "549.00 DA", "Num Enregistrement": "035/ 13 E 299 /15", "Code DCI": "13E299", "Forme": "COMP. PELLI.", "Dosage": "500MG", "Conditionnement": "B/03", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOTROP 50MG  GLES. B/30", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " SAIDAL GROUPE", "C.Pharmacologique": " ANTIDEPRESSEURS", "C.Therapeutique": " PSYCHIATRIE", "Info": " SERTRALINE CHLORHYDRATE EXPRIME EN SERTRALINE", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZOTROP", "Tarif de reference": "1290 DA", "PPA": "N/A", "Num Enregistrement": "003/ 16 A 099 /09", "Code DCI": "16A099", "Forme": "GLES.", "Dosage": "50MG ", "Conditionnement": "B/30", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOVIRAX 0.03 PDE OPHT T/4,5 G", "Img": "https://pharmnet-dz.com//img/medics/1969.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1969", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTIVIRAUX LOCAUX", "C.Therapeutique": " OPHTALMOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZOVIRAX", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 17 F 042 /98", "Code DCI": "17F042", "Forme": "PDE. OPHT.", "Dosage": "0.03", "Conditionnement": "T/4,5 G", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOVIRAX 250MG  PDRE.SOL.INJ. B/1FL", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=422", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTIVIRAUX", "C.Therapeutique": " INFECTIOLOGIE", "Info": " ACICLOVIR", "Liste": "Liste I", "Pays": "ROYAUME UNI", "Nom Commercial": "ZOVIRAX", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "112/ 13 P 098 /99", "Code DCI": "13P098", "Forme": "PDRE. SOL. INJ.", "Dosage": "250MG ", "Conditionnement": "B/1FL", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZOXAN LP 4MG COMP. LP B/28", "Img": "https://pharmnet-dz.com//img/medics/1183.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1183", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZOXAN LP", "Tarif de reference": "1540 DA", "PPA": " DA", "Num Enregistrement": "045/ 25 B 061 /13", "Code DCI": "25B061", "Forme": "COMP. LP", "Dosage": "4MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOXAN LP 8MG COMP. LP B/28", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1184", "Laboratoire": " PFIZER HOLDING FRANCE", "C.Pharmacologique": " MEDICAMENTS DE L'ADENOME PROSTATIQUE", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " DOXAZOSINE MESILATE EXPRIME EN DOXAZOSINE", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZOXAN LP", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "045/ 25 B 067 /13", "Code DCI": "25B067", "Forme": "COMP. LP", "Dosage": "8MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZOXIN 1G** PDRE. SOL. INJ. IM/IV B/1FL DE PDRE.", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=896", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " CEPHALOSPORINES", "C.Therapeutique": " INFECTIOLOGIE", "Info": " CEFOTAXIME SODIQUE", "Liste": "Liste I", "Pays": "JORDANIE", "Nom Commercial": "ZOXIN", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 13 B 327 /08", "Code DCI": "13B327", "Forme": "PDRE. SOL. INJ.", "Dosage": "1G**", "Conditionnement": "B/1FL DE PDRE.", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZYDENA 100MG  COMP PELL SEC  B/2", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " AUTRES", "C.Therapeutique": " UROLOGIE ET NEPHROLOGIE", "Info": " UDENAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZYDENA", "Tarif de reference": " N/A", "PPA": "N/A", "Num Enregistrement": "001/ 25 N 070 /14", "Code DCI": "25N070", "Forme": "COMP. PELLI.", "Dosage": "100MG ", "Conditionnement": "B/2", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZYDENA 200MG COMP PELL SECABLE B/2", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=4644", "Laboratoire": " HIKMA PHARMACEUTICALS", "C.Pharmacologique": " N/D", "C.Therapeutique": " N/D", "Info": " UDENAFIL", "Liste": "Liste I", "Pays": "ALGERIE", "Nom Commercial": "ZYDENA", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "001/25N071/16", "Code DCI": "N/D", "Forme": "COMP. SEC.", "Dosage": "200MG", "Conditionnement": "B/2", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZYLORIC 100MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/1397.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1397", "Laboratoire": " ASPEN PHARMA TRADING LIMITED", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "IRELAND", "Nom Commercial": "ZYLORIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "467/ 21 B 007 /98/14", "Code DCI": "21B007", "Forme": "COMP.", "Dosage": "100MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZYLORIC 300MG COMP. B/28", "Img": "https://pharmnet-dz.com//img/medics/1401.png", "Notice": "https://pharmnet-dz.com//notice.ashx?id=1452", "Laboratoire": " GLAXO SMITHKLINE", "C.Pharmacologique": " ANTIGOUTTEUX", "C.Therapeutique": " RHUMATOLOGIE", "Info": " ALLOPURINOL", "Liste": "Liste I", "Pays": "FRANCE", "Nom Commercial": "ZYLORIC", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "262/ 21 B 008 /98", "Code DCI": "21B008", "Forme": "COMP.", "Dosage": "300MG", "Conditionnement": "B/28", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZYRTEC 10MG/ML SOL BUV.GTTES B/01FL COMPTE GTTES DE 15ML", "Img": "https://pharmnet-dz.com//img/medic.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=4025", "Laboratoire": " UCB PHARMA", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "FRANCE", "Nom Commercial": "ZYRTEC", "Tarif de reference": "240.15 DA", "PPA": "348.00 DA", "Num Enregistrement": "046/ 01 A 041 /02", "Code DCI": "01A041", "Forme": "SOL. BUV. GTTES.", "Dosage": "10MG/ML", "Conditionnement": "B/01FL COMPTE GTTES DE 15ML", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZYRTIRIZINE 10MG COMP. PELLI. SEC B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " HUP.P.PHARMA SARL", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ZYRTIRIZINE", "Tarif de reference": " DA", "PPA": "N/A", "Num Enregistrement": "380/01A003/16", "Code DCI": "01A003", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": null}, {"Nom": "ZYTIGA 250MG COMP. B/1FL. DE 120", "Img": "https://pharmnet-dz.com//img/medics/1074.png", "Notice": "https://pharmnet-dz.com/notice.ashx?id=1074", "Laboratoire": " JANSSEN CILAG", "C.Pharmacologique": " N/D", "C.Therapeutique": " CANCEROLOGIE", "Info": " ABIRATERONE ACETATE", "Liste": "Liste I", "Pays": "BELGIQUE", "Nom Commercial": "ZYTIGA", "Tarif de reference": "0 DA", "PPA": " DA", "Num Enregistrement": "095/ 05 E 162 /13 ", "Code DCI": "05E162", "Forme": "COMP.", "Dosage": "250MG", "Conditionnement": "B/1FL. DE 120", "Commercialisation": true, "Remboursable": true}, {"Nom": "ZYTREX 10MG COM SECABLE B/10", "Img": "https://pharmnet-dz.com//img/medic.png", "Laboratoire": " LAM (LABORATOIRE ALGERIEN DU MEDICAMENT)", "C.Pharmacologique": " ANTIHISTAMINIQUES", "C.Therapeutique": " ALLERGOLOGIE", "Info": " CETIRIZINE DICHLORHYDRATE", "Liste": "Liste II", "Pays": "ALGERIE", "Nom Commercial": "ZYTREX", "Tarif de reference": "0 DA", "PPA": "0 DA", "Num Enregistrement": "077/01A003/17", "Code DCI": "01A003", "Forme": "COMP. SEC.", "Dosage": "10MG", "Conditionnement": "B/10", "Commercialisation": true, "Remboursable": true}]}